Citrus Sinensis ID: 037681
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LW83 | 850 | G-type lectin S-receptor- | yes | no | 0.667 | 0.262 | 0.672 | 3e-89 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.826 | 0.337 | 0.572 | 1e-88 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.730 | 0.287 | 0.625 | 9e-88 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.763 | 0.302 | 0.592 | 2e-84 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.709 | 0.284 | 0.605 | 1e-83 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.655 | 0.267 | 0.657 | 1e-81 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.826 | 0.325 | 0.552 | 8e-81 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.655 | 0.260 | 0.634 | 1e-80 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.658 | 0.268 | 0.636 | 3e-80 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.889 | 0.351 | 0.507 | 8e-80 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 328 bits (841), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 150/223 (67%), Positives = 189/223 (84%)
Query: 59 ELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKN 118
EL +FSF SVA AT+ FSD NKLGEGGFGPVYKG L G+E+A+KRLS+ S QGL E KN
Sbjct: 511 ELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKN 570
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
EA++IAK+QH NLV+LLGCC+E+DEK+LIYEY+PNKSLD+FLFD ++++L+ R +I+
Sbjct: 571 EAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIM 630
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
EGI++GLLYLH +SR+++IHRD+KA NILLD++M PKISDFGMARIF ESKANT RVA
Sbjct: 631 EGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVA 690
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYH 281
GTFGY+ PEY +G+ S KSDVFSFG+L+LEI+ G+KN F+H
Sbjct: 691 GTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHH 733
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 327 bits (837), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 161/281 (57%), Positives = 217/281 (77%), Gaps = 5/281 (1%)
Query: 1 MVSLIFVNLVIVAFYLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVEL 60
+VS++F+ L ++ F RR L + + + D M L+ I+ S ++R K EL
Sbjct: 427 LVSMVFL-LTMIGFIRRRILSLRFGSTI--DQEMLLRELGIDRS--CIHKRNERKSNNEL 481
Query: 61 PLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEA 120
+FSF SV +AT++FSD NKLGEGGFGPVYKG L G+E+A+KRLS+ S QGL E KNEA
Sbjct: 482 QIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNEA 541
Query: 121 LVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEG 180
++IAK+QH NLV++LGCCIE+DEK+LIYEY+ NKSLD+FLFD ++ +L+ R +I+EG
Sbjct: 542 ILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIMEG 601
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
I++GLLYLH +SR+++IHRD+KASNILLD++M PKISDFG+ARIF E++ANT RVAGT
Sbjct: 602 IIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRANTKRVAGT 661
Query: 241 FGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYH 281
FGY+ PEY +G+ S KSDVFSFG+L+LEI+ G+KN F+H
Sbjct: 662 FGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHH 702
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 9e-88, Method: Compositional matrix adjust.
Identities = 157/251 (62%), Positives = 194/251 (77%), Gaps = 7/251 (2%)
Query: 40 DIELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDE 99
DI + KA N ELP+FS +++A ATN+F N+LG GGFGPVYKGVL G E
Sbjct: 501 DIMIEGKAVNTS-------ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGRE 553
Query: 100 IAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFF 159
IAVKRLS +S QG+ E KNE ++IAK+QH+NLVRLLGCC E +EK+L+YEY+PNKSLDFF
Sbjct: 554 IAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFF 613
Query: 160 LFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDF 219
LFD TK+ L++ R IIEGI GLLYLH SR+RIIHRDLK SN+LLD EM PKISDF
Sbjct: 614 LFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDF 673
Query: 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEF 279
GMARIF GN+++ANT RV GT+GY+ PEY +G+ S+KSDV+SFG+LLLEI+SGK+NT
Sbjct: 674 GMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL 733
Query: 280 YHTGYLSINGY 290
+ + S+ GY
Sbjct: 734 RSSEHGSLIGY 744
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 157/265 (59%), Positives = 197/265 (74%), Gaps = 10/265 (3%)
Query: 36 LKADDIELSNKANNRRKSTK----------REVELPLFSFSSVAAATNNFSDTNKLGEGG 85
K DI +S+ NR S+ +LP+FSF SVA+AT +F++ NKLG+GG
Sbjct: 476 WKKKDITVSDIIENRDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGG 535
Query: 86 FGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145
FG VYKG ++G EIAVKRLS +S+QGL+E KNE L+IAK+QH+NLVRLLGCCIE +EK+
Sbjct: 536 FGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKM 595
Query: 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASN 205
L+YEY+PNKSLD FLFD +K+ L+ R ++I GI GLLYLH SR++IIHRDLKASN
Sbjct: 596 LLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASN 655
Query: 206 ILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGM 265
ILLD EM PKISDFGMARIF + ANT RV GT+GY+ PEY +GI S KSDV+SFG+
Sbjct: 656 ILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGV 715
Query: 266 LLLEILSGKKNTEFYHTGYLSINGY 290
L+LEI+SG+KN F T + S+ GY
Sbjct: 716 LILEIVSGRKNVSFRGTDHGSLIGY 740
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 152/251 (60%), Positives = 188/251 (74%), Gaps = 14/251 (5%)
Query: 30 FDLSMNLKADDIELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPV 89
FD S + D KA NR ELPLF +++ AATNNFS NKLG GGFGPV
Sbjct: 484 FDESFRFEQD------KARNR--------ELPLFDLNTIVAATNNFSSQNKLGAGGFGPV 529
Query: 90 YKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149
YKGVL EIAVKRLS S QG++E KNE +I+K+QH+NLVR+LGCC+E +EK+L+YE
Sbjct: 530 YKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYE 589
Query: 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD 209
YLPNKSLD+F+F +R L+ R++I+ GI G+LYLH SR+RIIHRDLKASNILLD
Sbjct: 590 YLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLD 649
Query: 210 KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLE 269
EM PKISDFGMARIF GN+ + T+RV GTFGY+ PEY +G SIKSDV+SFG+L+LE
Sbjct: 650 SEMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLE 709
Query: 270 ILSGKKNTEFY 280
I++GKKN+ F+
Sbjct: 710 IITGKKNSAFH 720
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (776), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 144/219 (65%), Positives = 178/219 (81%)
Query: 59 ELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKN 118
ELPLF F +AAATNNFS NKLG+GGFGPVYKG L +G EIAVKRLS S QGL+EL N
Sbjct: 493 ELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVN 552
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
E +VI+K+QH+NLV+LLGCCI +E++L+YE++P KSLD++LFD+ + LL+ TR II
Sbjct: 553 EVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNII 612
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
GI GLLYLH SR+RIIHRDLKASNILLD+ + PKISDFG+ARIF GNE +ANT RV
Sbjct: 613 NGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVV 672
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNT 277
GT+GY+ PEY G+ S KSDVFS G++LLEI+SG++N+
Sbjct: 673 GTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNS 711
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 8e-81, Method: Compositional matrix adjust.
Identities = 157/284 (55%), Positives = 196/284 (69%), Gaps = 8/284 (2%)
Query: 4 LIFVNLVIVAFYLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKRE-----V 58
L+ ++ +I F+ R++ +S + DL +++ D ++ R T +E +
Sbjct: 450 LLLLSFIIFHFWKRKQKRSITIQTPIVDL---VRSQDSLMNELVKASRSYTSKENKTDYL 506
Query: 59 ELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKN 118
ELPL + ++A ATNNFS NKLG+GGFG VYKG+L G EIAVKRLS S QG E N
Sbjct: 507 ELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMN 566
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
E +IAK+QH NLVRLLGCC+++ EK+LIYEYL N SLD LFD T+ L R II
Sbjct: 567 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 626
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
GI GLLYLH SR RIIHRDLKASN+LLDK M PKISDFGMARIF E++ANT RV
Sbjct: 627 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 686
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT 282
GT+GY+ PEY GI S+KSDVFSFG+LLLEI+SGK+N FY++
Sbjct: 687 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 730
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 300 bits (767), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 139/219 (63%), Positives = 178/219 (81%)
Query: 59 ELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKN 118
ELPLF F +A +T++FS NKLG+GGFGPVYKG L +G EIAVKRLS +S QGL+EL N
Sbjct: 508 ELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMN 567
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
E +VI+K+QH+NLV+LLGCCIE +E++L+YEY+P KSLD +LFD K+ +L+ TR I+
Sbjct: 568 EVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIM 627
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
EGI GLLYLH SR++IIHRDLKASNILLD+ + PKISDFG+ARIF+ NE +ANT RV
Sbjct: 628 EGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVV 687
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNT 277
GT+GY+ PEY +G S KSDVFS G++ LEI+SG++N+
Sbjct: 688 GTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNS 726
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (764), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 140/220 (63%), Positives = 177/220 (80%)
Query: 59 ELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKN 118
ELPLF F +A AT+NFS +NKLG+GGFGPVYKG+L +G EIAVKRLS S QGL+EL
Sbjct: 493 ELPLFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQASGQGLEELVT 552
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
E +VI+K+QH+NLV+L GCCI +E++L+YE++P KSLDF++FD + LL+ TR +II
Sbjct: 553 EVVVISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKLLDWNTRFEII 612
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
GI GLLYLH SR+RIIHRDLKASNILLD+ + PKISDFG+ARIF GNE +ANT RV
Sbjct: 613 NGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVV 672
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTE 278
GT+GY+ PEY G+ S KSDVFS G++LLEI+SG++N+
Sbjct: 673 GTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNSH 712
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 297 bits (760), Expect = 8e-80, Method: Compositional matrix adjust.
Identities = 163/321 (50%), Positives = 223/321 (69%), Gaps = 24/321 (7%)
Query: 1 MVSLI-FVNLVIVAF--YLRRKLKSKGENLML----------FDLSMNLKADDIELSNKA 47
++SLI V L++++F YLR++ + N + FDL + + EL +K+
Sbjct: 446 LISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFILE--ELEDKS 503
Query: 48 NNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSV 107
+R ELPLF S++A ATNNF+ NKLG GGFGPVYKGVL G EIAVKRLS
Sbjct: 504 RSR--------ELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSK 555
Query: 108 RSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRV 167
S QG++E KNE +I+K+QH+NLVR+LGCC+E +EK+L+YEYLPNKSLD+F+F +R
Sbjct: 556 SSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRA 615
Query: 168 LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227
L+ R+ II GI G+LYLH SR+RIIHRDLKASN+LLD EM PKI+DFG+ARIF G
Sbjct: 616 ELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGG 675
Query: 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-LS 286
N+ + +TNRV GT+GY+ PEY G SIKSDV+SFG+L+LEI++GK+N+ FY L
Sbjct: 676 NQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFYEESLNLV 735
Query: 287 INGYDQTQVASKIKLVESCLA 307
+ +D+ + I++++ +
Sbjct: 736 KHIWDRWENGEAIEIIDKLMG 756
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | ||||||
| 356514857 | 834 | PREDICTED: G-type lectin S-receptor-like | 0.823 | 0.329 | 0.692 | 1e-108 | |
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.850 | 0.328 | 0.657 | 1e-101 | |
| 297742753 | 637 | unnamed protein product [Vitis vinifera] | 0.850 | 0.445 | 0.657 | 1e-101 | |
| 224138268 | 818 | predicted protein [Populus trichocarpa] | 0.901 | 0.367 | 0.598 | 2e-98 | |
| 224083014 | 273 | predicted protein [Populus trichocarpa] | 0.802 | 0.981 | 0.653 | 3e-98 | |
| 302143114 | 457 | unnamed protein product [Vitis vinifera] | 0.829 | 0.606 | 0.641 | 7e-98 | |
| 357516499 | 750 | S-locus receptor kinase [Medicago trunca | 0.871 | 0.388 | 0.584 | 8e-98 | |
| 359493701 | 958 | PREDICTED: G-type lectin S-receptor-like | 0.835 | 0.291 | 0.637 | 9e-98 | |
| 359493703 | 1658 | PREDICTED: uncharacterized protein LOC10 | 0.853 | 0.171 | 0.622 | 2e-97 | |
| 302143117 | 570 | unnamed protein product [Vitis vinifera] | 0.838 | 0.491 | 0.629 | 3e-97 |
| >gi|356514857|ref|XP_003526119.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1018), Expect = e-108, Method: Compositional matrix adjust.
Identities = 191/276 (69%), Positives = 230/276 (83%), Gaps = 1/276 (0%)
Query: 15 YLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFSFSSVAAATNN 74
Y R+ + KGE+L+ F +SM++K +D EL+ +A+ K K+EV+LPLFSF SVAAATNN
Sbjct: 454 YWTRRQRRKGEDLLRFHVSMSMKVEDSELA-EAHRGAKVKKKEVKLPLFSFVSVAAATNN 512
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRL 134
FSD NKLGEGGFGPVYKG+L GDE+AVKRLS RS QG +EL+NEAL+IAK+QH NLVRL
Sbjct: 513 FSDANKLGEGGFGPVYKGILLNGDEVAVKRLSRRSGQGWEELRNEALLIAKLQHNNLVRL 572
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
LGCCI+RDEK+LIYE +PNKSLD FLFDATKR +L+ GTR++II+GI +G+LYLH +SR
Sbjct: 573 LGCCIDRDEKMLIYELMPNKSLDVFLFDATKRRMLDWGTRVRIIDGIAQGILYLHQYSRF 632
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
RIIHRDLKASNILLD M PKISDFGMARIF NE +ANTNR+ GT+GY+ PEY +G+
Sbjct: 633 RIIHRDLKASNILLDTNMNPKISDFGMARIFGDNELQANTNRIVGTYGYMSPEYAMEGLF 692
Query: 255 SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY 290
SIKSDVFSFG+LLLEILSGKKNT FY T ++ GY
Sbjct: 693 SIKSDVFSFGVLLLEILSGKKNTGFYQTNSFNLLGY 728
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 375 bits (964), Expect = e-101, Method: Compositional matrix adjust.
Identities = 188/286 (65%), Positives = 228/286 (79%), Gaps = 2/286 (0%)
Query: 5 IFVNLVIVAFYLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFS 64
I V V + +RR+L+ KGENL+LFDLS + + ELS + + K+EV+LP+FS
Sbjct: 480 ISVTSAFVIWGIRRRLRRKGENLLLFDLSNSSVDTNYELS-ETSKLWSGEKKEVDLPMFS 538
Query: 65 FSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIA 124
F+SV+AATNNFS NKLGEGGFGPVYKG KG E+AVKRLS RS QG +ELKNE ++IA
Sbjct: 539 FASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEELKNEVMLIA 598
Query: 125 KVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
K+QHKNLV+L G CIE+DEK+LIYEY+PNKSLDFFLFD TK +L TR+ II+G+ +G
Sbjct: 599 KLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWKTRVHIIKGVAQG 658
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
LLYLH +SR+RIIHRDLKASNILLDK+M P+ISDFGMARIF GNESKA TN + GT+GY+
Sbjct: 659 LLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKA-TNHIVGTYGYM 717
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY 290
PEY +G+ S KSDVFSFG+LLLEILSGKKNT FY T L++ GY
Sbjct: 718 SPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGY 763
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 375 bits (962), Expect = e-101, Method: Compositional matrix adjust.
Identities = 188/286 (65%), Positives = 228/286 (79%), Gaps = 2/286 (0%)
Query: 5 IFVNLVIVAFYLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFS 64
I V V + +RR+L+ KGENL+LFDLS + + ELS + + K+EV+LP+FS
Sbjct: 252 ISVTSAFVIWGIRRRLRRKGENLLLFDLSNSSVDTNYELS-ETSKLWSGEKKEVDLPMFS 310
Query: 65 FSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIA 124
F+SV+AATNNFS NKLGEGGFGPVYKG KG E+AVKRLS RS QG +ELKNE ++IA
Sbjct: 311 FASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEELKNEVMLIA 370
Query: 125 KVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
K+QHKNLV+L G CIE+DEK+LIYEY+PNKSLDFFLFD TK +L TR+ II+G+ +G
Sbjct: 371 KLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWKTRVHIIKGVAQG 430
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
LLYLH +SR+RIIHRDLKASNILLDK+M P+ISDFGMARIF GNESKA TN + GT+GY+
Sbjct: 431 LLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKA-TNHIVGTYGYM 489
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY 290
PEY +G+ S KSDVFSFG+LLLEILSGKKNT FY T L++ GY
Sbjct: 490 SPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGY 535
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138268|ref|XP_002326560.1| predicted protein [Populus trichocarpa] gi|222833882|gb|EEE72359.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 365 bits (937), Expect = 2e-98, Method: Compositional matrix adjust.
Identities = 189/316 (59%), Positives = 236/316 (74%), Gaps = 15/316 (4%)
Query: 2 VSLIFVNLVIVAFYLRR-KLKSKGE-----NLMLFDLSMNLKADDIELSNKANNRRKSTK 55
V+LI L I YLR+ KL KGE NL+ FD + + + + +NRRK+
Sbjct: 429 VTLITFGLFIYCCYLRKSKLHHKGEEDTSENLLFFDFDTCPNSTN-NVPSSVDNRRKN-- 485
Query: 56 REVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQE 115
VELPLFS+ SV+A T FS +KLGEGGFGPVYKG L+ G E+AVKRLS RS QGL+E
Sbjct: 486 --VELPLFSYESVSAVTEQFS--HKLGEGGFGPVYKGKLSNGVEVAVKRLSKRSGQGLEE 541
Query: 116 LKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL 175
+NE +VIA++QH+NLVRLLGCCIERDEK+LIYEY+PNKSLDFFLFDA KR +L+ G+R+
Sbjct: 542 FRNETMVIARLQHRNLVRLLGCCIERDEKILIYEYMPNKSLDFFLFDANKRQILDWGSRV 601
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
+IIEGI +GLLYLH +SR+RIIHRDLK SNILLD EM PKISDFGMARIF +E++ANT
Sbjct: 602 RIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIFGDSETEANTK 661
Query: 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQV 295
++AGT+GY+ PEY G+ SIKSDVFSFG+LLLEI+SG+KNT FYH L++ G+
Sbjct: 662 KIAGTYGYMSPEYAMDGLFSIKSDVFSFGVLLLEIVSGRKNTGFYHRDSLNLLGHAWKSW 721
Query: 296 ASK--IKLVESCLARP 309
S + L++ L P
Sbjct: 722 NSSRALDLMDPVLGDP 737
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224083014|ref|XP_002335428.1| predicted protein [Populus trichocarpa] gi|222834155|gb|EEE72632.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 364 bits (934), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 177/271 (65%), Positives = 220/271 (81%), Gaps = 3/271 (1%)
Query: 23 KGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLG 82
KG +L+LFD + + + E S+ +NR+ + +ELPLFS+ SV+ AT FSD KLG
Sbjct: 6 KGHDLLLFDFDTDPSSTNKE-SSSVDNRKNRWSKNMELPLFSYESVSVATGQFSD--KLG 62
Query: 83 EGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD 142
EGGFGPVYKG L KG EIAVKRLS RS QGL+E +NE ++IAK+QH+NLVRLLG CIERD
Sbjct: 63 EGGFGPVYKGKLPKGLEIAVKRLSERSGQGLEEFRNETILIAKLQHRNLVRLLGSCIERD 122
Query: 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLK 202
EK+LIYE +PNKSLDFFLFDA + +L+ GTR++IIEGI +GLLYLH +SR+RIIHRDLK
Sbjct: 123 EKMLIYECMPNKSLDFFLFDANRGQILDWGTRIRIIEGIAQGLLYLHRYSRLRIIHRDLK 182
Query: 203 ASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFS 262
SNILLD EM PKISDFGMARIF+GNE++ANTNR+ GT+GY+ PEY +G+ SIKSDVFS
Sbjct: 183 PSNILLDSEMNPKISDFGMARIFRGNETQANTNRIVGTYGYMSPEYAMEGLFSIKSDVFS 242
Query: 263 FGMLLLEILSGKKNTEFYHTGYLSINGYDQT 293
FG+L+LEI+SGKKNT FYH+ L++ G+ T
Sbjct: 243 FGVLVLEIVSGKKNTSFYHSDSLNLLGHLWT 273
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143114|emb|CBI20409.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 363 bits (932), Expect = 7e-98, Method: Compositional matrix adjust.
Identities = 179/279 (64%), Positives = 225/279 (80%), Gaps = 2/279 (0%)
Query: 12 VAFYLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFSFSSVAAA 71
V + + + + KGE+L++FD + + EL + N + K+EV+LP+FSF+SV+A+
Sbjct: 80 VIYGIWGRFRRKGEDLLVFDFGNSSEDTSYELG-ETNRLWRGEKKEVDLPMFSFASVSAS 138
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
TNNFS NKLGEGGFG VYKG L +G E+AVKRLS RS+QG +ELKNEA++IAK+QHKNL
Sbjct: 139 TNNFSIENKLGEGGFGSVYKGKLQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNL 198
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
V++LG CIERDEK+LIYEY+ NKSLDFFLFD KR +L R++IIEG+ +GLLYLH +
Sbjct: 199 VKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWEMRVRIIEGVAQGLLYLHQY 258
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
SR+R+IHRDLKASNILLDK+M PKISDFGMARIF GNESKA T + GT+GY+ PEYV +
Sbjct: 259 SRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKHIVGTYGYMSPEYVLR 317
Query: 252 GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY 290
G+ S KSDVFSFG+LLLEILSGKK TEFYH+G L++ GY
Sbjct: 318 GLFSTKSDVFSFGVLLLEILSGKKITEFYHSGSLNLLGY 356
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357516499|ref|XP_003628538.1| S-locus receptor kinase [Medicago truncatula] gi|355522560|gb|AET03014.1| S-locus receptor kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 363 bits (931), Expect = 8e-98, Method: Compositional matrix adjust.
Identities = 187/320 (58%), Positives = 231/320 (72%), Gaps = 29/320 (9%)
Query: 15 YLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFSFSSVAAATNN 74
Y RK + KG++L+ F++ M +K D E++ KA+ K ++EV+LPLFS SV+AATNN
Sbjct: 348 YWTRKQRRKGDDLLNFEVGMTMKVKDSEIT-KADKGAKVRRKEVKLPLFSLVSVSAATNN 406
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRL 134
FSDT KLGEGGFGPVYKG L G E+A+KRLS S QG +EL+NEAL+IAK+QH NLVRL
Sbjct: 407 FSDTKKLGEGGFGPVYKGTLLNGGEVAIKRLSRISGQGWEELRNEALLIAKLQHNNLVRL 466
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLF--------------------------DATKRVL 168
LGCCIERDEK+LIYE++PNKSLDFF+F DA KR +
Sbjct: 467 LGCCIERDEKMLIYEFMPNKSLDFFIFGLYFSETKISILFNSNCSCDIFLFKTDAVKRRM 526
Query: 169 LELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228
L+ TR++II+GI +GLLYLH +SR RIIHRDLKASNILLD M PKISDFGMARIF N
Sbjct: 527 LDWETRVRIIDGIAQGLLYLHQYSRFRIIHRDLKASNILLDANMNPKISDFGMARIFGEN 586
Query: 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN 288
+ANTNR+ GT+GY+ PEY +G+ SIKSDVFSFG+LLLEI+SGKKNT FY T ++
Sbjct: 587 VLQANTNRIVGTYGYMSPEYAMEGVYSIKSDVFSFGVLLLEIISGKKNTGFYQTNSFNLL 646
Query: 289 GY--DQTQVASKIKLVESCL 306
GY D S + L++S L
Sbjct: 647 GYAWDLWTNNSGMDLIDSKL 666
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493701|ref|XP_002281280.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 363 bits (931), Expect = 9e-98, Method: Compositional matrix adjust.
Identities = 179/281 (63%), Positives = 225/281 (80%), Gaps = 2/281 (0%)
Query: 10 VIVAFYLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFSFSSVA 69
V + + + + KGE+L++FD + + EL + N + K+EV+LP+FSF+SV+
Sbjct: 438 AFVIYGIWGRFRRKGEDLLVFDFGNSSEDTSYELG-ETNRLWRGEKKEVDLPMFSFASVS 496
Query: 70 AATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHK 129
A+TNNFS NKLGEGGFG VYKG L +G E+AVKRLS RS+QG +ELKNEA++IAK+QHK
Sbjct: 497 ASTNNFSIENKLGEGGFGSVYKGKLQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHK 556
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
NLV++LG CIERDEK+LIYEY+ NKSLDFFLFD KR +L R++IIEG+ +GLLYLH
Sbjct: 557 NLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWEMRVRIIEGVAQGLLYLH 616
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
+SR+R+IHRDLKASNILLDK+M PKISDFGMARIF GNESKA T + GT+GY+ PEYV
Sbjct: 617 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKHIVGTYGYMSPEYV 675
Query: 250 YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY 290
+G+ S KSDVFSFG+LLLEILSGKK TEFYH+G L++ GY
Sbjct: 676 LRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSGSLNLLGY 716
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493703|ref|XP_002281224.2| PREDICTED: uncharacterized protein LOC100245158 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 362 bits (928), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 178/286 (62%), Positives = 225/286 (78%), Gaps = 1/286 (0%)
Query: 5 IFVNLVIVAFYLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFS 64
I + V V + + R+ + KGE+L++FD + + + + N + K+EV+LP+FS
Sbjct: 1273 ISLTSVFVNYGIWRRFRRKGEDLLVFDFGNSSEDTNCYELGETNRLWRDEKKEVDLPMFS 1332
Query: 65 FSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIA 124
F+SV+A+TNNF NKLGEGGFG VYKG +G E+AVKRLS RS+QG +ELKNEA++IA
Sbjct: 1333 FASVSASTNNFCIENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEELKNEAMLIA 1392
Query: 125 KVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
K+QHKNLV++LG CIERDEK+LIYEY+ NKSLDFFLFD KR +L TR+ IIEG+ +G
Sbjct: 1393 KLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWETRVHIIEGVAQG 1452
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
LLYLH +SR+R+IHRDLKASNILLDK+M PKISDFGMARIF GNESKA T + GT+GY+
Sbjct: 1453 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKHIVGTYGYM 1511
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY 290
PEYV +G+ S KSDVFSFG+LLLEILSGKK TEFYH+ L++ GY
Sbjct: 1512 SPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSDSLNLLGY 1557
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143117|emb|CBI20412.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 361 bits (927), Expect = 3e-97, Method: Compositional matrix adjust.
Identities = 177/281 (62%), Positives = 223/281 (79%), Gaps = 1/281 (0%)
Query: 10 VIVAFYLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFSFSSVA 69
V V + + R+ + KGE+L++FD + + + + N + K+EV+LP+FSF+SV+
Sbjct: 191 VFVNYGIWRRFRRKGEDLLVFDFGNSSEDTNCYELGETNRLWRDEKKEVDLPMFSFASVS 250
Query: 70 AATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHK 129
A+TNNF NKLGEGGFG VYKG +G E+AVKRLS RS+QG +ELKNEA++IAK+QHK
Sbjct: 251 ASTNNFCIENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHK 310
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
NLV++LG CIERDEK+LIYEY+ NKSLDFFLFD KR +L TR+ IIEG+ +GLLYLH
Sbjct: 311 NLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWETRVHIIEGVAQGLLYLH 370
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
+SR+R+IHRDLKASNILLDK+M PKISDFGMARIF GNESKA T + GT+GY+ PEYV
Sbjct: 371 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKHIVGTYGYMSPEYV 429
Query: 250 YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY 290
+G+ S KSDVFSFG+LLLEILSGKK TEFYH+ L++ GY
Sbjct: 430 LRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSDSLNLLGY 470
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | ||||||
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.724 | 0.284 | 0.623 | 1.5e-85 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.694 | 0.273 | 0.655 | 4.7e-80 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.766 | 0.301 | 0.573 | 2.3e-78 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.694 | 0.275 | 0.646 | 9e-77 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.859 | 0.338 | 0.537 | 1.2e-74 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.859 | 0.340 | 0.544 | 1.5e-74 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.733 | 0.300 | 0.570 | 1.4e-73 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.823 | 0.331 | 0.531 | 2.8e-73 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.835 | 0.328 | 0.542 | 2.8e-73 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.778 | 0.332 | 0.545 | 7.5e-73 |
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 827 (296.2 bits), Expect = 1.5e-85, Sum P(2) = 1.5e-85
Identities = 151/242 (62%), Positives = 196/242 (80%)
Query: 40 DIELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDE 99
++ + + +R + EL +FSF SVA AT+ FSD NKLGEGGFGPVYKG L G+E
Sbjct: 492 ELGIERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEE 551
Query: 100 IAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFF 159
+A+KRLS+ S QGL E KNEA++IAK+QH NLV+LLGCC+E+DEK+LIYEY+PNKSLD+F
Sbjct: 552 VAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYF 611
Query: 160 LFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDF 219
LFD ++++L+ R +I+EGI++GLLYLH +SR+++IHRD+KA NILLD++M PKISDF
Sbjct: 612 LFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDF 671
Query: 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEF 279
GMARIF ESKANT RVAGTFGY+ PEY +G+ S KSDVFSFG+L+LEI+ G+KN F
Sbjct: 672 GMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSF 731
Query: 280 YH 281
+H
Sbjct: 732 HH 733
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 4.7e-80, P = 4.7e-80
Identities = 152/232 (65%), Positives = 188/232 (81%)
Query: 59 ELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKN 118
ELP+FS +++A ATN+F N+LG GGFGPVYKGVL G EIAVKRLS +S QG+ E KN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
E ++IAK+QH+NLVRLLGCC E +EK+L+YEY+PNKSLDFFLFD TK+ L++ R II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
EGI GLLYLH SR+RIIHRDLK SN+LLD EM PKISDFGMARIF GN+++ANT RV
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY 290
GT+GY+ PEY +G+ S+KSDV+SFG+LLLEI+SGK+NT + + S+ GY
Sbjct: 693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGY 744
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 788 (282.4 bits), Expect = 2.3e-78, P = 2.3e-78
Identities = 153/267 (57%), Positives = 200/267 (74%)
Query: 25 ENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEG 84
+N + D+S +++ DD K++ EL ++S + AT+NFSD+NKLGEG
Sbjct: 490 QNSAMLDISQSIRFDDDVEDGKSH----------ELKVYSLDRIRTATSNFSDSNKLGEG 539
Query: 85 GFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144
GFGPVY G L G+E+AVKRL S QGL+E KNE ++IAK+QH+NLVRLLGCCI R+EK
Sbjct: 540 GFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEK 599
Query: 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKAS 204
+L+YEY+PNKSLD FLF+ K+ LL+ R IIEGI GLLYLH SR+R++HRDLKAS
Sbjct: 600 ILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKAS 659
Query: 205 NILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFG 264
NILLD +MKPKISDFGMAR+F G++++ NTNRV GTFGY+ PEY +GI S+KSDV+ FG
Sbjct: 660 NILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFG 719
Query: 265 MLLLEILSGKKNTEFY-HTGYLSINGY 290
+L+LEI++GK+ F+ H L+I GY
Sbjct: 720 VLILEIITGKRAVSFHCHEDSLNIAGY 746
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 9.0e-77, P = 9.0e-77
Identities = 150/232 (64%), Positives = 187/232 (80%)
Query: 59 ELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKN 118
+LP+FSF SVA+AT +F++ NKLG+GGFG VYKG ++G EIAVKRLS +S+QGL+E KN
Sbjct: 509 DLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKN 568
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
E L+IAK+QH+NLVRLLGCCIE +EK+L+YEY+PNKSLD FLFD +K+ L+ R ++I
Sbjct: 569 EILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVI 628
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
GI GLLYLH SR++IIHRDLKASNILLD EM PKISDFGMARIF + ANT RV
Sbjct: 629 GGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVV 688
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY 290
GT+GY+ PEY +GI S KSDV+SFG+L+LEI+SG+KN F T + S+ GY
Sbjct: 689 GTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGY 740
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
Identities = 156/290 (53%), Positives = 203/290 (70%)
Query: 4 LIFVNLVIVAFYLRRKLKSKGENLMLFDL--SMNLKADDIELSNKANNRRKSTKREVELP 61
L+ ++ +I F+ R++ +S + DL S + +++ ++++ +++ +ELP
Sbjct: 450 LLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELP 509
Query: 62 LFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEAL 121
L + ++A ATNNFS NKLG+GGFG VYKG+L G EIAVKRLS S QG E NE
Sbjct: 510 LMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVR 569
Query: 122 VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGI 181
+IAK+QH NLVRLLGCC+++ EK+LIYEYL N SLD LFD T+ L R II GI
Sbjct: 570 LIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGI 629
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF 241
GLLYLH SR RIIHRDLKASN+LLDK M PKISDFGMARIF E++ANT RV GT+
Sbjct: 630 ARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTY 689
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-LSINGY 290
GY+ PEY GI S+KSDVFSFG+LLLEI+SGK+N FY++ L++ G+
Sbjct: 690 GYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGF 739
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 1.5e-74, P = 1.5e-74
Identities = 158/290 (54%), Positives = 198/290 (68%)
Query: 4 LIFVNLVIVAFYLRRKLKSKGENLMLFDL--SMNLKADDIELSNKANNRRKSTKREVELP 61
L+ ++ VI F+ R++ +S D S + +D+ +S + ++ +ELP
Sbjct: 446 LLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELP 505
Query: 62 LFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEAL 121
L ++A ATNNFS+ NKLG+GGFG VYKG L G EIAVKRLS S QG E NE
Sbjct: 506 LLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVR 565
Query: 122 VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGI 181
+IAK+QH NLVRLLGCC+++ EK+LIYEYL N SLD LFD T+ L R II GI
Sbjct: 566 LIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGI 625
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF 241
GLLYLH SR RIIHRDLKASN+LLDK M PKISDFGMARIF E++ANT RV GT+
Sbjct: 626 ARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTY 685
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-LSINGY 290
GY+ PEY GI S+KSDVFSFG+LLLEI+SGK+N FY++ L++ G+
Sbjct: 686 GYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGF 735
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 743 (266.6 bits), Expect = 1.4e-73, P = 1.4e-73
Identities = 141/247 (57%), Positives = 187/247 (75%)
Query: 46 KANNRRKSTKRE-VELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKR 104
+ N RK + E ++LP+F +++ AT++FS N LG GGFGPVYKG L G EIAVKR
Sbjct: 470 RGENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKR 529
Query: 105 LSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDAT 164
LS S QG++E KNE +IAK+QH+NLVRLLGCCI+ +E +LIYEY+PNKSLDFF+FD
Sbjct: 530 LSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDER 589
Query: 165 KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224
+ L+ R+ II G+ G+LYLH SR+RIIHRDLKA N+LLD +M PKISDFG+A+
Sbjct: 590 RSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKS 649
Query: 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY 284
F G++S+++TNRV GT+GY+PPEY G S+KSDVFSFG+L+LEI++GK N F H +
Sbjct: 650 FGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADH 709
Query: 285 -LSINGY 290
L++ G+
Sbjct: 710 DLNLLGH 716
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 2.8e-73, P = 2.8e-73
Identities = 150/282 (53%), Positives = 200/282 (70%)
Query: 3 SLIFVNLVIVAFYLRRKLKSKGENLMLFDLSMN-LKADDIELSNKANNRRKSTKREVELP 61
+ +F V++A + K + K N L + M L ++D+ + K ELP
Sbjct: 445 AFLFAGTVVLALWKIAKHREKNRNTRLLNERMEALSSNDVGAILVNQYKLK------ELP 498
Query: 62 LFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEAL 121
LF F +A ATNNFS TNKLG+GGFG VYKG L +G +IAVKRLS S QG++E NE +
Sbjct: 499 LFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVV 558
Query: 122 VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGI 181
VI+K+QH+NLVRLLG CIE +E++L+YE++P LD +LFD K+ LL+ TR II+GI
Sbjct: 559 VISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGI 618
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF 241
GL+YLH SR++IIHRDLKASNILLD+ + PKISDFG+ARIF+GNE + +T RV GT+
Sbjct: 619 CRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTY 678
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG 283
GY+ PEY G+ S KSDVFS G++LLEI+SG++N+ FY+ G
Sbjct: 679 GYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDG 720
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 2.8e-73, P = 2.8e-73
Identities = 153/282 (54%), Positives = 197/282 (69%)
Query: 4 LIFVNLVIVAFYLRRKLKSKGENLMLFD---LSMNLKADDIELSNKANNRRKSTKREVEL 60
L+ ++ +I + R++ +S + D S +L +++ +S++ + R++ ++EL
Sbjct: 452 LLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLEL 511
Query: 61 PLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEA 120
PL F VA ATNNFS+ NKLG+GGFG VYKG L G E+AVKRLS S QG E KNE
Sbjct: 512 PLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEV 571
Query: 121 LVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEG 180
+IA++QH NLVRLL CC++ EK+LIYEYL N SLD LFD ++ L R II G
Sbjct: 572 KLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIING 631
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
I GLLYLH SR RIIHRDLKASNILLDK M PKISDFGMARIF +E++ANT +V GT
Sbjct: 632 IARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGT 691
Query: 241 FGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT 282
+GY+ PEY GI S+KSDVFSFG+LLLEI+S K+N FY++
Sbjct: 692 YGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNS 733
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 736 (264.1 bits), Expect = 7.5e-73, P = 7.5e-73
Identities = 144/264 (54%), Positives = 197/264 (74%)
Query: 31 DLSMNLKADDIELSNKANNR---RKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFG 87
DL + L + +IE + ++R RK + ++ELP +V+ AT+ FS NKLG+GGFG
Sbjct: 418 DLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477
Query: 88 PVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147
PVYKG LA G E+AVKRLS SRQG++E KNE +IAK+QH+NLV++LG C++ +E++LI
Sbjct: 478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537
Query: 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNIL 207
YEY PNKSLD F+FD +R L+ R++II+GI G+LYLH SR+RIIHRDLKASN+L
Sbjct: 538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597
Query: 208 LDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLL 267
LD +M KISDFG+AR G+E++ANT RV GT+GY+ PEY G S+KSDVFSFG+L+
Sbjct: 598 LDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLV 657
Query: 268 LEILSGKKNTEFYHTGY-LSINGY 290
LEI+SG++N F + + L++ G+
Sbjct: 658 LEIVSGRRNRGFRNEEHKLNLLGH 681
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.30250002 | hypothetical protein (273 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 334 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 6e-47
Identities = 80/220 (36%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 80 KLGEGGFGPVYKGVL-----AKGDEIAVKRL-SVRSRQGLQELKNEALVIAKVQHKNLVR 133
KLGEG FG VYKG L K E+AVK L S Q ++E EA ++ K+ H N+V+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
LLG C E + ++ EY+ L +L R L L L I G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEY 248
IHRDL A N L+ + + KISDFG++R + + R G G +P PE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRG--GKLPIRWMAPES 174
Query: 249 VYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+ +G + KSDV+SFG+LL EI + G N E
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE 214
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 8e-47
Identities = 71/194 (36%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG-LQELKNEALVIAKVQHKNLVRLLGCC 138
LGEGGFG VY G ++A+K + L+EL E ++ K+ H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+ + L+ EY SL L + + L L+I+ I+EGL YLH + IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 199 RDLKASNILLDK-EMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE-YVYQGICSI 256
RDLK NILLD K K++DFG++++ ++S T GT Y+ PE + +G S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSE 173
Query: 257 KSDVFSFGMLLLEI 270
KSD++S G++L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 8e-47
Identities = 80/220 (36%), Positives = 111/220 (50%), Gaps = 28/220 (12%)
Query: 80 KLGEGGFGPVYKGVL-----AKGDEIAVKRL-SVRSRQGLQELKNEALVIAKVQHKNLVR 133
KLGEG FG VYKG L K E+AVK L S Q ++E EA ++ K+ H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
LLG C E + +++ EY+P L +L + L L L I G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEY 248
IHRDL A N L+ + + KISDFG++R + + +V G G +P PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKG--GKLPIRWMAPES 175
Query: 249 VYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+ +G + KSDV+SFG+LL EI + G N E
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE 215
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 77/211 (36%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 79 NKLGEGGFGPVYKGVLAKGD----EIAVKRL-SVRSRQGLQELKNEALVIAKVQHKNLVR 133
KLGEG FG VYKG L D E+AVK L S + ++ EA V+ K+ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFL------FDATKRVLLELGTRLQIIEGIVEGLLY 187
LLG C E + L+ EY+ L +L F + ++ L L L I +G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTFGYIP- 245
L + +HRDL A N L+ +++ KISDFG++R ++ + + T G +P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG------GKLPI 171
Query: 246 ----PEYVYQGICSIKSDVFSFGMLLLEILS 272
PE + GI + KSDV+SFG+LL EI +
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 2e-45
Identities = 77/221 (34%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 80 KLGEGGFGPVYKGVL-----AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVR 133
KLGEG FG VYKG L ++AVK L S + +E EA ++ K+ H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
LLG C + + ++ EY+P L FL L L LQ+ I +G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTFGYIP-----PE 247
+HRDL A N L+ + + KISDFG++R I++ + + G +P PE
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG------GKLPIKWMAPE 174
Query: 248 YVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+ G + KSDV+SFG+LL EI + G N E
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE 215
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-44
Identities = 74/200 (37%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 80 KLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSR--QGLQELKNEALVIAKVQHKNLVRLLG 136
KLG G FG VYK G +AVK L RS + Q + E ++ ++ H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
++D L+ EY L +L L +I I+ GL YLH + I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC-- 254
IHRDLK NILLD+ KI+DFG+A+ + S T GT Y+ PE V G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPE-VLLGGNGY 176
Query: 255 SIKSDVFSFGMLLLEILSGK 274
K DV+S G++L E+L+GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 8e-41
Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE-LKNEALVIAKVQHKNLV 132
+ KLGEG FG VY G +A+K + + + +E + E ++ K++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
RL + D+ L+ EY L L KR L + I+ L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHSK- 116
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
I+HRDLK NILLD++ K++DFG+AR E GT Y+ PE +
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
D++S G++L E+L+GK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-38
Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 79 NKLGEGGFGPVYKGVLAK-GDEIAVK--RLSVRSRQGLQELKNEALVIAKVQHKNLVRLL 135
LG G FG VY + G+ +AVK LS S + L+ L+ E +++ +QH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 136 GCCIERDEK-LLIY-EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
G + ++ L I+ EY+ SL L L E R + I+EGL YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQ-ILEGLAYLHSN-- 120
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
I+HRD+K +NIL+D + K++DFG A+ E+ T V GT ++ PE +
Sbjct: 121 -GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
+D++S G ++E+ +GK
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 6e-37
Identities = 63/203 (31%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 75 FSDTNKLGEGGFGPVYKG-VLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
F K+G+GGFG VYK G E+A+K + + S++ +++ NE ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLE--LGTRLQIIEGIVEGLLYLHLH 191
G +++DE ++ E+ SL L +T + L E + + + +++GL YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY---VCKELLKGLEYLHSN 117
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
IIHRD+KA+NILL + + K+ DFG++ N + GT ++ PE +
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVING 171
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
K+D++S G+ +E+ GK
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 70/196 (35%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQG---LQELKNEALVIAKVQHKNLVRLLG 136
KLG G FG V+ G ++AVK L + G + EA ++ K++H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
C E + ++ EY+ SL FL + L L + + I EG+ YL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SRNY 124
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGIC 254
IHRDL A NIL+ + + KI+DFG+AR+ + +E A R F + PE G
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA---REGAKFPIKWTAPEAANYGRF 181
Query: 255 SIKSDVFSFGMLLLEI 270
+IKSDV+SFG+LL EI
Sbjct: 182 TIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 79 NKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLV 132
+LGEG FG V G+++AVK L+ Q + + E ++ + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 133 RLLGCCIERDEK--LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ G C + + LI EYLP+ SL +L + + L L I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLG- 126
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK----ANTNRVAGTFGYIPP 246
S+ R IHRDL A NIL++ E KISDFG+A++ E K + F Y P
Sbjct: 127 -SQ-RYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWY-AP 181
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILS 272
E + S SDV+SFG+ L E+ +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 64/194 (32%), Positives = 104/194 (53%), Gaps = 15/194 (7%)
Query: 81 LGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE 140
+G+G FG V G +G ++AVK L Q EA V+ ++H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 141 RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRD 200
+ ++ EY+ SL +L + R ++ L +L + EG+ YL +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 201 LKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGICSIKS 258
L A N+L+ +++ K+SDFG+A+ +A+ + +G + PE + + S KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 259 DVFSFGMLLLEILS 272
DV+SFG+LL EI S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKN 130
N+ + +G G FG VYKG+ L GD +A+K++S+ + L+ + E ++ ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQ------IIEGIVEG 184
+V+ +G D +I EY N SL R +++ + +++G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL---------RQIIKKFGPFPESLVAVYVYQVLQG 111
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L YLH +IHRD+KA+NIL K+ K++DFG+A K N+ + V GT ++
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGTPYWM 166
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + S SD++S G ++E+L+G
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 71/213 (33%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 81 LGEGGFGPVYKGVLAKGDE------IAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKNLVR 133
LGEG FG VYKG L +E +A+K L + +Q E + EA +++ +QH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLF-------------DATKRVLLELGTRLQIIEG 180
LLG C + +++EYL + L FL D T + L+ L I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAG 239
I G+ YL H +HRDL A N L+ + + KISDFG++R I+ + + + +
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL- 188
Query: 240 TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++PPE + G + +SD++SFG++L EI S
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 6/198 (3%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRL 134
F+ KLG G FG V++G+ +A+K L Q+ + E + +++HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
C + +I E + SL FL +V L + + + + + EG+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
IHRDL A NIL+ +++ K++DFG+AR+ K + ++ ++ + + PE G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTF 181
Query: 255 SIKSDVFSFGMLLLEILS 272
S KSDV+SFG+LL E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-28
Identities = 73/203 (35%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELK----NEALVIAKVQHKNLVRLL 135
K+G+G FG VYKGVL E+AVK + RS +LK EA ++ + H N+V+L+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVK--TCRSTL-PPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
G C+++ ++ E +P SL FL K+ L + LQ+ G+ YL S+
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLE--SK-N 113
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVY 250
IHRDL A N L+ + KISDFGM+R E + V+ IP PE +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 251 QGICSIKSDVFSFGMLLLEILSG 273
G + +SDV+S+G+LL E S
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 25/226 (11%)
Query: 57 EVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE 115
E++ L S + + K+GEG G VYK A G E+A+K++ +R Q +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKEL 61
Query: 116 LKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL----DFFLFDATK----RV 167
+ NE L++ +H N+V + DE ++ EY+ SL + V
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV 121
Query: 168 LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227
E +++GL YLH +IHRD+K+ NILL K+ K++DFG A +
Sbjct: 122 CRE----------VLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAA--QL 166
Query: 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
+ K+ N V GT ++ PE + + K D++S G++ +E+ G
Sbjct: 167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-28
Identities = 70/199 (35%), Positives = 108/199 (54%), Gaps = 19/199 (9%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELK---NEALVIAKVQHKNLVRLLG 136
KLG G FG V+ G ++A+K L +QG + EA ++ ++QH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 137 CCIERDEKLLIYEYLPNKSL-DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ ++ +I EY+ N SL DF + L + + + I EG+ ++ R
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGI 253
IHRDL+A+NIL+ + + KI+DFG+AR+ + NE A R F + PE + G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA---REGAKFPIKWTAPEAINYGT 179
Query: 254 CSIKSDVFSFGMLLLEILS 272
+IKSDV+SFG+LL EI++
Sbjct: 180 FTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 75/222 (33%), Positives = 104/222 (46%), Gaps = 26/222 (11%)
Query: 79 NKLGEGGFGPVYKGVLA--KGD----EIAVKRL-SVRSRQGLQELKNEALVIAKVQHKNL 131
LG G FG VY+G+ GD ++AVK L S Q + EAL+++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRV----LLELGTRLQIIEGIVEGLLY 187
VRL+G ER + ++ E + L FL + R L + L + +G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKP----KISDFGMARIFKGNESKANTNRVAGTFGY 243
L IHRD+ A N LL + P KI+DFGMAR R +
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 244 IPPEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTE 278
+PPE GI + K+DV+SFG+LL EI S G+ N E
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-28
Identities = 63/195 (32%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
KLG G FG V++G+ +AVK L + L EA ++ K++H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA-EAQIMKKLRHPKLIQLYAVCT 71
Query: 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
+ ++ E + SL +L R L +L + + + G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 200 DLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGICSIK 257
DL A N+L+ + K++DFG+AR+ K + +A R F + PE SIK
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEA---REGAKFPIKWTAPEAALYNRFSIK 184
Query: 258 SDVFSFGMLLLEILS 272
SDV+SFG+LL EI++
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 79 NKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
+KLG G +G VY+GV K +AVK L + + ++E EA V+ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 138 CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRII 197
C +I E++ +L +L + R + L + I + YL + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126
Query: 198 HRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT---FGYIPPEYVYQGIC 254
HRDL A N L+ + K++DFG++R+ G+ A+ AG + PE +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAPESLAYNKF 182
Query: 255 SIKSDVFSFGMLLLEI 270
SIKSDV++FG+LL EI
Sbjct: 183 SIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 22/209 (10%)
Query: 79 NKLGEGGFGPVYKGV-LAKGDEIAVK--RLSVRSRQGLQELKNEALVIAKVQHKNLVRLL 135
NK+G G FG VY V L G+ +AVK R+ + ++E+ +E V+ ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
G + R++ + EY +L+ L R+L E R+ ++ ++EGL YLH H
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQ-LLEGLAYLHSH---G 119
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT--NRVAGTFGYIPPEYV---- 249
I+HRD+K +NI LD K+ DFG A K N + +AGT Y+ PE +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 250 ---YQGICSIKSDVFSFGMLLLEILSGKK 275
+ D++S G ++LE+ +GK+
Sbjct: 180 GKGHGRAA----DIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 21/206 (10%)
Query: 81 LGEGGFGPVYKGV-LAKGD----EIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRL 134
LG G FG VYKGV + +G+ +A+K L + + +E+ +EA V+A V H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTR--LQIIEGIVEGLLYLHLHS 192
LG C+ + LI + +P L ++ + +G++ L I +G+ YL
Sbjct: 75 LGICLS-SQVQLITQLMPLGCLLDYVRNHKDN----IGSQYLLNWCVQIAKGMSYLEEK- 128
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES--KANTNRVAGTFGYIPPEYVY 250
R++HRDL A N+L+ KI+DFG+A++ +E A +V ++ E +
Sbjct: 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP--IKWMALESIL 184
Query: 251 QGICSIKSDVFSFGMLLLEILS-GKK 275
I + KSDV+S+G+ + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGD-------EIAVKRLSVRSRQGLQELKNEALVIAKV 126
+ ++G+G FG VY V K D EI + +S + R+ + NE ++ K+
Sbjct: 1 KYEIIKQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKERE---DALNEVKILKKL 56
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL 186
H N+++ E+ + ++ EY L + K + QI++ V+ L
Sbjct: 57 NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG--KPFPEEQILDWFVQLCL 114
Query: 187 YL-HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
L +LHSR +I+HRD+K NI L K+ DFG++++ A T V GT Y+
Sbjct: 115 ALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLS 171
Query: 246 PEYVYQGIC-----SIKSDVFSFGMLLLEILSGKK 275
PE +C + KSD++S G +L E+ + K
Sbjct: 172 PE-----LCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 69/207 (33%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 81 LGEGGFGPVYKGVLAKGDE--IAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLL 135
LG+G FG V V K A+K L + R+ ++ E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 136 GCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+ +EKL L+ EY P L L + + E R E IV L YLH +
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAE-IVLALEYLH---SL 112
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
II+RDLK NILLD + K++DFG+A+ S+ NT GT Y+ PE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170
Query: 255 SIKSDVFSFGMLLLEILSGKKNTEFYH 281
D +S G+LL E+L+GK FY
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK--PPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-27
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGL---QELKNEALVIAKVQHKNLVRLLG 136
++G G FG V+ G + ++A+K + R+G ++ EA V+ K+ H LV+L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
C ER L++E++ + L +L +R T L + + EG+ YL + +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT---FGYIPPEYVYQGI 253
IHRDL A N L+ + K+SDFGM R ++ ++T GT + PE
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSK 177
Query: 254 CSIKSDVFSFGMLLLEILSGKK 275
S KSDV+SFG+L+ E+ S K
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-27
Identities = 72/196 (36%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
KLG G FG V+ G ++AVK L + +Q EA ++ +QH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 140 ERDEKLLIYEYLPNKSL-DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+ + +I EY+ SL DF D +VLL + I EG+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGICSI 256
RDL+A+N+L+ + + KI+DFG+AR+ + NE A R F + PE + G +I
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTA---REGAKFPIKWTAPEAINFGSFTI 183
Query: 257 KSDVFSFGMLLLEILS 272
KSDV+SFG+LL EI++
Sbjct: 184 KSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 20/202 (9%)
Query: 81 LGEGGFGPVYKGVLAKGDE----IAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKNLVRLL 135
+G G FG V +G L + +A+K L S + + EA ++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
G + ++I EY+ N SLD FL + + +G + ++ GI G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVY 250
+HRDL A NIL++ + K+SDFG++R + +E+ T G IP PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG-----GKIPIRWTAPEAIA 181
Query: 251 QGICSIKSDVFSFGMLLLEILS 272
+ SDV+SFG+++ E++S
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 70/204 (34%), Positives = 113/204 (55%), Gaps = 22/204 (10%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSV-----RSRQGLQELKNEALVIAKVQHKNLVRL 134
LG G FG VY+G+ L GD AVK +S+ ++ +++L+ E +++K+QH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 135 LGCCIERDEKLLIY-EYLPNKSLDFFL--FDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
LG E ++ L I+ E +P SL L + + ++ L TR QI+ G L YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLG----LEYLH-- 119
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY- 250
R +HRD+K +NIL+D K++DFGMA K + G+ ++ PE +
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 251 QGICSIKSDVFSFGMLLLEILSGK 274
QG + +D++S G +LE+ +GK
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 71/210 (33%), Positives = 117/210 (55%), Gaps = 24/210 (11%)
Query: 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSV---------RSRQGLQELKNEALVIAKVQHKN 130
+G G FG VY G+ A G+ +AVK++ + R R L L E ++ ++QH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFL--FDATKRVLLELGTRLQIIEGIVEGLLYL 188
+V+ LG ++ D + EY+P S+ L + A + L+ + I++GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKGLNYL 122
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN--ESKANTNR--VAGTFGYI 244
H IIHRD+K +NIL+D + KISDFG+++ + N +K N R + G+ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE V Q + K+D++S G L++E+L+GK
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (264), Expect = 5e-26
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQH-K 129
++ KLGEG FG VY K +A+K L+ + + ++ E ++A + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
N+V+L + L+ EY+ SL+ L ++ L L I+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 190 LHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNESKAN----TNRVAGTFGYI 244
IIHRD+K NILLD++ K+ DFG+A++ S ++ + GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 245 PPEYVYQGIC---SIKSDVFSFGMLLLEILSGK 274
PE + S SD++S G+ L E+L+G
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 71/207 (34%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 79 NKLGEGGFGPVYKGV--LAKGDEI--AVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVR 133
+LG G FG V KGV + G E+ AVK L G +E EA V+A++ H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFD---ATKRVLLELGTRLQIIEGIVEGLLYLHL 190
L+G C + +L+ E P L +L L EL + + G+ YL
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP----- 245
+HRDL A N+LL + KISDFGM+R + A T G P
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG----SDYYRATTAGRWPLKWYA 166
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILS 272
PE + G S KSDV+S+G+ L E S
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
KLGEG +G VYK + G +A+K + V LQE+ E ++ + +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 139 IERDEKLLIYEYLPNKS-LDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRII 197
+ + ++ EY S D + T + L E I+ ++GL YLH + + I
Sbjct: 68 FKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAA-ILYQTLKGLEYLHSN---KKI 121
Query: 198 HRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIK 257
HRD+KA NILL++E + K++DFG++ +K NT V GT ++ PE + + + K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNK 179
Query: 258 SDVFSFGMLLLEILSGK 274
+D++S G+ +E+ GK
Sbjct: 180 ADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 81 LGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGL---QELKNEALVIAKVQHKNLVRLLGC 137
LG G FG V+ G ++A+K + R+G + EA V+ K+ H NLV+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 138 CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRII 197
C ++ ++ EY+ N L +L ++ L L + + E + YL + I
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 198 HRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT---FGYIPPEYVYQGIC 254
HRDL A N L+ ++ K+SDFG+AR ++ ++ GT + PPE
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRF 178
Query: 255 SIKSDVFSFGMLLLEILSGKK 275
S KSDV+SFG+L+ E+ S K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 81 LGEGGFGPVYKGVLAKGDE------IAVKRLS-VRSRQGLQELKNEALVIAKVQHKNLVR 133
LGEG FG V+ G + +AVK L S ++ + EA ++ QH+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 134 LLGCCIERDEKLLIYEYLPNKSL---------DFFLFDATKRVLLELGTR--LQIIEGIV 182
G C E D ++++EY+ + L D + + EL LQI I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT-- 240
G++YL + +HRDL N L+ ++ KI DFGM+R + RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY----RVGGHTM 185
Query: 241 --FGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT 282
++PPE + + +SDV+SFG++L EI + K + +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 33/212 (15%)
Query: 79 NKLGEGGFGPVYKGV-LAKGDEIAVKRLSV-RSRQG-----LQELKNEALVIAKVQHKNL 131
++GEG +G VYK G+ +A+K++ + ++G ++E+K ++ K++H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLRHPNI 60
Query: 132 VRLLGCCIERDEK--LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
VRL + + +++EY+ + D + V ++ ++EGL YLH
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE-- 247
I+HRD+K SNIL++ + K++DFG+AR + S TNRV T Y PPE
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173
Query: 248 -----YVYQGICSIKSDVFSFGMLLLEILSGK 274
Y + D++S G +L E+ GK
Sbjct: 174 LGATRYGP------EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 33/216 (15%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSR-QGLQELKNEALVIAKVQHKN 130
++ LG+G G VYK G A+K++ V + ++L E + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL------LELGTRLQIIEGIVEG 184
+V+ G + E ++ EY+ SL D K+V L R I++G
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLA----DLLKKVGKIPEPVLAYIARQ-----ILKG 111
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L YLH ++ IIHRD+K SN+L++ + + KI+DFG++++ + + NT GT Y+
Sbjct: 112 LDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYM 167
Query: 245 PPE------YVYQGICSIKSDVFSFGMLLLEILSGK 274
PE Y Y +D++S G+ LLE GK
Sbjct: 168 SPERIQGESYSY------AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-24
Identities = 74/215 (34%), Positives = 109/215 (50%), Gaps = 32/215 (14%)
Query: 81 LGEGGFGPVYKG----VLAKGDE---IAVKRLSVRSR-QGLQELKNEALVIAKVQHKNLV 132
LG G FG VY+G +L G +AVK L + Q +E EA +++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRV----LLELGTRLQIIEGIVEGLLYL 188
+LLG C+ + + +I E + L +L DA LL L L I + +G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 189 HLHSRVRIIHRDLKASNILL-----DKEMKPKISDFGMAR-IFKGNESKANTNRVAGTFG 242
++ IHRDL A N L+ D + KI DFG+AR I+ K++ R G G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY-----KSDYYRKEGE-G 173
Query: 243 YIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
+P PE + G + +SDV+SFG+L+ EIL+
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 70/224 (31%), Positives = 112/224 (50%), Gaps = 28/224 (12%)
Query: 80 KLGEGGFGPVY----KGVLAKGDE--IAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+LGEG FG V+ +L + D+ +AVK L S Q+ + EA ++ +QH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFL---------FDATKRVL---LELGTRLQIIEGI 181
G C E L+++EY+ + L+ FL + V L LG L I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF 241
G++YL + + +HRDL N L+ + + KI DFGM+R + R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKK------NTE 278
++PPE + + +SD++SFG++L EI + GK+ NTE
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 38/220 (17%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRS-----RQGLQELKNEALVIAKV 126
+ ++LGEG G V K L I A+K ++ +Q L+EL+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 127 QHKNLVRLLGCCIERDEKLL--IYEYLPNKSLDFFLFDATKRVLLELGTR------LQII 178
+ +V+ G ++ + EY SLD + + + + G R +I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIA 111
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
E +++GL YLH SR +IIHRD+K SNILL ++ + K+ DFG+ S N +A
Sbjct: 112 ESVLKGLSYLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGV--------SGELVNSLA 160
Query: 239 GTFG----YIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
GTF Y+ PE + SI SDV+S G+ LLE+ +
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 67/196 (34%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
KLG G FG V+ K ++AVK + S ++ EA V+ +QH LV+L +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 140 ERDEKLLIYEYLPNKSL-DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
++ +I E++ SL DF D + L + I EG+ ++ + IH
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQ--PLPKLIDFSAQIAEGMAFIE---QRNYIH 125
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGICSI 256
RDL+A+NIL+ + KI+DFG+AR+ + NE A R F + PE + G +I
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTA---REGAKFPIKWTAPEAINFGSFTI 182
Query: 257 KSDVFSFGMLLLEILS 272
KSDV+SFG+LL+EI++
Sbjct: 183 KSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELK-----NEALVIAKV 126
++F +GEG F V + E A+K L RQ ++E K E V+ ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILD--KRQLIKEKKVKYVKIEKEVLTRL 58
Query: 127 -QHKNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
H +++L + +E L + EY PN L ++ K L+ I+
Sbjct: 59 NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLA 114
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA------ 238
L YLH IIHRDLK NILLDK+M KI+DFG A++ N S + A
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 239 ------------GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
GT Y+ PE + + SD+++ G ++ ++L+GK
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-24
Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 80 KLGEGGFGPVYKGVL-----AKGDEIAVKRLS-VRSRQGLQELKNEALVIAKVQHKNLVR 133
+LGE FG +YKG L +A+K L + + Q E + EA ++A++ H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLF--------------DATKRVLLELGTRLQIIE 179
LLG + +++EYL L FL D T + L+ G L I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 180 GIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVA 238
I G+ YL H +H+DL A NIL+ +++ KISD G++R I+ + + +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++PPE + G S SD++SFG++L EI S
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 4e-24
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 44/220 (20%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRL------------SVRSRQGLQELKNEAL 121
+ KLGEG +G VYK G+ +A+K++ ++R L+ELK
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK---- 56
Query: 122 VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGI 181
H N+V+LL + L++EY + L +L + L I+ +
Sbjct: 57 ------HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQL 107
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF 241
+ GL Y H H RI+HRDLK NIL++++ K++DFG+AR F G + T+ V T
Sbjct: 108 LRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TL 162
Query: 242 GYIPPE-------YVYQGICSIKSDVFSFGMLLLEILSGK 274
Y PE Y S D++S G + E+++GK
Sbjct: 163 WYRAPEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-24
Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 25/214 (11%)
Query: 80 KLGEGGFGPVYKGVL---AKGDE---IAVKRLSVRSRQGL-QELKNEALVIAKVQHKNLV 132
+LGE FG VYKG L A G++ +A+K L ++ L +E K+EA++ +++QH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLF-------------DATKRVLLELGTRLQIIE 179
LLG + +I+ Y + L FL D T + LE + I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 180 GIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVA 238
I G+ +L H ++H+DL N+L+ ++ KISD G+ R ++ + K N +
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++ PE + G SI SD++S+G++L E+ S
Sbjct: 189 -PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 6e-24
Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 11/195 (5%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
KLG G FG V+ G ++AVK L + + EA ++ K++H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV-V 70
Query: 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
+ ++ EY+ SL FL D R L +L + + + G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 200 DLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGICSIK 257
DL+++NIL+ + KI+DFG+AR+ + NE A R F + PE G +IK
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTA---RQGAKFPIKWTAPEAALYGRFTIK 183
Query: 258 SDVFSFGMLLLEILS 272
SDV+SFG+LL E+++
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-23
Identities = 67/227 (29%), Positives = 112/227 (49%), Gaps = 31/227 (13%)
Query: 73 NNFSDTNKLGEGGFGPVYK----GVLAKGDE--IAVKRLSVRSRQGLQ-ELKNEALVIAK 125
NN +G+G FG V++ G+L +AVK L + +Q + + EA ++A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGT------------ 173
H N+V+LLG C L++EY+ L+ FL + R L
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 174 -------RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IF 225
+L I + + G+ YL S + +HRDL N L+ + M KI+DFG++R I+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
+ KA+ N A ++PPE ++ + +SDV+++G++L EI S
Sbjct: 182 SADYYKASEND-AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-23
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGDE------IAVKRLSVRSRQGLQ-ELKNEALVIAKV 126
N + LG G FG V+ +E + VK L + LQ E + E + K+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL------LELGTRLQIIEG 180
HKN+VRLLG C E + +I EY L FL + L ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
I G+ +L S R +HRDL A N L+ + + K+S +++ +E N +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181
Query: 241 FGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++ PE V + S KSDV+SFG+L+ E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 26/254 (10%)
Query: 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKN 130
+F NK+G+G FG V+K V A A+K++ + +R+ +E +EA V+AK+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL-H 189
++R +++ + ++ EY N L L R L E Q+ ++ LL L H
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPED----QVWRFFIQILLGLAH 116
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
LHS+ +I+HRD+K+ N+ LD KI D G+A++ N + ANT + GT Y+ PE
Sbjct: 117 LHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELC 173
Query: 250 YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN-----------GYDQTQVASK 298
+ KSDV++ G++L E +GK + + G L + Y Q
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQ----QL 229
Query: 299 IKLVESCLARPFRQ 312
+L++ CL + +RQ
Sbjct: 230 AQLIDQCLTKDYRQ 243
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDE--IAVKRLSVRS-----RQGLQELKNEALVIAK 125
++ +LG G G V K VL + +AVK + + +Q L+EL ++ K
Sbjct: 1 DDLEYLGELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELD----ILHK 55
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLE-LGTRLQIIEGIVEG 184
+V G + + EY+ SLD L + R+ LG +I +++G
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG---KIAVAVLKG 112
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L YLH + +IIHRD+K SNIL++ + K+ DFG++ + S A T GT Y+
Sbjct: 113 LTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTF--VGTSSYM 166
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + S+KSD++S G+ L+E+ +G+
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-23
Identities = 64/201 (31%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 80 KLGEGGFGPVYKG----VLAKGDEIAVKRLSVRSRQG-LQELKNEALVIAKVQHKNLVRL 134
KLG+G FG V +G K +AVK L + + EA ++ + H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 135 LGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
G + L ++ E P SL L L + T I G+ YL
Sbjct: 62 YG--VVLTHPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESK-- 116
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES--KANTNRVAGTFGYIPPEYVYQ 251
R IHRDL A NILL + K KI DFG+ R NE + F + PE +
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRT 174
Query: 252 GICSIKSDVFSFGMLLLEILS 272
S SDV+ FG+ L E+ +
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 73/250 (29%), Positives = 123/250 (49%), Gaps = 39/250 (15%)
Query: 81 LGEGGFGPVYKGVLAKGD----EIAVK--RLSVRSRQGLQELKNEALVIAKVQHKNLVRL 134
LGEG FG V +G L++ D ++AVK +L + + ++E +EA + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 135 LGCCIERDEK------LLIYEYLPNKSLDFFLFD---ATKRVLLELGTRLQIIEGIVEGL 185
+G C E ++I ++ + L FL L L T L+ + I G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGT-FGY 243
YL S IHRDL A N +L ++M ++DFG+++ I+ G+ + R+A +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR--QGRIAKMPVKW 181
Query: 244 IPPEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYHTGYLSINGYDQTQVA 296
I E + + + KSDV++FG+ + EI + G +N E Y YL +G
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD--YL-RHG------- 231
Query: 297 SKIKLVESCL 306
+++K E CL
Sbjct: 232 NRLKQPEDCL 241
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-22
Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 11/193 (5%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
KLG+G FG V+ G +A+K L + + EA V+ K++H+ LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
+ ++ EY+ SL FL + L L + + I G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 200 DLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGICSIK 257
DL+A+NIL+ + + K++DFG+AR+ + NE A R F + PE G +IK
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTA---RQGAKFPIKWTAPEAALYGRFTIK 183
Query: 258 SDVFSFGMLLLEI 270
SDV+SFG+LL E+
Sbjct: 184 SDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 13/193 (6%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
+GEG FG V +G G ++AVK +++ Q E V+ K+ HKNLVRLLG I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
+ ++ E + +L FL R L+ + LQ + EG+ YL +++HR
Sbjct: 69 LHNGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124
Query: 200 DLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSD 259
DL A NIL+ ++ K+SDFG+AR+ + +++ + PE + S KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLP--VKWTAPEALKHKKFSSKSD 179
Query: 260 VFSFGMLLLEILS 272
V+S+G+LL E+ S
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 27/206 (13%)
Query: 81 LGEGGFGPVYKGVLA----KGDEIAVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRLL 135
+G G FG V++G+L K +A+K L + + Q+ +EA ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII---EGIVEGLLYLHLHS 192
G + ++I EY+ N +LD +L D + Q++ GI G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEF-----SSYQLVGMLRGIAAGMKYL---S 124
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PE 247
+ +HRDL A NIL++ ++ K+SDFG++R+ + + T + G IP PE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRWTAPE 180
Query: 248 YV-YQGICSIKSDVFSFGMLLLEILS 272
+ Y+ S SDV+SFG+++ E++S
Sbjct: 181 AIAYRKFTS-ASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-22
Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
+LG G FG V G ++A+K + S E EA V+ K+ H+ LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
++ ++ EY+ N L +L + KR + L++ + + EG+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 200 DLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGICSIK 257
DL A N L+D + K+SDFG++R +E T+ V F + PPE + S K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 258 SDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKI 299
SDV++FG+L+ E+ Y G + ++ ++ K+
Sbjct: 182 SDVWAFGVLMWEV---------YSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-22
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKR-----LSVRSRQGLQELKNEALVIAKVQHKNLVRL 134
LG+G FG VY + G E+AVK+ S +++ + L+ E ++ +QH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 135 LGCCIERDEKLLIY-EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
GC + DE L I+ EY+P S+ L L E TR + I+EG+ YLH +
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLHSN-- 123
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR-VAGTFGYIPPEYVYQG 252
I+HRD+K +NIL D K+ DFG ++ + S + V GT ++ PE +
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
K+DV+S G ++E+L+ K
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 9e-22
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSV----------RSRQGLQELKNEALVIAKVQHK 129
+G+G +G VY + G+ +AVK++ + R + ++ L++E + + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 130 NLVRLLGCCIERDEKLL-IY-EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
N+V+ LG E E+ L I+ EY+P S+ L + E E ++EGL Y
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAY 123
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
LH I+HRDLKA N+L+D + KISDFG+++ + G+ ++ PE
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 248 YV--YQGICSIKSDVFSFGMLLLEILSGKK 275
+ Y S K D++S G ++LE+ +G++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-21
Identities = 84/253 (33%), Positives = 124/253 (49%), Gaps = 23/253 (9%)
Query: 81 LGEGGFGPV--YKGVLAK---GDEIAVKRLSVRSRQGLQE-LKNEALVIAKVQHKNLVRL 134
LGEG FG V Y A G+ +AVK L Q K E ++ + H+N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 135 LGCCIERDEK--LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
GCC E+ K LI EY+P SL +L + L L L + I EG+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNE-SKANTNRVAGTFGYIPPEYVY 250
IHRDL A N+LLD + KI DFG+A+ + +G+E + + + F Y E +
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183
Query: 251 QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIKLVESCLARPF 310
+ S SDV+SFG+ L E+L+ + + + + G Q Q+ + ++L+E L R
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM-TVVRLIE-LLERGM 241
Query: 311 RQYC---CILKVR 320
R C C +V
Sbjct: 242 RLPCPKNCPQEVY 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-21
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
LG+G +G VY L+ IA+K + R + +Q L E + + ++H+N+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
E + E +P SL L + T + + I+EGL YLH +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHR 132
Query: 200 DLKASNILLDKEMKP-KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI--CSI 256
D+K N+L++ KISDFG ++ G T GT Y+ PE + +G
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAPEVIDKGPRGYGA 190
Query: 257 KSDVFSFGMLLLEILSGK 274
+D++S G ++E+ +GK
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-21
Identities = 67/198 (33%), Positives = 101/198 (51%), Gaps = 17/198 (8%)
Query: 81 LGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGL-QELK----NEALVIAKVQHKNLVRLL 135
LG+G FG V+KG L +AVK ++ L QELK +EA ++ + H N+V+L+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKT----CKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
G C +R ++ E +P DF F K+ L+ ++ G+ YL +
Sbjct: 59 GVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--- 113
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFK-GNESKANTNRVAGTFGYIPPEYVYQGIC 254
IHRDL A N L+ + KISDFGM+R G S + ++ + PE + G
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP--IKWTAPEALNYGRY 171
Query: 255 SIKSDVFSFGMLLLEILS 272
S +SDV+S+G+LL E S
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 2e-21
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 19/207 (9%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQG---LQELKNEALVIAKVQHKN 130
F+D ++G G FG VY + +E+ A+K++S +Q Q++ E + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ GC + L+ EY + D L + K+ L E+ I G ++GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGLAYLHS 143
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
H+ +IHRD+KA NILL + + K++DFG A I S AN+ GT ++ PE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIA----SPANS--FVGTPYWMAPEVIL 194
Query: 251 ---QGICSIKSDVFSFGMLLLEILSGK 274
+G K DV+S G+ +E+ K
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-21
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 81 LGEGGFGPVYKGV------LAKGDEIAVKRLSVRSRQG-LQELKNEALVIAKVQHKNLVR 133
LGEG FG V K A +AVK L + L++L +E ++ +V H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFL---------------------FDATKRVLLELG 172
L G C + LLI EY SL FL D L +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 173 TRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232
+ I G+ YL + ++++HRDL A N+L+ + K KISDFG++R +S
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++ ++ E ++ I + +SDV+SFG+LL EI++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-21
Identities = 64/195 (32%), Positives = 105/195 (53%), Gaps = 11/195 (5%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
KLG+G FG V+ G ++A+K L + + EA ++ K++H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAV-V 70
Query: 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
+ ++ E++ SL FL + + L+L + + I +G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 200 DLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGICSIK 257
DL+A+NIL+ + KI+DFG+AR+ + NE A R F + PE G +IK
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTA---RQGAKFPIKWTAPEAALYGRFTIK 183
Query: 258 SDVFSFGMLLLEILS 272
SDV+SFG+LL E+++
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-21
Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 10/219 (4%)
Query: 57 EVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE 115
E+ L + SV ++ K+G+G G VY + +A G E+A+K+++++ + +
Sbjct: 3 EILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL 62
Query: 116 LKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL 175
+ NE LV+ + +H N+V L + DE ++ EYL SL D ++ G
Sbjct: 63 IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIA 118
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
+ ++ L +LH + ++IHRD+K+ NILL + K++DFG +SK +T
Sbjct: 119 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST- 174
Query: 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
+ GT ++ PE V + K D++S G++ +E++ G+
Sbjct: 175 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 81 LGEGGFGPVYKGVL-----AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLL 135
LG+G FG V G+ +AVK+L + + L++ + E ++ +QH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 136 GCCIE--RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
G C R L+ EYLP SL +L +R L+ L I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYL---GS 126
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAG---TFGYIPPEYVY 250
R +HRDL NIL++ E + KI DFG+ ++ ++ + R G F Y PE +
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLT 184
Query: 251 QGICSIKSDVFSFGMLLLEILS 272
+ S+ SDV+SFG++L E+ +
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-21
Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 10/219 (4%)
Query: 57 EVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE 115
E+ L S SV ++ K+G+G G VY + +A G E+A+K+++++ + +
Sbjct: 3 EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL 62
Query: 116 LKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL 175
+ NE LV+ + ++ N+V L + DE ++ EYL SL D ++ G
Sbjct: 63 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIA 118
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
+ ++ L +LH + ++IHRD+K+ NILL + K++DFG +SK +T
Sbjct: 119 AVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST- 174
Query: 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
+ GT ++ PE V + K D++S G++ +E++ G+
Sbjct: 175 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-21
Identities = 60/198 (30%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 81 LGEGGFGPVYKGVLAKGDE-----IAVKRLS-VRSRQGLQELKNEALVIAKVQHKNLVRL 134
LG G FG VYKG+ E +A+K L+ + E +EAL++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
LG C+ +L + + +P+ L ++ + + +L L I +G++YL
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQL--LLNWCVQIAKGMMYLE---ER 128
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
R++HRDL A N+L+ KI+DFG+AR+ +G+E + N + ++ E ++
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 255 SIKSDVFSFGMLLLEILS 272
+ +SDV+S+G+ + E+++
Sbjct: 189 THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 5e-21
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 28/200 (14%)
Query: 71 ATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS-RQG-----LQELKNEALVI 123
++ KLGEG FG VYK + G +A+K++ + + + G L+E+K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 124 AKVQHKNLVRLLGCCIER-----DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
K++H N+V L+ +ER ++ +Y P D V L +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN---------E 229
++EG+ YLH I+HRD+KA+NIL+D + KI+DFG+AR + G
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 230 SKANTNRVAGTFGYIPPEYV 249
+ T Y PPE +
Sbjct: 179 GTRKYTNLVVTRWYRPPELL 198
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-21
Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 74 NFSDTNKLGEGGFGPVY--------KGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAK 125
+ +G G FG V+ K V+ K +I V++++ R Q NE V+
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIK--QIPVEQMTKDERLAAQ---NECQVLKL 55
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185
+ H N++ +E +++ EY P +L ++ LL+ T L I+ L
Sbjct: 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLAL 114
Query: 186 LYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
++H I+HRDLK NILLDK +M KI DFG+++I ++SKA T V GT YI
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGTPCYI 168
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTE 278
PE + KSD+++ G +L E+ S K+ E
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 6e-21
Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 18/275 (6%)
Query: 54 TKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG 112
+ E+ L S SV ++ K+G+G G VY + +A G E+A+++++++ +
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 113 LQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELG 172
+ + NE LV+ + ++ N+V L + DE ++ EYL SL D ++ G
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEG 116
Query: 173 TRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232
+ ++ L +LH + ++IHRD+K+ NILL + K++DFG +SK
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172
Query: 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK---NTEFYHTGYL-SIN 288
+ + GT ++ PE V + K D++S G++ +E++ G+ N YL + N
Sbjct: 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 289 GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323
G + Q K+ S + R F C + V G
Sbjct: 232 GTPELQNPEKL----SAIFRDFLNRCLDMDVEKRG 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQG-LQELKNEALVIAKVQHKNLV 132
F+ ++G+G FG VYKG+ + E+ A+K + + + +++++ E V+++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
R G ++ + +I EYL S D K LE I+ I++GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
R IHRD+KA+N+LL ++ K++DFG+A + K NT GT ++ PE + Q
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
K+D++S G+ +E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 39/212 (18%)
Query: 80 KLGEGGFGPVYK-GVLAKGDEIAVKRLSVRSRQG---LQELKNEALVIAKVQHKNLVRLL 135
++GEG G V+K G+ +A+K++++R +G Q L+ E + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLL 65
Query: 136 -----GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTR---LQIIEGIVEGLLY 187
G +L+ EY+P+ L L D +R L E + +++G+
Sbjct: 66 DVFPHGSGF-----VLVMEYMPS-DLSEVLRDE-ERPLPEAQVKSYMRMLLKGVA----- 113
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
++H+ I+HRDLK +N+L+ + KI+DFG+AR+F E + +++VA T Y PE
Sbjct: 114 -YMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPE 170
Query: 248 YVY------QGICSIKSDVFSFGMLLLEILSG 273
+Y G+ D+++ G + E+L+G
Sbjct: 171 LLYGARKYDPGV-----DLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQG---LQELKNEALVIAKVQHKN 130
FSD ++G G FG VY + E+ A+K++S +Q Q++ E + K++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
++ GC + L+ EY + D L + K+ L E+ + G ++GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AVTHGALQGLAYLHS 133
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
H+ +IHRD+KA NILL + K+ DFG A I A N GT ++ PE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 251 ---QGICSIKSDVFSFGMLLLEI 270
+G K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 28/217 (12%)
Query: 80 KLGEGGFGPVY----KGVLAKGDEI--AVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+LGEG FG V+ + + D+I AVK L S ++ EA ++ +QH+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFL-FDATKRVLLELGT---------RLQIIEGIVE 183
G C+E D ++++EY+ + L+ FL VL+ G L I + I
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAG---- 239
G++YL + +HRDL N L+ + + KI DFGM+R + + RV G
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTML 184
Query: 240 TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKK 275
++PPE + + +SDV+S G++L EI + GK+
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-20
Identities = 70/272 (25%), Positives = 133/272 (48%), Gaps = 18/272 (6%)
Query: 57 EVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE 115
E+ L + S+ ++ K+G+G G V+ + +A G E+A+K+++++ + +
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL 62
Query: 116 LKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL 175
+ NE LV+ ++++ N+V L + DE ++ EYL SL D ++
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIA 118
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
+ ++ L +LH + ++IHRD+K+ N+LL + K++DFG +SK +T
Sbjct: 119 AVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST- 174
Query: 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK---NTEFYHTGYL-SINGYD 291
+ GT ++ PE V + K D++S G++ +E++ G+ N YL + NG
Sbjct: 175 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323
+ Q K+ S + R F C + V G
Sbjct: 234 ELQNPEKL----SPIFRDFLNRCLEMDVEKRG 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-20
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 81 LGEGGFGPVYKGVL---AKGD-EIAVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRLL 135
+G G FG V G L K + +A+K L + + ++ +EA ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFL--FDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
G + +++ EY+ N SLD FL D V+ +G ++ GI G+ YL S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG----MLRGIASGMKYL---SD 124
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEY 248
+ +HRDL A NIL++ + K+SDFG++R+ + + A T R G IP PE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTAPEA 180
Query: 249 VYQGICSIKSDVFSFGMLLLEILS 272
+ + SDV+S+G+++ E++S
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 75/259 (28%), Positives = 118/259 (45%), Gaps = 45/259 (17%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQGL---QELKNEALVIAKVQHKN 130
F+D ++G G FG VY + +E+ A+K++S +Q Q++ E + +++H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ GC + L+ EY + D + + K+ L E+ I G ++GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIA-AICHGALQGLAYLHS 133
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV- 249
H R IHRD+KA NILL + K++DFG A + + N GT ++ PE +
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVIL 184
Query: 250 ------YQGICSIKSDVFSFGMLLLEILSGKKNTEF--------YHTGY-----LSINGY 290
Y G K DV+S G+ +E L+ +K F YH LS N +
Sbjct: 185 AMDEGQYDG----KVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW 239
Query: 291 DQTQVASKIKLVESCLARP 309
V+SCL +
Sbjct: 240 SD----YFRNFVDSCLQKI 254
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-20
Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGL------QELKNEALVIAKVQHKNLV 132
LG+G +G VY G+ +G IAVK++ + + L ++L+ E ++ ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFL--FDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ LG C++ + + E++P S+ L F + T+ QI++G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMAR---IFKGNESKANTNR-VAGTFGYIPP 246
+ ++HRD+K +N++L K+ DFG AR + + +N + + GT ++ P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSGK 274
E + + KSD++S G + E+ +GK
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-20
Identities = 63/193 (32%), Positives = 103/193 (53%), Gaps = 13/193 (6%)
Query: 81 LGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE 140
+G+G FG V G +G+++AVK +++ Q EA V+ +++H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 141 RDEKLLIY-EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
L I EY+ SL +L + R +L L+ + E + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 200 DLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSD 259
DL A N+L+ ++ K+SDFG+ + E+ + + + PE + + S KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 260 VFSFGMLLLEILS 272
V+SFG+LL EI S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-20
Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 28/223 (12%)
Query: 81 LGEGGFGPVYKGVLAKGDEI---AVK--RLSVRSRQGLQELKNEALVIAKVQHKNLVRLL 135
LGEG FG V +G L + D I AVK ++++ +R +++ +EA+ + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 136 GCCIERDEK------LLIYEYLPNKSLDFFLFDA---TKRVLLELGTRLQIIEGIVEGLL 186
G C++ E ++I ++ + L FL + L ++ + I G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA-RIFKGNESKANTNRVAGT-FGYI 244
YL S IHRDL A N +L++ M ++DFG++ +I+ G+ + R+A +I
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR--QGRIAKMPVKWI 181
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFY 280
E + + + KSDV+SFG+ + EI + G +N+E Y
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-20
Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 81 LGEGGFGPVYKGVLA----KGDEIAVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRLL 135
+G G FG V +G L + +A+K L + + ++ +EA ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLF--DATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
G + ++I E++ N +LD FL D V+ +G ++ GI G+ YL S
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG----MLRGIAAGMKYL---SE 124
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEY 248
+ +HRDL A NIL++ + K+SDFG++R + + S G G IP PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAPEA 182
Query: 249 VYQGICSIKSDVFSFGMLLLEILS 272
+ + SDV+S+G+++ E++S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 81 LGEGGFGPVYKGVLA---KGD---EIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLV 132
LG+G FG VY+G+ KG+ +A+K ++ R+ ++ L NEA V+ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFL-NEASVMKEFNCHHVV 72
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLF----DATKRVLLELGTRLQIIE---GIVEGL 185
RLLG L++ E + L +L +A L T + I+ I +G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTFGYI 244
YL + +HRDL A N ++ +++ KI DFGM R I++ + + + ++
Sbjct: 133 AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWM 188
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILS 272
PE + G+ + KSDV+SFG++L E+ +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-20
Identities = 69/204 (33%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 80 KLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQ-ELKN----EALVIAKVQHKNLVR 133
++G G FG V+ G L A +AVK R+ L +LK EA ++ + H N+VR
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKS----CRETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
L+G C ++ ++ E + + DF F T+ L++ +Q++E G+ YL
Sbjct: 58 LIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---S 112
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEY 248
IHRDL A N L+ ++ KISDFGM+R E + G IP PE
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 249 VYQGICSIKSDVFSFGMLLLEILS 272
+ G S +SDV+SFG+LL E S
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-20
Identities = 68/245 (27%), Positives = 115/245 (46%), Gaps = 30/245 (12%)
Query: 80 KLGEGGFGPVY----KGVLAKGDE--IAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+LGEG FG V+ + D+ +AVK L + ++ + EA ++ +QH+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFF----------LFDATKRVL---LELGTRLQIIEG 180
G C + D ++++EY+ + L+ F L D R L L L I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAG- 239
I G++YL + +HRDL N L+ + KI DFGM+R + + RV G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184
Query: 240 ---TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVA 296
++PPE + + +SDV+SFG++L EI + K F + I Q +V
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 244
Query: 297 SKIKL 301
+ ++
Sbjct: 245 ERPRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-20
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGL---QELKNEALVIAKVQHKNLVRLLG 136
+LG G FG V+ G ++A+K + +G ++ EA V+ K+ H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
C ++ ++ E++ N L +L ++ L L + + + EG+ YL R
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSF 121
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVYQGIC 254
IHRDL A N L+ K+SDFGM R +E T+ F + PPE
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY---TSSSGAKFPVKWSPPEVFNFSKY 178
Query: 255 SIKSDVFSFGMLLLEILSGKK 275
S KSDV+SFG+L+ E+ + K
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-20
Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 81 LGEGGFGPVYK-GVLAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+GGFG V V A G A K+L ++ R+G Q NE ++ KV + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
+D+ L+ + L + +++ + E + I+ GL HLH R RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLE--HLHQR-RI 116
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI 256
++RDLK N+LLD +ISD G+A KG AGT GY+ PE + +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 257 KSDVFSFGMLLLEILSGK 274
D F+ G L E+++G+
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 9e-20
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQ---GLQELKNEALVIAKVQHKN 130
F +++G G FG VY + +E+ AVK++S +Q Q++ E + +++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ GC ++ L+ EY + D L + K+ L E+ I G ++GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGLAYLHS 139
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
H+ +IHRD+KA NILL + + K++DFG A S AN+ GT ++ PE +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVIL 190
Query: 251 ---QGICSIKSDVFSFGMLLLEILSGK 274
+G K DV+S G+ +E+ K
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 79 NKLGEGGFGPVYKGV-LAKGDEIAVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRLLG 136
+G G VY + L +++A+KR+ + + + + EL+ E +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
+ DE L+ YL SL + + R L+ +++ +++GL YLH + +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 197 IHRDLKASNILLDKEMKPKISDFGM-ARIFKGNESKANT-NRVAGTFGYIPPEYVYQGI- 253
IHRD+KA NILL ++ KI+DFG+ A + G + GT ++ PE + Q
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
K+D++SFG+ +E+ +G
Sbjct: 184 YDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-19
Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 81 LGEGGFGPVYKGV-LAKGDEI----AVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRL 134
LG G FG V+KG+ + +GD I A+K + RS RQ QE+ + L + + H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEG--IVEGLLYLHLHS 192
LG C +L + + P SL D ++ L + + I +G+ YL H
Sbjct: 75 LGICPGASLQL-VTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH- 128
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
R++HR+L A NILL + +I+DFG+A + ++ K + ++ E + G
Sbjct: 129 --RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 253 ICSIKSDVFSFGMLLLEILS 272
+ +SDV+S+G+ + E++S
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 80 KLGEGGFGPVY----KGVLAKGDEI-------------AVKRLSV-RSRQGLQELKNEAL 121
KLGEG FG V+ G+ ++ AVK L S ++ E
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 122 VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFL--------FDATKRVLLELGT 173
+++++ N+ RLLG C +I EY+ N L+ FL A L T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 174 RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233
L + I G+ YL + +HRDL N L+ K KI+DFGM+R N ++
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184
Query: 234 TNRVAGT----FGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
RV G ++ E V G + KSDV++FG+ L EIL+
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 78 TNKLGEGGFGPVYK------GVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
+LG+G FG VYK G+ A A K + + S + L++ E ++++ +H N+
Sbjct: 10 IGELGDGAFGKVYKAQHKETGLFA-----AAKIIQIESEEELEDFMVEIDILSECKHPNI 64
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
V L ++ ++ E+ +LD + +R L E R + ++E L +LH H
Sbjct: 65 VGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH 122
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
++IHRDLKA NILL + K++DFG++ K K +T GT ++ PE V
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVV-- 175
Query: 252 GICSI--------KSDVFSFGMLLLEI 270
C K+D++S G+ L+E+
Sbjct: 176 -ACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-19
Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELK--------NEALVIAKVQHKNL 131
+LG+G FG VY K +RL V + EL EA +++K+ H +
Sbjct: 7 RLGKGSFGTVYLVKDKKAVA--EERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFL--FDATKRVLLELGTRLQIIEGIVEGLLYLH 189
V+ +ERD +I EY + LD L T + L E Q+ E ++ LL +H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN----QVCEWFIQLLLGVH 120
Query: 190 -LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
+H R RI+HRDLKA NI L + KI DFG++R+ G+ A T GT Y+ PE
Sbjct: 121 YMHQR-RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176
Query: 249 V-YQGICSIKSDVFSFGMLLLEI 270
+ +QG S KSD++S G +L E+
Sbjct: 177 LKHQGYDS-KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 19/203 (9%)
Query: 79 NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR-SRQGL-QELKNEALVIAKVQ---HKNLV 132
++GEG +G VYK L G +A+K++ V S +G+ E ++ +++ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 133 RLLGCC----IERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
RLL C +R+ KL L++E++ ++ L +L K L T ++ ++ G+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGL-PPETIKDLMRQLLRGVDF 122
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
LH H RI+HRDLK NIL+ + + KI+DFG+ARI+ E + V T Y PE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTS--VVVTLWYRAPE 176
Query: 248 YVYQGICSIKSDVFSFGMLLLEI 270
+ Q + D++S G + E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV---LAKGD---EIAVKRLSVRSRQGLQE-LKNEALVIAK 125
NN S LG G FG V + L+K D ++AVK L + +E L +E +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 126 V-QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
+ H+N+V LLG C L+I EY L FL + L L L + +G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
+ +L + IHRDL A N+LL KI DFG+AR + ++N V +
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARL 205
Query: 245 P-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
P PE ++ + + +SDV+S+G+LL EI S
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSV-RSRQGLQELKNEALVIAKVQHKNLV 132
F+ +G+G FG VYK + +A+K + + + +++++ E +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+ G ++ + +I EY S D K L+ I+ ++ GL YLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLH--- 115
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
IHRD+KA+NILL +E K++DFG++ SK NT GT ++ PE + Q
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQS 173
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
K+D++S G+ +E+ G+
Sbjct: 174 GYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVRSRQGLQE---LKNEALVIAK 125
+F ++G+GG+G V+ LAK G+ +A+KR+ L E + E ++
Sbjct: 1 KDFQILTQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT 57
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185
+ + LV+LL + + L EY+P DF VL E R + E + E +
Sbjct: 58 TKSEWLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAE-MFEAV 114
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
LH + IHRDLK N L+D K++DFG++ KG + AN+ V G+ Y+
Sbjct: 115 DALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANS--VVGSPDYMA 166
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSG 273
PE + D +S G +L E L G
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 71 ATNNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQGLQELKNEALVIAKV-QH 128
T F +GEG +G VYK K ++ A+K + + + +E+K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62
Query: 129 KNLVRLLGCCIER------DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQ------ 176
N+ G I++ D+ L+ E S+ D K L + G RL+
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT----DLVKG-LRKKGKRLKEEWIAY 117
Query: 177 IIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236
I+ + GL YLH + ++IHRD+K NILL K + K+ DFG++ + NT
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-- 172
Query: 237 VAGTFGYIPPEYV---YQGICSI--KSDVFSFGMLLLEILSGK 274
GT ++ PE + Q S +SDV+S G+ +E+ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 84 GGFGPVYKGVLAK----GDEIAVKRLSVRSRQG---LQELKNEALVIAKVQHKNLVRLLG 136
G +G V+ LAK GD A+K + + ++ E ++++ Q +V+L
Sbjct: 4 GAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGT------RLQIIEGIVEGLLYLH 189
+ + L L+ EYLP L +L +G+ R+ I E IV L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDL--------ASLLENVGSLDEDVARIYIAE-IVLALEYLH 110
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-------IFKGNESKANTNRVAGTFG 242
+ IIHRDLK NIL+D K++DFG+++ I ++ K + R+ GT
Sbjct: 111 SNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED-KRIVGTPD 166
Query: 243 YIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
YI PE + S D +S G +L E L G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 63/202 (31%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 81 LGEGGFGPVYKGVLAKGDEI--AVKRLSVRS--RQGLQE-LKNEALVIAKVQHKNLVRLL 135
LG GGFG V V K A+K + R G QE + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 136 GCCIERDEKLL--IYEYLPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+D+K + + EY L + R L + T I +V YLH
Sbjct: 60 --RTFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
II+RDLK N+LLD K+ DFG A+ K S T GT Y+ PE +
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK---SGQKTWTFCGTPEYVAPEIILNK 167
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
D +S G+LL E+L+G+
Sbjct: 168 GYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 74 NFSDTNKLGEGGFGPVYK-GVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKN 130
+F KLG+G +G VYK L+ A+K + + S++ ++ NE ++A V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 131 LVR-----LLGC--CIERDEKLLIYEYLPNKSLDFFLFD-ATKRVLLELGTRLQIIEGIV 182
++ L G CI + EY P L + KR L+ +I ++
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFG 242
GL LH +I+HRDLK++NILL KI D G++++ K N +K GT
Sbjct: 114 RGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPH 166
Query: 243 YIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGK 274
Y+ PE V++G S KSD++S G LL E+ +
Sbjct: 167 YMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 22/231 (9%)
Query: 79 NKLGEGGFGPVYKGVLAKGD--EIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRL 134
+G+G FG V K V K D + K + + + Q+L +E ++ +++H N+VR
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 135 LGCCIERDEKLL--IYEYLPNKSLDFFLFDATK-RVLLELGTRLQIIEGIVEGLLYLH-- 189
I+R + L + EY L + K R +E +I+ ++ L H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
++HRDLK +NI LD K+ DFG+A+I + S A T GT Y+ PE +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQL 182
Query: 250 YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIK 300
KSD++S G L+ E+ + F +Q Q+ASKIK
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALS--PPF--------TARNQLQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 80 KLGEGGFGPVYKGVLAKGDEI-AVKRLSVR------SRQGLQELKNEALVIAKVQHKNLV 132
K+GEG +G VYK EI A+K++ +R + L+E+K ++ ++ H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+LL + + L++E++ D + ++ L + +++GL + H H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY-Q 251
I+HRDLK N+L++ E K++DFG+AR F G+ + T+ V T Y PE +
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVV-TRWYRAPELLLGD 173
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
S D++S G + E+LS +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 6e-18
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 43/217 (19%)
Query: 79 NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG---------LQELKNEALVIAKVQH 128
KLGEG + VYK G +A+K++ + R+ L+E+K ++ +++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK----LLQELKH 61
Query: 129 KNLVRLLGCCIERDEKLLIYEYLP--------NKSLDFFLFDATKRVLLELGTRLQIIEG 180
N++ LL + L++E++ +KS+ D K +L L+
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMT---LR---- 113
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
GL YLH + I+HRDLK +N+L+ + K++DFG+AR F G+ ++ T++V T
Sbjct: 114 ---GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-T 165
Query: 241 FGYIPPEYVYQGICSIKS---DVFSFGMLLLEILSGK 274
Y PE ++ G D++S G + E+L
Sbjct: 166 RWYRAPELLF-G-ARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 21/234 (8%)
Query: 74 NFSDTNKLGEGGFGPVY-------KGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV 126
+F +G+G FG V K + A + K+ V + ++ + NE ++ ++
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAM--KYMNKQKCVE-KGSVRNVLNERRILQEL 57
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL 186
H LV L + + L+ + L L + L + K E + I E IV L
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALE 114
Query: 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
YLH IIHRD+K NILLD++ I+DF +A + T +GT GY+ P
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAP 168
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIK 300
E + + S+ D +S G+ E L GK + + Q + +
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGK--RPYRGHSRTIRDQIRAKQETADVL 220
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 7e-18
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 49/203 (24%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQ------GLQELKNEALVIAK 125
+ + K+G+G FG V+K K +I A+K++ + + + L+E+K ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQL 67
Query: 126 VQHKNLVRLLGCCIERDEKL----------LIYEY--------LPNKSLDFFLFDATKRV 167
++H+N+V L+ C R + L++E+ L NK++ F L K+V
Sbjct: 68 LKHENVVNLIEIC--RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL-SEIKKV 124
Query: 168 LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227
+ L + GL Y+H R +I+HRD+KA+NIL+ K+ K++DFG+AR F
Sbjct: 125 MKML----------LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 228 NE-SKAN--TNRVAGTFGYIPPE 247
++ SK N TNRV T Y PPE
Sbjct: 172 SKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-18
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 41/211 (19%)
Query: 80 KLGEGGFGPVYK------GVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+LG+G FG VYK G LA A K + +S + L++ E ++A H +V+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALA-----AAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQ------IIEGIVEGLLY 187
LLG + ++ E+ P ++D ++LEL L I ++E L Y
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVD--------AIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
LH ++IIHRDLKA N+LL + K++DFG++ K ++ + GT ++ PE
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPE 180
Query: 248 YVYQGICSI--------KSDVFSFGMLLLEI 270
V +C K+D++S G+ L+E+
Sbjct: 181 VV---MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 9e-18
Identities = 54/210 (25%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG-LQELKNEALVIAKVQH---K 129
+ +G G +G VY+G + G +A+K +++ + + +++ E ++++++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQ-----IIEGIVEG 184
N+ + G ++ +I EY S+ R L++ G + II ++
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKYISVIIREVLVA 113
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L Y+H +V +IHRD+KA+NIL+ K+ DFG+A + N SK +T GT ++
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWM 168
Query: 245 PPEYVYQGIC-SIKSDVFSFGMLLLEILSG 273
PE + +G K+D++S G+ + E+ +G
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 22/205 (10%)
Query: 81 LGEGGFGPVYKGVLAK--------GDEIAVKRLSVRSRQG-LQELKNEALVIAKVQHKNL 131
LGEG FG V L + G+++AVK L S + +LK E ++ + H+N+
Sbjct: 12 LGEGHFGKVE---LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 132 VRLLGCCIERDEK--LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
V+ G C E LI E+LP+ SL +L ++ L +L+ I +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI--NLKQQLKYAVQICKGMDYLG 126
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES--KANTNRVAGTFGYIPPE 247
SR + +HRDL A N+L++ E + KI DFG+ + + ++ + + F Y PE
Sbjct: 127 --SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APE 182
Query: 248 YVYQGICSIKSDVFSFGMLLLEILS 272
+ Q I SDV+SFG+ L E+L+
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEI----AVKRL-SVRSRQGLQELKNEALVIAKVQH 128
F LG G FG VYKG+ + +G+++ A+K L S + +E+ +EA V+A V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTR--LQIIEGIVEGLL 186
++ RLLG C+ +L I + +P L D + +G++ L I +G+
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMN 123
Query: 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
YL R++HRDL A N+L+ KI+DFG+A++ +E + + ++
Sbjct: 124 YLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILS 272
E + I + +SDV+S+G+ + E+++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 79 NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
++G G +G VYK +A G+ +A+K + + + ++ E ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 138 CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL-HLHSRVRI 196
+ RD+ ++ EY SL ++ T+ L EL QI E L L +LH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSEL----QIAYVCRETLKGLAYLHET-GK 122
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV------- 249
IHRD+K +NILL ++ K++DFG++ +K + GT ++ PE
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGG 180
Query: 250 YQGICSIKSDVFSFGMLLLE 269
Y G C D+++ G+ +E
Sbjct: 181 YDGKC----DIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 80 KLGEGGFGPVYKGVLAKG---DE----IAVKRL----SVRSRQGLQELKNEALVIAKVQH 128
+LG+G FG VY+G+ AKG DE +A+K + S+R R E NEA V+ +
Sbjct: 13 ELGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVMKEFNC 68
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLF-------DATKRVLLELGTRLQIIEGI 181
++VRLLG + L+I E + L +L + + L +Q+ I
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF 241
+G+ YL+ + + +HRDL A N ++ ++ KI DFGM R + +
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEI 270
++ PE + G+ + SDV+SFG++L EI
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 38/220 (17%)
Query: 81 LGEGGFGPVYKGVLAKGDE-------IAVKRL-SVRSRQGLQELKNEALVIAKV-QHKNL 131
LGEG FG V K A G + +AVK L + + L +L +E ++ + +HKN+
Sbjct: 20 LGEGAFGQVVKAE-AVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFL-------FDATKRVLLELGTRL------QII 178
+ LLG C + ++ EY + +L FL A+ L
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRV 237
+ G+ +L + + IHRDL A N+L+ ++ KI+DFG+AR I + + TN
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN-- 193
Query: 238 AGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
G +P PE ++ + + +SDV+SFG+LL EI +
Sbjct: 194 ----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 73 NNFSDTNKLGEGGFGPVYKG-VLAKGDEIAVKRLSVRSRQGLQELKNEAL----VIAKVQ 127
N + +GEG +G V K A G+ +A+K+ + + +++K AL V+ +++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
H+N+V L + L++EY+ L+ L +A+ L R I +++ + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRS-YIWQLLQAIAY 115
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
H H IIHRD+K NIL+ + K+ DFG AR + + T+ VA T Y PE
Sbjct: 116 CHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 248 YVYQGICSIK----SDVFSFGMLLLEILSG 273
+ + DV++ G ++ E+L G
Sbjct: 172 LL---VGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 58/203 (28%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQG-LQELKNEALVIAKVQHKNLV 132
F+ ++G+G FG V+KG+ + ++ A+K + + + +++++ E V+++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 133 RLLGCCIERDEKLLIYEYLPNKS-LDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
+ G ++ + +I EYL S LD L A ++ T L+ I++GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLK---EILKGLDYLHSE 120
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
+ IHRD+KA+N+LL ++ K++DFG+A + K NT GT ++ PE + Q
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
K+D++S G+ +E+ G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 56/200 (28%), Positives = 107/200 (53%), Gaps = 18/200 (9%)
Query: 80 KLGEGGFGPVYKGVLAK----GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLL 135
K+GEG G V +A+ G ++AVK + +R +Q + L NE +++ QH+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ +E ++ E+L +L D + L + E +++ L YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG--- 137
Query: 196 IIHRDLKASNILLDKEMKPKISDFGM-ARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
+IHRD+K+ +ILL + + K+SDFG A+I K + + + GT ++ PE + +
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---LVGTPYWMAPEVISRTPY 194
Query: 255 SIKSDVFSFGMLLLEILSGK 274
+ D++S G++++E++ G+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSV-RSRQGL--QELKNEALVIAKVQHK 129
F N++GEG +G VY+ EI A+K++ + R G+ L+ E ++ ++H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 130 NLVRLLGCCIER--DEKLLIYEY----LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVE 183
N+V L + + D L+ EY L + L D E + ++ ++
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLAS------LLDNMPTPFSESQVKC-LMLQLLR 119
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGY 243
GL YLH + IIHRDLK SN+LL + KI+DFG+AR + G +K T +V T Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWY 174
Query: 244 IPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
PE + + D+++ G +L E+L+ K
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 52/234 (22%)
Query: 66 SSVAAATNNFSD---TNKLGEGGFGPVYKGV-LAKGDEIAVKRL------SVRSRQGLQE 115
S +A + S+ N++G G G VYK + G A+K + +VR RQ +E
Sbjct: 64 GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR-RQICRE 122
Query: 116 LKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLD-------FFLFDATKRVL 168
++ ++ V H N+V+ E ++ E++ SL+ FL D +++L
Sbjct: 123 IE----ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL 178
Query: 169 LELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228
G+ YLH R I+HRD+K SN+L++ KI+DFG++RI
Sbjct: 179 --------------SGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--A 219
Query: 229 ESKANTNRVAGTFGYIPPEYV--------YQGICSIKSDVFSFGMLLLEILSGK 274
++ N GT Y+ PE + Y G D++S G+ +LE G+
Sbjct: 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA---GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 66/199 (33%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKV-QHKNLVRLL 135
LG+G FG V L DE+ AVK L + ++ E V+A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
C +D + EY+ L F + E R E IV GL +LH
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHERG--- 116
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
II+RDLK N+LLD E KI+DFGM + +G T+ GT YI PE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 256 IKSDVFSFGMLLLEILSGK 274
D ++ G+LL E+L+G+
Sbjct: 175 PAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVK--RLSVRSRQGLQELKNEALVIAKVQHKN 130
NF K+GEG +G VYK G+ +A+K RL + E ++ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 131 LVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
+V+LL I + KL L++E+L ++ L F+ DA+ + L + +++GL + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
H R++HRDLK N+L++ E K++DFG+AR F G + T+ V T Y PE +
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 250 YQGICSIKS---DVFSFGMLLLEILSGK 274
C S D++S G + E+++ +
Sbjct: 173 LG--CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-17
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKG---------DEIAVKRLSVRSRQGLQELKNEALVIAK 125
+ K+GEG FG K +L K EI + ++S + R+ E + E V++
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSN 55
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185
++H N+V+ E ++ +Y L + +A + VL QI++ V+
Sbjct: 56 MKHPNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFP---EDQILDWFVQIC 111
Query: 186 LYL-HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L L H+H R +I+HRD+K+ NI L K+ K+ DFG+AR+ A T GT Y+
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYL 168
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + KSD+++ G +L E+ + K
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-17
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGD---------EIAVKRLSVRSRQGLQELKNEALVIA 124
+ K+GEG FG +Y LAK EI + ++ V+ ++ K E +++A
Sbjct: 1 RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEAS---KKEVILLA 54
Query: 125 KVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL---QIIEGI 181
K++H N+V E ++ EY D KR+ + G QI+
Sbjct: 55 KMKHPNIVTFFASFQENGRLFIVMEYCDGG-------DLMKRINRQRGVLFSEDQILSWF 107
Query: 182 VEGLLYL-HLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNESKANTNRVAG 239
V+ L L H+H R +I+HRD+K+ NI L K M K+ DFG+AR N+S G
Sbjct: 108 VQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVG 164
Query: 240 TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
T Y+ PE + K+D++S G +L E+ + K
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 32/213 (15%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHK 129
+ K+GEG G V +A G ++AVK++ +R +Q + L NE +++ QH
Sbjct: 20 YLDNFVKIGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQ------IIEGIVE 183
N+V + + DE ++ E+L +L T V TR+ + +++
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGAL-------TDIV---THTRMNEEQIATVCLAVLK 126
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR--VAGTF 241
L +LH +IHRD+K+ +ILL + + K+SDFG F SK R + GT
Sbjct: 127 ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTP 179
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
++ PE + + + D++S G++++E++ G+
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-17
Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 81 LGEGGFGPVYKGVLAKGDE-----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRL 134
LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTR--LQIIEGIVEGLLYLHLHS 192
LG C+ +L + + +P L D + +G++ L I +G+ YL
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQIAKGMSYLE--- 126
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
VR++HRDL A N+L+ KI+DFG+AR+ +E++ + + ++ E +
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 253 ICSIKSDVFSFGMLLLEILS 272
+ +SDV+S+G+ + E+++
Sbjct: 187 RFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-17
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 35/216 (16%)
Query: 80 KLGEGGFGPVYKGV---LAKGD---EIAVKRL----SVRSRQGLQELKNEALVIAKVQHK 129
+LG+G FG VY+G + KG+ +AVK + S+R R E NEA V+
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCH 69
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLF-------DATKRVLLELGTRLQIIEGIV 182
++VRLLG + L++ E + + L +L + R L +Q+ I
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTF 241
+G+ YL+ + +HRDL A N ++ + KI DFGM R I++ + + G
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR------KGGK 180
Query: 242 GYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
G +P PE + G+ + SD++SFG++L EI S
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 9e-17
Identities = 54/202 (26%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQG-LQELKNEALVIAKVQHKNLV 132
F+ K+G+G FG V+KG+ + ++ A+K + + + +++++ E V+++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+ G ++ + +I EYL S D + L+ I+ I++GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
+ IHRD+KA+N+LL + + K++DFG+A +++ N GT ++ PE + Q
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
K+D++S G+ +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-17
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSV------RSRQG-LQELKNEALVI 123
NF K+G+G F VYK + L G +A+K++ + ++RQ L+E+ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 124 AKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFL--FDATKRVLLELGTRLQIIEGI 181
++ H N+++ L IE +E ++ E L + F KR++ E T + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPER-TIWKYFVQL 115
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF 241
L H+HS+ RI+HRD+K +N+ + K+ D G+ R F + A++ + GT
Sbjct: 116 CSALE--HMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEI 270
Y+ PE +++ + KSD++S G LL E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 80 KLGEGGFGPVYKGVLAK--GDEIAVKRLSVRSRQG---LQELKNEALV--IAKVQHKNLV 132
++GEG +G V+K K G +A+KR+ V++ + L ++ A++ + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 133 RLLGCCI----ERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
RL C +R+ KL L++E++ ++ L +L D + T ++ ++ GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
LH H R++HRDLK NIL+ + K++DFG+ARI+ + V T Y PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 248 YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ Q + D++S G + E+ K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRL-----SVRSRQGLQELKNEALVIAKVQHKNLVRL 134
LG+G FG VY + G E+A K++ S + + + L+ E ++ +QH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 135 LGCCIERDEKLL--IYEYLPNKSLDFFLFDATKR--VLLELGTRLQIIEGIVEGLLYLHL 190
GC +R EK L EY+P S+ D K L E TR + I+EG+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTR-KYTRQILEGMSYLHS 124
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMA-RIFKGNESKANTNRVAGTFGYIPPEYV 249
+ I+HRD+K +NIL D K+ DFG + R+ S V GT ++ PE +
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 250 YQGICSIKSDVFSFGMLLLEILSGK 274
K+DV+S G ++E+L+ K
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-16
Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 20/206 (9%)
Query: 80 KLGEGGFGPVYKGVL---AKGDEIAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKNLVRLL 135
+LG G FG V KGV K ++A+K L + + ++ E+ EA ++ ++ + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
G C E + +L+ E L+ FL + K+ + + ++++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVY 250
+HRDL A N+LL + KISDFG+++ ++S A + G P PE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAGKWPLKWYAPECIN 171
Query: 251 QGICSIKSDVFSFGMLLLEILS-GKK 275
S +SDV+S+G+ + E S G+K
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 62/205 (30%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQGLQELK-NEALVIAKVQHKNL 131
NF KLGEG + VYKG EI A+K + + + +G E ++ +++H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
VRL ++ +L++EY+ +K L ++ R L+ T +++G+ + H +
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
R++HRDLK N+L++K + K++DFG+AR F G +N V T Y P+ V
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV-TLWYRAPD-VLL 173
Query: 252 G--ICSIKSDVFSFGMLLLEILSGK 274
G S D++S G ++ E+++G+
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSR-QGLQELK-NEALVIAKVQHKN 130
+++ K+GEG +G VYKG G +A+K++ + S +G+ E ++ ++QH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 131 LVRLLGCCIERDEKLLIYEYLP---NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
+V L ++ LI+E+L K LD L QI++GI+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----- 115
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
HSR R++HRDLK N+L+D + K++DFG+AR F G + T+ V T Y PE
Sbjct: 116 -FCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPE 171
Query: 248 YVYQGI-CSIKSDVFSFGMLLLEILSGK 274
+ S D++S G + E+ + K
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 81 LGEGGFGPVYKGVLAKGD---EIAVKRLS-VRSRQGLQELKNEALVIAKV-QHKNLVRLL 135
+GEG FG V K + K + A+KR+ S+ ++ E V+ K+ H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFL-----------FDATKRVLLELGTR--LQIIEGIV 182
G C R L EY P+ +L FL F L ++ L +
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFG 242
G+ YL S+ + IHRDL A NIL+ + KI+DFG++R G E V T G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV-----YVKKTMG 183
Query: 243 YIPP-----EYVYQGICSIKSDVFSFGMLLLEILS 272
+P E + + + SDV+S+G+LL EI+S
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 57/179 (31%), Positives = 97/179 (54%), Gaps = 26/179 (14%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEAL----VIAKVQHKNLVRL 134
K+GEG +G VYK G+ +A+K+ +R + + + A+ ++ ++ H N+VRL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKK--IRLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 135 LGCCIERDEKL-LIYEYLPNKSLDFFLF-DATKRVLLELGTRLQIIEG----IVEGLLYL 188
L + + KL L++E+L LD + D++ G +I+ +++G+ Y
Sbjct: 64 LDV-VHSENKLYLVFEFL---DLDLKKYMDSSP----LTGLDPPLIKSYLYQLLQGIAYC 115
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
H H R++HRDLK N+L+D+E K++DFG+AR F G + T+ V T Y PE
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 73/217 (33%), Positives = 105/217 (48%), Gaps = 38/217 (17%)
Query: 81 LGEGGFGPVYKGVLAK-GDEI--AVKRL-SVRSRQGLQELKNEALVIAKV-QHKNLVRLL 135
+GEG FG V + ++ K G ++ A+K L S ++ E V+ K+ H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL-------LELGTR--------LQIIEG 180
G C R + EY P +L FL RVL E GT LQ
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
+ G+ YL S + IHRDL A N+L+ + + KI+DFG++R G E V T
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEV-----YVKKT 176
Query: 241 FGYIPP-----EYVYQGICSIKSDVFSFGMLLLEILS 272
G +P E + + + KSDV+SFG+LL EI+S
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 39/210 (18%)
Query: 81 LGEGGFGPVYK-------GVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
LG G G V K V+AK + SVR +Q L+EL+ ++ + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR-KQILRELQ----IMHECRSPYIVS 67
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELG-TRLQ----IIEGIVEGLLYL 188
G + + + E++ SLD R+ + G ++ I +VEGL YL
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLD--------RIYKKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF----GYI 244
+ + RI+HRD+K SNIL++ + K+ DFG+ S N +A TF Y+
Sbjct: 120 Y--NVHRIMHRDIKPSNILVNSRGQIKLCDFGV--------SGELINSIADTFVGTSTYM 169
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + G ++KSDV+S G+ ++E+ GK
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 29/218 (13%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS-RQG-----LQELKNEALVIAKVQ 127
F ++GEG +G VYK G+ +A+K++ + + ++G ++E+K ++ ++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQLN 64
Query: 128 HKNLVRLLGCCIERDEKL----------LIYEYLPNKSLDFFLFDATKRVLLELGTRLQI 177
H+N+V L ++ + L L++EY+ + D + V
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVHFSEDHIKSF 121
Query: 178 IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV 237
++ ++EGL Y H + +HRD+K SNILL+ + + K++DFG+AR++ ES+ TN+V
Sbjct: 122 MKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 238 AGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGK 274
T Y PPE + + DV+S G +L E+ + K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 29/205 (14%)
Query: 80 KLGEGGFGPVYK------GVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+LG+G FG VYK GVLA A K + +S + L++ E ++A H N+V+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLA-----AAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
LL + ++ E+ ++D + + +R L E R+ + + +E L YLH +
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN-- 122
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+IIHRDLKA NIL + K++DFG++ K + + GT ++ PE V +
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVV---M 176
Query: 254 CSI--------KSDVFSFGMLLLEI 270
C K+DV+S G+ L+E+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 81 LGEGGFGPVYKGVLAK-GDEIAVKRLS-VRSRQGLQE-----LKNEALVIAKVQHKNLVR 133
LG G F Y+ K G +AVK+++ VR+ QE L+ E ++A++ H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFL--FDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
+LG E L E++ S+ L + A K ++ + E ++ GL YLH +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 192 SRVRIIHRDLKASNILLDKEMKP-KISDFGMARIFKGNESKAN--TNRVAGTFGYIPPEY 248
+IIHRD+K +N+L+D + +I+DFG A + A ++ GT ++ PE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGK 274
+ DV+S G +++E+ + K
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-16
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 81 LGEGGFGP--VYK----GVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRL 134
LG+G FG +Y+ L E+ + RLS + R+ NE ++++ +QH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL---NEIVILSLLQHPNIIAY 64
Query: 135 LGCCIERDEKLLI-YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
++ D LLI EY +L + K L E L + IV + Y+H +
Sbjct: 65 YNHFMD-DNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
I+HRD+K NI L K K+ DFG+++I S A T V GT Y+ PE
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVK 177
Query: 254 CSIKSDVFSFGMLLLEILSGKK 275
+ KSD+++ G +L E+L+ K+
Sbjct: 178 YNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 80 KLGEGGFGPVYKGV--LAKGDEI--AVKRLSVRSRQGLQEL-KNEALVIAKVQHKNLVRL 134
+GEG FG VY+GV + ++I AVK + ++E EA ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+G E + ++ E P L +L + L+L + + + L YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
R +HRD+ A N+L+ K+ DFG++R + +ES ++ ++ PE +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRRF 185
Query: 255 SIKSDVFSFGMLLLEILS-GKK 275
+ SDV+ FG+ + EIL G K
Sbjct: 186 TSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLS----VRSRQGLQELKNEALVIAKVQHKNLV 132
+G G FG V+ L + A+K ++ +R +Q Q + NE V+ +V H ++
Sbjct: 9 VGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSHPFII 64
Query: 133 RLLGCCIERDEKLL--IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
RL E D++ L + EY+P L +L ++ + T L IV L YLH
Sbjct: 65 RLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHS 119
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
I++RDLK NILLDKE K++DFG A+ + + T + GT Y+ PE +
Sbjct: 120 KE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVIQ 171
Query: 251 QGICSIKSDVFSFGMLLLEILSGK 274
+ D ++ G+L+ E+L G
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 80 KLGEGGFGPVY----KGVLAKGDE-------------IAVKRL-SVRSRQGLQELKNEAL 121
KLGEG FG V+ +G+ D+ +AVK L ++ + E
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 122 VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFL--------FDATKRVLLELGT 173
++++++ N++RLL CI D +I EY+ N L+ FL + V + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 174 RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKA 232
+ + I G+ YL S + +HRDL N L+ K KI+DFGM+R ++ G+ +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
R ++ E + G + SDV++FG+ L EIL+
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 80 KLGEGGFGPVY----KGVLA-----------KGDEIAVKRL-SVRSRQGLQELKNEALVI 123
KLGEG FG V+ +G+ + +AVK L + ++ + E ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 124 AKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTR--------- 174
+++++ N++RLLG C+ D +I EY+ N L+ FL
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 175 LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT 234
L + I G+ YL + + +HRDL N L+ KI+DFGM+R +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 235 NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
R ++ E + G + SDV++FG+ L E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSV---RSRQGLQELKNEALVIAKVQHK 129
NF K+G G F VY+ L +A+K++ + + Q+ E ++ ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFL--FDATKRVLLELGTRLQIIE--GIVEGL 185
N+++ L IE +E ++ E L + F KR++ E ++ VE
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
H+HSR R++HRD+K +N+ + K+ D G+ R F + A++ + GT Y+
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEI 270
PE +++ + KSD++S G LL E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
EA+++ V H +++R+ + ++ LP+ S D + + + L + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
+ I+EGL YLH RIIHRD+K NI ++ + I D G A+ +A
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
GT PE + + + K+D++S G++L E+L+
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 63/243 (25%), Positives = 114/243 (46%), Gaps = 23/243 (9%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSV---RSRQGLQELKNEALVIAKVQHK 129
NF K+G G F VY+ L G +A+K++ + + + E ++ ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFL--FDATKRVLLELGTRLQIIEGIVEGLLY 187
N+++ IE +E ++ E L + F KR++ E T + + L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE-KTVWKYFVQLCSALE- 120
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
H+HSR R++HRD+K +N+ + K+ D G+ R F + A++ + GT Y+ PE
Sbjct: 121 -HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 248 YVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIKLVESCLA 307
+++ + KSD++S G LL E+ + + + FY D+ + S K +E C
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYG---------DKMNLYSLCKKIEQCDY 225
Query: 308 RPF 310
P
Sbjct: 226 PPL 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 55/198 (27%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 80 KLGEGGFGPV-YKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
K+GEG G V V + G +AVK++ +R +Q + L NE +++ QH+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+ DE ++ E+L +L D + + +++ L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR--VAGTFGYIPPEYVYQGICSI 256
RD+K+ +ILL + + K+SDFG F SK R + GT ++ PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 257 KSDVFSFGMLLLEILSGK 274
+ D++S G++++E++ G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRL--SVRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
LG G +G V K I AVKR+ +V S++ + L + + + V V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 138 CIERDEKLLIYEYLPNKSLDFF---LFDATKRVLLE-LGTRLQIIEGIVEGLLYLHLHSR 193
R+ + I + + SLD F ++D + + LG +I IV+ L YLH S+
Sbjct: 69 LF-REGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILG---KIAVSIVKALEYLH--SK 122
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN--ESKANTNRVAGTFGYIPPEYV-- 249
+ +IHRD+K SN+L+++ + K+ DFG++ G +S A T AG Y+ PE +
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTID-AGCKPYMAPERINP 177
Query: 250 ---YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT 282
+G +KSDV+S G+ ++E+ +G+ + + T
Sbjct: 178 ELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKT 212
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 81 LGEGGFGPVYKGVLAKGDEI----AVKRLS-VRSRQGLQELKNEALVIAKVQHKNLVRLL 135
+G+G FG VY G L D AVK L+ + + +++ E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 136 GCCIERD-EKLLIYEYLPNKSLDFFLFDATKRVLLE--LGTRLQIIEGIVEGLLYLHLHS 192
G C+ + L++ Y+ + L F+ T ++ +G LQ+ +G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV----AKGMEYL---A 115
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTF--GYIPPEYVY 250
+ +HRDL A N +LD+ K++DFG+AR E + N ++ E +
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 251 QGICSIKSDVFSFGMLLLEILS 272
+ KSDV+SFG+LL E+++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 81 LGEGGFGPVYK----GVLAKGDE----IAVKRLSVR-SRQGLQELKNEALVIAKV-QHKN 130
LGEG FG V + G+ + +AVK L + + L +L +E ++ + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFL-----------FDATK--RVLLELGTRLQI 177
++ LLG C + +I EY +L FL FD TK L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 178 IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV 237
+ G+ YL SR R IHRDL A N+L+ ++ KI+DFG+AR + T+
Sbjct: 140 AYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 238 AGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++ PE ++ + + +SDV+SFG+L+ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 77/255 (30%), Positives = 121/255 (47%), Gaps = 29/255 (11%)
Query: 80 KLGEGGFGPVYKGVLA--KGDE-IAVKRLSVRSRQGL--QELKNEALVIAKVQHKNLVRL 134
+LG G FG V KG+ K ++ +AVK L + EL EA V+ ++ + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLF---DATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
+G C E + +L+ E L+ FL T++ + EL + + G+ YL
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL------VHQVSMGMKYLEET 114
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES--KANTNRVAGTFGYIPPEYV 249
+ +HRDL A N+LL + KISDFG+++ +E+ KA T+ Y P
Sbjct: 115 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 250 YQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSINGYDQTQVASKIKLVESCLAR 308
Y S KSDV+SFG+L+ E S G+K Y + G + TQ+ + +E
Sbjct: 172 YYKFSS-KSDVWSFGVLMWEAFSYGQKP-------YKGMKGNEVTQMIESGERMECPQRC 223
Query: 309 PFRQYCCILKVRTFG 323
P Y + T+G
Sbjct: 224 PPEMYDLMKLCWTYG 238
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 19/183 (10%)
Query: 80 KLGEGGFGPVYKGVLAKGD---EIAVKRL--SVRSRQGL-QELKNEALVIAKVQHKNLVR 133
+G G +G VYK G E A+K+ G+ Q E ++ +++H+N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 134 LLGCCIERDEKL--LIYEYLPNKSLDFFLFD-ATKRVLLELGTRLQIIEGIVEGLLYLHL 190
L+ +E +K L+++Y + F KRV + ++ I+ G+ YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 191 HSRVRIIHRDLKASNILLDKEMKP----KISDFGMARIFKGNESK--ANTNRVAGTFGYI 244
+ ++HRDLK +NIL+ E KI D G+AR+F K A+ + V T Y
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN-APLKPLADLDPVVVTIWYR 182
Query: 245 PPE 247
PE
Sbjct: 183 APE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 80 KLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
K+GEG G V G ++AVK++ +R +Q + L NE +++ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+ DE ++ E+L +L D + + ++ L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR--VAGTFGYIPPEYVYQGICSI 256
RD+K+ +ILL + + K+SDFG F SK R + GT ++ PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 257 KSDVFSFGMLLLEILSGK 274
+ D++S G++++E++ G+
Sbjct: 198 EVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 6e-15
Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 38/217 (17%)
Query: 81 LGEGGFGPVYKGVLAKGD---EIAVKRL-SVRSRQGLQELKNEALVIAKV-QHKNLVRLL 135
+GEG FG V K + K + A+KR+ S+ ++ E V+ K+ H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL-------LELGTR--------LQIIEG 180
G C R L EY P+ +L FL RVL + T L
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
+ G+ YL S+ + IHRDL A NIL+ + KI+DFG++R G E V T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV-----YVKKT 169
Query: 241 FGYIPP-----EYVYQGICSIKSDVFSFGMLLLEILS 272
G +P E + + + SDV+S+G+LL EI+S
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 8e-15
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 26/156 (16%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKR-----------LSVRSRQGLQELKNEALVIAKVQ 127
+LG+G FG VY G+ +A+K+ +++R + L++L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE--------- 56
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
H N+V+L E DE ++EY+ +L + L K II I++GL +
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223
+H H HRDLK N+L+ KI+DFG+AR
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 9e-15
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 51/234 (21%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQG----------------------LQELK 117
KLGEG FG V+ + ++ + R+G L+E+K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 118 NEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLE------- 170
++++++ N++RLLG C++ D +I EY+ N L+ FL + L +
Sbjct: 72 ----ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGND 124
Query: 171 ------------LGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISD 218
+ L + I G+ YL S + +HRDL N L+ + + KI+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 219 FGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
FGM+R + R ++ E + G + SDV++FG+ L EIL
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-15
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 81 LGEGGFGPVYKGVLA-KGDEIAVKRL-----SVRSRQGLQELKNEALVIAKVQHKNLVRL 134
LG+G FG VY A G E+AVK++ S + + + L+ E ++ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 135 LGCCIERDEKLL--IYEYLPNKSLDFFLFDATKR--VLLELGTRLQIIEGIVEGLLYLHL 190
GC + E+ L E++P S+ D K L E TR + I+EG+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTR-KYTRQILEGVSYLHS 124
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG-NESKANTNRVAGTFGYIPPEYV 249
+ I+HRD+K +NIL D K+ DFG ++ + S V GT ++ PE +
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 250 YQGICSIKSDVFSFGMLLLEILSGK 274
K+D++S G ++E+L+ K
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-15
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 81 LGEGGFGPVYKGVL-AKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+GGFG V + A G A K+L+ ++ R+G + E ++AKV H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATK--------RVLLELGTRLQIIEGIVEGLLY 187
+ L L+ + L + +++ + R QII G+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA---QIISGLE----- 111
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
HLH R RII+RDLK N+LLD + +ISD G+A K +SK T AGT G++ PE
Sbjct: 112 -HLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPE 167
Query: 248 YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ D F+ G+ L E+++ +
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG---LQELKNEALV--IAKVQHKNLVR 133
++G G +G VYK G +A+K + V++ + L ++ AL+ + H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 134 LLGCC----IERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
L+ C +R+ K+ L++E++ ++ L +L D L T ++ + GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
H + I+HRDLK NIL+ + K++DFG+ARI+ + V T Y PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGK 274
+ Q + D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 81 LGEGGFGPVY--------KGVLAKGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKN 130
LGEG FG V K K +AVK L + + L +L +E ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFL-----------FDATK--RVLLELGTRLQI 177
++ LLG C + ++ EY +L +L FD K L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 178 IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV 237
+ G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 238 AGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++ PE ++ + + +SDV+SFG+LL EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 81 LGEGGFGPVYKGVLA-KGDEIAVKRL-----SVRSRQGLQELKNEALVIAKVQHKNLVRL 134
LG G FG VY A G E+AVK++ S + + + L+ E ++ ++H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 135 LGCCIERDE-KLLIY-EYLPNKSLDFFLFDATKR--VLLELGTRLQIIEGIVEGLLYLHL 190
GC + +E KL I+ EY+P S+ D K L E TR + I++G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTR-RYTRQILQGVSYLHS 124
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMA-RIFKGNESKANTNRVAGTFGYIPPEYV 249
+ I+HRD+K +NIL D K+ DFG + RI S V GT ++ PE +
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 250 YQGICSIKSDVFSFGMLLLEILSGK 274
K+DV+S ++E+L+ K
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 81 LGEGGFGPVYKGVLAKG-----------DEIAVKRL-SVRSRQGLQELKNEALVIAKV-Q 127
LGEG FG V V+A+ ++AVK L S + + L +L +E ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLF-------------DATKRVLLELGTR 174
HKN++ LLG C + +I EY +L +L L
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 175 LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKAN 233
+ + G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR I + K
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 234 TNRVAGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
TN G +P PE ++ I + +SDV+SFG+LL EI +
Sbjct: 200 TN------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 65/214 (30%), Positives = 112/214 (52%), Gaps = 30/214 (14%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDE-IAVKRLSVRSRQGLQELKNEAL----VIAKVQHK 129
+ K+GEG +G VYK +E IA+K+ +R Q + + + A+ ++ ++QH
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKK--IRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 130 NLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLF-DATKRVLLELGTRLQIIEG----IVE 183
N+VRL + +++L L++EYL LD D++ + ++I+ I+
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYL---DLDLKKHMDSSP----DFAKNPRLIKTYLYQILR 113
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKP-KISDFGMARIFKGNESKANTNRVAGTFG 242
G+ Y H H R++HRDLK N+L+D+ K++DFG+AR F G + T+ V T
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLW 168
Query: 243 YIPPEYVYQGIC--SIKSDVFSFGMLLLEILSGK 274
Y PE + G S D++S G + E+++ K
Sbjct: 169 YRAPE-ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 36/210 (17%)
Query: 81 LGEGGFGPVY--KGVLAK--GDEIAVK-----RLSVRSRQGLQELKNEALVIAKVQHKNL 131
LG+G FG V+ + + G A+K L VR R K E ++A+V H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV---RTKMERDILAEVNHPFI 60
Query: 132 VRLLGCCIERDEKL-LIYEYLPNKSL-------DFFLFDATKRVLLELGTRLQIIEGIVE 183
V+L + + KL LI ++L L F + K L EL L
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD------- 112
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGY 243
HLHS + II+RDLK NILLD+E K++DFG+++ +E KA + GT Y
Sbjct: 113 -----HLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 164
Query: 244 IPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
+ PE V + + +D +SFG+L+ E+L+G
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 75 FSDTNKLGEGGFGPVYK-GVLAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKN 130
F LG+GGFG V V A G A K+L ++ R+G NE ++ KV +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+V L +D L+ + L F ++ + E E I GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLH- 119
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMA-RIFKGNESKANTNRVAGTFGYIPPEYV 249
+ RI++RDLK NILLD +ISD G+A + +G K RV GT GY+ PE V
Sbjct: 120 --QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG---RV-GTVGYMAPEVV 173
Query: 250 YQGICSIKSDVFSFGMLLLEILSGK 274
+ D ++ G LL E+++G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-14
Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRS-----RQGLQELKNEALVIAKV 126
+ D ++G G FG V K + G +AVKR+ ++ L +L V+ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD----VVMRS 59
Query: 127 QH-KNLVRLLGCCIERDEKLLIYEYLPNKSLDFF---LFDATKRVLLE--LGTRLQIIEG 180
+V+ G + + E L + SLD F +++ K V+ E LG +I
Sbjct: 60 SDCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPEEILG---KIAVA 115
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN--ESKANTNRVA 238
V+ L YL ++IIHRD+K SNILLD+ K+ DFG++ G +S A T R A
Sbjct: 116 TVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKT-RDA 168
Query: 239 GTFGYIPPEYV----YQGICSIKSDVFSFGMLLLEILSGK 274
G Y+ PE + G ++SDV+S G+ L E+ +GK
Sbjct: 169 GCRPYMAPERIDPSARDGY-DVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 23/222 (10%)
Query: 81 LGEGGFGPVYKGVLAK---GDEIAVKRLSVR----------SRQGLQELKNEALVIAK-V 126
LG G FG VYK V K + +A+K ++V + + ++ +E +I + +
Sbjct: 8 LGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSL-DFFLFDATKRVLLELGTRLQIIEGIVEGL 185
+H N+VR +E D ++ + + L + F K+ I +V L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
YLH RI+HRDL +NI+L ++ K I+DFG+A+ K ESK + V GT Y
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTS--VVGTILYSC 181
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI 287
PE V K+DV++FG +L ++ + FY T LS+
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNMLSL 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 7e-14
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLS----VRSRQGLQELKNEALVIAKVQHKNLV 132
LG G FG V L + G A+K LS V+ +Q ++ + NE ++ ++H LV
Sbjct: 9 LGTGSFGRVM---LVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64
Query: 133 RLLGCCIERDEKLL--IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
L G +D+ L + EY+P L F + R E R + +V L YLH
Sbjct: 65 NLYGS--FQDDSNLYLVMEYVPGGEL-FSHLRKSGR-FPEPVARFYAAQ-VVLALEYLH- 118
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
+ I++RDLK N+LLD + KI+DFG A+ KG T + GT Y+ PE +
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIIL 171
Query: 251 QGICSIKSDVFSFGMLLLEILSG 273
D ++ G+L+ E+L+G
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 33/211 (15%)
Query: 83 EGGFGPVYKGVL-----AKGDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLG 136
EG FG ++ G+L K +E+ VK + + + + L E+ ++ + H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 137 CCIERDEKLLIYEYLPNKS-LDFFLFDA-----------TKRVLLELGTRLQIIEGIVEG 184
CIE E + N L FL + + L+ + +QI G+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA--IQIACGMS-- 131
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNES--KANTNRVAGTF 241
+LH R +IH+D+ A N ++D+E++ KI+D ++R +F + N NR
Sbjct: 132 ----YLHKR-GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR---PV 183
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++ E + S SDV+SFG+LL E+++
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE-IAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKNLVRLLG 136
+KLGEG + VYKG D +A+K + + +G E ++ ++H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
L++EYL +K L +L D + + +L + + ++ GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFLFQ-LLRGLNYCH---RRKV 125
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI-CS 255
+HRDLK N+L+++ + K++DFG+AR K +K +N V T Y PP+ + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRPPDILLGSTDYS 183
Query: 256 IKSDVFSFGMLLLEILSGK 274
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 68/202 (33%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQGLQELKNEALVIAK------VQHKNLVR 133
LG+G FG V L +E A+K L + L++ E ++ + +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL--KKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 134 LLGCCIERDEKLL-IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
L C + E L + EYL L F + + + E R E I+ GL +LH
Sbjct: 61 LF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAE-IICGLQFLHKKG 116
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
II+RDLK N+LLDK+ KI+DFGM + E KA+T GT YI PE +
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQ 171
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
+ D +SFG+LL E+L G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 65/198 (32%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 81 LGEGGFGPVYK-GVLAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+GGFG V V A G A K+L ++ R+G NE ++ KV + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
+D L+ + L F +++ E E I GL LH R RI
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDLH---RERI 123
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI 256
++RDLK NILLD +ISD G+A E+ RV GT GY+ PE V +
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGRV-GTVGYMAPEVVKNERYTF 180
Query: 257 KSDVFSFGMLLLEILSGK 274
D + G L+ E++ GK
Sbjct: 181 SPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 67/200 (33%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 81 LGEGGFGPVYKGVL-AKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+G FG V L KG+ AVK L V ++ E V+A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 137 CCIERDEKLL-IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
C + E L + E+L L F + D + +L IV GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI-C 254
II+RDLK N++LD++ KI+DFGM + +++A+T GT YI PE + QG+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPE-ILQGLKY 173
Query: 255 SIKSDVFSFGMLLLEILSGK 274
+ D +SFG+LL E+L G+
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 81 LGEGGFGPVYKGVLAKGDE--------IAVKRLSVR-SRQGLQELKNEALVIAKV-QHKN 130
LGEG FG V D+ +AVK L + + L +L +E ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFL-----------FDATKRVLLELGTRLQIIE 179
++ LLG C + +I EY +L +L +D RV E T ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA-RVPDEQMTFKDLVS 141
Query: 180 ---GIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236
+ G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++ PE ++ + + +SDV+SFG+L+ EI +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 61/226 (26%), Positives = 111/226 (49%), Gaps = 33/226 (14%)
Query: 81 LGEGGFGPVYKGVLAKGD----EIAVKRLS--VRSRQGLQELKNEALVIAKVQHKNLVRL 134
LG+G FG V + L D ++AVK L + S ++E EA + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 135 LGCCIERDEK------LLIYEYLPNKSLDFFLFDA---TKRVLLELGTRLQIIEGIVEGL 185
+G + K ++I ++ + L FL + + L L T ++ + I G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGN---ESKANTNRVAGTF 241
YL S IHRDL A N +L++ M ++DFG+++ I+ G+ + A+ V
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK--- 180
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFY 280
++ E + + + SDV++FG+ + EI++ G +N+E Y
Sbjct: 181 -WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 29/206 (14%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLSVRSRQGLQELKNEALVIAK------VQHKN 130
LG+G FG V +LA+ G AVK L + LQ+ E + K H
Sbjct: 3 LGKGSFGKV---MLARLKESGRLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 131 LVRLLGCCIERDEKLL-IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
L +L CC + ++L + E++ L F + R E R E I L++LH
Sbjct: 58 LTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAE-ITSALMFLH 113
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR--IFKGNESKANTNRVAGTFGYIPPE 247
II+RDLK N+LLD E K++DFGM + IF G T+ GT YI PE
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPE 166
Query: 248 YVYQGICSIKSDVFSFGMLLLEILSG 273
+ + + D ++ G+LL E+L G
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDE-IAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+ D LG G G V+ V + D+ +AVK++ + Q ++ E +I ++ H N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 134 L--------------LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGT------ 173
+ +G E + ++ EY+ + +LE G
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM----------ETDLANVLEQGPLSEEHA 116
Query: 174 RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNES-K 231
RL + + ++ GL Y+H ++HRDLK +N+ ++ E + KI DFG+ARI + S K
Sbjct: 117 RLFMYQ-LLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172
Query: 232 ANTNRVAGTFGYIPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
+ T Y P + K+ D+++ G + E+L+GK
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 71 ATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQ-ELKNEALVIAKVQH 128
A ++ + KLGEG + VYKG+ G +A+K +S+++ +G+ EA ++ ++H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 129 KNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
N+V LL I E L ++EY+ + + L RL + + ++ GL Y
Sbjct: 63 ANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFMFQ-LLRGLAY 118
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
+H I+HRDLK N+L+ + K++DFG+AR K S+ ++ V T Y PP+
Sbjct: 119 IH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPD 173
Query: 248 YVYQGICSIKS--DVFSFGMLLLEILSGK 274
V G S D++ G + +E+L G+
Sbjct: 174 -VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 75 FSDTNKLGEGGFGPVYK-GVLAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKN 130
F LG+GGFG V V A G A KRL ++ R+G NE ++ KV +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+V L +D L+ + L F +++ E E I+ GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLH- 119
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
R ++RDLK NILLD +ISD G+A K E ++ RV GT GY+ PE +
Sbjct: 120 --RENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMAPEVLN 174
Query: 251 QGICSIKSDVFSFGMLLLEILSGK 274
++ D + G L+ E++ G+
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 23/233 (9%)
Query: 81 LGEGGFGPVYKGVLAKGDEI----AVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+G FG V+ L ++ A+K+ V ++ E V++ + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 137 CCIERDEKLL-IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
C + E L + EYL L F + K +L I+ GL +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG--- 116
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
I++RDLK NILLD + KI+DFGM + + A T GT YI PE + +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 256 IKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIKLVESCLAR 308
D +SFG+LL E+L G+ +G+D+ ++ I++ C R
Sbjct: 175 TSVDWWSFGVLLYEMLIGQS----------PFHGHDEEELFQSIRMDNPCYPR 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-13
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 81 LGEGGFGPVYKGVLAKGDE----IAVK--RLSVRSRQGLQELKNEALVIAKVQHKNLVRL 134
LG G FG + +G L + +A+ R +Q L EAL + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRL 71
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
G + +++ EY+ N +LD FL + L G + ++ G+ G+ YL S +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYL---SEM 126
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFG------YIPPEY 248
+H+ L A +L++ ++ KIS F + E K+ + T + PE
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEA--IYTTMSGKSPVLWAAPEA 179
Query: 249 VYQGICSIKSDVFSFGMLLLEILS 272
+ S SDV+SFG+++ E++S
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 77 DTNKLGEGGFGPVYKGVLAKGD-EIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLL 135
+ N + G G YKG K + VK + + +E + K+QH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKE--INDVNSIPS--SEIADMGKLQHPNIVKLI 749
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELG--TRLQIIEGIVEGLLYLHLHSR 193
G C LI+EY+ K+L VL L R +I GI + L +LH
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNL--------SEVLRNLSWERRRKIAIGIAKALRFLHCRCS 801
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
++ +L I++D + +P + + + Y+ PE
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKD 854
Query: 254 CSIKSDVFSFGMLLLEILSGKKNTE 278
+ KSD++ FG++L+E+L+GK +
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE-IAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKNLVRLLG 136
KLGEG + V+KG + +A+K + + +G E ++ ++H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ D+ L L++EYL +K L ++ D ++ + + I+ GL Y H R +
Sbjct: 72 I-VHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRK 124
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY-QGIC 254
++HRDLK N+L+++ + K++DFG+AR K +K +N V T Y PP+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 255 SIKSDVFSFGMLLLEILSGK 274
S + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 34/209 (16%)
Query: 80 KLGEGGFGPVYK-------------GVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV 126
K+GEG +G V+K + D+ +K++++R + L++LK
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK--------- 58
Query: 127 QHKNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185
H NLV L+ R KL L++EY + L+ + R + E + +II ++ +
Sbjct: 59 -HPNLVNLIEV-FRRKRKLHLVFEYCDHTVLN--ELEKNPRGVPEHLIK-KIIWQTLQAV 113
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
+ H H+ IHRD+K NIL+ K+ + K+ DFG ARI G T+ VA T Y
Sbjct: 114 NFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVA-TRWYRA 168
Query: 246 PEY-VYQGICSIKSDVFSFGMLLLEILSG 273
PE V DV++ G + E+L+G
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 81 LGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCI 139
+G G +G VYKG K ++A ++ + +E+K E ++ K H+N+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 140 ER------DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
++ D+ L+ E+ S+ L TK L+ I I+ GL +LH H
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY--- 250
++IHRD+K N+LL + + K+ DFG++ + NT GT ++ PE +
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDE 187
Query: 251 --QGICSIKSDVFSFGMLLLEILSG 273
KSD++S G+ +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 43/98 (43%), Positives = 56/98 (57%), Gaps = 13/98 (13%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR--IFKGNESKANTNRVA 238
I GL +LH II+RDLK N++LD E KI+DFGM + IF G T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162
Query: 239 GTFGYIPPEYV-YQGICSIKS-DVFSFGMLLLEILSGK 274
GT YI PE + YQ KS D ++FG+LL E+L+G+
Sbjct: 163 GTPDYIAPEIIAYQPYG--KSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQGLQELKNEALVIAK------VQHKNLVR 133
LG+G FG V L DE+ A+K L + LQ+ + + K +H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVL--KKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
L C +D + EY+ L F + + K E +R E + L++LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAE-VTLALMFLHRHG- 116
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+I+RDLK NILLD E K++DFGM + +G + T GT YI PE + +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
D ++ G+L+ E+++G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 46/223 (20%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRS-RQG-----LQELKNEALVIAKV 126
+ N++ EG +G VY+ K EI A+K+L + ++G L+E+ ++ K+
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN----ILLKL 61
Query: 127 QHKNLVRL----LGC----------CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELG 172
QH N+V + +G +E D K L+ E + FL K ++
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQP----FLQSEVKCLM---- 112
Query: 173 TRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232
LQ++ G+ HLH I+HRDLK SN+LL+ KI DFG+AR +
Sbjct: 113 --LQLLSGVA------HLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163
Query: 233 NTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGK 274
V T Y PE + S D++S G + E+L+ K
Sbjct: 164 TQLVV--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 81 LGEGGFGPV------YKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRL 134
LG+GGFG V G + ++ KRL +S + + L+ E ++ KV +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKVNSPFIVNL 58
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+ L+ + L + +++ +R L E+ + I G+L HLHS +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGIL--HLHS-M 114
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
I++RD+K N+LLD + ++SD G+A K ++ + AGT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPY 171
Query: 255 SIKSDVFSFGMLLLEILSGK 274
S D F+ G + E+++G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 81 LGEGGFGPVYK-GVLAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+GGFG V V A G A K+L ++ R+G NE ++ KV + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
+D L+ + L F +++ E E + GL L R RI
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RERI 123
Query: 197 IHRDLKASNILLDKEMKPKISDFGMA-RIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
++RDLK NILLD +ISD G+A +I +G + RV GT GY+ PE + +
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG---RV-GTVGYMAPEVINNEKYT 179
Query: 256 IKSDVFSFGMLLLEILSGK 274
D + G L+ E++ G+
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
+GEG FG D+ A+K + + +S +++ + EA+++AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES- 66
Query: 139 IERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL-HLHSRVRI 196
E D L ++ EY L K +L I++ V+ L + H+H + R+
Sbjct: 67 FEADGHLYIVMEYCDGGDL----MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-RV 121
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI 256
+HRD+K+ NI L + K K+ DFG AR+ + A T GT Y+PPE +
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNN 179
Query: 257 KSDVFSFGMLLLEILSGK 274
KSD++S G +L E+ + K
Sbjct: 180 KSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 81 LGEGGFGPVYKGVLA-KGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKN--LVRL 134
+G GGFG VY A G A+K L ++ +QG NE ++++ V + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 135 LGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
+ +KL I + + L + L + V E R E I+ GL H+H+R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAE-IILGLE--HMHNR 116
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+++RDLK +NILLD+ +ISD G+A F SK + GT GY+ PE + +G+
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGV 171
Query: 254 CSIKS-DVFSFGMLLLEILSG 273
S D FS G +L ++L G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 65 FSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRL------SVRSRQGLQELK 117
F +V TN + D +G G FG V G +A+K++ V +++ +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 118 NEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQI 177
++ ++H+N++ L I E + L L R+L Q
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLH--------RLLTSRPLEKQF 109
Query: 178 IE----GIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233
I+ I+ GL Y+H ++HRDLK SNIL+++ KI DFG+ARI +
Sbjct: 110 IQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM 162
Query: 234 TNRVAGTFGYIPPEYV--YQGICSIKSDVFSFGMLLLEILSGK 274
T V+ + Y PE + +Q ++ D++S G + E+L GK
Sbjct: 163 TGYVSTRY-YRAPEIMLTWQKY-DVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 25/199 (12%)
Query: 84 GGFGPVYKGVLAK----GDEIAVKRLSVRSRQGLQELKN----EALVIAKVQHKNLVRLL 135
G FG VY LAK GD A+K L ++ N A+++ + + + +L
Sbjct: 7 GAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+D L+ EYL + T L E + I E +V G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAE-VVLGVEDLHQRG--- 117
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
IIHRD+K N+L+D+ K++DFG++R G E+K + GT Y+ PE G+
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLENK----KFVGTPDYLAPE-TILGVGD 170
Query: 256 IK-SDVFSFGMLLLEILSG 273
K SD +S G ++ E L G
Sbjct: 171 DKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 55/234 (23%)
Query: 79 NKLGEGGFGPVYKGV-LAKGDEIAVKRLSV--------RSRQ----------GLQELKNE 119
LGEG +G V K G +A+K++ + + RQ L+ELK
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-- 72
Query: 120 ALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN---KSLD--FFLFDATKRVLLELGTR 174
++ +++H+N++ L+ +E D L+ + + + K +D L ++ + +L
Sbjct: 73 --IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL----- 125
Query: 175 LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF--------- 225
LQI+ G+ LH +HRDL +NI ++ + KI+DFG+AR +
Sbjct: 126 LQILNGLNV------LHKW-YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 226 ---KGNESKAN-TNRVAGTFGYIPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
+ + + T++V T Y PE + + D++S G + E+L+GK
Sbjct: 179 SKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 81 LGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCI 139
+G G +G VYKG K ++A ++ + +E+K E ++ K H+N+ G I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 140 ER------DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
++ D+ L+ E+ S+ L TK L+ I I+ GL +LH H
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHAH-- 140
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY--- 250
++IHRD+K N+LL + + K+ DFG++ + NT GT ++ PE +
Sbjct: 141 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDE 197
Query: 251 --QGICSIKSDVFSFGMLLLEILSG 273
+SD++S G+ +E+ G
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 62 LFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEA 120
+ S+ T+ + +G+G +G VYK K G AVK L S +E++ E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 121 LVIAKV-QHKNLVRLLGCCIERDEKL-----LIYEYLPNKSLDFFLFDATKRVLLELGTR 174
++ + H N+V+ G + D+ + L+ E S+ + + LL G R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 175 LQIIEGIVEGLLY------LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228
L E ++ +LY HLH+ RIIHRD+K +NILL E K+ DFG++
Sbjct: 125 LD--EAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 229 ESKANTNRVAGTFGYIPPEYV-----YQGICSIKSDVFSFGMLLLEILSG 273
+ NT+ GT ++ PE + Y + DV+S G+ +E+ G
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 32/213 (15%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ------HKNLV 132
+++G G FG V G +G ++ R+ V+ + + L + +VQ H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFL--------FDATKRVLLELGTRLQIIEGIVEG 184
+ LG CIE LL+ E+ P L +L A K VL + + G
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE------VASG 112
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
LL+LH + IH DL N L ++ KI D+G+A + + A ++
Sbjct: 113 LLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169
Query: 245 PPEYV---YQGICSIK----SDVFSFGMLLLEI 270
PE V Q + S+++S G+ + E+
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 59/199 (29%), Positives = 109/199 (54%), Gaps = 14/199 (7%)
Query: 80 KLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSR-QGLQELK-NEALVIAKVQHKNLVRLLG 136
K+GEG +G V+K + EI A+KR+ + +G+ E ++ +++HKN+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ D+KL L++EY ++ L + FD+ ++ + +++GL + H H
Sbjct: 67 V-LHSDKKLTLVFEYC-DQDLKKY-FDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG-IC 254
++HRDLK N+L++K + K++DFG+AR F G + + V T Y PP+ ++ +
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 255 SIKSDVFSFGMLLLEILSG 273
S D++S G + E+ +
Sbjct: 178 STSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 81 LGEGGFGPVYKGVLA-KGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKN--LVRL 134
+G GGFG VY A G A+K L ++ +QG NE ++++ V + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 135 LGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
+ +KL I + + L + L + V E R E I+ GL H+H+R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATE-IILGLE--HMHNR 116
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+++RDLK +NILLD+ +ISD G+A F SK + GT GY+ PE + +G
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGT 171
Query: 254 CSIKS-DVFSFGMLLLEILSG 273
S D FS G +L ++L G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 81 LGEGGFGPVYKGVLAKGDE----IAVKRLS----VRSRQGLQELKNEALVIAKVQHKNLV 132
LG+GG+G V++ G + A+K L VR+++ K E ++ V+H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 133 RLLGCCIERDEKL-LIYEYLPNKSL-------DFFLFDATKRVLLELGTRLQIIEGIVEG 184
L+ + KL LI EYL L F+ D L E+ L+
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE-------- 114
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR--IFKGNESKANTNRVAGTFG 242
HLH + II+RDLK NILLD + K++DFG+ + I +G T+ GT
Sbjct: 115 ----HLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIE 165
Query: 243 YIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
Y+ PE + + D +S G L+ ++L+G
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 8e-12
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRL-------SVRSRQGLQELKNEALVIAK 125
++F ++LG G G V K I ++L ++R+ Q ++EL+ V+ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN-QIIRELQ----VLHE 59
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185
+V G E + E++ SLD L +A KR+ E+ ++ I ++ GL
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSI--AVLRGL 116
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
YL + +I+HRD+K SNIL++ + K+ DFG++ G + N GT Y+
Sbjct: 117 AYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMS 170
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + S++SD++S G+ L+E+ G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 73 NNFSDTNKLGEGGFGPVYKG-VLAKGDEIAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKN 130
+++ KLGEG + VYKG G +A+K + ++ +G EA ++ ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+V L ++ L++EY+ + D L +L + + ++ GL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQ-LLRGLSYIH- 120
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
+ I+HRDLK N+L+ + K++DFG+AR K S +N V T Y PP+ +
Sbjct: 121 --QRYILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVV-TLWYRPPDVLL 176
Query: 251 QGI-CSIKSDVFSFGMLLLEILSG 273
S D++ G + +E++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 70/218 (32%), Positives = 103/218 (47%), Gaps = 34/218 (15%)
Query: 81 LGEGGFGPVYKG-VLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHK-----NLVRL 134
+G G G VYK G +AVK++ R G +E L+ V K +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL--QIIEGIVEGLLYLHL-H 191
G I D + I L + LD L KR+ + + ++ IV+ L YL H
Sbjct: 80 YGYFI-TDSDVFICMELMSTCLDKLL----KRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMA-RIFKGNESKANTNRVAGTFGYIPPEYV- 249
+IHRD+K SNILLD K+ DFG++ R+ +SKA T R AG Y+ PE +
Sbjct: 135 G---VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERID 187
Query: 250 ---YQGICSIKSDVFSFGMLLLEILSGK-----KNTEF 279
I++DV+S G+ L+E+ +G+ TEF
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 24/193 (12%)
Query: 97 GDEIAVKRLSVRSRQGLQE---LKNEALVIAKVQHKNLVRLLGCCIERDEKLL-IYEYLP 152
G E+A+K L + + + + E + A++ H N+V LL L ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 153 NKSLDFFLFDATKRVLLELGT---RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL- 208
++L L A L T LQ+++ + H++ I+HRDLK NI++
Sbjct: 63 GRTLREVL--AADGALPAGETGRLMLQVLDALA------CAHNQ-GIVHRDLKPQNIMVS 113
Query: 209 --DKEMKPKISDFGMARIFKGNESKA-----NTNRVAGTFGYIPPEYVYQGICSIKSDVF 261
K+ DFG+ + G T V GT Y PE + + SD++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 262 SFGMLLLEILSGK 274
++G++ LE L+G+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 74 NFSDTNKLGEGGFGPVY----KGVLAKGDEIAVKRLS----VRSRQGLQELKNEALVIAK 125
NF LG G +G V+ G G A+K L V+ + + + E V+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 126 VQHKNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
V+ + L + D KL LI +Y+ L L+ E+ R+ I E IV
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV--RVYIAE-IVLA 117
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L +LH ++ II+RD+K NILLD E ++DFG+++ F E + GT Y+
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYM 173
Query: 245 PPEYVYQGICSIKS--DVFSFGMLLLEILSG 273
PE + G D +S G+L E+L+G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 81 LGEGGFGPV----YKG--------VLAKGDEIAVKRLSVRSRQGLQELKNEA---LVIAK 125
LG G FG V YK L KGD IA R ++ L E
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA--------RDEVESLMCEKRIFETANS 58
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185
+H LV L C D + EY L + V E +V GL
Sbjct: 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAAC-VVLGL 114
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
YLH + +I++RDLK N+LLD E KI+DFG+ + G + +T GT ++
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFLA 169
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSG 273
PE + + + D + G+L+ E+L G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 81 LGEGGFGPVYKGVLAKGDEI----AVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
+G G + V L K + I VK+ V + + ++ E V + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 137 CCIERDEKLL-IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
C + + +L + EY+ L F + +R L E R E I L YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 116
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
II+RDLK N+LLD E K++D+GM + +G T+ GT YI PE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 256 IKSDVFSFGMLLLEILSGK 274
D ++ G+L+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK--GDEIAVKRLSVRSRQGLQ-ELKNEALVIAKVQHK 129
++F ++LG G G V+K V K G +A K + + + ++ ++ E V+ +
Sbjct: 5 DDFEKISELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
+V G E + E++ SLD L A + LG ++ +++GL YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYLR 120
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
+ +I+HRD+K SNIL++ + K+ DFG++ G + N GT Y+ PE +
Sbjct: 121 --EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERL 174
Query: 250 YQGICSIKSDVFSFGMLLLEILSGK 274
S++SD++S G+ L+E+ G+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-11
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 81 LGEGGFGPVYKGVL----AKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVR 133
LG+G FG V +L A G A+K L + ++ + E+ V+ +H L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
L +D + EY+ L F L + +RV E TR E IV L YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAE-IVSALDYLH---S 113
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+I++RDLK N++LDK+ KI+DFG+ + +G A GT Y+ PE +
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
D + G+++ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 81 LGEGGFGPVYKG-VLAKGDEIAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKNLVRLLGCC 138
LG G G VYK L +AVK + + LQ ++ +E ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+ + E++ SLD + +++ + R+ + +V+GL YL ++I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAV--AVVKGLTYLW---SLKILH 118
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKS 258
RD+K SN+L++ + K+ DFG++ + +K GT Y+ PE + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERISGEQYGIHS 174
Query: 259 DVFSFGMLLLEILSGK 274
DV+S G+ +E+ G+
Sbjct: 175 DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 68/216 (31%), Positives = 111/216 (51%), Gaps = 38/216 (17%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEI-AVKRL--SVRSRQG----------LQELKNEALVIAK 125
KLG+G +G V+K + + E+ A+K++ + R+ LQEL +
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65
Query: 126 VQHKNLVRLLGCC-IERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVE 183
H N+V+LL E D+ + L++EY ++ L + +LE + I+ +++
Sbjct: 66 --HPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRYIMYQLLK 118
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF-KGNESKAN---TNRVAG 239
L Y +HS +IHRDLK SNILL+ + + K++DFG+AR + E+ N T+ VA
Sbjct: 119 ALKY--IHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA- 174
Query: 240 TFGYIPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
T Y PE + K D++S G +L E+L GK
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 8/99 (8%)
Query: 184 GLLYL-------HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236
GLL++ H+HS+ +IHRD+K++NILL K+ DFG ++++ S
Sbjct: 146 GLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204
Query: 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
GT Y+ PE + S K+D+FS G+LL E+L+ K+
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 81 LGEGGFGPVYKGVLAKGDEI----AVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
+G G + V L K D+I VK+ V + + ++ E V + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
C + +L L+ EY+ L F + +R L E R E I L +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHERG--- 116
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
II+RDLK N+LLD + K++D+GM + +G T+ GT YI PE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 256 IKSDVFSFGMLLLEILSGK 274
D ++ G+L+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 34/209 (16%)
Query: 80 KLGEGGFGPVY-------------KGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV 126
+GEG +G V K L D+ VK++++R + L++L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR--------- 58
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL-LELGTRLQIIEGIVEGL 185
H+NLV L+ + L++E++ + LD D K L+ + + I+ G+
Sbjct: 59 -HENLVNLIEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGI 113
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
+ H H+ IIHRD+K NIL+ + K+ DFG AR + T+ VA T Y
Sbjct: 114 EFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVA-TRWYRA 168
Query: 246 PEYVYQGICSIKS-DVFSFGMLLLEILSG 273
PE + ++ D+++ G L+ E+L+G
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRL-------SVRSRQGLQELKNEALVIAKV 126
+F +LG G G V K + I ++L ++R+ Q ++ELK V+ +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-QIIRELK----VLHEC 56
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL 186
+V G E + E++ SLD L A + LG +I ++ GL
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG---KISIAVLRGLT 113
Query: 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN--ESKANTNRVAGTFGYI 244
YL + +I+HRD+K SNIL++ + K+ DFG++ G +S AN+ GT Y+
Sbjct: 114 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANS--FVGTRSYM 165
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + +++SD++S G+ L+E+ G+
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 57/200 (28%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 79 NKLGEGGFGPVYKG-VLAKGDEIAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKNLVRLLG 136
+KLGEG + V+KG + +A+K + + +G E ++ ++H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
I + L L++EYL + L +L D ++ ++ + + ++ GL Y H + +
Sbjct: 71 I-IHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRK 123
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI-C 254
I+HRDLK N+L++++ + K++DFG+AR K +K +N V T Y PP+ +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 255 SIKSDVFSFGMLLLEILSGK 274
S D++ G +L E+ +G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKNLVRLLGC 137
KLGEG + VYKG G +A+K + + +G EA ++ ++H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 138 CIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
I + L L++EYL + L ++ D L RL + + ++ GL Y H + R+
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRLFLFQ-LLRGLAYCH---QRRV 124
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC-S 255
+HRDLK N+L+ + + K++DFG+AR K SK +N V T Y PP+ + S
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVV-TLWYRPPDVLLGSTEYS 182
Query: 256 IKSDVFSFGMLLLEILSG 273
D++ G + E+ +G
Sbjct: 183 TSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 33/83 (39%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
L SR + IHRDL A NILL + KI DFG+AR + ++ PE +
Sbjct: 189 LASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247
Query: 250 YQGICSIKSDVFSFGMLLLEILS 272
+ + + +SDV+SFG+LL EI S
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 51/218 (23%)
Query: 81 LGEGGFGPVYKGVLAKGDE-IAVKRLSVRSRQGLQELKN---EALVIAKVQHKNLVRLLG 136
+G G +G V K +A+K+LS R Q K E ++ + H+N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 137 CCIERDEKLLIYEYLPNKSLDFF--------LFDATKRVLLELGT--RLQ---------I 177
+ P SL+ F L A +L + Q +
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGA------DLNNIVKCQKLSDDHIQFL 123
Query: 178 IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV 237
+ I+ GL Y+H IIHRDLK SNI ++++ + KI DFG+AR + + T V
Sbjct: 124 VYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEM-TGYV 176
Query: 238 AGTFGYIPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
A T Y PE + + ++ D++S G ++ E+L+GK
Sbjct: 177 A-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 53/228 (23%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQ-----GLQELKNEALVIAKVQ 127
+ + + +GEG +G V G ++A+K++S Q L+E+K ++ + +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61
Query: 128 HKNLVRLLG-----------------CCIERD-EKLLIYEYLPNKSLDFFLFDATKRVLL 169
H+N++ +L +E D KL+ ++L N + +FL+
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-------- 113
Query: 170 ELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229
QI+ G L Y+H ++HRDLK SN+LL+ KI DFG+ARI
Sbjct: 114 ------QILRG----LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160
Query: 230 --SKANTNRVAGTFGYIPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
+ T VA T Y PE + K+ D++S G +L E+LS +
Sbjct: 161 DHTGFLTEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
+++ ++G G +G VYK L G+ AVK + + ++ E ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQI---IEGIVEGLLYL 188
V G + R++ + EY SL ++ T + + LQI ++GL YL
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPL-----SELQIAYVCRETLQGLAYL 122
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
H + +HRD+K +NILL K++DFG+A K + A GT ++ PE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEV 177
Query: 249 V-------YQGICSIKSDVFSFGMLLLEI 270
Y +C D+++ G+ +E+
Sbjct: 178 AAVEKNGGYNQLC----DIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 81 LGEGGFGPVYKGVL---------AKGDEIAVKRLSVRSRQGLQELKNE-ALVIAKVQHKN 130
LG+G F +YKGVL G E++V + S E A +++++ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
LV+L G C+ RDE +++ EY+ LD FL V L +L + + + L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNV--SLHWKLDVAKQLASALHYLE- 118
Query: 191 HSRVRIIHRDLKASNILL-----DKEMKP--KISDFGMARIFKGNESKANTNRVAGTFGY 243
+++H ++ NIL+ ++ P K+SD G+ E + R+ +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER--VERIP----W 170
Query: 244 IPPEYVYQGICSIKS--DVFSFGMLLLEILSGKK 275
I PE + G S+ D +SFG LLEI S +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+F ++G G +G VYK + G+ A+K + + + ++ E +++ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII---EGIVEGLLYLH 189
G + RD+ + E+ SL ++ T + + QI ++GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPL-----SESQIAYVSRETLQGLYYLH 123
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
+ +HRD+K +NILL K++DFG++ +K + GT ++ PE
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVA 178
Query: 250 -------YQGICSIKSDVFSFGMLLLEI 270
Y +C D+++ G+ +E+
Sbjct: 179 AVERKGGYNQLC----DIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 80 KLGEGGFGPVYKGVLAKG---DEIAVKRLSVRSRQGLQELKN---EALVIAKVQHKNLVR 133
++G G FG V G + G ++ VK L R +QE EA +QH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKEL--RVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLL--ELGTRLQIIEGIVEGLLYLHLH 191
LG C E LL+ E+ P L +L K L+ + T ++ I GLL+LH +
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
+ IH DL N LL ++ KI D+G++ + +++ +I PE V
Sbjct: 120 N---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 74 NFSDTNKLGEGGFGPV----YKGVLAKGDEIAVKRLS------VRSRQGLQELKNEALVI 123
+ +LG+G +G V ++ + +A+K+++ + +++ L+ELK L+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56
Query: 124 AKVQHKNLVRLLGCCIERDEK---LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQ---- 176
HKN+ L I L +YE L +A ++ G L
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEEL---------MEADLHQIIRSGQPLTDAHF 107
Query: 177 --IIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN- 233
I I+ GL Y+H ++HRDLK N+L++ + + KI DFG+AR F N +
Sbjct: 108 QSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 234 --TNRVAGTFGYIPPEYV--YQGICSIKSDVFSFGMLLLEILSGK 274
T VA T Y PE + +Q + DV+S G +L E+L K
Sbjct: 165 FMTEYVA-TRWYRAPEIMLSFQS-YTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 34/83 (40%), Positives = 47/83 (56%), Gaps = 1/83 (1%)
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
L SR + IHRDL A NILL + KI DFG+AR + ++ PE +
Sbjct: 195 LASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 253
Query: 250 YQGICSIKSDVFSFGMLLLEILS 272
+ + +I+SDV+SFG+LL EI S
Sbjct: 254 FDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 81 LGEGGFGPVYKGVLAK-GD-------EIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
LG+G F ++KG+ + GD E+ +K L R + A +++++ HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
G C+ DE +++ EY+ SLD +L + L+ + +L++ + + L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 193 RVRIIHRDLKASNILL-----DKEMKP---KISDFGMARIFKGNESKANTNRVAGTFGYI 244
+ H ++ A N+LL K P K+SD G++ E R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERIP----WV 171
Query: 245 PPEYVYQG-ICSIKSDVFSFGMLLLEILSG 273
PPE + S+ +D +SFG L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 4e-10
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 55/229 (24%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS------VRSRQGLQELKNEALVIAKVQ 127
+ +G G +G V V + G ++A+K++S + +++ L+E+K ++ ++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK----LLRHLR 57
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFF-------LFDA-------TKRVLLELGT 173
H+N++ LL ++ P DF L + + + L +
Sbjct: 58 HENIIGLL---------DILR---PPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD--D 103
Query: 174 RLQ-IIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232
+Q + I+ GL YLH +IHRDLK SNIL++ KI DFG+AR +E +
Sbjct: 104 HIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 233 N--TNRVAGTFGYIPPEYVYQGICSIKS-----DVFSFGMLLLEILSGK 274
T V T Y PE + S D++S G + E+L+ K
Sbjct: 161 GFLTEYVV-TRWYRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR--IFKGNESKANTNRVA 238
I GL +LH II+RDLK N++LD E KI+DFGM + ++ G T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
GT YI PE + D ++FG+LL E+L+G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-10
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS-RQGL--QELKNEALVIAKVQH 128
+ + K+GEG +G VYK G +A+K+ + +G+ L+ +L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 129 KNLVRLLGCCIERDEK-------LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGI 181
+VRLL +E E+ L++EYL + L F+ D+ R G +
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGR-----GPGRPLPAKT 111
Query: 182 VEGLLY------LHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNESKANT 234
++ +Y H H ++HRDLK N+L+DK+ KI+D G+ R F K+ T
Sbjct: 112 IKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-IPVKSYT 169
Query: 235 NRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSG 273
+ + T Y PE + S D++S G + E+
Sbjct: 170 HEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 33/83 (39%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
L SR + IHRDL A NILL + KI DFG+AR + ++ PE +
Sbjct: 190 LASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248
Query: 250 YQGICSIKSDVFSFGMLLLEILS 272
+ + + +SDV+SFG+LL EI S
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV-AG 239
I GL +LH R II+RDLK N++LD E KI+DFGM K + T R G
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMC---KEHMVDGVTTRTFCG 163
Query: 240 TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
T YI PE + D +++G+LL E+L+G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 61/197 (30%), Positives = 90/197 (45%), Gaps = 42/197 (21%)
Query: 97 GDEIAVKRLSVRSRQGLQELKN---EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153
G +A+K+LS R Q + K E +++ V HKN++ LL + P
Sbjct: 41 GQNVAIKKLS-RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQ 87
Query: 154 KSLDFF--------LFDAT--KRVLLELG-TRL-----QIIEGIVEGLLYLHLHSRVRII 197
KSL+ F L DA + + ++L R+ Q++ GI HLHS II
Sbjct: 88 KSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK------HLHS-AGII 140
Query: 198 HRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIK 257
HRDLK SNI++ + KI DFG+AR S T V T Y PE +
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYYRAPEVILGMGYKEN 197
Query: 258 SDVFSFGMLLLEILSGK 274
D++S G ++ E++ G
Sbjct: 198 VDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 81 LGEGGFGPVYKGVL----AKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVR 133
LG+G FG V +L A G A+K L + ++ + E+ V+ +H L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
L D + EY L F L + +RV E R E IV L YLH SR
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLH--SR 114
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+++RD+K N++LDK+ KI+DFG+ + +G A GT Y+ PE +
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
D + G+++ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
I+ GL YLH I+HRD+K N+L++ KI DFG+AR+ + +ESK T V
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 241 FGYIPPEYV-----YQGICSIKSDVFSFGMLLLEILSGK 274
+ Y PE + Y D++S G + E+L +
Sbjct: 169 Y-YRAPEILMGSRHYTS----AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 74 NFSDTNKLGEGGFGPVY----KGVLAKGDEIAVKRLS----VRSRQGLQELKNEALVIAK 125
NF LG G +G V+ G A+K L V+ + ++ + E V+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 126 VQHKNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
V+ + L + + KL LI +Y+ + L+ + E R E I+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGE-IILA 117
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L +LH ++ I++RD+K NILLD E ++DFG+++ F +E K T GT Y+
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL-SEEKERTYSFCGTIEYM 173
Query: 245 PPEYVY-QGICSIKSDVFSFGMLLLEILSG 273
PE + +G D +S G+L+ E+L+G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLSVRSRQGLQELKN----EALVIAKVQHKNLV 132
+G+G FG V +LAK G AVK L ++ +E + +++ ++H LV
Sbjct: 3 IGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 133 RLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
L + EKL + +Y+ L F L +R LE R E + + YLH
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLH-- 113
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
+ II+RDLK NILLD + ++DFG+ + +G E + T+ GT Y+ PE + +
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 252 GICSIKSDVFSFGMLLLEILSG 273
D + G +L E+L G
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVR 133
LG+G FG V +L K G A+K L + ++ + E V+ +H L
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
L D + EY L F L + +RV E R E IV L YLH S
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SE 114
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+++RDLK N++LDK+ KI+DFG+ + +G + A GT Y+ PE +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
D + G+++ E++ G+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 59/190 (31%), Positives = 99/190 (52%), Gaps = 28/190 (14%)
Query: 95 AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE---YL 151
K + + KR+ SR +Q L+NE L + ++ H+N++++ E++L E Y+
Sbjct: 190 PKCERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKI--------EEILRSEANTYM 240
Query: 152 PNKSLDFFL--------FDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKA 203
+ DF L FD R LL+ TR I++ ++ + Y+H ++IHRD+K
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLK-QTR-AIMKQLLCAVEYIH---DKKLIHRDIKL 295
Query: 204 SNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFS 262
NI L+ + K + DFG A F+ E +A GT PE + G C I +D++S
Sbjct: 296 ENIFLNCDGKIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWS 353
Query: 263 FGMLLLEILS 272
G++LL++LS
Sbjct: 354 CGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGD--EIAVKRLS----VRSRQGLQELKNEALVIAKVQ 127
+F+ LG G FG V D +A+KR ++ +Q + + +E ++ +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ-VDHVFSERKILNYIN 89
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLF-DATKRVLLELGT--RLQIIEGIVEG 184
H V L G + L+ E++ +FF F KR ++G QI+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFPNDVGCFYAAQIV------ 141
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L++ +L S + I++RDLK N+LLDK+ K++DFG A++ T + GT YI
Sbjct: 142 LIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYI 195
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSG 273
PE + +D ++ G+ + EIL G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 45/221 (20%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS------VRSRQGLQELKNEALVIAKVQ 127
+ + + +G G +G V K G +AVK+LS + +++ +EL+ ++ ++
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLKHMK 74
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFF--LFDATKRVLLELGTRLQ--------- 176
H+N++ LL + P +SL+ F ++ T + +L ++
Sbjct: 75 HENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 122
Query: 177 --IIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT 234
+I I+ GL Y+H IIHRDLK SN+ ++++ + KI DFG+AR + T
Sbjct: 123 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT 175
Query: 235 NRVAGTFGYIPPEYVYQGI-CSIKSDVFSFGMLLLEILSGK 274
VA T Y PE + + + D++S G ++ E+L+G+
Sbjct: 176 GYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 79 NKLGEGGFGPVYK------GVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
++LG+G +G VYK GV EI ++ + Q + EL ++ K +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIV 62
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
G + EY+ SLD + +I +V+GL +L
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--E 120
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN--ESKANTNRVAGTFGYIPPEYVY 250
IIHRD+K +N+L++ + K+ DFG++ GN S A TN G Y+ PE +
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN--IGCQSYMAPERIK 174
Query: 251 QG------ICSIKSDVFSFGMLLLEILSGK 274
G +++SDV+S G+ +LE+ G+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 81 LGEGGFGPVYKGVLA--KGDEI--AVKRLS----VRSRQGLQELKNEALVIAKVQHKNLV 132
+G+G FG V +LA K +E AVK L ++ ++ + +++ V+H LV
Sbjct: 3 IGKGSFGKV---LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
L D+ + +Y+ L + L +R LE R E I L YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLH--- 113
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
+ I++RDLK NILLD + ++DFG+ + + E T+ GT Y+ PE +++
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 253 ICSIKSDVFSFGMLLLEILSG 273
D + G +L E+L G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 32/81 (39%), Positives = 46/81 (56%), Gaps = 10/81 (12%)
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVYQ 251
IHRDL A NILL KI DFG+AR + + ++N V +P PE ++
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNARLPVKWMAPESIFN 290
Query: 252 GICSIKSDVFSFGMLLLEILS 272
+ + +SDV+S+G+LL EI S
Sbjct: 291 CVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 81 LGEGGFGPVYKGVLAKGDEI----AVKRLSVRSRQGLQELKNEALVI-AKVQHKNLVRLL 135
+G G + V L K I +K+ V + + ++ E V H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH-LHSRV 194
C + E++ L F + +R L E R E L L+ LH R
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEIS----LALNFLHER- 115
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
II+RDLK N+LLD E K++D+GM + +G T+ GT YI PE +
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 255 SIKSDVFSFGMLLLEILSGK 274
D ++ G+L+ E+++G+
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRL 134
+G+G +G V L + G + +K+L++R SR+ + + EA ++++++H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 135 LGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVE---GLLYLHL 190
D L ++ + L L + ++L E Q++E V+ L YLH
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPEN----QVVEWFVQIAMALQYLH- 119
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
I+HRDLK N+ L + K+ D G+AR+ + A+T + GT Y+ PE
Sbjct: 120 --EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFS 175
Query: 251 QGICSIKSDVFSFGMLLLEILSGK 274
+ KSDV++ G + E+ + K
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 40/212 (18%)
Query: 81 LGEGGFGPVYKGVLAK-GDEIAVKRLS--VRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
+G G +G V + + G+++A+K+LS +S + E ++ +QH+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80
Query: 138 CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEG--------------IVE 183
+ + ++ DF+L V+ + T LQ I G ++
Sbjct: 81 --DVFTSAVSG----DEFQDFYL------VMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC 128
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGY 243
GL Y+H IIHRDLK N+ ++++ + KI DFG+AR + A T Y
Sbjct: 129 GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 180
Query: 244 IPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
PE + + ++ D++S G ++ E+L+GK
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 41/128 (32%), Positives = 66/128 (51%), Gaps = 27/128 (21%)
Query: 169 LELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR----- 223
L+L L+ + +G+ +L + IHRD+ A N+LL KI DFG+AR
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 224 ---IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKK---- 275
+ KGN R+ ++ PE ++ + +++SDV+S+G+LL EI S GK
Sbjct: 266 SNYVVKGNA------RLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
Query: 276 ---NTEFY 280
N++FY
Sbjct: 318 ILVNSKFY 325
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLS---VRSRQGLQELKNEALVIAK-VQHKNLV 132
+G+G FG V LAK G AVK L + ++ + + E V+ K V+H LV
Sbjct: 3 IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
L D+ + +Y+ L F L +R E R E I L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLH--- 113
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
+ II+RDLK NILLD + ++DFG+ + +G E T+ GT Y+ PE + +
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 253 ICSIKSDVFSFGMLLLEILSG 273
D + G +L E+L G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 35/230 (15%)
Query: 65 FSSVAAATNNFSDTNKLGEGGFGPVYKGVLAK--GDEIAVKRLSVRSRQGLQELKNEALV 122
F S ++ + +G+G +G V+K VL K G + AVK L +E++ E +
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-EEIEAEYNI 67
Query: 123 I-AKVQHKNLVRLLGCCIERDEK-----LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQ 176
+ A H N+V+ G ++D K L+ E S+ D K L+ G R++
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT----DLVKG-FLKRGERME 122
Query: 177 --IIEGIV-EGLLYL-HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232
II I+ E L+ L HLH + IHRD+K +NILL E K+ DFG++ +
Sbjct: 123 EPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 233 NTNRVAGTFGYIPPEYV---------YQGICSIKSDVFSFGMLLLEILSG 273
NT+ GT ++ PE + Y C DV+S G+ +E+ G
Sbjct: 182 NTS--VGTPFWMAPEVIACEQQLDSTYDARC----DVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 27/225 (12%)
Query: 64 SFSSVAAATN-NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALV 122
S S A+ ++ + L G G V+ V K + K++ V++ G + E +
Sbjct: 82 SSSDPASVVRMQYNILSSLTPGSEGEVF--VCTKHGDEQRKKVIVKAVTGGKTPGREIDI 139
Query: 123 IAKVQHKNLVRLLG--------CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTR 174
+ + H+ ++ L+ C + K ++ Y+ L L
Sbjct: 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP------------LPLEQA 187
Query: 175 LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT 234
+ I ++E L YLH IIHRD+K NI LD+ + DFG A +
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 235 NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEF 279
+GT PE + K+D++S G++L E +S K T F
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVR 133
LG+G FG V +L + G A+K L + ++ + E+ V+ +H L
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
L D + EY L F L + +RV E R E IV L YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALGYLH---S 113
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+++RDLK N++LDK+ KI+DFG+ + +G A GT Y+ PE +
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
D + G+++ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 80 KLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQE---LKN----EALVIAKVQHKNL 131
+G+GG G VY +A+K++ R+ L E LK EA + A + H +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI----REDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFL-----FDATKRVLLE---LGTRLQIIEGIVE 183
V + C + D Y+ +L L ++ + L E +G L I I
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE-----SKANTN--- 235
+ Y+H S+ ++HRDLK NILL + I D+G A K E +
Sbjct: 125 TIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 236 --------RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
++ GT Y+ PE + S +D+++ G++L ++L+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 117 KNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQ 176
++E +A H +V+ D+ LLI EY L+ K++ L L
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN-------KQIKQRLKEHLP 165
Query: 177 IIEGIVEGLLYLHL-------HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229
E V GLL+ + HSR +++HRDLK++NI L K+ DFG ++ + +
Sbjct: 166 FQEYEV-GLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
S + GT Y+ PE + S K+D++S G++L E+L+
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
EA ++ + H ++++L G LI LP D + + A KR + + L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI-AICDILAIE 188
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV- 237
++ + YLH + RIIHRD+KA NI ++ + DFG A N N+
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF----PVDINANKYY 241
Query: 238 --AGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
AGT PE + + D++S G++L E+ +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLS---VRSRQGLQELKNEALVIAK-VQHKNLV 132
+G+G FG V +LAK G AVK L V +R+ + + E V+ K V+H LV
Sbjct: 3 IGKGSFGKV---LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
L ++ + +++ L F L +R E R E I L YLH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLH--- 113
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
+ I++RDLK NILLD + ++DFG+ + +G T GT Y+ PE + +
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 253 ICSIKSDVFSFGMLLLEILSG 273
D + G +L E+L G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQ-ELKNEALVIAKVQHKNLVRLLGCC 138
K+G G +G VYK G + L G+ E ++ +++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 139 IER-DEKL-LIYEYLPNKSLDFFLFDAT-----KRVLLELGTRLQIIEGIVEGLLYLHLH 191
+ D K+ L+++Y + F K V L G ++ I++G+ YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 192 SRVRIIHRDLKASNILLDKE----MKPKISDFGMARIFKGN-ESKANTNRVAGTFGYIPP 246
++HRDLK +NIL+ E + KI+D G AR+F + A+ + V TF Y P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 247 EYVYQGICSIKS-DVFSFGMLLLEILSGK 274
E + K+ D+++ G + E+L+ +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGDE----IAVKRLS----VRSRQGLQELKNEALVIAK 125
NF LG G +G V+ G + A+K L V+ + + + E V+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 126 VQHKNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
++ + L + D KL LI +Y+ L F + + E ++ E IV
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE-IVLA 117
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L +LH ++ II+RD+K NILLD ++DFG+++ F +E + GT Y+
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 245 PPEYVYQGICSIKS--DVFSFGMLLLEILSG 273
P+ V G D +S G+L+ E+L+G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 73/241 (30%), Positives = 104/241 (43%), Gaps = 61/241 (25%)
Query: 65 FSSVAAATNNFSDTNK------LGEGGFGPV---YKGVLAKGDEIAVKRLSVRSRQGLQE 115
F SV A + F+ + +G G G V + VL G +AVK+LS R Q
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-RPFQNQTH 63
Query: 116 LKN---EALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFF--------LFDAT 164
K E +++ V HKN++ LL + P KSL+ F L DA
Sbjct: 64 AKRAYRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDAN 111
Query: 165 --KRVLLELGTR------LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216
+ + +EL Q++ GI HLHS IIHRDLK SNI++ + KI
Sbjct: 112 LCQVIHMELDHERMSYLLYQMLCGI------KHLHS-AGIIHRDLKPSNIVVKSDCTLKI 164
Query: 217 SDFGMARIFKGNESKANTNRVAG----TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
DFG+AR A TN + T Y PE + D++S G ++ E++
Sbjct: 165 LDFGLAR-------TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217
Query: 273 G 273
G
Sbjct: 218 G 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 56/217 (25%), Positives = 110/217 (50%), Gaps = 37/217 (17%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRL------SVRSRQGLQELKNEALVIAKVQ 127
+ D ++G G +G V + + G ++A+K+L + +++ +EL+ ++ ++
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKHMK 72
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLF------DATKRVLLE-LGT-RLQ-II 178
H+N++ LL D L ++ DF+L D K + E L R+Q ++
Sbjct: 73 HENVIGLLDV-FTPDLSL-------DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
+++GL Y+H IIHRDLK N+ ++++ + KI DFG+AR ++ +
Sbjct: 125 YQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYV 176
Query: 239 GTFGYIPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
T Y PE + + ++ D++S G ++ E+L+GK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 27/76 (35%), Positives = 43/76 (56%)
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI 256
+HRDL A N+LL + KI DFG+AR + + + ++ PE ++ + +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 257 KSDVFSFGMLLLEILS 272
SDV+S+G+LL EI S
Sbjct: 319 LSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 45/202 (22%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 81 LGEGGFGPVYKGVLAKGDEIAVKR--LSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
+ + K +AVK+ L S++ L+ L+ E + ++QH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
I E ++ + S + L L EL I++ ++ L Y+H IH
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIH---SKGFIH 124
Query: 199 RDLKASNILLDKEMKPKISDFGMAR-IFKGNESKAN----TNRVAGTFGYIPPEYVYQGI 253
R +KAS+ILL + K +S + + K + + ++ PE + Q +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184
Query: 254 C--SIKSDVFSFGMLLLEILSG 273
+ KSD++S G+ E+ +G
Sbjct: 185 QGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 34/237 (14%)
Query: 54 TKREVELPLFSF-SSVAAATNNFSDTNKLGEGGFGPV---YKGVLAKGDEIAVKRLS--V 107
+KR+ S + + +G G G V Y +L + +A+K+LS
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLSRPF 61
Query: 108 RSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFF-------- 159
+++ + E +++ V HKN++ LL + P KSL+ F
Sbjct: 62 QNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVME 109
Query: 160 LFDATKRVLLELGTRLQIIEGIVEGLL--YLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217
L DA ++++ + + ++ +L HLHS IIHRDLK SNI++ + KI
Sbjct: 110 LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
DFG+AR S T V + Y PE + D++S G ++ E++ G
Sbjct: 169 DFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 45/215 (20%)
Query: 81 LGEGGFGPVYKGVLAK-GDEIAVKRLS------VRSRQGLQELKNEALVIAKVQHKNLVR 133
+G G +G V + ++AVK+LS + +R+ +EL+ ++ ++H+N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR----LLKHMKHENVIG 78
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFF--LFDATKRVLLELGTRLQ-----------IIEG 180
LL + P S++ F ++ T + +L ++ +I
Sbjct: 79 LLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ 126
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
++ GL Y+H IIHRDLK SN+ ++++ + +I DFG+AR T VA T
Sbjct: 127 LLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVA-T 178
Query: 241 FGYIPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
Y PE + + ++ D++S G ++ E+L GK
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 20/43 (46%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223
++ GL Y+H +IHRDLK SN+L++++ + +I DFGMAR
Sbjct: 116 LLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 80 KLGEGGFGPVYKGVLAKG-DEIAVKRLSVRSRQGL---QELKNEALVIAKVQHKNLVRLL 135
K+G G +G VYK G DE K +++ +G E ++ +++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDE---KEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 136 GCCIERDEK--LLIYEYLPNKSLDFFLF----DATKRVL-LELGTRLQIIEGIVEGLLYL 188
+ ++ L+++Y + F A K+ + L ++ I++G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 189 HLHSRVRIIHRDLKASNILLDKE----MKPKISDFGMARIFKGN-ESKANTNRVAGTFGY 243
H + ++HRDLK +NIL+ E + KI+D G AR+F + A+ + V TF Y
Sbjct: 125 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 244 IPPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
PE + K+ D+++ G + E+L+ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 31/151 (20%), Positives = 56/151 (37%), Gaps = 15/151 (9%)
Query: 76 SDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV--R 133
S L G VY + K ++ +K SR+ + + E ++ + K L +
Sbjct: 1 SSIKLLKGGLTNRVYL-LGTKDEDYVLKIN--PSREKGADREREVAILQLLARKGLPVPK 57
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
+L L+ E++ ++LD + + + +L L LH
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAK----------LHQLPL 107
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARI 224
+ + H DL NIL+D I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 54/245 (22%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK--GDEIAVKRL---SVRSRQGLQELKNEALVIAKVQ 127
++F +G G FG V + V K G A+K+L + ++ + ++ E ++A+
Sbjct: 1 DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD 59
Query: 128 HKNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL 186
+ +V+L + + L LI EYLP + L K E TR I E I
Sbjct: 60 NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI----- 111
Query: 187 YLHLHS--RVRIIHRDLKASNILLDKEMKPKISDFGM------------ARIFKGNE--- 229
L + S ++ IHRD+K N+LLD + K+SDFG+ RI
Sbjct: 112 -LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 230 ----------SKANT-----NRVA------GTFGYIPPEYVYQGICSIKSDVFSFGMLLL 268
SK NR A GT YI PE Q + + D +S G+++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 269 EILSG 273
E+L G
Sbjct: 231 EMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 26/76 (34%), Positives = 43/76 (56%)
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI 256
+HRDL A N+L+ + KI DFG+AR + + + ++ PE ++ + +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 257 KSDVFSFGMLLLEILS 272
SDV+SFG+LL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 4e-07
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 75 FSDTNKLGEGGFGPV---YKGVLAKGDEIAVKRLS--VRSRQGLQELKNEALVIAKVQHK 129
+ + +G G G V Y VL + +A+K+LS +++ + E +++ V HK
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFF--------LFDATKRVLLELGTRLQIIEGI 181
N++ LL + P KSL+ F L DA ++++ + + +
Sbjct: 77 NIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 182 VEGLL--YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAG 239
+ +L HLHS IIHRDLK SNI++ + KI DFG+AR S T V
Sbjct: 125 LYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 181
Query: 240 TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
+ Y PE + D++S G ++ E++ K
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQGLQELKNEAL----VIAKVQ 127
N F +GEG +G V K + EI A+K+ + + +E+K L ++ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
+N+V L R + L++EY+ L+ L + + R I + +++ + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQ-LIKAIHW 115
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTFGYIPP 246
H + I+HRD+K N+L+ K+ DFG AR + +G+ AN T Y P
Sbjct: 116 CH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSP 170
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSGK 274
E + D++S G +L E+ G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 79 NKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKN--EALVIAKVQ-HKNLVRL 134
K+GEG F V K K G A+K + + + L+++ N E + ++ H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 135 LGCCIERDEKLL----------IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
+ +R L +YE + + KR L E + + + +++
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGR----------KRPLPEKRVKSYMYQ-LLKS 112
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L ++H + I HRD+K NIL+ ++ K++DFG R G SK T Y
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYR 165
Query: 245 PPE-YVYQGICSIKSDVFSFGMLLLEILS 272
PE + G K D+++ G + EILS
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 55/233 (23%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLS----VRSRQGLQELKNEALVIAKVQHKNLV 132
+G G FG V+ L + G A+K L ++ Q + ++ E ++A +V
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64
Query: 133 RLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
+L + +E L L+ EY+P L L K V E R I E +V L +H
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAE-LVLALDSVH-- 118
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMA-RIFKGNESKANTNR-------------- 236
++ IHRD+K NIL+D + K++DFG+ ++ K + + N
Sbjct: 119 -KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 237 ------------VAGTFGYIPPEYV----YQGICSIKSDVFSFGMLLLEILSG 273
GT YI PE + Y C D +S G++L E+L G
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC----DWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 13/148 (8%)
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
+ N ++L +LI +Y+ K D F + L E + II +VE L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYI--KDGDLFDLLKKEGKLSEAEVKK-IIRQLVEALND 124
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKP-KISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
LH H IIH D+K N+L D+ + D+G+ +I G S + GT Y P
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTPSCYD-----GTLDYFSP 175
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSGK 274
E + + D ++ G+L E+L+GK
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 37/210 (17%)
Query: 79 NKLGEGGFGPV----YKGVLAKGDEIAVKRLS----VRSRQGLQELKNEALVIAKVQHKN 130
LG G FG V +KG G+ A+K L ++ +Q +Q + E ++ ++ H
Sbjct: 24 ETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPF 79
Query: 131 LVRLLGCCIERDEKLLIYEYLPN-------KSLDFFLFDATKRVLLELGTRLQIIEGIVE 183
+V ++ + + + E++ + F D K EL
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV----------- 128
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGY 243
L + +LHS+ II+RDLK N+LLD + K++DFG A+ + T + GT Y
Sbjct: 129 -LAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181
Query: 244 IPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
+ PE + D ++ G+LL E ++G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 181 IVEGLLYL-HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK-ANTNRVA 238
I E +L L HLH + I++RDLK NILLD + DFG++ K N + TN
Sbjct: 102 IAELVLALEHLH-KYDIVYRDLKPENILLDATGHIALCDFGLS---KANLTDNKTTNTFC 157
Query: 239 GTFGYIPPEYVYQGICSIKS-DVFSFGMLLLEILSG 273
GT Y+ PE + K D +S G+L+ E+ G
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 3/85 (3%)
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
+LH +I+RDLK NILLD + + DFG+ ++ ++ K NT GT Y+ PE
Sbjct: 108 NLHK-FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPEL 164
Query: 249 VYQGICSIKSDVFSFGMLLLEILSG 273
+ + D ++ G+LL E+L+G
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 65/252 (25%), Positives = 99/252 (39%), Gaps = 59/252 (23%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV--LAKGDEIAVKRL---SVRSRQGLQELKNEALVIAKVQ 127
+F +G+G FG V + V G A+K L + + L +K E V+A+
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
+V L + LI E+LP L L E TR + E V +
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAE-CVLAIEA 116
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA-------------RIFKGNESK--- 231
+H ++ IHRD+K NIL+D+ K+SDFG++ ++ +G +K
Sbjct: 117 VH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 232 ANTNRVA-----------------------------GTFGYIPPE-YVYQGICSIKSDVF 261
N N VA GT YI PE ++ QG + D +
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWW 232
Query: 262 SFGMLLLEILSG 273
S G ++ E L G
Sbjct: 233 SLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 69/304 (22%), Positives = 117/304 (38%), Gaps = 81/304 (26%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEIAV------KRLSVRSRQGLQELKNEALVIAKVQH 128
F LG G FG V + K D A+ ++ V +R + +K E ++A+ +
Sbjct: 3 FVKIKTLGIGAFGEVC--LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
+ +V+L ++D + +Y+P + L V E+ R I E L L
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYIAE------LTL 112
Query: 189 HLHS--RVRIIHRDLKASNILLDKEMKPKISDFGMARIF----------KGNESKANT-- 234
+ S ++ IHRD+K NIL+D + K++DFG+ F KG+ + ++
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 235 ---------------------------------NRVAGTFGYIPPEYV----YQGICSIK 257
+ + GT YI PE + Y +C
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC--- 229
Query: 258 SDVFSFGMLLLEILSGK------KNTEFYHTGYLSINGYDQTQVASKIKLVESCLARPFR 311
D +S G++L E+L G+ TE T IN + + ++KL
Sbjct: 230 -DWWSVGVILFEMLVGQPPFLAPTPTE---TQLKVINWENTLHIPPQVKLSPEA-VDLIT 284
Query: 312 QYCC 315
+ CC
Sbjct: 285 KLCC 288
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 3e-06
Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 40/246 (16%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAV-KRLSVRSRQGLQELKNEALVIA-----KV 126
N + K+G G FG V+ + E K +S R GL+E + LVI ++
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR---GLKEREKSQLVIEVNVMREL 69
Query: 127 QHKNLVRLLGCCIER-DEKLLI-YEYLPNKSLDFFLFDATKRV-LLELGTRLQIIEGIVE 183
+HKN+VR + + + ++KL I E+ L + K +E + I ++
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 184 GLLYLHL----HSRVRIIHRDLKASNILLDKEMK-----------------PKISDFGMA 222
L Y H + R++HRDLK NI L ++ KI DFG++
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI--KSDVFSFGMLLLEILSGKKNTEFY 280
+ G ES A++ GT Y PE + S KSD+++ G ++ E+ SGK T F+
Sbjct: 190 KNI-GIESMAHS--CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFH 244
Query: 281 HTGYLS 286
S
Sbjct: 245 KANNFS 250
|
Length = 1021 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
++ GL Y+H ++HRDLK SN+LL+ KI DFG+AR +E T
Sbjct: 117 LLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171
Query: 241 FGYIPPEYVYQGICSIKS---DVFSFGMLLLEILSGK 274
Y PE + CS + DV+S G + E+L K
Sbjct: 172 RWYRAPELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN--TNRVA 238
++ L Y+H + + HRDLK NIL + + K KI DFG+AR+ + A T+ VA
Sbjct: 112 LLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 239 GTFGYIPPEYV--YQGICSIKSDVFSFGMLLLEILSGK 274
T Y PE + + D++S G + E+L+GK
Sbjct: 169 -TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 10/106 (9%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA-G 239
I E +L +H ++ +HRD+K N+LLD +++DFG K N+ + VA G
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC--LKMNQDGTVQSSVAVG 165
Query: 240 TFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFY 280
T YI PE + G + D +S G+ + E+L G+ T FY
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 63/251 (25%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDEIAV------KRLSVRSRQGLQELKNEALVIAKVQH 128
F +G G FG V ++ K D A+ ++ V R +K E ++A+ +
Sbjct: 3 FVKIKTIGIGAFGEVC--LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
+ +V+L ++D + +Y+P + L + E R I E + + +
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RLGIFEEDLARFYIAE-LTCAIESV 117
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF----------KGNESKANT---- 234
H ++ IHRD+K NIL+D++ K++DFG+ F KG+ + ++
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 235 NRVA---------------------------GTFGYIPPEYV----YQGICSIKSDVFSF 263
+ GT YI PE + Y +C D +S
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC----DWWSV 230
Query: 264 GMLLLEILSGK 274
G++L E+L G+
Sbjct: 231 GVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 47/239 (19%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQE------LKNEALVIAKVQ 127
+F +G G FG V ++ K D V + + + + E ++ E ++ +
Sbjct: 2 DFESLKVIGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD 59
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
+V++ ++ LI E+LP + L K L E T+ I E ++ +
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVL-AIDS 116
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK--------------------- 226
+H ++ IHRD+K N+LLD + K+SDFG+ K
Sbjct: 117 IH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 227 ---GNESKANT---NR------VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
++ KA T NR GT YI PE Q + D +S G+++ E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 46/155 (29%), Positives = 69/155 (44%), Gaps = 28/155 (18%)
Query: 138 CIERDEKLL--IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEG-----IVEGLLYLHL 190
C +D+K L + EY+P L + L + + E E +L L
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDL------------VNLMSNYDVPEKWAKFYTAEVVLALDA 157
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES-KANTNRVAGTFGYIPPEYV 249
+ +IHRD+K N+LLDK K++DFG K +E+ + GT YI PE +
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVL 215
Query: 250 YQ----GICSIKSDVFSFGMLLLEILSGKKNTEFY 280
G + D +S G+ L E+L G +T FY
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 47/240 (19%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQE------LKNEALVIAKV 126
++F +G G FG V ++ K D + + + + + E ++ E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVR--LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL 186
+V++ ++ LI E+LP + L K L E T+ I E + L
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETV----L 112
Query: 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK-------------------- 226
+ ++ IHRD+K N+LLD + K+SDFG+ K
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 227 ----GNESKANT---NR------VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
++ KA T NR GT YI PE Q + D +S G+++ E+L G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQH 128
+F + +G G FG V A GD A+K + + +++ + + E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 129 KNLVRLLGCCIERDEKLLIYEYLP--------NKSLDFFLFDATKRVLLELGTRLQIIEG 180
+ +L ++D L+ EY P N+ D F D + L EL
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAEL--------- 111
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
V + +H V HRD+K N+L+D+ K++DFG A N+ N+ GT
Sbjct: 112 -VLAIHSVHQMGYV---HRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGT 166
Query: 241 FGYIPPEYV------YQGICSIKSDVFSFGMLLLEILSGK 274
YI PE + +G ++ D +S G++ E++ G+
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
+HS + IHRD+K N+LLDK K++DFG + E + GT YI PE +
Sbjct: 158 IHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 250 YQ----GICSIKSDVFSFGMLLLEILSGKKNTEFY 280
G + D +S G+ L E+L G +T FY
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 12/107 (11%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA-RIFKGNESKANTNRVA- 238
+ E +L + ++ +HRD+K N+LLDK +++DFG R+ ++N VA
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN---VAV 164
Query: 239 GTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFY 280
GT YI PE + +G + D +S G+ + E+L G+ T FY
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 20/52 (38%), Positives = 31/52 (59%), Gaps = 3/52 (5%)
Query: 173 TRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224
++ I + L YLH H IIHRDLK N+L+ E K++DFG++++
Sbjct: 105 MAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 81 LGEGGFGPVYKGVLAKGDE--IAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLL 135
+G G FG V + V K + A+K LS + R E ++A + +V+L
Sbjct: 51 IGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL- 108
Query: 136 GCCIERDEKLL--IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
+D+K L + EY+P L + + + E R E +V L +H
Sbjct: 109 -HYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAE-VVLALDAIH---S 160
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV---- 249
+ IHRD+K N+LLDK K++DFG + + GT YI PE +
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 250 YQGICSIKSDVFSFGMLLLEILSGKKNTEFY 280
G + D +S G+ L E+L G +T FY
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI---------FKGNESKA 232
V L YLH + I+HRDLK N+L+ K++DFG+++I ++G+ K
Sbjct: 111 VLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 233 NTN----RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
+V GT YI PE + + D ++ G++L E L G
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRL---SVRSRQGLQELKNEALVIAKVQ 127
F LG G FG V LA+ A+K L V R + +K E ++A+
Sbjct: 3 FVKIKTLGIGAFGEV---CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD 59
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGI--VEGL 185
++ +VRL ++D + +Y+P + L + E R I E VE +
Sbjct: 60 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESV 117
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226
++ IHRD+K NIL+D++ K++DFG+ F+
Sbjct: 118 ------HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 53/204 (25%), Positives = 82/204 (40%), Gaps = 46/204 (22%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLA-----KGDEIAVKRLSVRSRQGLQEL-KNEAL------ 121
+F KLGEG FG VYK L K + +K+ + G E+ NE +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT---EYGAVEIWMNERVRRACPN 189
Query: 122 VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL-DF-----FLFDATKRVLLELG--- 172
A + L + + DE L++ Y +L D F ++ +L ++
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 173 ----TRLQIIEGIVEGLLYL--HLHSRVRIIHRDLKASNILLDKEMKP-KISDFGMARIF 225
+II+ I+ +L+ LHS I+HRD+K NI+ + KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306
Query: 226 KGNESKANTNRVAGTFGYIPPEYV 249
RV YIP E++
Sbjct: 307 ----------RVG--INYIPKEFL 318
|
Length = 566 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 120 ALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIE 179
A ++ +V HK++V L G C+ E +++ E++ LD F+ K +L + ++ +
Sbjct: 55 ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM--HRKSDVLTTPWKFKVAK 112
Query: 180 GIVEGLLYLHLHSRVRIIHRDLKASNILL-----DKEMKP--KISDFGMARIFKGNESKA 232
+ L YL ++H ++ NILL D E P K+SD G+ +
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC- 168
Query: 233 NTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEI 270
R+ +I PE V SI +D +SFG L EI
Sbjct: 169 -VERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 79 NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
N +G G FG VY+ + + +++A+K++ Q Q E L++ + H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 138 ----CIERDEKLL----IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
C +++EK + + E++P + A L L + L Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 190 LHSRVRIIHRDLKASNILLDKEMKP-KISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
S+ I HRDLK N+L+D K+ DFG A+ + + + + F Y PE
Sbjct: 188 --SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRF-YRAPEL 241
Query: 249 VYQGI-CSIKSDVFSFGMLLLEILSG 273
+ + D++S G ++ E++ G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 46/224 (20%)
Query: 81 LGEGGFGPVYKGVL-------AKGDEIAVKRLSVRSRQGLQELK---------------- 117
LG+G +Y G L + DE+ + V +EL+
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 118 --NEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL 175
A ++++V H +L + G C+ E +++ E++ + LD L RV + ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV--PVAWKI 120
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-----MKP--KISDFGMARIFKGN 228
+ + + L YL + ++H ++ A NILL + P K+SD G++ F
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKS--DVFSFGMLLLEI 270
+ R+ +I PE V G S+ + D +SFG LLEI
Sbjct: 176 SREERVERIP----WIAPECV-PGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 22/154 (14%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIA---VKRL--SVRSRQGLQELKN-EALVIAKVQHKNLVR 133
++G G FG V + +A VK L + S++ + L+ + I +QH N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI--LQHPNILQ 59
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFL------FDATKRVLLELGTRLQIIEGIVEGLLY 187
LG C+E LL++EY L +L ++ +LL+ ++ I G+ +
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTH 114
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221
+H H+ +H DL N L ++ K+ D+G+
Sbjct: 115 MHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 18/164 (10%)
Query: 118 NEALVIAKVQHKNLVRLLGCCIERDEKL----LIYEYLPNKSLDFFLFDATKRVLLELGT 173
NE + ++ N++++ G I+ + L LI EY L L K L T
Sbjct: 67 NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKDLSFKT 123
Query: 174 RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233
+L + +GL +L+ +++L + + L+ + K KI G+ +I K N
Sbjct: 124 KLDMAIDCCKGLY--NLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK-N 180
Query: 234 TNRVAGTFGYIPPEYVYQGICS---IKSDVFSFGMLLLEILSGK 274
N + Y + + I S IK D++S G++L EI +GK
Sbjct: 181 VNFMV----YFSYK-MLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 37/226 (16%)
Query: 80 KLGEGGFGPVYKGVLAKGDEI-AVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLL 135
LG+G G V+ L ++ A+K L + R ++ + E ++A + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 136 GCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+ + L L+ +Y P L L + L E R E ++ L YLHL
Sbjct: 68 -ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-VLLALEYLHLLG-- 123
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMA---------------------------RIFKG 227
I++RDLK NILL + +SDF ++
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
E +N GT YI PE + D ++ G+LL E+L G
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA-GTFGYIPPEYVY- 250
++ +HRD+K NIL+D +++DFG K E + VA GT YI PE +
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 251 ----QGICSIKSDVFSFGMLLLEILSGKKNTEFY 280
+G + D +S G+ + E+L G+ T FY
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 43/144 (29%), Positives = 63/144 (43%), Gaps = 13/144 (9%)
Query: 81 LGEGGFGPVYKGV---LAKGD---EIAVKRLSVRSRQGLQE-LKNEALVIAKV-QHKNLV 132
LG G FG V + L K D +AVK L + +E L +E +++ + QHKN+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
LLG C L+I EY L FL + L + +I E + Y ++
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSD---YKNITL 162
Query: 193 RVRIIHRDLKASNILLDK--EMKP 214
+ I D S+ D EM+P
Sbjct: 163 EKKYIRSDSGFSSQGSDTYVEMRP 186
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
Y+H IIHRD+K N+L++ + DFG A +G+ S +AGT P
Sbjct: 275 YIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 247 EYVYQGICSIKSDVFSFGMLLLE 269
E + + D++S G+++ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 29/107 (27%), Positives = 56/107 (52%), Gaps = 14/107 (13%)
Query: 177 IIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF----KGNESKA 232
I+ G + GL YLH + IHR++KAS+IL+ + +S G++ ++ G ++K
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160
Query: 233 N---TNRVAGTFGYIPPEYVYQGIC--SIKSDVFSFGMLLLEILSGK 274
++ PE + Q + ++KSD++S G+ E+ +G+
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.28 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.1 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.01 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.73 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.64 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.51 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.42 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.36 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.33 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.25 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.24 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.12 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.04 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.98 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.94 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.87 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.84 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.77 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.62 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.6 | |
| PLN02236 | 344 | choline kinase | 97.6 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.46 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.38 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.21 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.12 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.04 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.02 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.93 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.9 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.73 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.64 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.59 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.56 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.26 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.22 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.08 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.02 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.72 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=356.39 Aligned_cols=236 Identities=28% Similarity=0.436 Sum_probs=199.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.+|...+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||.++++++.++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 68999999999999999999955 5899999999765 66777888999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC------CceEEeeccccc
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE------MKPKISDFGMAR 223 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~------~~~kl~Dfg~~~ 223 (334)
||.||+|..+++.+.. +++..+..++.||+.|+++||+++ ||||||||+|||++.. -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999977654 999999999999999999999999 9999999999999764 468999999999
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------cccchhc
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---------NGYDQTQ 294 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---------~~~~~~~ 294 (334)
.+.... ...+.+|++.|||||++....|+.|+|+||+|+++|++++|++||+.....++-. .......
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 876433 3456799999999999999999999999999999999999999998544332111 1111113
Q ss_pred ccchhhhccccccCCccchhhhh
Q 037681 295 VASKIKLVESCLARPFRQYCCIL 317 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~ 317 (334)
...+.+++-+.+.+++.+|++..
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~ 263 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFE 263 (429)
T ss_pred cCchhhhhhHHHhcCccccCchH
Confidence 44556777777777776665544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-51 Score=344.75 Aligned_cols=245 Identities=26% Similarity=0.344 Sum_probs=205.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++++.||+|+||+|+.++.+ +++.+|+|+++.. .....+....|..+|.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 479999999999999999999954 5888999998643 334567789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
+||+.||.|...|.+... +++..+.-++.+|+.||.|||+.+ |+||||||+|||+|.+|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999865443 899999999999999999999999 99999999999999999999999999985332
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccchhcccchhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYDQTQVASKIK 300 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~ 300 (334)
. ...+.+++||+.|||||++.+..++.++|.||||+++|||++|.+||...+... ..+.....-.+....+
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ard 255 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARD 255 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHH
Confidence 2 234556899999999999999999999999999999999999999998765331 0111111114567888
Q ss_pred hccccccCCccchh----hhhhhhhccC
Q 037681 301 LVESCLARPFRQYC----CILKVRTFGF 324 (334)
Q Consensus 301 ~i~~~l~~~~~~~~----~~~~~~~~~~ 324 (334)
++.+.|.++|++|. ...++++..+
T Consensus 256 ll~~LL~rdp~~RLg~~~d~~~ik~Hpf 283 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLGGPGDAEEIKRHPF 283 (357)
T ss_pred HHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence 99999999999994 3445555444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=362.31 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=213.1
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.+|...+.||+|||+++|.+++ .+|+.||+|++... .....+.+.+|+++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999997 78999999999642 5566788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
|+|..++|..+++.+ .++++..+..++.||+.||.|||+++ |+|||||..|++++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988633 34999999999999999999999998 999999999999999999999999999988755
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC----cccccccch--hcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG----YLSINGYDQ--TQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----~~~~~~~~~--~~~~~~~~~i 302 (334)
... ..+.+|||.|.|||++.....+..+||||+||+||.||.|++||+...-. ......+.. ..+....++|
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI 249 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLI 249 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHH
Confidence 433 34589999999999999999999999999999999999999999865221 111111111 2566678899
Q ss_pred cccccCCccchhhhhhhhhccCC
Q 037681 303 ESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
.+.|..+|..|+++.++....|-
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhh
Confidence 99999999999999999887764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=342.15 Aligned_cols=243 Identities=26% Similarity=0.359 Sum_probs=207.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc-ceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE-KLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e 149 (334)
++.+.++.||+|..|+||++.++ ++..+|+|.+... +....+++.+|++++++.+|||||+++|.|..++. .+++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 46777899999999999999966 5778999999544 45556789999999999999999999999999995 999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||++|+|+.++.... .+++.....++.++++||.|||+ ++ |+||||||+|||++..|.|||||||.+..+.+.
T Consensus 159 YMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999986553 38999999999999999999996 66 999999999999999999999999999876544
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc---cccc---------ch-hcc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---INGY---------DQ-TQV 295 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---~~~~---------~~-~~~ 295 (334)
....+.||..|||||.+.+..|+.++||||||++++|+.+|+.|+....++... +..+ .. ..+
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 345678999999999999999999999999999999999999998764222111 1111 11 145
Q ss_pred cchhhhccccccCCccchhhhhhhhhccCC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
..+..+++.||+++|..|++..++....+-
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 568899999999999999999998887663
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=352.01 Aligned_cols=246 Identities=45% Similarity=0.754 Sum_probs=206.2
Q ss_pred CCCccChhHHHHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEE
Q 037681 59 ELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138 (334)
Q Consensus 59 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 138 (334)
....|++.++..++++|...+.||+|+||.||+|...+|..||||++.........+|.+|+.++.+++|||+|+++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56679999999999999999999999999999999998899999988755433145699999999999999999999999
Q ss_pred EecCc-ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 139 IERDE-KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 139 ~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
.+.+. .++|+||+++|+|+++++..... +++|.++.+|+.++|.||+|||....++|+||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99994 99999999999999999876544 78999999999999999999999888889999999999999999999999
Q ss_pred eccccccccCCCCccccccc-cccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccC-Ccccccccchh--
Q 037681 218 DFGMARIFKGNESKANTNRV-AGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT-GYLSINGYDQT-- 293 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-~~~~~~~~~~~-- 293 (334)
|||+|...+.. ....... .||.+|+|||+...+..+.|+||||||++++|++||++|.+...+ +...+..|...
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999654431 1111112 799999999999999999999999999999999999998876542 23334554433
Q ss_pred cccchhhhcccccc
Q 037681 294 QVASKIKLVESCLA 307 (334)
Q Consensus 294 ~~~~~~~~i~~~l~ 307 (334)
....+.+++|+.+.
T Consensus 298 ~~~~~~eiiD~~l~ 311 (361)
T KOG1187|consen 298 EEGKLREIVDPRLK 311 (361)
T ss_pred HCcchhheeCCCcc
Confidence 22245555555543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=339.05 Aligned_cols=245 Identities=23% Similarity=0.327 Sum_probs=202.6
Q ss_pred hhcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccCh-------hhHHHHHHHHHHHHhcCCCCcceEeeEEEecC
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSR-------QGLQELKNEALVIAKVQHKNLVRLLGCCIERD 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 142 (334)
..+.|.+.+.||+|+||.|-+|. .++|+.||||+++.... .....+.+|+++|++|+|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678899999999999999999 56799999999964311 12234679999999999999999999999999
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC---CceEEeec
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE---MKPKISDF 219 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Df 219 (334)
..||||||++||.|.+.+-.+. .+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999988885544 3788888999999999999999999 9999999999999766 67999999
Q ss_pred cccccccCCCCccccccccccCCccCccccccCC---CCcchhhHhHHHHHHHHHhCCCCCCCccCCc----------cc
Q 037681 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI---CSIKSDVFSFGMLLLEILSGKKNTEFYHTGY----------LS 286 (334)
Q Consensus 220 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~----------~~ 286 (334)
|+|+... ....+.+.|||+.|.|||++.++. +..++|+||+||+||-+++|.+||.....+. ..
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 9998764 233467789999999999998654 3458899999999999999999997654431 11
Q ss_pred ccccch-hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 287 INGYDQ-TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 287 ~~~~~~-~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+....| ..++...++|+.+|.-+|+.|++..+..+.++
T Consensus 401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 111111 25667889999999999999999888766554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=345.75 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=212.6
Q ss_pred hhcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcce
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 145 (334)
...+|...+.||+|+|++|++|+ ..++..+|||++... .+...+.+..|.++|.+| +||+|++++..|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34789999999999999999999 457999999998643 344456778899999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+|+||+++|+|..++.... .+++..+..++.||+.||+|||++| ||||||||+|||+|.+++++|+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999996654 3999999999999999999999999 999999999999999999999999999887
Q ss_pred cCCCCc---------cc--cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc-----
Q 037681 226 KGNESK---------AN--TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING----- 289 (334)
Q Consensus 226 ~~~~~~---------~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----- 289 (334)
...... .. ...++||..|.+||++.++..+..+|+|+|||++|+|+.|++||...++- ..|..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqkI~~l~ 303 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQKIQALD 303 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHHHHHhc
Confidence 543221 11 14478999999999999999999999999999999999999999875442 22221
Q ss_pred --cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 --YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 --~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.....+...++|++.|..+|.+|.+..+++...|
T Consensus 304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 22225677899999999999999999999998877
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=340.49 Aligned_cols=245 Identities=31% Similarity=0.473 Sum_probs=201.7
Q ss_pred CCCcCCccccCCcccEEEEEecCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-cceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-EKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 150 (334)
+..+.+.||+|+||+||+|.+.....||+|.+.... ....+.|.+|+.+|.+++|||||+++|+|.++. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 444556799999999999998844449999997543 222568999999999999999999999999888 79999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 229 (334)
+++|+|..++... ....+++..++.++.||+.|+.|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999774 34459999999999999999999998863 99999999999999997 99999999998654321
Q ss_pred CccccccccccCCccCccccc--cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--------cccccchhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVY--QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------SINGYDQTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~ 299 (334)
.......||..|||||++. ...++.|+||||||+++|||+||+.||........ .-..........+.
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 2233367999999999999 56899999999999999999999999988764200 00011111556688
Q ss_pred hhccccccCCccchhhhhhhhhcc
Q 037681 300 KLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+++.||..+|..|+++.++....
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHHHHH
Confidence 899999999999999988765543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-50 Score=325.60 Aligned_cols=241 Identities=23% Similarity=0.327 Sum_probs=201.0
Q ss_pred cCCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEee-EEEecCc-ceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLG-CCIERDE-KLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~lv 147 (334)
.+|++.+.||+|.||.||++. ..+|..+|.|.+... +....+.+.+|+.+|++|+|||||++++ .+.+++. .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 578999999999999999999 568999999988633 5566778899999999999999999999 4555555 8999
Q ss_pred EEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCC-CeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 148 YEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRV-RIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
||+|.+|+|..+++..+ .+..+++..+|+++.|++.||..+|+.-+. .|.||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999886543 345699999999999999999999984221 3899999999999999999999999999987
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------cccccc-cchhcccc
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG-------YLSING-YDQTQVAS 297 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~-~~~~~~~~ 297 (334)
..... .....+|||.||+||.+.+..|+.++||||+||++|||+.-++||...+-- ..++.. +....+..
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTD 256 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence 65433 334578999999999999999999999999999999999999999765210 112211 12235667
Q ss_pred hhhhccccccCCccchhh
Q 037681 298 KIKLVESCLARPFRQYCC 315 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~ 315 (334)
+.+++.-|+..+++.||+
T Consensus 257 l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPD 274 (375)
T ss_pred HHHHHHHHccCCcccCCC
Confidence 888999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=314.88 Aligned_cols=230 Identities=27% Similarity=0.349 Sum_probs=197.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||.|+||+|.+++.+ +|..+|+|+++.. .-.+.+...+|..+|+.+.||+++++.+.|.+.+..|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 378999999999999999999954 5889999999744 344567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||.+||.|..+++...+ +++..+.-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999976554 999999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc-------chhcccchhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY-------DQTQVASKIK 300 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~ 300 (334)
. +.+.||||.|+|||++.+..+..++|.|||||++|||+.|.+||....+- ..+.+. ..-....+.+
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-~iY~KI~~~~v~fP~~fs~~~kd 270 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-QIYEKILEGKVKFPSYFSSDAKD 270 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-HHHHHHHhCcccCCcccCHHHHH
Confidence 2 55689999999999999999999999999999999999999999765542 111111 1114556777
Q ss_pred hccccccCCccch
Q 037681 301 LVESCLARPFRQY 313 (334)
Q Consensus 301 ~i~~~l~~~~~~~ 313 (334)
++.+.|+.|-.+|
T Consensus 271 Ll~~LL~vD~t~R 283 (355)
T KOG0616|consen 271 LLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHhhhhHhh
Confidence 8887777776655
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=331.37 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=204.8
Q ss_pred HHhhcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
....++|+++..||+|+||.||+|+ ..+|..+|+|+++.. ...+++.+..|..+|...++|+||+++..|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 3455899999999999999999999 456999999999754 456778899999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+||||++||++..+|.... .+++..+..++.+++.|++.||+.| ++||||||+|+|||..|++||+|||++..
T Consensus 217 YLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999986544 4999999999999999999999999 99999999999999999999999999854
Q ss_pred ccCCC--------------------Cccc-----c--------------------ccccccCCccCccccccCCCCcchh
Q 037681 225 FKGNE--------------------SKAN-----T--------------------NRVAGTFGYIPPEYVYQGICSIKSD 259 (334)
Q Consensus 225 ~~~~~--------------------~~~~-----~--------------------~~~~g~~~y~aPE~~~~~~~~~~~D 259 (334)
+.... .... . ...+|||.|+|||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 32100 0000 0 0136999999999999999999999
Q ss_pred hHhHHHHHHHHHhCCCCCCCccCC--cccccccchh--------cccchhhhccccccCCccchhh---hhhhhhccC
Q 037681 260 VFSFGMLLLEILSGKKNTEFYHTG--YLSINGYDQT--------QVASKIKLVESCLARPFRQYCC---ILKVRTFGF 324 (334)
Q Consensus 260 iwslG~il~ell~g~~p~~~~~~~--~~~~~~~~~~--------~~~~~~~~i~~~l~~~~~~~~~---~~~~~~~~~ 324 (334)
.||||||+||||.|-+||....+. ...+..|... ......++|.+|+- ++.+|-. +.+|+..++
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPf 447 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPF 447 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCc
Confidence 999999999999999999876654 2223333221 34567889999887 7777743 555665544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=331.11 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=206.7
Q ss_pred hhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc----Ch-hhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCc
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR----SR-QGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDE 143 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 143 (334)
..+.|.+.+.||+|+||+|+.|.+ .++..||+|.+... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 347899999999999999999984 56899999976543 11 23456778999999999 9999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeecccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMA 222 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~ 222 (334)
.|+||||+.||+|.+++... ..+.+..+..++.|++.|++|||+++ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999998663 33888999999999999999999999 9999999999999999 99999999999
Q ss_pred ccccCCCCccccccccccCCccCccccccCC-CC-cchhhHhHHHHHHHHHhCCCCCCCccCC---------cccccccc
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGI-CS-IKSDVFSFGMLLLEILSGKKNTEFYHTG---------YLSINGYD 291 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DiwslG~il~ell~g~~p~~~~~~~---------~~~~~~~~ 291 (334)
.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.... ...+..+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc
Confidence 8763 1223355679999999999999866 65 7899999999999999999999985433 12222222
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
. +.....++.++|..+|.+|.++.++......-
T Consensus 247 ~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~ 279 (370)
T KOG0583|consen 247 L--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQ 279 (370)
T ss_pred C--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence 2 66778899999999999999999888655533
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=310.50 Aligned_cols=242 Identities=20% Similarity=0.276 Sum_probs=197.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
+.|+.+..+|+|+||.||+++++ +|+.||||++.... +...+-..+|+++|++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888999999999999999965 59999999986432 3344567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
||+..-|+++- ...++ ++.+.+..++.|++.|+.|+|+++ ++||||||+|||++.+|.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eLe-~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELE-RYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHH-hccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 99987666554 33333 788999999999999999999999 999999999999999999999999999977532
Q ss_pred CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------------------------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG------------------------- 283 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------------------------- 283 (334)
....+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|+...+-
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 223445678999999999887 68999999999999999999999988743210
Q ss_pred ------------cccccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 284 ------------YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 284 ------------~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
..++...........++++.+||..+|.+|.+-.++...
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 001111111134467889999999999999776655443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=331.39 Aligned_cols=245 Identities=26% Similarity=0.415 Sum_probs=212.9
Q ss_pred hcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
...|.....||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4568888999999999999998 557899999999887777778889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
++||+|.+.+... .+++.++..|+.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999998887443 3899999999999999999999999 99999999999999999999999999987765543
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------cccccccchhcccchhhh
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---------YLSINGYDQTQVASKIKL 301 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~ 301 (334)
......||+.|||||+.....|++++||||||++++||+-|++||-...+- ..+-.+.....+..+.++
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 345678999999999999999999999999999999999999998542211 001011112256779999
Q ss_pred ccccccCCccchhhhhhhhhccCC
Q 037681 302 VESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
++.||..++.+|.+..++++..|-
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhh
Confidence 999999999999999999988773
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=332.46 Aligned_cols=243 Identities=28% Similarity=0.372 Sum_probs=207.6
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSV--RSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|.+.+.||+|+||+||+|+.+ +.+.||+|.+.. +.+...+.+.+|++++++++||||+.++++|+.....++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999954 688999999964 355667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+.| +|..++....+ ++++.+..++.+++.||.|||+++ |.|||+||.|||++.+|.+|+||||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 99999866544 999999999999999999999998 9999999999999999999999999999776443
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC------cccccccchhcccchhhhcc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG------YLSINGYDQTQVASKIKLVE 303 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~i~ 303 (334)
. ..+...|||.|||||+..+++|+..+|+||+||++||+++|++||-...-- ..+-..|....+.....+++
T Consensus 155 ~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 155 S--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQ 232 (808)
T ss_pred e--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHH
Confidence 2 344578999999999999999999999999999999999999998532110 00011222245667888999
Q ss_pred ccccCCccchhhhhhhhhccC
Q 037681 304 SCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..|.++|.+|-++..+....|
T Consensus 233 gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred HHhhcChhhcccHHHHhcChH
Confidence 999999999999988776554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=330.86 Aligned_cols=247 Identities=31% Similarity=0.471 Sum_probs=205.7
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
+.+..++.||+|-||.||.|.+.....||+|.++... -..+.|.+|+.+|++|+|++||+++++|..++..||||||++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3445678999999999999999877799999997552 234678899999999999999999999999889999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
.|+|.++|+. ..+..++..+.+.++.||++|++||++++ +|||||..+||||+++..+||+|||+|+...++....
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999976 33445889999999999999999999998 9999999999999999999999999999655444322
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-cc--cccchh----cccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-SI--NGYDQT----QVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-~~--~~~~~~----~~~~~~~~i~~ 304 (334)
.....-+..|.|||.+..+.++.|||||||||+||||+| |+.|++.+..... .. .++... -+..+-++...
T Consensus 361 -~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 361 -SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred -cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence 222334678999999999999999999999999999999 9999887654311 11 111111 45668889999
Q ss_pred cccCCccchhhhhhhhhccCC
Q 037681 305 CLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~~~~ 325 (334)
|+..+|++||++..++..-..
T Consensus 440 CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 440 CWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred HhhCCcccCCCHHHHHHHHHH
Confidence 999999999999877665443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.88 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=200.0
Q ss_pred hhcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccce
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKL 145 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 145 (334)
..+.|+.+++||+|+||.||+|+ ..+|+.||+|++.... +.......+|+.+|++|+||||+++.+...+. +..|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34679999999999999999999 5579999999997554 55567778999999999999999999998876 6899
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
||+|||++ +|.-++.. ....+++.++..++.||+.||+|+|+.+ |.|||||.+|||||++|.+||+|||+|+++
T Consensus 195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999987 56555533 3345999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCC--------------ccccc--
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------YLSIN-- 288 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------~~~~~-- 288 (334)
........+ ..+-|.+|.|||++.+. .|+.++|+||.||||.||++|++.|+....- ...|.
T Consensus 269 ~~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 665544333 34569999999998865 7999999999999999999999998754211 00111
Q ss_pred -----ccc--------------hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 -----GYD--------------QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 -----~~~--------------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
... .......+++++..|.-+|.+|++..+...-.+
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey 402 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY 402 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence 000 003445778889999999999988776554433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=319.18 Aligned_cols=248 Identities=27% Similarity=0.435 Sum_probs=203.6
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC--cceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD--EKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 149 (334)
.++...+.||+|+||.||++.+. +|...|||.+...+....+.+.+|+.+|++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 46777899999999999999965 48999999987664444778999999999999999999999855444 5889999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeeccccccccC-
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFGMARIFKG- 227 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~- 227 (334)
|+++|+|.+++..... .+++..+..+..||++||.|||+++ ++||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999976553 4999999999999999999999998 999999999999999 79999999999986553
Q ss_pred CCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCc-cCC--------cccccccchhcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFY-HTG--------YLSINGYDQTQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~-~~~--------~~~~~~~~~~~~~~ 297 (334)
...........||+.|||||++.++ ....++|||||||++.||+||++||... ... ......+....+..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence 1122223457899999999999854 3345999999999999999999999863 111 11111222225567
Q ss_pred hhhhccccccCCccchhhhhhhhhccCC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
..+++..|+.++|..|++..++....+.
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 8899999999999999999998887764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=329.28 Aligned_cols=239 Identities=26% Similarity=0.357 Sum_probs=199.5
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCc
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDE 143 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 143 (334)
....++|...+.||+|+||+|+++..+ +++.+|||.++.. ..+.++..+.|..++...+ ||.++.++.+|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999954 6889999999754 4566778888999988875 9999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
+|+||||+.||++..+. ....+++..+.-++..++.||.|||+++ |+|||||.+|||+|.+|++||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999943332 2234899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccc
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVAS 297 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~ 297 (334)
.-.. ....+.+++|||.|+|||++.+..|+.++|.|||||+|||||.|+.||...+.+.. .+ ..+....+..
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~e 594 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKE 594 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHH
Confidence 5332 22356779999999999999999999999999999999999999999986544311 00 1112224666
Q ss_pred hhhhccccccCCccchhhh
Q 037681 298 KIKLVESCLARPFRQYCCI 316 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~ 316 (334)
...++++.|.++|++|...
T Consensus 595 a~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHhccCcccccCC
Confidence 7888999999999888543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=310.19 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=208.6
Q ss_pred hcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++...||.|..++||+|+ .+.+..||||+++... ....+.+.+|+..++.++||||++++.+|..+..+|+||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3799999999999999999999 5678999999997543 3336889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
||.+|++.++++..-..+ +++..+..|+.++++||.|||++| -+|||||+.||||+.+|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999987665444 899999999999999999999999 9999999999999999999999999876554332
Q ss_pred Ccc-cc-ccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--------------ccc
Q 037681 230 SKA-NT-NRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--------------GYD 291 (334)
Q Consensus 230 ~~~-~~-~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--------------~~~ 291 (334)
... .. ..+.||++|||||++.. ..|+.|+||||||++..||.+|..||..+.+-...+. .+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d 260 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD 260 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence 221 11 56789999999999653 4689999999999999999999999998864321110 111
Q ss_pred hh--cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 292 QT--QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 292 ~~--~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+. ......+++..||.++|.+|++..++.+..|
T Consensus 261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 11 3446788999999999999999888876654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=316.23 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=213.2
Q ss_pred cCCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..|...+.||+|+||.||+|. ..+++.||+|++... .....+.+++|+.++..++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 467778999999999999999 557889999999855 455578899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
|.||++.+.+.... .+++..+..++.+++.|+.|||.++ .+|||||+.||++..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999885433 3578888889999999999999998 99999999999999999999999999987765544
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc-------ccchhcccchhhhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN-------GYDQTQVASKIKLVE 303 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~i~ 303 (334)
. ..++.||+.|||||++.+..|+.|+||||||++++||++|.+|+...++....+. ......+..+.+++.
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHH
Confidence 3 3668999999999999988999999999999999999999999999887632211 111124566899999
Q ss_pred ccccCCccchhhhhhhhhccCCcc
Q 037681 304 SCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
.||.++|..|++..++.+..|--+
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHhhcCcccCcCHHHHhhhHHHHh
Confidence 999999999999998887776433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=325.10 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=207.3
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.-|...+.||.|+-|.|.+|++ .+|+.+|||.+... .......+.+|+.+|+-+.|||++++++++++...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577889999999999999995 57999999999644 3444667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|.|.+++..+. ++++..+.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999885544 4899999999999999999999998 999999999999999999999999999763322
Q ss_pred CCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc----cc--hhcccchhhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING----YD--QTQVASKIKL 301 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----~~--~~~~~~~~~~ 301 (334)
....+.||.++|.|||++.+.+| +.++||||.|||||.||||+.||++.+-..+.+.- +. ........++
T Consensus 166 ---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdL 242 (786)
T KOG0588|consen 166 ---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDL 242 (786)
T ss_pred ---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHH
Confidence 23455799999999999999877 57899999999999999999999976543222111 11 1156677889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..||..|-++.+|.+..+
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHHhccCccccccHHHHhhCch
Confidence 99999999999999999988776
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=316.32 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=196.9
Q ss_pred hhcCCCcCCccccCCcccEEEEEe------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecC
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL------AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERD 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 142 (334)
..++|++.+.||+|+||.||+|.+ .++..||+|++... .......+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 347899999999999999999974 23567999998643 233456788999999999 8999999999887654
Q ss_pred -cceEEEEecCCCChhhhhhhccc--------------------------------------------------------
Q 037681 143 -EKLLIYEYLPNKSLDFFLFDATK-------------------------------------------------------- 165 (334)
Q Consensus 143 -~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 165 (334)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999988864321
Q ss_pred ---ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCC
Q 037681 166 ---RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFG 242 (334)
Q Consensus 166 ---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~ 242 (334)
..++++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 123677888999999999999999998 99999999999999999999999999976533222222223446778
Q ss_pred ccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc---c-----cccchhcccchhhhccccccCCccch
Q 037681 243 YIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS---I-----NGYDQTQVASKIKLVESCLARPFRQY 313 (334)
Q Consensus 243 y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~---~-----~~~~~~~~~~~~~~i~~~l~~~~~~~ 313 (334)
|+|||++.+..++.++||||||+++|||++ |+.||......... + ..........+.+++..|+..+|.+|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999998999999999999999999997 99999764322100 0 00011134567889999999999999
Q ss_pred hhhhhhhhc
Q 037681 314 CCILKVRTF 322 (334)
Q Consensus 314 ~~~~~~~~~ 322 (334)
+++.++.+.
T Consensus 322 Ps~~el~~~ 330 (338)
T cd05102 322 PTFSALVEI 330 (338)
T ss_pred cCHHHHHHH
Confidence 999887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=306.80 Aligned_cols=240 Identities=23% Similarity=0.382 Sum_probs=207.5
Q ss_pred cCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSV---RSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.+|++.+.||+|.||+|-+|. +..|..||||.++. .+++..-.+.+|+++|+.|+||||+.++++|++.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 689999999999999999998 57899999998864 35556667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||..+|.|.+++.++.. +++..+..++.||+.|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+...
T Consensus 133 EYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999966554 999999999999999999999998 999999999999999999999999999876433
Q ss_pred CCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCcc----cccccchh-cccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----SINGYDQT-QVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~i 302 (334)
....+++|++-|.+||++.+.+| ++.+|-||||++||.|..|..||+..+.... .--.+.+. ......-+|
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLI 283 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLI 283 (668)
T ss_pred ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHH
Confidence 34566899999999999998877 5789999999999999999999987543210 00112222 566677899
Q ss_pred cccccCCccchhhhhhhhh
Q 037681 303 ESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~ 321 (334)
..+|..+|+.|.++..+.+
T Consensus 284 RwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHHHhcCcccchhHHHHhh
Confidence 9999999999999998765
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=286.74 Aligned_cols=244 Identities=21% Similarity=0.353 Sum_probs=198.6
Q ss_pred cCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQ--GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|...+.||+|.||.||+|+ ..+|+.||||+++..... ......+|++.|+.++|+||+.++++|...+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 578889999999999999999 567999999999855332 24567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|++. +|+..+++.. ..++...+..++.+++.|++|||.+. |.||||||.|+|++.+|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9975 7888886543 45899999999999999999999998 9999999999999999999999999999876544
Q ss_pred CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCcc--------------CCcccccc-----
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYH--------------TGYLSING----- 289 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~--------------~~~~~~~~----- 289 (334)
..... .+-|.+|.|||.+.+ ..|+..+|+||.||++.||+-|.+-|+... +....|..
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 33222 256899999998875 579999999999999999999988765331 11111111
Q ss_pred ---------------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 ---------------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 ---------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..........+++...+.-+|.+|-+..+..+...
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 11113456788899999999999987777655543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=332.43 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=207.9
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
.+....+.||+|.||+||+|... +.+.||||.++..... ..++|++|++++..++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 45566789999999999999843 2456999999866554 7889999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhccc-----------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCce
Q 037681 146 LIYEYLPNKSLDFFLFDATK-----------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
+|+|||..|+|.++|..+.. +.+++..+.+.|+.|||.|++||-++. +|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999975432 233888999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCC-------ccc
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTG-------YLS 286 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~-------~~~ 286 (334)
||+|||+++.....+.........-..+|||||.+..+++|++||||||||+|||+++ |+-||...... ...
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9999999987655544443433445789999999999999999999999999999998 99998776554 122
Q ss_pred ccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 287 INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 287 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+-.....-+..+-++...|+.+.|.+|+++.+|.+.
T Consensus 723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~ 758 (774)
T KOG1026|consen 723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSR 758 (774)
T ss_pred cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 222233356678889999999999999999987653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=310.50 Aligned_cols=240 Identities=25% Similarity=0.299 Sum_probs=198.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999965 68899999986432 234566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999998886543 3888999999999999999999998 999999999999999999999999998765322
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--ccc----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--LSI----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~----~~~~~~~~~~~~~~i 302 (334)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ... ..+.......+.+++
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 229 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLI 229 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHH
Confidence 223568999999999998889999999999999999999999997643220 000 001111345678999
Q ss_pred cccccCCccchhh-----hhhhhhcc
Q 037681 303 ESCLARPFRQYCC-----ILKVRTFG 323 (334)
Q Consensus 303 ~~~l~~~~~~~~~-----~~~~~~~~ 323 (334)
..||..+|.+|++ +.++....
T Consensus 230 ~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 230 KKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred HHHcCCCHHHccCCccCCHHHHhcCc
Confidence 9999999999984 55555544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=301.39 Aligned_cols=248 Identities=23% Similarity=0.281 Sum_probs=205.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|+.++.||.|.-|+||++... ++..+|+|++... ......+.+.|.+||+.++||.++.++..|+.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 56888999999999999999965 4688999999744 3555677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC-
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG- 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~- 227 (334)
|||+||+|..+++.+.. ..+++..+.-++.+++.||+|||..| ||+|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999988876554 45899999999999999999999998 99999999999999999999999998643310
Q ss_pred --------------------------------CCC---------------------ccccccccccCCccCccccccCCC
Q 037681 228 --------------------------------NES---------------------KANTNRVAGTFGYIPPEYVYQGIC 254 (334)
Q Consensus 228 --------------------------------~~~---------------------~~~~~~~~g~~~y~aPE~~~~~~~ 254 (334)
... ......++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011123569999999999999999
Q ss_pred CcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccch--------hcccchhhhccccccCCccchhh----hhhhhhc
Q 037681 255 SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQ--------TQVASKIKLVESCLARPFRQYCC----ILKVRTF 322 (334)
Q Consensus 255 ~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~i~~~l~~~~~~~~~----~~~~~~~ 322 (334)
+.++|+|+|||++|||+.|+.||...+....-..-..+ .......++|.+.|.++|.+|.. ..+|+..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 99999999999999999999999887654211111111 13467889999999999999977 6667766
Q ss_pred cC
Q 037681 323 GF 324 (334)
Q Consensus 323 ~~ 324 (334)
.|
T Consensus 393 pF 394 (459)
T KOG0610|consen 393 PF 394 (459)
T ss_pred cc
Confidence 55
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=314.63 Aligned_cols=240 Identities=23% Similarity=0.303 Sum_probs=197.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|.+. +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 68999999999999999999965 5889999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999998886543 3788889999999999999999998 999999999999999999999999999765322
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i 302 (334)
.....||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ .. ............+++
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLV 246 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHH
Confidence 1235689999999999998899999999999999999999999965432100 00 000111344577899
Q ss_pred cccccCCccchhh-----hhhhhhcc
Q 037681 303 ESCLARPFRQYCC-----ILKVRTFG 323 (334)
Q Consensus 303 ~~~l~~~~~~~~~-----~~~~~~~~ 323 (334)
..||..+|.+|.+ +.++....
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 9999999999975 45555444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=312.35 Aligned_cols=238 Identities=24% Similarity=0.290 Sum_probs=194.0
Q ss_pred CccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCC
Q 037681 79 NKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
+.||+|+||.||+|.. .+|+.+|+|++... .......+.+|+.++++++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 46889999998643 2334456788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccc
Q 037681 155 SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT 234 (334)
Q Consensus 155 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 234 (334)
+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 9988875433 4889999999999999999999998 9999999999999999999999999987432211 123
Q ss_pred ccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------cccccchhcccchhhhccccccC
Q 037681 235 NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------SINGYDQTQVASKIKLVESCLAR 308 (334)
Q Consensus 235 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~ 308 (334)
....||+.|+|||++.+..++.++||||+||++|||++|+.||........ .-..........+.+++..||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence 345799999999999999999999999999999999999999965322110 00011112455688899999999
Q ss_pred Cccchh-----hhhhhhhccC
Q 037681 309 PFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 309 ~~~~~~-----~~~~~~~~~~ 324 (334)
+|.+|+ +..++.+..+
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCC
Confidence 999998 6766665544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=314.07 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=201.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|.+. +++.||+|++... .......+..|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 5889999998643 2234566788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999885433 4788999999999999999999998 99999999999999999999999999875432
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--ccccc---------c---hhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SINGY---------D---QTQ 294 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~~---------~---~~~ 294 (334)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+..+ . ...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcccccc
Confidence 22345689999999999988999999999999999999999999975433210 00000 0 012
Q ss_pred ccchhhhccccccCCccchhhhhhhhhccC
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+.+++..|+..++..|+++.++....+
T Consensus 230 s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 230 SDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred CHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 456788999999999999999988887654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=285.77 Aligned_cols=244 Identities=27% Similarity=0.351 Sum_probs=206.6
Q ss_pred hcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|.||.||.|+ .+++-.||+|++... .....+++.+|+++-+.|+||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3799999999999999999999 456778999998543 233346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
+||.++|.+...|+... ...+++.....++.|+|.|+.|+|..+ ++||||||+|+|++..+.+||+|||.+..-+
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999998887543 234889999999999999999999888 9999999999999999999999999987533
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--ccccc----cchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--LSING----YDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~~----~~~~~~~~~~~~ 301 (334)
.....+.+||..|.|||...+...+..+|+|++|++.||++.|.+||+....+. ..+.. +....+....++
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence 233456899999999999999999999999999999999999999998765331 11111 112256778899
Q ss_pred ccccccCCccchhhhhhhhhcc
Q 037681 302 VESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
|..|+..+|..|+.+.++....
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HHHHhccCccccccHHHHhhhH
Confidence 9999999999999988876544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=311.16 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=201.6
Q ss_pred hhcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccChhhHHH--HHHHHHHHHhcC-CCCcceEeeEEEecC-cce
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE--LKNEALVIAKVQ-HKNLVRLLGCCIERD-EKL 145 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~ 145 (334)
..++|.+++.||.|+||.||+|+ ..+|..||||+++..-.. .++ -.+|+..|++++ ||||+++.+++.+.+ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34789999999999999999999 557999999998744222 233 268999999999 999999999999888 899
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+|||||+. +|.++++.+ +.++++..+..|+.||++||+|+|.+| ++|||+||+|||+.....+||+|||+|+..
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999976 777777665 456999999999999999999999999 999999999999998889999999999876
Q ss_pred cCCCCccccccccccCCccCccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCccC--------------Cccccc--
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGKKNTEFYHT--------------GYLSIN-- 288 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------------~~~~~~-- 288 (334)
... ...+..+.|.+|.|||++. ++.|+.+.|+||+|||++|+.+-++-|+.-.+ ....+.
T Consensus 161 ~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 433 3455678899999999875 67899999999999999999999998875421 111111
Q ss_pred --------------------ccchhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 289 --------------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 289 --------------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
...........+++..|+.=||..|++..+-.++.+-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff 294 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF 294 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence 1111145567788899999999999999988877763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=303.74 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=196.9
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.|+..+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999995 578999999886432 2233457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999987775432 234789999999999999999999998 9999999999999999999999999997653222
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----------cccccchhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------SINGYDQTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------~~~~~~~~~~~~~~ 299 (334)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||........ ....+.........
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 233 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHH
Confidence 1 2234689999999999999999999999999999999999999975432100 00111112455678
Q ss_pred hhccccccCCccchhh-----hhhhhhcc
Q 037681 300 KLVESCLARPFRQYCC-----ILKVRTFG 323 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~-----~~~~~~~~ 323 (334)
+++..||..+|.+|++ +.++.+..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 8999999999999986 55555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=313.21 Aligned_cols=241 Identities=23% Similarity=0.297 Sum_probs=197.9
Q ss_pred cCCCcCCccccCCcccEEEEEecC--CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK--GDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 689999999999999999998543 368999988533 233456778999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999998886543 3889999999999999999999998 99999999999999999999999999976432
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--ccc----cccchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--LSI----NGYDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~----~~~~~~~~~~~~~~ 301 (334)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+ ..+.........++
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 1 233578999999999998889999999999999999999999997643310 000 00111134457789
Q ss_pred ccccccCCccchh-----hhhhhhhccC
Q 037681 302 VESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
+..|+..+|.+|. ++.++....+
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 9999999999984 5666665544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=308.20 Aligned_cols=237 Identities=24% Similarity=0.279 Sum_probs=192.1
Q ss_pred CccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCC
Q 037681 79 NKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
+.||+|+||.||++.. .+|..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 46899999998643 2334456778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccc
Q 037681 155 SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT 234 (334)
Q Consensus 155 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 234 (334)
+|..++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9988775433 4889999999999999999999998 9999999999999999999999999986432211 122
Q ss_pred ccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchhhhccccccC
Q 037681 235 NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKIKLVESCLAR 308 (334)
Q Consensus 235 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~ 308 (334)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... -..........+.+++..||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccC
Confidence 3356899999999999899999999999999999999999999654322100 0011122455678899999999
Q ss_pred Cccchh-----hhhhhhhcc
Q 037681 309 PFRQYC-----CILKVRTFG 323 (334)
Q Consensus 309 ~~~~~~-----~~~~~~~~~ 323 (334)
+|.+|. +..++.+..
T Consensus 233 dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCC
Confidence 999997 555555443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=302.53 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=198.6
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--------------hhhHHHHHHHHHHHHhcCCCCcce
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--------------RQGLQELKNEALVIAKVQHKNLVR 133 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~ 133 (334)
....++|++.+.||+|.||.|-+|.+. +++.||||++.... ....+.+.+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999954 68999999995321 112457899999999999999999
Q ss_pred EeeEEEec--CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC
Q 037681 134 LLGCCIER--DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE 211 (334)
Q Consensus 134 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 211 (334)
++++..++ +..|||+|||..|.+... ...+..+++.+++.++.+++.||+|||.++ |+||||||+|+|++++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99998764 578999999999887432 222223899999999999999999999999 9999999999999999
Q ss_pred CceEEeeccccccccCCC---CccccccccccCCccCccccccCC----CCcchhhHhHHHHHHHHHhCCCCCCCccCC-
Q 037681 212 MKPKISDFGMARIFKGNE---SKANTNRVAGTFGYIPPEYVYQGI----CSIKSDVFSFGMLLLEILSGKKNTEFYHTG- 283 (334)
Q Consensus 212 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~p~~~~~~~- 283 (334)
|++||+|||.+..+.... .........|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.+...-
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 999999999998663221 112223367999999999987632 456899999999999999999999654221
Q ss_pred --------cccccccchhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 284 --------YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 284 --------~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
.+.+.. .......+.++|.++|.++|.+|-++..++...+.
T Consensus 327 l~~KIvn~pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 327 LFDKIVNDPLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHHHHhcCcccCCC-cccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 111111 11235668889999999999999999988877664
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=322.61 Aligned_cols=246 Identities=19% Similarity=0.210 Sum_probs=202.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-C-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-K-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+.+++.++||||+++++++...+..|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 35899999999999999999854 3 577888887666666666788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++|+|.+++... ....++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999887543 23445888999999999999999999998 9999999999999999999999999998765433
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccchhcccchhhhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYDQTQVASKIKLV 302 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~i 302 (334)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............+.+++
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 2223344679999999999999999999999999999999999999997543210 000001112345688899
Q ss_pred cccccCCccchhhhhhhhh
Q 037681 303 ESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~ 321 (334)
..||..+|..|++..++..
T Consensus 304 ~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHhccChhhCcCHHHHHh
Confidence 9999999999999877654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=313.17 Aligned_cols=203 Identities=25% Similarity=0.336 Sum_probs=174.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|... +++.+|+|++... .......+..|+.++.+++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999854 5889999998643 2334466788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999886533 4889999999999999999999998 999999999999999999999999998754321
Q ss_pred CCc---------------------------------cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCC
Q 037681 229 ESK---------------------------------ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275 (334)
Q Consensus 229 ~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 275 (334)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCcc
Q 037681 276 NTEFYH 281 (334)
Q Consensus 276 p~~~~~ 281 (334)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=316.10 Aligned_cols=245 Identities=22% Similarity=0.331 Sum_probs=194.4
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.|+.++.||+|+||+||+|.. .+++.+|+|++... .......+..|+.++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 688899999999999999985 46889999998643 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++++||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998886533 3788889999999999999999998 9999999999999999999999999975431100
Q ss_pred C---------------------------------------------ccccccccccCCccCccccccCCCCcchhhHhHH
Q 037681 230 S---------------------------------------------KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFG 264 (334)
Q Consensus 230 ~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 264 (334)
. ........||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001234699999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCccCCccc--cccc------ch--hcccchhhhccc--cccCCccchhhhhhhhhccC
Q 037681 265 MLLLEILSGKKNTEFYHTGYLS--INGY------DQ--TQVASKIKLVES--CLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 265 ~il~ell~g~~p~~~~~~~~~~--~~~~------~~--~~~~~~~~~i~~--~l~~~~~~~~~~~~~~~~~~ 324 (334)
|++|||++|+.||......... ...+ .. .......+++.+ |+..++..|.++.+++...+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 9999999999999764432111 0000 00 123456677776 44555666788888777655
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=310.10 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=212.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc-ceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE-KLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 148 (334)
++|+.++++|+|+||.++.++++ ++..+++|.+... ..........|+.+++++.|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 68999999999999999999855 5778999999744 23334577899999999999999999999999988 89999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
+||+||++.+.+...+ +..++++.+..|+.|++.|+.|||+.. |+|||||+.||+++.++.|+|.|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999887655 566999999999999999999999887 999999999999999999999999999987655
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------ccccchhcccchhhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------INGYDQTQVASKIKL 301 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~ 301 (334)
.. ......||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+-..+- +..........+..+
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 42 344578999999999999999999999999999999999999999876543211 111122256778889
Q ss_pred ccccccCCccchhhhhhhhhccCCcc
Q 037681 302 VESCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
+..|+..+|+.|++..++.......|
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999998887754433
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=307.25 Aligned_cols=238 Identities=24% Similarity=0.299 Sum_probs=193.3
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999954 6899999998643 2334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccc
Q 037681 155 SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT 234 (334)
Q Consensus 155 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 234 (334)
+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 9988775433 4889999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhccccccC
Q 037681 235 NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLVESCLAR 308 (334)
Q Consensus 235 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i~~~l~~ 308 (334)
....||+.|+|||.+.+..++.++|||||||++|+|++|+.||......... . ..........+.+++..||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCC
Confidence 3457899999999999889999999999999999999999999654322100 0 011112345688899999999
Q ss_pred Cccchh-----hhhhhhhccC
Q 037681 309 PFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 309 ~~~~~~-----~~~~~~~~~~ 324 (334)
+|.+|+ +..++....+
T Consensus 233 dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCC
Confidence 999996 5666665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=302.84 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=196.4
Q ss_pred cCCCcCCccccCCcccEEEEEecC-----------------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-----------------GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRL 134 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~ 134 (334)
++|.+.+.||+|+||.||+|.+.+ +..||+|.+... .......+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 688999999999999999997532 336999988754 33445678899999999999999999
Q ss_pred eeEEEecCcceEEEEecCCCChhhhhhhcc----------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 037681 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDAT----------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198 (334)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH 198 (334)
++++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999998875432 1123677888999999999999999998 999
Q ss_pred ccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh--CCCC
Q 037681 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS--GKKN 276 (334)
Q Consensus 199 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p 276 (334)
|||||+||+++.++.+||+|||++................++..|+|||.+.++.++.++||||||+++|||++ |..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999976543322222233456788999999988899999999999999999997 5566
Q ss_pred CCCccCCccc--------------ccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 277 TEFYHTGYLS--------------INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 277 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
|......... ...........+.+++..|+..+|.+|+++.++..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 6544322100 000011134567899999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=283.80 Aligned_cols=252 Identities=23% Similarity=0.246 Sum_probs=207.0
Q ss_pred HhhcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc-----
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE----- 143 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 143 (334)
...++|.+.+.||+|||+-||+++ ..++..+|+|++.....+..+...+|++..++++|||+++++++...+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 445799999999999999999999 56788999999988877888899999999999999999999998765443
Q ss_pred ceEEEEecCCCChhhhhhhccc-ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATK-RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
.|++++|...|+|.+.+..... +..+++.++++|+.++++||++||... +++.||||||.||++.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 7999999999999988876553 347999999999999999999999885 46999999999999999999999999998
Q ss_pred ccccCCCCc-------cccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--ccccc--
Q 037681 223 RIFKGNESK-------ANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--YLSIN-- 288 (334)
Q Consensus 223 ~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~~-- 288 (334)
+........ ........|..|.|||.+. +...+.++|||||||+||+|+.|..||+..... ...+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 765321110 1112234688999999886 456788999999999999999999999855332 11111
Q ss_pred ----ccchh--cccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 ----GYDQT--QVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 ----~~~~~--~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
++... .++.+.+++..|++.+|.+||++.++.+.
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11111 67789999999999999999999887653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=305.45 Aligned_cols=244 Identities=25% Similarity=0.325 Sum_probs=201.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 378999999999999999999965 6888999988754 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999886543 3788999999999999999999753 39999999999999999999999999987543221
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-----------------cc-----
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-----------------SI----- 287 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----------------~~----- 287 (334)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ..
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2335689999999999988999999999999999999999999964321000 00
Q ss_pred ----------------------cccc----------hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 ----------------------NGYD----------QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ----------------------~~~~----------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+. ......+.+++.+||..+|++|+++.++....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000 002345678999999999999999999887665
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=311.31 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=205.1
Q ss_pred HHHHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 67 SVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 67 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
++.+..+...+...||+|.||+||+|.+- -.||||.++.. ..++.+.|+.|+.++++-+|.||+-+.|+|..++.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 34445567778899999999999999975 35999999754 45678899999999999999999999999998877
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
.+|+.+|+|.+|..+++.... .++..+.+.|+.|+++|+.|||.++ |+|||||..||++.+++.|||+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 999999999999999976554 3889999999999999999999998 99999999999999999999999999975
Q ss_pred ccCCCCccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc-----------ccc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI-----------NGY 290 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-----------~~~ 290 (334)
-..-..........|...|||||++. ..+|+.++||||||+++|||+||..||.....+..-| ...
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 43332223334456788999999986 4578999999999999999999999998333221111 111
Q ss_pred chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 291 DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 291 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...-.....+++..|+..+++.|+.+.++....+
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 1114557889999999999999999988877333
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=301.38 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=197.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|+||.||+|.+. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999965 5888999988643 23345677889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|++++++..+... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9999877655432 224888999999999999999999998 9999999999999999999999999997654322
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------c--------------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------S-------------- 286 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~-------------- 286 (334)
. .......|++.|+|||++.+..++.++|+||+||++|||++|++||+....... +
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2 122335689999999999888899999999999999999999999975422100 0
Q ss_pred -----cccc----------chhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 287 -----INGY----------DQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 287 -----~~~~----------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+... ....+..+.+++..||..+|.+|+++.++.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp 285 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 0000 000233478899999999999999998877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=314.90 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=196.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999964 6899999999643 2344566788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999886533 4899999999999999999999998 999999999999999999999999998654321
Q ss_pred CCcc------------------------------------ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh
Q 037681 229 ESKA------------------------------------NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272 (334)
Q Consensus 229 ~~~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 272 (334)
.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999998899999999999999999999
Q ss_pred CCCCCCCccCCcc--cccccc--------hhcccchhhhccccccCCccchhh---hhhhhhccC
Q 037681 273 GKKNTEFYHTGYL--SINGYD--------QTQVASKIKLVESCLARPFRQYCC---ILKVRTFGF 324 (334)
Q Consensus 273 g~~p~~~~~~~~~--~~~~~~--------~~~~~~~~~~i~~~l~~~~~~~~~---~~~~~~~~~ 324 (334)
|..||........ ....+. ........+++..++. +|.+|.+ +.++....+
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 9999975432210 000010 0124456778888885 7777776 777666554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=304.54 Aligned_cols=227 Identities=23% Similarity=0.282 Sum_probs=187.3
Q ss_pred cccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 81 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
||+|+||.||+|.+. ++..||+|.+... .......+..|+.++.+++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 5889999998642 334456778899999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 236 (334)
..++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 98886533 3889999999999999999999998 99999999999999999999999999875332221 2334
Q ss_pred ccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhccccccCCc
Q 037681 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLVESCLARPF 310 (334)
Q Consensus 237 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i~~~l~~~~ 310 (334)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||........ .. ..........+.+++..||..+|
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCH
Confidence 5789999999999999999999999999999999999999975422210 00 00111234567889999999999
Q ss_pred cchhh
Q 037681 311 RQYCC 315 (334)
Q Consensus 311 ~~~~~ 315 (334)
.+|.+
T Consensus 233 ~~R~~ 237 (312)
T cd05585 233 TRRLG 237 (312)
T ss_pred HHcCC
Confidence 99964
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=304.72 Aligned_cols=235 Identities=26% Similarity=0.328 Sum_probs=190.4
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCC-CcceEeeEEEecCcceEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHK-NLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 148 (334)
+|++.+.||+|+||.||+|... +++.||+|++... .....+.+..|..++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999955 5788999998643 233456678899999999765 6888999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999988875433 3788999999999999999999998 999999999999999999999999998643211
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i 302 (334)
. .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......... . ............+++
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 232 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSIC 232 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 1 1233457899999999999999999999999999999999999999754322100 0 001112345577899
Q ss_pred cccccCCccchhhh
Q 037681 303 ESCLARPFRQYCCI 316 (334)
Q Consensus 303 ~~~l~~~~~~~~~~ 316 (334)
..|+..+|.+|.+.
T Consensus 233 ~~~l~~~P~~R~~~ 246 (324)
T cd05587 233 KGLLTKHPAKRLGC 246 (324)
T ss_pred HHHhhcCHHHcCCC
Confidence 99999999999765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=302.09 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=194.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 378999999999999999999965 68899999986443 2223456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++ +|..++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVHT-DLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCCc-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9964 6666654332 33788889999999999999999998 9999999999999999999999999987543221
Q ss_pred CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------------cccc----
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------------SING---- 289 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------------~~~~---- 289 (334)
.......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||........ .+..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 11223467899999998865 4578899999999999999999999975422100 0000
Q ss_pred --cc--------h----------hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 --YD--------Q----------TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 --~~--------~----------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.. . .......+++..||..+|.+|+++.++.+..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 00 0 01234668999999999999999999887665
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=314.26 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=191.9
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999985 46889999988543 2334567788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999998885433 3788899999999999999999998 999999999999999999999999998632210
Q ss_pred CC-------------c--------------------------------cccccccccCCccCccccccCCCCcchhhHhH
Q 037681 229 ES-------------K--------------------------------ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSF 263 (334)
Q Consensus 229 ~~-------------~--------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 263 (334)
.. . .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 00012468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCccCCcc--cccccc------h--hcccchhhhccccccCCccch---hhhhhhhhccC
Q 037681 264 GMLLLEILSGKKNTEFYHTGYL--SINGYD------Q--TQVASKIKLVESCLARPFRQY---CCILKVRTFGF 324 (334)
Q Consensus 264 G~il~ell~g~~p~~~~~~~~~--~~~~~~------~--~~~~~~~~~i~~~l~~~~~~~---~~~~~~~~~~~ 324 (334)
||++|||++|+.||........ ....+. . .......+++.+|+. ++.+| +++.++....+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 9999999999999975432110 000000 0 123456788888886 55544 46666555443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=314.19 Aligned_cols=244 Identities=22% Similarity=0.315 Sum_probs=191.1
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.|++++.||+|+||.||+|.. .+++.+|+|.+... .......+.+|+.++++++||||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 688899999999999999995 46889999998643 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998885532 3788889999999999999999998 9999999999999999999999999975321000
Q ss_pred ---------------------------------------------CccccccccccCCccCccccccCCCCcchhhHhHH
Q 037681 230 ---------------------------------------------SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFG 264 (334)
Q Consensus 230 ---------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 264 (334)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCccCCccc--ccccc--------hhcccchhhhccccccCCccchhh---hhhhhhccC
Q 037681 265 MLLLEILSGKKNTEFYHTGYLS--INGYD--------QTQVASKIKLVESCLARPFRQYCC---ILKVRTFGF 324 (334)
Q Consensus 265 ~il~ell~g~~p~~~~~~~~~~--~~~~~--------~~~~~~~~~~i~~~l~~~~~~~~~---~~~~~~~~~ 324 (334)
|++|||++|++||....+.... ...+. ........+++.+++ .+|.+|.+ ..+++...+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 307 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF 307 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence 9999999999999764332100 00000 112445666676654 57777765 555555443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=298.52 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=194.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 67999999999999999999954 68899999986432 22345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++ +|..++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 7877775432 24788899999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cc---------
Q 037681 231 KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LS--------- 286 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~--------- 286 (334)
......+++.|+|||.+.+ ..++.++||||+||++|+|++|++||....... ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1233467899999998865 568999999999999999999999986432110 00
Q ss_pred -----cccc--------chhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 287 -----INGY--------DQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 287 -----~~~~--------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+..+ .........+++.+||..+|.+|+++.++.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 0000 001234567899999999999999999887654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=303.58 Aligned_cols=238 Identities=26% Similarity=0.325 Sum_probs=191.4
Q ss_pred CccccCCcccEEEEEe----cCCCEEEEEEeccc----ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 79 NKLGEGGFGPVYKGVL----AKGDEIAVKRLSVR----SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+.||+|+||.||++.. .+++.+|+|.+... .......+..|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 25788999998642 223345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++.... .+.+..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999988875433 3778888899999999999999998 99999999999999999999999999864322221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhccc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLVES 304 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i~~ 304 (334)
......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. ............+++..
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKK 233 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 22335689999999999988899999999999999999999999976432210 00 00111134567899999
Q ss_pred cccCCccchh-----hhhhhhhccC
Q 037681 305 CLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 305 ~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
|+..+|.+|+ +..++....+
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCC
Confidence 9999999998 5665555443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=314.66 Aligned_cols=245 Identities=21% Similarity=0.305 Sum_probs=194.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|... +++.+|+|.+... .......+.+|++++++++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999954 5889999998643 2234566789999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999885533 4788888999999999999999998 999999999999999999999999997532100
Q ss_pred C-----------------------------------------CccccccccccCCccCccccccCCCCcchhhHhHHHHH
Q 037681 229 E-----------------------------------------SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLL 267 (334)
Q Consensus 229 ~-----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il 267 (334)
. .........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00011234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCccCCcc--cccccc--------hhcccchhhhccccccCCccchh---hhhhhhhccC
Q 037681 268 LEILSGKKNTEFYHTGYL--SINGYD--------QTQVASKIKLVESCLARPFRQYC---CILKVRTFGF 324 (334)
Q Consensus 268 ~ell~g~~p~~~~~~~~~--~~~~~~--------~~~~~~~~~~i~~~l~~~~~~~~---~~~~~~~~~~ 324 (334)
|||++|+.||........ ....+. ........+++..++ .+|.+|. ++.++....+
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 999999999976543211 011110 112345666777655 5888887 6777776655
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.01 Aligned_cols=244 Identities=19% Similarity=0.275 Sum_probs=192.7
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----cce
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-----EKL 145 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 145 (334)
+|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++...+ ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999954 6899999988632 2233456789999999999999999999886433 479
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||++ ++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 57877775433 3889999999999999999999998 999999999999999999999999999754
Q ss_pred cCCCC-ccccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------c---
Q 037681 226 KGNES-KANTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------L--- 285 (334)
Q Consensus 226 ~~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~--- 285 (334)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||....... .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 112234568999999999865 678999999999999999999999996532100 0
Q ss_pred --------------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 --------------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 --------------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+..........+.+++..||..+|.+|+++.++....+
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 000000012344678999999999999999998887665
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=310.13 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=198.9
Q ss_pred hhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecC
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERD 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 142 (334)
..++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3468999999999999999998842 2357999998643 333456788999999999 8999999999999999
Q ss_pred cceEEEEecCCCChhhhhhhccc---------------------------------------------------------
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATK--------------------------------------------------------- 165 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 165 (334)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999988754211
Q ss_pred ----------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccc
Q 037681 166 ----------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235 (334)
Q Consensus 166 ----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 235 (334)
...+++..+..++.||+.||.|||+++ ++||||||+||++++++.+||+|||++.............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 123677888999999999999999998 9999999999999999999999999987654332222222
Q ss_pred cccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccccc----c----chhcccchhhhccccc
Q 037681 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSING----Y----DQTQVASKIKLVESCL 306 (334)
Q Consensus 236 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~----~----~~~~~~~~~~~i~~~l 306 (334)
...++..|+|||++.+..++.++||||||+++|||++ |+.||............ . .......+.+++..|+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 2345678999999988899999999999999999997 99999765432110000 0 0013466888999999
Q ss_pred cCCccchhhhhhhhhc
Q 037681 307 ARPFRQYCCILKVRTF 322 (334)
Q Consensus 307 ~~~~~~~~~~~~~~~~ 322 (334)
..+|.+|+++.++...
T Consensus 353 ~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 353 NLEPTERPTFSQISQL 368 (374)
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999987654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=305.63 Aligned_cols=237 Identities=23% Similarity=0.273 Sum_probs=191.3
Q ss_pred CccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCC
Q 037681 79 NKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
+.||+|+||.||++.. .+|..+|+|.+... .......+..|+.++..++||||+++.+++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46889999998643 2334456778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 155 SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 155 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
+|..++.... .+++..+..++.||+.||.|||+ .+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 9988775433 48899999999999999999997 67 99999999999999999999999999865322211 1
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... -..........+.+++..||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhh
Confidence 23356899999999999899999999999999999999999999654322100 000111235567889999999
Q ss_pred CCccchh-----hhhhhhhcc
Q 037681 308 RPFRQYC-----CILKVRTFG 323 (334)
Q Consensus 308 ~~~~~~~-----~~~~~~~~~ 323 (334)
.+|.+|+ +..++.+..
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCC
Confidence 9999996 566655443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.31 Aligned_cols=232 Identities=27% Similarity=0.363 Sum_probs=186.9
Q ss_pred CCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHH---HhcCCCCcceEeeEEEecCcceEE
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVI---AKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
|++.+.||+|+||.||+|.+. +++.||+|.++.. .....+.+..|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999954 6899999998643 223345566666655 566899999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|...+.. ..+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999877643 24899999999999999999999998 99999999999999999999999999864322
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~ 301 (334)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ .+ ..........+.++
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 231 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISI 231 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 11 123346789999999999999999999999999999999999999975432210 00 00111134567889
Q ss_pred ccccccCCccchhh
Q 037681 302 VESCLARPFRQYCC 315 (334)
Q Consensus 302 i~~~l~~~~~~~~~ 315 (334)
+.+||..+|.+|++
T Consensus 232 i~~~L~~dP~~R~~ 245 (324)
T cd05589 232 MRRLLRRNPERRLG 245 (324)
T ss_pred HHHHhhcCHhHcCC
Confidence 99999999999973
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=309.41 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=197.9
Q ss_pred hcCCCcCCccccCCcccEEEEEe------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL------AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 143 (334)
.++|++.+.||+|+||.||+|.+ .++..||+|+++.. .....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 46899999999999999999973 23567999998643 233446788999999999 89999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhccc----------------------------------------------------------
Q 037681 144 KLLIYEYLPNKSLDFFLFDATK---------------------------------------------------------- 165 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 165 (334)
.++||||+++|+|..++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988854321
Q ss_pred --------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 166 --------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 166 --------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124678889999999999999999998 999999999999999999999999999765433222
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccccc----cc----chhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSIN----GY----DQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~----~~----~~~~~~~~~~~i 302 (334)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||........... .+ .......+.+++
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 22222345677999999999999999999999999999998 8889876432210000 00 011344678999
Q ss_pred cccccCCccchhhhhhhhhc
Q 037681 303 ESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~ 322 (334)
..|+..+|.+|+++.++...
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.94 Aligned_cols=238 Identities=25% Similarity=0.335 Sum_probs=191.2
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|... +++.+|+|.+... .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 5789999998643 233445667788888866 799999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|...+.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 99988875433 3788899999999999999999998 99999999999999999999999999875322221 2
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--cc----ccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--IN----GYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~----~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .. ...........+++..||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhc
Confidence 23456899999999999889999999999999999999999999765332100 00 0011134567889999999
Q ss_pred CCccchh-------hhhhhhhccC
Q 037681 308 RPFRQYC-------CILKVRTFGF 324 (334)
Q Consensus 308 ~~~~~~~-------~~~~~~~~~~ 324 (334)
.+|.+|. ++.++.+..+
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcCCc
Confidence 9999998 5566655543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=301.08 Aligned_cols=235 Identities=27% Similarity=0.352 Sum_probs=187.0
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|.+. +++.||+|.++.. .....+....|..++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999954 5888999998643 223344455666676654 899999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99988875433 3888999999999999999999998 9999999999999999999999999987543222 22
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... + ............+++..||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 33457899999999999889999999999999999999999999754321100 0 00111134557789999999
Q ss_pred CCccchhhhh-hhhh
Q 037681 308 RPFRQYCCIL-KVRT 321 (334)
Q Consensus 308 ~~~~~~~~~~-~~~~ 321 (334)
.+|.+|.++. .++.
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05592 233 RDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHcCCChHHHHc
Confidence 9999998764 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=308.86 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=201.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|... +++.||+|++... .......+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999965 6899999998643 2244567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999988654 34889999999999999999999988 999999999999999999999999998765433
Q ss_pred C---------------------------CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCcc
Q 037681 229 E---------------------------SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYH 281 (334)
Q Consensus 229 ~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 281 (334)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012233568999999999999999999999999999999999999997654
Q ss_pred CCc--cccccc------chh--cccchhhhccccccCCccchhh-hhhhhhccC
Q 037681 282 TGY--LSINGY------DQT--QVASKIKLVESCLARPFRQYCC-ILKVRTFGF 324 (334)
Q Consensus 282 ~~~--~~~~~~------~~~--~~~~~~~~i~~~l~~~~~~~~~-~~~~~~~~~ 324 (334)
... ..+..+ ... ....+.+++..|+. +|.+|.+ +.++....+
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 221 001110 011 25667889999997 8999988 888877654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=301.84 Aligned_cols=230 Identities=26% Similarity=0.358 Sum_probs=187.5
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||+||+|... +++.||+|.+... .....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5889999998643 233455667888888876 699999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
|+|..++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 99988875443 3889999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ .. ............+++..||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence 2345789999999999988999999999999999999999999976533210 00 00111134567889999999
Q ss_pred CCccchhhh
Q 037681 308 RPFRQYCCI 316 (334)
Q Consensus 308 ~~~~~~~~~ 316 (334)
.+|.+|++.
T Consensus 233 ~dP~~R~~~ 241 (320)
T cd05590 233 KNPTMRLGS 241 (320)
T ss_pred cCHHHCCCC
Confidence 999999887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=308.23 Aligned_cols=229 Identities=28% Similarity=0.426 Sum_probs=191.6
Q ss_pred cCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 77 DTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
.++=||.|+.|.||.|+.. +..||||+++.. -..+++-|++|+||||+.+.|+|.....++||||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3567999999999999976 788999988532 24577889999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 236 (334)
...|+.... +.......|..+||.|+.|||.+. |+|||||.-||||..+..|||+|||.++..... ...-.
T Consensus 200 ~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS 270 (904)
T KOG4721|consen 200 YEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS 270 (904)
T ss_pred HHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence 999966543 788888999999999999999998 999999999999999999999999998765433 22334
Q ss_pred ccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc------ccc--chhcccchhhhccccccC
Q 037681 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI------NGY--DQTQVASKIKLVESCLAR 308 (334)
Q Consensus 237 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~------~~~--~~~~~~~~~~~i~~~l~~ 308 (334)
++||..|||||++.+.+.+.|+|||||||+|||||||..||.+......-| ... ...-..-+.-++..||..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 789999999999999999999999999999999999999998764431100 000 111344466688899999
Q ss_pred Cccchhhhhhhhhc
Q 037681 309 PFRQYCCILKVRTF 322 (334)
Q Consensus 309 ~~~~~~~~~~~~~~ 322 (334)
.|++|+++.+++..
T Consensus 351 KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 351 KPRNRPSFRQILLH 364 (904)
T ss_pred CCCCCccHHHHHHH
Confidence 99999999887653
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=320.54 Aligned_cols=251 Identities=27% Similarity=0.299 Sum_probs=202.4
Q ss_pred hcCCCcCCccccCCcccEEEEEecCC-CEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEE-Ee---c---C
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKG-DEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCC-IE---R---D 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~-~~---~---~ 142 (334)
..++++.+.|.+|||+.||+|....+ ..+|+|++-..++...+.+.+|+++|++|. |+|||.+++.. .. . -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35678889999999999999996655 999999998888899999999999999996 99999999942 21 1 1
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..++.||||.||.|-+++..+.... +++..+++|+.|+++|+++||.+ .++|+|||||-+||||+.+++.||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 3578999999999999887654433 99999999999999999999998 566999999999999999999999999998
Q ss_pred ccccCCCCcccc-------ccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccc-
Q 037681 223 RIFKGNESKANT-------NRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYD- 291 (334)
Q Consensus 223 ~~~~~~~~~~~~-------~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~- 291 (334)
.-.......... -...-|+.|.|||.+. +...++|+|||||||+||-|+....||+....-...-..+.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~ 273 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSF 273 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccC
Confidence 643221110000 0123689999999874 67899999999999999999999999997633211101111
Q ss_pred ---hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 292 ---QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 292 ---~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
......+.++|..||..+|..|+.|.++...-+
T Consensus 274 P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 274 PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 236778999999999999999999998876544
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=302.08 Aligned_cols=235 Identities=26% Similarity=0.334 Sum_probs=190.4
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
+|++.+.||+|+||.||+|... +++.+|+|.+... ..........|..++..+ +||+|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999965 5789999998643 222334566777888777 5899999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999988875433 3888999999999999999999998 999999999999999999999999998753221
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i 302 (334)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... + ..+.........+++
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 232 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 232 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence 1 1223457899999999999999999999999999999999999999765432100 0 001122455678899
Q ss_pred cccccCCccchhhh
Q 037681 303 ESCLARPFRQYCCI 316 (334)
Q Consensus 303 ~~~l~~~~~~~~~~ 316 (334)
..|+..+|.+|.+.
T Consensus 233 ~~~l~~~p~~R~~~ 246 (323)
T cd05616 233 KGLMTKHPGKRLGC 246 (323)
T ss_pred HHHcccCHHhcCCC
Confidence 99999999999763
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.07 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=194.7
Q ss_pred CCCcCCccccCCcccEEEEEec----CCCEEEEEEeccc----ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcc
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVR----SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 144 (334)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5888999999999999998852 5789999998632 223345678899999999 599999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||+++|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999988885533 3889999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cccc--------cchh
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SING--------YDQT 293 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~--------~~~~ 293 (334)
....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ .+.. ....
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 4332221 22345799999999998765 478899999999999999999999965332210 0000 0111
Q ss_pred cccchhhhccccccCCccchh-----hhhhhhhccC
Q 037681 294 QVASKIKLVESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
......+++..||..+|.+|+ ++.++.+..+
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 344578899999999999998 5556655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=301.13 Aligned_cols=229 Identities=22% Similarity=0.317 Sum_probs=186.4
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|.+. +++.||+|.++.. .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999954 6889999999743 233456678899999988 799999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
|+|..++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 99988775432 4899999999999999999999998 9999999999999999999999999986422111 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---cccccc------------chhcccch
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---LSINGY------------DQTQVASK 298 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~~~~~------------~~~~~~~~ 298 (334)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||+...... .....+ .......+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 232 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 334578999999999999999999999999999999999999997432211 000000 01123456
Q ss_pred hhhccccccCCccchhh
Q 037681 299 IKLVESCLARPFRQYCC 315 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~ 315 (334)
.+++..||..+|.+|.+
T Consensus 233 ~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 233 SSVLKGFLNKDPKERLG 249 (329)
T ss_pred HHHHHHHhccCHHHcCC
Confidence 78999999999999976
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.50 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=202.8
Q ss_pred hhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD----- 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 142 (334)
..++|.+.+.||+|+||+||+|.. .+|+.||+|.+... .......+.+|+..+..++|+||+++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 347999999999999999999984 46899999998643 3445567889999999999999999988775432
Q ss_pred ---cceEEEEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEee
Q 037681 143 ---EKLLIYEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISD 218 (334)
Q Consensus 143 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 218 (334)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 2579999999999999886532 2345889999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccc
Q 037681 219 FGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYD 291 (334)
Q Consensus 219 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~ 291 (334)
||+++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 999976543322223345679999999999999999999999999999999999999997543210 0001111
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
......+.+++..||..+|.+|+++.++....
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 22455688899999999999999998876643
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=295.07 Aligned_cols=243 Identities=24% Similarity=0.340 Sum_probs=190.2
Q ss_pred cCCCcCCccccCCcccEEEEEec--CCCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCcceEeeEEEe-----
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA--KGDEIAVKRLSVRS--RQGLQELKNEALVIAKV---QHKNLVRLLGCCIE----- 140 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~----- 140 (334)
++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999853 46789999886432 22234556677777665 69999999999853
Q ss_pred cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecc
Q 037681 141 RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFG 220 (334)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 220 (334)
....++||||++ ++|..++..... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999997 578777754332 34788999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--------------ccc
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------YLS 286 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------~~~ 286 (334)
++...... .......|++.|+|||.+.+..++.++|||||||++|||++|++||...... ...
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 99765432 1233456899999999998889999999999999999999999999754321 000
Q ss_pred cc-------------------ccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 287 IN-------------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 287 ~~-------------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+. .........+.+++.+||..+|++|+++.++...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp 288 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 288 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence 00 00011234457899999999999999999887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=300.12 Aligned_cols=237 Identities=27% Similarity=0.366 Sum_probs=189.4
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|.+. +|..||+|.++... .........|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 58899999986431 23345566777777754 899999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|..++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 99988875432 3788999999999999999999998 9999999999999999999999999986432111 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------cccccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------SINGYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||........ ............+.+++..||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFE 232 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcc
Confidence 3346789999999999999999999999999999999999999975432210 0000111134567789999999
Q ss_pred CCccchhhhh-hhhhcc
Q 037681 308 RPFRQYCCIL-KVRTFG 323 (334)
Q Consensus 308 ~~~~~~~~~~-~~~~~~ 323 (334)
.+|.+|.++. +++...
T Consensus 233 ~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 233 RDPTRRLGVVGNIRGHP 249 (316)
T ss_pred CCHHHcCCChHHHHcCC
Confidence 9999998874 565443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=307.30 Aligned_cols=245 Identities=22% Similarity=0.247 Sum_probs=197.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||.||++... ++..+|+|.+... .......+..|+.+++.++||||+++++++.+.+..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 468999999999999999999954 6889999998632 223345577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++|+|..++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999887543 2788888899999999999999998 99999999999999999999999999876533
Q ss_pred CCCccccccccccCCccCccccccC----CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--ccc------cccch--h
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQG----ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--LSI------NGYDQ--T 293 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~------~~~~~--~ 293 (334)
... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... ..+ ..+.. .
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 221 122345799999999988643 47889999999999999999999997543210 000 00111 1
Q ss_pred cccchhhhccccccCCccc--hhhhhhhhhccC
Q 037681 294 QVASKIKLVESCLARPFRQ--YCCILKVRTFGF 324 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~--~~~~~~~~~~~~ 324 (334)
.+....+++..||..+|.. |.++.++....+
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 3556788999999887766 778888766654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=299.07 Aligned_cols=236 Identities=27% Similarity=0.361 Sum_probs=188.6
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHh-cCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAK-VQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|.+. +++.||+|.+.... .........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999986431 2334556667777776 4899999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
|+|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 99998885432 3788899999999999999999998 9999999999999999999999999986432211 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||......... . ............+++.+||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhc
Confidence 23456899999999999889999999999999999999999999754322100 0 00111134457789999999
Q ss_pred CCccchhhhh-hhhhc
Q 037681 308 RPFRQYCCIL-KVRTF 322 (334)
Q Consensus 308 ~~~~~~~~~~-~~~~~ 322 (334)
.+|.+|.++. +++..
T Consensus 233 ~~P~~R~~~~~~l~~h 248 (316)
T cd05619 233 REPERRLGVKGDIRQH 248 (316)
T ss_pred cCHhhcCCChHHHHcC
Confidence 9999998875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=294.10 Aligned_cols=232 Identities=20% Similarity=0.261 Sum_probs=189.9
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccChh---hHHHHHHHHHHHHhcCCCCcceEeeEEEe----cCcceEEEEec
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQ---GLQELKNEALVIAKVQHKNLVRLLGCCIE----RDEKLLIYEYL 151 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 151 (334)
..||+|++|.||+|.. +|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999987 5889999998754322 25677899999999999999999999877 34678999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH-SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
++|+|.+++.... .+++.....++.|++.|+.|||+. + ++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999986543 378899999999999999999974 6 8899999999999999999999999987543221
Q ss_pred ccccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc------cccchhcccchhh
Q 037681 231 KANTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI------NGYDQTQVASKIK 300 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~------~~~~~~~~~~~~~ 300 (334)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .. ..........+.+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 253 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKC 253 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence 12357889999999876 6889999999999999999999999986532210 00 0011123456889
Q ss_pred hccccccCCccchhhhhhhhhc
Q 037681 301 LVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
++..||..+|..|+++.++...
T Consensus 254 li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 254 IVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHhcCCcccCcCHHHHHHH
Confidence 9999999999999999887653
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=300.13 Aligned_cols=229 Identities=23% Similarity=0.317 Sum_probs=185.5
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|... +++.+|+|.+... .......+..|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 5789999998643 333455677888888877 799999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|..++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 99988775433 3889999999999999999999998 9999999999999999999999999986432211 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc---ccc------------cchhcccch
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---ING------------YDQTQVASK 298 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---~~~------------~~~~~~~~~ 298 (334)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ... .........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 232 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHH
Confidence 23457899999999999999999999999999999999999999643221100 000 011134456
Q ss_pred hhhccccccCCccchhh
Q 037681 299 IKLVESCLARPFRQYCC 315 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~ 315 (334)
.+++..||..+|.+|.+
T Consensus 233 ~~ll~~~L~~dP~~R~~ 249 (329)
T cd05618 233 ASVLKSFLNKDPKERLG 249 (329)
T ss_pred HHHHHHHhcCCHHHcCC
Confidence 68999999999999976
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=291.01 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=210.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+-|.++..||+|+||.||++.++ +|+.+|||++... ...+++.+|+.++.+++.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 45778899999999999999955 6999999998655 34588999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
..|+..+.++.+++ ++++..+..++..-+.||+|||... -+|||||..|||++.+|..||+|||.|..+.+...
T Consensus 111 GAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 111 GAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 99999999876544 5899999999999999999999887 89999999999999999999999999987654333
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc---------ccchhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN---------GYDQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~i 302 (334)
..+++.||+.|||||++..-.|..++||||||++..||.-|++||.+.++-..-+. ...+..+...-+++
T Consensus 185 -KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 -KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred -hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 34567899999999999999999999999999999999999999999887522211 11222566788999
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+||.+.|++|.+..++.+..|
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhh
Confidence 9999999999998888776555
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=293.52 Aligned_cols=248 Identities=26% Similarity=0.412 Sum_probs=201.7
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999842 244589998876666666788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc----------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 147 IYEYLPNKSLDFFLFDAT----------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999998886432 1234889999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------cccc
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------LSIN 288 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~~~~ 288 (334)
+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |.+||....... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999875533222222223345778999999988889999999999999999998 999986553321 0011
Q ss_pred ccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 289 GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 289 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.........+.+++..|+..+|.+|+++.++...-
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l 276 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 11112455788999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=284.12 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=193.2
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCcceEeeEEEe--cCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQ--GLQELKNEALVIAKVQHKNLVRLLGCCIE--RDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 146 (334)
.+.|+.++.|++|+||.||+|+++ ++..||+|+++...+. ..-.-.+|+.+|.+++|||||.+.++... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 468999999999999999999954 6888999999865322 22345789999999999999999998764 346899
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|||||+. +|..++..-. .++...++..++.|++.|++|||.+. |+||||||+|+|++..|.+||+|||+|+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999987 6777775544 34888999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCcc--------------------CCcc
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYH--------------------TGYL 285 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~--------------------~~~~ 285 (334)
... ...+..+-|.+|.|||++.+. .|+++.|+||+|||+.||+++++-|+.-. ++..
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 442 234445679999999998864 68999999999999999999999886331 1111
Q ss_pred ccccc--------ch--------h--cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 SINGY--------DQ--------T--QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ~~~~~--------~~--------~--~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+..+ .. . ..+.-.+++...|.-+|.+|++..+=...++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 11111 00 0 1244567888888999999988876554443
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=298.49 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=198.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 378999999999999999999965 5788899988654 33445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999886533 3788899999999999999999742 29999999999999999999999999987543221
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-----------------------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS----------------------- 286 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~----------------------- 286 (334)
.....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.........
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 22346899999999999888999999999999999999999998643211000
Q ss_pred ---c----------------cccc-----h-----hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 287 ---I----------------NGYD-----Q-----TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 287 ---~----------------~~~~-----~-----~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. ..+. . .....+.+++.+||..+|.+|+++.++....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0 0000 0 01234578999999999999999999876544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=292.83 Aligned_cols=247 Identities=28% Similarity=0.423 Sum_probs=200.5
Q ss_pred cCCCcCCccccCCcccEEEEEecC------CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
++|.+.+.||+|+||.||+|...+ +..+|+|.+...... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 578889999999999999998543 467999998754333 4578899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcc-----------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCce
Q 037681 146 LIYEYLPNKSLDFFLFDAT-----------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
+||||+++++|.+++.... ....+++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999886532 1234788899999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------cc
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------LS 286 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~~ 286 (334)
+|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999875433222112223345778999999999999999999999999999998 999986543321 00
Q ss_pred ccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 287 INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 287 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
...........+.+++..|+..+|.+|+++.++...
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 277 (280)
T cd05049 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 001111245668899999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=290.35 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=196.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|++.+.||+|+||.||+|.+. .+..+|+|.++.. .......+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357899999999999999999743 3568999998754 23344678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999886533 34889999999999999999999998 9999999999999999999999999875432
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------ccccccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------LSINGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~~~~~~~~~~~~~~ 298 (334)
.... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||....... .............+
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 2111 11112335678999999999999999999999999999775 999997543221 00000011134567
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..|+..+|.+|+++.++.+.
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~ 261 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSI 261 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHH
Confidence 889999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=291.87 Aligned_cols=247 Identities=29% Similarity=0.452 Sum_probs=200.1
Q ss_pred cCCCcCCccccCCcccEEEEEecC-C-----CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-G-----DEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
++|++.+.||+|+||.||+|.... + ..+++|.+... .......+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578899999999999999998543 2 57899988644 3344567889999999999999999999999988999
Q ss_pred EEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC
Q 037681 146 LIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM 212 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 212 (334)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999988865321 134788889999999999999999998 99999999999999999
Q ss_pred ceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc------
Q 037681 213 KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL------ 285 (334)
Q Consensus 213 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~------ 285 (334)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999876533322222333456788999999988899999999999999999998 9999875433211
Q ss_pred -cccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 286 -SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 286 -~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
............+.+++..|+..+|.+|+++.++...
T Consensus 242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0001111235678899999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=305.77 Aligned_cols=246 Identities=21% Similarity=0.239 Sum_probs=193.4
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
..++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3478999999999999999999965 5888999988532 22334567889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++|+|..++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999988543 2788889999999999999999998 9999999999999999999999999997653
Q ss_pred CCCCccccccccccCCccCccccccC----CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--ccc------cccch--
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQG----ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--LSI------NGYDQ-- 292 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~------~~~~~-- 292 (334)
.... .......||+.|+|||++.+. .++.++|+||+||++|||++|+.||....... ..+ ..+..
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 2221 122345799999999998654 37889999999999999999999997543210 000 00001
Q ss_pred hcccchhhhccccccCCcc--chhhhhhhhhccC
Q 037681 293 TQVASKIKLVESCLARPFR--QYCCILKVRTFGF 324 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~--~~~~~~~~~~~~~ 324 (334)
.......+++..++..++. .|+++.++....+
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 1244466777777764443 3667777776654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=291.51 Aligned_cols=237 Identities=26% Similarity=0.367 Sum_probs=191.3
Q ss_pred cccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 81 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.+++.++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999954 68899999986432 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccc
Q 037681 157 DFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235 (334)
Q Consensus 157 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 235 (334)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88774422 2345889999999999999999999998 99999999999999999999999999876543322 123
Q ss_pred cccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc--------cccchhcccchhhhcccc
Q 037681 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI--------NGYDQTQVASKIKLVESC 305 (334)
Q Consensus 236 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~--------~~~~~~~~~~~~~~i~~~ 305 (334)
...||+.|+|||.+.+..++.++|+||||+++|||++|+.||........ .. ..........+.+++..|
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence 35689999999999999999999999999999999999999975432100 00 011112355678899999
Q ss_pred ccCCccchh-----hhhhhhhc
Q 037681 306 LARPFRQYC-----CILKVRTF 322 (334)
Q Consensus 306 l~~~~~~~~-----~~~~~~~~ 322 (334)
|..+|.+|+ ++.++...
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcC
Confidence 999999998 44555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=300.85 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=195.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|+..+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 357888899999999999999954 6899999998644 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.... ..++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999985432 2466777889999999999999998 9999999999999999999999999997654322
Q ss_pred CccccccccccCCccCcccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-cccc---------ccchhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ-----GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-LSIN---------GYDQTQ 294 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~---------~~~~~~ 294 (334)
. ......||..|+|||.+.. ...+.++|||||||++|||++|+.||....... ..+. ......
T Consensus 223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (353)
T PLN00034 223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300 (353)
T ss_pred c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence 1 1233568999999998743 334568999999999999999999997332211 0000 001113
Q ss_pred ccchhhhccccccCCccchhhhhhhhhccCCcc
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
...+.+++..||..+|.+|+++.++....+-..
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 456889999999999999999999988876443
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=298.04 Aligned_cols=237 Identities=28% Similarity=0.353 Sum_probs=191.5
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||+||+|.+. +++.+|+|.+... .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999998643 233445667888888887 699999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 99988875433 3899999999999999999999998 9999999999999999999999999986432211 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i~~~l~ 307 (334)
.....|++.|+|||++.+..++.++|+|||||++|+|++|+.||........ .. ............+++..||.
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcc
Confidence 2335689999999999999999999999999999999999999975432210 00 00111234567899999999
Q ss_pred CCccchhhh-----hhhhhcc
Q 037681 308 RPFRQYCCI-----LKVRTFG 323 (334)
Q Consensus 308 ~~~~~~~~~-----~~~~~~~ 323 (334)
.+|.+|++. .++....
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcCC
Confidence 999999988 6555543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=304.48 Aligned_cols=245 Identities=21% Similarity=0.299 Sum_probs=199.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||++... +|+.+|+|.++.. .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999954 6889999998743 2334566788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999886542 24889999999999999999999998 999999999999999999999999999765433
Q ss_pred CCccccccccccCCccCccccc------cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--------cccccch--
Q 037681 229 ESKANTNRVAGTFGYIPPEYVY------QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------SINGYDQ-- 292 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------~~~~~~~-- 292 (334)
... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ....+..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCC
Confidence 221 222346899999999986 45678899999999999999999999975432210 0001111
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.....+.+++..|+. +|.+|.++.++....+
T Consensus 235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 134567889999997 8999999988876654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=292.53 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=198.0
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
+|++.+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999954 68899999986432 2223456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|..++.... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999988775432 234889999999999999999999998 9999999999999999999999999987653222
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc--------cccchhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI--------NGYDQTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~--------~~~~~~~~~~~~ 299 (334)
. .....|+..|+|||.+.+..++.++||||+|+++|||++|+.||........ .+ ..........+.
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 1 1234689999999999988999999999999999999999999976433110 00 011112345678
Q ss_pred hhccccccCCccchh-----hhhhhhhccC
Q 037681 300 KLVESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
+++..|+..+|.+|. ++.+++...+
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 899999999999999 6667666544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=305.99 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=199.0
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEec
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIER 141 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 141 (334)
...++|.+.+.||+|+||.||+|.+. .+..||+|++... .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34578999999999999999999853 1346999998643 3334567889999999996 99999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhccc--------------------------------------------------------
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATK-------------------------------------------------------- 165 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 165 (334)
+..|+||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999988754311
Q ss_pred -------------------------------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 166 -------------------------------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 166 -------------------------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
...+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 123677788899999999999999988 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccc
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSI 287 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~ 287 (334)
+.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999876543322222233456788999999988899999999999999999997 999987643321100
Q ss_pred c--------ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 288 N--------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 288 ~--------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
. .........+.+++..|+..+|.+|+++.++.+.
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 0 0011134567889999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=304.62 Aligned_cols=248 Identities=21% Similarity=0.235 Sum_probs=194.1
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
....++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 334579999999999999999999965 5888999998532 223345677899999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+||||+++|+|..++... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 9999999999999887543 2788888899999999999999998 99999999999999999999999999976
Q ss_pred ccCCCCccccccccccCCccCccccccC----CCCcchhhHhHHHHHHHHHhCCCCCCCccCC--cccc------cccc-
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQG----ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--YLSI------NGYD- 291 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~------~~~~- 291 (334)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...+ ..+.
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 543221 122345799999999998653 3788999999999999999999999754321 0000 0011
Q ss_pred -hhcccchhhhccccccCCcc--chhhhhhhhhccC
Q 037681 292 -QTQVASKIKLVESCLARPFR--QYCCILKVRTFGF 324 (334)
Q Consensus 292 -~~~~~~~~~~i~~~l~~~~~--~~~~~~~~~~~~~ 324 (334)
........+++..|+..++. .|+++.++.+..+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 11344567788888874443 2566776666543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=307.21 Aligned_cols=245 Identities=21% Similarity=0.296 Sum_probs=191.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||++... +++.+|+|.+... .......+..|+.++..++||||+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999954 6889999998643 2334567788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999885533 3889999999999999999999998 999999999999999999999999998654221
Q ss_pred CCc---------------------------------cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCC
Q 037681 229 ESK---------------------------------ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275 (334)
Q Consensus 229 ~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 275 (334)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113469999999999999999999999999999999999999
Q ss_pred CCCCccCCcc--cccccc------h--hcccchhhhccccccCCccchh---hhhhhhhccC
Q 037681 276 NTEFYHTGYL--SINGYD------Q--TQVASKIKLVESCLARPFRQYC---CILKVRTFGF 324 (334)
Q Consensus 276 p~~~~~~~~~--~~~~~~------~--~~~~~~~~~i~~~l~~~~~~~~---~~~~~~~~~~ 324 (334)
||........ ....+. . .......+++..++. +|..|. ++.++....+
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 9976543210 000000 0 123455666666553 666665 3455555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=301.52 Aligned_cols=229 Identities=27% Similarity=0.303 Sum_probs=187.8
Q ss_pred CccccCCcccEEEEEe----cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 79 NKLGEGGFGPVYKGVL----AKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
+.||+|+||.||++.. .+|+.+|+|++.... ......+..|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999986432 2233456789999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|..++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 99998887543 34899999999999999999999998 9999999999999999999999999987543221 1
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchhhhccccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKIKLVESCL 306 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l 306 (334)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ...........+.+++..||
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l 233 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALF 233 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 223457899999999998888899999999999999999999999754322100 00011113456788999999
Q ss_pred cCCccchhh
Q 037681 307 ARPFRQYCC 315 (334)
Q Consensus 307 ~~~~~~~~~ 315 (334)
..+|.+|++
T Consensus 234 ~~~P~~R~~ 242 (318)
T cd05582 234 KRNPANRLG 242 (318)
T ss_pred hcCHhHcCC
Confidence 999999988
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=298.84 Aligned_cols=231 Identities=25% Similarity=0.288 Sum_probs=185.0
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHH-HHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEAL-VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||+||+|.+. +|+.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986432 222334445544 56779999999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 99988875433 4888999999999999999999998 9999999999999999999999999986432211 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--c----ccccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--S----INGYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~----~~~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . -............+++..||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 3345789999999999999999999999999999999999999975432110 0 001111245567889999999
Q ss_pred CCccchhhhh
Q 037681 308 RPFRQYCCIL 317 (334)
Q Consensus 308 ~~~~~~~~~~ 317 (334)
.+|.+|++..
T Consensus 233 ~~p~~R~~~~ 242 (323)
T cd05575 233 KDRTKRLGAK 242 (323)
T ss_pred cCHHhCCCCC
Confidence 9999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=298.39 Aligned_cols=235 Identities=25% Similarity=0.342 Sum_probs=189.8
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 148 (334)
+|+..+.||+|+||+||+|... +|+.||+|.+... .....+.+..|..++..+. |++|+++.+++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999954 6889999998643 2333456778888888885 577888999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999988875433 3889999999999999999999998 999999999999999999999999998753222
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i 302 (334)
.. ......||+.|+|||++.+..++.++|+||+||++|+|++|+.||........ .. ..+.........+++
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 232 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSIC 232 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 11 22345689999999999988999999999999999999999999976533210 00 001112345677899
Q ss_pred cccccCCccchhhh
Q 037681 303 ESCLARPFRQYCCI 316 (334)
Q Consensus 303 ~~~l~~~~~~~~~~ 316 (334)
..|+..+|.+|.+.
T Consensus 233 ~~~l~~~p~~R~~~ 246 (323)
T cd05615 233 KGLMTKHPSKRLGC 246 (323)
T ss_pred HHHcccCHhhCCCC
Confidence 99999999999763
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=285.99 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=198.8
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEec--ccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe-----cCcc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLS--VRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE-----RDEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 144 (334)
..|...+.||.|+||.|..+.. .+|..||||++. .......++..+|+.+|+.++|+||+.+++++.. -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 5666679999999999999995 478999999997 4566677888999999999999999999999865 3457
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+|+|+| ..+|...++... .++...+..+++||+.||.|+|+.+ ++||||||.|++++.+..+||+|||+|+.
T Consensus 102 YiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 9999999 457888875443 3899999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccccCCccCccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCccC--------------C------
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGKKNTEFYHT--------------G------ 283 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------------~------ 283 (334)
..........+..+.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+.+. +
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 75443334446677899999999876 56899999999999999999999998874421 0
Q ss_pred -----------------cccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 -----------------YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 -----------------~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..++...........+++++++|.-+|.+|-+..+-...++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 11111112224456788899999999999988776555443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.27 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=197.5
Q ss_pred hhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
..++|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3478999999999999999998743 2467999988543 23344568899999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhccc-------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 144 KLLIYEYLPNKSLDFFLFDATK-------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998865322 123567788999999999999999988 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------cccc
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------LSIN 288 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~~~~ 288 (334)
+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999875433222211222345778999999988889999999999999999999 788887543321 0001
Q ss_pred ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.........+.+++..|+..+|.+|+++.++.+.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111234457889999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.80 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=202.3
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56888899999999999999742 245688998876666666778999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc
Q 037681 147 IYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK 213 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 213 (334)
||||+++++|.+++..... ...+++..++.++.||+.|++|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999865321 234788999999999999999999998 999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------c
Q 037681 214 PKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------L 285 (334)
Q Consensus 214 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~ 285 (334)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 99999999875433222222233456788999999988899999999999999999999 999986544321 0
Q ss_pred cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
............+.+++..|+..+|.+|+++.++.+.-.
T Consensus 242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 111111124556889999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.32 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=201.4
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++||||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36899999999999999999998888889999876433 23567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999886543 234788889999999999999999988 999999999999999999999999999865432221
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--cc-cc----chhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--IN-GY----DQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~~-~~----~~~~~~~~~~~i~ 303 (334)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......... +. .+ .......+.+++.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1222345678999999988889999999999999999998 99999754332100 00 00 1113456888999
Q ss_pred ccccCCccchhhhhhhhhcc
Q 037681 304 SCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~ 323 (334)
+|+..+|++|+++.++.+.-
T Consensus 239 ~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 239 TCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred HHccCCcccCcCHHHHHHHH
Confidence 99999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=286.13 Aligned_cols=242 Identities=27% Similarity=0.368 Sum_probs=196.9
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 5788899999999999999998878889999876332 234578889999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+|+|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999998886433 24788999999999999999999998 999999999999999999999999998754322221
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--cc-----cccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SI-----NGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~-----~~~~~~~~~~~~~~i~~ 304 (334)
......++..|+|||.+.+..++.++|+||||+++|||++ |+.||........ .+ ..........+.+++..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122235668999999988889999999999999999999 8999865433210 00 00011134457889999
Q ss_pred cccCCccchhhhhhhhh
Q 037681 305 CLARPFRQYCCILKVRT 321 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~ 321 (334)
|+..+|..|+++.++..
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=278.91 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=204.6
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC--------hhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS--------RQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
-..|+-.+.||.|..+.|.++.+ .+|+..|+|++.... ....+.-.+|+.+|+++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35788889999999999998884 568899999885321 12234456899999998 699999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
...|+|+|.|+.|.|.+++.... .++++....|+.|+.+|++|||..+ ||||||||+|||++++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999996544 4999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCccccc------cCCCCcchhhHhHHHHHHHHHhCCCCCCCc---------cCCccc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVY------QGICSIKSDVFSFGMLLLEILSGKKNTEFY---------HTGYLS 286 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~p~~~~---------~~~~~~ 286 (334)
++.+..+.. ....+|||+|+|||.+. ...|+..+|+||+|+++|.|+.|-+||=-. ..+.-.
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 998765543 45679999999999885 235788999999999999999999998311 222333
Q ss_pred ccccchh-cccchhhhccccccCCccchhhhhhhhhccCCcccc
Q 037681 287 INGYDQT-QVASKIKLVESCLARPFRQYCCILKVRTFGFNLPNA 329 (334)
Q Consensus 287 ~~~~~~~-~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~ 329 (334)
+.+-.|. .+....++|..||..+|.+|-+..+.....+..+.+
T Consensus 247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 3333333 566788999999999999998887777666654433
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.03 Aligned_cols=246 Identities=20% Similarity=0.248 Sum_probs=190.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|..++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999954 5889999998632 2334456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999885432 23788999999999999999999998 999999999999999999999999998754432
Q ss_pred CCccccccccccCCccCcccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-----------cccccccch
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQ-----GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG-----------YLSINGYDQ 292 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-----------~~~~~~~~~ 292 (334)
.. .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||...... ...+.....
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccC
Confidence 22 11223468999999999863 45788999999999999999999999653211 011111111
Q ss_pred hcccchhhhccccccC--CccchhhhhhhhhccC
Q 037681 293 TQVASKIKLVESCLAR--PFRQYCCILKVRTFGF 324 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~--~~~~~~~~~~~~~~~~ 324 (334)
.......+++..++.. .+..|+++.++....+
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 1344566777776643 2333566666666554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=298.78 Aligned_cols=246 Identities=25% Similarity=0.368 Sum_probs=205.7
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR-QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.+...+.+.||+|-||.|.++....+..||+|.++.... .....|.+|+++|.+|+||||++++|+|..++.+++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 345567889999999999999988789999999986644 4458899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++|+|..++..+.... +......+|+.||+.|++||.+.+ +|||||.++|+|++.++++||+|||+++.+.....
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999998775433 566677889999999999999998 99999999999999999999999999986655555
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh--CCCCCCCccCCc-----c---------cccccchhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS--GKKNTEFYHTGY-----L---------SINGYDQTQ 294 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~~~~-----~---------~~~~~~~~~ 294 (334)
........-..+|||+|.+..++++.++|+|+||+++||+++ .+.||...+.+. . ........-
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 444445566889999999999999999999999999999876 888997665430 0 011111113
Q ss_pred ccchhhhccccccCCccchhhhhhhhh
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
...+.+++-+|+.++-.+|+++.++-.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 456778999999999999999887644
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=285.17 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=200.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-----RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++.+.||+|++|.||.|... +++.+++|.+.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999954 68999999886332 2234568889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|+||+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999988875433 3788899999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCccc-cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--------cccccchhcccc
Q 037681 227 GNESKAN-TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------SINGYDQTQVAS 297 (334)
Q Consensus 227 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------~~~~~~~~~~~~ 297 (334)
....... .....|+..|+|||.+.+..++.++||||+|+++|||++|+.||........ ............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHH
Confidence 2211111 1234578899999999988899999999999999999999999865432110 001111224556
Q ss_pred hhhhccccccCCccchhhhhhhhhcc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+.+++..|+..+|..|+++.++....
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 78899999999999999998887654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=289.51 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=198.0
Q ss_pred cCCCcCCccccCCcccEEEEEe-----cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++.+.||+|+||.||+|.. .++..+++|.+... .......+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5788899999999999999984 24578999988643 33445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhccc--------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC
Q 037681 147 IYEYLPNKSLDFFLFDATK--------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM 212 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 212 (334)
||||+++++|.+++..... ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999988753221 224778889999999999999999998 99999999999999999
Q ss_pred ceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------
Q 037681 213 KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY------- 284 (334)
Q Consensus 213 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~------- 284 (334)
.+||+|||++................++..|+|||.+.+..++.++|+||||+++|||++ |..||.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999976543322222233445678999999988889999999999999999998 998986532210
Q ss_pred ccccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 285 LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 285 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.............+.+++..|+..+|..|+++.++...
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 00111112235567889999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.87 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=194.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGD----EIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.+|++.+.||+|+||.||+|.+. ++. .||+|.+... .....+.+..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999853 343 3899988643 344556788999999999999999999998764 5789
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999886543 23788889999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-cc------cccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-SI------NGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-~~------~~~~~~~~~~~ 298 (334)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||+....... .. ..........+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 3332222222334678999999999999999999999999999998 9999875432110 00 00011123457
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..|+..+|..|+++.++...
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 789999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=296.57 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=207.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh---hhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR---QGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 146 (334)
...|++.+.||+|.||.||+++.+ +|+.+|+|.+..... .....+.+|+.+|+++. ||||+.+.++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 367999999999999999999965 599999999965433 24568899999999998 9999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC----CceEEeecccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE----MKPKISDFGMA 222 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~ 222 (334)
|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.+ ++||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999888665 2899999999999999999999998 9999999999999533 47999999999
Q ss_pred ccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------cccccccchh
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---------YLSINGYDQT 293 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---------~~~~~~~~~~ 293 (334)
..... .......+||+.|+|||++....++..+||||+|+++|.|++|.+||...... ..++..-.+.
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~ 263 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD 263 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc
Confidence 87654 23456689999999999999999999999999999999999999999866522 2222222222
Q ss_pred -cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 294 -QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 294 -~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
......++++.++..+|..|.++.+....++
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 5777889999999999999999888777543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=289.47 Aligned_cols=241 Identities=34% Similarity=0.520 Sum_probs=190.0
Q ss_pred cCCccccCCcccEEEEEec-----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 77 DTNKLGEGGFGPVYKGVLA-----KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999966 2567999999653 344578899999999999999999999999988889999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++|+|.+++... ....+++..+..|+.|++.||.|||+.+ ++|+||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999765 2234899999999999999999999998 99999999999999999999999999986532222
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--cccc-----cchhcccchhhhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SING-----YDQTQVASKIKLV 302 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~~~-----~~~~~~~~~~~~i 302 (334)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||........ .+.. ........+.+++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 222233456778999999998889999999999999999999 7899876633210 0000 1111355688999
Q ss_pred cccccCCccchhhhhhhhh
Q 037681 303 ESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~ 321 (334)
..|+..+|.+|+++.++..
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999988754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=286.37 Aligned_cols=244 Identities=21% Similarity=0.307 Sum_probs=198.9
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 36899999999999999999995 46888999998765555556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999998875432 4789999999999999999999988 99999999999999999999999999976532221
Q ss_pred ccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------cc--cc--chhccc
Q 037681 231 KANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------IN--GY--DQTQVA 296 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~--~~--~~~~~~ 296 (334)
......|+..|+|||.+. ...++.++|+||+|+++|||++|+.||....+.... +. .. ......
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 122346888999999874 345778999999999999999999998644322100 00 00 011245
Q ss_pred chhhhccccccCCccchhhhhhhhhcc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+.+++..|+..+|.+|+++.++....
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 678899999999999999998877643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.80 Aligned_cols=230 Identities=22% Similarity=0.322 Sum_probs=186.8
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|... +++.+|+|.+... .....+.+..|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 5788999999743 233456678899999888 699999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|..++.... .+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 99988775433 3899999999999999999999998 9999999999999999999999999986432211 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-ccccc------------cchhcccchhh
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-LSING------------YDQTQVASKIK 300 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~------------~~~~~~~~~~~ 300 (334)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ..........+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 232 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASH 232 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 234578999999999999999999999999999999999999996433211 00000 01112445788
Q ss_pred hccccccCCccchhhh
Q 037681 301 LVESCLARPFRQYCCI 316 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~ 316 (334)
++.+||..+|.+|.+.
T Consensus 233 li~~~L~~dP~~R~~~ 248 (327)
T cd05617 233 VLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHhccCHHHcCCC
Confidence 9999999999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=297.24 Aligned_cols=231 Identities=24% Similarity=0.293 Sum_probs=183.4
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHH-HHHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEA-LVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||+||+|.+. +++.+|+|.+.... ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57889999986432 12223344444 456778999999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 99988885433 3778888889999999999999998 9999999999999999999999999987532221 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .. ..........+.+++.+|+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcc
Confidence 3345799999999999999999999999999999999999999975432210 00 00111245567889999999
Q ss_pred CCccchhhhh
Q 037681 308 RPFRQYCCIL 317 (334)
Q Consensus 308 ~~~~~~~~~~ 317 (334)
.+|.+|.+..
T Consensus 233 ~~p~~R~~~~ 242 (325)
T cd05602 233 KDRTKRLGAK 242 (325)
T ss_pred cCHHHCCCCC
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.92 Aligned_cols=239 Identities=20% Similarity=0.219 Sum_probs=192.0
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..+|++.+.||+|+||.||+|.. .+++.||+|... ...+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36899999999999999999995 468899999653 23467899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+. ++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 86 57776664432 3788999999999999999999998 9999999999999999999999999986532211
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC----------------------ccccc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG----------------------YLSIN 288 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----------------------~~~~~ 288 (334)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ..+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 11223457999999999999889999999999999999999999876422110 00000
Q ss_pred ------------------------ccch--hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 ------------------------GYDQ--TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ------------------------~~~~--~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.|.. .....+.+++.+||..+|.+|++..++....+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 0000 01335778899999999999999999887655
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.48 Aligned_cols=245 Identities=30% Similarity=0.425 Sum_probs=199.2
Q ss_pred hcCCCcCCccccCCcccEEEEEecC--C--CE-EEEEEecc---cChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK--G--DE-IAVKRLSV---RSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~--~--~~-vaiK~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
-++-...+.||+|+||.||+|.... + .. ||+|..+. .......++.+|++++++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455667899999999999999543 2 23 89998874 357778899999999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
+++|||+|+||+|+++|+.... .++..+...++.+.+.||+|||+++ ++||||..+|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999976554 4889999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc----ccccccch----hc
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY----LSINGYDQ----TQ 294 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~----~~~~~~~~----~~ 294 (334)
.-. ..........-...|+|||.+....++.++|||||||++||+++ |..||....... .....+.. ..
T Consensus 311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~ 388 (474)
T KOG0194|consen 311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT 388 (474)
T ss_pred CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence 532 11111111134678999999999999999999999999999999 888987664320 00001111 24
Q ss_pred ccchhhhccccccCCccchhhhhhhhhcc
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
...+..+...|+..+|..|+++.++.+..
T Consensus 389 p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 389 PKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred HHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 45567788899999999999998876554
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=284.48 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=201.3
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.++|++.+.||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 36789999999999999999998778889999986443 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999886543 234789999999999999999999998 999999999999999999999999999865422111
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc------ccc-ccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL------SIN-GYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~------~~~-~~~~~~~~~~~~~i~ 303 (334)
.......+..|+|||.+.+..++.++|+||||+++|||++ |+.||........ ... .........+.+++.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 1111223457999999988899999999999999999999 9999876443210 000 011124567888999
Q ss_pred ccccCCccchhhhhhhhhccC
Q 037681 304 SCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.|+..+|.+|+++.++...-.
T Consensus 239 ~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 239 DCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred HHhhcCcccCCCHHHHHHHHh
Confidence 999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=294.59 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=207.1
Q ss_pred cCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.-|...+.||+|.|+.|-+|+ .-+|..||||++.... ......+.+|+.-|+..+|||||++|++......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457888999999999999998 5689999999997553 3334567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeeccccccccCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFGMARIFKGN 228 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 228 (334)
.-++|+|.+|+..+..+ +.+..+.+++.||+.|+.|+|+.. +|||||||+||.+.+ -|-+||.|||++..+.++
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999877665 899999999999999999999998 999999999998854 588999999999877554
Q ss_pred CCccccccccccCCccCccccccCCCC-cchhhHhHHHHHHHHHhCCCCCCCccCCccc--ccc--cchh--cccchhhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICS-IKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--ING--YDQT--QVASKIKL 301 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~--~~~~--~~~~~~~~ 301 (334)
.. ..+.+|+..|-|||++.+..|+ +++||||||||||.|.+|++||+..++.+.. +.. |.-+ ....-.++
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 33 4557999999999999998876 6799999999999999999999987665322 111 2222 46678889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
|..+|.++|.+|.++.++.+-.+
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred HHHHHhcCchhhccHHHHhcccc
Confidence 99999999999999998876443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.45 Aligned_cols=202 Identities=26% Similarity=0.413 Sum_probs=171.1
Q ss_pred cCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCC-cceEeeEEEecC------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSR--QGLQELKNEALVIAKVQHKN-LVRLLGCCIERD------ 142 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------ 142 (334)
..|+.++.||+|+||+||+|+ ..+|+.||+|++..... .......+|+.++++++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 567778899999999999999 45789999999975533 34566789999999999999 999999998877
Q ss_pred cceEEEEecCCCChhhhhhhcccc-cccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKR-VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
..++|+||++. +|..++...... ..++...+..++.||+.||+|||+++ |+||||||.||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78999999865 788877655422 23677889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFY 280 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~ 280 (334)
|+.+.-.. .......+|..|.|||++.+. .|+...||||+||+++||+++++-|+..
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~ 224 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD 224 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC
Confidence 98554222 123345679999999999876 7999999999999999999999888754
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=296.79 Aligned_cols=244 Identities=20% Similarity=0.235 Sum_probs=189.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||++... +++.+|+|.+... .......+..|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999955 5788999988642 2233455778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999986532 24788899999999999999999998 999999999999999999999999998765432
Q ss_pred CCccccccccccCCccCcccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-----------cccccccch
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQ-----GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG-----------YLSINGYDQ 292 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-----------~~~~~~~~~ 292 (334)
.. .......||+.|+|||++.+ +.++.++|+||||+++|+|++|+.||...... ...+.....
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccc
Confidence 22 11233568999999998865 46788999999999999999999999654221 011111111
Q ss_pred hcccchhhhccccccCCccc--hhhhhhhhhc
Q 037681 293 TQVASKIKLVESCLARPFRQ--YCCILKVRTF 322 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~--~~~~~~~~~~ 322 (334)
.......+++.+|+..++.. +.++.++...
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 13456777787777644322 2344444443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=285.99 Aligned_cols=245 Identities=27% Similarity=0.429 Sum_probs=204.1
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
..+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 46799999999999999999998878999999998666656677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999986543 234789999999999999999999998 999999999999999999999999999765432211
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-cc----cchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-NG----YDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-~~----~~~~~~~~~~~~i~ 303 (334)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......... . .. ........+.+++.
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence 112345678999999988889999999999999999998 89999754332100 0 00 01124466889999
Q ss_pred ccccCCccchhhhhhhhhc
Q 037681 304 SCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~ 322 (334)
.|+..+|.+|+++.++...
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~ 257 (261)
T cd05148 239 ECWAAEPEDRPSFKALREE 257 (261)
T ss_pred HHcCCCchhCcCHHHHHHH
Confidence 9999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=286.05 Aligned_cols=231 Identities=24% Similarity=0.356 Sum_probs=187.1
Q ss_pred cccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 81 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
||+|+||.||++... +|+.+|+|.+.... ......+..|++++++++||||+++.+++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999854 68999999886321 12234456799999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 236 (334)
..++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 88775433 234788889999999999999999998 99999999999999999999999999876543221 223
Q ss_pred ccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cccc--------c-chhcccchhhhcccc
Q 037681 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SING--------Y-DQTQVASKIKLVESC 305 (334)
Q Consensus 237 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~--------~-~~~~~~~~~~~i~~~ 305 (334)
..|+..|+|||++.+..++.++|+||+||++|||++|+.||........ .... . .........+++..|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF 233 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHH
Confidence 4689999999999888899999999999999999999999975432110 0000 0 011355678999999
Q ss_pred ccCCccchhhhhh
Q 037681 306 LARPFRQYCCILK 318 (334)
Q Consensus 306 l~~~~~~~~~~~~ 318 (334)
|..+|.+|++..+
T Consensus 234 L~~~P~~R~~~~~ 246 (277)
T cd05607 234 LAKKPEDRLGSRE 246 (277)
T ss_pred hccCHhhCCCCcc
Confidence 9999999998844
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=284.29 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=199.5
Q ss_pred cCCCcCCccccCCcccEEEEEecC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||.||+|.+.. ...+|+|.+... .......+.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 678999999999999999998642 357899988644 334456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++..... .+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999998865432 4889999999999999999999988 99999999999999999999999999987642
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccchh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVASKI 299 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~~~ 299 (334)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ...........+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY 238 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 222222222345678999999988899999999999999999998 99998654322100 0001112356788
Q ss_pred hhccccccCCccchhhhhhhhhc
Q 037681 300 KLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+++..|+..+|.+|+++.++...
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=282.10 Aligned_cols=239 Identities=27% Similarity=0.377 Sum_probs=191.6
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
+.||+|+||.||+|... +++.+|+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 6889999987643 344456788999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 236 (334)
.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99885432 34789999999999999999999998 99999999999999999999999999875432211111111
Q ss_pred ccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--cc-----cccchhcccchhhhccccccC
Q 037681 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SI-----NGYDQTQVASKIKLVESCLAR 308 (334)
Q Consensus 237 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~-----~~~~~~~~~~~~~~i~~~l~~ 308 (334)
..++..|+|||.+.++.++.++|+||||+++|||++ |..||........ .. ..........+.+++..|+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCC
Confidence 223457999999988889999999999999999998 8888865432200 00 001111355688899999999
Q ss_pred Cccchhhhhhhhhc
Q 037681 309 PFRQYCCILKVRTF 322 (334)
Q Consensus 309 ~~~~~~~~~~~~~~ 322 (334)
+|.+|+++.++...
T Consensus 236 ~p~~Rps~~~~~~~ 249 (252)
T cd05084 236 DPGQRPSFSTVHQE 249 (252)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999987653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=297.56 Aligned_cols=231 Identities=23% Similarity=0.285 Sum_probs=183.4
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHH-HHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEAL-VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||+||+|... +|+.+|+|++... .......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999954 6899999998643 2223344555554 46778999999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|..++... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 9998877543 24889999999999999999999998 9999999999999999999999999986432211 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--ccc----ccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SIN----GYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~----~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ... ...........+++..|+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLE 232 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhc
Confidence 3345789999999999999999999999999999999999999975432210 000 0011134456788999999
Q ss_pred CCccchhhhh
Q 037681 308 RPFRQYCCIL 317 (334)
Q Consensus 308 ~~~~~~~~~~ 317 (334)
.+|.+|.+..
T Consensus 233 ~~p~~R~~~~ 242 (325)
T cd05604 233 KDRQRRLGAK 242 (325)
T ss_pred cCHHhcCCCC
Confidence 9998887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.21 Aligned_cols=230 Identities=23% Similarity=0.289 Sum_probs=182.5
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHH-HHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEAL-VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|... +++.+|+|.+.... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 58899999986432 222334455544 67889999999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 9998777543 23788888999999999999999998 9999999999999999999999999986432211 12
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhcccccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLVESCLA 307 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i~~~l~ 307 (334)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .. ............+++..||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence 3345789999999999988999999999999999999999999975432100 00 00111134457789999999
Q ss_pred CCccchhhh
Q 037681 308 RPFRQYCCI 316 (334)
Q Consensus 308 ~~~~~~~~~ 316 (334)
.+|.+|.+.
T Consensus 233 ~~p~~R~~~ 241 (321)
T cd05603 233 KDQRRRLGA 241 (321)
T ss_pred CCHhhcCCC
Confidence 999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=285.93 Aligned_cols=240 Identities=21% Similarity=0.323 Sum_probs=197.4
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|+||.||+|.+ .+++.+|+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3688899999999999999985 56889999988644 333456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..+. .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999986542 2677888899999999999999998 9999999999999999999999999987543221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc--cc------------c-chhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--NG------------Y-DQTQV 295 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~------------~-~~~~~ 295 (334)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... .. . .....
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCC
Confidence 223568999999999998899999999999999999999999996533221000 00 0 00123
Q ss_pred cchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
..+.+++.+|+..+|.+|+++.++....+-.
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 4577899999999999999999988776643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=303.02 Aligned_cols=240 Identities=29% Similarity=0.420 Sum_probs=200.9
Q ss_pred CCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.|+.++.||.|+||.||.|. ..+.+.||||++... +.+....+.+|+..|.+++|||++.+.|||......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46778899999999999999 456888999999744 44557789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
||-| +-.+++.-..+ ++.+..+..|+.+.+.||+|||+++ .+|||||..|||+++.|.|||+|||.|....+
T Consensus 107 YClG-SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHhc-cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 9965 66666644433 4888899999999999999999999 99999999999999999999999999975432
Q ss_pred CccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccC----------Ccccccccchhccc
Q 037681 230 SKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHT----------GYLSINGYDQTQVA 296 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----------~~~~~~~~~~~~~~ 296 (334)
.+.++|||.|||||++. .+.|+-++||||||++..||.-.++|...++. +.+.+.+ ...+.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs--~eWS~ 252 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS--NEWSD 252 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC--chhHH
Confidence 34578999999999985 57899999999999999999999999754422 1222221 11345
Q ss_pred chhhhccccccCCccchhhhhhhhhccCCcc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
.+..++|.||.+.|..|++-.++....|...
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 5788999999999999999988888777543
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=289.24 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=197.4
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRSR-QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
.+|.+.+.||+|+||.||+|... +++.+|+|.+..... .....+..|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 46778899999999999999853 246799999875432 33466889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcc-------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC
Q 037681 146 LIYEYLPNKSLDFFLFDAT-------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM 212 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 212 (334)
+++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999998874321 1234778889999999999999999998 99999999999999999
Q ss_pred ceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCC-------c
Q 037681 213 KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTG-------Y 284 (334)
Q Consensus 213 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~-------~ 284 (334)
.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||...... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999876543322222233446788999999988889999999999999999998 88888654332 0
Q ss_pred ccccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 285 LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 285 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.............+.+++..|+..+|..|+++.++...
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 01111112234457889999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=283.65 Aligned_cols=242 Identities=27% Similarity=0.397 Sum_probs=197.2
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|.+.+.||+|+||.||.|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5788899999999999999987767779999886433 234678899999999999999999999998889999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 9999998865332 4889999999999999999999998 999999999999999999999999998754332211
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~ 304 (334)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ ............+.+++..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1112235678999999988889999999999999999998 9999875543210 0000111134568889999
Q ss_pred cccCCccchhhhhhhhh
Q 037681 305 CLARPFRQYCCILKVRT 321 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~ 321 (334)
|+..+|.+|+++.++..
T Consensus 237 cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 237 CWHEKAEERPTFQQLLS 253 (256)
T ss_pred HcCCCcccCCCHHHHHH
Confidence 99999999999988754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=287.00 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=199.9
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|...+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 57888999999999999999732 355788998876666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhccc------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCce
Q 037681 147 IYEYLPNKSLDFFLFDATK------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
+|||+++++|.+++..... ...+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998865421 124788999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c----
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I---- 287 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~---- 287 (334)
+|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |++||......... .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999875433222112222345678999999988899999999999999999998 99998654332100 0
Q ss_pred -cccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 288 -NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 288 -~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
..........+.+++..|+..+|.+|+++.++...
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~ 277 (280)
T cd05092 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSR 277 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00011234568899999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=285.17 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=198.7
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
++|++.+.||+|+||.||+|.. .++..+|+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 5788899999999999999985 468899999987665555567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 9999999875433 4889999999999999999999998 99999999999999999999999999875532211
Q ss_pred cccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc----cccc-------hhcccc
Q 037681 232 ANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI----NGYD-------QTQVAS 297 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~----~~~~-------~~~~~~ 297 (334)
......|+..|+|||.+. ...++.++|+|||||++|+|++|+.||....+..... .... ......
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 123356899999999874 4568889999999999999999999986443211000 0000 012335
Q ss_pred hhhhccccccCCccchhhhhhhhhcc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+.+++..|+..+|++|+++.++....
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCC
Confidence 67899999999999999998877653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.13 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=202.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.+.|++.+.||.|+||.||+|... ++..+++|.+........+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367999999999999999999965 5889999999877766778889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++.... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 99999988765433 24889999999999999999999988 9999999999999999999999999886532221
Q ss_pred ccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--cc-----c--cchhccc
Q 037681 231 KANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--IN-----G--YDQTQVA 296 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~-----~--~~~~~~~ 296 (334)
.......++..|+|||.+. ...++.++|+||||+++|||++|+.||......... +. . .......
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 1123345788999999885 345678999999999999999999998765422100 00 0 0111234
Q ss_pred chhhhccccccCCccchhhhhhhhhccCC
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
...+++..|+..+|.+|+++.++....+-
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 272 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFV 272 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 57889999999999999999998876653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=316.43 Aligned_cols=240 Identities=22% Similarity=0.286 Sum_probs=192.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|.+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999965 5899999998643 2333567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhccc--------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecc
Q 037681 149 EYLPNKSLDFFLFDATK--------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFG 220 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 220 (334)
||++|++|.+++..... ....+...++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999988854211 123456678899999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCC----------------ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc
Q 037681 221 MARIFKGNES----------------KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY 284 (334)
Q Consensus 221 ~~~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 284 (334)
++........ ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521110 001123468999999999999999999999999999999999999997543321
Q ss_pred ccccccc---------hhcccchhhhccccccCCccchhh
Q 037681 285 LSINGYD---------QTQVASKIKLVESCLARPFRQYCC 315 (334)
Q Consensus 285 ~~~~~~~---------~~~~~~~~~~i~~~l~~~~~~~~~ 315 (334)
....... ......+.+++.+|+..+|.+|.+
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence 1111000 112345778999999999999954
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=281.45 Aligned_cols=243 Identities=28% Similarity=0.416 Sum_probs=201.5
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||+|++|.||+|... ++..+++|.+... .......+..|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999964 6889999988643 344566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999886542 335888999999999999999999988 99999999999999999999999999876543322
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccccchhcccchhhhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGYDQTQVASKIKLVE 303 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~ 303 (334)
......|++.|+|||+..+..++.++|+||||+++++|++|+.||........ ............+.+++.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLID 234 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence 12334678899999999988899999999999999999999999975542210 011111123456889999
Q ss_pred ccccCCccchhhhhhhhhc
Q 037681 304 SCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~ 322 (334)
+|+..+|++|+++.++...
T Consensus 235 ~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 235 QCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHccCCcccCcCHHHHhhC
Confidence 9999999999999887654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=294.41 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=196.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec-C
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER-D 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~ 142 (334)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+..|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 468999999999999999999632 2468999988643 233446678899999999 899999999988754 4
Q ss_pred cceEEEEecCCCChhhhhhhccc---------------------------------------------------------
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATK--------------------------------------------------------- 165 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 165 (334)
..+++|||+++++|..++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988754221
Q ss_pred -ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCcc
Q 037681 166 -RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244 (334)
Q Consensus 166 -~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~ 244 (334)
...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++..+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125788999999999999999999988 9999999999999999999999999998654333222233345677899
Q ss_pred CccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc---cccc-----cchhcccchhhhccccccCCccchhh
Q 037681 245 PPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL---SING-----YDQTQVASKIKLVESCLARPFRQYCC 315 (334)
Q Consensus 245 aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~---~~~~-----~~~~~~~~~~~~i~~~l~~~~~~~~~ 315 (334)
|||.+.+..++.++|||||||++|||++ |+.||........ .+.. ........+.+++..|+..+|.+|++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999999999999998 9999865332110 0000 01113456788999999999999999
Q ss_pred hhhhhhc
Q 037681 316 ILKVRTF 322 (334)
Q Consensus 316 ~~~~~~~ 322 (334)
+.++.+.
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=296.32 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=204.4
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEec--ccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLS--VRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 148 (334)
...|+++++||+||.+.||++...+.+.+|+|++. ..+......+..|+..|.+|+ |.+|++++++-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 45799999999999999999998878888988775 346677888999999999994 999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||- ..+|..+|...... ++.-.+..+..|++.|+.++|++| |||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus 440 E~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 974 45888888665433 332367789999999999999999 999999999999965 68999999999988777
Q ss_pred CCccccccccccCCccCccccccC-----------CCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc---------
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQG-----------ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--------- 288 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--------- 288 (334)
.........+||+.||+||.+... +.++++||||||||||+|+.|++||..+......+.
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 666666667899999999998532 256789999999999999999999987642211111
Q ss_pred ccchhcccc-hhhhccccccCCccchhhhhhhhhccCCcc
Q 037681 289 GYDQTQVAS-KIKLVESCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 289 ~~~~~~~~~-~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
.+......+ +.++...||+++|.+|+++.++....|--|
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 111111222 889999999999999999999999988665
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=284.60 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=192.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCC----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGD----EIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++.+.||+|+||.||+|.+. +++ .+++|.+.... ......+..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888999999999999999954 344 47777775332 233466778888999999999999999875 456789
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999986533 24889999999999999999999988 9999999999999999999999999997654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-cc------cccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-SI------NGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-~~------~~~~~~~~~~~ 298 (334)
............++..|+|||.+.++.++.++||||||+++||+++ |+.||........ .+ ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 3332222334557778999999988899999999999999999998 9999976543210 00 00001123356
Q ss_pred hhhccccccCCccchhhhhhhhh
Q 037681 299 IKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.+++..|+..+|..|+++.++..
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHH
Confidence 77889999999999999988655
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=285.15 Aligned_cols=239 Identities=25% Similarity=0.359 Sum_probs=185.5
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----cceEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-----EKLLI 147 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv 147 (334)
.|...+.+|+|+||.||.|.. .+++.||||++-...+. -.+|+.+|+.++|||||+++-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466678999999999999994 45799999988644332 247899999999999999999987533 23579
Q ss_pred EEecCCCChhhhhhhc-ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeeccccccc
Q 037681 148 YEYLPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIF 225 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~ 225 (334)
|||++. +|...++.. ..+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 677776532 12334777888889999999999999988 9999999999999977 89999999999987
Q ss_pred cCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------------------
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------------- 283 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------------- 283 (334)
..+... .....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|...+..
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 655432 22445889999999876 47999999999999999999999998743211
Q ss_pred --------cccccc------cchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 284 --------YLSING------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 284 --------~~~~~~------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
...+.. +......+..+++.++|.-+|..||+-.+....+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 011111 1111456788899999999999998666554443
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.19 Aligned_cols=245 Identities=26% Similarity=0.427 Sum_probs=200.0
Q ss_pred CCCcCCccccCCcccEEEEEecCCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS------RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
+|.+.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998789999999886432 22345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
+||+++++|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999885533 3788899999999999999999988 99999999999999999999999999875432
Q ss_pred CCC----ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhc
Q 037681 228 NES----KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQ 294 (334)
Q Consensus 228 ~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~ 294 (334)
... ........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF 234 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence 111 1112234688999999999888899999999999999999999999975432210 011111113
Q ss_pred ccchhhhccccccCCccchhhhhhhhhccC
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+.+++..|+..+|.+|+++.++..-++
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 456788999999999999999998876543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=275.02 Aligned_cols=239 Identities=26% Similarity=0.359 Sum_probs=198.3
Q ss_pred hhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
..+.|++.+.||+|.|+.|+++.+ .+|+.+|+|.++.. .....+.+.+|+.+-+.|+||||+++.+.+.+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 347889999999999999999984 57999999988633 344667889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEeecccccc
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKISDFGMARI 224 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~ 224 (334)
+|++.|+.|-.-+-.+ ...++..+-..+.||++||.|+|.++ |||||+||+|+++-. .--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999996555333 44888999999999999999999998 999999999999943 34599999999987
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccC---------Ccccccccchh-c
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT---------GYLSINGYDQT-Q 294 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---------~~~~~~~~~~~-~ 294 (334)
+.+.. ......|||+|||||++...+++..+|||+.|++||-|+.|.+||-+-.. +..++.+-.|. .
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~i 239 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTV 239 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcC
Confidence 76322 23446799999999999999999999999999999999999999976221 13333332233 5
Q ss_pred ccchhhhccccccCCccchhhhhh
Q 037681 295 VASKIKLVESCLARPFRQYCCILK 318 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~ 318 (334)
++...++++++|.-+|.+|-+..+
T Consensus 240 s~~Ak~LvrrML~~dP~kRIta~E 263 (355)
T KOG0033|consen 240 TPEAKSLIRRMLTVNPKKRITADE 263 (355)
T ss_pred CHHHHHHHHHHhccChhhhccHHH
Confidence 677889999999999998865554
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=287.65 Aligned_cols=244 Identities=23% Similarity=0.385 Sum_probs=202.5
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..+|++.+.||+|++|.||+|.. .+++.+++|.+..........+.+|+.+++.++||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 36899999999999999999995 46889999998766555567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999887432 3788899999999999999999998 99999999999999999999999999875433221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc---------cchhcccchhhh
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING---------YDQTQVASKIKL 301 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~ 301 (334)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....+....... ........+.++
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 122346888999999998888899999999999999999999999654332110000 011133457889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+|+..+|..|+++.++....+
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChh
Confidence 99999999999999998887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=286.10 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=203.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||.|+||.||+|... ++..+|+|.+........+.+..|++++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 367999999999999999999964 6889999999877666777889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++.... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999998885533 24889999999999999999999998 99999999999999999999999998865432211
Q ss_pred ccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccc--cchhccc
Q 037681 231 KANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SING--YDQTQVA 296 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~--~~~~~~~ 296 (334)
......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||........ .... .......
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS 236 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence 123346889999999875 34567899999999999999999999976543210 0000 0111345
Q ss_pred chhhhccccccCCccchhhhhhhhhccC
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.+++..|+..+|.+|+++.++.+.++
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 6788999999999999999998887665
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=297.95 Aligned_cols=243 Identities=21% Similarity=0.294 Sum_probs=193.0
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----cce
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-----EKL 145 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 145 (334)
+|++.+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 578899999999999999995 46899999988643 2334567889999999999999999999998776 689
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+|+||+.+ +|...+... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 81 lv~e~~~~-~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQS-DLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecccc-CHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999974 666665432 24889999999999999999999998 999999999999999999999999999764
Q ss_pred cCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-----------ccc-----
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-----------SIN----- 288 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----------~~~----- 288 (334)
...... ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||........ +..
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 332221 22234578999999998764 578999999999999999999999975432100 000
Q ss_pred ----------------------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 ----------------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ----------------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...........+++..||..+|.+|+++.++....+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 000112445678999999999999999998876554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=283.97 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=200.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999954 6899999987532 3344566888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
||+++++|..++.... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988775432 2344788899999999999999999998 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------ccc-chhcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---------NGY-DQTQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---------~~~-~~~~~~~ 297 (334)
... ......|++.|+|||.+.+..++.++|+||+|+++|||++|+.||.........+ ... .......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 221 1223467889999999988889999999999999999999999985432211000 000 1113456
Q ss_pred hhhhccccccCCccchhhhhhhhhcc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+.+++..|+..+|.+|+++.++...-
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 88899999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=282.02 Aligned_cols=245 Identities=25% Similarity=0.392 Sum_probs=195.0
Q ss_pred CCcCCccccCCcccEEEEEecC----CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc-----
Q 037681 75 FSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE----- 143 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 143 (334)
|.+.+.||+|+||.||.|.... +..+|+|.+... .......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998542 367999988743 33445678899999999999999999998876554
Q ss_pred -ceEEEEecCCCChhhhhhhcc---cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeec
Q 037681 144 -KLLIYEYLPNKSLDFFLFDAT---KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDF 219 (334)
Q Consensus 144 -~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 219 (334)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999988875432 2235888999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccc
Q 037681 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYD 291 (334)
Q Consensus 220 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~ 291 (334)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........ ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99986543322222222335678999999988889999999999999999999 8899875433210 001111
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
......+.+++..|+..+|.+|+++.++...
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2245578899999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=285.77 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=195.1
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788899999999999999964 68999999886432 23346778899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
++ ++|..++........+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 577777755444456899999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------c------ccc-
Q 037681 231 KANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------L------SIN- 288 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~------~~~- 288 (334)
......+++.|+|||.+.+. .++.++|+||||+++|+|+||++||....... . .+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 12223568899999987654 57889999999999999999999996432100 0 000
Q ss_pred ------cc--------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 ------GY--------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ------~~--------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+ .........+++.+||..+|.+|+++.++.+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 00 0012345568999999999999999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=289.56 Aligned_cols=244 Identities=21% Similarity=0.335 Sum_probs=194.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|.+.+.||+|+||.||+|... ++..+|+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999954 57889999986442 22334577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++ +|..++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 6766664432 24788889999999999999999998 99999999999999999999999999875432221
Q ss_pred ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--------------cc--------
Q 037681 231 KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------------SI-------- 287 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------------~~-------- 287 (334)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||........ .+
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223457899999998865 5688999999999999999999999965432100 00
Q ss_pred ------cc--------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 ------NG--------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ------~~--------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.. ..........+++.+||..+|.+|++..++....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 00 00112345678999999999999999998776544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=293.43 Aligned_cols=246 Identities=20% Similarity=0.232 Sum_probs=190.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||++... +++.+|+|.+... .......+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999965 5778999988532 2233445788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999986532 24788899999999999999999998 999999999999999999999999998754322
Q ss_pred CCccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-----------ccccccch
Q 037681 229 ESKANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-----------LSINGYDQ 292 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----------~~~~~~~~ 292 (334)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..+.....
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccc
Confidence 21 1223356899999999886 3467889999999999999999999997543210 00111111
Q ss_pred hcccchhhhccccccCCc--cchhhhhhhhhccC
Q 037681 293 TQVASKIKLVESCLARPF--RQYCCILKVRTFGF 324 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~--~~~~~~~~~~~~~~ 324 (334)
.......+++..++..++ ..|+++.++....+
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 134456777777775433 33456666665543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.29 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=200.0
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
-|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++.+...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 4677899999999999999965 477889998876666667788899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|..++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 999988765422 34889999999999999999999998 99999999999999999999999999865432211
Q ss_pred ccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhcccch
Q 037681 233 NTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQVASK 298 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~~~~~ 298 (334)
......++..|+|||.+. +..++.++|+||+||++|||++|++||........ ............+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence 123356889999999874 34577899999999999999999999875432210 0000011134568
Q ss_pred hhhccccccCCccchhhhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+++..|+..+|.+|+++.++....+
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCCC
Confidence 89999999999999999998887766
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=286.93 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=196.2
Q ss_pred hcCCCcCCccccCCcccEEEEEecC---------------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK---------------GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLL 135 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~ 135 (334)
.++|++.+.||+|+||.||++.... ...||+|.+... .......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3689999999999999999987532 224899988644 334456788999999999999999999
Q ss_pred eEEEecCcceEEEEecCCCChhhhhhhccc---------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCe
Q 037681 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATK---------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNI 206 (334)
Q Consensus 136 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Ni 206 (334)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999998854321 123678888999999999999999998 99999999999
Q ss_pred eeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh--CCCCCCCccCCc
Q 037681 207 LLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS--GKKNTEFYHTGY 284 (334)
Q Consensus 207 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~~~~ 284 (334)
+++.++.+||+|||++................++..|+|||.+.++.++.++|+||||+++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875433322222223345678999999988889999999999999999998 566776543211
Q ss_pred c--------------cccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 285 L--------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 285 ~--------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
. ............+.+++..|+..+|.+|+++.++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 0 0000011134568899999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=282.99 Aligned_cols=245 Identities=21% Similarity=0.319 Sum_probs=202.9
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||.|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++.+...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 368999999999999999999964 5788999999866655678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++.... ..+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999998875542 34889999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccCccccccC---CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc-------c----ccchhccc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQG---ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI-------N----GYDQTQVA 296 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-------~----~~~~~~~~ 296 (334)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.......... . ........
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 12234678899999998776 78899999999999999999999997654221100 0 00111234
Q ss_pred chhhhccccccCCccchhhhhhhhhcc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+.+++..|+..+|..|+++.++....
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~ 261 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHP 261 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 578999999999999999998877654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=285.03 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=199.9
Q ss_pred hcCCCcCCccccCCcccEEEEEecC------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
.++|++.+.||+|+||.||+|.... +..+|+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3688999999999999999998542 3679999986442 34456788999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhccc-------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 145 LLIYEYLPNKSLDFFLFDATK-------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
++||||+++++|..++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999998865322 123678889999999999999999988 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------ccccc
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------LSING 289 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~~~~~ 289 (334)
|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.||....... .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9999876543322222233456788999999988889999999999999999998 999987543220 00000
Q ss_pred cchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 290 YDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 290 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
........+.+++..|+..+|.+|+++.++.+.
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111135567899999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=304.16 Aligned_cols=243 Identities=20% Similarity=0.278 Sum_probs=187.6
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--------
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-------- 141 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------- 141 (334)
...+|++.+.||+|+||.||+|... +++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3468999999999999999999964 68899999885332 2345799999999999999999886432
Q ss_pred CcceEEEEecCCCChhhhhhh-cccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeec
Q 037681 142 DEKLLIYEYLPNKSLDFFLFD-ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDF 219 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Df 219 (334)
...++||||+++ ++..++.. ......+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999986 55555432 223345889999999999999999999998 99999999999998664 6999999
Q ss_pred cccccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------------
Q 037681 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------- 285 (334)
Q Consensus 220 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------- 285 (334)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||........
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99986543221 223468999999998865 4689999999999999999999999975422100
Q ss_pred -------------ccccc-----c----hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 -------------SINGY-----D----QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 -------------~~~~~-----~----~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+... . ........+++..||..+|.+|++..++....+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 00000 0 012345788999999999999999888776655
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.98 Aligned_cols=244 Identities=24% Similarity=0.383 Sum_probs=203.2
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36899999999999999999995 47999999999765555557788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999887432 3788899999999999999999998 99999999999999999999999999875433221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc---------chhcccchhhh
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY---------DQTQVASKIKL 301 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~ 301 (334)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||............. .......+.++
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 1223468889999999988889999999999999999999999996543321111000 01123456789
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+|+..+|..|+++.++....+
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCch
Confidence 99999999999999999888665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=283.42 Aligned_cols=242 Identities=30% Similarity=0.437 Sum_probs=198.6
Q ss_pred CCcCCccccCCcccEEEEEecC-CCEEEEEEecccChhhHH--HHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 75 FSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQ--ELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
|++++.||+|+||+||++.... ++.+|+|.+......... ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6678999999999999999664 668999999766544332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred ccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 99999998862 334899999999999999999999998 99999999999999999999999999875421 12
Q ss_pred cccccccccCCccCccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--cccccccc--------h-h--cccc
Q 037681 232 ANTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--YLSINGYD--------Q-T--QVAS 297 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~~~~~--------~-~--~~~~ 297 (334)
.......++..|+|||.+. +...+.++|+||+|+++|+|++|..||...... ...+.... . . ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHH
Confidence 2334456899999999998 888999999999999999999999999865111 00000000 0 0 1267
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..||..+|.+|+++.++.+..+
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 899999999999999999998877543
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=280.72 Aligned_cols=243 Identities=27% Similarity=0.385 Sum_probs=196.9
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4688899999999999999998777789999876332 233567889999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++..... .+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999998865432 4789999999999999999999998 9999999999999999999999999987653322111
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc------ccc-ccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL------SIN-GYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~------~~~-~~~~~~~~~~~~~i~~ 304 (334)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||........ ... .........+.+++..
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 111223457999999988899999999999999999999 8999875433210 000 0011145668899999
Q ss_pred cccCCccchhhhhhhhhc
Q 037681 305 CLARPFRQYCCILKVRTF 322 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~ 322 (334)
|+..+|.+|+++.++...
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=287.53 Aligned_cols=244 Identities=22% Similarity=0.383 Sum_probs=203.1
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.+|++.+.||.|++|.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5799999999999999999985 568999999987655555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|..++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 999999887432 3789999999999999999999998 99999999999999999999999999875433221
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------cccchhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---------NGYDQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~i 302 (334)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ..........+.+++
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 1223468889999999988889999999999999999999999997643321000 000111344577899
Q ss_pred cccccCCccchhhhhhhhhccCC
Q 037681 303 ESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
.+|+..+|.+|+++.++....+-
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred HHHhhcChhhCCCHHHHhhChHh
Confidence 99999999999999988877663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.66 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=196.6
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.|+..+.||+|+||.||++... +++.+|+|.+.... ......+..|+.++++++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999954 68899999886432 2223456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999888754332 34888999999999999999999988 9999999999999999999999999987543222
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--cccc--------ccchhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--LSIN--------GYDQTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~--------~~~~~~~~~~~ 299 (334)
. .....|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... .... ...........
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDAR 233 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHH
Confidence 1 123468999999999998899999999999999999999999997543210 0000 01111344578
Q ss_pred hhccccccCCccchhh-----hhhhhhccC
Q 037681 300 KLVESCLARPFRQYCC-----ILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~-----~~~~~~~~~ 324 (334)
+++..||..+|..|++ +.++.+..+
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 8999999999999988 566665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=283.41 Aligned_cols=248 Identities=28% Similarity=0.400 Sum_probs=196.4
Q ss_pred hcCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
.++|.+.+.||+|++|.||+|.+. .+..|++|.+.... ......+..|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467899999999999999999965 35678999876443 33345688899999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhccc----ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC---ceEEe
Q 037681 145 LLIYEYLPNKSLDFFLFDATK----RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM---KPKIS 217 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~ 217 (334)
++||||+++++|.+++..... ...+++..+..++.||+.|++|||+.+ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999998865432 124888999999999999999999998 99999999999998654 59999
Q ss_pred eccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-c------cc
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-I------NG 289 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-~------~~ 289 (334)
|||++.................+..|+|||.+.+..++.++|||||||++|||++ |+.||+........ . ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999976532222111222234567999999988899999999999999999997 99998754322100 0 00
Q ss_pred cchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 290 YDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 290 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
........+.+++..|+..+|.+|+++.++...
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111134567889999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=286.70 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=199.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47899999999999999999954 5788899988644 333456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|.+++... ..+++..+..++.|++.||.|||+ ++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999998654 337889999999999999999997 46 9999999999999999999999999986543221
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc---------ccc-----------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---------ING----------- 289 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---------~~~----------- 289 (334)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......... ...
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 22356889999999998888999999999999999999999998532211000 000
Q ss_pred -----c-------------------chhcccchhhhccccccCCccchhhhhhhhhccCCcc
Q 037681 290 -----Y-------------------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 290 -----~-------------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
. .......+.+++..|+..+|.+|+++.++....+-..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0 0001234678999999999999999999888876433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=280.85 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=197.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.+|++.+.||+|++|.||+|... ++..+|+|.+... ......+.+|++++++++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 46888899999999999999954 5888999988643 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999885533 234788899999999999999999988 999999999999999999999999998765432211
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--ccc-----ccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SIN-----GYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~~-----~~~~~~~~~~~~~i~ 303 (334)
......++..|+|||.+.+..++.++||||||+++|||++ |..||+....... .+. .........+.+++.
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1112234668999999988899999999999999999998 9999865432210 000 011113456888999
Q ss_pred ccccCCccchhhhhhhhhc
Q 037681 304 SCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~ 322 (334)
+|+..+|.+|+++.++...
T Consensus 240 ~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHccCCcccCCCHHHHHHH
Confidence 9999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=284.59 Aligned_cols=234 Identities=26% Similarity=0.369 Sum_probs=191.4
Q ss_pred CCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 75 FSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
|+..+.||+|+||+||+|.+ .+++.+|+|.+.... ......+.+|+.++++++|+||+++.+.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999995 468899999886432 22234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999988775433 234899999999999999999999998 9999999999999999999999999986543221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc--------cccchhcccchhh
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI--------NGYDQTQVASKIK 300 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~--------~~~~~~~~~~~~~ 300 (334)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||........ .. ..+.........+
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHH
Confidence 12234689999999999888999999999999999999999999975432100 00 0111223455788
Q ss_pred hccccccCCccchhh
Q 037681 301 LVESCLARPFRQYCC 315 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~ 315 (334)
++..|+..+|.+|++
T Consensus 235 li~~~l~~~P~~R~~ 249 (285)
T cd05632 235 ICKMLLTKDPKQRLG 249 (285)
T ss_pred HHHHHccCCHhHcCC
Confidence 999999999999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=280.84 Aligned_cols=245 Identities=24% Similarity=0.408 Sum_probs=191.2
Q ss_pred CCcCCccccCCcccEEEEEecC-CC--EEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec------Cc
Q 037681 75 FSDTNKLGEGGFGPVYKGVLAK-GD--EIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER------DE 143 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 143 (334)
|.+.+.||+|+||.||+|.+.. +. .+|+|.++.. .....+.+..|+.+++.++||||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999654 33 5899987643 345567788999999999999999999987432 24
Q ss_pred ceEEEEecCCCChhhhhhhcc---cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecc
Q 037681 144 KLLIYEYLPNKSLDFFLFDAT---KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFG 220 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 220 (334)
.+++|||+++|+|..++.... ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999988764321 2234789999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccch
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQ 292 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~ 292 (334)
++................+++.|+|||...+..++.++||||||+++|||++ |+.||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 9986543322111222345778999999998899999999999999999999 8899875432110 0000111
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhc
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.....+.+++..|+..+|.+|+++.++...
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 134557889999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.41 Aligned_cols=242 Identities=22% Similarity=0.252 Sum_probs=193.0
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD----- 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 142 (334)
..++|++.+.||+|+||.||++.+. +|..+|+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3479999999999999999999954 5889999998633 3344567789999999999999999999986543
Q ss_pred -cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 143 -EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 143 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
..|+||||++++ +...+.. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 468999999865 4444321 2778888999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------------c---
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------------L--- 285 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------------~--- 285 (334)
+....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... .
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 87543221 1233568999999999999999999999999999999999999997432100 0
Q ss_pred ---------------c---------ccccch--------hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ---------------S---------INGYDQ--------TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ---------------~---------~~~~~~--------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. +..|.. .....+.+++.+||..+|.+|+++.++....+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0 000000 01345678999999999999999999888765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=280.24 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=199.4
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+|++.+.||.|+||.||++... +++.+|+|.++.. .....+.+..|+.+++.++||||+++++.+...+..|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999954 6889999988643 3445567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|..++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 9999988775432 334788999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccccchhcccchhhhccc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGYDQTQVASKIKLVES 304 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~ 304 (334)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||........ ..............+++.+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 12235688899999999888899999999999999999999999975432110 0111111134457789999
Q ss_pred cccCCccchhhhhhhhhc
Q 037681 305 CLARPFRQYCCILKVRTF 322 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~ 322 (334)
|+..+|.+|+++.++.+-
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=279.95 Aligned_cols=244 Identities=27% Similarity=0.424 Sum_probs=197.4
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 68999999999999999999988888899998865433 3456889999999999999999999875 456899999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 999999886533 234788999999999999999999998 999999999999999999999999999765432211
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--ccc-----ccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SIN-----GYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~~-----~~~~~~~~~~~~~i~~ 304 (334)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .+. .........+.+++..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 1112235567999999988889999999999999999999 8999865432210 000 0111134568899999
Q ss_pred cccCCccchhhhhhhhhcc
Q 037681 305 CLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~~ 323 (334)
|+..+|.+|+++.++.++.
T Consensus 239 ~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 239 CWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HcccCcccCcCHHHHHHHH
Confidence 9999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=284.62 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=196.5
Q ss_pred hhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3478999999999999999999743 24479999876432 2334467789999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhccc-------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 144 KLLIYEYLPNKSLDFFLFDATK-------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
.++||||+++|+|.+++..... ....+...+..++.|++.||.|||+++ ++||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999865321 233566778899999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------ccc
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SIN 288 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~ 288 (334)
+|||+++...............++..|+|||.+.++.++.++|+||||+++|||++ |..||........ ...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999875433222222222345678999999988889999999999999999998 7888865332210 000
Q ss_pred ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.........+.+++..|+..+|.+|+++.++.+.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 274 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1111234568899999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.60 Aligned_cols=248 Identities=30% Similarity=0.477 Sum_probs=204.4
Q ss_pred cCCCcCCccccCCcccEEEEEecC--CC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK--GD----EIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~--~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
..-+..+.||+|.||.||.|...+ |. .||+|.++.. +.+....|.+|..+|+.++||||++++|+|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345667899999999999999543 43 3889988643 5677789999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhccc----ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 146 LIYEYLPNKSLDFFLFDATK----RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
+++|||.+|+|..++++.+. ...++....+.++.|||+|+.||+++. +|||||..+|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987621 234888899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccccc----c-cchh--
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSIN----G-YDQT-- 293 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~----~-~~~~-- 293 (334)
|+.+.+.+.........-...|||||.+..+.++.|+|||||||++||++| |..||........... + ..+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 995544444333333334578999999999999999999999999999999 9999987655422210 0 1111
Q ss_pred cccchhhhccccccCCccchhhhhhhhhcc
Q 037681 294 QVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
-...+.+++..|+.-+|.+|+++..+.+..
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHhhh
Confidence 355677999999999999999988876633
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=283.69 Aligned_cols=246 Identities=28% Similarity=0.406 Sum_probs=195.9
Q ss_pred CCCcCCccccCCcccEEEEEecC------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
+|++.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998531 2468888876443 3345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc---------------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCC
Q 037681 147 IYEYLPNKSLDFFLFDAT---------------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASN 205 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N 205 (334)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999998875421 1134788899999999999999999988 9999999999
Q ss_pred eeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc
Q 037681 206 ILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY 284 (334)
Q Consensus 206 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~ 284 (334)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||+...+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876533222212223345678999999988889999999999999999998 999987544321
Q ss_pred c-cc-c---cc--chhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 285 L-SI-N---GY--DQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 285 ~-~~-~---~~--~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
. .. . .. .......+.+++..|+..+|.+|+++.++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 0 00 0 00 11134578899999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=279.28 Aligned_cols=243 Identities=26% Similarity=0.396 Sum_probs=202.5
Q ss_pred cCCCcCCccccCCcccEEEEEecC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
++|++.+.||+|+||.||+|.... ++.+++|.+..... .+.+.+|++++++++||||+++++++.+....|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 689999999999999999999664 78999998865433 678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999885433 34899999999999999999999998 99999999999999999999999999876543321
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--c-----c--chhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--G-----Y--DQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--~-----~--~~~~~~~~~~~i 302 (334)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||........... . . .......+.+++
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 12234578899999999888899999999999999999999999976543211100 0 0 011234678899
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..|+..+|.+|+++.++....+
T Consensus 234 ~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred HHHHhcChhhCcCHHHHhcCCC
Confidence 9999999999999998876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=279.82 Aligned_cols=245 Identities=28% Similarity=0.442 Sum_probs=199.0
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh---------hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR---------QGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
+|.+...||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999854 588999998854321 123567889999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.++++||+++++|..++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999885543 3788889999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCCc----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccccch
Q 037681 224 IFKGNESK----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGYDQ 292 (334)
Q Consensus 224 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~ 292 (334)
........ .......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||+....... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS 234 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCc
Confidence 66422111 111234578899999999888899999999999999999999999976433210 0001111
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.....+.+++..|+..+|.+|+++.++....+
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 23456788999999999999999998877654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=284.79 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=188.1
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCcceEeeEEEec-----C
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKV---QHKNLVRLLGCCIER-----D 142 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~-----~ 142 (334)
+|++.+.||+|+||.||+|.+. +++.+|+|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999965 68899999886432 22233455677776665 799999999988642 3
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..+++|||+++ +|..++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 46899999985 7777765432 234789999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cccc
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LSIN 288 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~~~ 288 (334)
........ .....|+..|+|||.+.+..++.++||||+||++|+|++|++||....... ..+.
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 76542221 223467899999999988899999999999999999999999985432110 0000
Q ss_pred -------------------ccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 289 -------------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 289 -------------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
...........+++.+||..+|.+|++..++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp 286 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 00011233457899999999999999998887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=281.95 Aligned_cols=244 Identities=23% Similarity=0.354 Sum_probs=202.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999955 68899999986543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999887543 4889999999999999999999988 99999999999999999999999999977643321
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------ccccchh-cccchhhhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------INGYDQT-QVASKIKLV 302 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~~~~~~-~~~~~~~~i 302 (334)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+.... ....... ....+.+++
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 123346788999999999888999999999999999999999999765432110 0000111 345688899
Q ss_pred cccccCCccchhhhhhhhhccCC
Q 037681 303 ESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
..|+..+|.+|+++.++.+.++-
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhh
Confidence 99999999999999988776553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=286.67 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=199.4
Q ss_pred HhhcCCCcCCccccCCcccEEEEEecC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
...++|++.+.||+|+||.||++.... ...+|+|.+... .......+.+|+.++.++ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344689999999999999999998542 357899988643 334456688999999999 799999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhc-------------ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDA-------------TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
+..+++|||+++++|..++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999988643 12345888999999999999999999988 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc---
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY--- 284 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~--- 284 (334)
+.++.+||+|||.+................++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999986543322222222335678999999988899999999999999999998 999986543220
Q ss_pred ----ccccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 285 ----LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 285 ----~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.............+.+++..|+..+|.+|+++.++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 00001111234568889999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=283.23 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=201.4
Q ss_pred ccccccCCCccChhHHHHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHh--cCCCC
Q 037681 53 STKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAK--VQHKN 130 (334)
Q Consensus 53 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~ 130 (334)
.+.....+|.+-...+. .+..+.+.||+|.||.||+|.++ |..||||++...++ +...+|.+++.. |+|+|
T Consensus 194 tSGSGSGlplLVQRTia---rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHEN 266 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHEN 266 (513)
T ss_pred cCCCCCCchhHhHHhhh---heeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccch
Confidence 34445677777666665 57788899999999999999998 89999999976655 456778888776 59999
Q ss_pred cceEeeEEEecC----cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhh-----hcCCCCeEeccC
Q 037681 131 LVRLLGCCIERD----EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH-----LHSRVRIIHRDL 201 (334)
Q Consensus 131 iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~ivH~dl 201 (334)
|+.+++.-..++ ++++|++|.+.|+|.++|... .++.+..++++..+|.||++|| .+|++.|.||||
T Consensus 267 ILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 267 ILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred hhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 999998754332 579999999999999999653 3889999999999999999999 468889999999
Q ss_pred CCCCeeeCCCCceEEeeccccccccCC--CCccccccccccCCccCccccccCCC------CcchhhHhHHHHHHHHHh-
Q 037681 202 KASNILLDKEMKPKISDFGMARIFKGN--ESKANTNRVAGTFGYIPPEYVYQGIC------SIKSDVFSFGMLLLEILS- 272 (334)
Q Consensus 202 kp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~------~~~~DiwslG~il~ell~- 272 (334)
|+.||||..++.+.|+|+|+|...... ......+..+||.+|||||++..... -..+||||||.++||+..
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999766543 22334556789999999999875432 236899999999999885
Q ss_pred ---------CCCCCCCccCCcccccccchh------------------cccchhhhccccccCCccchhhhhhhhh
Q 037681 273 ---------GKKNTEFYHTGYLSINGYDQT------------------QVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 273 ---------g~~p~~~~~~~~~~~~~~~~~------------------~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
-+.||.+..+..+++...... ......++...|+..+|..|.+...++.
T Consensus 423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 245776655544433322111 2234667788899999998888776654
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.92 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=199.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999965 6899999988643 344456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|..++........+++..+..++.|++.|+.|||+ .+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999998888654333458999999999999999999996 46 9999999999999999999999999987543221
Q ss_pred CccccccccccCCccCccccccC------CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----------cccccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQG------ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------SINGYDQT 293 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------~~~~~~~~ 293 (334)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||+....... ........
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 2234578899999988544 347899999999999999999999965432210 00011111
Q ss_pred cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 294 QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
......+++.+|+..+|.+|+++.++....+
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 3456778999999999999999998887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=277.42 Aligned_cols=244 Identities=24% Similarity=0.308 Sum_probs=202.1
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|+..+.||.|+||.||.+.. .+++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999984 46889999988643 345566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999886543 345789999999999999999999988 99999999999999999999999999876543322
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccccchhcccchhhhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGYDQTQVASKIKLVE 303 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~ 303 (334)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||+....... .+..........+.+++.
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence 22335689999999999888889999999999999999999999876433210 111111123556888999
Q ss_pred ccccCCccchhhhhhhhhcc
Q 037681 304 SCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~ 323 (334)
.|+..+|.+|+++.++....
T Consensus 235 ~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 235 SLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHcccCcccCCCHHHHhhCc
Confidence 99999999999988876654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=278.21 Aligned_cols=234 Identities=25% Similarity=0.312 Sum_probs=192.2
Q ss_pred hcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|+.++.||+|.||+|-+++ ..+|+.+|+|+++.. .......-..|-++|...+||.+..+...|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3689999999999999999999 557999999998744 344556677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||..||.|..++...+ .+++.....+-.+|+.||.|||+++ ||+||||.+|+|+|.+|++||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999988885533 3888888889999999999999988 9999999999999999999999999997421
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-cc-----cccchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-SI-----NGYDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~-----~~~~~~~~~~~~~~ 301 (334)
.....+.+++|||.|+|||++....|+.++|.|.+||++|||++|+.||-....+.+ .+ ..+....++....+
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 223456779999999999999999999999999999999999999999865433311 00 01112234445556
Q ss_pred ccccccCCccch
Q 037681 302 VESCLARPFRQY 313 (334)
Q Consensus 302 i~~~l~~~~~~~ 313 (334)
+-..|.++|.+|
T Consensus 399 LsGLL~kdP~kR 410 (516)
T KOG0690|consen 399 LSGLLKKDPKKR 410 (516)
T ss_pred HHHHhhcChHhh
Confidence 666666676655
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=295.88 Aligned_cols=241 Identities=19% Similarity=0.235 Sum_probs=194.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec---CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA---KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
..+|++.+.||+|+||.||++... .+..|++|.+... ....+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999743 3567899987533 23467999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
|++. ++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 166 e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 467666632 234899999999999999999999998 999999999999999999999999999765543
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc----------------ccccc---
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY----------------LSING--- 289 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----------------~~~~~--- 289 (334)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333344679999999999998999999999999999999999999986432210 00000
Q ss_pred ---------cc---------------hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 ---------YD---------------QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 ---------~~---------------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+. ......+.+++..||..+|.+|++..++....+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 00 001234566889999999999999999888766
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=278.11 Aligned_cols=241 Identities=31% Similarity=0.425 Sum_probs=198.4
Q ss_pred CccccCCcccEEEEEecC----CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLAK----GDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|.... +..+++|.+...... ..+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 788999998755333 367889999999999999999999999998999999999999
Q ss_pred CChhhhhhhccc------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 154 KSLDFFLFDATK------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 154 ~~L~~~l~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
++|.+++..... ...+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999866421 245899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------ccccccchhcccchh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------LSINGYDQTQVASKI 299 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~~~~~~~~~~~~~~~ 299 (334)
...........++..|+|||.+.+..++.++||||+|+++|+|++ |..||....... .............+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 332222334557889999999988889999999999999999999 699997653320 000011112356788
Q ss_pred hhccccccCCccchhhhhhhhhc
Q 037681 300 KLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+++..|+..+|..|+++.++...
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999887653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=279.14 Aligned_cols=243 Identities=27% Similarity=0.393 Sum_probs=196.2
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||.||+|.+.++..+|+|.+..... ..+.+.+|+.++++++||||+++++.+. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 57999999999999999999977777899998864322 3357889999999999999999999874 456899999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 999999886532 234788899999999999999999988 999999999999999999999999999765433221
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc------c-cccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS------I-NGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~------~-~~~~~~~~~~~~~~i~~ 304 (334)
......++..|+|||...+..++.++|+||||+++|+|++ |+.||......... . ..........+.+++..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 1122345678999999988889999999999999999999 88888654332100 0 00112245668899999
Q ss_pred cccCCccchhhhhhhhhc
Q 037681 305 CLARPFRQYCCILKVRTF 322 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~ 322 (334)
|+..+|.+|+++.++..+
T Consensus 239 ~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 239 CWRKEPEERPTFEYLQAF 256 (262)
T ss_pred HccCCcccCCCHHHHHHH
Confidence 999999999999887765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=281.30 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=193.7
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGD----EIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
.++|++.+.||+|+||+||+|.+ .+|. .||+|.+... .......+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 36889999999999999999984 3444 4799988643 33445678899999999999999999999875 4578
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+++||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999998886533 24888999999999999999999998 999999999999999999999999999866
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccc
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVAS 297 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~ 297 (334)
.............++..|+|||...+..++.++||||||+++|||++ |..||+....... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence 43322211222335678999999988889999999999999999998 9999875432100 000001113445
Q ss_pred hhhhccccccCCccchhhhhhhhh
Q 037681 298 KIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
+.+++..|+..+|..|+++.++..
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 678999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=281.86 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=200.1
Q ss_pred hcCCCcCCccccCCcccEEEEEecC-----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe-cCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK-----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE-RDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 144 (334)
.++|++.+.||+|+||.||+|.+.. +..|++|.+... .......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4789999999999999999999665 678999988643 34456778899999999999999999998776 4678
Q ss_pred eEEEEecCCCChhhhhhhcccc-----cccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeec
Q 037681 145 LLIYEYLPNKSLDFFLFDATKR-----VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDF 219 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 219 (334)
++++||+++++|..++...... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999988654322 45889999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc------ccc-ccc
Q 037681 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL------SIN-GYD 291 (334)
Q Consensus 220 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~------~~~-~~~ 291 (334)
|+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||....+... ... ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 99976543322211222345678999999988889999999999999999999 9999975432110 000 001
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
......+.+++..|+..+|++|+++.++...-
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 11245688999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=286.29 Aligned_cols=246 Identities=28% Similarity=0.402 Sum_probs=197.9
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 144 (334)
++|.+.+.||+|+||.||+|... ++..+|+|.++.. .....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 67999999999999999999742 2457999988644 234456788999999999 799999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
+++|||+++++|..++..... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999998864332 33789999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc---cc-cc----chhcc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS---IN-GY----DQTQV 295 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~---~~-~~----~~~~~ 295 (334)
..............++..|+|||.+.+..++.++||||+|+++|||++ |..||......... .. .+ .....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAP 270 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCC
Confidence 543322112222346778999999998899999999999999999998 99998654332100 00 00 01134
Q ss_pred cchhhhccccccCCccchhhhhhhhhc
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
..+.+++..|+..+|.+|+++.++...
T Consensus 271 ~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 271 AEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 567889999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=278.76 Aligned_cols=246 Identities=28% Similarity=0.411 Sum_probs=199.8
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.++|++.+.||+|+||.||+|...+++.+|+|.+..... ....+.+|+.++++++||||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 468999999999999999999988899999998864432 3467889999999999999999999864 56789999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999998875533 335788999999999999999999988 999999999999999999999999998765422211
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc------ccc-ccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL------SIN-GYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~------~~~-~~~~~~~~~~~~~i~ 303 (334)
......++..|+|||.+.+..++.++||||||+++||+++ |+.||........ ... .........+.+++.
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1122345678999999988889999999999999999999 9999975433210 000 001113456889999
Q ss_pred ccccCCccchhhhhhhhhccC
Q 037681 304 SCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+|+..+|.+|+++.++.++..
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 238 LCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred HHccCChhhCCCHHHHHHHhh
Confidence 999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.34 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=197.0
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec------C
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER------D 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~ 142 (334)
+.+.|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4578899999999999999999954 58889999886443 3345678899999998 699999999998753 3
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..|++|||+++++|..++.... ...+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 5789999999999999886532 234788999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc-------ccc
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI-------NGY 290 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-------~~~ 290 (334)
........ ......|+..|+|||++. +..++.++|+||+||++|||++|+.||.......... ...
T Consensus 159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 159 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred eecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 76432221 223456899999999886 3357889999999999999999999997543221100 000
Q ss_pred -chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 291 -DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 291 -~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.......+.+++..|+..+|.+|+++.++....+
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 0112356788999999999999999988876543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=286.50 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=195.9
Q ss_pred hcCCCcCCccccCCcccEEEEEec--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA--------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
.++|.+.+.||+|+||.||++... ++..+|+|.+... .......+..|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 368999999999999999999742 2346999988743 234456788899999999 799999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
+..|+||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999865432 124788899999999999999999988 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc---
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY--- 284 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~--- 284 (334)
+.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|||++ |..||.......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999875532221111222234568999999988889999999999999999998 888886543211
Q ss_pred ----ccccccchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 285 ----LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 285 ----~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.............+.+++..|+..+|..|+++.++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 254 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 0000111113456778999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=283.48 Aligned_cols=243 Identities=27% Similarity=0.384 Sum_probs=192.7
Q ss_pred cCCCcCCccccCCcccEEEEEecC-CC--EEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-GD--EIAVKRLSV-RSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||.||+|...+ +. .+++|.++. ......+.+..|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998653 33 468887763 2344456788999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhhhcc-------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCce
Q 037681 148 YEYLPNKSLDFFLFDAT-------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999885432 1124788899999999999999999988 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--cc----
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SI---- 287 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~---- 287 (334)
||+|||++...... ........+..|+|||.+.+..++.++||||||+++|||++ |+.||........ ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999998632111 11111223557999999988889999999999999999997 9999976533210 00
Q ss_pred -cccchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 288 -NGYDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 288 -~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
..........+.+++..|+..+|.+|+++.++..
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011123456789999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=282.78 Aligned_cols=248 Identities=27% Similarity=0.370 Sum_probs=198.6
Q ss_pred hcCCCcCCccccCCcccEEEEEecC-----------------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcce
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK-----------------GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVR 133 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~ 133 (334)
.++|++.+.||+|+||.||+|.... +..+|+|.+... .....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3689999999999999999988542 245899988644 3345677889999999999999999
Q ss_pred EeeEEEecCcceEEEEecCCCChhhhhhhccc--------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCC
Q 037681 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATK--------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASN 205 (334)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N 205 (334)
+++++...+..+++|||+++++|..++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999998865431 124789999999999999999999998 9999999999
Q ss_pred eeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh--CCCCCCCccCC
Q 037681 206 ILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS--GKKNTEFYHTG 283 (334)
Q Consensus 206 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~~~ 283 (334)
|+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876543322222333456778999999988889999999999999999998 66777644322
Q ss_pred cc-----cc---------cccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 284 YL-----SI---------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 284 ~~-----~~---------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.. .. ..........+.+++..|+..+|.+|+++.++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~ 293 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF 293 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence 10 00 00001123568999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=293.55 Aligned_cols=235 Identities=23% Similarity=0.296 Sum_probs=183.4
Q ss_pred cccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhc---CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKV---QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 81 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
||+|+||+||+|... +++.||+|++.... .........|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999954 58999999986431 22233445566676655 699999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99988875433 3889999999999999999999998 9999999999999999999999999986532221 12
Q ss_pred cccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccc-hhcccchhhhcccc
Q 037681 234 TNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYD-QTQVASKIKLVESC 305 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~-~~~~~~~~~~i~~~ 305 (334)
.....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........ .. .... ........+++..|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~ 232 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL 232 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence 3345799999999998754 478999999999999999999999865432110 00 0000 11345667899999
Q ss_pred ccCCccchh----hhhhhhhcc
Q 037681 306 LARPFRQYC----CILKVRTFG 323 (334)
Q Consensus 306 l~~~~~~~~----~~~~~~~~~ 323 (334)
|..+|.+|. ++.++....
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCc
Confidence 999999997 455555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=284.78 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=197.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA--------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
.++|.+.+.||+|+||.||+|... ++..+|+|..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 468899999999999999999731 2447899988643 234456788999999999 899999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
+..+++|||+++++|..++..... ...+++..+..++.|++.||.|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999998865421 124678889999999999999999998 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-- 285 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-- 285 (334)
+.++.+||+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999976543322222223345678999999988889999999999999999998 7888865422210
Q ss_pred cc-----cccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 286 SI-----NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 286 ~~-----~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.. ..........+.+++..|+..+|.+|+++.++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 00 00011234568889999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=282.93 Aligned_cols=240 Identities=25% Similarity=0.335 Sum_probs=197.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||++.+. +++.+|+|.+... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999954 5899999988643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999998885543 4889999999999999999999988 999999999999999999999999998765433
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--c----ccccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--S----INGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~----~~~~~~~~~~~~~~~i 302 (334)
.....|++.|+|||.+.+...+.++|+||||+++|+|++|+.||........ . -..........+.+++
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 229 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLI 229 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHH
Confidence 2234688999999999888889999999999999999999999865432100 0 0011112356678899
Q ss_pred cccccCCccchh-----hhhhhhhcc
Q 037681 303 ESCLARPFRQYC-----CILKVRTFG 323 (334)
Q Consensus 303 ~~~l~~~~~~~~-----~~~~~~~~~ 323 (334)
..|+..+|.+|. ++.++...+
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 230 RNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred HHHccCCHHHccCcccCCHHHHHcCc
Confidence 999999999997 555555444
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=278.09 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=201.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|... +|+.+|+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999966 7899999988532 3334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
||+++++|..++.... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998876432 2345789999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc---------ccccch-hcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---------INGYDQ-TQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---------~~~~~~-~~~~~ 297 (334)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... ...... .....
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence 221 122345788999999998888999999999999999999999998644322100 000111 23446
Q ss_pred hhhhccccccCCccchhhhhhhhhcc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+.+++..|+..+|..|+++.++.+.-
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 78899999999999999998876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=279.88 Aligned_cols=245 Identities=21% Similarity=0.331 Sum_probs=199.9
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|++|.||+|.. .++..+++|.+... .......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999995 57899999987542 3334467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
||+++++|..++.... ....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999998875422 2345889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc---------cc-hhcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING---------YD-QTQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---------~~-~~~~~~ 297 (334)
.... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....+...+.. .. ......
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence 3221 22346888999999998888999999999999999999999998644322111100 00 113446
Q ss_pred hhhhccccccCCccchhhhhhhhhc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+.+++..|+..+|.+|+++.++...
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHHH
Confidence 8889999999999999999876554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=274.00 Aligned_cols=238 Identities=26% Similarity=0.346 Sum_probs=192.8
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCChh
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLD 157 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 157 (334)
+.||+|+||.||+|...++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998788999999886443 333456889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccc
Q 037681 158 FFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV 237 (334)
Q Consensus 158 ~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 237 (334)
.++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 8875433 34788999999999999999999998 999999999999999999999999998754322211 11122
Q ss_pred cccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccchhhhccccccCC
Q 037681 238 AGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASKIKLVESCLARP 309 (334)
Q Consensus 238 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~~ 309 (334)
.++..|+|||.+.+..++.++||||||+++|++++ |..||........ ............+.+++.+|+..+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 34667999999988889999999999999999998 9999875432210 000111124567888999999999
Q ss_pred ccchhhhhhhhhc
Q 037681 310 FRQYCCILKVRTF 322 (334)
Q Consensus 310 ~~~~~~~~~~~~~ 322 (334)
|.+|+++.++...
T Consensus 235 p~~Rp~~~~l~~~ 247 (250)
T cd05085 235 PENRPKFSELQKE 247 (250)
T ss_pred cccCCCHHHHHHH
Confidence 9999999887653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=291.45 Aligned_cols=242 Identities=21% Similarity=0.231 Sum_probs=192.2
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD----- 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 142 (334)
..++|++.+.||+|+||.||++... .++.+|+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4479999999999999999999854 5889999998643 3334567788999999999999999999986543
Q ss_pred -cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 143 -EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 143 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
..|+||||++++ +...+.. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~~-l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhccc-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 468999999764 5444421 2788888999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-----------------
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY----------------- 284 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----------------- 284 (334)
+....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 97543221 1233568999999999998899999999999999999999999996432100
Q ss_pred --------------ccc-----cc----c--------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 --------------LSI-----NG----Y--------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 --------------~~~-----~~----~--------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
... .. . .......+.+++..||..+|.+|+++.++....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 000 00 0 0001234578999999999999999999888654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=294.78 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=197.6
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEec
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIER 141 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 141 (334)
...++|.+.+.||+|+||.||+|.+. .+..||+|++... .....+.+.+|+.++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33467888999999999999999853 2457999999744 2333457889999999997 99999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhccc--------------------------------------------------------
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATK-------------------------------------------------------- 165 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 165 (334)
+..++||||+++|+|.+++.....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999998864321
Q ss_pred ---------------------------------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCe
Q 037681 166 ---------------------------------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNI 206 (334)
Q Consensus 166 ---------------------------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Ni 206 (334)
...+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 123566778889999999999999888 99999999999
Q ss_pred eeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc
Q 037681 207 LLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL 285 (334)
Q Consensus 207 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~ 285 (334)
+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999976433222112223356788999999988889999999999999999998 8899865432211
Q ss_pred ccc----c----cchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 286 SIN----G----YDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 286 ~~~----~----~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
... . ........+.+++..|+..+|..|+++.++...
T Consensus 351 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 000 0 001134567789999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=276.98 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=203.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|++.++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999954 57889999886432 33567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++........+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999866443345889999999999999999999998 99999999999999999999999999876543322
Q ss_pred c--cccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----------cccccc--hhcc
Q 037681 231 K--ANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------SINGYD--QTQV 295 (334)
Q Consensus 231 ~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------~~~~~~--~~~~ 295 (334)
. .......|+..|+|||.+... .++.++|+||||+++|+|++|+.||........ .+.... ....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence 2 122334688999999998776 788999999999999999999999975533210 000000 0123
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
....+++..|+..+|..|+++.++...++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 238 KSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 45788999999999999999998877543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=275.81 Aligned_cols=245 Identities=21% Similarity=0.309 Sum_probs=199.4
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec-CcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-DEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 149 (334)
+|++.+.||+|++|.||.+.+. +++.+|+|.+... .....+.+..|++++++++|||++++++.+... ...|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5888999999999999999954 5788999998643 234456788999999999999999999987644 45789999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++.... ...+++.++..++.|++.|+++||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999998886532 334789999999999999999999998 9999999999999999999999999987654322
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccccchhcccchhhhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGYDQTQVASKIKLV 302 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i 302 (334)
. ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||+....... .+............+++
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI 234 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence 1 22335688999999999999999999999999999999999999875432110 01011112445688899
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..|+..+|.+|+++.++....+
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred HHHhccCcccCCCHHHHhcCCC
Confidence 9999999999999998877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=279.69 Aligned_cols=244 Identities=23% Similarity=0.385 Sum_probs=201.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..|+..+.||.|+||.||+|.+. ++..+|+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999964 58899999887443 44567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999887532 3788889999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc-------cccchhcccchhhhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI-------NGYDQTQVASKIKLVE 303 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~i~ 303 (334)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||....+..... ..........+.+++.
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHH
Confidence 1223457889999999988889999999999999999999999997654321110 0111123456788999
Q ss_pred ccccCCccchhhhhhhhhccCC
Q 037681 304 SCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
.|+..+|.+|+++.++....+.
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred HHcccCcccCcCHHHHHhChHh
Confidence 9999999999999998776653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=276.49 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=196.5
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|++|.||+|.+..+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999876433 23466888999999999999999999875 456899999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999886532 234788899999999999999999988 999999999999999999999999999765432211
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc------c-cccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS------I-NGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~------~-~~~~~~~~~~~~~~i~~ 304 (334)
......++..|+|||...+...+.++|+||||+++|+|++ |+.||......... . ..........+.+++..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 1122345678999999988889999999999999999999 89998764332100 0 00111234568889999
Q ss_pred cccCCccchhhhhhhhhcc
Q 037681 305 CLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~~ 323 (334)
|+..+|.+|+++.++.++-
T Consensus 239 ~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 239 CWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HccCCcccCcCHHHHHHHH
Confidence 9999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=280.69 Aligned_cols=244 Identities=22% Similarity=0.305 Sum_probs=196.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|++|.||+|... +|+.+|+|++.... ....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47889999999999999999965 58899999886432 2233567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|..+..... .+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887764322 3889999999999999999999988 9999999999999999999999999997654332
Q ss_pred CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------------------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--------------------- 287 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------------------- 287 (334)
. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..........
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457888999998865 557889999999999999999999997543210000
Q ss_pred ----------------cccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 ----------------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ----------------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
............+++..|+..+|.+|+++.++....+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 0000112445778999999999999999998876554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=314.61 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=197.0
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccce
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKL 145 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 145 (334)
..++|++++.||+|+||+||+|.+. ++..+|+|.+... .......+..|+.++++++||||++++++|... ...|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3479999999999999999999965 5778899988643 334456788999999999999999999998654 4589
Q ss_pred EEEEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCC----CCeEeccCCCCCeeeCCC---------
Q 037681 146 LIYEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSR----VRIIHRDLKASNILLDKE--------- 211 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~----~~ivH~dlkp~Nill~~~--------- 211 (334)
+||||+++++|..++.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+|||++.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999998886532 22458999999999999999999998541 249999999999999642
Q ss_pred --------CceEEeeccccccccCCCCccccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCcc
Q 037681 212 --------MKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTEFYH 281 (334)
Q Consensus 212 --------~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~ 281 (334)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3489999999976533221 233568999999999854 458899999999999999999999997543
Q ss_pred CCcccccc------cc-hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 282 TGYLSING------YD-QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 282 ~~~~~~~~------~~-~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.....+.. .. ......+.+++..||..+|..|+++.++...++
T Consensus 248 ~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred cHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 21110000 00 113456888999999999999999998876544
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=279.72 Aligned_cols=245 Identities=25% Similarity=0.386 Sum_probs=194.7
Q ss_pred cCCCcCCccccCCcccEEEEEe-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 145 (334)
.+|++.+.||+|+||.||++.. .++..||+|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999974 24788999998776666677889999999999999999999987543 4578
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999885432 24789999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCcc-ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----------ccc----c-
Q 037681 226 KGNESKA-NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------SIN----G- 289 (334)
Q Consensus 226 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------~~~----~- 289 (334)
....... ......++..|+|||.+.+..++.++|+||||+++|||++|..|+........ ... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4332211 11112234569999999888899999999999999999998776543211100 000 0
Q ss_pred --------cchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 290 --------YDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 290 --------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
........+.+++..|+..+|.+|+++.++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 001123468889999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=282.01 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=194.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec-----------------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcce
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-----------------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVR 133 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~ 133 (334)
.++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 367999999999999999998532 2346899988644 3344567889999999999999999
Q ss_pred EeeEEEecCcceEEEEecCCCChhhhhhhccc--------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCC
Q 037681 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATK--------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASN 205 (334)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N 205 (334)
+++++...+..+++|||+++++|..++..... ...+++..+..++.|++.|++|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999988865331 123667889999999999999999998 9999999999
Q ss_pred eeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh--CCCCCCCccCC
Q 037681 206 ILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS--GKKNTEFYHTG 283 (334)
Q Consensus 206 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~~~ 283 (334)
|+++.++.++|+|||++..+.............++..|+|||...++.++.++|+||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999876533322222222344678999999888889999999999999999998 77787654322
Q ss_pred ccc--c------------cccchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 284 YLS--I------------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 284 ~~~--~------------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
... . ..........+.+++..|+..+|.+|+++.++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 100 0 0000112356778999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=289.63 Aligned_cols=242 Identities=22% Similarity=0.276 Sum_probs=192.0
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEec------C
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIER------D 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 142 (334)
.++|++.+.||.|+||+||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47899999999999999999995 468899999986432 23345677899999999999999999987643 3
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..|++++++ +++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 468999987 6788776642 23889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------------ccc-c
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG-------------YLS-I 287 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------------~~~-~ 287 (334)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ... +
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 764322 223468999999999876 56889999999999999999999999643210 000 0
Q ss_pred ccc-----------------------chhcccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 288 NGY-----------------------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 288 ~~~-----------------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
... .........+++..|+..+|.+|+++.++....+-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 000 000122356899999999999999999988877643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=274.89 Aligned_cols=237 Identities=25% Similarity=0.395 Sum_probs=187.8
Q ss_pred ccccCCcccEEEEEec---CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCC
Q 037681 80 KLGEGGFGPVYKGVLA---KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKS 155 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 155 (334)
.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999854 35569999886543 333467889999999999999999999885 457899999999999
Q ss_pred hhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc-cc
Q 037681 156 LDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA-NT 234 (334)
Q Consensus 156 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~ 234 (334)
|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......... ..
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 998885432 34889999999999999999999998 9999999999999999999999999987543322211 11
Q ss_pred ccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-----cccchhcccchhhhccccc
Q 037681 235 NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-----NGYDQTQVASKIKLVESCL 306 (334)
Q Consensus 235 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-----~~~~~~~~~~~~~~i~~~l 306 (334)
....++..|+|||.+.+..++.++||||||+++||+++ |..||......... + ..........+.+++..|+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 11223578999999988889999999999999999996 99999765432100 0 0011123567888999999
Q ss_pred cCCccchhhhhhhhhc
Q 037681 307 ARPFRQYCCILKVRTF 322 (334)
Q Consensus 307 ~~~~~~~~~~~~~~~~ 322 (334)
..+|++|+++.++...
T Consensus 236 ~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 236 IYKWEDRPNFAKVEER 251 (257)
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999887654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=301.17 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=207.0
Q ss_pred cCCCcCCccccCCcccEEEEEecC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+.|+|+..||.|+||+||+|.++. +-..|.|++...+....+.+.-|+++|..++||+|+++++.|...+.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 456788899999999999999764 3345678888888888999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
+||-.+..+..-. ..+.+.++..+++|++.||.|||++. |+|||||..|||++-+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 9999988775433 34899999999999999999999998 9999999999999999999999999975432 222
Q ss_pred cccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc---------cchhcccc
Q 037681 232 ANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING---------YDQTQVAS 297 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---------~~~~~~~~ 297 (334)
.....+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|....++-...+.- .....+..
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 2344578999999999864 568999999999999999999999998776554222111 01114556
Q ss_pred hhhhccccccCCccchhhhhhhhhccCC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
+.+++..||.++|+.|++..++...++.
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 8899999999999999999999888774
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=283.38 Aligned_cols=244 Identities=22% Similarity=0.325 Sum_probs=194.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 68999999999999999999864 58899999986442 23345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++ +|..++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LDK-DLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred ccc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 974 7877765432 24788899999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--------------cccc--------
Q 037681 231 KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------YLSI-------- 287 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------~~~~-------- 287 (334)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...... ...+
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1223456889999998765 45788999999999999999999999753321 0000
Q ss_pred ------ccc--------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 ------NGY--------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ------~~~--------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+ .........+++..|+..+|.+|+++.++....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000 0112334678999999999999999998877544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=284.03 Aligned_cols=240 Identities=22% Similarity=0.321 Sum_probs=182.8
Q ss_pred CCccccCCcccEEEEEec---CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe--cCcceEEEEecC
Q 037681 78 TNKLGEGGFGPVYKGVLA---KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE--RDEKLLIYEYLP 152 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 152 (334)
.+.||+|+||.||+|... ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999886432 23456789999999999999999999865 345789999986
Q ss_pred CCChhhhhhhcc------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee----CCCCceEEeecccc
Q 037681 153 NKSLDFFLFDAT------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL----DKEMKPKISDFGMA 222 (334)
Q Consensus 153 ~~~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~ 222 (334)
+ +|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 6666553221 1234888899999999999999999998 9999999999999 45678999999999
Q ss_pred ccccCCCC-ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--------------
Q 037681 223 RIFKGNES-KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------------- 286 (334)
Q Consensus 223 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------------- 286 (334)
........ ........||+.|+|||++.+ ..++.++||||+||++|||++|++||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 76543321 112234568999999999876 45889999999999999999999999643221000
Q ss_pred ---------cccc-------------c-----------------hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 287 ---------INGY-------------D-----------------QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 287 ---------~~~~-------------~-----------------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+... . ........+++..||..+|.+|.+..++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 0000 0 00122356789999999999999998877654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=280.86 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=197.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 368999999999999999999853 46789999886442 33456788999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhccc-------------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCC
Q 037681 145 LLIYEYLPNKSLDFFLFDATK-------------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASN 205 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~-------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N 205 (334)
+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999998864321 124678888999999999999999988 9999999999
Q ss_pred eeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc
Q 037681 206 ILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY 284 (334)
Q Consensus 206 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~ 284 (334)
|+++.++.++|+|||.+.................+..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432221111222234667999999988899999999999999999998 888885443221
Q ss_pred -------ccccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 285 -------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 285 -------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.............+.+++..|+..+|.+|+++.++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~ 285 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 00001111234568899999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=282.35 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=199.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+.|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35677789999999999999854 57889999886442 34556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999888743 23788999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------ccccchhcccchhhhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------INGYDQTQVASKIKLVE 303 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~i~ 303 (334)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+....+.... ...........+.+++.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 122345788999999999888999999999999999999999998754332110 00011113445788999
Q ss_pred ccccCCccchhhhhhhhhccC
Q 037681 304 SCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.|+..+|..|+++.++....+
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred HHccCCcccCcCHHHHHHhHH
Confidence 999999999999998877544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.76 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=189.7
Q ss_pred ccccCCcccEEEEEe---cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCC
Q 037681 80 KLGEGGFGPVYKGVL---AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~---~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
.||+|+||.||+|.+ .++..+|+|.++.. .....+.+..|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999974 35788999988643 2334567889999999999999999999875 45678999999999
Q ss_pred ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc-c
Q 037681 155 SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA-N 233 (334)
Q Consensus 155 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~ 233 (334)
+|.+++.... .+++..+..++.|++.|++|||+++ ++|+||||+||+++.++.++|+|||++.......... .
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9998885433 3889999999999999999999998 9999999999999999999999999997654332211 1
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccchhhhcccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASKIKLVESC 305 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~ 305 (334)
.....++..|+|||.+.+..++.++|+||||+++|||++ |+.||........ ............+.+++..|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLC 234 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 112234578999999988889999999999999999998 9999976433200 00011112456688999999
Q ss_pred ccCCccchhhhhhhhhccC
Q 037681 306 LARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 306 l~~~~~~~~~~~~~~~~~~ 324 (334)
+..+|.+|+++..+.....
T Consensus 235 ~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 235 WTYGVDERPGFAVVELRLR 253 (257)
T ss_pred hccCchhCcCHHHHHHHHh
Confidence 9999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=276.64 Aligned_cols=244 Identities=29% Similarity=0.434 Sum_probs=200.1
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.++|++.+.||+|+||.||+|...+++.+|+|.+..... ..+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 478999999999999999999988788899998874432 3467889999999999999999999999888999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ...+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999886543 234788999999999999999999998 999999999999999999999999998765432111
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccccc--------cchhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSING--------YDQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~i 302 (334)
......++..|+|||.+.+..++.++|+||+|+++|++++ |+.||....... .+.. ........+.+++
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELYDLM 237 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1112234568999999988889999999999999999998 999986543221 0000 0111345688899
Q ss_pred cccccCCccchhhhhhhhhc
Q 037681 303 ESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+|+..+|.+|+++.++..+
T Consensus 238 ~~~l~~~p~~Rp~~~~l~~~ 257 (261)
T cd05034 238 LQCWDKDPEERPTFEYLQSF 257 (261)
T ss_pred HHHcccCcccCCCHHHHHHH
Confidence 99999999999999887765
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.46 Aligned_cols=245 Identities=25% Similarity=0.375 Sum_probs=194.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-----SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 144 (334)
.+|+..+.||+|+||.||+|... ++..+++|.+... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999854 5889999988533 223445688899999999999999999998753 567
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++++||+++++|.+++.... .+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999998885433 3788888999999999999999888 99999999999999999999999999875
Q ss_pred ccCCCC-ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc--------cccchhcc
Q 037681 225 FKGNES-KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--------NGYDQTQV 295 (334)
Q Consensus 225 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------~~~~~~~~ 295 (334)
...... ........++..|+|||.+.+..++.++|+||+|+++|||++|+.||.......... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS 235 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcC
Confidence 432111 111223457889999999988889999999999999999999999997553221100 00011123
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++ .|+..+|.+|+++.++.+..+
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 3455566 688899999999999887655
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=283.71 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=195.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA--------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
.++|.+.+.||+|+||.||+|... ....+|+|.+... .......+..|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 368889999999999999999742 2446899988643 334456788999999999 699999999999998
Q ss_pred CcceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
+..+++|||+++++|..++..... ...+++..+..++.|++.||.|||+++ ++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 899999999999999998865321 234788889999999999999999988 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-cc
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-LS 286 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-~~ 286 (334)
+.++.+||+|||.++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999976543222111222234567999999988889999999999999999999 888886543210 00
Q ss_pred -cc-----ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 287 -IN-----GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 287 -~~-----~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.. .........+.+++..|+..+|..|+++.++...
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 0011124467789999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=283.00 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=199.8
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
.|+....||+|+||.||+|... +++.+|+|.+........+.+.+|+.++..++||||+++++.+..++..++++||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3444568999999999999854 689999999876555555678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|..++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 102 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 102 GGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 9999887643 23788999999999999999999998 99999999999999999999999999875433221
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccccchhcccchhhhcc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSINGYDQTQVASKIKLVE 303 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~i~ 303 (334)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....... .............+.+++.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 1233568899999999988889999999999999999999999986443210 0000011113445788999
Q ss_pred ccccCCccchhhhhhhhhccCCc
Q 037681 304 SCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
.|+..+|.+|+++.++....+-+
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhc
Confidence 99999999999999988876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.14 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=197.5
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++++.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 345555678999999999999954 5778999998766666677889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|..++.........++..+..++.|++.|++|||+.+ ++|+||||+||+++. ++.++|+|||.+.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 999999998865432211277888899999999999999988 999999999999976 6789999999987553322
Q ss_pred CccccccccccCCccCccccccCC--CCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc---------ccchhcccch
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGI--CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN---------GYDQTQVASK 298 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~---------~~~~~~~~~~ 298 (334)
. ......|++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||........... .........+
T Consensus 164 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd06624 164 P--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA 241 (268)
T ss_pred C--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence 1 122245788999999986543 78899999999999999999999865433211100 0111134457
Q ss_pred hhhccccccCCccchhhhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+++..|+..+|.+|+++.++...++
T Consensus 242 ~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 242 KNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred HHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 78999999999999999998876543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=274.22 Aligned_cols=241 Identities=27% Similarity=0.384 Sum_probs=198.9
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-----RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
+|+..+.||+|++|.||+|... ++..+++|.+.... ....+.+..|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999965 78999999886433 33556788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
+||+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999885433 3788899999999999999999998 99999999999999999999999999876533
Q ss_pred CCCccccccccccCCccCccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--------cccccchhcccch
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGI-CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------SINGYDQTQVASK 298 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------~~~~~~~~~~~~~ 298 (334)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||........ ............+
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHH
Confidence 22 123356889999999987766 88999999999999999999999976542211 1111111234567
Q ss_pred hhhccccccCCccchhhhhhhhhcc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+++..|+..+|..|+++.++....
T Consensus 232 ~~li~~~l~~~p~~Rp~~~~~l~~~ 256 (258)
T cd06632 232 KDFILKCLQRDPSLRPTAAELLEHP 256 (258)
T ss_pred HHHHHHHhhcCcccCcCHHHHhcCC
Confidence 7899999999999999998877654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=286.64 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=193.9
Q ss_pred hcCCCcCCccccCCcccEEEEEe------cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec-C
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL------AKGDEIAVKRLSVRS-RQGLQELKNEALVIAKV-QHKNLVRLLGCCIER-D 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~ 142 (334)
.++|.+.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36899999999999999999973 346789999987532 33456788999999999 689999999988654 4
Q ss_pred cceEEEEecCCCChhhhhhhccc---------------------------------------------------------
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATK--------------------------------------------------------- 165 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 165 (334)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999988754211
Q ss_pred -------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccccccc
Q 037681 166 -------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238 (334)
Q Consensus 166 -------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 238 (334)
...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123677788899999999999999998 9999999999999999999999999987653322212222234
Q ss_pred ccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccc--------cccchhcccchhhhccccccCC
Q 037681 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSI--------NGYDQTQVASKIKLVESCLARP 309 (334)
Q Consensus 239 g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~~ 309 (334)
++..|+|||.+.+..++.++||||||+++|+|++ |..||.......... ..........+.+++..|+..+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5678999999988899999999999999999997 999987543221000 0000112346788899999999
Q ss_pred ccchhhhhhhhhc
Q 037681 310 FRQYCCILKVRTF 322 (334)
Q Consensus 310 ~~~~~~~~~~~~~ 322 (334)
|.+|+++.++...
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=277.46 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=195.2
Q ss_pred cCCCcCCccccCCcccEEEEEecC-C---CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-G---DEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.+|++.+.||+|+||.||+|.... + ..||+|.+... .......+..|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 467889999999999999999543 3 35999988644 444567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|..++.... ..+++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999886543 34788999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCccccc-ccc--ccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc------ccc-ccchhccc
Q 037681 228 NESKANTN-RVA--GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL------SIN-GYDQTQVA 296 (334)
Q Consensus 228 ~~~~~~~~-~~~--g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~------~~~-~~~~~~~~ 296 (334)
........ ... .+..|+|||.+.+..++.++||||||+++||+++ |..||........ ... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence 22211111 111 2357999999988899999999999999999886 9999865432210 000 00011244
Q ss_pred chhhhccccccCCccchhhhhhhhhc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+.+++..|+..+|.+|+++.++...
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 57889999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=279.38 Aligned_cols=243 Identities=28% Similarity=0.400 Sum_probs=192.3
Q ss_pred cCC-CcCCccccCCcccEEEEEe-----cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Cc
Q 037681 73 NNF-SDTNKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DE 143 (334)
Q Consensus 73 ~~y-~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 143 (334)
++| ++.+.||+|+||+||++.. .++..+|+|.+.... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8889999999999988652 357789999986543 33456788999999999999999999988764 35
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.+++|||+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 78999999999999888543 3899999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCCcc-ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc----------cc--
Q 037681 224 IFKGNESKA-NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN----------GY-- 290 (334)
Q Consensus 224 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----------~~-- 290 (334)
......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+........... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 654322211 11122356679999999888899999999999999999999999864322100000 00
Q ss_pred ----------chhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 291 ----------DQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 291 ----------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.......+.+++..|+..+|.+|+++.++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~ 277 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPI 277 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 01123567889999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.14 Aligned_cols=244 Identities=19% Similarity=0.258 Sum_probs=190.4
Q ss_pred cCCccccC--CcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 77 DTNKLGEG--GFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 77 ~~~~lg~G--~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+++.||+| +|++||++.. .+|+.||+|.+... .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7889999985 56899999998643 2334566788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999998865332 23788999999999999999999998 999999999999999999999999865433211110
Q ss_pred -----cccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------ccc---------
Q 037681 232 -----ANTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SIN--------- 288 (334)
Q Consensus 232 -----~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~--------- 288 (334)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 01112346778999999875 4588999999999999999999999974321100 000
Q ss_pred ------------------------------------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 ------------------------------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ------------------------------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.........+.+++..||..+|.+|+++.++....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 000011235668999999999999999998876544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.05 Aligned_cols=245 Identities=25% Similarity=0.429 Sum_probs=196.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCC---EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGD---EIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~---~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|+..+.||+|+||.||+|... ++. .+++|.+... .....+.+..|++++++++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 57888899999999999999964 333 6899988654 344456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|..++.... ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999885533 34788999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCccc-cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--cc-----cccchhcccch
Q 037681 228 NESKAN-TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SI-----NGYDQTQVASK 298 (334)
Q Consensus 228 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~-----~~~~~~~~~~~ 298 (334)
...... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||........ .+ ...........
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 239 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV 239 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 221111 111223457999999988889999999999999999997 9999865432200 00 00111134567
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..|+..+|.+|+++.++...
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 899999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=282.63 Aligned_cols=244 Identities=27% Similarity=0.377 Sum_probs=192.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCC--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGD--EIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|+.++.++ +||||+++++++.+.+..|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 68899999999999999999964 444 3577766532 334456788899999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCce
Q 037681 148 YEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
|||+++++|..++..... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999998864321 234788999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--cccc--
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SING-- 289 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~~~-- 289 (334)
||+|||++...... .......++..|+|||.+.+..++.++||||||+++|||+| |..||........ ....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 99999998532111 11111234567999999988889999999999999999998 9999864432210 0000
Q ss_pred ---cchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 290 ---YDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 290 ---~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
........+.+++..|+..+|.+|+++.++...
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011134567789999999999999998876653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.30 Aligned_cols=240 Identities=21% Similarity=0.307 Sum_probs=182.1
Q ss_pred CccccCCcccEEEEEecC---CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCC
Q 037681 79 NKLGEGGFGPVYKGVLAK---GDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997433 3468888775432 333456788999999999999999999999999999999999999
Q ss_pred Chhhhhhhccc--ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 155 SLDFFLFDATK--RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 155 ~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+|.+++..... ....++.....++.||+.|++|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 123467778899999999999999998 9999999999999999999999999986533222111
Q ss_pred ccccccccCCccCcccccc-------CCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc----------ccc--cccch
Q 037681 233 NTNRVAGTFGYIPPEYVYQ-------GICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY----------LSI--NGYDQ 292 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~----------~~~--~~~~~ 292 (334)
......++..|+|||++.. ..++.++||||||+++|||++ |..||....+.. ..+ .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 1222345678999998642 356789999999999999999 788886543210 000 01111
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhc
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.......+++..|+ .+|.+|+++.++.+.
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 13334556777777 489999999888765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=274.95 Aligned_cols=232 Identities=23% Similarity=0.325 Sum_probs=183.8
Q ss_pred CccccCCcccEEEEEecC-------------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 79 NKLGEGGFGPVYKGVLAK-------------GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
+.||+|+||.||+|...+ ...+++|.+..........+..|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998432 2258888877655555667888999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc-------eEEee
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK-------PKISD 218 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-------~kl~D 218 (334)
+||||+++++|..++.... ..+++..++.++.||+.|++|||+.+ ++||||||+||+++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999988875432 34888999999999999999999988 999999999999986654 89999
Q ss_pred ccccccccCCCCccccccccccCCccCccccc-cCCCCcchhhHhHHHHHHHHH-hCCCCCCCccCCccc-c----cccc
Q 037681 219 FGMARIFKGNESKANTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEIL-SGKKNTEFYHTGYLS-I----NGYD 291 (334)
Q Consensus 219 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-~g~~p~~~~~~~~~~-~----~~~~ 291 (334)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......... + ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLV 229 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCC
Confidence 9998654221 2235788899999886 567889999999999999998 588887653321100 0 0011
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhh
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
......+.+++..|+..+|.+|+++.++..
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112345778999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=294.65 Aligned_cols=242 Identities=19% Similarity=0.192 Sum_probs=192.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..+|.+.+.||+|+||.||+|.+. .++.||+|.... ..+.+|++++++++||||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 347999999999999999999965 578899996432 3356899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+. ++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 96 57777664432 24899999999999999999999998 99999999999999999999999999976543322
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--cc------------------cccc-
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--YL------------------SING- 289 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~------------------~~~~- 289 (334)
........||..|+|||++.+..++.++|||||||++|||++|..|+...... .. .+..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22223456999999999999999999999999999999999987654221100 00 0000
Q ss_pred -------------------------cch--hcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 290 -------------------------YDQ--TQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 290 -------------------------~~~--~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
|.. .......+++..||..+|.+|++..++....+-
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 000 012356779999999999999999998877653
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=276.66 Aligned_cols=243 Identities=26% Similarity=0.416 Sum_probs=194.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCC----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGD----EIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.+|++.+.||+|+||.||+|.+. +|. .+|+|...... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 57888999999999999999854 333 58888876443 3445678899999999999999999999987 78899
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|+||+++|+|.+++..... .+++..+..++.|++.|++|||+++ ++|+||||+||+++.++.+||+|||.+....
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999998865432 3889999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--ccc-----cchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--ING-----YDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~~~-----~~~~~~~~~ 298 (334)
............++..|+|||.+.+..++.++|+||||+++||+++ |+.||+........ +.. ........+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 3322221222234568999999988889999999999999999998 99999765432100 000 011134567
Q ss_pred hhhccccccCCccchhhhhhhhh
Q 037681 299 IKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.+++..|+..+|..|+++.++..
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 78899999999999998877544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.68 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=196.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-C---CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-K---GDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.+|++.+.||+|+||.||+|.+. + +..+|+|.++... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999853 2 3368999886432 34456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999886543 24788999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCcc-ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--ccc-c----cchhcccch
Q 037681 228 NESKA-NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SIN-G----YDQTQVASK 298 (334)
Q Consensus 228 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~~-~----~~~~~~~~~ 298 (334)
..... ......++..|+|||.+.+..++.++|+||||+++||+++ |+.||........ .+. . ........+
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL 238 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHH
Confidence 22111 1111223567999999988889999999999999999886 9999876533210 000 0 001124467
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..|+..+|..|+++.++...
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 239 HQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred HHHHHHHcccCchhCCCHHHHHHH
Confidence 889999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.54 Aligned_cols=239 Identities=28% Similarity=0.382 Sum_probs=193.9
Q ss_pred CccccCCcccEEEEEecC--C--CEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLAK--G--DEIAVKRLSVRSR-QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+..|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998543 3 2689999876655 566788999999999999999999999988 888999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc-c
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK-A 232 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 232 (334)
++|..++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999998866442 35889999999999999999999998 999999999999999999999999999866432221 1
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--------cccccchhcccchhhhcc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--------SINGYDQTQVASKIKLVE 303 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~i~ 303 (334)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ............+.+++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence 1122456788999999988899999999999999999998 9999864432210 000011113456788999
Q ss_pred ccccCCccchhhhhhhhhc
Q 037681 304 SCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~ 322 (334)
.|+..+|.+|+++.++...
T Consensus 236 ~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 236 QCWAHNPADRPTFAALREF 254 (257)
T ss_pred HHCCCCcccCCCHHHHHHH
Confidence 9999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=278.50 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=197.6
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||+|++|.||+|.+. +|..+++|.+.... ......+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999964 68899999987543 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+ +++|..++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999998875543 34899999999999999999999998 99999999999999999999999999876543321
Q ss_pred ccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------------------------
Q 037681 231 KANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------------- 284 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------------- 284 (334)
.......|+..|+|||.+.+. .++.++||||+|+++|||++|++||.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 112234688999999988654 46889999999999999999988875432100
Q ss_pred -----------ccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 -----------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 -----------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+..........+.+++.+|+..+|.+|+++.++....+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 0000001112456778999999999999999998877654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=289.37 Aligned_cols=241 Identities=22% Similarity=0.263 Sum_probs=192.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec------C
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER------D 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 142 (334)
.++|++.+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999954 5889999998643 334456778899999999999999999987643 3
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..|+||||+++ +|...+.. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 46999999976 55555422 2678888999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------------
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------ 284 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------ 284 (334)
....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 7543221 1233568999999999999999999999999999999999999996432100
Q ss_pred -------------ccccccc-----------------hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 -------------LSINGYD-----------------QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 -------------~~~~~~~-----------------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+..+. ........+++..||..+|.+|+++.++....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 0000000 001234678999999999999999999887654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=274.83 Aligned_cols=245 Identities=23% Similarity=0.320 Sum_probs=193.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-----SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 144 (334)
++|++.+.||+|+||.||.|... ++..|++|.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999964 5889999987532 123456788899999999999999999998764 457
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999998885433 3788888999999999999999998 99999999999999999999999999875
Q ss_pred ccCCCC-ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cc-cccchhcc
Q 037681 225 FKGNES-KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SI-NGYDQTQV 295 (334)
Q Consensus 225 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~-~~~~~~~~ 295 (334)
...... ........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS 235 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhC
Confidence 432111 1112234588899999999888899999999999999999999999975432210 00 00011123
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
....+++..|+. +|.+|+++.++....+
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 446678888884 7899999988876554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=282.14 Aligned_cols=243 Identities=22% Similarity=0.339 Sum_probs=198.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+.|.....||+|+||.||++... ++..+|+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34555678999999999999854 68899999987665556677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++... .+++..+..++.||+.|+.|||+++ ++||||||+||+++.++.++|+|||++........
T Consensus 102 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 102 EGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 999998887432 3788899999999999999999998 99999999999999999999999999875433222
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------cccc---cchhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------SING---YDQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~---~~~~~~~~~~~~i 302 (334)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||........ .+.. ........+.+++
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 12335688999999999888899999999999999999999999865332110 0000 0011244577889
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..|+..+|.+|+++.++....+
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred HHHccCChhHCcCHHHHhhChh
Confidence 9999999999999998887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=283.50 Aligned_cols=235 Identities=27% Similarity=0.383 Sum_probs=198.6
Q ss_pred hcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.+.|..-+.||+||||.|+-+. ..+|..+|.|.+... .+........|..+|.+++.+.||.+-..|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 4578888999999999999998 457999999987533 233344567899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
+..|.||+|..++.+..+ ..++++.+.-++.+|+.||++||+.. ||+||+||+|||+|+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987765 34899999999999999999999988 99999999999999999999999999988765
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--ccccc--------ccchhcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--YLSIN--------GYDQTQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~~--------~~~~~~~~~ 297 (334)
+.. ....+||.+|||||++.++.|+...|.|||||++|||+.|+.||..+..- ...+. .+....++.
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE 416 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence 543 23347999999999999999999999999999999999999999876432 11111 122225667
Q ss_pred hhhhccccccCCccch
Q 037681 298 KIKLVESCLARPFRQY 313 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~ 313 (334)
..++++..|.++|.+|
T Consensus 417 akslc~~LL~Kdp~~R 432 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKR 432 (591)
T ss_pred HHHHHHHHHccCHHHh
Confidence 7888888999999887
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=275.72 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=196.8
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC----------hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS----------RQGLQELKNEALVIAKVQHKNLVRLLGCCIERD 142 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 142 (334)
+|.+.+.||.|+||.||+|... +|+.+|+|.+.... ....+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 68899999875321 112346788999999999999999999999999
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988654 34888999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccCccccccCC--CCcchhhHhHHHHHHHHHhCCCCCCCccCC-----------cccccc
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGI--CSIKSDVFSFGMLLLEILSGKKNTEFYHTG-----------YLSING 289 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~-----------~~~~~~ 289 (334)
................|+..|+|||.+.+.. ++.++|+||||+++|++++|..||...... ...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 7643322222223356888999999987654 788999999999999999999998643221 001110
Q ss_pred -cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 -YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 -~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
........+.+++..|+..+|..|+++.++.+..+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 11113456888999999999999999998876653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=271.55 Aligned_cols=238 Identities=29% Similarity=0.408 Sum_probs=192.3
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCChh
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR-QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLD 157 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 157 (334)
+.||+|+||.||++...+++.+++|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999976699999998865433 35567889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccc
Q 037681 158 FFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV 237 (334)
Q Consensus 158 ~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 237 (334)
.++.... ..+++..+..++.+++.|+.|||+++ ++||||+|+||+++.++.++|+|||.+...............
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 8885432 24788889999999999999999998 999999999999999999999999998754322211111222
Q ss_pred cccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc--cccc-----ccchhcccchhhhccccccCC
Q 037681 238 AGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY--LSIN-----GYDQTQVASKIKLVESCLARP 309 (334)
Q Consensus 238 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~--~~~~-----~~~~~~~~~~~~~i~~~l~~~ 309 (334)
.++..|+|||.+.++.++.++|+||||+++|+|++ |..||....... .... .........+.+++..|+..+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 235 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYD 235 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccC
Confidence 34567999999988889999999999999999999 888886543221 0000 001113457888999999999
Q ss_pred ccchhhhhhhhh
Q 037681 310 FRQYCCILKVRT 321 (334)
Q Consensus 310 ~~~~~~~~~~~~ 321 (334)
|.+|+++.++..
T Consensus 236 p~~Rp~~~ell~ 247 (251)
T cd05041 236 PENRPSFSEIYN 247 (251)
T ss_pred hhhCcCHHHHHH
Confidence 999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=272.97 Aligned_cols=240 Identities=28% Similarity=0.411 Sum_probs=199.1
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.++|++.+.||.|+||.||+|... |+.+|+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 368899999999999999999875 88999999975544 5677889999999999999999999999888999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++..... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999998865432 24899999999999999999999998 99999999999999999999999999976532211
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc------ccc-ccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL------SIN-GYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~------~~~-~~~~~~~~~~~~~i~ 303 (334)
...++..|+|||.+.+..++.++|+||||+++|++++ |+.||........ ... .........+.+++.
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHH
Confidence 2234567999999988889999999999999999997 9999865532210 000 011123567889999
Q ss_pred ccccCCccchhhhhhhhhc
Q 037681 304 SCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~ 322 (334)
.|+..+|.+|+++.++...
T Consensus 234 ~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 234 DCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHhccChhhCcCHHHHHHH
Confidence 9999999999999887654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=279.74 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=198.5
Q ss_pred hhHHHHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEE---
Q 037681 65 FSSVAAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCI--- 139 (334)
Q Consensus 65 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~--- 139 (334)
++.+..+.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445566789999999999999999999854 57889999876432 2235677899999999 6999999999874
Q ss_pred --ecCcceEEEEecCCCChhhhhhhc-ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 140 --ERDEKLLIYEYLPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 140 --~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
.++..++||||+++++|..++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345679999999999998877532 22345788899999999999999999988 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccCcccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--ccc
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-----GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--ING 289 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~ 289 (334)
+|||++........ ......|+..|+|||.+.. ..++.++||||+||++|||++|+.||......... ...
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 99999876543221 1223468999999998753 44788999999999999999999998765432110 000
Q ss_pred cc-------hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 290 YD-------QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 290 ~~-------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.. ......+.+++.+|+..+|.+|+++.++....
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00234578899999999999999998877643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=272.75 Aligned_cols=242 Identities=29% Similarity=0.387 Sum_probs=191.7
Q ss_pred CccccCCcccEEEEEecC----CCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLAK----GDEIAVKRLSVRSR-QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|.+.. +..+|+|.+..... ...+.+..|+.+++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998432 26799998874433 34567889999999999999999999876 4567999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc-
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA- 232 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 232 (334)
++|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||.+..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999986544 4889999999999999999999988 9999999999999999999999999987654332211
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--cc-----cccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SI-----NGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~-----~~~~~~~~~~~~~~i~~ 304 (334)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ..........+.+++..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1111223567999999988899999999999999999998 9999976543210 00 00111134567899999
Q ss_pred cccCCccchhhhhhhhhccCCcc
Q 037681 305 CLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
|+..+|.+|+++.++...-...+
T Consensus 234 cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 234 CWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HhcCChhhCcCHHHHHHHHHhcc
Confidence 99999999999999877654443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=277.63 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=193.5
Q ss_pred cCCCcCCccccCCcccEEEEEe-----cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 144 (334)
..|++++.||+|+||.||.+.. .++..||+|.+.... ......+.+|+.++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999973 347789999986443 44456789999999999999999999998875 567
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||+++++|..++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999885432 24789999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC----------cccc------
Q 037681 225 FKGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG----------YLSI------ 287 (334)
Q Consensus 225 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----------~~~~------ 287 (334)
....... .......++..|+|||.+.+..++.++||||||+++|||++++.|....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5433221 1122345677899999998888999999999999999999987764321100 0000
Q ss_pred ------cccchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 288 ------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 288 ------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
..........+.+++..|+..+|.+|+++.++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0001113456889999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=273.73 Aligned_cols=240 Identities=25% Similarity=0.327 Sum_probs=184.7
Q ss_pred CccccCCcccEEEEEecC---CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCC
Q 037681 79 NKLGEGGFGPVYKGVLAK---GDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
+.||+|+||.||+|...+ +..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998543 4578999886443 233356888999999999999999999999999999999999999
Q ss_pred Chhhhhhhccc--ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 155 SLDFFLFDATK--RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 155 ~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+|.+++..... ....++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99998865332 224567778889999999999999998 9999999999999999999999999986543322222
Q ss_pred ccccccccCCccCccccccC-------CCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-c------cccc-----h
Q 037681 233 NTNRVAGTFGYIPPEYVYQG-------ICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-I------NGYD-----Q 292 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-~------~~~~-----~ 292 (334)
......++..|+|||++.+. .++.++|+||||+++|||++ |+.||+........ . .... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 22234577889999988542 35789999999999999996 99999765432110 0 0000 0
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhc
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.......+++..|+ .+|.+|+++.++...
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~ 266 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLL 266 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence 12334566888898 579999999987654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=273.37 Aligned_cols=244 Identities=26% Similarity=0.395 Sum_probs=197.7
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.++|++.+.||+|+||.||++...++..+++|.+... ....+.+.+|+.++++++|+||+++.+.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4689999999999999999999777788999987643 3345678899999999999999999999887 7789999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999886533 334788889999999999999999988 999999999999999999999999998765432221
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc------ccc-ccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL------SIN-GYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~------~~~-~~~~~~~~~~~~~i~ 303 (334)
......++..|+|||.+.+..++.++|+||||+++|++++ |+.||........ ... .........+.+++.
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 1122345677999999988889999999999999999999 9999875433210 000 011123456888999
Q ss_pred ccccCCccchhhhhhhhhc
Q 037681 304 SCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~ 322 (334)
.|+..+|.+|+++.++.+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~ 256 (260)
T cd05073 238 RCWKNRPEERPTFEYIQSV 256 (260)
T ss_pred HHcccCcccCcCHHHHHHH
Confidence 9999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=273.17 Aligned_cols=244 Identities=24% Similarity=0.317 Sum_probs=199.3
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||+|+||.+|.+.. .+|+.+++|.+... .......+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999995 46889999988643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++.... ...+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999988875432 224788899999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccccchhcccchhhhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGYDQTQVASKIKLVE 303 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~ 303 (334)
......|++.|+|||.+.+...+.++|+||||+++++|++|+.||........ ............+.+++.
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence 12234578899999999888899999999999999999999999865432110 000011113456788999
Q ss_pred ccccCCccchhhhhhhhhcc
Q 037681 304 SCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~ 323 (334)
.|+..+|.+|+++.++....
T Consensus 235 ~~l~~~p~~Rp~~~~vl~~~ 254 (256)
T cd08218 235 QLFKRNPRDRPSVNSILEKN 254 (256)
T ss_pred HHhhCChhhCcCHHHHhhCc
Confidence 99999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=319.50 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=204.3
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
+-+++....||.|.||.||-|.+ .+|...|+|.++.. .......+.+|..++..++|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34667788999999999999994 56888999988633 3445567789999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
|||++|+|.+.+...+. .++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++|||.|..+.++
T Consensus 1314 EyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999865443 666677788999999999999999 999999999999999999999999999877655
Q ss_pred CC--ccccccccccCCccCccccccC---CCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--------ccchhcc
Q 037681 229 ES--KANTNRVAGTFGYIPPEYVYQG---ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--------GYDQTQV 295 (334)
Q Consensus 229 ~~--~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--------~~~~~~~ 295 (334)
.. ........||+.|||||++.+. .-..++||||+|||..||+||++||..++.++.-+. +..+..+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls 1467 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLS 1467 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhh
Confidence 31 2233456799999999999754 356789999999999999999999987766532221 2222255
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..-.++++.||..+|++|....++++..+
T Consensus 1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred HhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 66788999999999999988878877655
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=283.45 Aligned_cols=247 Identities=25% Similarity=0.349 Sum_probs=195.3
Q ss_pred cCCCcCCccccCCcccEEEEEecC--------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK--------GDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERD 142 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 142 (334)
.+|++.+.||+|+||.||+|.... +..+|+|.+... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 578999999999999999997421 236899987643 334467788999999999 7999999999999999
Q ss_pred cceEEEEecCCCChhhhhhhcc-------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC
Q 037681 143 EKLLIYEYLPNKSLDFFLFDAT-------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD 209 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~ 209 (334)
..++++||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999886532 1224778888999999999999999998 99999999999999
Q ss_pred CCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--c
Q 037681 210 KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--S 286 (334)
Q Consensus 210 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~ 286 (334)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........ .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999876543222212222334567999999999999999999999999999998 8888865432210 0
Q ss_pred cc-----ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 287 IN-----GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 287 ~~-----~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+. .........+.+++..|+..+|.+|+++.++...
T Consensus 249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 00 0011134467789999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=278.37 Aligned_cols=243 Identities=24% Similarity=0.396 Sum_probs=201.2
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
++|.+.+.||+|+||.||++.. .+++.+++|.+........+.+..|+.++++++||||+++++.+...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6899999999999999999985 468899999987555555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|..++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999888542 2678889999999999999999998 99999999999999999999999998875543222
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc-------c--chhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING-------Y--DQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~-------~--~~~~~~~~~~~i 302 (334)
......|++.|+|||.+.+..++.++|+||||+++|++++|+.||............ . .......+.+++
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 122346888999999998888999999999999999999999999754332110000 0 001234577899
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..|+..+|.+|+++.++....+
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred HHHccCChhhCcCHHHHhcCHH
Confidence 9999999999999988877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=278.93 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=195.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||++.+. +++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999965 57899999886443 233457788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|..++.... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999985543 4788999999999999999999988 999999999999999999999999988632110
Q ss_pred CC-------------ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------c
Q 037681 229 ES-------------KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------S 286 (334)
Q Consensus 229 ~~-------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~ 286 (334)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 00 0011124578899999999888899999999999999999999999864332210 0
Q ss_pred ccccchhcccchhhhccccccCCccchhh---hhhhhhccC
Q 037681 287 INGYDQTQVASKIKLVESCLARPFRQYCC---ILKVRTFGF 324 (334)
Q Consensus 287 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~---~~~~~~~~~ 324 (334)
...........+.+++.+|+..+|.+|++ +.++....+
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 00000113455788999999999999987 455555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=272.15 Aligned_cols=245 Identities=27% Similarity=0.468 Sum_probs=200.2
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR--QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||+|+||.||+|... +++.+++|.+..... .....+..|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999854 688999999875543 3677889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999885432 3788889999999999999999998 99999999999999999999999999876543322
Q ss_pred ccc--cccccccCCccCccccccCC---CCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--------ccccchh--cc
Q 037681 231 KAN--TNRVAGTFGYIPPEYVYQGI---CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--------INGYDQT--QV 295 (334)
Q Consensus 231 ~~~--~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--------~~~~~~~--~~ 295 (334)
... .....++..|+|||.+.+.. .+.++||||||+++|++++|+.||......... ....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence 111 12346788999999988766 889999999999999999999999754322100 0000111 24
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++..|+..+|.+|+++.++....+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 56788999999999999999988776543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=273.49 Aligned_cols=244 Identities=22% Similarity=0.353 Sum_probs=197.7
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS------RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
+|+..+.||+|++|.||+|.. .+++.+|+|.+.... ....+.+..|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999985 568999999886432 2235678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeeccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARIF 225 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~ 225 (334)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999885433 4788999999999999999999998 99999999999998775 5999999998765
Q ss_pred cCCCCc--cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc-----------cccch
Q 037681 226 KGNESK--ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI-----------NGYDQ 292 (334)
Q Consensus 226 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-----------~~~~~ 292 (334)
...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch
Confidence 433111 11223467889999999988889999999999999999999999986443211000 00011
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.....+.+++..|+..+|.+|++..++....
T Consensus 235 ~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~ 265 (268)
T cd06630 235 HLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265 (268)
T ss_pred hhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence 1345677899999999999999998887654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.87 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=198.8
Q ss_pred hHHHHhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEe---
Q 037681 66 SSVAAATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIE--- 140 (334)
Q Consensus 66 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--- 140 (334)
.++..+.+.|++.+.||.|+||.||+|.+ .+++.+|+|.+.... .....+..|+.++.++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 33444557899999999999999999996 468899999886443 3345678899999998 79999999999853
Q ss_pred ---cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 141 ---RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 141 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
....|++|||+++++|..++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 346799999999999998886533 234778888999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc----
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN---- 288 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~---- 288 (334)
|||++........ ......|+..|+|||.+. +..++.++|+||||+++|||++|+.||....+......
T Consensus 164 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 241 (282)
T cd06636 164 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 241 (282)
T ss_pred eCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC
Confidence 9999875432211 123356889999999875 34577899999999999999999999976543211110
Q ss_pred ---ccch-hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 ---GYDQ-TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ---~~~~-~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.... .....+.+++..|+..+|.+|++..++....+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 0000 13456789999999999999999988876543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=272.76 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=200.3
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe--cCcceEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE--RDEKLLIY 148 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 148 (334)
+|++.+.||.|+||.||++.+ .+++.+|+|.+... .....+.+..|+.++++++||||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 578889999999999999985 46889999988633 34445678889999999999999999998764 34578999
Q ss_pred EecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhh-----hcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 149 EYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLH-----LHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
||+++++|..++.... ....+++..++.++.||+.||.||| +.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999998886532 2345889999999999999999999 666 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------cccccccchhcc
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG-------YLSINGYDQTQV 295 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~~~ 295 (334)
........ ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...... ............
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS 235 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccC
Confidence 86543322 122346899999999998888999999999999999999999999765321 011111122245
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++..|+..+|.+|+++.++.+.++
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~ 264 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPL 264 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence 66888999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=272.32 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=204.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR-QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|++|.||+|... +++.+++|.+..... .....+.+|+..+.+++|||++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999965 589999999875543 4567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|.+++... ..+++..++.++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998654 348999999999999999999999 88 9999999999999999999999999987654332
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccC-C---------cccccccchh-cccch
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT-G---------YLSINGYDQT-QVASK 298 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-~---------~~~~~~~~~~-~~~~~ 298 (334)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... . .......... ....+
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 21 1234678899999999888899999999999999999999999976641 0 0011111122 34568
Q ss_pred hhhccccccCCccchhhhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+++..|+..+|..|+++.++....+
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHH
Confidence 88999999999999999998877654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=281.63 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=200.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR---QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|+..+.||+|++|.||+|... +++.+|+|.+..... ...+.+..|+++++.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999965 489999999865432 34567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999886432 345889999999999999999999998 999999999999999999999999998654321
Q ss_pred CCc---------------------------cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCcc
Q 037681 229 ESK---------------------------ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYH 281 (334)
Q Consensus 229 ~~~---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 281 (334)
... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123457889999999998889999999999999999999999996543
Q ss_pred CCcccc--c----ccchh--cccchhhhccccccCCccchhh----hhhhhhccC
Q 037681 282 TGYLSI--N----GYDQT--QVASKIKLVESCLARPFRQYCC----ILKVRTFGF 324 (334)
Q Consensus 282 ~~~~~~--~----~~~~~--~~~~~~~~i~~~l~~~~~~~~~----~~~~~~~~~ 324 (334)
...... . .+... ....+.+++..|+..+|..|++ +.++....+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 221000 0 00111 3566899999999999999999 777776543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=272.00 Aligned_cols=242 Identities=27% Similarity=0.418 Sum_probs=196.3
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+..|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 57888899999999999999977788899998864322 23568889999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999998885433 24788899999999999999999998 9999999999999999999999999987543322111
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--c----cccc-chhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--S----INGY-DQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~----~~~~-~~~~~~~~~~~i~~ 304 (334)
.....++..|+|||.+.++.++.++|+||||+++|||++ |+.||........ . .... .......+.+++..
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 112234678999999988889999999999999999998 9999875432210 0 0000 11135568889999
Q ss_pred cccCCccchhhhhhhhh
Q 037681 305 CLARPFRQYCCILKVRT 321 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~ 321 (334)
|+..+|.+|+++.++.+
T Consensus 237 ~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 237 CWKERPEDRPSFSLLLH 253 (256)
T ss_pred HcccChhhCCCHHHHHH
Confidence 99999999999988765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=274.32 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=201.2
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+-|+..+.||.|+||.||+|.. .++..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4577788999999999999985 468899999876432 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999988743 23789999999999999999999988 99999999999999999999999999875533221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccccchhcccchhhhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGYDQTQVASKIKLVE 303 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~ 303 (334)
......++..|+|||.+.+...+.++|+||||+++|+|++|..||........ ............+.+++.
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 234 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence 12234578899999999888889999999999999999999999976543210 000111123456888999
Q ss_pred ccccCCccchhhhhhhhhccCCcc
Q 037681 304 SCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
.|+..+|.+|+++.++....+-..
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhh
Confidence 999999999999999888665443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=270.32 Aligned_cols=243 Identities=30% Similarity=0.441 Sum_probs=196.6
Q ss_pred CCcCCccccCCcccEEEEEecC-----CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 75 FSDTNKLGEGGFGPVYKGVLAK-----GDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
+++.+.||.|+||.||++.+.. +..+|+|.+...... ..+.+..|+..+..++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999653 378999998655433 5678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++...... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999888653321 1789999999999999999999998 999999999999999999999999999765443
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------ccccccchhcccchhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------LSINGYDQTQVASKIK 300 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~ 300 (334)
...... ...+++.|+|||.+.+..++.++|+||+|+++++|++ |++||....... .............+.+
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 221111 2236789999999988889999999999999999998 888887543220 0000011114556888
Q ss_pred hccccccCCccchhhhhhhhhc
Q 037681 301 LVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
++..|+..+|.+|+++.++...
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhh
Confidence 9999999999999999887653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=276.55 Aligned_cols=242 Identities=23% Similarity=0.352 Sum_probs=198.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|+||+||++... +|+.+|+|.+.... ....+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 67889999999999999999954 58889999876442 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|..++... ..+++..+..++.+++.|+.|||+ ++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999998887543 247899999999999999999997 46 9999999999999999999999999986542221
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------c---c-cccc--------c
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------L---S-INGY--------D 291 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~---~-~~~~--------~ 291 (334)
.....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||....... . . +... .
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234 (284)
T ss_pred ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence 223568999999999988889999999999999999999999997543310 0 0 0000 0
Q ss_pred hh-cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 292 QT-QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 292 ~~-~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.. ....+.+++..|+..+|.+|+++.++....+
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00 2335778999999999999999999887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=276.03 Aligned_cols=241 Identities=25% Similarity=0.314 Sum_probs=200.1
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
+|++.+.||.|+||.||+|... +++.+|+|.+... .....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999965 5899999998643 22456788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+.+++|..++... ..+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999888554 34889999999999999999999998 9999999999999999999999999987654322
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--cc-------cccccchhcccchhh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--YL-------SINGYDQTQVASKIK 300 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~-------~~~~~~~~~~~~~~~ 300 (334)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .. ............+.+
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHH
Confidence 123356788999999998888999999999999999999999999865431 00 000111113567889
Q ss_pred hccccccCCccchhhh--hhhhhcc
Q 037681 301 LVESCLARPFRQYCCI--LKVRTFG 323 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~--~~~~~~~ 323 (334)
++..|+..+|.+|.+. .++....
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l~~~~ 256 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDLKNHP 256 (258)
T ss_pred HHHHHccCChhHcCCccHHHHhcCC
Confidence 9999999999999988 6665543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.49 Aligned_cols=238 Identities=27% Similarity=0.385 Sum_probs=199.8
Q ss_pred ccccCCcccEEEEEecC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCChhh
Q 037681 80 KLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDF 158 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 158 (334)
.||+|.||+||.|++.+ ...+|||.+..++....+-+..|+.+.++|+|.|||+++|++.+++..-+.||..+||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999665 44689999988877778889999999999999999999999999998899999999999999
Q ss_pred hhhhccccccc--chHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeeccccccccCCCCccccc
Q 037681 159 FLFDATKRVLL--ELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFGMARIFKGNESKANTN 235 (334)
Q Consensus 159 ~l~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 235 (334)
+++.. .+++ ++.+.-.+..||++||.|||++. |||||||-+|||++. .|.+||+|||.++.+..-. ..+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence 99654 3445 78888899999999999999998 999999999999964 6899999999998765333 3355
Q ss_pred cccccCCccCccccccC--CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-----cc----ccccchhcccchhhhccc
Q 037681 236 RVAGTFGYIPPEYVYQG--ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-----LS----INGYDQTQVASKIKLVES 304 (334)
Q Consensus 236 ~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~----~~~~~~~~~~~~~~~i~~ 304 (334)
++.||..|||||++..+ .|+.++|||||||++.||.||++||-....+. .. ........+.....+|-+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 68899999999999865 48899999999999999999999997665541 11 111222356667789999
Q ss_pred cccCCccchhhhhhhhhccC
Q 037681 305 CLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~~~ 324 (334)
|+..+|..|++...+..=.|
T Consensus 815 cFepd~~~R~sA~~LL~DpF 834 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPF 834 (1226)
T ss_pred HcCCCcccCccHHHhccCcc
Confidence 99999999999887765444
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=274.66 Aligned_cols=231 Identities=22% Similarity=0.301 Sum_probs=182.0
Q ss_pred ccccCCcccEEEEEecC-------------------------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceE
Q 037681 80 KLGEGGFGPVYKGVLAK-------------------------GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRL 134 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 134 (334)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 12478888865555555678889999999999999999
Q ss_pred eeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC--
Q 037681 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-- 212 (334)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-- 212 (334)
++++.+....++||||+++++|..++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999998885432 24788889999999999999999988 99999999999997543
Q ss_pred -----ceEEeeccccccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHH-hCCCCCCCccCCcc
Q 037681 213 -----KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEIL-SGKKNTEFYHTGYL 285 (334)
Q Consensus 213 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-~g~~p~~~~~~~~~ 285 (334)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999987543211 12346788999998865 56889999999999999995 69999875433211
Q ss_pred -cccc----cchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 286 -SING----YDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 286 -~~~~----~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.... ........+.+++..|+..+|.+|+++.++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 231 ERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred HHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 0000 01112345788999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=274.11 Aligned_cols=242 Identities=22% Similarity=0.331 Sum_probs=199.6
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455567999999999999985 4688999998876555556678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++.. ..+++..+..++.|++.|++|||+++ ++||||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999988755 23788899999999999999999998 99999999999999999999999998865433221
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccccchhcccchhhhcc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSINGYDQTQVASKIKLVE 303 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~i~ 303 (334)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... .............+.+++.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence 1223458899999999988889999999999999999999999986532210 0000011113456889999
Q ss_pred ccccCCccchhhhhhhhhccC
Q 037681 304 SCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.|+..+|.+|+++.++....+
T Consensus 251 ~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 251 RMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred HHcccChhhCcCHHHHccCcc
Confidence 999999999999999887666
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.14 Aligned_cols=237 Identities=24% Similarity=0.395 Sum_probs=194.0
Q ss_pred CCccccCCcccEEEEEec-CCCEEEEEEec----ccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc--ceEEEEe
Q 037681 78 TNKLGEGGFGPVYKGVLA-KGDEIAVKRLS----VRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE--KLLIYEY 150 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~ 150 (334)
...||+|+|-+||+|.+. +|-.||--.++ .......+++..|+.+|+.|+||||+++++++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999964 47777754333 2345567899999999999999999999999988766 6689999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 229 (334)
+..|+|..|+++.+. .+.+.+..|+.||+.||.|||++ .+||+|||||.+||+|+.+ |.|||+|+|+|.......
T Consensus 125 ~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999977765 78889999999999999999999 5679999999999999765 899999999999765443
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc---------chhcccchhh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY---------DQTQVASKIK 300 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~ 300 (334)
. ....|||.|||||... ..|...+||||||++++||.|+..||..-..+..-+.+. .........+
T Consensus 201 a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~ 275 (632)
T KOG0584|consen 201 A----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVRE 275 (632)
T ss_pred c----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHH
Confidence 3 2268999999999764 889999999999999999999999997655442222211 1115667889
Q ss_pred hccccccCCccchhhhhhhhhccC
Q 037681 301 LVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+|++|+.- .+.|.+..++..-.|
T Consensus 276 fIekCl~~-~~~R~sa~eLL~d~F 298 (632)
T KOG0584|consen 276 FIEKCLAT-KSERLSAKELLKDPF 298 (632)
T ss_pred HHHHHhcC-chhccCHHHHhhChh
Confidence 99999977 888888887765544
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=273.53 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=198.3
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecC------
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERD------ 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------ 142 (334)
++++|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4589999999999999999999964 578899998875543 346788999999999 7999999999997654
Q ss_pred cceEEEEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 3799999999999988875432 2345889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCcccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------ccc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQ-----GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------ING 289 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~~ 289 (334)
+........ ......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||......... ...
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 876543221 1233468899999998753 34678899999999999999999999754322100 000
Q ss_pred c--chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 Y--DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 ~--~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. .......+.+++..|+..+|.+|+++.++....+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 0 0112346788999999999999999998876543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=276.28 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=197.6
Q ss_pred hHHHHhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecC-
Q 037681 66 SSVAAATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERD- 142 (334)
Q Consensus 66 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~- 142 (334)
.++..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...+
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 33444568999999999999999999996 468899999886432 2235677899999998 7999999999987543
Q ss_pred ----cceEEEEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 143 ----EKLLIYEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 143 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 5799999999999988875322 2335789999999999999999999988 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccCccccccC-----CCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--cc--
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG-----ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--IN-- 288 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~-- 288 (334)
|||++......... .....|+..|+|||.+... .++.++|+||||+++|||++|+.||......... ..
T Consensus 171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 99998765422211 2234578899999987543 3678999999999999999999998765432100 00
Q ss_pred ---cc--chhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 289 ---GY--DQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 289 ---~~--~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.. .......+.+++..|+..+|..|+++.++....
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 00 011233577899999999999999999887654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=286.14 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=204.5
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
...|.+.+.||+|.|+.|.+|.+ .++..||||.+... +......+.+|+++|+.++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 36799999999999999999994 46999999999754 3334456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+.+|.+.+++..+.. +.+..+..++.|+..|++|||+++ |||||||++||+++.+.++||+|||++..+..+
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999976654 666888999999999999999999 999999999999999999999999999987643
Q ss_pred CCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCccc----ccccchh--cccchhhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS----INGYDQT--QVASKIKL 301 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~----~~~~~~~--~~~~~~~~ 301 (334)
. .....+|++.|.|||++.+..+ ++++|+||+|+++|.|+.|..||+...-..+. ...+... ......++
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence 3 3456799999999999988765 67999999999999999999999865432111 1111111 46667788
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++.|--+|.+|.++.++-..++
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcc
Confidence 88888889999988877665443
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=270.12 Aligned_cols=244 Identities=26% Similarity=0.360 Sum_probs=199.6
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|+..+.||+|++|.||++... +++.+|+|.+... .......+..|+.++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999854 6888999988643 334467788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|.+++.... ...+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999886533 234788999999999999999999998 9999999999999855 458999999997654322
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------ccccchhcccchhhhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------INGYDQTQVASKIKLV 302 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~i 302 (334)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||+........ ...........+.+++
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLI 233 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHH
Confidence 1 22346788999999998888899999999999999999999999765432110 0111111345688899
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..|+..+|..|+++.++....+
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~ 255 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPI 255 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCC
Confidence 9999999999999998876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.68 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=191.2
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
+++|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++.+++...+..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 478999999999999999999854 68899999986443 2223466789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|++ +++..++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 56655554322 23677888889999999999999998 9999999999999999999999999987543221
Q ss_pred CccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc---------------------c
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---------------------I 287 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---------------------~ 287 (334)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||+...+.... +
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1 12234578899999988754 5788999999999999999999999754321000 0
Q ss_pred cccc------------------hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 288 NGYD------------------QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 288 ~~~~------------------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
..+. ......+.+++..|+..+|..|+++.++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~ 289 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP 289 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence 0000 00234567899999999999999998876654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.62 Aligned_cols=243 Identities=22% Similarity=0.327 Sum_probs=192.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR-QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 68999999999999999999965 688999999864322 2234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++ +|..++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 88887754332 4788999999999999999999998 99999999999999999999999999865322111
Q ss_pred ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------------cc-------
Q 037681 231 KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------------SI------- 287 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------------~~------- 287 (334)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ .+
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1122346788999998865 4578899999999999999999999965431000 00
Q ss_pred -------ccc--------chhc--ccchhhhccccccCCccchhhhhhhhhcc
Q 037681 288 -------NGY--------DQTQ--VASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 288 -------~~~--------~~~~--~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
... .... .....+++..|+..+|..|+++.++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~ 289 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence 000 0001 14556899999999999999998877654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=283.09 Aligned_cols=240 Identities=22% Similarity=0.257 Sum_probs=187.7
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
....+|++.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++...+..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34468999999999999999999965 5778999975322 2346899999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
|++.+ +|..++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 137 e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYSS-DLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccCC-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99964 6766664432 34889999999999999999999998 999999999999999999999999998743221
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCC-CCccCC----------------------cc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNT-EFYHTG----------------------YL 285 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~-~~~~~~----------------------~~ 285 (334)
.......||..|+|||++.+..++.++|||||||++|||+++..|+ ...... ..
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 1122356899999999999999999999999999999999865544 221100 00
Q ss_pred ccc-----------------------cc--c--hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 SIN-----------------------GY--D--QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ~~~-----------------------~~--~--~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+. .+ . ........+++.+||..+|.+|+++.++.+..+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 000 00 0 001223445889999999999999999887754
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=279.59 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=193.2
Q ss_pred CCCcCCccccCCcccEEEEEec---CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccce
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA---KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKL 145 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 145 (334)
+|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999987532 34456678899999999999999999999988 7789
Q ss_pred EEEEecCCCChhhhhhhcc--cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC----CCceEEeec
Q 037681 146 LIYEYLPNKSLDFFLFDAT--KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK----EMKPKISDF 219 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~Df 219 (334)
+||||+++ ++..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 4555443222 1235889999999999999999999998 999999999999999 899999999
Q ss_pred cccccccCCCC-ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------------
Q 037681 220 GMARIFKGNES-KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------ 285 (334)
Q Consensus 220 g~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------ 285 (334)
|++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|++||........
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876543322 112233467889999998765 4578999999999999999999999975433210
Q ss_pred -----------------cccccch-----------------------hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 -----------------SINGYDQ-----------------------TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 -----------------~~~~~~~-----------------------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+..+.. .......+++..|+..+|.+|+++.++....+
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 0000000 12335678899999999999999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=270.73 Aligned_cols=238 Identities=27% Similarity=0.401 Sum_probs=192.7
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEE-ecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI-ERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~ 151 (334)
++|++.+.||+|+||.||++... |..+++|.+.... ..+.+.+|+.++++++|+|++++++++. ..+..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 58899999999999999999765 7889999885432 3467889999999999999999999764 456789999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999886543 234788999999999999999999998 9999999999999999999999999987543221
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--cc----c-ccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SI----N-GYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~----~-~~~~~~~~~~~~~i~ 303 (334)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ .+ . .........+.+++.
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 12334667999999988889999999999999999998 9999865422110 00 0 011113456788999
Q ss_pred ccccCCccchhhhhhhhhc
Q 037681 304 SCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~ 322 (334)
.|+..+|.+|+++.++...
T Consensus 234 ~~l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 234 QCWHLDAATRPSFLQLREQ 252 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 9999999999999887653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=276.88 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=192.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHH-HHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALV-IAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|+||.||+|.+. +|..||+|.++... ......+..|... ++.++||||+++++++...+..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999965 68999999886442 2223345556554 566789999999999999999999999
Q ss_pred ecCCCChhhhhhhc-ccccccchHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 150 YLPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLHLH-SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 150 ~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|++ ++|..++... .....+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 5777666442 2334689999999999999999999987 6 99999999999999999999999999876532
Q ss_pred CCCccccccccccCCccCcccccc----CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc--------c-chhc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQ----GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING--------Y-DQTQ 294 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--------~-~~~~ 294 (334)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........+.. . ....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 21 1122457889999998864 45688999999999999999999999754332111100 0 0113
Q ss_pred ccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
...+.+++..|+..+|.+|+++.++....+-.
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 265 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence 45678899999999999999999988766543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=278.10 Aligned_cols=242 Identities=21% Similarity=0.307 Sum_probs=190.6
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||+|+||.||+|.+. +|..+|+|.+.... ......+.+|+.++++++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999964 68899999886432 22335677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++ +|..++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 6666654322 34899999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------------------------
Q 037681 231 KANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------------------ 285 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------------------ 285 (334)
......++..|+|||.+.+. .++.++||||||+++|+|++|..|+....+...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 12234578899999988764 478999999999999999999988532211000
Q ss_pred ---cccc---------cchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 286 ---SING---------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 286 ---~~~~---------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.... ..........+++..||..+|.+|+++.++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 0000 0011234567899999999999999998887643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=295.37 Aligned_cols=242 Identities=21% Similarity=0.213 Sum_probs=186.2
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCC------CCcceEeeEEEec-C
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH------KNLVRLLGCCIER-D 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~-~ 142 (334)
..++|++.+.||+|+||+||+|.+. +++.||||+++... ........|+.++..++| ++++++++++... +
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 4578999999999999999999954 57889999986432 223445667777777654 4588899888765 4
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCC---------
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEM--------- 212 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~--------- 212 (334)
..++|||++ +++|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 678999987 567777765432 48899999999999999999997 47 99999999999998765
Q ss_pred -------ceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-
Q 037681 213 -------KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY- 284 (334)
Q Consensus 213 -------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~- 284 (334)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+......
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998753221 1234678999999999999999999999999999999999999997533210
Q ss_pred ----------c--cccc-------------------c---------ch-------hcccchhhhccccccCCccchhhhh
Q 037681 285 ----------L--SING-------------------Y---------DQ-------TQVASKIKLVESCLARPFRQYCCIL 317 (334)
Q Consensus 285 ----------~--~~~~-------------------~---------~~-------~~~~~~~~~i~~~l~~~~~~~~~~~ 317 (334)
. .+.. . .. .....+.+++..||..+|.+|+++.
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 0 0000 0 00 0123356899999999999999999
Q ss_pred hhhhccCC
Q 037681 318 KVRTFGFN 325 (334)
Q Consensus 318 ~~~~~~~~ 325 (334)
++....+-
T Consensus 434 e~L~Hp~~ 441 (467)
T PTZ00284 434 QMTTHPYV 441 (467)
T ss_pred HHhcCccc
Confidence 98886653
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=271.04 Aligned_cols=230 Identities=26% Similarity=0.416 Sum_probs=184.6
Q ss_pred CccccCCcccEEEEEecCCC-----------EEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 79 NKLGEGGFGPVYKGVLAKGD-----------EIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
+.||+|+||.||+|.+.... .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999975433 4777876544333 5778899999999999999999999988 778999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-------ceEEeecc
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-------KPKISDFG 220 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg 220 (334)
|||+++++|..++..... .+++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999998865442 4788899999999999999999988 99999999999999887 79999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccC--CCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-ccccc----cch
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQG--ICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-LSING----YDQ 292 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-~~~~~----~~~ 292 (334)
++..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..|+....... ..... ...
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 227 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM 227 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC
Confidence 9875432 1223467789999998776 78899999999999999999 577776653221 00000 011
Q ss_pred hcccchhhhccccccCCccchhhhhhhhh
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.....+.+++..|+..+|.+|+++.++..
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12357889999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=274.69 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=200.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|+..+.||.|++|.||++.+. +++.+++|.+.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888899999999999999965 68899999886543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999886543 348889999999999999999998 77 9999999999999999999999999986543221
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc------------cchh-ccc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING------------YDQT-QVA 296 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~------------~~~~-~~~ 296 (334)
. ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ .... ...
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 1 1156788999999998889999999999999999999999999754311110000 0000 244
Q ss_pred chhhhccccccCCccchhhhhhhhhccC
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.+++..|+..+|.+|+++.++....+
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 5788999999999999999998876654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=273.84 Aligned_cols=246 Identities=25% Similarity=0.325 Sum_probs=197.7
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
++|++.+.||+|+||.||+|... +.+.+++|.+...... ....+..|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 68899999999999999999854 2456889987654333 4577899999999999999999999999989999
Q ss_pred EEEEecCCCChhhhhhhcccc------cccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeec
Q 037681 146 LIYEYLPNKSLDFFLFDATKR------VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDF 219 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 219 (334)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999988654422 14899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------ccccc-c
Q 037681 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------LSING-Y 290 (334)
Q Consensus 220 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~~~~~-~ 290 (334)
|++....... ........++..|+|||.+.+...+.++||||||+++|+|++ |..||....... ..+.. .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 9986432221 112223356778999999988888999999999999999999 888886543321 00000 0
Q ss_pred chhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 291 DQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 291 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.......+.+++..|+..+|..|+++.++...
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 11234568899999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=277.51 Aligned_cols=243 Identities=26% Similarity=0.423 Sum_probs=191.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCC----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGD----EIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|+..+.||+|+||.||+|.+. +|. .+|+|.+.... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 67888999999999999999853 444 46888776432 23344678899999999999999999998754 4679
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
++||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999998875433 23788899999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-ccccc------cchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-LSING------YDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-~~~~~------~~~~~~~~~ 298 (334)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..+.. ........+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 3332222223345778999999988899999999999999999997 899986542210 00000 001123457
Q ss_pred hhhccccccCCccchhhhhhhhh
Q 037681 299 IKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.+++..|+..+|..|+++.++..
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 78899999999999999887554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=272.19 Aligned_cols=243 Identities=23% Similarity=0.331 Sum_probs=194.5
Q ss_pred cCCCcCCccccCCcccEEEEEecC----CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|.+.+.||+|+||.||+|...+ ...+++|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 578889999999999999998543 2468899886544 4556788999999999999999999998875 557899
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999986533 24789999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-----cccchhcccchh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-----NGYDQTQVASKI 299 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-----~~~~~~~~~~~~ 299 (334)
.... ......++..|+|||.+....++.++||||||+++||+++ |..||......... + ..........+.
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 3211 1112334568999999988889999999999999999996 99999765432110 0 000111345788
Q ss_pred hhccccccCCccchhhhhhhhhc
Q 037681 300 KLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+++..|+..+|..|+++.++...
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=271.29 Aligned_cols=238 Identities=27% Similarity=0.380 Sum_probs=186.8
Q ss_pred CccccCCcccEEEEEecC-CC--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLAK-GD--EIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|...+ +. .+++|.+... .......+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999653 43 4688877633 344556788999999999 799999999999999999999999999
Q ss_pred CChhhhhhhcc-------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecc
Q 037681 154 KSLDFFLFDAT-------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFG 220 (334)
Q Consensus 154 ~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 220 (334)
++|.+++.... ....+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999886432 1124788899999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc--cccc-----ccch
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY--LSIN-----GYDQ 292 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~--~~~~-----~~~~ 292 (334)
++...... ........+..|+|||.+.+..++.++|+||||+++|||++ |+.||....... .... ....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 98532111 11111233567999999988889999999999999999997 999986543210 0000 0011
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhc
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.....+.+++..|+..+|.+|+++.++...
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 134567889999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=276.56 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=198.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|++|.||+|.+. +++.|++|.+... .....+.+.+|++++++++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999965 5889999988643 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|++++++..+.... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99987776655332 23789999999999999999999998 9999999999999999999999999987654433
Q ss_pred CccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-----------------------c
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-----------------------L 285 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----------------------~ 285 (334)
. .......++..|+|||.+.+. .++.++|+||||+++|+|++|++||....... .
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122335678899999999887 88999999999999999999999986431100 0
Q ss_pred -----cccc----------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 -----SING----------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 -----~~~~----------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.. +.......+.+++..|+..+|++|+++.++...++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 0000 00002456788999999999999999988877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=278.31 Aligned_cols=195 Identities=26% Similarity=0.414 Sum_probs=156.5
Q ss_pred CccccCCcccEEEEEec---CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe--cCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA---KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE--RDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 153 (334)
..||+|+||.||+|... ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999854 35689999886432 23457789999999999999999999854 4567899999876
Q ss_pred CChhhhhhhc------ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee----CCCCceEEeeccccc
Q 037681 154 KSLDFFLFDA------TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL----DKEMKPKISDFGMAR 223 (334)
Q Consensus 154 ~~L~~~l~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~ 223 (334)
+|..++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 555554321 12234788899999999999999999998 9999999999999 456789999999998
Q ss_pred cccCCCCc-cccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 037681 224 IFKGNESK-ANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEF 279 (334)
Q Consensus 224 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~ 279 (334)
........ .......||+.|+|||.+.+ ..++.++|||||||++|||+||++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 65433221 12234568999999998876 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.23 Aligned_cols=241 Identities=29% Similarity=0.434 Sum_probs=191.3
Q ss_pred CccccCCcccEEEEEecC-------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 79 NKLGEGGFGPVYKGVLAK-------GDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998542 2578999875432 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcc----cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-----ceEEeeccc
Q 037681 151 LPNKSLDFFLFDAT----KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-----KPKISDFGM 221 (334)
Q Consensus 151 ~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~ 221 (334)
+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999886532 1234788899999999999999999888 99999999999998877 899999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchh
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQT 293 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~ 293 (334)
+................++..|+|||.+.++.++.++||||||+++|||++ |+.||........ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 876543322222223345778999999998999999999999999999998 9999865432110 00001111
Q ss_pred cccchhhhccccccCCccchhhhhhhhhc
Q 037681 294 QVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
....+.+++..|+..+|.+|+++.++.+.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 266 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEI 266 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 34567899999999999999999987653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=276.67 Aligned_cols=244 Identities=22% Similarity=0.314 Sum_probs=195.3
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh-----hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR-----QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
+|++.+.||+|++|.||+|... +++.|++|.+..... .....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999954 689999999864432 2334567899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+ +++|..++.... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889998885543 24899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------c------c
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------L------S 286 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~------~ 286 (334)
... ......++..|+|||.+.+ ..++.++|+||||+++|||++|.+||....... . .
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 221 1222346788999998854 467889999999999999999988775432210 0 0
Q ss_pred ccc--------------cchhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 287 ING--------------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 287 ~~~--------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
... ........+.+++..|+..+|.+|+++.++....+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~ 285 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence 000 001123456789999999999999999999887663
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=261.68 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=199.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++.+.+..||.|+.|+|+++..+ +|..+|||.+... +.+..+++...++++.+.+ +|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 45566788999999999999955 5889999998643 5666788888888887765 8999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
.|.. .++.++... ..++++..+-++...++.||.||-.+. +|+|||+||+|||+|+.|++||||||++..+.+..
T Consensus 172 lMs~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 8743 455555443 335889999999999999999998765 59999999999999999999999999997765433
Q ss_pred CccccccccccCCccCcccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc----------ccccccchhccc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ---GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY----------LSINGYDQTQVA 296 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----------~~~~~~~~~~~~ 296 (334)
. .+...|.+.|||||.+.- ..|+..+||||||++++||.||+.||..-..+. .+........++
T Consensus 247 A---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp 323 (391)
T KOG0983|consen 247 A---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSP 323 (391)
T ss_pred c---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCH
Confidence 2 334579999999999863 468889999999999999999999998744331 122222222567
Q ss_pred chhhhccccccCCccchhhhhhhhhccCCc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
...++++.||.+++.+|+...++.+..|-.
T Consensus 324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred HHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 789999999999999999999988877744
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.09 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=202.6
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
+|+..+.||+|++|.||++... ++..+++|++..........+.+|++.+++++|||++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999965 688999999976655566788999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++.... ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999998886542 34899999999999999999999988 99999999999999999999999999876543321
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccchhc--ccchhhhcc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYDQTQ--VASKIKLVE 303 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~--~~~~~~~i~ 303 (334)
.....++..|+|||.+.+...+.++|+||||+++|+|++|+.||....... .......... ...+.+++.
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence 234568899999999988889999999999999999999999987652210 0111111111 556889999
Q ss_pred ccccCCccchhhhhhhhhcc
Q 037681 304 SCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~ 323 (334)
.|+..+|..|+++.++....
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred HHccCChhhCCCHHHHhcCC
Confidence 99999999999998877654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=270.03 Aligned_cols=239 Identities=23% Similarity=0.344 Sum_probs=184.1
Q ss_pred CccccCCcccEEEEEecC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe-cCcceEEEEecC
Q 037681 79 NKLGEGGFGPVYKGVLAK----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE-RDEKLLIYEYLP 152 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 152 (334)
+.||+|+||.||+|.+.+ +..+|+|.+... .....+.+..|+.+++.++||||+++++++.. ++..++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 346899988533 34456778889999999999999999998764 556799999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC--
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES-- 230 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 230 (334)
+++|..++..... ..++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999865332 2567778889999999999999988 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCccCCccc--c-----cccchhcccchhhhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG-KKNTEFYHTGYLS--I-----NGYDQTQVASKIKLV 302 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~--~-----~~~~~~~~~~~~~~i 302 (334)
........++..|+|||.+.+..++.++||||||+++|||++| .+||+........ . ..........+.+++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVM 235 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 1111223457789999999888899999999999999999995 5666543221000 0 000111245678899
Q ss_pred cccccCCccchhhhhhhhhc
Q 037681 303 ESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~ 322 (334)
..|+..+|.+|+++.++...
T Consensus 236 ~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 236 LSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHcCCChhhCCCHHHHHHH
Confidence 99999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=276.84 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=194.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999965 58899999875332 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|..+..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999998887654322 3789999999999999999999998 9999999999999999999999999987654332
Q ss_pred CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------------------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------------ 284 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------------ 284 (334)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|++||+......
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 1223457889999998865 457789999999999999999999986432100
Q ss_pred ----cccccc---------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 ----LSINGY---------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 ----~~~~~~---------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...... .......+.+++..|+..+|.+|+++.++....+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 000000 0012345778999999999999999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=269.61 Aligned_cols=236 Identities=26% Similarity=0.344 Sum_probs=194.8
Q ss_pred cccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 81 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
||.|++|.||+|... +++.+++|.+.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 58899999986432 23456788999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 236 (334)
.+++.... .++...+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 99885543 3788999999999999999999988 9999999999999999999999999997654332 1223
Q ss_pred ccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc----------cccchhcccchhhhccccc
Q 037681 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI----------NGYDQTQVASKIKLVESCL 306 (334)
Q Consensus 237 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~----------~~~~~~~~~~~~~~i~~~l 306 (334)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+.... ..........+.+++.+|+
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 231 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHc
Confidence 467889999999888889999999999999999999999997655211000 0011112456889999999
Q ss_pred cCCccchhh-----hhhhhhccCC
Q 037681 307 ARPFRQYCC-----ILKVRTFGFN 325 (334)
Q Consensus 307 ~~~~~~~~~-----~~~~~~~~~~ 325 (334)
..+|.+|++ +.++++.++-
T Consensus 232 ~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 232 RRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred cCChhhCcCCcccCHHHHhcChhh
Confidence 999999999 7777776653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=272.07 Aligned_cols=243 Identities=21% Similarity=0.366 Sum_probs=198.8
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC---CCCcceEeeEEEecCcceEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQ---HKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.|+..+.||+|+||.||+|.+ .++..+++|.+... .......+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 577889999999999999995 56889999988643 3444567888999999996 999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999887542 4889999999999999999999998 999999999999999999999999999866543
Q ss_pred CCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------ccccchh-cccchh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------INGYDQT-QVASKI 299 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~~~~~~-~~~~~~ 299 (334)
.. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... ....... ....+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLR 232 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHH
Confidence 32 1233468889999998865 45688999999999999999999999755332110 0011111 344678
Q ss_pred hhccccccCCccchhhhhhhhhccCC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
+++..|+..+|.+|++..++....+.
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHh
Confidence 89999999999999999888776553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=273.23 Aligned_cols=232 Identities=25% Similarity=0.394 Sum_probs=183.9
Q ss_pred CccccCCcccEEEEEecC-C-------CEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 79 NKLGEGGFGPVYKGVLAK-G-------DEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+.||+|+||.||+|.... + ..+++|.+........+.+..|..+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 2 24788877655555567788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc--------eEEeecccc
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK--------PKISDFGMA 222 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg~~ 222 (334)
+++|+|..++..... .+++..+..++.||+.||+|||+.+ ++||||||+||+++.++. ++++|||.+
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999865432 4788899999999999999999998 999999999999987765 699999988
Q ss_pred ccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCC-CCCCCccCCc-ccccc----cchhcc
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGK-KNTEFYHTGY-LSING----YDQTQV 295 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~-~p~~~~~~~~-~~~~~----~~~~~~ 295 (334)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+....... ..+.. ......
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKW 229 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCc
Confidence 64322 223457888999999876 45789999999999999999985 5554433211 00000 011123
Q ss_pred cchhhhccccccCCccchhhhhhhhh
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
..+.+++..|+..+|.+|+++.++..
T Consensus 230 ~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 230 TELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHH
Confidence 45788999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=306.58 Aligned_cols=250 Identities=23% Similarity=0.276 Sum_probs=199.3
Q ss_pred hHHHHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec
Q 037681 66 SSVAAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSV---RSRQGLQELKNEALVIAKVQHKNLVRLLGCCIER 141 (334)
Q Consensus 66 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 141 (334)
..+....++|++++.||+|+||.|..++.+ +++.||.|+++. -......-|..|..+|...+.+.|+.+...|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 344555689999999999999999999954 688899999864 2344456788999999999999999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
.++|+||||++||+|-.++.... .+++..+..++..|+.||.-||+.| +|||||||+|||+|..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999886554 4899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCccccc----c-CCCCcchhhHhHHHHHHHHHhCCCCCCCc-----------cCCcc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVY----Q-GICSIKSDVFSFGMLLLEILSGKKNTEFY-----------HTGYL 285 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~DiwslG~il~ell~g~~p~~~~-----------~~~~~ 285 (334)
+-.+..+.. ......+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||-.. +....
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL 300 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc
Confidence 987654333 3345578999999999986 3 67899999999999999999999998522 12223
Q ss_pred cccccchhcccchhhhccccccCCccchhh---hhhhhhccC
Q 037681 286 SINGYDQTQVASKIKLVESCLARPFRQYCC---ILKVRTFGF 324 (334)
Q Consensus 286 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~---~~~~~~~~~ 324 (334)
.|+ -....+....++|.+.+. +++.|.. +..++...|
T Consensus 301 ~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 301 SFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred CCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 333 111145556666665553 3333333 555555554
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=268.94 Aligned_cols=237 Identities=30% Similarity=0.438 Sum_probs=191.7
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.++++++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5789999999999999999875 57889999886432 336788999999999999999999998654 5799999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|..++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||.+......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999886543 234788899999999999999999988 999999999999999999999999998653221
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--ccc-----ccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SIN-----GYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~~-----~~~~~~~~~~~~~i~~ 304 (334)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||........ ... .........+.+++..
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence 112234567999999988899999999999999999998 9999875533210 000 0011134567889999
Q ss_pred cccCCccchhhhhhhhhc
Q 037681 305 CLARPFRQYCCILKVRTF 322 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~ 322 (334)
|+..+|..|+++.++...
T Consensus 233 ~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 233 CWETEPKKRPSFHKLREK 250 (254)
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=273.87 Aligned_cols=243 Identities=23% Similarity=0.335 Sum_probs=192.1
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||.|++|.||+|+.. +|+.+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999964 68899999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+. ++|..++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 57877765433 234889999999999999999999988 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccCccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------------------------
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGI-CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------------------ 285 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------------------ 285 (334)
......++..|+|||.+.+.. ++.++||||||+++|+|+||+.||........
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 122234688899999886544 68899999999999999999999864321100
Q ss_pred ---cccccc--------hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 286 ---SINGYD--------QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 286 ---~~~~~~--------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+..+. ......+.+++..|+..+|.+|+++.++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 282 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence 000000 01234456799999999999999998887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.00 Aligned_cols=196 Identities=27% Similarity=0.368 Sum_probs=168.4
Q ss_pred CCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-C-----CCcceEeeEEEecCcceE
Q 037681 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-H-----KNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~l 146 (334)
+|++.+.||+|+||+|.+|. ..+++.||||+++.. .....+...|+.+|..++ | -|+|+++++|...++.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78999999999999999999 456999999999744 444566678999999997 4 489999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC--CceEEeecccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE--MKPKISDFGMARI 224 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~ 224 (334)
|+|.+. .+|.++++.+.-. .++...+..++.||+.||.+||+.+ |||+||||+||||.+- ..|||+|||.++.
T Consensus 266 VfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999885 4888888765533 4899999999999999999999998 9999999999999643 3799999999987
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFY 280 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 280 (334)
...... ...-+..|.|||++.+.+|+.+.||||||||++||++|.+-|+..
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 543322 345678899999999999999999999999999999998877643
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=272.00 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=205.1
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
..+.|+..+.||+|++|.||+|.+. ++..+++|.+..... ....+..|++.++.++|+|++++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3467888999999999999999965 688999999875544 45678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999986644 24899999999999999999999988 9999999999999999999999999886543322
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------ccccc--chhcccchhh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGY--DQTQVASKIK 300 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~--~~~~~~~~~~ 300 (334)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+... ..... .......+.+
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 1 12234578899999999888899999999999999999999999875433210 00000 0113455888
Q ss_pred hccccccCCccchhhhhhhhhccCCcc
Q 037681 301 LVESCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
++..|+..+|..|+++.++....+..+
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999999999887665444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=290.21 Aligned_cols=202 Identities=29% Similarity=0.412 Sum_probs=173.8
Q ss_pred CCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------cceE
Q 037681 75 FSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------EKLL 146 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~l 146 (334)
+...+.||+|+||.||+|++ .+|..||||.++.. .....+...+|++++++++|||||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999994 57999999998743 3344567789999999999999999999865544 4579
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC--CCC--ceEEeecccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD--KEM--KPKISDFGMA 222 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg~~ 222 (334)
|||||.+|+|...+....+...+++...+.++.++..||.|||+++ |+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988777777999999999999999999999998 99999999999983 323 3699999999
Q ss_pred ccccCCCCccccccccccCCccCccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCccC
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGKKNTEFYHT 282 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 282 (334)
+-+.++. ......||..|.+||... .+.|+..+|.|||||++|+..||..||.-...
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9876554 455688999999999988 48899999999999999999999999965433
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=269.43 Aligned_cols=243 Identities=24% Similarity=0.366 Sum_probs=195.0
Q ss_pred CCCcCCccccCCcccEEEEEecC--CCEEEEEEeccc----------ChhhHHHHHHHHHHHHh-cCCCCcceEeeEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAK--GDEIAVKRLSVR----------SRQGLQELKNEALVIAK-VQHKNLVRLLGCCIE 140 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 140 (334)
+|++.+.||+|+||.||+|.... ++.+|+|.+... .......+..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999654 678999987532 22234556778888765 799999999999999
Q ss_pred cCcceEEEEecCCCChhhhhhhc-ccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEee
Q 037681 141 RDEKLLIYEYLPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISD 218 (334)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~D 218 (334)
.+..+++|||+++++|.+++... .....+++..++.++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998877442 223458889999999999999999996 55 99999999999999999999999
Q ss_pred ccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccc
Q 037681 219 FGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYD 291 (334)
Q Consensus 219 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~ 291 (334)
||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC
Confidence 99997654332 2234568889999999998889999999999999999999999986542210 0000000
Q ss_pred h-hcccchhhhccccccCCccchhhhhhhhhc
Q 037681 292 Q-TQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 292 ~-~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
. .....+.+++..|+..+|..|+++.++...
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 1 134568889999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=272.65 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=195.9
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+|++.+.||.|++|.||+|.+. +|..+|+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999965 58899999987543 223456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++ +|..++........+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 77777755444455899999999999999999999998 99999999999999999999999999875432211
Q ss_pred cccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--------------------cccc-
Q 037681 232 ANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------------------SING- 289 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------------------~~~~- 289 (334)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ ....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1222456888999998765 4568899999999999999999999864432100 0000
Q ss_pred --------------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 --------------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 --------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..........+++..|+..+|.+|+++.++.+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 00112455678999999999999999988876643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=298.38 Aligned_cols=243 Identities=25% Similarity=0.399 Sum_probs=199.3
Q ss_pred cCCCcCCccccCCcccEEEEEecC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
+...|.+.||.|.||.|+.|.++. ...||||.++.. .+.+...|+.|+.||-+++||||+++.|+........+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345678899999999999999652 346999999855 566778899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
.|||++|+|+.+|+.+.. .++..+...++..|+.|+.||.+.+ +|||||..+|||++.+..+|++|||+++.+.+
T Consensus 709 TEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999987654 3888899999999999999999888 99999999999999999999999999998765
Q ss_pred CCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc---ccccc----hhcccch
Q 037681 228 NESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS---INGYD----QTQVASK 298 (334)
Q Consensus 228 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~---~~~~~----~~~~~~~ 298 (334)
+... ..+..-.-..+|.|||.+...+++.++||||+|++|||.++ |.+||=++...+.- -.++. .+-+..+
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence 5421 11222223578999999999999999999999999999887 99998655433110 01111 1135568
Q ss_pred hhhccccccCCccchhhhhhhh
Q 037681 299 IKLVESCLARPFRQYCCILKVR 320 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~ 320 (334)
..+.-.|++++...|+.+.++-
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV 885 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIV 885 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHH
Confidence 8888899999988888776643
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=274.39 Aligned_cols=240 Identities=27% Similarity=0.386 Sum_probs=193.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
..|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++.+++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888999999999999999954 6899999988633 2334467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++ ++.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~g-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCLG-SASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhCC-CHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99975 5555553322 24889999999999999999999998 999999999999999999999999998654321
Q ss_pred CCccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------ccccc-chhcccc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGY-DQTQVAS 297 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~-~~~~~~~ 297 (334)
....++..|+|||.+. ...++.++||||||+++|||++|++||........ ..... .......
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY 242 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHH
Confidence 2345788999999874 45688899999999999999999999865432110 00000 0112345
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..|+..+|.+|+++.++....+
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 788999999999999999999887654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=265.68 Aligned_cols=244 Identities=26% Similarity=0.385 Sum_probs=203.7
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--CcceEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKLLIY 148 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 148 (334)
+|...+.||+|++|.||+|... ++..+++|.+.... ....+.+.+|+.++++++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999965 68899999986554 24567889999999999999999999999988 8899999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++.... .+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999886544 4899999999999999999999988 999999999999999999999999999876544
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccccchhcccchh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSINGYDQTQVASKI 299 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~ 299 (334)
..........++..|+|||.+.+...+.++|+||||+++|+|++|+.||....... .............+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 32111234568889999999988889999999999999999999999997654210 011111222456788
Q ss_pred hhccccccCCccchhhhhhhhhcc
Q 037681 300 KLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+++..|+..+|..|+++.++....
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCC
Confidence 999999999999999998877654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=268.98 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=191.5
Q ss_pred CCcCCccccCCcccEEEEEec----CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------ 142 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 142 (334)
|.+.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999843 3678999988643 3445667889999999999999999999886542
Q ss_pred cceEEEEecCCCChhhhhhhcc---cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeec
Q 037681 143 EKLLIYEYLPNKSLDFFLFDAT---KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDF 219 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 219 (334)
..++++||+++|+|..++.... ....+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999987764322 1224788889999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccc
Q 037681 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYD 291 (334)
Q Consensus 220 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~ 291 (334)
|.+................+++.|++||.+.+..++.++||||||+++|+|++ |++||........ ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 99876543322222223345678999999988889999999999999999999 8899865432110 000011
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
......+.+++..|+..+|..|+++.++...
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1234568889999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=267.93 Aligned_cols=240 Identities=19% Similarity=0.305 Sum_probs=180.4
Q ss_pred CccccCCcccEEEEEecCCC---EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCC
Q 037681 79 NKLGEGGFGPVYKGVLAKGD---EIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
+.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999854333 45666665432 334567889999999999999999999999999999999999999
Q ss_pred Chhhhhhhccc-ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 155 SLDFFLFDATK-RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 155 ~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
+|..++..... ....+...+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99998865422 233566777899999999999999988 99999999999999999999999999754322211112
Q ss_pred cccccccCCccCcccccc-------CCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc----------ccc--cccchh
Q 037681 234 TNRVAGTFGYIPPEYVYQ-------GICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY----------LSI--NGYDQT 293 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~----------~~~--~~~~~~ 293 (334)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||....... ..+ ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence 233467889999998743 245778999999999999997 566775433210 000 001111
Q ss_pred cccchhhhccccccCCccchhhhhhhhhc
Q 037681 294 QVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
....+.+++..|+ .+|.+|+++.++.+.
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 3444666888898 569999999987654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=266.99 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=194.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-----SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 144 (334)
.+|++.+.||+|+||.||+|.+. ++..+++|.+... .......+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999954 5889999987532 233456788999999999999999999998764 457
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++++||+++++|.+++.... .+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999998875432 3788889999999999999999998 99999999999999999999999999976
Q ss_pred ccCCCC-ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cc-cccchhcc
Q 037681 225 FKGNES-KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SI-NGYDQTQV 295 (334)
Q Consensus 225 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~-~~~~~~~~ 295 (334)
...... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ +. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~ 235 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccC
Confidence 432111 1112234588999999999888889999999999999999999999975432210 00 00111134
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
....+++..|+.. +..|++..++.+..+
T Consensus 236 ~~~~~~i~~~l~~-~~~r~~~~~~~~~~~ 263 (264)
T cd06653 236 DACRDFLKQIFVE-EKRRPTAEFLLRHPF 263 (264)
T ss_pred HHHHHHHHHHhcC-cccCccHHHHhcCCC
Confidence 5678889999984 588888887766543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=271.96 Aligned_cols=193 Identities=30% Similarity=0.455 Sum_probs=163.5
Q ss_pred CCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhc--CCCCcceEeeEEEecC----cceEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV--QHKNLVRLLGCCIERD----EKLLI 147 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv 147 (334)
..+..+++|+|+||.||+|.+. ++.||||++... ..+.+..|.++++.. .|+||+++++.-...+ .+++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4455678999999999999976 699999988643 447788888888764 7999999999876555 68999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc------CCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH------SRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
++|.+.|+|.++|..+. ++|....+++..+++||+|||+. .+++|+|||||+.||||.+|+++.|+|||+
T Consensus 287 t~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999996654 89999999999999999999963 356799999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCC-CC-----cchhhHhHHHHHHHHHhCC
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGI-CS-----IKSDVFSFGMLLLEILSGK 274 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~DiwslG~il~ell~g~ 274 (334)
|..+............+||.+|||||++.+.. +. .+.||||+|.+||||++.-
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 99887665555555578999999999987642 22 3689999999999999843
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=261.82 Aligned_cols=237 Identities=23% Similarity=0.307 Sum_probs=192.1
Q ss_pred CccccCCcccEEEEE-ecCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 79 NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
+.||+|+++.|-.++ ..+|..+|||++.........++.+|++++.+. .|+||+.++++|++++..|+|||-+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999998 678999999999877777788999999999998 599999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC---ceEEeeccccccccCCCC---
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM---KPKISDFGMARIFKGNES--- 230 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~--- 230 (334)
...+..+. .+++..+.++..+|+.||.+||..| |.|||+||+|||...-. -+|||||.+..-+..+..
T Consensus 164 LshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 88886554 3899999999999999999999998 99999999999996544 389999998764422211
Q ss_pred --ccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------------------
Q 037681 231 --KANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------- 284 (334)
Q Consensus 231 --~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------- 284 (334)
.....+.+|+..|||||+.. ...|+.++|.||||+|+|-||+|-+||.......
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 12233467999999999864 3468899999999999999999999997654321
Q ss_pred -----ccccccchh-cccchhhhccccccCCccchhhhhhhhh
Q 037681 285 -----LSINGYDQT-QVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 285 -----~~~~~~~~~-~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
-.+....|. .+....+++...+.+++.+|.+..++..
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 122322333 3445667777778888887776666554
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=270.45 Aligned_cols=237 Identities=27% Similarity=0.396 Sum_probs=190.2
Q ss_pred cccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 81 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
||+|+||+||+|... +|..+|+|.+.... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999886432 22344567899999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 236 (334)
.+++..... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 988865432 34889999999999999999999998 9999999999999999999999999987643321 1223
Q ss_pred ccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--ccccc--------ccchhcccchhhhccccc
Q 037681 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--YLSIN--------GYDQTQVASKIKLVESCL 306 (334)
Q Consensus 237 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~~--------~~~~~~~~~~~~~i~~~l 306 (334)
..++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ...+. .........+.+++.+||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 45788999999998888999999999999999999999999654331 00000 011113556889999999
Q ss_pred cCCccchh-----hhhhhhhccC
Q 037681 307 ARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 307 ~~~~~~~~-----~~~~~~~~~~ 324 (334)
..+|.+|+ +..++....+
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~ 256 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPL 256 (277)
T ss_pred cCChhHccCCCcccHHHHHhChh
Confidence 99999999 5555655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=311.54 Aligned_cols=235 Identities=25% Similarity=0.383 Sum_probs=185.6
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
..|...+.||+|+||.||+|.. .++..||+|++...... ...|++.+++++||||++++++|.+.+..|+||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4677788999999999999996 57899999988643221 134688899999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++|+|.++++. +++..+..++.|++.|++|||....++++||||||+||+++.++..++. ||.......
T Consensus 766 ~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999998842 7889999999999999999996544559999999999999998888775 665433211
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccc--------------------
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYD-------------------- 291 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~-------------------- 291 (334)
.....+++.|+|||++.+..++.++|||||||++|||+||+.||+...........|.
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1123578999999999999999999999999999999999999854322111111110
Q ss_pred ----hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 292 ----QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 292 ----~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
........+++..|+..+|.+|+++.++...-.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 011223556778999999999999998765543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=271.01 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=197.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--CcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 148 (334)
++|+..+.||.|++|.||+|.+. +++.+|+|.+... .......+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999964 5888999988643 234456788999999999999999999998654 3679999
Q ss_pred EecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988765322 2345788899999999999999999998 99999999999999999999999999865432
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---cccccccch------------
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---YLSINGYDQ------------ 292 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~~~~~~~~------------ 292 (334)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||+..... ...+..+..
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 21 12345788899999998889999999999999999999999999765221 001011000
Q ss_pred ---hcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 293 ---TQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 293 ---~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
.....+.+++..|+..+|.+|+++.++....+-
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 012356789999999999999999998887764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.19 Aligned_cols=243 Identities=22% Similarity=0.286 Sum_probs=193.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--CcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 147 (334)
++|++.+.||.|+||.||+|... +++.+++|.++... ......+.+|+.++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999965 58899999986443 22234567899999999999999999998877 789999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
+||+++ +|..++..... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 88777754332 4899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc----------------------
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------------------- 284 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------------------- 284 (334)
... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||.......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 12234578899999988654 46889999999999999999999986432110
Q ss_pred -----------c---cccccchh--cccchhhhccccccCCccchhhhhhhhhcc
Q 037681 285 -----------L---SINGYDQT--QVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 285 -----------~---~~~~~~~~--~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
. .+...... ......+++..|+..+|++|+++.++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~ 291 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCC
Confidence 0 00000000 144567899999999999999998887654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.95 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=197.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-----CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEe--cCcc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-----KGDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIE--RDEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 144 (334)
++|++.+.||+|+||.||+|.+. ++..+|+|.+...... ....+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 57788899999999999999843 3678999998755443 56788999999999999999999999887 5578
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
+++|||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999865432 4889999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc----------cccc---
Q 037681 225 FKGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS----------INGY--- 290 (334)
Q Consensus 225 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~----------~~~~--- 290 (334)
....... .......++..|+|||.+.+..++.++|+||||+++|||++|..|+......... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6432221 1111223456799999998888999999999999999999999987543221110 0000
Q ss_pred ---------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 291 ---------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 291 ---------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.......+.+++..|+..+|.+|+++.++...-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 0012345778999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.43 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=191.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCc-----
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDE----- 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~----- 143 (334)
++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999954 68899999876432 223456788999999995 6999999999887665
Q ss_pred ceEEEEecCCCChhhhhhhccc--ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeecc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATK--RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFG 220 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg 220 (334)
.|+||||+++ +|..++..... ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 67776654322 245799999999999999999999998 999999999999998 8899999999
Q ss_pred ccccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------c
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------L 285 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~ 285 (334)
++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....... .
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9875432211 1122346888999998765 457899999999999999999999986432110 0
Q ss_pred c------------ccc--------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 S------------ING--------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ~------------~~~--------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. +.. ........+.+++..||..+|.+|+++.++....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 0 000 00113455778999999999999999988776543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.81 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=192.2
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----cc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-----EK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 144 (334)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+... .......+..|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 37899999999999999999985 46899999998643 2334456788999999999999999999876543 46
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+++||+++ ++...+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 66665532 23889999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCCc-cccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--------------ccccc
Q 037681 225 FKGNESK-ANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------YLSIN 288 (334)
Q Consensus 225 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------~~~~~ 288 (334)
....... .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... ...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5332211 11223468899999998654 56889999999999999999999999643210 00000
Q ss_pred -----------------------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 -----------------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 -----------------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.........+.+++..|+..+|.+|+++.++....+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000112445778999999999999999999887755
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=266.88 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=189.8
Q ss_pred HHHHhhcCCCcCCcc--ccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecC
Q 037681 67 SVAAATNNFSDTNKL--GEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERD 142 (334)
Q Consensus 67 ~~~~~~~~y~~~~~l--g~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 142 (334)
+.....++|++.+.+ |+|+||.||++.. .++..+|+|.+....... .|+.....+ +||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445678888877 9999999999995 467889999876432211 122222222 7999999999999999
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeeccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGM 221 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~ 221 (334)
..++||||+++++|..++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 9999999999999999886543 5899999999999999999999998 99999999999999988 999999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc----------c
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY----------D 291 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~----------~ 291 (334)
+...... ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||............+ .
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc
Confidence 8754322 12357899999999998889999999999999999999999997443221111111 1
Q ss_pred hhcccchhhhccccccCCccchh-hhhhhhhccC
Q 037681 292 QTQVASKIKLVESCLARPFRQYC-CILKVRTFGF 324 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~-~~~~~~~~~~ 324 (334)
......+.+++..||..+|.+|. ++.++.+..+
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 12456688899999999999997 4677766544
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.89 Aligned_cols=244 Identities=24% Similarity=0.327 Sum_probs=197.7
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||+|+||.||+|... +|..+|+|.+... .....+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999965 5889999988643 123345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++ .++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999998886533 234789999999999999999999998 99999999999998875 46999999987654322
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------ccccchhcccchhhhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------INGYDQTQVASKIKLV 302 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~i 302 (334)
. ......|++.|+|||.+.+..++.++|+||||+++++|++|+.||......... +..........+.+++
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI 234 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHH
Confidence 1 122245888999999998888999999999999999999999998654321100 0001111345688899
Q ss_pred cccccCCccchhhhhhhhhcc
Q 037681 303 ESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~ 323 (334)
..|+..+|.+|+++.++....
T Consensus 235 ~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 235 SQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred HHHhccChhhCcCHHHHhhCC
Confidence 999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=264.20 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=203.8
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||.|++|.||++.+. +++.+++|.+.... ......+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999965 68899999987543 35567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|.+++.... ....+++..+..++.+++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999998886542 1345899999999999999999999998 9999999999999999999999999997654332
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccchhcccchhhhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYDQTQVASKIKLV 302 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~i 302 (334)
.......|++.|+|||...+..++.++|+||+|+++++|++|+.||....... .............+.+++
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 12233468889999999988889999999999999999999999987653221 001111112445678899
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..|+..+|.+|+++.++....+
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred HHHcCCChhhCcCHHHHhcCCC
Confidence 9999999999999998876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=271.31 Aligned_cols=238 Identities=23% Similarity=0.334 Sum_probs=195.5
Q ss_pred CCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 78 TNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
...||+|+||.||++.. .+++.+|+|++..........+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 45799999999999986 46889999998755555566788999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 236 (334)
.+++... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 8876432 3788899999999999999999998 99999999999999999999999998875433221 1223
Q ss_pred ccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------ccccc---cchhcccchhhhcccccc
Q 037681 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------LSING---YDQTQVASKIKLVESCLA 307 (334)
Q Consensus 237 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~---~~~~~~~~~~~~i~~~l~ 307 (334)
..|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ..+.. ........+.+++..|+.
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 467899999999988888999999999999999999999986432210 00000 011134567789999999
Q ss_pred CCccchhhhhhhhhccC
Q 037681 308 RPFRQYCCILKVRTFGF 324 (334)
Q Consensus 308 ~~~~~~~~~~~~~~~~~ 324 (334)
.+|.+|+++.++....+
T Consensus 256 ~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 256 RDPAQRATAAELLKHPF 272 (292)
T ss_pred CCcccCcCHHHHhcChH
Confidence 99999999998887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=269.01 Aligned_cols=242 Identities=23% Similarity=0.330 Sum_probs=192.1
Q ss_pred CCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
|++.+.||.|++|.||+|... +|..||+|++.... ......+.+|+.++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999954 69999999886443 223456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
+ ++|..++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 578887754432 34889999999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------c------c----
Q 037681 232 ANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------L------S---- 286 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~------~---- 286 (334)
......++..|+|||.+.+. .++.++|+||||+++|+|++|++||....... . .
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11223468889999987654 57889999999999999999999986432100 0 0
Q ss_pred ---ccc--------cchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 287 ---ING--------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 287 ---~~~--------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+.. ..........+++..|+..+|.+|+++.++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 000 0111234577899999999999999998887654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=262.96 Aligned_cols=243 Identities=25% Similarity=0.375 Sum_probs=201.1
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR--QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999855 578999999875543 4567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999888554 34899999999999999999999998 99999999999999999999999999986543322
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccchhcccchhhhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYDQTQVASKIKLVE 303 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~i~ 303 (334)
. .....++..|+|||...+...+.++|+||+|+++|+|++|+.||....... .............+.+++.
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLM 232 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 1 233467889999999887778899999999999999999999986543210 0000111123456788999
Q ss_pred ccccCCccchhhhhhhhhccC
Q 037681 304 SCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.|+..+|+.|+++.++....+
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~ 253 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPW 253 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCC
Confidence 999999999999988876543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=275.38 Aligned_cols=256 Identities=27% Similarity=0.372 Sum_probs=203.9
Q ss_pred HhhcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccC-------hhhHHHHHHHHHHHHhcCCCCcceEeeEEEe-
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS-------RQGLQELKNEALVIAKVQHKNLVRLLGCCIE- 140 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 140 (334)
...++|-.+.+||+|||+.||+|. ......||+|+-..+. ....+...+|..+.+.|+||.||+++++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 334678889999999999999999 4457788998764321 2223456789999999999999999999875
Q ss_pred cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC---CCCceEEe
Q 037681 141 RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD---KEMKPKIS 217 (334)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~ 217 (334)
.+.+|-|+|||+|.+|+.+|+.+.. ++++.+..|+.||+.||.||... +++|+|-||||.|||+. ..|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 4567899999999999999976654 89999999999999999999987 56799999999999994 44789999
Q ss_pred eccccccccCCCCc-----cccccccccCCccCccccccC----CCCcchhhHhHHHHHHHHHhCCCCCCCccCC-----
Q 037681 218 DFGMARIFKGNESK-----ANTNRVAGTFGYIPPEYVYQG----ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG----- 283 (334)
Q Consensus 218 Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~----- 283 (334)
|||+++.+.++... ..+....||.+|++||.+.-+ ..+.++||||.|||+|+.+.|+.||.-....
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99999988655432 234557899999999987533 4678999999999999999999999643221
Q ss_pred cccccccc-------hhcccchhhhccccccCCccchhhhhhhhhccCCcccc
Q 037681 284 YLSINGYD-------QTQVASKIKLVESCLARPFRQYCCILKVRTFGFNLPNA 329 (334)
Q Consensus 284 ~~~~~~~~-------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~ 329 (334)
+..+.... ...+....++|..||+..-++|..+.++..-.+-+|..
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 11111111 11455678899999999999999999888888777754
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=268.38 Aligned_cols=235 Identities=26% Similarity=0.350 Sum_probs=182.4
Q ss_pred ccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHH---HHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 80 KLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALV---IAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~---l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
.||+|+||.||++... +++.+|+|.+.... .........|..+ +...+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 58899999885432 1112223344433 334479999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|..++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999988875433 4899999999999999999999998 9999999999999999999999999986543221
Q ss_pred ccccccccCCccCccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-cccc--------cchhcccchhhhc
Q 037681 233 NTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-SING--------YDQTQVASKIKLV 302 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~--------~~~~~~~~~~~~i 302 (334)
.....|+..|+|||.+. +..++.++|+||+|+++|+|++|+.||........ .+.. ........+.+++
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLL 230 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHH
Confidence 22346899999999886 45688999999999999999999999975433211 0100 0111345678899
Q ss_pred cccccCCccchh-----hhhhhhhccC
Q 037681 303 ESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
..|+..+|.+|+ ++.++.+..+
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 231 EGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 999999999998 4777766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=277.83 Aligned_cols=245 Identities=18% Similarity=0.290 Sum_probs=194.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe----cCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE----RDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 145 (334)
++|++.+.||+|++|.||+|... +|..||+|++... .......+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 78999999999999999999954 6899999998643 22345667889999999999999999998763 34579
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+. ++|..++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 5787777433 23899999999999999999999998 999999999999999999999999998765
Q ss_pred cCCCCc--cccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------------
Q 037681 226 KGNESK--ANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------ 284 (334)
Q Consensus 226 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------ 284 (334)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 332211 11123468889999998765 468899999999999999999999996532100
Q ss_pred -------------------ccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 -------------------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 -------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+..........+.+++..|+..+|.+|+++.++...++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 0000001113556788999999999999999988776554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=269.43 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=190.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||.|++|.||+|... +|+.+|+|.+.... ......+.+|++++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999965 68899999886432 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeeccccccccCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFGMARIFKGN 228 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 228 (334)
|+++ +|..++.... ...+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9965 6666654322 223578888899999999999999988 999999999999985 567999999999754322
Q ss_pred CCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--------------cccc------
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------YLSI------ 287 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------~~~~------ 287 (334)
.. ......+++.|+|||.+.+ ..++.++||||+|+++|+|+||++||...... ...+
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 11 1122356889999998865 45788999999999999999999998643210 0000
Q ss_pred ccc---------------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 NGY---------------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ~~~---------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+ .........+++..|+..+|.+|+++.++....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~ 286 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 000 0112445678999999999999999998877554
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=271.26 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=193.4
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCcceEeeEEEec--CcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR--QGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 146 (334)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 368999999999999999999964 689999999864322 2233456799999999999999999998765 45799
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+.+ +|..++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 6777665432 34889999999999999999999998 9999999999999999999999999997654
Q ss_pred CCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------------------
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------------- 284 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------------- 284 (334)
.... ......++..|+|||.+.+ ..++.++||||+|+++|||++|++||.......
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 3221 1122345788999998865 567899999999999999999999986432210
Q ss_pred ------------ccccccc---hhcccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 285 ------------LSINGYD---QTQVASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 285 ------------~~~~~~~---~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
..+.... ........+++..|+..+|++|+++.++....+-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0000000 00244567799999999999999999988776643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=264.46 Aligned_cols=243 Identities=27% Similarity=0.332 Sum_probs=200.6
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|++.+.||+|++|.||++... +++.+++|.+... .......+.+|+.++++++||||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788899999999999999854 6889999988643 334456778899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|..++.... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999998876532 2245888999999999999999999998 9999999999999999999999999997654431
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccccchhcccchhhhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGYDQTQVASKIKLV 302 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i 302 (334)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........ .+..........+.+++
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHH
Confidence 2224578899999999888899999999999999999999999976543210 01111112345688999
Q ss_pred cccccCCccchhhhhhhhhcc
Q 037681 303 ESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~ 323 (334)
..|+..+|.+|+++.++...+
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 234 RSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred HHHcCCCcccCCCHHHHhcCC
Confidence 999999999999999887654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=266.93 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=191.8
Q ss_pred CCCcCCccccCCcccEEEEEe----cCCCEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcc
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL----AKGDEIAVKRLSVRS----RQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 144 (334)
+|++.+.||.|+||.||.|.. .+|..+|+|.+.... ....+.+..|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 368899999986432 22346678899999999 599999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999886533 3788899999999999999999988 99999999999999999999999999876
Q ss_pred ccCCCCccccccccccCCccCccccccC--CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--ccccc--------cch
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQG--ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--LSING--------YDQ 292 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~~--------~~~ 292 (334)
...... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ..+.. +..
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc
Confidence 533221 112235688999999998753 46789999999999999999999986432210 00000 111
Q ss_pred hcccchhhhccccccCCccchh-----hhhhhhhccC
Q 037681 293 TQVASKIKLVESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
.....+.+++.+|+..+|.+|+ ++.++....+
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~ 270 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence 1234577899999999999995 5555555433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=264.89 Aligned_cols=236 Identities=26% Similarity=0.345 Sum_probs=184.2
Q ss_pred ccccCCcccEEEEEec-CCCEEEEEEecccCh---hhHHHHHHHH---HHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 80 KLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR---QGLQELKNEA---LVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
.||+|+||.||+|... +++.||+|.+..... ........|. ..++..+||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 588999998864321 1112233333 34445689999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|..++... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99998887543 34899999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-cccc--------ccchhcccchhhhc
Q 037681 233 NTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-LSIN--------GYDQTQVASKIKLV 302 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~--------~~~~~~~~~~~~~i 302 (334)
.....|+..|+|||.+.++ .++.++|+||+|+++|+|++|+.||....... .... .+.........+++
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 230 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 230 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHH
Confidence 2234689999999998754 68899999999999999999999997653211 0000 01111346788999
Q ss_pred cccccCCccchh-----hhhhhhhccCC
Q 037681 303 ESCLARPFRQYC-----CILKVRTFGFN 325 (334)
Q Consensus 303 ~~~l~~~~~~~~-----~~~~~~~~~~~ 325 (334)
..|+..+|..|. ++.++.+..+-
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 231 EGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred HHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 999999999998 77777765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=269.03 Aligned_cols=244 Identities=26% Similarity=0.389 Sum_probs=200.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 147 (334)
++|.+.+.||+|++|.||+|... +++.+++|.+... .......+..|..++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999964 6899999988642 2334467888999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999886543 4899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCc------------------cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc-
Q 037681 228 NESK------------------ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN- 288 (334)
Q Consensus 228 ~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~- 288 (334)
.... .......++..|+|||...+...+.++|+||||++++++++|+.||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHH
Confidence 2211 12223457889999999988889999999999999999999999997553210 000
Q ss_pred ------ccchhcccchhhhccccccCCccchhhh----hhhhhcc
Q 037681 289 ------GYDQTQVASKIKLVESCLARPFRQYCCI----LKVRTFG 323 (334)
Q Consensus 289 ------~~~~~~~~~~~~~i~~~l~~~~~~~~~~----~~~~~~~ 323 (334)
...........+++..|+..+|.+|++. .++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 234 ILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred HHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 0111134567899999999999999999 6666544
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=269.90 Aligned_cols=240 Identities=28% Similarity=0.399 Sum_probs=192.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
..|+..+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.++++++|||++++++++.+.+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778899999999999999954 6889999988633 2334457888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++ ++.+.+... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 666655432 234889999999999999999999998 99999999999999999999999998864322
Q ss_pred CCccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------ccccc-chhcccc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGY-DQTQVAS 297 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~-~~~~~~~ 297 (334)
.....|+..|+|||.+. ++.++.++|+||||+++|||++|+.||........ ..... .......
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHH
Confidence 12345788999999874 45688899999999999999999999865432110 00000 1113345
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..|+..+|..|+++.++....+
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChh
Confidence 788999999999999999998877554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=274.80 Aligned_cols=244 Identities=24% Similarity=0.341 Sum_probs=192.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecC--cce
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERD--EKL 145 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~--~~~ 145 (334)
.++|++.+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +||||+++++++...+ ..|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 468999999999999999999965 5888999988532 233445677899999999 9999999999986543 579
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+++ +|..++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999974 887776442 4788888999999999999999988 999999999999999999999999998765
Q ss_pred cCCCCc---cccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-----------------
Q 037681 226 KGNESK---ANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY----------------- 284 (334)
Q Consensus 226 ~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----------------- 284 (334)
...... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 433221 12233568899999998764 567889999999999999999999986432110
Q ss_pred --------------------ccccccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 285 --------------------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 285 --------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.............+.+++..|+..+|.+|+++.++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 000000011244577899999999999999988877654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=264.84 Aligned_cols=237 Identities=25% Similarity=0.353 Sum_probs=192.3
Q ss_pred cccCCcccEEEEEec-CCCEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR---QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 81 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
||.|+||.||++... +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 499999999864432 4556788999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC------
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES------ 230 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------ 230 (334)
..++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 98886543 4899999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchh--cccchhhhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQT--QVASKIKLV 302 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~--~~~~~~~~i 302 (334)
........++..|+|||...+...+.++|+||||+++|++++|+.||......... . ..+... ....+.+++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHH
Confidence 11223345788999999998888899999999999999999999998754322100 0 001111 256788999
Q ss_pred cccccCCccchhhh---hhhhhcc
Q 037681 303 ESCLARPFRQYCCI---LKVRTFG 323 (334)
Q Consensus 303 ~~~l~~~~~~~~~~---~~~~~~~ 323 (334)
..|+..+|.+|+++ .++.+..
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCc
Confidence 99999999999998 5544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=275.51 Aligned_cols=243 Identities=21% Similarity=0.291 Sum_probs=192.4
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----cc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-----EK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 144 (334)
++|.+.+.||+|+||+||+|.. .++..||+|.+... .......+..|+.+++.++||||+++++++.... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999995 46899999988643 2333456778999999999999999999876542 47
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+|+||+. ++|..++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 99999996 5777776443 34899999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--------------c-----
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------Y----- 284 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------~----- 284 (334)
..... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|++||...... .
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 53321 11223457889999998764 46889999999999999999999998643210 0
Q ss_pred ------------------ccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 ------------------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 ------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+..........+.+++..|+..+|.+|+++.++.+..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 0000001113445678999999999999999999887755
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=268.26 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=192.6
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46677789999999999999954 58999999986432 334567888999999996 9999999999999999999999
Q ss_pred ecCCCChhhhhhh--cccccccchHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 150 YLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHLH-SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 150 ~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|++. ++..+... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9865 44443211 11224588999999999999999999975 6 9999999999999999999999999987654
Q ss_pred CCCCccccccccccCCccCccccccC---CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-----------cccc-cc
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQG---ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-----------SING-YD 291 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----------~~~~-~~ 291 (334)
.... .....|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||........ .+.. ..
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 3221 1223578899999998765 688999999999999999999999875432100 0000 00
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
......+.+++..|+..+|.+|+++.++....+-
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 1134557899999999999999999998877653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=270.04 Aligned_cols=245 Identities=21% Similarity=0.343 Sum_probs=189.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE------ 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 143 (334)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 68999999999999999999954 68899999886432 2223455789999999999999999999876543
Q ss_pred --ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 144 --KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 144 --~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
.++||||+.+ +|...+.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4999999975 6766664332 24889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------
Q 037681 222 ARIFKGNESK--ANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------------- 284 (334)
Q Consensus 222 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------------- 284 (334)
+......... .......++..|+|||.+.+. .++.++|+||||+++|||++|++||.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9765432211 112234578889999987654 46889999999999999999999986432110
Q ss_pred ---ccc---ccc------------ch------hcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 285 ---LSI---NGY------------DQ------TQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 285 ---~~~---~~~------------~~------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
... ..+ .. .......+++..|+..+|.+|+++.++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~ 308 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD 308 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence 000 000 00 0123456799999999999999998887654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=270.19 Aligned_cols=235 Identities=26% Similarity=0.342 Sum_probs=188.6
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcce
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 145 (334)
...+|..+..||+|+||+|.++..+ +.+.+|||+++.. .....+--..|.++|... +-|.++.+..+|++-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3468899999999999999999855 4667999988643 233334445677777765 4689999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+.||+|-..+++-.+ +.+..+.-++.+|+-||-+||++| |++||||.+||+++.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999888766544 788889999999999999999998 999999999999999999999999999742
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchh
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKI 299 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~ 299 (334)
-.....+.+++|||.|+|||++...+|+..+|.||+||+||||+.|++||+.-+...+- -..+....+....
T Consensus 501 --i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv 578 (683)
T KOG0696|consen 501 --IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAV 578 (683)
T ss_pred --ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHH
Confidence 22344567799999999999999999999999999999999999999999876543110 0112222344555
Q ss_pred hhccccccCCccch
Q 037681 300 KLVESCLARPFRQY 313 (334)
Q Consensus 300 ~~i~~~l~~~~~~~ 313 (334)
+++...|.+.|.+|
T Consensus 579 ~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 579 AICKGLLTKHPGKR 592 (683)
T ss_pred HHHHHHhhcCCccc
Confidence 66666666666555
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=274.17 Aligned_cols=242 Identities=21% Similarity=0.251 Sum_probs=192.3
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD----- 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 142 (334)
..++|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999954 6899999988532 3344456778999999999999999999886443
Q ss_pred -cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 143 -EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 143 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
..|+||||+.+ +|...+... ++...+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 46999999975 666655321 788889999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------------cc---
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG-------------YL--- 285 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------------~~--- 285 (334)
+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 976533221 22345788999999999999999999999999999999999998643210 00
Q ss_pred --------------------cccccch-------------hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 --------------------SINGYDQ-------------TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 --------------------~~~~~~~-------------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+..... .......+++.+||..+|..|+++.++....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 0000000 01223578999999999999999999887664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=279.35 Aligned_cols=233 Identities=23% Similarity=0.304 Sum_probs=194.8
Q ss_pred cCCCcCCccccCCcccEEEEEecCCC-EEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGD-EIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.+++++..||-||||.|=++...... .+|+|.++.. +..+.+.+..|..+|..++.|.||++|..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 57778899999999999999865433 3777776532 4555678889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
|-|-||.+...++.+.. ++..++..++..+++|++|||.++ |++|||||+|++++.+|-+||.|||+|+.+..+
T Consensus 500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999966544 899999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---cccccc-----cchhcccchhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---YLSING-----YDQTQVASKIK 300 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~~~~~-----~~~~~~~~~~~ 300 (334)
. .+.+++|||.|.|||++.++..+.++|.||||+++|||++|++||...++- ..-+.+ +.........+
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 3 466789999999999999999999999999999999999999999876553 111111 12224555666
Q ss_pred hccccccCCccchh
Q 037681 301 LVESCLARPFRQYC 314 (334)
Q Consensus 301 ~i~~~l~~~~~~~~ 314 (334)
++.+....+|..|.
T Consensus 651 Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 651 LIKKLCRDNPTERL 664 (732)
T ss_pred HHHHHHhcCcHhhh
Confidence 77777777776663
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=266.10 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=194.7
Q ss_pred CCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR--QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
|++.+.||.|++|.||+|... +++.+++|.+..... .....+..|+.++++++||||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 667889999999999999954 688999998864432 34567788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++ ++..++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 76 7777665432 34889999999999999999999998 99999999999999999999999999876544321
Q ss_pred cccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cccccc------
Q 037681 232 ANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LSINGY------ 290 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~~~~~------ 290 (334)
......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||....... ..+...
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 12224578889999998776 78899999999999999999999986433200 000000
Q ss_pred ----------------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 291 ----------------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 291 ----------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.......+.+++..|+..+|.+|+++.++....+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0113456788999999999999999998876543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=261.16 Aligned_cols=227 Identities=23% Similarity=0.289 Sum_probs=181.2
Q ss_pred CccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHH-HhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVI-AKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|... +++.+|+|.+.... ......+..|..++ ...+|||++++++++...+..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999854 58899999886432 22223344454443 445899999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|..++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999885433 4789999999999999999999998 99999999999999999999999998865322
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccc-hhcccchhhhcc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYD-QTQVASKIKLVE 303 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~-~~~~~~~~~~i~ 303 (334)
.....++..|+|||.+.+..++.++||||+|+++|+|++|..||........ .+.... ......+.+++.
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 229 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHH
Confidence 2234578899999999888889999999999999999999999965432210 000000 113567889999
Q ss_pred ccccCCccchhhhh
Q 037681 304 SCLARPFRQYCCIL 317 (334)
Q Consensus 304 ~~l~~~~~~~~~~~ 317 (334)
+|+..+|..|++..
T Consensus 230 ~~l~~~p~~R~~~~ 243 (260)
T cd05611 230 RLLCMDPAKRLGAN 243 (260)
T ss_pred HHccCCHHHccCCC
Confidence 99999999999554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=287.61 Aligned_cols=249 Identities=20% Similarity=0.245 Sum_probs=182.3
Q ss_pred hhcCCCcCCccccCCcccEEEEEecC--CCEEEEEEe--------------c---ccChhhHHHHHHHHHHHHhcCCCCc
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLAK--GDEIAVKRL--------------S---VRSRQGLQELKNEALVIAKVQHKNL 131 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~--------------~---~~~~~~~~~~~~e~~~l~~l~h~~i 131 (334)
..++|++++.||+|+||+||++..+. +...+.|.+ . .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34789999999999999999987432 222222211 0 1122234567899999999999999
Q ss_pred ceEeeEEEecCcceEEEEecCCCChhhhhhhccc--ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC
Q 037681 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATK--RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD 209 (334)
Q Consensus 132 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~ 209 (334)
+++++++...+..|+|++++.+ ++..++..... ........+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999865 55555433211 111335567789999999999999998 99999999999999
Q ss_pred CCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCC-CCCccCC-----
Q 037681 210 KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKN-TEFYHTG----- 283 (334)
Q Consensus 210 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p-~~~~~~~----- 283 (334)
.++.+||+|||++..+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999986543322 112235789999999999999999999999999999999998754 3322110
Q ss_pred ----------cccccc-------c----------------ch--hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 ----------YLSING-------Y----------------DQ--TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 ----------~~~~~~-------~----------------~~--~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+.. + .. .....+.+++.+||..+|.+|++..++....+
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 000000 0 00 01223455688999999999999999887655
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=264.94 Aligned_cols=239 Identities=21% Similarity=0.240 Sum_probs=187.1
Q ss_pred CCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCcceEeeEEEec--CcceEEEE
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQ-HKNLVRLLGCCIER--DEKLLIYE 149 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 149 (334)
|++.+.||+|+||.||+|... +++.+|+|.++... ........+|+.++.++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 667889999999999999954 68899999886432 222233457888888885 99999999999987 88999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++ ++.+.+.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 6666664432 34899999999999999999999998 999999999999999 999999999997654322
Q ss_pred CccccccccccCCccCccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------------c----------
Q 037681 230 SKANTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------------L---------- 285 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------------~---------- 285 (334)
. .....++..|+|||.+. +..++.++|+||+||++|||++|.+||+..+... .
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1 12245788999999765 4567889999999999999999999996543210 0
Q ss_pred ----cccc--------cchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 286 ----SING--------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 286 ----~~~~--------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+.. ........+.+++.+|+..+|.+|+++.++....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~ 280 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence 0000 0011346688899999999999999998887654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=266.55 Aligned_cols=243 Identities=25% Similarity=0.374 Sum_probs=193.8
Q ss_pred CCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--CcceEEEE
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKLLIYE 149 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 149 (334)
|++.+.||.|++|.||+|... +++.+|+|.+... .......+.+|+.++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999965 4889999999755 234456678899999999999999999999988 78999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++ +|..++.... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 7777765432 34899999999999999999999988 9999999999999999999999999997654332
Q ss_pred CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cccccc----
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LSINGY---- 290 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~~~~~---- 290 (334)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..+...
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 1 11223356788999997764 457899999999999999999999986543210 000000
Q ss_pred ------------------chh-cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 291 ------------------DQT-QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 291 ------------------~~~-~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
... ....+.+++..|+..+|.+|+++.++....+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 000 1556788999999999999999988876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.72 Aligned_cols=244 Identities=17% Similarity=0.190 Sum_probs=177.8
Q ss_pred hcCCCcCCccccCCcccEEEEEecC----CCEEEEEEecccChhhH-----------HHHHHHHHHHHhcCCCCcceEee
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVRSRQGL-----------QELKNEALVIAKVQHKNLVRLLG 136 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~ 136 (334)
.++|.+.+.||+|+||+||+|...+ +..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3689999999999999999999654 34556665432221110 01122334456678999999999
Q ss_pred EEEecC----cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC
Q 037681 137 CCIERD----EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM 212 (334)
Q Consensus 137 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 212 (334)
++.... ..++++|++.. ++...+.... ..++..+..++.|++.||+|||+.+ ++||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 23677887644 4544443221 2567788899999999999999998 99999999999999999
Q ss_pred ceEEeeccccccccCCCC-----ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--
Q 037681 213 KPKISDFGMARIFKGNES-----KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-- 285 (334)
Q Consensus 213 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-- 285 (334)
.++|+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999986542221 1112234699999999999999999999999999999999999999976632210
Q ss_pred -----ccccc-------chhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 286 -----SINGY-------DQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 286 -----~~~~~-------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
++... .......+.++++.|+..+|++|+++.++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 00000 01124457789999999999999999887753
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=269.89 Aligned_cols=247 Identities=24% Similarity=0.341 Sum_probs=189.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------ 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 142 (334)
.++|++.+.||+|++|.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 479999999999999999999954 68899999886432 222345678999999999999999999875543
Q ss_pred --cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecc
Q 037681 143 --EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFG 220 (334)
Q Consensus 143 --~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 220 (334)
..++|+||+.+ ++...+... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999876 455554332 234899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCc---------cccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------
Q 037681 221 MARIFKGNESK---------ANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------ 284 (334)
Q Consensus 221 ~~~~~~~~~~~---------~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------ 284 (334)
++......... .......+++.|+|||.+.+ ..++.++||||||+++|||++|++||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 98765332211 11123356888999998765 457889999999999999999999986432210
Q ss_pred --------ccccc----------------------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 --------LSING----------------------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 --------~~~~~----------------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.. ........+.+++..|+..+|.+|+++.++....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 00000 00112245678999999999999999988876553
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=265.69 Aligned_cols=239 Identities=27% Similarity=0.389 Sum_probs=190.9
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.|...+.||+|+||+||+|... ++..+++|.+... .......+.+|+.+++.++|||++++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3666788999999999999954 6889999988643 23344567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+.+ ++..++.... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 102 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred cCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 9975 5656554322 34889999999999999999999998 9999999999999999999999999885422
Q ss_pred CccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccc-hhcccch
Q 037681 230 SKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYD-QTQVASK 298 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~-~~~~~~~ 298 (334)
......|+..|+|||.+. +..++.++|+||||+++|+|++|.+||....... ....... ......+
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence 122356888999999874 4568889999999999999999999986543211 0000000 1123457
Q ss_pred hhhccccccCCccchhhhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+++..|+..+|.+|+++.++....+
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcc
Confidence 88999999999999999998887655
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=273.26 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=191.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec----------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIER---------- 141 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------- 141 (334)
.+|.+.+.||.|+||.||+|... +|..||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 68999999999999999999954 6889999998766656667788999999999999999999876543
Q ss_pred ----CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEE
Q 037681 142 ----DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKI 216 (334)
Q Consensus 142 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl 216 (334)
...++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++. ++.++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34689999997 477766632 23788999999999999999999998 999999999999974 557899
Q ss_pred eeccccccccCCCC-ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc----------
Q 037681 217 SDFGMARIFKGNES-KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------- 284 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------- 284 (334)
+|||.+........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+..
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999875432211 111122357889999997654 567889999999999999999999996432100
Q ss_pred --------------------------ccccccchhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 285 --------------------------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 285 --------------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
.++............+++..|+..+|.+|+++.++....+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 00000001123446689999999999999999998876664
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=266.71 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=192.8
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERD----- 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 142 (334)
..++|++.+.||+|+||.||+|... +|+.||+|.++... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999965 58899999986432 233356678999999999999999999987654
Q ss_pred -----cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 143 -----EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 143 -----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
..++|+||+++ ++...+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 68999999987 555555432 234889999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------------
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG------------- 283 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------------- 283 (334)
|||.+......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||......
T Consensus 159 dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 159 DFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred cccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99998765433221 1122345778999998764 45788999999999999999999999643210
Q ss_pred ----cccccc-------------------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 ----YLSING-------------------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 ----~~~~~~-------------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..++.. ........+.+++..|+..+|.+|+++.++....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000000 00113456789999999999999999988876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=266.78 Aligned_cols=243 Identities=28% Similarity=0.388 Sum_probs=194.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
+.|+..+.||+|+||.||+|... +++.+++|.+... .......+.+|+++++.++|||++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777889999999999999954 5788999988632 3334456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+. +++...+.... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 46766654332 34788999999999999999999988 999999999999999999999999998754321
Q ss_pred CCccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------ccccc-chhcccc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGY-DQTQVAS 297 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~-~~~~~~~ 297 (334)
....++..|+|||.+. ...++.++||||||+++|+|++|+.||........ ..... .......
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHH
Confidence 2345788999999874 35678899999999999999999999865432110 00000 1113445
Q ss_pred hhhhccccccCCccchhhhhhhhhccCCcc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
+.+++.+|+..+|.+|+++.++....+...
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 778999999999999999999888777544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=264.57 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=191.3
Q ss_pred cCCCcCCccccCCcccEEEEEecC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRS-RQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|++|.||+|.+.. ++.+|+|.+.... ......+..|+.++.+.. ||||+++++++.+....|++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 688999999999999999999764 8899999986432 233455667777776664 9999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
|+++ ++..+..... ..+++..+..++.|++.|++|||+ ++ ++||||+|+||+++.++.++|+|||++......
T Consensus 95 ~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 6666554322 258889999999999999999997 46 999999999999999999999999998765332
Q ss_pred CCccccccccccCCccCccccccCC----CCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc--------cc--cchhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGI----CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--------NG--YDQTQ 294 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------~~--~~~~~ 294 (334)
.. .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.........+ .. .....
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF 245 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence 21 12235788899999987543 7889999999999999999999996532211000 00 01113
Q ss_pred ccchhhhccccccCCccchhhhhhhhhccC
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+.+++..|+..+|.+|+++.++....+
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 445788999999999999999999887765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=283.35 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=212.4
Q ss_pred hhHHHHhhcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEe--
Q 037681 65 FSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIE-- 140 (334)
Q Consensus 65 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-- 140 (334)
+..++..++.|++...||.|.+|.||+++ ..+++..|+|+...... ..++++.|.++++.+ +|||++.+++++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34455667889999999999999999999 45688899998865533 336778889999887 69999999999863
Q ss_pred ---cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 141 ---RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 141 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
++.+++|||||.+|+..++++... +..+.|..+..|+..++.|+.+||.+. ++|||||-.|||++.++.|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 567899999999999999987765 566999999999999999999999988 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccCcccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc---
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-----GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING--- 289 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--- 289 (334)
|||.+..+.. ......+..|||.|||||++.. ..|+..+|+||||++..||--|.+|+.+.++....+.-
T Consensus 166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN 243 (953)
T KOG0587|consen 166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 243 (953)
T ss_pred eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence 9999876543 3334556789999999999863 34677899999999999999999999988875222211
Q ss_pred -----c-chhcccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 290 -----Y-DQTQVASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 290 -----~-~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
. .....+.+.++|..||.+++++|+++.++...+|-.
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 1 111566788999999999999999999998887743
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=284.15 Aligned_cols=237 Identities=26% Similarity=0.401 Sum_probs=192.2
Q ss_pred cCCccccCCcccEEEEEe-cCCC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 77 DTNKLGEGGFGPVYKGVL-AKGD----EIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~-~~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..+.||+|+||+||+|.+ +.|+ +||+|++... ..+...++.+|+-+|.+++|||+++++++|.... ..+|++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 367899999999999994 4444 5889988643 4555688999999999999999999999998766 7889999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++|+|.++++.++. .+-.+..+.|+.||++|+.|||.+. +|||||..+||||..-.++|+.|||+++....+..
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999977554 4778889999999999999999888 99999999999999999999999999998766555
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-cccc----cchh--cccchhhhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-SING----YDQT--QVASKIKLV 302 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-~~~~----~~~~--~~~~~~~~i 302 (334)
........-.+.|+|-|.+....++.++|||||||++||++| |..|++.....+. ++.. ..+. -+.+..-++
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 444444445778999999999999999999999999999999 9999987644311 1111 1111 233455667
Q ss_pred cccccCCccchhhhhhh
Q 037681 303 ESCLARPFRQYCCILKV 319 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~ 319 (334)
-+||..+...|+.+.++
T Consensus 934 vkCwmid~~~rp~fkel 950 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKEL 950 (1177)
T ss_pred HHHhccCcccCccHHHH
Confidence 78998888777766553
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=271.24 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=196.1
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----cce
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-----EKL 145 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 145 (334)
+|++.+.||.|++|.||+|... +++.+++|.+.... ....+.+.+|+.+++.++||||+++.+++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999965 48999999886543 444567889999999999999999999988775 689
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
++|||+++ +|..++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+...
T Consensus 81 lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 7777764432 5899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCC-ccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------ccc--
Q 037681 226 KGNES-KANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LSI-- 287 (334)
Q Consensus 226 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~~-- 287 (334)
..... ........++..|+|||.+.+. .++.++|+||||+++|+|++|++||....... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 43321 0112334578899999999877 78999999999999999999999996543210 000
Q ss_pred ---------------------cccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 ---------------------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ---------------------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..........+.+++..||..+|.+|+++.++....+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 0000112345678999999999999999998877654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=267.98 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=192.7
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe-cCcceE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE-RDEKLL 146 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 146 (334)
.+++|++.+.||.|+||.||+|... ++..+|+|.+... .....+.+..|+.++++++||||+++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4578999999999999999999854 7899999987532 23344677889999999999999999999876 457889
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
++||+ +++|..++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 88 v~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 88 VTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred Eeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 99998 4578777643 23678888899999999999999998 9999999999999999999999999987532
Q ss_pred CCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------------------
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------------- 284 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------------- 284 (334)
.. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......
T Consensus 160 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 160 PQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred CC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 21 122456888999998765 568899999999999999999999996543200
Q ss_pred ----c------------cccccchhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 285 ----L------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 285 ----~------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
. +...........+.+++..|+..+|.+|+++.++....+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 0 0000001123567889999999999999999988777653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=266.96 Aligned_cols=243 Identities=20% Similarity=0.224 Sum_probs=187.2
Q ss_pred cCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCC
Q 037681 77 DTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
+.+.+|.|+++.|+++.. +++.+|+|++... .....+.+..|+.+++.++||||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344445555555555443 6899999998644 4456678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC----
Q 037681 155 SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES---- 230 (334)
Q Consensus 155 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 230 (334)
+|.+++..... ..+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99998865432 23788889999999999999999998 99999999999999999999999998865432211
Q ss_pred -ccccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc----------------cc-
Q 037681 231 -KANTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN----------------GY- 290 (334)
Q Consensus 231 -~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----------------~~- 290 (334)
........++..|+|||.+.+ ..++.++|+||+|+++|||++|+.||.........+. ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 111223456778999999865 3578899999999999999999999975322100000 00
Q ss_pred -----------------------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 291 -----------------------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 291 -----------------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.........+++..||..+|.+|+++.++.+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0001234667999999999999999998887665
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=268.48 Aligned_cols=245 Identities=22% Similarity=0.274 Sum_probs=191.0
Q ss_pred cCCCc-CCccccCCcccEEEEEec-CCCEEEEEEecccChhh--------------HHHHHHHHHHHHhcCCCCcceEee
Q 037681 73 NNFSD-TNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQG--------------LQELKNEALVIAKVQHKNLVRLLG 136 (334)
Q Consensus 73 ~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~~ 136 (334)
++|.. .+.||.|+||+||+|.+. +++.||+|.+....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56764 467999999999999954 68999999886432111 124678999999999999999999
Q ss_pred EEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 137 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
++...+..++||||++ ++|..++... ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 5787777443 23889999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCC------------ccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCC
Q 037681 217 SDFGMARIFKGNES------------KANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG 283 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 283 (334)
+|||++........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|++||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999876541110 1111223467889999988764 4688999999999999999999998644321
Q ss_pred c--------------ccccc--------------------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 Y--------------LSING--------------------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 ~--------------~~~~~--------------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. ..+.. ........+.+++..|+..+|.+|+++.++....+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 0 00000 00112455778999999999999999998887655
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=269.15 Aligned_cols=241 Identities=21% Similarity=0.308 Sum_probs=191.6
Q ss_pred hhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD----- 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 142 (334)
..++|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 457899999999999999999984 46899999988532 2333456789999999999999999999987654
Q ss_pred -cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 143 -EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 143 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
..++||||+ +++|..++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 348999998 6788777643 23889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------------
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------------- 285 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------------- 285 (334)
+...... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||........
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8754322 123457889999998875 4578899999999999999999999964321100
Q ss_pred ----------------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ----------------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ----------------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+..........+.+++..|+..+|.+|+++.++....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000000112334678999999999999999988876655
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=269.37 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=192.5
Q ss_pred HHHHhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--
Q 037681 67 SVAAATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-- 141 (334)
Q Consensus 67 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 141 (334)
++-...++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 3445668999999999999999999985 46889999988643 223345678899999999999999999988643
Q ss_pred ----CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 142 ----DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 142 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
...|++++++ +++|..++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 3357888876 67887776432 3788999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-----------
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------- 285 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------- 285 (334)
|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........
T Consensus 163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99998753221 223467889999998766 5678899999999999999999999864321100
Q ss_pred --c----c--------------------cccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 --S----I--------------------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 --~----~--------------------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. + ............+++..|+..+|.+|.+..++....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0 0 0000012344678999999999999999998887765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=293.08 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=193.8
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe-------
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE------- 140 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 140 (334)
...++|+.++.||+||||.||+++++ +|..||||++... +......+.+|+..+++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34578999999999999999999966 8999999999755 45556778999999999999999999862100
Q ss_pred --------------------------------------------------------------------------------
Q 037681 141 -------------------------------------------------------------------------------- 140 (334)
Q Consensus 141 -------------------------------------------------------------------------------- 140 (334)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred -------------------------c-------CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHh
Q 037681 141 -------------------------R-------DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188 (334)
Q Consensus 141 -------------------------~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~L 188 (334)
. ..+||-||||+..++.+++..+.-. -.....++++.+|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 0 1237889999988887777543321 14677899999999999999
Q ss_pred hhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc----------------CCCCccccccccccCCccCccccccC
Q 037681 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK----------------GNESKANTNRVAGTFGYIPPEYVYQG 252 (334)
Q Consensus 189 H~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~~~~ 252 (334)
|++| |+||||||.||+++++++|||+|||+|+... .+......+...||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998621 00111133456799999999998754
Q ss_pred ---CCCcchhhHhHHHHHHHHHhCCCCCCCccC----------Cccccc-ccchhcccchhhhccccccCCccchhhhhh
Q 037681 253 ---ICSIKSDVFSFGMLLLEILSGKKNTEFYHT----------GYLSIN-GYDQTQVASKIKLVESCLARPFRQYCCILK 318 (334)
Q Consensus 253 ---~~~~~~DiwslG~il~ell~g~~p~~~~~~----------~~~~~~-~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~ 318 (334)
.|+.|+|+||||+|++||+. ||..... +..+.. .......+....+|..++..+|.+||+..+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 49999999999999999995 3442211 111211 122334555677888899999999999999
Q ss_pred hhhccCCcc
Q 037681 319 VRTFGFNLP 327 (334)
Q Consensus 319 ~~~~~~~~~ 327 (334)
+..-.+-+|
T Consensus 868 LL~s~llpp 876 (1351)
T KOG1035|consen 868 LLNSELLPP 876 (1351)
T ss_pred HhhccCCCc
Confidence 998888776
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=273.62 Aligned_cols=232 Identities=26% Similarity=0.363 Sum_probs=186.5
Q ss_pred CccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCC
Q 037681 79 NKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKS 155 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 155 (334)
+.||+|-||+||-|++ ++|+.||||++... ...+...+.+|+.+|..++||.||.+-..|++.+..|+|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 6899999999999994 57999999999643 33444778999999999999999999999999999999999997755
Q ss_pred hhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEeeccccccccCCCCcc
Q 037681 156 LDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 156 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
|+..+... .+.+++.....++.||+.||.|||.++ |+|+||||+|||+.. ..++||||||.|+.++...
T Consensus 650 LEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 650 LEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred HHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 55555433 344888888999999999999999998 999999999999954 4579999999999876443
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------cccccccchh-cccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG-------YLSINGYDQT-QVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~i~~ 304 (334)
....+.|||.|+|||++.++.|...-|+||.|+|+|--++|.-||+...+- ...+..-.|. .+...+++|+.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 344578999999999999999999999999999999999999999754321 1111112222 45566777777
Q ss_pred cccCCccchhhhhh
Q 037681 305 CLARPFRQYCCILK 318 (334)
Q Consensus 305 ~l~~~~~~~~~~~~ 318 (334)
.|+..-++|-++.+
T Consensus 802 LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDK 815 (888)
T ss_pred HHHHHHHHhcchHh
Confidence 77666555554444
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=260.69 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=189.3
Q ss_pred CCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCcceEeeEEEecCc-----
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKV---QHKNLVRLLGCCIERDE----- 143 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 143 (334)
|++.+.||+|+||.||+|.+. +++.+|+|.+.... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 48999999986432 22234566777777665 69999999999988776
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.+++|||+++ +|..++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 78777754322 24889999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--------------c---
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------------S--- 286 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------------~--- 286 (334)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|++||........ .
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 6543321 1223478889999999988999999999999999999999999875432100 0
Q ss_pred --------cc--------ccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 287 --------IN--------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 287 --------~~--------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+. ...........+++..|+..+|.+|+++.++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 00 00001234567889999999999999998877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=266.88 Aligned_cols=244 Identities=23% Similarity=0.282 Sum_probs=188.8
Q ss_pred CCCcCCccccCCcccEEEEEec-C--CCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec----Cc
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-K--GDEIAVKRLSVR--SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER----DE 143 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~ 143 (334)
+|++.+.||+|+||.||++... . +..+|+|.+... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999954 3 778999988642 222345678899999999 599999999875432 34
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+++||+. ++|..++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688899886 5787777433 24889999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCc--cccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-----------------
Q 037681 224 IFKGNESK--ANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG----------------- 283 (334)
Q Consensus 224 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----------------- 283 (334)
........ .......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|++||......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 11233568999999998765 46889999999999999999999998653210
Q ss_pred --------------------cccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 --------------------YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 --------------------~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+..........+.+++.+|+..+|.+|+++.++..-.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00000111113456788999999999999999988776554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=255.38 Aligned_cols=204 Identities=25% Similarity=0.384 Sum_probs=167.7
Q ss_pred cCCCcCCccccCCcccEEEEEecC-----CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEe-cCcc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-----GDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIE-RDEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 144 (334)
..|+.+..||+|+||.||+|..++ ...+|||+++... .......-+|+.+++.++|||++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 579999999999999999997332 2368999887442 2234567789999999999999999999988 7788
Q ss_pred eEEEEecCCCChhhhhhhc--ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC----CceEEee
Q 037681 145 LLIYEYLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE----MKPKISD 218 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~D 218 (334)
++++||.+. +|...++-+ .....++...+..|+.||+.|+.|||++. |.||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 454544322 22346889999999999999999999998 9999999999999887 8999999
Q ss_pred ccccccccCCCCcc-ccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCc
Q 037681 219 FGMARIFKGNESKA-NTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFY 280 (334)
Q Consensus 219 fg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~ 280 (334)
||+++.+.+.-... ....++-|..|.|||++.+. -|+++.||||.|||+.||+|-++-|...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999876543322 34456679999999998875 5899999999999999999998887643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=254.23 Aligned_cols=202 Identities=25% Similarity=0.365 Sum_probs=178.9
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecc---cChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSV---RSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|..++.||+|+|++|..+.+ ++.+.+|+|+++. +..+.++.++.|..++.+. +||.+|.+..+|+++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46899999999999999999994 4688899998863 4566677888888888877 79999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|.||.+||+|-..++.+++ ++++.+..+..+|..||.|||+.| |++||||.+|||+|..|++||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999877766555 899999999999999999999998 9999999999999999999999999997422
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCcc
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYH 281 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 281 (334)
.....+++++|||.|.|||++.+..|...+|.|+||++++||+.|+.||+.-.
T Consensus 403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 22234667899999999999999999999999999999999999999998543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=261.83 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=190.6
Q ss_pred CCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh-hhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEEec
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR-QGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
|++.+.||+|++|.||+|... +++.+++|++..... .......+|+..+++++ |||++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999965 578899998864322 22233457899999999 999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
+++|..++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 778877775443 234899999999999999999999998 99999999999999999999999999876533221
Q ss_pred cccccccccCCccCccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------------------------
Q 037681 232 ANTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------------------- 285 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------------------- 285 (334)
.....++..|+|||.+. +..++.++|+||||+++++|++|++||........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22345788999999875 45578999999999999999999999864422100
Q ss_pred -----------cccccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 286 -----------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 286 -----------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+............+++..|+..+|.+|+++.++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~ 281 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence 00000011235678999999999999999998877654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=261.56 Aligned_cols=240 Identities=25% Similarity=0.321 Sum_probs=189.5
Q ss_pred CCCcCCccccCCcccEEEEEec----CCCEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcc
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVRS----RQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 144 (334)
+|++.+.||+|++|.||++... ++..+|+|.+.... ......+..|+.++.++ +||||+++.+.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999843 46789999886321 23345678899999999 599999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||+++++|..++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999988875432 3788899999999999999999988 99999999999999999999999999876
Q ss_pred ccCCCCccccccccccCCccCccccccCC--CCcchhhHhHHHHHHHHHhCCCCCCCccCCc--cccc--------ccch
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGI--CSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--LSIN--------GYDQ 292 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~--------~~~~ 292 (334)
....... ......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||....... ..+. ....
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK 233 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc
Confidence 5433221 122345788999999987654 7889999999999999999999986432110 0000 0011
Q ss_pred hcccchhhhccccccCCccchhhhhhhh
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVR 320 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~ 320 (334)
.....+.+++.+|+..+|+.|+++..+.
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~ 261 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGAD 261 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHH
Confidence 1244578899999999999998865443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=268.33 Aligned_cols=239 Identities=22% Similarity=0.328 Sum_probs=188.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------ 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 142 (334)
.++|.+.+.||+|+||.||+|... +|+.+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999954 6899999988643 2233456789999999999999999999987543
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..++|+||+.. +|..+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999864 565443 123788899999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----------------
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------------- 285 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------------- 285 (334)
...... .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 753221 223457889999998876 4688899999999999999999999975421000
Q ss_pred ---------------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ---------------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ---------------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+..........+.+++..|+..+|.+|+++.++....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~ 299 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000000012344678999999999999999988876544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=258.77 Aligned_cols=245 Identities=26% Similarity=0.314 Sum_probs=192.3
Q ss_pred CCCcCCccccCCcccEEEEEecC-CCEEEEEEecc---c--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSV---R--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~---~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
+|.+.+.||+|+||.||++.... +..+++|.++. . .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999998543 44455555432 1 122334566789999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhc-ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 148 YEYLPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
+||+++++|..++... .....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998887542 22345899999999999999999999988 999999999999975 569999999987654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccchhcccchh
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYDQTQVASKI 299 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~ 299 (334)
.... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ...............
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN 234 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHH
Confidence 3222 1223457889999999888888999999999999999999999986432211 011111122345678
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++..|+..+|..|+++.++....+
T Consensus 235 ~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 235 SIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred HHHHHHhcCChhhCcCHHHHhhCCC
Confidence 8999999999999999998876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=264.91 Aligned_cols=242 Identities=21% Similarity=0.281 Sum_probs=187.0
Q ss_pred CccccC--CcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEG--GFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G--~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
..||+| +||+||.+.+ .+|+.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999996 46999999998643 334457788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc-
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA- 232 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 232 (334)
+++..++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999988865432 23788889999999999999999988 9999999999999999999999998654322111100
Q ss_pred ----ccccccccCCccCccccccC--CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-----------ccc-------
Q 037681 233 ----NTNRVAGTFGYIPPEYVYQG--ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-----------SIN------- 288 (334)
Q Consensus 233 ----~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----------~~~------- 288 (334)
......++..|+|||++.+. .++.++||||+|+++|||++|+.||........ ++.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 01112345679999998764 478899999999999999999999975422100 000
Q ss_pred -------------------------------cc----chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 -------------------------------GY----DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 -------------------------------~~----~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.. .......+.+++..||..+|.+|+++.++.+-.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00 0012335778999999999999999998765543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=252.75 Aligned_cols=241 Identities=21% Similarity=0.226 Sum_probs=192.8
Q ss_pred hhcCCCcC-CccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEe----cCc
Q 037681 71 ATNNFSDT-NKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIE----RDE 143 (334)
Q Consensus 71 ~~~~y~~~-~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 143 (334)
.+++|.+. +.||-|-.|.|..+.+ .+|+.+|+|++... ....+|+++.-.. .|||||.+++++++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677765 4689999999999985 46899999988643 3346777765555 59999999999875 345
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEeecc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKISDFG 220 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg 220 (334)
+.+|||.++||.|...+.++. ...+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 678999999999988887654 345899999999999999999999998 999999999999954 4469999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------------cccc
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG-------------YLSI 287 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------------~~~~ 287 (334)
+|+.-.. .....+.+-|+.|.|||++....|+..+|+||+||++|-|++|-+||-..+.. .-.|
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 9976432 22344567899999999999999999999999999999999999999655432 1122
Q ss_pred cccchh-cccchhhhccccccCCccchhhhhhhhhcc
Q 037681 288 NGYDQT-QVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 288 ~~~~~~-~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
..-.|. .++...++|+..|.-+|.+|-++.++-...
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 222333 466788899999999999999988765543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=256.37 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=193.3
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccCh-hhHHHHHHHHHHHHh-cCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSR-QGLQELKNEALVIAK-VQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++.+-+..||.|+||+|++-.+ +.|+..|||+++.... ...+++..|.+...+ -+.||||+++|.+-.++..++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3445567899999999999985 4699999999986543 455677778876554 479999999999999999999999
Q ss_pred ecCCCChhhhhhhc--ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 150 YLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 150 ~~~~~~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
.|+- +++.+.... ..+..++++....|....+.||.||-..- .|+|||+||+|||++..|.+||||||++..+.+
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9854 666544321 22345888888899999999999997654 499999999999999999999999999876544
Q ss_pred CCCccccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC----------cccccccc---h
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG----------YLSINGYD---Q 292 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----------~~~~~~~~---~ 292 (334)
+.. .+...|...|||||.+.. ..|+.++|+||||++|||+.||+.|+....+- ..+..... .
T Consensus 221 SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 221 SIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred HHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 322 233468899999999863 34889999999999999999999998765332 11111111 1
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
.....+..++.-|+.++-+.|+....++++.+-
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy 330 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY 330 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence 145568889999999999999999999888763
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=254.18 Aligned_cols=234 Identities=26% Similarity=0.351 Sum_probs=191.6
Q ss_pred cccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 81 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
||.|+||.||.+... +++.+++|.+.... ......+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 58899999886442 23456788999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcccccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 236 (334)
.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 98885543 3889999999999999999999988 9999999999999999999999999987654322 12233
Q ss_pred ccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc--c--ccchhcccchhhhccccccCCc
Q 037681 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI--N--GYDQTQVASKIKLVESCLARPF 310 (334)
Q Consensus 237 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~--~--~~~~~~~~~~~~~i~~~l~~~~ 310 (334)
..++..|+|||...+...+.++|+||||+++|++++|+.||........ .. . .........+.+++..|+..+|
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCH
Confidence 5678899999999888889999999999999999999999965432100 00 0 0111135668899999999999
Q ss_pred cchhhh---hhhhhc
Q 037681 311 RQYCCI---LKVRTF 322 (334)
Q Consensus 311 ~~~~~~---~~~~~~ 322 (334)
..|++. .+++..
T Consensus 233 ~~R~~~~~~~~l~~~ 247 (250)
T cd05123 233 TKRLGSGGAEEIKAH 247 (250)
T ss_pred hhCCCcccHHHHHhC
Confidence 999998 555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=271.09 Aligned_cols=210 Identities=24% Similarity=0.367 Sum_probs=176.7
Q ss_pred cCCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
+-|..++.||-|+||.|.++. ..+...+|.|.++.. .+.+...++.|.+||...+++.||+++..|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457778999999999999998 444667899988643 4566778899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
+|++||++-.+|-.. +.+++..+..++.++..|+++.|..| ++||||||+|||||.+|++||+|||++.-+.-.
T Consensus 709 dYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 999999998877443 34889999999999999999999888 999999999999999999999999998644211
Q ss_pred CC----------c------------------------------cccccccccCCccCccccccCCCCcchhhHhHHHHHH
Q 037681 229 ES----------K------------------------------ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLL 268 (334)
Q Consensus 229 ~~----------~------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ 268 (334)
+. . ......+||+.|+|||++....++..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00 0 0011245999999999999999999999999999999
Q ss_pred HHHhCCCCCCCccCCccccc
Q 037681 269 EILSGKKNTEFYHTGYLSIN 288 (334)
Q Consensus 269 ell~g~~p~~~~~~~~~~~~ 288 (334)
||+.|++||-...+....+.
T Consensus 863 em~~g~~pf~~~tp~~tq~k 882 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYK 882 (1034)
T ss_pred HHhhCCCCccCCCCCcceee
Confidence 99999999987766644433
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=269.54 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=192.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc-----
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE----- 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 143 (334)
.++|++.+.||+|++|.||+|.+. +++.+|+|.+... .......+.+|+.++++++|||++++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 478999999999999999999965 5889999988643 23344667789999999999999999998766554
Q ss_pred -ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 144 -KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 144 -~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 79999998 5688877743 23899999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----------------
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------------- 285 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------------- 285 (334)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 764322 223457888999998765 4678899999999999999999999864322100
Q ss_pred ---------------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ---------------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ---------------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+..........+.+++..|+..+|.+|+++.++....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 000000112456778999999999999999999887654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=259.26 Aligned_cols=242 Identities=25% Similarity=0.345 Sum_probs=194.5
Q ss_pred CCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
|+..+.||+|++|.||+|+.. +++.+++|.+.... ......+..|+.++++++|||++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999987542 334567788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++ +|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 DM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred Cc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 84 8988886542 24899999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------------------------
Q 037681 232 ANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------------------- 283 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------------------- 283 (334)
......++..|+|||.+.+. .++.++|+||||+++|||++|++||......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223457789999998766 7899999999999999999999998643210
Q ss_pred ccccccc--------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 YLSINGY--------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 ~~~~~~~--------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+..+ .......+.+++..|+..+|.+|+++.++....+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 0000000 0012346888999999999999999988776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.68 Aligned_cols=242 Identities=29% Similarity=0.443 Sum_probs=202.2
Q ss_pred cCCCcCCccccCCcccEEEEEecC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.+....+.||-|-||.||.|.|+. ...||||.++.. .-..++|.+|+.+|+.++|||+|+++|+|..+..+|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 455566899999999999999775 678999988743 445689999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
..|+|.+||++..+. .++.-..++++.||..|++||...+ ++||||..+|+|+.++..+|++|||+++++..+...
T Consensus 346 ~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999999876543 3677778899999999999999888 999999999999999999999999999988765442
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCC--c-ccccccchh----cccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTG--Y-LSINGYDQT----QVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~--~-~~~~~~~~~----~~~~~~~~i~ 303 (334)
. .....-...|.|||-+....++.|+|||+|||+|||+.| |..||+...-. + +.-.++... -.+..-++..
T Consensus 422 A-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 A-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred c-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 2 222233668999999999999999999999999999998 99999876443 1 111223333 4667888999
Q ss_pred ccccCCccchhhhhhhh
Q 037681 304 SCLARPFRQYCCILKVR 320 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~ 320 (334)
.||.=.|.+|+++.++-
T Consensus 501 aCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHhcCCcccCccHHHHH
Confidence 99999999999987764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=266.91 Aligned_cols=242 Identities=26% Similarity=0.404 Sum_probs=197.4
Q ss_pred CCCcCCccccCCcccEEEEEecC---CC--EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAK---GD--EIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~---~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
..+..+.||.|-||.||+|++.+ |. .||||..+.+ .....+.|..|.-+|+.++||||++++|+|.+ ...++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 33455789999999999999532 43 4788877653 44557889999999999999999999999975 468999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
||.++.|.|..+++.++. .++......++.||..||+|||+.. +|||||..+|||+....-+||+|||+++.+.+
T Consensus 469 mEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999976554 4888899999999999999999998 99999999999999999999999999998876
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--cc-----ccchhcccchh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--IN-----GYDQTQVASKI 299 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~~-----~~~~~~~~~~~ 299 (334)
....... ...-...|||||.+.-..++.++|||-|||++||+++ |..||........- +. .....-+..+-
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY 622 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence 6544332 3345778999999999999999999999999999987 99999876443211 00 01111355677
Q ss_pred hhccccccCCccchhhhhhhhhc
Q 037681 300 KLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+.-+||+-+|.+|+.+.++...
T Consensus 623 slmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred HHHHHHhccCcccCCcHHHHHHH
Confidence 88899999999999988877654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=250.91 Aligned_cols=217 Identities=21% Similarity=0.150 Sum_probs=174.0
Q ss_pred CCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCChhhhhhh
Q 037681 84 GGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFD 162 (334)
Q Consensus 84 G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 162 (334)
|.+|.||++.+ .+++.+|+|.+.... ....|...+....||||+++++++.+.+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 468899999986543 223445555566799999999999999999999999999999888855
Q ss_pred cccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCC
Q 037681 163 ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFG 242 (334)
Q Consensus 163 ~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~ 242 (334)
.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 43 3889999999999999999999988 999999999999999999999999987654322 112345778
Q ss_pred ccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc--cchhcccchhhhccccccCCccchhhh
Q 037681 243 YIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING--YDQTQVASKIKLVESCLARPFRQYCCI 316 (334)
Q Consensus 243 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~~~~~~~~ 316 (334)
|+|||...+..++.++|+||+|+++|||++|+.|+............ ........+.+++.+|+..+|.+|.+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 99999998888899999999999999999999887643222111111 111134567789999999999999875
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=281.76 Aligned_cols=145 Identities=27% Similarity=0.412 Sum_probs=130.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|.+.+.||+|+||.||+|.+. ++..||+|++... .......+..|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 68999999999999999999965 6889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
||+.+++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999885433 3788889999999999999999988 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=271.88 Aligned_cols=242 Identities=26% Similarity=0.367 Sum_probs=199.5
Q ss_pred cCCCcCCccccCCcccEEEEEec--CCC--EEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA--KGD--EIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++....++||+|+||.|+.|.|. .|+ .||||.+...... ....|.+|+.+|.+|+|||++++||+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34556689999999999999965 344 4799999866544 67889999999999999999999999887 678899
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
||.+++|+|.+.|+. ..+..+.......++.|||.|+.||.++. +|||||..+|+++-....|||+|||+.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 34456778888899999999999999998 99999999999999888999999999998765
Q ss_pred CCCcccc-ccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccccc--------cchhcccc
Q 037681 228 NESKANT-NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSING--------YDQTQVAS 297 (334)
Q Consensus 228 ~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~--------~~~~~~~~ 297 (334)
+.....+ ....-...|+|||.+....++.++|||+|||++|||+| |+.||-....- .-+.. ....-.++
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-qIL~~iD~~erLpRPk~csed 343 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-QILKNIDAGERLPRPKYCSED 343 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-HHHHhccccccCCCCCCChHH
Confidence 5443222 22334567999999999999999999999999999999 88898754332 11111 11124667
Q ss_pred hhhhccccccCCccchhhhhhhh
Q 037681 298 KIKLVESCLARPFRQYCCILKVR 320 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~ 320 (334)
+-++...||...|.+||++--++
T Consensus 344 IY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 344 IYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred HHHHHHHhccCCccccccHHHHH
Confidence 88899999999999999988775
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=235.72 Aligned_cols=214 Identities=27% Similarity=0.383 Sum_probs=173.1
Q ss_pred cCCCcCCccccCCcccEEEEE-ecCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++...+..||+|++|.|-+.+ ..+|+..|+|.+... +.+..++...|+++..+. .+|++|.++|.....+..++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 455557789999999998888 457999999999754 334446677888876655 79999999999999999999999
Q ss_pred ecCCCChhhhhhhc-ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 150 YLPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 150 ~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
.|+. +|+.+.... ..+..+++..+-+|+..++.||.|||++- .++|||+||+|||++.+|++|+||||.+-.+.++
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9864 676655432 34556899999999999999999999875 5999999999999999999999999999876544
Q ss_pred CCccccccccccCCccCccccc----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccch
Q 037681 229 ESKANTNRVAGTFGYIPPEYVY----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQ 292 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 292 (334)
... +...|...|+|||.+. +..|+.++||||||+++.||.+++.||+....+...+.+...
T Consensus 203 iAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 203 IAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 322 2245888999999885 346889999999999999999999999887666555444333
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=267.36 Aligned_cols=238 Identities=24% Similarity=0.295 Sum_probs=193.0
Q ss_pred hhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
..+.|+....+|.|+|+.|-.+.. .+++..++|++.... ....+|+.++... +||||+++.+++.+....|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 367888889999999999999984 468889999987552 2234566555544 7999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee-CCCCceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL-DKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~ 227 (334)
|.+.++.+.+.+..... .. ..+..|+.+|+.|+.|||.+| +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988666544332 23 677789999999999999998 9999999999999 6889999999999987554
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc------ccchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN------GYDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~ 301 (334)
. ....+-|..|.|||++....++.++|+||||++||+||+|+.||..-..+ ..+. ......+....++
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~~s~~vS~~AKdL 542 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPKFSECVSDEAKDL 542 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCccccccCHHHHHH
Confidence 3 22346688999999999999999999999999999999999999764333 1111 1113356678899
Q ss_pred ccccccCCccchhhhhhhhhccCC
Q 037681 302 VESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
+..+|+.+|..|.++.+++...+.
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhccCChhhCcChhhhccCcch
Confidence 999999999999999988776654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=222.30 Aligned_cols=198 Identities=25% Similarity=0.424 Sum_probs=164.3
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+|...+.||+|.+|+||+|++. +++.||+|.++.. ++.......+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5666789999999999999954 5788999988644 344456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
|.. +|..+.-.. .+.++.+.+..++.|+++|+.++|+++ +.|||+||.|.+++.+|.+|++|||+++.+.....
T Consensus 83 cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 964 555554322 234889999999999999999999999 99999999999999999999999999987654321
Q ss_pred ccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 037681 231 KANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILS-GKKNTEF 279 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~-g~~p~~~ 279 (334)
+ .+...-|..|.+|.++.+. -|++..|+||-||++.|+.. |++.|+.
T Consensus 157 -c-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 157 -C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred -e-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 1 2223458899999998875 58899999999999999987 6665653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=267.88 Aligned_cols=248 Identities=29% Similarity=0.380 Sum_probs=195.4
Q ss_pred hcCCCcCCccccCCcccEEEEEec----C----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA----K----GDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~----~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
.++..+.+.||+|.||+|++|... . ...||||.++.. .....+.+..|+++|+.+ .||||+.++|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 345566779999999999999832 1 346899988743 345678899999999999 599999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhcc-------cc------cccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDAT-------KR------VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~-------~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
+..++|+||+..|+|..+++..+ .+ ..++....+.++.||+.|++||++.. ++||||..+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999997765 00 23788899999999999999999887 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCcc-ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc
Q 037681 209 DKEMKPKISDFGMARIFKGNESKA-NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS 286 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~ 286 (334)
..+..+||+|||+++......... ......-...|||||.+....++.++||||||++|||++| |..||.........
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 999999999999998654433322 1111113456999999999999999999999999999999 88999763211110
Q ss_pred cc----ccchh----cccchhhhccccccCCccchhhhhhhhhc
Q 037681 287 IN----GYDQT----QVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 287 ~~----~~~~~----~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+. +.... -....-++...|+..+|.+|+++.++..+
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 11 11111 24456678899999999999998886654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=236.76 Aligned_cols=230 Identities=26% Similarity=0.342 Sum_probs=190.2
Q ss_pred CcccEEEEEec-CCCEEEEEEecccChhh-HHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCChhhhhhh
Q 037681 85 GFGPVYKGVLA-KGDEIAVKRLSVRSRQG-LQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFD 162 (334)
Q Consensus 85 ~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 162 (334)
+||.||+|... +|+.+++|.+....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999987654444 67889999999999999999999999999999999999999999988855
Q ss_pred cccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCC
Q 037681 163 ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFG 242 (334)
Q Consensus 163 ~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~ 242 (334)
... ++...+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 433 788999999999999999999998 9999999999999999999999999998654332 2233457889
Q ss_pred ccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc-------ccchh---cccchhhhccccccCCccc
Q 037681 243 YIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN-------GYDQT---QVASKIKLVESCLARPFRQ 312 (334)
Q Consensus 243 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-------~~~~~---~~~~~~~~i~~~l~~~~~~ 312 (334)
|++||...+..++.++|+||+|++++++++|..||........... ..... ....+.+++..|+..+|.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 231 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEK 231 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchh
Confidence 9999999888889999999999999999999999976322110000 00000 3356788999999999999
Q ss_pred hhhhhhhhhcc
Q 037681 313 YCCILKVRTFG 323 (334)
Q Consensus 313 ~~~~~~~~~~~ 323 (334)
|+++.++.+..
T Consensus 232 Rp~~~~~~~~~ 242 (244)
T smart00220 232 RLTAEEALQHP 242 (244)
T ss_pred ccCHHHHhhCC
Confidence 99999887644
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=255.32 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=179.5
Q ss_pred hcCCCcCCccccCCcccEEEEEe-----------------cCCCEEEEEEecccChhhHHH--------------HHHHH
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-----------------AKGDEIAVKRLSVRSRQGLQE--------------LKNEA 120 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~--------------~~~e~ 120 (334)
.++|++.+.||+|+||.||+|.. ..+..||||++........+. ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999963 235679999986543322222 23466
Q ss_pred HHHHhcCCCCc-----ceEeeEEEe--------cCcceEEEEecCCCChhhhhhhccc---------------------c
Q 037681 121 LVIAKVQHKNL-----VRLLGCCIE--------RDEKLLIYEYLPNKSLDFFLFDATK---------------------R 166 (334)
Q Consensus 121 ~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~ 166 (334)
.++.+++|.++ ++++++|.. .+..++|+||+++++|.+++..... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777766544 677777653 3467999999999999988864211 1
Q ss_pred cccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCc
Q 037681 167 VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPP 246 (334)
Q Consensus 167 ~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP 246 (334)
..+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++......... ......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 12456778899999999999999988 999999999999999999999999998654322111 11122347899999
Q ss_pred cccccCCC----------------------CcchhhHhHHHHHHHHHhCCC-CCCCccCC-------ccccccc------
Q 037681 247 EYVYQGIC----------------------SIKSDVFSFGMLLLEILSGKK-NTEFYHTG-------YLSINGY------ 290 (334)
Q Consensus 247 E~~~~~~~----------------------~~~~DiwslG~il~ell~g~~-p~~~~~~~-------~~~~~~~------ 290 (334)
|.+..... ..+.|+||+||++|+|++|.. |+.....- ......|
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98753321 124799999999999999875 66432110 0000001
Q ss_pred ------chhcccchhhhccccccCCc---cchhhhhhhhhccCCccc
Q 037681 291 ------DQTQVASKIKLVESCLARPF---RQYCCILKVRTFGFNLPN 328 (334)
Q Consensus 291 ------~~~~~~~~~~~i~~~l~~~~---~~~~~~~~~~~~~~~~~~ 328 (334)
.........+++.++|..++ .+|.+..+..+.++-.|.
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 01134556778888998765 679999999888887664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=264.03 Aligned_cols=248 Identities=20% Similarity=0.217 Sum_probs=168.3
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-C----CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeE------EE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-K----GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGC------CI 139 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~ 139 (334)
..++|++.+.||+|+||.||+|.+. + +..||+|++...... +....+ .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3478999999999999999999965 4 689999987543221 111111 1222222333322222 23
Q ss_pred ecCcceEEEEecCCCChhhhhhhcccc-----------------cccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 037681 140 ERDEKLLIYEYLPNKSLDFFLFDATKR-----------------VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLK 202 (334)
Q Consensus 140 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk 202 (334)
.....++|+||+++++|.+++...... .......+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 456789999999999998887543210 01123446679999999999999998 9999999
Q ss_pred CCCeeeCC-CCceEEeeccccccccCCCCccccccccccCCccCccccccC----------------------CCCcchh
Q 037681 203 ASNILLDK-EMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG----------------------ICSIKSD 259 (334)
Q Consensus 203 p~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~D 259 (334)
|+|||++. ++.+||+|||++..+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 57899999999976543222 122346789999999965322 2334569
Q ss_pred hHhHHHHHHHHHhCCCCCCCcc--------CCcccccccchh------------------cccchhhhccccccCCccch
Q 037681 260 VFSFGMLLLEILSGKKNTEFYH--------TGYLSINGYDQT------------------QVASKIKLVESCLARPFRQY 313 (334)
Q Consensus 260 iwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~------------------~~~~~~~~i~~~l~~~~~~~ 313 (334)
|||+||++|||+++..|++... ....++..|... ......+++..||..+|.+|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999999999999876654310 001111111110 01123379999999999999
Q ss_pred hhhhhhhhccCCc
Q 037681 314 CCILKVRTFGFNL 326 (334)
Q Consensus 314 ~~~~~~~~~~~~~ 326 (334)
++..++.+.++--
T Consensus 442 ~ta~e~L~Hpff~ 454 (566)
T PLN03225 442 ISAKAALAHPYFD 454 (566)
T ss_pred CCHHHHhCCcCcC
Confidence 9999998877743
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=253.85 Aligned_cols=199 Identities=24% Similarity=0.359 Sum_probs=167.6
Q ss_pred HhhcCCCcCCccccCCcccEEEEEecC-CCEEEEEEecccC--------hhhHHHHHHHHHHHHhcC---CCCcceEeeE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRS--------RQGLQELKNEALVIAKVQ---HKNLVRLLGC 137 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~~iv~~~~~ 137 (334)
....+|...+.+|.|+||.|++|.++. ...|+||.+.... ....-.+-.|+.+|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 344679999999999999999999664 5678889875321 111223567999999997 9999999999
Q ss_pred EEecCcceEEEEecC-CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 138 CIERDEKLLIYEYLP-NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 138 ~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
|++++.+|++||-.. +.+|.+++..++. +++..+..|+.|++.|+++||+++ |||||||-+||.++.+|-+||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence 999999999999754 4577777755444 899999999999999999999999 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCC
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTE 278 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~ 278 (334)
+|||.+.....+ ....++||..|.|||++.+.+| +..-|||++|++||.++....||-
T Consensus 712 idfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999765433 3556889999999999988766 566899999999999999999873
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=233.43 Aligned_cols=201 Identities=25% Similarity=0.472 Sum_probs=163.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-------- 141 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------- 141 (334)
+.|+....+|+|.||.||+|+.+ +|+.||+|++-.. .+.......+|+++|..+.|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 56777889999999999999954 5888898876432 233345668899999999999999999987542
Q ss_pred CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
...|+||.+|+. +|.-++.+.. ..++...+..++.++..||.|+|... |+|||+||.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999986 6666665442 34888999999999999999999888 99999999999999999999999999
Q ss_pred cccccCCC--CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 037681 222 ARIFKGNE--SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEF 279 (334)
Q Consensus 222 ~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~ 279 (334)
++.+.... .....+..+-|..|.+||.+.+ ..++++.|||+-||++.||.||.+-++.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 97664322 2222334456999999998875 5799999999999999999999988764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=255.09 Aligned_cols=243 Identities=25% Similarity=0.336 Sum_probs=190.5
Q ss_pred CCcCCccccCCccc-EEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEecC
Q 037681 75 FSDTNKLGEGGFGP-VYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 75 y~~~~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
|.-.+.+|.|+.|+ ||+|... |+.||||++-.. ......+|+..|+.- +||||+++++.-.+....|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34446789999987 7999876 889999987533 334567899999888 59999999999999999999999996
Q ss_pred CCChhhhhhhcccc-cccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---C--CceEEeecccccccc
Q 037681 153 NKSLDFFLFDATKR-VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---E--MKPKISDFGMARIFK 226 (334)
Q Consensus 153 ~~~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~--~~~kl~Dfg~~~~~~ 226 (334)
. +|++++...... ........+....|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 899988664111 11122445788999999999999988 999999999999965 2 468999999999876
Q ss_pred CCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCccCCccccc-------ccchhcccc
Q 037681 227 GNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG-KKNTEFYHTGYLSIN-------GYDQTQVAS 297 (334)
Q Consensus 227 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~~~-------~~~~~~~~~ 297 (334)
.+... .......||.+|+|||++.....+.++||||+||++|+.++| ..||.+.-....++. .........
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~e 742 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCE 742 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHH
Confidence 55432 234567799999999999988888899999999999999996 999987644422222 111112226
Q ss_pred hhhhccccccCCccchhhhhhhhhccCC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
..++|..++..+|..|++...+...++-
T Consensus 743 A~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 743 AKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred HHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 7789999999999999999998876653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=236.24 Aligned_cols=199 Identities=24% Similarity=0.292 Sum_probs=165.0
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC--CC----CcceEeeEEEecC
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ--HK----NLVRLLGCCIERD 142 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~----~iv~~~~~~~~~~ 142 (334)
..+++|.+++.+|+|.||.|-.+.+. .+..||+|+++.- ....+...-|++++.++. .| -++.+.+||...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 44689999999999999999999843 4788999988633 223355577999999994 23 3788889999999
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC------------
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK------------ 210 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~------------ 210 (334)
..++|+|.+ |-++.+++.++. -.+++...+..++.|+++++++||+.+ ++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 999999987 457888886543 346889999999999999999999998 999999999999832
Q ss_pred --------CCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 037681 211 --------EMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEF 279 (334)
Q Consensus 211 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 279 (334)
+..|+++|||.|+.-... ....+.|..|.|||++.+-.++.++||||+||||+|+.||..-|+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 235899999999864322 2456789999999999999999999999999999999999987753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-31 Score=222.22 Aligned_cols=199 Identities=32% Similarity=0.444 Sum_probs=171.3
Q ss_pred CCcCCccccCCcccEEEEEecC-CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 75 FSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
|.+.+.||.|++|.||++.... ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999764 889999999765544 56788999999999999999999999999899999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|..++...... +++..+..++.+++.++.+||+.+ ++|+|++|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 99999888654321 688899999999999999999998 999999999999999999999999998865433211
Q ss_pred ccccccccCCccCcccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 037681 233 NTNRVAGTFGYIPPEYV-YQGICSIKSDVFSFGMLLLEILSGKKNTEF 279 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~~~ 279 (334)
......++..|++||.. ....++.++|+|+||+++++|++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335678889999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-33 Score=225.94 Aligned_cols=238 Identities=19% Similarity=0.332 Sum_probs=182.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeE-EEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGC-CIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e 149 (334)
+.|.+.++||+|.||.+-++.++ +.+.+++|.+. ......+.|.+|...--.| .|.||+.-+++ |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 68999999999999999999966 46678888775 4445567888888765556 48999987765 677788889999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC--CCCceEEeeccccccccC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD--KEMKPKISDFGMARIFKG 227 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~ 227 (334)
|++.|+|..-+... .+-+.....++.|++.|+.|||+.+ +||||||.+||||- +..++||||||..+..+.
T Consensus 103 ~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999997766432 2678888899999999999999998 99999999999993 345899999999875432
Q ss_pred CCCccccccccccCCccCccccccC-----CCCcchhhHhHHHHHHHHHhCCCCCCCccCC---cccccccchh------
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQG-----ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---YLSINGYDQT------ 293 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~~~~~~~~~------ 293 (334)
.. ....-+..|.|||..... ...+.+|+|.||++++..+||..||+..... +..+..|...
T Consensus 176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 21 122345679999986532 2457799999999999999999999844332 3333333322
Q ss_pred -----cccchhhhccccccCCccchhhhhhhhhcc
Q 037681 294 -----QVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 294 -----~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+++..++..+-|..+|++||-+.+.+.++
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 455667777888889999998877766554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=230.11 Aligned_cols=259 Identities=21% Similarity=0.299 Sum_probs=205.0
Q ss_pred hHHHHhhcCCCcCCccccCCcccEEEEEecC------CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCcceEeeEE
Q 037681 66 SSVAAATNNFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138 (334)
Q Consensus 66 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 138 (334)
+++.....+++....+-+|.||.||.|.+.+ .+.|.+|.++. .+.-+...+..|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4455566778888899999999999997653 33456666643 3455667788999999999999999999998
Q ss_pred Eec-CcceEEEEecCCCChhhhhh-----hcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC
Q 037681 139 IER-DEKLLIYEYLPNKSLDFFLF-----DATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM 212 (334)
Q Consensus 139 ~~~-~~~~lv~e~~~~~~L~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 212 (334)
.+. ...++++.+..-|+|..++. +......++..+...++.|++.|++|||+++ ++|.||..+|++|++..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 654 56789999999999999997 3333345777888899999999999999998 99999999999999999
Q ss_pred ceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc---cc
Q 037681 213 KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS---IN 288 (334)
Q Consensus 213 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~---~~ 288 (334)
++||+|=.+++.+-+.+..+.......+..||+||.+.+..|+.++|+||||++||||+| |+.|+...++-+.. .+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 999999999887655555555555556788999999999999999999999999999999 99999877664221 12
Q ss_pred ccchh----cccchhhhccccccCCccchhhhhhhhhccCCcc
Q 037681 289 GYDQT----QVASKIKLVESCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 289 ~~~~~----~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
++.-. -+..+..+.--||+-.|+.|++..++..-..+|.
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 22222 3445677777799999999999888755444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=216.33 Aligned_cols=208 Identities=21% Similarity=0.393 Sum_probs=171.3
Q ss_pred hhcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecC--cceE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERD--EKLL 146 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~l 146 (334)
..++|++++.+|+|.++.||.|. ..+.+.++||.+++-. .+.+.+|+.+|..|. ||||++++++..++. ...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45799999999999999999999 4568899999987443 367889999999997 999999999988765 4579
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeeccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIF 225 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~ 225 (334)
|+||..+.+...+. . .++...+..++.+++.||.|+|+.| |.|||+||.|+++|.. ..++|+|.|+|.++
T Consensus 113 iFE~v~n~Dfk~ly---~---tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---P---TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh---h---hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999887775543 2 2777888899999999999999999 9999999999999865 46999999999876
Q ss_pred cCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccchh
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQT 293 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 293 (334)
-.+.. .+....+..|--||++.. ..++..-|+|||||++..|+..+.||...+++...+...+..
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 43322 233456778899998864 568889999999999999999999998877775555544433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=227.40 Aligned_cols=200 Identities=24% Similarity=0.366 Sum_probs=162.5
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----cc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-----EK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 144 (334)
.+.+-.+.||.|+||.||.+.+ ++|+.|++|++..- +-...+.+.+|+++|..++|.|++..++...-.. ..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3556678999999999999985 47999999987532 2334577889999999999999999998866443 35
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+++|.+.. +|+..+- ....++...+.-+++||++||.|||+.+ |.||||||.|+|++.+..+||||||+++.
T Consensus 133 YV~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 778887754 5666553 3345888888999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFY 280 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~ 280 (334)
........ .+...-|..|.|||++.+. .|+.+.||||.||++.|++..+.-|+..
T Consensus 206 ee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 206 WDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred cchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 55444333 3334568999999998864 6899999999999999999888777643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=245.86 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=206.4
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|+.+..+|.|++|.||++++ .+++..|+|.++........-++.|+-+++..+||||+.+++.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 47899999999999999999994 46899999999988878888889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
|.+|+|++..+- .+++++.++...+.+.+.|++|||+.+ -+|||||-.||++++.|.+|++|||.+..+....
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence 999999887643 345999999999999999999999998 8899999999999999999999999987654322
Q ss_pred ccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc-c----------ccchhccc
Q 037681 231 KANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI-N----------GYDQTQVA 296 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~----------~~~~~~~~ 296 (334)
.....+.||+.|||||+-. .+.|...+|||++|+...|+---++|-.+.++....+ . .-.....+
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 2344578999999999763 5678899999999999999999898877665541110 0 01111566
Q ss_pred chhhhccccccCCccchhhhhhhhhccC
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.+++.-++.++|++|++..++....+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~f 273 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPF 273 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheecee
Confidence 7889999999999999999887665443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=235.17 Aligned_cols=206 Identities=21% Similarity=0.241 Sum_probs=175.1
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCC------CCcceEeeEEEec
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH------KNLVRLLGCCIER 141 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~ 141 (334)
....++|.+....|+|-|++|..|.+. .|+.||||+|..+ +.-.+.=+.|+++|++|+. -|+++++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 345678999999999999999999954 5889999999744 3333455789999999953 4899999999999
Q ss_pred CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeecc
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFG 220 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg 220 (334)
+++|||||-+. .+|.+.|........+....+..++.|+..||..|-.++ |+|.||||+|||+++. ..+||||||
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 99999999874 588999988877777999999999999999999999998 9999999999999865 468999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG 283 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 283 (334)
.|.....+.. +...-+..|.|||++.+-+|+...|+||.||+||||.||+..|+....+
T Consensus 583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 9987654432 1233456799999999999999999999999999999999999876554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=209.15 Aligned_cols=209 Identities=34% Similarity=0.531 Sum_probs=179.7
Q ss_pred cccCCcccEEEEEec-CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCChhh
Q 037681 81 LGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDF 158 (334)
Q Consensus 81 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 158 (334)
||+|++|.||++... +++.+++|.+...... ..+.+.+|+..++.+.|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999998755432 35678899999999999999999999999999999999999999999
Q ss_pred hhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeeccccccccCCCCccccccc
Q 037681 159 FLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFGMARIFKGNESKANTNRV 237 (334)
Q Consensus 159 ~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 237 (334)
++.... ..++...+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 886542 24788999999999999999999998 999999999999999 89999999999976543321 12234
Q ss_pred cccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccchhcccchhhhccccccCCccchhhh
Q 037681 238 AGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIKLVESCLARPFRQYCCI 316 (334)
Q Consensus 238 ~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~ 316 (334)
.+...|++||..... ..+.++|+|++|++++++ ..+.+++..|+..+|..|+++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 578889999998777 788899999999999999 568899999999999999988
Q ss_pred hhhhh
Q 037681 317 LKVRT 321 (334)
Q Consensus 317 ~~~~~ 321 (334)
.++.+
T Consensus 209 ~~l~~ 213 (215)
T cd00180 209 KEILE 213 (215)
T ss_pred HHHhh
Confidence 77654
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-29 Score=206.75 Aligned_cols=193 Identities=26% Similarity=0.335 Sum_probs=159.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec------Cc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER------DE 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 143 (334)
.+|.-++.+|.|.- .|..+.+. .++.||+|++... .....++..+|...+..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57888889999987 55555533 5889999987422 344567788999999999999999999998643 34
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+|||++.. +|...+.. .++-.++..++.|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 6999999965 67666542 2677888999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTE 278 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 278 (334)
.-.. ....+....|..|.|||++.+..+.+.+||||+||++.||++|+.-|+
T Consensus 167 ~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 167 TEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred ccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 5322 123455678899999999999889999999999999999999998876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=211.62 Aligned_cols=132 Identities=27% Similarity=0.352 Sum_probs=106.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----C---CCcceEeeEEEec-
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-----H---KNLVRLLGCCIER- 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~~- 141 (334)
..+|.+.+.||.|.|++||++.+. ..+.||+|+.+.. ....+....|+++|++++ | .+||++++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368999999999999999999854 4667999988643 233456688999999983 2 3699999999754
Q ss_pred ---CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 142 ---DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 142 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
.+.+||+|++.. +|..++....-+ .++...+.+|+.|++.||.|||... +|+|.||||+|||+
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 468999999955 555555443322 2889999999999999999999876 69999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=208.60 Aligned_cols=201 Identities=26% Similarity=0.445 Sum_probs=165.2
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEec----CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCc
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDE 143 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 143 (334)
....+.|..++.||.|+|+.||++.+. .+..||+|.+...+. ...+..|+++|..+ .+.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344578899999999999999999843 467899998865433 36688999999999 59999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeecccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMA 222 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~ 222 (334)
..+|+||++.....+++.. ++...+..++..++.||.++|.+| ||||||||.|++.+.. +.-.|+|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999998888743 667888899999999999999999 9999999999999754 67899999998
Q ss_pred ccccCCC------------------------------------------CccccccccccCCccCcccccc-CCCCcchh
Q 037681 223 RIFKGNE------------------------------------------SKANTNRVAGTFGYIPPEYVYQ-GICSIKSD 259 (334)
Q Consensus 223 ~~~~~~~------------------------------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~D 259 (334)
....... .........||++|.|||++.. ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7211000 0000112459999999999875 45788999
Q ss_pred hHhHHHHHHHHHhCCCCCCCc
Q 037681 260 VFSFGMLLLEILSGKKNTEFY 280 (334)
Q Consensus 260 iwslG~il~ell~g~~p~~~~ 280 (334)
|||.|+|+.-+++++.||-..
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999998543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=208.00 Aligned_cols=167 Identities=20% Similarity=0.214 Sum_probs=129.3
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEec--CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLA--KGDEIAVKRLSVR-----SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER 141 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 141 (334)
....++|.+.+.||+|+||+||+|.+. +++.+|||++... .....+.+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 344578999999999999999999854 5777899986532 22335668999999999999999853322 2
Q ss_pred CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccC-CCCCeeeCCCCceEEeecc
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDL-KASNILLDKEMKPKISDFG 220 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg 220 (334)
+..|+||||++|++|... . . .. ...++.|++.||.|||+++ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~--~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R--P----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C--c----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 468999999999998622 1 1 11 1467889999999999998 999999 9999999999999999999
Q ss_pred ccccccCCCCccc------cccccccCCccCcccccc
Q 037681 221 MARIFKGNESKAN------TNRVAGTFGYIPPEYVYQ 251 (334)
Q Consensus 221 ~~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~ 251 (334)
+++.+........ .....+++.|+|||.+..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9987654322111 134568889999999863
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-28 Score=237.06 Aligned_cols=193 Identities=17% Similarity=0.126 Sum_probs=137.3
Q ss_pred cCC-CCcceEeeEE-------EecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 037681 126 VQH-KNLVRLLGCC-------IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRII 197 (334)
Q Consensus 126 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv 197 (334)
++| +||.+++++| ......+.++|++ +++|.+++... ...+++..+..++.||+.||.|||+++ |+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 455 5788888877 2334567788987 55999988543 234899999999999999999999998 99
Q ss_pred eccCCCCCeeeCCCC-------------------ceEEeeccccccccCCCC--------------ccccccccccCCcc
Q 037681 198 HRDLKASNILLDKEM-------------------KPKISDFGMARIFKGNES--------------KANTNRVAGTFGYI 244 (334)
Q Consensus 198 H~dlkp~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~g~~~y~ 244 (334)
||||||+|||++..+ .+|++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 455556665543211000 00011135788999
Q ss_pred CccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc-----cccchhcccchhhhccccccCCccchhhhhhh
Q 037681 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI-----NGYDQTQVASKIKLVESCLARPFRQYCCILKV 319 (334)
Q Consensus 245 aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~ 319 (334)
|||++.+..++.++|||||||+||||++|.+|+.........+ .............++..||..+|..|+++.++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 9999999999999999999999999999998875322110000 00001122344567778999999999999998
Q ss_pred hhccC
Q 037681 320 RTFGF 324 (334)
Q Consensus 320 ~~~~~ 324 (334)
....+
T Consensus 263 l~h~~ 267 (793)
T PLN00181 263 LQSEF 267 (793)
T ss_pred hhchh
Confidence 77655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=187.76 Aligned_cols=204 Identities=24% Similarity=0.385 Sum_probs=170.0
Q ss_pred hcCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC-CCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH-KNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 149 (334)
...|.+++.||+|+||.+|.|. ..+|..||||.-+.... ...+..|..+...|++ ..|..+..+..+.....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999999 66799999998754332 2456788999999964 678888888888899999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC---CceEEeecccccccc
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE---MKPKISDFGMARIFK 226 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~ 226 (334)
.+ |.+|+++..-.... ++.++++-++-|++.-++|+|.++ ++||||||+|+|..-+ ..+.|+|||+++.+.
T Consensus 92 LL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 67888876544433 788899999999999999999998 9999999999999543 569999999998765
Q ss_pred CCCC-----ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC
Q 037681 227 GNES-----KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG 283 (334)
Q Consensus 227 ~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 283 (334)
+... ........||.+|.+-....+...+...|+-|+|.+|.++.-|..||+.....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 4322 22334567999999999998889999999999999999999999999876554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=192.23 Aligned_cols=203 Identities=22% Similarity=0.343 Sum_probs=171.1
Q ss_pred cCCCcCCccccCCcccEEEEE-ecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
-.|.+.+.||+|+||.++.|+ .-++++||||.-...++ ..++..|...++.|. .++|...+.+..++-.-.+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999999 55799999997654432 356778888888884 79999999988888888999998
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-----CCceEEeeccccccc
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-----EMKPKISDFGMARIF 225 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~ 225 (334)
+ |.+|+++.--...+ ++.+++..++.|++.-++|+|++. +|+|||||+|+||.. ...+.++|||+|+.+
T Consensus 106 L-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 7 66888876544443 899999999999999999999998 999999999999953 345999999999987
Q ss_pred cCCCCc-----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC
Q 037681 226 KGNESK-----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG 283 (334)
Q Consensus 226 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 283 (334)
.+.... .......||.+||+-....+.+.+...|+-|||-++++.|-|..||+....+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 654332 2233457999999999999999999999999999999999999999887554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=201.23 Aligned_cols=203 Identities=26% Similarity=0.299 Sum_probs=165.5
Q ss_pred CCCcCCccccCCcccEEEEEecCC--CEEEEEEecccChhhHHHHHHHHHHHHhcCC----CCcceEeeEE-EecCcceE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAKG--DEIAVKRLSVRSRQGLQELKNEALVIAKVQH----KNLVRLLGCC-IERDEKLL 146 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~~l 146 (334)
+|.+.+.||+|+||.||.|..... ..+|+|............+..|..++..+.. +++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996553 4688887765433333367888899888863 6899999999 47778899
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-----CceEEeeccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-----MKPKISDFGM 221 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~Dfg~ 221 (334)
||+.+ |.+|.++..... ...++..++..++.|++.+|++||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 678988775544 445899999999999999999999999 9999999999999754 4699999999
Q ss_pred cc--cccCCCC---cc--c-cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCcc
Q 037681 222 AR--IFKGNES---KA--N-TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYH 281 (334)
Q Consensus 222 ~~--~~~~~~~---~~--~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 281 (334)
++ .+..... .. . .....||..|+++....+...+++.|+||++.++.+++.|..||....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 98 3322221 11 1 223569999999999999999999999999999999999999986544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=184.58 Aligned_cols=151 Identities=18% Similarity=0.074 Sum_probs=119.3
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
|+|.+++.... ..+++..++.++.|++.||.|||+++ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 67888886432 34899999999999999999999775 999999999999999 99987643321
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccc--------------hhccc--c
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYD--------------QTQVA--S 297 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~--------------~~~~~--~ 297 (334)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.... ..... .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARS 140 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhh
Confidence 2578999999999999999999999999999999999999865432211111100 01111 5
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..|+..+|..|+++.++....+
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHH
Confidence 888999999999999999998876554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=185.75 Aligned_cols=240 Identities=28% Similarity=0.419 Sum_probs=186.5
Q ss_pred CCcCCccccCCcccEEEEEecCCCEEEEEEecccChh---hHHHHHHHHHHHHhcCCC-CcceEeeEEEecCcceEEEEe
Q 037681 75 FSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQ---GLQELKNEALVIAKVQHK-NLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 150 (334)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|..++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999876 78899988644322 467788999999999988 799999999777778999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 229 (334)
+.++++..++........++......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999866543321124888899999999999999999998 99999999999999988 79999999997554333
Q ss_pred Ccc----ccccccccCCccCcccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---ccccc-----c---cc
Q 037681 230 SKA----NTNRVAGTFGYIPPEYVYQ---GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---YLSIN-----G---YD 291 (334)
Q Consensus 230 ~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~~~~-----~---~~ 291 (334)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||...... ..... . ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 2355679999999999987 57888999999999999999999997665531 00000 0 00
Q ss_pred hh--cc------cchhhhccccccCCccchhhhhhh
Q 037681 292 QT--QV------ASKIKLVESCLARPFRQYCCILKV 319 (334)
Q Consensus 292 ~~--~~------~~~~~~i~~~l~~~~~~~~~~~~~ 319 (334)
.. .. ....+++..++..++..|......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~ 272 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHH
Confidence 01 11 246678888888877777655543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-25 Score=181.07 Aligned_cols=172 Identities=16% Similarity=0.157 Sum_probs=131.6
Q ss_pred HhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccCh---hhHHH------HHHHHHHHHhcCCCCcceEeeEEEe
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR---QGLQE------LKNEALVIAKVQHKNLVRLLGCCIE 140 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~ 140 (334)
...++|.+.+.+|.|+||.||++.. ++..+|+|.+..... ..... +.+|+..+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3457999999999999999999655 577899999964422 22222 5789999999999999999988664
Q ss_pred c--------CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC
Q 037681 141 R--------DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM 212 (334)
Q Consensus 141 ~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 212 (334)
. +..+++|||++|.+|.++.. ++. ....+++.++..+|..+ ++|||++|+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999976631 222 24568999999999998 99999999999999988
Q ss_pred ceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHH
Q 037681 213 KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEIL 271 (334)
Q Consensus 213 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell 271 (334)
++|+|||........... ..+.....+..++|+||||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987643211110 01233444567899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=173.22 Aligned_cols=138 Identities=15% Similarity=0.139 Sum_probs=107.1
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChh--h------------------------HHHHHHHHHHHHhcCCCCc
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQ--G------------------------LQELKNEALVIAKVQHKNL 131 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i 131 (334)
...||+|+||.||+|...+|+.||+|+++..... . ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999998643211 0 0122459999999988877
Q ss_pred ceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHh-hhcCCCCeEeccCCCCCeeeCC
Q 037681 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL-HLHSRVRIIHRDLKASNILLDK 210 (334)
Q Consensus 132 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~dlkp~Nill~~ 210 (334)
....... ....++||||++++++...... ...++...+..++.|++.+|.++ |+.+ |+||||||+||++++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 4433322 2234899999999877544322 22478889999999999999999 6888 999999999999984
Q ss_pred CCceEEeecccccc
Q 037681 211 EMKPKISDFGMARI 224 (334)
Q Consensus 211 ~~~~kl~Dfg~~~~ 224 (334)
+.++|+|||++..
T Consensus 154 -~~v~LiDFG~a~~ 166 (190)
T cd05147 154 -GKLYIIDVSQSVE 166 (190)
T ss_pred -CcEEEEEcccccc
Confidence 7899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=169.04 Aligned_cols=140 Identities=21% Similarity=0.247 Sum_probs=109.7
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChh---------------------h-----HHHHHHHHHHHHhcCCCCc
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQ---------------------G-----LQELKNEALVIAKVQHKNL 131 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~~i 131 (334)
...||+|++|+||+|.+.+|+.||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999778999999998754211 0 1223578899999999987
Q ss_pred ceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCC
Q 037681 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDK 210 (334)
Q Consensus 132 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~ 210 (334)
.....+... ..++||||++++++...... ...++......++.|++.++.+||+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443322 34899999998865433211 1236788889999999999999999 88 99999999999998
Q ss_pred CCceEEeecccccccc
Q 037681 211 EMKPKISDFGMARIFK 226 (334)
Q Consensus 211 ~~~~kl~Dfg~~~~~~ 226 (334)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-24 Score=201.73 Aligned_cols=240 Identities=21% Similarity=0.235 Sum_probs=180.0
Q ss_pred cCCccccCCcccEEEEEec-CCCEEEEEEec-----ccChhh-HHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 77 DTNKLGEGGFGPVYKGVLA-KGDEIAVKRLS-----VRSRQG-LQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~-----~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
....+|.|.+|.|+.+... .....+.|... ...... ...+..|..+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988777633 23333443322 111111 2226678888888999999888887777666666699
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
||++ +|..++... ..+....+-.++.|++.|+.|||+.| |.|||+||+|+++..+|.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 888877544 23788888999999999999999999 9999999999999999999999999998765444
Q ss_pred Cc--cccccccccCCccCccccccCCCCc-chhhHhHHHHHHHHHhCCCCCCCccCCcccc---cc--c---c-------
Q 037681 230 SK--ANTNRVAGTFGYIPPEYVYQGICSI-KSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---NG--Y---D------- 291 (334)
Q Consensus 230 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~~~~---~~--~---~------- 291 (334)
.. ......+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||.........+ .. + .
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 33 4455678999999999999888865 6899999999999999999986544332210 00 0 0
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
......-..++-..|+-+|.+|.++.++..-.
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 00334455677888899999999999887643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=159.96 Aligned_cols=186 Identities=19% Similarity=0.142 Sum_probs=137.4
Q ss_pred CcCCccccCCcccEEEEEecCCCEEEEEEecccChh----hHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEEe
Q 037681 76 SDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQ----GLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 76 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.+...|++|+||+|+.+.. .+.+++.+.+...... ....+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 6888888777644331 1235789999999995 5889999886 446999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccC-CCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDL-KASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+.|.+|..... .. ...++.|++.++.++|++| |+|||| ||+||+++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~---------~~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP---------RG-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh---------hh-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998854321 11 1347789999999999999 999999 7999999999999999999998543322
Q ss_pred Cc----cc-------cccccccCCccCcccccc-CCCC-cchhhHhHHHHHHHHHhCCCCCCC
Q 037681 230 SK----AN-------TNRVAGTFGYIPPEYVYQ-GICS-IKSDVFSFGMLLLEILSGKKNTEF 279 (334)
Q Consensus 230 ~~----~~-------~~~~~g~~~y~aPE~~~~-~~~~-~~~DiwslG~il~ell~g~~p~~~ 279 (334)
.. .. ......++.|++|+...- ...+ ...+.++-|.-+|.++|++.|.-.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 00 001235777888875431 1222 567999999999999999987543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-24 Score=200.71 Aligned_cols=249 Identities=19% Similarity=0.193 Sum_probs=181.9
Q ss_pred CCCcCCccccCCcccEEEEEecCCCEEEEEEecccC-hhhHHHH---HHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS-RQGLQEL---KNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
+|...+.||++.|=+|.+|++..|. |+||++-... .-....+ ..|++ ....++||++++.-+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677899999999999999988887 8888874332 2223333 33444 555689999999998777888899999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc-CC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK-GN 228 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~-~~ 228 (334)
|..+ +|.+.+ ..++.+...+...|+.||+.|+..+|..| |+|+|||.+||||+.-+-+.|+||..-+..- ..
T Consensus 102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9866 666666 45566888888999999999999999998 9999999999999999899999998765321 11
Q ss_pred CCcc----ccccccccCCccCccccccC----------C-CCcchhhHhHHHHHHHHHh-CCCCCCCcc-----CCcccc
Q 037681 229 ESKA----NTNRVAGTFGYIPPEYVYQG----------I-CSIKSDVFSFGMLLLEILS-GKKNTEFYH-----TGYLSI 287 (334)
Q Consensus 229 ~~~~----~~~~~~g~~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ell~-g~~p~~~~~-----~~~~~~ 287 (334)
+... ...+.....+|.|||.+... . .+++.||||+||++.||++ |++||+... .+....
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 1111 11122334579999987531 1 5688999999999999998 799987431 111111
Q ss_pred ccc--chhcccchhhhccccccCCccchhhhhhhhh--ccCCcccccC
Q 037681 288 NGY--DQTQVASKIKLVESCLARPFRQYCCILKVRT--FGFNLPNALN 331 (334)
Q Consensus 288 ~~~--~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~ 331 (334)
... ...+...+.+++-.+++++|.+|-+...... -+..||+.++
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy 302 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFY 302 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHH
Confidence 111 1115557888999999999999988666443 4667776553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=161.99 Aligned_cols=137 Identities=23% Similarity=0.336 Sum_probs=105.8
Q ss_pred CcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhc-----CCCCcceEeeEEEecC---cce-E
Q 037681 76 SDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-----QHKNLVRLLGCCIERD---EKL-L 146 (334)
Q Consensus 76 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~~~-l 146 (334)
.-.+.||+|+||.||. ++.....+||++........+.+.+|+.+++.+ +||||++++++++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999995 443333479988765444557789999999999 5799999999998874 333 7
Q ss_pred EEEe--cCCCChhhhhhhcccccccchHHHHHHHHHHHHHH-HHhhhcCCCCeEeccCCCCCeeeCC----CCceEEee-
Q 037681 147 IYEY--LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL-LYLHLHSRVRIIHRDLKASNILLDK----EMKPKISD- 218 (334)
Q Consensus 147 v~e~--~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~D- 218 (334)
|+|| +++++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+||+++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999542 14544 35677788777 9999999 999999999999963 34799999
Q ss_pred ccccc
Q 037681 219 FGMAR 223 (334)
Q Consensus 219 fg~~~ 223 (334)
||...
T Consensus 154 ~G~~~ 158 (210)
T PRK10345 154 IGEST 158 (210)
T ss_pred CCCcc
Confidence 55443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=193.89 Aligned_cols=197 Identities=19% Similarity=0.206 Sum_probs=160.1
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ---HKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 148 (334)
...|.|.+.||+|+||+||+|...+|+.||+|+-+..+... |.--.+++.+|+ -+.|.++...+.-.+..++|+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 46789999999999999999997779999999877654432 222233444444 345666666667788899999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-------CCceEEeeccc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-------EMKPKISDFGM 221 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~~kl~Dfg~ 221 (334)
||.+.|+|.+++. ....+++..+..+..|++..++.||..+ |||+||||+|+||.. +..++|+|||.
T Consensus 774 ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 9999999999986 3344899999999999999999999998 999999999999932 34599999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNT 277 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~ 277 (334)
+.-+..-.........++|-.+-.+|...|++++.++|.|.++.+++-||.|+..-
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 86554322233455678899999999999999999999999999999999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-23 Score=166.80 Aligned_cols=234 Identities=20% Similarity=0.290 Sum_probs=175.8
Q ss_pred CcCCccccCCcccEEEEEecCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 76 SDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 76 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
...-.|.+...|..|+|+++ |..++.|++.... ......|..|.-.|+-+.||||+++++.|..+....++..|++.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34456888899999999998 5566667776442 22345688888889989999999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
|+|...++... ....+..++.+++.++++|++|||+..+ -|----|.+..+++|++.+.+|.- +-+++. ..
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfs------fq 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQ 342 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceee------ee
Confidence 99999987754 4457888999999999999999999863 244557999999999998777641 111110 00
Q ss_pred cccccccCCccCccccccCCCC---cchhhHhHHHHHHHHHhCCCCCCCccCCccc----ccccchh----cccchhhhc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICS---IKSDVFSFGMLLLEILSGKKNTEFYHTGYLS----INGYDQT----QVASKIKLV 302 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~---~~~DiwslG~il~ell~g~~p~~~~~~~~~~----~~~~~~~----~~~~~~~~i 302 (334)
.......|.|++||.+...+-+ .++|+|||++++||+-|...||.+..+-+.. +.+.... ......+++
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 1112347889999999866533 5799999999999999999999887664222 2222111 344456677
Q ss_pred cccccCCccchhhhhhh
Q 037681 303 ESCLARPFRQYCCILKV 319 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~ 319 (334)
.-|+.++|-+|+.+..+
T Consensus 423 ~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHhcCCCCcCCCccee
Confidence 88999999999876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=166.31 Aligned_cols=230 Identities=19% Similarity=0.253 Sum_probs=145.5
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcC----------CCCcceEeeEEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQ----------HKNLVRLLGCCI 139 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~~ 139 (334)
.+...+.||.|+++.||.+++. +++++|+|+..... ....+.+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455688999999999999965 58999999885332 223556666654444332 222333333322
Q ss_pred e---------cC--------cceEEEEecCCCChhhhhhh---ccc-ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 037681 140 E---------RD--------EKLLIYEYLPNKSLDFFLFD---ATK-RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198 (334)
Q Consensus 140 ~---------~~--------~~~lv~e~~~~~~L~~~l~~---~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH 198 (334)
- .. +.+++|+-+ -++|..++.. ... ...+....+..+..|+++.+++||..| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1 11 235677766 4577666432 111 123445566778899999999999999 999
Q ss_pred ccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCcccccc--------CCCCcchhhHhHHHHHHHH
Q 037681 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ--------GICSIKSDVFSFGMLLLEI 270 (334)
Q Consensus 199 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 270 (334)
+||+|+|++++.+|.++|+||+.....+.... . ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988765322111 1 223577999997643 2468899999999999999
Q ss_pred HhCCCCCCCccCCc---ccccccchhcccchhhhccccccCCccch
Q 037681 271 LSGKKNTEFYHTGY---LSINGYDQTQVASKIKLVESCLARPFRQY 313 (334)
Q Consensus 271 l~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~~~~~ 313 (334)
.+|+.||+...+.. .++.... ...+....+|...|..++.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999998765542 2344444 566677888888888888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-22 Score=183.40 Aligned_cols=186 Identities=26% Similarity=0.306 Sum_probs=151.5
Q ss_pred ccccCCcccEEEEEe----cCCCEEEEEEecccChhh--HHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEEecC
Q 037681 80 KLGEGGFGPVYKGVL----AKGDEIAVKRLSVRSRQG--LQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
.+|+|+||.|+++.. ..|.-+|.|+........ ......|..++...+ ||.++++...++.++..+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998762 236667888775332111 114456777888886 9999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+|.+...+.... .+++.....+...++-|++++|+.+ ++|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999877664433 3666677778888999999999998 99999999999999999999999999876433222
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEF 279 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 279 (334)
.+||..|||||++. .....+|.||+|++++||+||..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999987 566789999999999999999999976
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=167.23 Aligned_cols=181 Identities=23% Similarity=0.301 Sum_probs=129.4
Q ss_pred CCCCcceEeeEEEe---------------------------cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHH
Q 037681 127 QHKNLVRLLGCCIE---------------------------RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIE 179 (334)
Q Consensus 127 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ 179 (334)
.|||||++++.|.+ +..+|+||...+. +|..++..+. .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 59999999987643 2245899987754 7888885443 46667778999
Q ss_pred HHHHHHHHhhhcCCCCeEeccCCCCCeee--CCC--CceEEeeccccccccCCCCc----cccccccccCCccCcccccc
Q 037681 180 GIVEGLLYLHLHSRVRIIHRDLKASNILL--DKE--MKPKISDFGMARIFKGNESK----ANTNRVAGTFGYIPPEYVYQ 251 (334)
Q Consensus 180 qi~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~--~~~kl~Dfg~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~ 251 (334)
|+++|+.|||.+| |.|||+|++|||+ ++| ..+.++|||++---....-. ...-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 333 35899999987432221111 11112347778999998764
Q ss_pred CC------CCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccchh--------cccchhhhccccccCCccchhh
Q 037681 252 GI------CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQT--------QVASKIKLVESCLARPFRQYCC 315 (334)
Q Consensus 252 ~~------~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~i~~~l~~~~~~~~~ 315 (334)
.+ .-.|+|.|+.|.+.||+++...||-......++...+.+. ......+++-..|.++|.+|.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVS 503 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCC
Confidence 32 2248999999999999999999986643333333344333 3344666777788888888855
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=156.63 Aligned_cols=142 Identities=18% Similarity=0.189 Sum_probs=110.2
Q ss_pred CCCcCCccccCCcccEEEEE--ecCCCEEEEEEecccChh------------------------hHHHHHHHHHHHHhcC
Q 037681 74 NFSDTNKLGEGGFGPVYKGV--LAKGDEIAVKRLSVRSRQ------------------------GLQELKNEALVIAKVQ 127 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~--~~~~~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 127 (334)
.|.+.+.||+|++|.||+|. ..+|+.||+|.+...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58889999999999999998 567999999998643210 0123568999999997
Q ss_pred CC--CcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCC
Q 037681 128 HK--NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASN 205 (334)
Q Consensus 128 h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N 205 (334)
+. .+.++++. ...++||||++++++...... ...++......++.|++.++.+||+++ .++|+||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 53 34444442 245899999999888655422 123566667889999999999999776 49999999999
Q ss_pred eeeCCCCceEEeeccccccc
Q 037681 206 ILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 206 ill~~~~~~kl~Dfg~~~~~ 225 (334)
|+++ ++.++|+|||.+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 789999999998653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.8e-20 Score=152.02 Aligned_cols=134 Identities=20% Similarity=0.301 Sum_probs=112.1
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR--------QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+.||+|++|.||+|.. .|..+++|+...... .....+.+|+.++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 578899997653221 1124577899999999999988877777778889999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++|++|.+++.... . .+..++.+++.++.+||+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999988874321 1 77789999999999999998 99999999999999 78899999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=168.10 Aligned_cols=198 Identities=24% Similarity=0.371 Sum_probs=154.1
Q ss_pred HHhcCCCCcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCe-EeccC
Q 037681 123 IAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI-IHRDL 201 (334)
Q Consensus 123 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i-vH~dl 201 (334)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.... ..+++.....++.+|+.|+.|||+.. | +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 356889999999999999999999999999999999997633 34889999999999999999999765 4 99999
Q ss_pred CCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCC-------CCcchhhHhHHHHHHHHHhCC
Q 037681 202 KASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI-------CSIKSDVFSFGMLLLEILSGK 274 (334)
Q Consensus 202 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~g~ 274 (334)
++.|++++....+||+|||+.................-..-|.|||.+.+.. .+.+.|+||+|++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987654211111111122455799999987531 466799999999999999999
Q ss_pred CCCCCccCCccc--------------ccccch---hcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 275 KNTEFYHTGYLS--------------INGYDQ---TQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 275 ~p~~~~~~~~~~--------------~~~~~~---~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
.||+.......+ +....+ .....+..++..|+.++|.+|+++.+++..-..
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 999864332110 110111 123357888999999999999999988776543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=147.13 Aligned_cols=137 Identities=21% Similarity=0.250 Sum_probs=107.9
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChh----------------------hHHHHHHHHHHHHhcCCC-
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQ----------------------GLQELKNEALVIAKVQHK- 129 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~- 129 (334)
..|.+.+.||+|+||.||++...+|+.+|||++...... .......|..++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 347888999999999999999888999999987532200 112356788889888877
Q ss_pred -CcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 130 -NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 130 -~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
.+++.++ ....++||||+++++|..... ......++.+++.++.++|+.+ ++|+||+|+||++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 4444443 245689999999999865432 1234578899999999999988 9999999999999
Q ss_pred CCCCceEEeeccccccc
Q 037681 209 DKEMKPKISDFGMARIF 225 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~ 225 (334)
+.++.++|+|||++...
T Consensus 159 ~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 DDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCcEEEEECCccccC
Confidence 99999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-19 Score=146.73 Aligned_cols=130 Identities=22% Similarity=0.340 Sum_probs=105.2
Q ss_pred ccccCCcccEEEEEecCCCEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR--------QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.||+|+||.||+|.. +|..+++|....... .....+.+|++++..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 478899998643211 12355778999999999887665555556677789999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
+|++|.+.+.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999987763321 0 68999999999999998 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-20 Score=177.01 Aligned_cols=199 Identities=22% Similarity=0.271 Sum_probs=139.5
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|+.++++..|++|.||.++++ +.+.+|+| ++..+- +.+ .++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilR--nilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILR--NILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhh--ccccccCCccee------------------
Confidence 478999999999999999999866 46677773 332211 110 022222333333
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC--
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN-- 228 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 228 (334)
|+-...+.. .++++... +.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+.....
T Consensus 136 ---gDc~tllk~---~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc---CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 222333322 12244332 77899999888 999999999999999999999999987642110
Q ss_pred ------C-----CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------ccccc
Q 037681 229 ------E-----SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---------YLSIN 288 (334)
Q Consensus 229 ------~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---------~~~~~ 288 (334)
. .......++||+.|.|||++....|+..+|+|++|+++||.+-|..||....++ ...+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 0 011223468999999999999999999999999999999999999999876433 22233
Q ss_pred ccchhcccchhhhccccccCCccch
Q 037681 289 GYDQTQVASKIKLVESCLARPFRQY 313 (334)
Q Consensus 289 ~~~~~~~~~~~~~i~~~l~~~~~~~ 313 (334)
.-++.......++++..|..+|..|
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhh
Confidence 3333356667788888888887655
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=167.39 Aligned_cols=136 Identities=20% Similarity=0.321 Sum_probs=110.1
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--------ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--------SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
..|...+.||+|+||.||+|.+... .+++|+.... .....+.+.+|++++..++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4556678999999999999987644 3444432111 111235678999999999999999888877777788
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999987763 24578999999999999998 9999999999999 577899999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.7e-20 Score=164.63 Aligned_cols=171 Identities=24% Similarity=0.297 Sum_probs=132.8
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..|+.|++|.-.+|.+++..+......++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999876666667888899999999999999 66 999999999999999999999999998
Q ss_pred ccccCCC----CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccC----Ccccccccchh
Q 037681 223 RIFKGNE----SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHT----GYLSINGYDQT 293 (334)
Q Consensus 223 ~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~----~~~~~~~~~~~ 293 (334)
....... .........||..||+||.+.+..|+.++||||||++|+|+++ =..+++.... ....+......
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhh
Confidence 7665443 1233455679999999999999999999999999999999998 2222221111 12222222233
Q ss_pred cccchhhhccccccCCccchhhhhhh
Q 037681 294 QVASKIKLVESCLARPFRQYCCILKV 319 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~~~~~~ 319 (334)
.-.....++...+...|.+|++..+.
T Consensus 484 d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 484 DYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCcHHHHHHHHhcCCCcccCchHHHH
Confidence 44456678888999999999855443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=136.82 Aligned_cols=136 Identities=19% Similarity=0.254 Sum_probs=97.6
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChh--hHHH----------------------HHHHHHHHHhcCCCC--c
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQ--GLQE----------------------LKNEALVIAKVQHKN--L 131 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~~--i 131 (334)
.+.||+|+||+||+|...+|+.||+|++...... .... ...|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999988643211 1111 134566666664433 4
Q ss_pred ceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCC
Q 037681 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDK 210 (334)
Q Consensus 132 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~ 210 (334)
.+.+++ ...++||||++++.+......... .. ..+..++.+++.++.++|. ++ ++|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 346899999999654321111110 11 5667899999999999998 77 99999999999999
Q ss_pred CCceEEeeccccccc
Q 037681 211 EMKPKISDFGMARIF 225 (334)
Q Consensus 211 ~~~~kl~Dfg~~~~~ 225 (334)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-19 Score=169.77 Aligned_cols=246 Identities=21% Similarity=0.291 Sum_probs=188.4
Q ss_pred hcCCCcCCccccCCcccEEEEEecC--CCEEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK--GDEIAVKRLSVRS--RQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 146 (334)
...|.+.+.||+|+|+.|-...... ...+|.|.+.... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3578888999999999998887533 4456666665332 333445556777777776 9999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhh-hcCCCCeEeccCCCCCeeeCCCC-ceEEeecccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH-LHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARI 224 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~ 224 (334)
.++|..++++...+.. ......+...+-.++.|+..++.|+| ..+ +.|+|+||+|.+++..+ .++++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999998776631 11113566667789999999999999 887 99999999999999999 999999999998
Q ss_pred ccC-CCCccccccccc-cCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccchh--------
Q 037681 225 FKG-NESKANTNRVAG-TFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQT-------- 293 (334)
Q Consensus 225 ~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-------- 293 (334)
+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+..|...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 776 555555556778 9999999998874 56778999999999999999999998765543332222221
Q ss_pred ---cccchhhhccccccCCccchhhhhhhhh
Q 037681 294 ---QVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 294 ---~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.......++.+++..++..|-++..+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccc
Confidence 3445666777777777777766665543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-17 Score=129.20 Aligned_cols=135 Identities=21% Similarity=0.218 Sum_probs=112.5
Q ss_pred cCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC--CCcceEeeEEEecCcceEEEEecCCC
Q 037681 77 DTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH--KNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
+++.||.|.++.||++...+ ..+++|....... ...+..|..++..++| +++++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999754 7889998864433 4678899999999976 58999999888888899999999988
Q ss_pred ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 155 SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 155 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
.+..+ +......++.+++.++.+||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 3455567889999999999986444599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.6e-16 Score=134.41 Aligned_cols=135 Identities=21% Similarity=0.223 Sum_probs=103.0
Q ss_pred CCccc-cCCcccEEEEEecCCCEEEEEEecccC-------------hhhHHHHHHHHHHHHhcCCCCc--ceEeeEEEec
Q 037681 78 TNKLG-EGGFGPVYKGVLAKGDEIAVKRLSVRS-------------RQGLQELKNEALVIAKVQHKNL--VRLLGCCIER 141 (334)
Q Consensus 78 ~~~lg-~G~~g~V~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~ 141 (334)
...|| .||.|+||.+... +..+++|.+.... ......+.+|+.++.++.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 7899999998765 6788888774210 1223567889999999998875 6777765443
Q ss_pred Cc----ceEEEEecCC-CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 142 DE----KLLIYEYLPN-KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 142 ~~----~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
.. .++|||++++ .+|.+++... .++.. .+.+++.++.+||+.| |+|+||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 6888776432 24433 3568999999999999 999999999999998889999
Q ss_pred eecccccc
Q 037681 217 SDFGMARI 224 (334)
Q Consensus 217 ~Dfg~~~~ 224 (334)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-15 Score=138.43 Aligned_cols=141 Identities=22% Similarity=0.266 Sum_probs=98.1
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHH----------------------------------------HHH
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQ----------------------------------------ELK 117 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~----------------------------------------~~~ 117 (334)
.+.||.|++|+||+|+..+|+.||||+.++....... .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3689999999999999999999999998654221110 123
Q ss_pred HHHHHHHhc----CCCCcceEeeEEE-ecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHH-HHHHhhhc
Q 037681 118 NEALVIAKV----QHKNLVRLLGCCI-ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVE-GLLYLHLH 191 (334)
Q Consensus 118 ~e~~~l~~l----~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~-~l~~LH~~ 191 (334)
.|...+.++ .|.+-+.+-.++. ..+..++||||++|++|.+........ . ....++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence 344444444 2222233333332 245679999999999998776432111 1 23346666665 46788988
Q ss_pred CCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 192 ~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.3e-14 Score=134.79 Aligned_cols=144 Identities=16% Similarity=0.182 Sum_probs=94.5
Q ss_pred hcCCCcCCccccCCcccEEEEEecC-CCEEEEEEecccChhh----------------------------------HHH-
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQG----------------------------------LQE- 115 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~----------------------------------~~~- 115 (334)
...|+. +.||+|++|+||+|+.++ |+.||||+.++..... .+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 346776 799999999999999877 9999999997542110 111
Q ss_pred -----HHHHHHHHHhc----CCCCcceEeeEEEe-cCcceEEEEecCCCChhhhhhhcccc---cccchHHHHHHHHHHH
Q 037681 116 -----LKNEALVIAKV----QHKNLVRLLGCCIE-RDEKLLIYEYLPNKSLDFFLFDATKR---VLLELGTRLQIIEGIV 182 (334)
Q Consensus 116 -----~~~e~~~l~~l----~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~---~~l~~~~~~~i~~qi~ 182 (334)
+.+|+..+.++ .+...+.+-.++.+ .+..++||||++|+.+.+.......+ ..+....+..++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 22333333333 23333333344433 45678999999999997643211111 1233333444444443
Q ss_pred HHHHHhhhcCCCCeEeccCCCCCeeeCCCC----ceEEeecccccccc
Q 037681 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEM----KPKISDFGMARIFK 226 (334)
Q Consensus 183 ~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~ 226 (334)
..| ++|+|++|.||+++.++ .++++|||++..+.
T Consensus 278 -------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 456 99999999999999888 99999999987654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-13 Score=127.01 Aligned_cols=166 Identities=15% Similarity=0.195 Sum_probs=126.8
Q ss_pred ecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHH
Q 037681 94 LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGT 173 (334)
Q Consensus 94 ~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 173 (334)
..++.+|.|...+..+........+-++.|+.++||||+++++.++..+..|+|+|.+. .|..++.+. ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHH
Confidence 45688898888876666555667788899999999999999999999999999999874 455555432 2455
Q ss_pred HHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCC
Q 037681 174 RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253 (334)
Q Consensus 174 ~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 253 (334)
...-+.||+.||.|||+.+ .++|++|..+.|+++..|..||++|..+........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 5678899999999998655 499999999999999999999999998865332221 111112233466676554333
Q ss_pred CCcchhhHhHHHHHHHHHhC
Q 037681 254 CSIKSDVFSFGMLLLEILSG 273 (334)
Q Consensus 254 ~~~~~DiwslG~il~ell~g 273 (334)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 246999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-14 Score=121.18 Aligned_cols=201 Identities=19% Similarity=0.190 Sum_probs=141.7
Q ss_pred HHHhcCCCCcceEeeEEEecC-----cceEEEEecCCCChhhhhhhccc-ccccchHHHHHHHHHHHHHHHHhhhcCCCC
Q 037681 122 VIAKVQHKNLVRLLGCCIERD-----EKLLIYEYLPNKSLDFFLFDATK-RVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195 (334)
Q Consensus 122 ~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 195 (334)
-+-.+.|.||+++..++.+.. ...++.||+..|++..+|++... ...+......+|+.||+.||.|||+.. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 445567999999998876533 45789999999999999976432 345778888899999999999999994 66
Q ss_pred eEeccCCCCCeeeCCCCceEEeeccccccccC---CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh
Q 037681 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKG---NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272 (334)
Q Consensus 196 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 272 (334)
|+|+++..+.|++..+|-+|+.-- .....-. ...........+.++|.|||.-.....+.++|||+||+...+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999988887431 1111000 000111222346789999998766677889999999999999998
Q ss_pred CCCCCCCccCC---cccccccchh-cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 273 GKKNTEFYHTG---YLSINGYDQT-QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 273 g~~p~~~~~~~---~~~~~~~~~~-~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
|..--...... .......... ....-.+++.+|+...|..|+++..+....+
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred heeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcCce
Confidence 87542211111 1111111111 3445677999999999999999887665544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.1e-14 Score=111.74 Aligned_cols=131 Identities=21% Similarity=0.171 Sum_probs=96.3
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcc-eEeeEEEecCcceEEEEecCCCCh
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV-RLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
++.++.|.++.||++... +..+++|....... ....+..|+.+++.+.+.+++ +++... .+..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999998865 77899998754332 123457889999988655544 444443 3346899999999887
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcC--CCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS--RVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
.... .. ...++.+++.++..||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~--------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED--------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 11 1235678999999999886 22359999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.7e-12 Score=105.26 Aligned_cols=136 Identities=14% Similarity=0.103 Sum_probs=98.3
Q ss_pred CCccccCCcccEEEEEecC-------CCEEEEEEecccC------------h----------hhHHHH----HHHHHHHH
Q 037681 78 TNKLGEGGFGPVYKGVLAK-------GDEIAVKRLSVRS------------R----------QGLQEL----KNEALVIA 124 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~------------~----------~~~~~~----~~e~~~l~ 124 (334)
...||.|.-+.||.|...+ +..+|+|+.+... . ...+.+ .+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 4789999774210 0 011222 38999999
Q ss_pred hcCC--CCcceEeeEEEecCcceEEEEecCCCChhh-hhhhcccccccchHHHHHHHHHHHHHHHHh-hhcCCCCeEecc
Q 037681 125 KVQH--KNLVRLLGCCIERDEKLLIYEYLPNKSLDF-FLFDATKRVLLELGTRLQIIEGIVEGLLYL-HLHSRVRIIHRD 200 (334)
Q Consensus 125 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~d 200 (334)
++.. -++.+.+++ ...++||||+.+..+.. .+.+ ..++......+..+++.++..| |..+ ++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9853 456666654 56789999998754421 2221 1245556677889999999998 8888 99999
Q ss_pred CCCCCeeeCCCCceEEeeccccccc
Q 037681 201 LKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 201 lkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
|++.||++++ +.+.|+|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.8e-13 Score=124.52 Aligned_cols=198 Identities=24% Similarity=0.333 Sum_probs=154.2
Q ss_pred cCCCcCCcccc--CCcccEEEEEe---cCCCEEEEEEec--ccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcc
Q 037681 73 NNFSDTNKLGE--GGFGPVYKGVL---AKGDEIAVKRLS--VRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~--G~~g~V~~~~~---~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 144 (334)
..|.+.+.+|. |.+|.||.+.. .++..+|+|.-+ .........-.+|+....+++ |++.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 46777889999 99999999986 357788988733 222233333355666666664 99999988999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHH----HHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeec
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVE----GLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDF 219 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Df 219 (334)
|+-+|.+. .+|..+.... ...++....+....+... |+.++|+.. ++|-|+||.||+...+ ..++++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999986 5666665432 234778888888888888 999999998 9999999999999998 89999999
Q ss_pred cccccccCCCCccc---cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 037681 220 GMARIFKGNESKAN---TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNT 277 (334)
Q Consensus 220 g~~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~ 277 (334)
|+...+........ .....|...|++||.. ++.++...|+|++|.+..+..+|..+.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccc
Confidence 99987765442211 1223578889999965 667788999999999999999987754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.8e-12 Score=99.35 Aligned_cols=131 Identities=23% Similarity=0.309 Sum_probs=101.0
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS--------RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..+++|+-+.++.+.+. |.++++|.-.++. .-......+|+.++.++.--.|.-..-+..++....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999998664 4456666432221 11234567899999998776766666666778888999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++|..|.+.+... ...++..+-..+.-||..+ |+|+||+++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998887543 2457777888889999998 99999999999998764 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-11 Score=104.07 Aligned_cols=142 Identities=17% Similarity=0.264 Sum_probs=107.0
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCC--CcceEeeEEEec---CcceEEEEecC
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR-QGLQELKNEALVIAKVQHK--NLVRLLGCCIER---DEKLLIYEYLP 152 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~~~ 152 (334)
+.|+.|..+.||++...+|..+++|....... .....+..|..++..+.+. .+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999876668899998754322 1345678999999999763 457777776553 25689999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS---------------------------------------- 192 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------- 192 (334)
|.++...+.. ..++......++.+++.++..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988665421 12566677777888888888887421
Q ss_pred -------------CCCeEeccCCCCCeeeCC--CCceEEeecccccc
Q 037681 193 -------------RVRIIHRDLKASNILLDK--EMKPKISDFGMARI 224 (334)
Q Consensus 193 -------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~ 224 (334)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234899999999999998 56689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.7e-11 Score=95.84 Aligned_cols=143 Identities=22% Similarity=0.296 Sum_probs=107.2
Q ss_pred cCCccccCCcccEEEEEecCCCEEEEEEeccc--------ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 77 DTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--------SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
....+-+|+-+.|+.+... |+.++||.-... ..-..++..+|+..+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567889999999999876 788788754222 1122456788999999987666665555677777889999
Q ss_pred EecCC-CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC---ceEEeecccccc
Q 037681 149 EYLPN-KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM---KPKISDFGMARI 224 (334)
Q Consensus 149 e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~ 224 (334)
||++| .++.+++...-... .+......++..|-+.+.-||..+ ++|+||+.+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 46777776544332 223333678899999999999998 99999999999996554 358999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-12 Score=125.34 Aligned_cols=242 Identities=19% Similarity=0.213 Sum_probs=165.7
Q ss_pred HhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
...+++.+.+.+-+|.++.++.+.- ..|...+++..... .....+....+-.++-.-.+|.++...-.+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 4557888889999999999998873 33544444433211 1222233333433433345566666655555566789
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
++++|..+++|...++... ..+.+........+..+++|||... +.|+|++|.|.+...+++.++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999887775543 3566666667778999999999876 899999999999999999999999843221
Q ss_pred c------CC---------------CC----c----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCC
Q 037681 226 K------GN---------------ES----K----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKN 276 (334)
Q Consensus 226 ~------~~---------------~~----~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 276 (334)
. +. .. . .......||+.|.+||...+......+|+|+.|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 1 00 00 0 112234689999999999999999999999999999999999999
Q ss_pred CCCccCC--cccccc----c---chhcccchhhhccccccCCccchhhhh
Q 037681 277 TEFYHTG--YLSING----Y---DQTQVASKIKLVESCLARPFRQYCCIL 317 (334)
Q Consensus 277 ~~~~~~~--~~~~~~----~---~~~~~~~~~~~i~~~l~~~~~~~~~~~ 317 (334)
|+...+. ..++.. | .........+++...+..++.+|-.+.
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9876543 111111 1 111344455666667777777765544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.2e-10 Score=92.63 Aligned_cols=125 Identities=27% Similarity=0.362 Sum_probs=82.5
Q ss_pred cEEEEEecCCCEEEEEEecccC--------------h------------hhHHHHHHHHHHHHhcCCC--CcceEeeEEE
Q 037681 88 PVYKGVLAKGDEIAVKRLSVRS--------------R------------QGLQELKNEALVIAKVQHK--NLVRLLGCCI 139 (334)
Q Consensus 88 ~V~~~~~~~~~~vaiK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~ 139 (334)
.||.|...+|..+|+|..+... . .......+|.+.|.++... ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899998889999999874210 0 0123467899999999866 46666654
Q ss_pred ecCcceEEEEecC--CCChhhhhhhcccccccchHHHHHHHHHHHHHHHH-hhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 140 ERDEKLLIYEYLP--NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY-LHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 140 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
...++||||++ |..+..+. ... ++......++.+++..+.. +|..| ++|+||++.||+++++ .+.+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24689999998 55554332 211 2234456677888885555 57787 9999999999999887 8999
Q ss_pred eeccccccc
Q 037681 217 SDFGMARIF 225 (334)
Q Consensus 217 ~Dfg~~~~~ 225 (334)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=7e-12 Score=114.23 Aligned_cols=197 Identities=20% Similarity=0.221 Sum_probs=146.7
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEe--cCCCEEEEEEecccChhhHHHH--HHHHHHHHhc-CCCCcceEeeEEEecCc
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVL--AKGDEIAVKRLSVRSRQGLQEL--KNEALVIAKV-QHKNLVRLLGCCIERDE 143 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~~~~~~~--~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 143 (334)
.....+|..+..||.|.|+.|+.... .++..+++|.+...-.....++ ..|+-+...+ .|.++++++..+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456788999999999999998873 3577888887753322222221 3455555555 48888988888887788
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeecccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMA 222 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~ 222 (334)
.|+--|||.++++.... .....+++...+++..|++.++.++|+.. ++|+|++|+||++..+ +..++.|||++
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 88999999999987665 22334788888999999999999999887 9999999999999875 78899999998
Q ss_pred ccccCCCCccccccccccCCcc--CccccccCCCCcchhhHhHHHHHHHHHhCCCC
Q 037681 223 RIFKGNESKANTNRVAGTFGYI--PPEYVYQGICSIKSDVFSFGMLLLEILSGKKN 276 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 276 (334)
..+.-.... .....++. +|.......+..+.|++|||..+.+.++|..-
T Consensus 415 t~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 415 TRLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccceeccc-----ccccccccccchhhccccccccccccccccccccccccCccc
Confidence 643211111 12233344 55555566788899999999999999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.1e-10 Score=101.87 Aligned_cols=169 Identities=21% Similarity=0.325 Sum_probs=125.4
Q ss_pred cccEEEEE-ecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe----cCcceEEEEecCC-CChhhh
Q 037681 86 FGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE----RDEKLLIYEYLPN-KSLDFF 159 (334)
Q Consensus 86 ~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~~ 159 (334)
-.+.|++. ..+|..|++|++.............-++.++++.|+|+|++.+++.. +..+++|++|.++ ++|-++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 36789998 56899999999954333222233455778999999999999999873 3457899999987 455544
Q ss_pred hhhcc------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 160 LFDAT------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 160 l~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
..... .+...++..+|.++.|+..||.++|+.| +..+-|.|.+|+++.+.+++|...|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 33221 1223677899999999999999999999 99999999999999999999998887655432
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCC
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKN 276 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 276 (334)
+.. |-+.+ ..+-|.=.||.+++.|.||...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 01111 1246899999999999999654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.8e-09 Score=92.54 Aligned_cols=139 Identities=17% Similarity=0.123 Sum_probs=96.1
Q ss_pred cccCCcccEEEEEecCCCEEEEEEecccChh-----------hHHHHHHHHHHHHhcCCCCc--ceEeeEEEe-----cC
Q 037681 81 LGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQ-----------GLQELKNEALVIAKVQHKNL--VRLLGCCIE-----RD 142 (334)
Q Consensus 81 lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~ 142 (334)
+-......|.++.. +|+.+.||........ ....+.+|...+.++...+| ++.+.+.+. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344666544 4788999976432211 11136788888888854333 344445443 23
Q ss_pred cceEEEEecCCC-ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-------CCce
Q 037681 143 EKLLIYEYLPNK-SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-------EMKP 214 (334)
Q Consensus 143 ~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~~ 214 (334)
..++|+|++++. +|.+++..... ...+......++.+++..+.-||..| |+|+|+++.|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 468999999986 78888743221 22455667789999999999999999 999999999999975 4689
Q ss_pred EEeecccccc
Q 037681 215 KISDFGMARI 224 (334)
Q Consensus 215 kl~Dfg~~~~ 224 (334)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-09 Score=91.21 Aligned_cols=135 Identities=20% Similarity=0.245 Sum_probs=97.4
Q ss_pred CCcCCccccCCcccEEEEEecCCCEEEEEEecccC----------------------hhhHHHHHHHHHHHHhcCCC--C
Q 037681 75 FSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS----------------------RQGLQELKNEALVIAKVQHK--N 130 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--~ 130 (334)
+.+..+||.|.-|.||.|..+.|.++|+|.-+... .-.....++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999653210 01123467899999998755 6
Q ss_pred cceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC
Q 037681 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK 210 (334)
Q Consensus 131 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 210 (334)
+.+.+++ +...+|||+++|..|...- ++.+....++..|++-+.-+-..| +||+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7776654 5568999999997663221 122233344555555555444566 999999999999999
Q ss_pred CCceEEeecccccc
Q 037681 211 EMKPKISDFGMARI 224 (334)
Q Consensus 211 ~~~~kl~Dfg~~~~ 224 (334)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.5e-09 Score=98.20 Aligned_cols=143 Identities=18% Similarity=0.274 Sum_probs=93.1
Q ss_pred CCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhH------------------------------H----H----
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGL------------------------------Q----E---- 115 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~------------------------------~----~---- 115 (334)
.|+. ..|+.++-|+||+|+..+|+.||||+.++.-.... + .
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 4443 68999999999999999999999999865422211 1 1
Q ss_pred --HHHHHHHHHhc-----CCCCcceEeeEEE-ecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHH-HH
Q 037681 116 --LKNEALVIAKV-----QHKNLVRLLGCCI-ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG-LL 186 (334)
Q Consensus 116 --~~~e~~~l~~l-----~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~-l~ 186 (334)
+..|...+.++ +.|++ .+=.++. -.+...++|||++|..+.+.......+ .+.+. ++..++++ +.
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~---ia~~~~~~f~~ 279 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKE---LAELLVRAFLR 279 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHH---HHHHHHHHHHH
Confidence 22344444443 13332 2223333 356779999999999988775333322 34322 23333322 22
Q ss_pred HhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 187 ~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
.+=..| ++|.|..|.||+++.+|++.+.|||+...+.
T Consensus 280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 222245 9999999999999999999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=6e-08 Score=79.09 Aligned_cols=139 Identities=16% Similarity=0.145 Sum_probs=100.2
Q ss_pred cccCCcccEEEEEecCCCEEEEEEeccc------ChhhHHHHHHHHHHHHhcCCCC--cceEeeEEEe--cC--cceEEE
Q 037681 81 LGEGGFGPVYKGVLAKGDEIAVKRLSVR------SRQGLQELKNEALVIAKVQHKN--LVRLLGCCIE--RD--EKLLIY 148 (334)
Q Consensus 81 lg~G~~g~V~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~--~~--~~~lv~ 148 (334)
-|+||.+.|+..... |+.+-+|+-... -+.....|.+|...+.++..-+ +.+....... +. ..++|+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 567899999986654 557888876411 1334578899999999885322 4444422111 11 257999
Q ss_pred EecCC-CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc--eEEeecccccc
Q 037681 149 EYLPN-KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK--PKISDFGMARI 224 (334)
Q Consensus 149 e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~ 224 (334)
|-+++ .+|.+++.+... .+.+......+..+++.++.-||+.| +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97765 478777754322 23567777889999999999999999 999999999999986667 99999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.7e-08 Score=82.44 Aligned_cols=106 Identities=24% Similarity=0.279 Sum_probs=82.1
Q ss_pred HHHHHHHHHHHHhcCCC--CcceEeeEEEecC----cceEEEEecCCC-ChhhhhhhcccccccchHHHHHHHHHHHHHH
Q 037681 113 LQELKNEALVIAKVQHK--NLVRLLGCCIERD----EKLLIYEYLPNK-SLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185 (334)
Q Consensus 113 ~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l 185 (334)
.....+|...+..|... .+++.+.+.+... ..++|+|++++. +|.+++..... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 34567788887777533 3455666655432 348999999984 78888755332 55666778999999999
Q ss_pred HHhhhcCCCCeEeccCCCCCeeeCCCC---ceEEeecccccc
Q 037681 186 LYLHLHSRVRIIHRDLKASNILLDKEM---KPKISDFGMARI 224 (334)
Q Consensus 186 ~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~ 224 (334)
.-||..| |+|+|+++.|||++.++ .+.++||+-+..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999998887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.8e-08 Score=86.11 Aligned_cols=193 Identities=15% Similarity=0.146 Sum_probs=123.9
Q ss_pred cCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEE------EecCc-ceEEE
Q 037681 77 DTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCC------IERDE-KLLIY 148 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------~~~~~-~~lv~ 148 (334)
..+.||+|+-+.+|..--- +. .+.|+........... .+..|... .||-+..=+.|= -+.+. .-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3678999999999964321 22 2445554332222121 12223332 455433211111 11122 34566
Q ss_pred EecCCC-Chhhhhhh---cccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 149 EYLPNK-SLDFFLFD---ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 149 e~~~~~-~L~~~l~~---~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
+.+.+. ....++.. +......+|...++.+..++.+.+.||..| -+-+|++++|+|+++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 666654 22333321 222345789999999999999999999999 89999999999999999999998654433
Q ss_pred ccCCCCccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhC-CCCCCCc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSG-KKNTEFY 280 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g-~~p~~~~ 280 (334)
.. ......-..|.+.|.+||.-. +..-+...|.|.||+++++++.| +.||...
T Consensus 167 ~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 NA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 21 112233356899999999754 33456789999999999999986 9998754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.3e-07 Score=76.96 Aligned_cols=139 Identities=18% Similarity=0.157 Sum_probs=84.2
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cceEeeEEEecCcceEEEEecCCCC-
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN--LVRLLGCCIERDEKLLIYEYLPNKS- 155 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~- 155 (334)
.+||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25567788765432 3355788999999886443 4677777777777889999999963
Q ss_pred hhhhhhh-------------------ccc-ccccchHHH-HHHHHH----------HHH-HHHHhhh-cCCCCeEeccCC
Q 037681 156 LDFFLFD-------------------ATK-RVLLELGTR-LQIIEG----------IVE-GLLYLHL-HSRVRIIHRDLK 202 (334)
Q Consensus 156 L~~~l~~-------------------~~~-~~~l~~~~~-~~i~~q----------i~~-~l~~LH~-~~~~~ivH~dlk 202 (334)
+...+.. +.- ......... ..+..+ +.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111100 000 000000000 001000 000 1112211 122347899999
Q ss_pred CCCeeeCCCCceEEeeccccc
Q 037681 203 ASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 203 p~Nill~~~~~~kl~Dfg~~~ 223 (334)
|.||++++++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=4e-07 Score=74.62 Aligned_cols=138 Identities=18% Similarity=0.171 Sum_probs=88.9
Q ss_pred HhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHH---------HHHHHHHHhcCC---CCcceEeeE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQEL---------KNEALVIAKVQH---KNLVRLLGC 137 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~~e~~~l~~l~h---~~iv~~~~~ 137 (334)
....+|.+.+.+-......|.+-.. +|..+++|..+.......+.+ .+.+..+.++.. .....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3456788888887777666666544 478899998765433222221 233333333322 233333333
Q ss_pred EE-----ecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC
Q 037681 138 CI-----ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM 212 (334)
Q Consensus 138 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 212 (334)
.+ .....+++|||++|..|.+... +++ .+...+++++.-||+.| ++|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 22 2234568999999988855431 222 24456778899999999 9999999999999865
Q ss_pred ceEEeeccccc
Q 037681 213 KPKISDFGMAR 223 (334)
Q Consensus 213 ~~kl~Dfg~~~ 223 (334)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.3e-09 Score=96.30 Aligned_cols=141 Identities=18% Similarity=0.277 Sum_probs=92.4
Q ss_pred HHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC-cccc------ccccccCCccCcccccc
Q 037681 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES-KANT------NRVAGTFGYIPPEYVYQ 251 (334)
Q Consensus 179 ~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~------~~~~g~~~y~aPE~~~~ 251 (334)
.+.+.|+.|+|... ++||++|.|++|.++.++..||+.|+.+........ .... .-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999776 699999999999999999999999998765433111 0000 00123557999999999
Q ss_pred CCCCcchhhHhHHHHHHHHHh-CCCCCCCccCC----------cccccccchhcccchhhhccccccCCccchhhhhhhh
Q 037681 252 GICSIKSDVFSFGMLLLEILS-GKKNTEFYHTG----------YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVR 320 (334)
Q Consensus 252 ~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~ 320 (334)
...+.++|+||+|+++|.+.. |+.-+...... ......+......++.+-+.+.+..+...|+++..+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 888999999999999999994 44444332111 0000111111344555556666666666666554444
Q ss_pred h
Q 037681 321 T 321 (334)
Q Consensus 321 ~ 321 (334)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 3
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.1e-07 Score=84.40 Aligned_cols=140 Identities=17% Similarity=0.257 Sum_probs=87.9
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccChhh-------------------------------HHH------HHHHHH
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQG-------------------------------LQE------LKNEAL 121 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~~------~~~e~~ 121 (334)
+.||..+.|+||+|+.++|+.||||+-++.-+.. .+. |..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999876432111 011 223333
Q ss_pred HHHh----cCCCCc---ceEeeEEEe-cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHH-HhhhcC
Q 037681 122 VIAK----VQHKNL---VRLLGCCIE-RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL-YLHLHS 192 (334)
Q Consensus 122 ~l~~----l~h~~i---v~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~ 192 (334)
-..+ +.|-+. |.+=.++.+ .+...++|||++|..+.+...-...+ ++... ++..+.++.. -+=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~---i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHD---ILNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC--CCHHH---HHHHHHHHHHHHHHhcC
Confidence 2222 234441 112222322 45678999999999887664333322 44443 3333333322 222345
Q ss_pred CCCeEeccCCCCCeeeCC----CCceEEeecccccccc
Q 037681 193 RVRIIHRDLKASNILLDK----EMKPKISDFGMARIFK 226 (334)
Q Consensus 193 ~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~~~~~ 226 (334)
++|+|-.|.||+++. ++.+.+.|||+.....
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999983 6789999999987543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.5e-07 Score=73.85 Aligned_cols=148 Identities=22% Similarity=0.232 Sum_probs=96.7
Q ss_pred hHHHHhhcCCCcCC---ccccCCcccEEEEEecCCCEEEEEEecccChhh------------------------HHHHHH
Q 037681 66 SSVAAATNNFSDTN---KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQG------------------------LQELKN 118 (334)
Q Consensus 66 ~~~~~~~~~y~~~~---~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~ 118 (334)
..+....++..+.. .|.+|.-+.||+|...++..+|+|+........ .....+
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 33444444444444 455678888999998889999999885332111 012356
Q ss_pred HHHHHHhcCCC--CcceEeeEEEecCcceEEEEecCCCCh-hhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCC
Q 037681 119 EALVIAKVQHK--NLVRLLGCCIERDEKLLIYEYLPNKSL-DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRV 194 (334)
Q Consensus 119 e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ 194 (334)
|..-|.++... .+.+.+++. ...+||||+..... .-.| +...++......+..++++.+.-|-. .+
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~-- 187 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG-- 187 (268)
T ss_pred HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC--
Confidence 77777777433 334444432 34799999976521 1111 11223343566777888888887766 55
Q ss_pred CeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 195 RIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 195 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||+||+.-|||+. ++.+.++|+|-+...
T Consensus 188 -LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 -LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred -cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 779999999988654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.1e-07 Score=76.79 Aligned_cols=78 Identities=22% Similarity=0.303 Sum_probs=55.9
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--CcceEeeEEEe---cCcceEEEEecC
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHK--NLVRLLGCCIE---RDEKLLIYEYLP 152 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~~ 152 (334)
++.++.|..+.||++...+ ..+++|..... .....+..|..+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578899999999998776 68999986544 4556778888888888533 35566664432 234689999999
Q ss_pred CCChhh
Q 037681 153 NKSLDF 158 (334)
Q Consensus 153 ~~~L~~ 158 (334)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.3e-09 Score=94.81 Aligned_cols=189 Identities=17% Similarity=0.106 Sum_probs=136.6
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-cceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN-LVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~ 150 (334)
+.-+...+.+++|+++++++.+....+....+.+... ....-++++|.+++||| .+..++-+..+....+++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3445556778999999999887443444445544322 33456788999999999 77777777778888999999
Q ss_pred cCCC-ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNK-SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+.++ +-.... ......+...+...++..-+++++++|+.. =+|+| ||+..+ +..+..||+....+....
T Consensus 316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 9887 221111 111222444555567777778899999775 57888 777665 578999999887665443
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTE 278 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 278 (334)
..+...+++.++|||+...+.+..+.|.|++|+-..++.-|-+|-.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2445678999999999999999999999999998888887877743
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.8e-06 Score=72.41 Aligned_cols=75 Identities=15% Similarity=0.124 Sum_probs=53.0
Q ss_pred ccccCCc-ccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEEecCCCChh
Q 037681 80 KLGEGGF-GPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYEYLPNKSLD 157 (334)
Q Consensus 80 ~lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 157 (334)
.|..|.. +.||+.... +..+++|...... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 778988654 4678888775433 345677888888874 344667788777667789999999998776
Q ss_pred h
Q 037681 158 F 158 (334)
Q Consensus 158 ~ 158 (334)
.
T Consensus 81 ~ 81 (244)
T cd05150 81 A 81 (244)
T ss_pred H
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.3e-06 Score=71.07 Aligned_cols=105 Identities=20% Similarity=0.197 Sum_probs=81.3
Q ss_pred HHHHHHHHhcCC-CCcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCC
Q 037681 117 KNEALVIAKVQH-KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195 (334)
Q Consensus 117 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 195 (334)
..|.-++..+.+ +++++++|+|- .+++.||.+.+++......-..-...+|..+.+++.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888865 69999999983 4778999987755321000011112689999999999999999999855555
Q ss_pred eEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 196 IIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 196 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+...|++|+|+-+++++++|++|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.8e-06 Score=66.73 Aligned_cols=129 Identities=20% Similarity=0.222 Sum_probs=88.9
Q ss_pred CcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcce-EeeEEEecCcceEEEEecCCC
Q 037681 76 SDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR-LLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 76 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~ 154 (334)
...+.||+|++|.||+|.+. |..+|+|+-... .....+..|+++|..+.-.++.+ ++.+. ..++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34678999999999999887 568888876543 33478899999999998766654 44332 234559999998
Q ss_pred ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC-CCCeeeCCCCceEEeecccccc
Q 037681 155 SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLK-ASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 155 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk-p~Nill~~~~~~kl~Dfg~~~~ 224 (334)
.|...-.. .+.+.. ..++++---|...| |-|+.|. |...++.+++.+.|+||..|+.
T Consensus 98 ~L~~~~~~------~~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIG------GDRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhc------ccHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88654311 122222 23444444455556 9999886 6656665666899999999874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.8e-06 Score=82.08 Aligned_cols=79 Identities=16% Similarity=0.371 Sum_probs=57.2
Q ss_pred CCccccCCcccEEEEEecCC---CEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCc--ceEeeEEEec---CcceEE
Q 037681 78 TNKLGEGGFGPVYKGVLAKG---DEIAVKRLSVRS-RQGLQELKNEALVIAKVQ-HKNL--VRLLGCCIER---DEKLLI 147 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv 147 (334)
++.++.|.++.+|+....++ ..+++|+..... ......+.+|..+++.+. |+++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56788999999999876543 367777654322 122356789999999995 6665 7778877664 467999
Q ss_pred EEecCCCCh
Q 037681 148 YEYLPNKSL 156 (334)
Q Consensus 148 ~e~~~~~~L 156 (334)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.3e-05 Score=65.42 Aligned_cols=128 Identities=18% Similarity=0.271 Sum_probs=89.8
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccC----------------hhhHHHHHHHHHHHHhcC------CCCcceEe
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS----------------RQGLQELKNEALVIAKVQ------HKNLVRLL 135 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~~ 135 (334)
...||+|+.-.||. +++.....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999999985 6777778899886554 223455667777666665 88999999
Q ss_pred eEEEecCcceEEEEecCC------CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC
Q 037681 136 GCCIERDEKLLIYEYLPN------KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD 209 (334)
Q Consensus 136 ~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~ 209 (334)
|+.+++...-+|+|.+.+ .+|.+++... .++. . +...+-+-..||-.+. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999888888887642 2455665322 2444 3 3333444456677666 99999999999994
Q ss_pred CC--C--ceEEee
Q 037681 210 KE--M--KPKISD 218 (334)
Q Consensus 210 ~~--~--~~kl~D 218 (334)
.. + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.4e-06 Score=69.42 Aligned_cols=74 Identities=15% Similarity=0.245 Sum_probs=47.0
Q ss_pred CCccccCCcc-cEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC---CcceEeeEEEec---CcceEEEEe
Q 037681 78 TNKLGEGGFG-PVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHK---NLVRLLGCCIER---DEKLLIYEY 150 (334)
Q Consensus 78 ~~~lg~G~~g-~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~ 150 (334)
++.++.|+.. .||+. +..+++|..... .....+..|.+++..+... -+.++++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567877776 48875 345777764432 2345788899999887532 344455444332 234889999
Q ss_pred cCCCChh
Q 037681 151 LPNKSLD 157 (334)
Q Consensus 151 ~~~~~L~ 157 (334)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9998774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.3e-05 Score=68.83 Aligned_cols=139 Identities=14% Similarity=0.095 Sum_probs=77.1
Q ss_pred ccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-ceEeeEEEecCcceEEEEecCCCChhh
Q 037681 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL-VRLLGCCIERDEKLLIYEYLPNKSLDF 158 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~ 158 (334)
.+..|-.+.+|+.. .++..+++|..........-...+|..+++.+...++ .+++.... .++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45567778899886 4467788886543322211134678888888864433 33443321 368999999876642
Q ss_pred h-------h----------hhccc-ccccchH-HHHHHHHHH---------HHHHHHhhhc-----CCCCeEeccCCCCC
Q 037681 159 F-------L----------FDATK-RVLLELG-TRLQIIEGI---------VEGLLYLHLH-----SRVRIIHRDLKASN 205 (334)
Q Consensus 159 ~-------l----------~~~~~-~~~l~~~-~~~~i~~qi---------~~~l~~LH~~-----~~~~ivH~dlkp~N 205 (334)
. . +.... ..+++.. ....+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 0 11000 0111111 111111111 1111112111 12348999999999
Q ss_pred eeeCCCCceEEeecccccc
Q 037681 206 ILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 206 ill~~~~~~kl~Dfg~~~~ 224 (334)
|++++++ +.++||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 89999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.7e-05 Score=67.13 Aligned_cols=74 Identities=18% Similarity=0.297 Sum_probs=47.9
Q ss_pred CccccCCcccEEEEEecC--CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-ceEeeEEEecCcceEEEEecCCCC
Q 037681 79 NKLGEGGFGPVYKGVLAK--GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL-VRLLGCCIERDEKLLIYEYLPNKS 155 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~ 155 (334)
+.|..|-...+|++...+ +..+++|........ .-...+|..++..+...++ ++++..+. ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467778888999987654 578888876533222 1233578888888854444 44444332 247999999977
Q ss_pred hh
Q 037681 156 LD 157 (334)
Q Consensus 156 L~ 157 (334)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.6e-05 Score=68.40 Aligned_cols=77 Identities=12% Similarity=0.110 Sum_probs=56.2
Q ss_pred cCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC---CCcceEeeEEEe---cCcceEEEEe
Q 037681 77 DTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH---KNLVRLLGCCIE---RDEKLLIYEY 150 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~ 150 (334)
..+.||.|..+.||.....++ .+++|..+. ......+..|...++.+.. -.+.++++++.. .+..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 356899999999999865545 466676432 1123578889999988853 367888887754 3668999999
Q ss_pred cCCCCh
Q 037681 151 LPNKSL 156 (334)
Q Consensus 151 ~~~~~L 156 (334)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.7e-05 Score=62.40 Aligned_cols=125 Identities=22% Similarity=0.370 Sum_probs=88.8
Q ss_pred cCCCcCCccccCCc-ccEEEEEecCCCEEEEEEecc---cC-----------h-------hhHHHHHHHHHHHHhcC---
Q 037681 73 NNFSDTNKLGEGGF-GPVYKGVLAKGDEIAVKRLSV---RS-----------R-------QGLQELKNEALVIAKVQ--- 127 (334)
Q Consensus 73 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~vaiK~~~~---~~-----------~-------~~~~~~~~e~~~l~~l~--- 127 (334)
.+++.++.||.|.- |.||++... |+.+|+|.+.. .. . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68888999999999 999999876 78999999321 00 0 12235778888887774
Q ss_pred CCCc--ceEeeEEEecC------------------cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHH
Q 037681 128 HKNL--VRLLGCCIERD------------------EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187 (334)
Q Consensus 128 h~~i--v~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~ 187 (334)
+.++ ++++|+..-.. ..-||.||.+... .+. ..-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4455 99999874321 1246777765542 012 2334567777888
Q ss_pred hhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 188 LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99888 999999999986 4589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.6e-05 Score=67.99 Aligned_cols=76 Identities=14% Similarity=0.232 Sum_probs=54.4
Q ss_pred CCccccCCcccEEEEEecCC-CEEEEEEeccc-----C--hhhHHHHHHHHHHHHhcC---CCCcceEeeEEEecCcceE
Q 037681 78 TNKLGEGGFGPVYKGVLAKG-DEIAVKRLSVR-----S--RQGLQELKNEALVIAKVQ---HKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 146 (334)
.+.||.|.+..||++...+| +.++||.-.+. . .-..++...|.+.|..+. -.++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46899999999999998776 48999985421 1 123456777888887763 2456777766 4466789
Q ss_pred EEEecCCCC
Q 037681 147 IYEYLPNKS 155 (334)
Q Consensus 147 v~e~~~~~~ 155 (334)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.2e-05 Score=77.80 Aligned_cols=201 Identities=22% Similarity=0.211 Sum_probs=136.4
Q ss_pred HHHHHHHHHHHHhcCCCCcceEeeEEEecCc----ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHh
Q 037681 113 LQELKNEALVIAKVQHKNLVRLLGCCIERDE----KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188 (334)
Q Consensus 113 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~L 188 (334)
......|...+.++.|+|++.++.+..+... ..+..+++..-++...+.... ..+..+...+..++.+|+.|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHH
Confidence 3445667888888999999999998765432 235567888777776664433 478888889999999999999
Q ss_pred hhcCCCCeEeccCCCC---CeeeCCCCceEEe--eccccccccCCCCccccccccccCCccCccccccCCCCc--chhhH
Q 037681 189 HLHSRVRIIHRDLKAS---NILLDKEMKPKIS--DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI--KSDVF 261 (334)
Q Consensus 189 H~~~~~~ivH~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Diw 261 (334)
|+.. ..|.-+..+ +.-.+.++.+.+. ||+......+..... ....+..+.+||......... ..|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHH
Confidence 9886 666666555 4455666677776 888877655433221 122355678888776655544 47999
Q ss_pred hHHHHHHHHHhCCCCCCCccCCcccccccchhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 262 SFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 262 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
.+|.....+..|..+-.........+.. .......+.+..|+..+.+.|.+..++....+.
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~~~~~l~~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAVPVSLLDV---LSTSELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred HHHHHHhhhhhcCcccccccchhhhhcc---ccchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 9999999999988764432221111110 011146677788888888888777777666653
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00015 Score=63.58 Aligned_cols=143 Identities=15% Similarity=0.089 Sum_probs=83.7
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cceEeeE------EEecCcceEEEE
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN--LVRLLGC------CIERDEKLLIYE 149 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e 149 (334)
.+.+..|....+|+.... +..+++|.... .....+..|+.++..+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777877899998654 45688887754 22355667888877774332 4444432 223456689999
Q ss_pred ecCCCChhh----hh----------hhcccc--------cccchHHH----------HHHHHHHHHHHHHhhh----cCC
Q 037681 150 YLPNKSLDF----FL----------FDATKR--------VLLELGTR----------LQIIEGIVEGLLYLHL----HSR 193 (334)
Q Consensus 150 ~~~~~~L~~----~l----------~~~~~~--------~~l~~~~~----------~~i~~qi~~~l~~LH~----~~~ 193 (334)
|++|..+.. .. +..... ....+... ......+..++.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877632 00 000000 00011000 0011112334444443 112
Q ss_pred CCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 194 VRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 194 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999887778999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00041 Score=61.62 Aligned_cols=143 Identities=15% Similarity=0.110 Sum_probs=76.0
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cceEeeE------EEecCcceEEEE
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN--LVRLLGC------CIERDEKLLIYE 149 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e 149 (334)
.+.++.|....+|.....+| .+++|+..... ...+..|..++..|...+ +.+.+.. ....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35566777789999876545 68888775222 233444555555553211 3333321 223456789999
Q ss_pred ecCCCChhh-----h------h---hhcccc--------cccch-HHHH------------HHH-HHHHHHHHHhhhc--
Q 037681 150 YLPNKSLDF-----F------L---FDATKR--------VLLEL-GTRL------------QII-EGIVEGLLYLHLH-- 191 (334)
Q Consensus 150 ~~~~~~L~~-----~------l---~~~~~~--------~~l~~-~~~~------------~i~-~qi~~~l~~LH~~-- 191 (334)
|++|..+.. . + +..... ..+.+ .... ..+ ..+...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 0 0 000000 00001 1100 011 1111122233211
Q ss_pred --CCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 192 --SRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 192 --~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
-+.+++|+|+.|+||+++++...-++||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999998765568999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=64.16 Aligned_cols=74 Identities=24% Similarity=0.369 Sum_probs=47.3
Q ss_pred CccccCCcccEEEEEecC-------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-ceEeeEEEecCcceEEEEe
Q 037681 79 NKLGEGGFGPVYKGVLAK-------GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL-VRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~ 150 (334)
+.+..|-...+|+....+ +..+++|...... ........|..++..+...++ .++++.+. + ..|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 455666667899887554 4788888865433 222445778888888754333 34555543 2 358999
Q ss_pred cCCCChh
Q 037681 151 LPNKSLD 157 (334)
Q Consensus 151 ~~~~~L~ 157 (334)
++|..+.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=2.2e-05 Score=67.67 Aligned_cols=134 Identities=16% Similarity=0.187 Sum_probs=93.8
Q ss_pred CCCcCCccccCCcccEEEEEecCCCEEEEEEeccc---------Ch--------h-----hHHHHHHHHHHHHhcCC-C-
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR---------SR--------Q-----GLQELKNEALVIAKVQH-K- 129 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~---------~~--------~-----~~~~~~~e~~~l~~l~h-~- 129 (334)
-+.+.++||-|.-+.+|.+-...|++.++|.-+.. .+ . ..-...+|...|+.|.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 46788999999999999999999999998854211 00 0 01124578888888843 2
Q ss_pred CcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC
Q 037681 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD 209 (334)
Q Consensus 130 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~ 209 (334)
-+.+.+++ +..++|||++.+-.|...-.- .+. ..+...+..-+--|-.+| +||+|.+--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec------CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 23444443 456899999988877433211 122 234455555666777777 99999999999999
Q ss_pred CCCceEEeeccccc
Q 037681 210 KEMKPKISDFGMAR 223 (334)
Q Consensus 210 ~~~~~kl~Dfg~~~ 223 (334)
+++.++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997553
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0011 Score=58.46 Aligned_cols=143 Identities=17% Similarity=0.119 Sum_probs=80.3
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cceEeeEE------EecCcceEEEE
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN--LVRLLGCC------IERDEKLLIYE 149 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~------~~~~~~~lv~e 149 (334)
.+.++.|....+|+....+| .+++|...... ....+..|.+++..|...+ +.+++... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789998875544 57788764321 1234556667776664222 34444321 12455689999
Q ss_pred ecCCCChhhh--------------hhhccccc--c-------cchHHHH------------HHHHHHHHHHHHhhh----
Q 037681 150 YLPNKSLDFF--------------LFDATKRV--L-------LELGTRL------------QIIEGIVEGLLYLHL---- 190 (334)
Q Consensus 150 ~~~~~~L~~~--------------l~~~~~~~--~-------l~~~~~~------------~i~~qi~~~l~~LH~---- 190 (334)
|++|..+... ++...... . -.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654210 01100000 0 0000000 001123334554532
Q ss_pred cCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 191 ~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
..+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123459999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00091 Score=58.15 Aligned_cols=74 Identities=18% Similarity=0.241 Sum_probs=48.2
Q ss_pred cCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCcceEeeEEEecCcceEEEEecCC
Q 037681 77 DTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ---HKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
..+.++.|....+|... .+++.+.+|.-. ......+..|.+-|+.|. --.+.+.+++....+..|+++||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 35678889999999876 568889999765 333356778888777773 45678899998888888999999987
Q ss_pred C
Q 037681 154 K 154 (334)
Q Consensus 154 ~ 154 (334)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00062 Score=60.02 Aligned_cols=140 Identities=18% Similarity=0.191 Sum_probs=94.3
Q ss_pred CcCCccccCCcccEEEEEecCCCEEEEEEeccc-----C--------------------hhh-HHHHHHHHHHHHhcCCC
Q 037681 76 SDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR-----S--------------------RQG-LQELKNEALVIAKVQHK 129 (334)
Q Consensus 76 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-----~--------------------~~~-~~~~~~e~~~l~~l~h~ 129 (334)
++...|..|.-+.||.|...+|..+|||+.+.. + +.- .-...+|+.-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344678889999999999999999999987421 0 000 11246788888888776
Q ss_pred CcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC
Q 037681 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD 209 (334)
Q Consensus 130 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~ 209 (334)
.|.-.--... ....+||+|+...... ...-+...++...+..+-.|++.-+.-|-+.+ .+||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 6542111111 2347899999643321 11122334666677777778888777776555 499999999999986
Q ss_pred CCCceEEeeccccc
Q 037681 210 KEMKPKISDFGMAR 223 (334)
Q Consensus 210 ~~~~~kl~Dfg~~~ 223 (334)
+ |.+.++|.+-+.
T Consensus 300 d-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSV 312 (520)
T ss_pred C-CEEEEEEccccc
Confidence 5 589999987664
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0008 Score=60.35 Aligned_cols=141 Identities=16% Similarity=0.182 Sum_probs=79.6
Q ss_pred CccccCCcccEEEEEecC-----CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcc-eEeeEEEecCcceEEEEecC
Q 037681 79 NKLGEGGFGPVYKGVLAK-----GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV-RLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~ 152 (334)
..+-.|-...+|++...+ +..+++|...........+ ..|..+++.+...++. ++++.+.. + .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 455457778899887432 3678888775443333333 6788888888654443 45555532 2 5899998
Q ss_pred CCChhhh-h----------------hhcc--c-ccccchHHHHHHHHHH-----------------HHHHHHh----hh-
Q 037681 153 NKSLDFF-L----------------FDAT--K-RVLLELGTRLQIIEGI-----------------VEGLLYL----HL- 190 (334)
Q Consensus 153 ~~~L~~~-l----------------~~~~--~-~~~l~~~~~~~i~~qi-----------------~~~l~~L----H~- 190 (334)
+.++... + +... . ..+..+..+..+..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 0 0000 0 0011122222222111 1111112 11
Q ss_pred cCCCCeEeccCCCCCeeeCC-CCceEEeecccccc
Q 037681 191 HSRVRIIHRDLKASNILLDK-EMKPKISDFGMARI 224 (334)
Q Consensus 191 ~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~ 224 (334)
.....++|+|+++.||++++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11234899999999999976 46799999998754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0015 Score=57.28 Aligned_cols=138 Identities=17% Similarity=0.231 Sum_probs=84.1
Q ss_pred cCCccccCCcccEEEEEecCCCEEEEEEec--ccChhhHHHHHHHHHHHHhcCC--CCcceEeeEEEecC--cceEEEEe
Q 037681 77 DTNKLGEGGFGPVYKGVLAKGDEIAVKRLS--VRSRQGLQELKNEALVIAKVQH--KNLVRLLGCCIERD--EKLLIYEY 150 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e~ 150 (334)
+++.+-.|-...+|..... +++++++ .. ...........+|..+++.+.- --+...++.|.++. ..|.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3444433333345544433 7788888 32 2334455667788888888753 23445566666655 67999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHH-HHHHHHHHHhhhc--------------------------------------
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQII-EGIVEGLLYLHLH-------------------------------------- 191 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~-~qi~~~l~~LH~~-------------------------------------- 191 (334)
++|......+.... .. .+++ ..++..|.-||+-
T Consensus 107 veGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 107 VEGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred ecceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 99854432221100 00 1122 2455555555521
Q ss_pred -----------------CCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 192 -----------------SRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 192 -----------------~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
+...++|+|+.+.|++++.++-+-+.||+++..
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 123599999999999999988899999999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0027 Score=55.09 Aligned_cols=30 Identities=27% Similarity=0.611 Sum_probs=25.2
Q ss_pred CeEeccCCCCCeeeCCCCc-eEEeecccccc
Q 037681 195 RIIHRDLKASNILLDKEMK-PKISDFGMARI 224 (334)
Q Consensus 195 ~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~ 224 (334)
.++|+|++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 56999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0019 Score=58.55 Aligned_cols=73 Identities=15% Similarity=0.148 Sum_probs=50.8
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEeccc----Ch---hhHHHHHHHHHHHHhcC---CCCcceEeeEEEecCcceEE
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR----SR---QGLQELKNEALVIAKVQ---HKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv 147 (334)
.+.||.|....||+.... +..++||+-... .. ....+...|...|+.+. -..+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 568999999999998764 567889876521 11 13344455666666653 247888888876 457889
Q ss_pred EEecCC
Q 037681 148 YEYLPN 153 (334)
Q Consensus 148 ~e~~~~ 153 (334)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.21 E-value=5.7e-05 Score=76.97 Aligned_cols=162 Identities=11% Similarity=-0.057 Sum_probs=115.8
Q ss_pred HHHHHHHHHHhcCCCCcceEeeEEEe--cCcceEEEEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhc
Q 037681 115 ELKNEALVIAKVQHKNLVRLLGCCIE--RDEKLLIYEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLH 191 (334)
Q Consensus 115 ~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~ 191 (334)
....|.+.++...|+++.....-... ....+.+++|+.+|.+...+-... +..+++...+.....+.+.+..-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34455556666789888776655433 335688999999999988775543 334455555555544445555555543
Q ss_pred CC--CCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHH
Q 037681 192 SR--VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLE 269 (334)
Q Consensus 192 ~~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~e 269 (334)
.. .-.+|+++|+-|.+|..+.++++.++|+.+... ..........+++.|+.|++...-.++.++|+|..|+.+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 22 227899999999999999999999999997321 22222334567888999998888888888999999999999
Q ss_pred HHhCCCCCC
Q 037681 270 ILSGKKNTE 278 (334)
Q Consensus 270 ll~g~~p~~ 278 (334)
...|..+|-
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 999988864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0046 Score=55.15 Aligned_cols=73 Identities=14% Similarity=0.237 Sum_probs=44.5
Q ss_pred CccccCCcccEEEEEecC----CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-ceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLAK----GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL-VRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.|..|=...+|+....+ +..+++|.........+ .-.+|..+++.+..-++ .++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445446667788876442 23788887754433222 23578888888865555 34555552 22 48899887
Q ss_pred CCh
Q 037681 154 KSL 156 (334)
Q Consensus 154 ~~L 156 (334)
..+
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 766
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0076 Score=53.74 Aligned_cols=73 Identities=15% Similarity=0.202 Sum_probs=48.7
Q ss_pred ccccCCcccEEEEEecCC-CEEEEEEeccc-------ChhhHHHHHHHHHHHHhcC--CC-CcceEeeEEEecCcceEEE
Q 037681 80 KLGEGGFGPVYKGVLAKG-DEIAVKRLSVR-------SRQGLQELKNEALVIAKVQ--HK-NLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~ 148 (334)
.||.|....||++..++| ..++||.-.+. -+-...+..-|...|+... -| .+++++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999997654 58999976311 1233455667777777653 34 44445433 455667999
Q ss_pred EecCCC
Q 037681 149 EYLPNK 154 (334)
Q Consensus 149 e~~~~~ 154 (334)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.003 Score=56.98 Aligned_cols=74 Identities=12% Similarity=0.147 Sum_probs=50.1
Q ss_pred CCccccCCcccEEEEEecC-CCEEEEEEeccc------ChhhHHHHHHHHHHHHhcC--CC-CcceEeeEEEecCcceEE
Q 037681 78 TNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVR------SRQGLQELKNEALVIAKVQ--HK-NLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv 147 (334)
.+.||.|.-.-||++...+ +..++||.-... -+-..++..-|.+.|+... .| ++++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5689999999999998743 567999975321 1233566677888887763 35 45555543 45566788
Q ss_pred EEecCC
Q 037681 148 YEYLPN 153 (334)
Q Consensus 148 ~e~~~~ 153 (334)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.017 Score=50.99 Aligned_cols=32 Identities=25% Similarity=0.357 Sum_probs=28.0
Q ss_pred CCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 193 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
+.+++|+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 33599999999999999998999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0026 Score=52.87 Aligned_cols=30 Identities=37% Similarity=0.541 Sum_probs=21.0
Q ss_pred CeEeccCCCCCeee-CCCCceEEeecccccc
Q 037681 195 RIIHRDLKASNILL-DKEMKPKISDFGMARI 224 (334)
Q Consensus 195 ~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~ 224 (334)
.++|+|+.|.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38999999999999 8888999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.02 Score=50.73 Aligned_cols=140 Identities=21% Similarity=0.233 Sum_probs=78.8
Q ss_pred ccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC---cce---Eee----EEEecCcceEEEE
Q 037681 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN---LVR---LLG----CCIERDEKLLIYE 149 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~---iv~---~~~----~~~~~~~~~lv~e 149 (334)
.|.+ .-..+|+....+|.. ++|..... .....+..|...+..|.-.+ .++ .-| ....+...+.+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 557789988776666 88877654 34466677778877773221 122 111 1111236678999
Q ss_pred ecCCCChhh-hh--------------h----hcc--c---ccccchH-----------------HHHHHHHHHHHHHHHh
Q 037681 150 YLPNKSLDF-FL--------------F----DAT--K---RVLLELG-----------------TRLQIIEGIVEGLLYL 188 (334)
Q Consensus 150 ~~~~~~L~~-~l--------------~----~~~--~---~~~l~~~-----------------~~~~i~~qi~~~l~~L 188 (334)
|++|..+.. .. + ... . .....|. .+..+...+....+.+
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988872 11 0 000 0 0011121 1222222222222222
Q ss_pred hhcCCCC---eEeccCCCCCeeeCCCCc-eEEeeccccc
Q 037681 189 HLHSRVR---IIHRDLKASNILLDKEMK-PKISDFGMAR 223 (334)
Q Consensus 189 H~~~~~~---ivH~dlkp~Nill~~~~~-~kl~Dfg~~~ 223 (334)
-..-... +||+|+.|+||+++.+.. +.++||+.+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2221222 999999999999999875 8999999875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.055 Score=47.75 Aligned_cols=29 Identities=28% Similarity=0.362 Sum_probs=25.2
Q ss_pred CCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 194 VRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 194 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.046 Score=45.41 Aligned_cols=75 Identities=23% Similarity=0.341 Sum_probs=51.7
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhc---CCCCcceEeeEEEecCcceEEEEecCCCC
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV---QHKNLVRLLGCCIERDEKLLIYEYLPNKS 155 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 155 (334)
+.+.-|.--..|...+ ..+++.+|. +.......|..|+.-|..+ +.-.+.+++.+..+.+..|+|+||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~---n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKC---NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEe---cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444455555555443 366788884 3344456677777655555 45678889999999999999999999877
Q ss_pred hh
Q 037681 156 LD 157 (334)
Q Consensus 156 L~ 157 (334)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 75
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.053 Score=48.26 Aligned_cols=72 Identities=13% Similarity=0.089 Sum_probs=44.6
Q ss_pred CCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cceEe---e--EEEecCcceEEEEecCCCCh
Q 037681 84 GGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN--LVRLL---G--CCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 84 G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~---~--~~~~~~~~~lv~e~~~~~~L 156 (334)
+.-..||.....++..+++|..+.. ......+..|.+.+..|.... ++... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 4457799988777888999977532 223456677777777663221 22212 1 12234567889999988654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.011 Score=52.31 Aligned_cols=71 Identities=21% Similarity=0.246 Sum_probs=53.6
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..|++|++- |+++.. + ....+++...++.+.+..+.-+...- +.-|||+..+||+|+ +|+|-|+||.++
T Consensus 300 y~yl~~kdh-gt~is~-i------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-e------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 456777764 444421 1 12467788889888888777776554 588999999999999 899999999999
Q ss_pred cc
Q 037681 223 RI 224 (334)
Q Consensus 223 ~~ 224 (334)
+.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 84
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.046 Score=49.72 Aligned_cols=75 Identities=17% Similarity=0.320 Sum_probs=44.1
Q ss_pred CCccccCCcccEEEEEecCC--CE-----EEEEEecccChhhHHHHHHHHHHHHhcCCCCc-ceEeeEEEecCcceEEEE
Q 037681 78 TNKLGEGGFGPVYKGVLAKG--DE-----IAVKRLSVRSRQGLQELKNEALVIAKVQHKNL-VRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~--~~-----vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 149 (334)
++.|..|-...+|++...++ .. |.++.......... .-.+|..+++.+...++ .++++.+. -.++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 34565577788999875432 22 33333211111111 22568889998875555 44555553 258999
Q ss_pred ecCCCChh
Q 037681 150 YLPNKSLD 157 (334)
Q Consensus 150 ~~~~~~L~ 157 (334)
|++|..+.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99998774
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.078 Score=54.56 Aligned_cols=32 Identities=34% Similarity=0.506 Sum_probs=26.1
Q ss_pred CCCeEeccCCCCCeeeCCCC--ceE-Eeecccccc
Q 037681 193 RVRIIHRDLKASNILLDKEM--KPK-ISDFGMARI 224 (334)
Q Consensus 193 ~~~ivH~dlkp~Nill~~~~--~~k-l~Dfg~~~~ 224 (334)
+..+||+|+++.||+++.++ ++. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 34599999999999998875 454 999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.039 Score=45.59 Aligned_cols=117 Identities=19% Similarity=0.139 Sum_probs=70.8
Q ss_pred CCcccEEEEEecCCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCChhhhhhh
Q 037681 84 GGFGPVYKGVLAKGDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFD 162 (334)
Q Consensus 84 G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 162 (334)
++.++.-.+..+-| +..+|++...+-. ....+..+..+++++. .|+++..= +.-.+-++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 44455554443333 3456666544333 3455677788887764 57776621 22234588898854321
Q ss_pred cccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 163 ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 163 ~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
.. ..++..=+.+|.-.|+. ....+|+|-.|+||+-|..|.+||.|-+..
T Consensus 142 ------~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 ------NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 11 11222224567778854 235999999999999999999999997653
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.026 Score=50.80 Aligned_cols=63 Identities=19% Similarity=0.199 Sum_probs=41.4
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE 211 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 211 (334)
...++-+|..|.++..++.... .++.....++.-.+.|+.-+---. .++|.|+.|.||++.-+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEec
Confidence 3457778888888888875443 344455556555556654433222 39999999999999533
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.15 Score=47.40 Aligned_cols=74 Identities=15% Similarity=0.113 Sum_probs=45.2
Q ss_pred CCccccCCcccEEEEEecC---------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcc-eEeeEEEecCcceEE
Q 037681 78 TNKLGEGGFGPVYKGVLAK---------GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV-RLLGCCIERDEKLLI 147 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv 147 (334)
++.|..|=.-.+|++...+ ++.|++++......... .-..|..+++.+...+|- ++++.+. -..|
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 4556566667788887542 35788887654433333 235677777777654543 3555442 3457
Q ss_pred EEecCCCCh
Q 037681 148 YEYLPNKSL 156 (334)
Q Consensus 148 ~e~~~~~~L 156 (334)
.||++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899998755
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 334 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-33 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-07 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-111
Identities = 91/219 (41%), Positives = 136/219 (62%), Gaps = 3/219 (1%)
Query: 63 FSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQ-ELKNEAL 121
FS + A++NFS+ N LG GGFG VYKG LA G +AVKRL QG + + + E
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 122 VIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATK-RVLLELGTRLQIIEG 180
+I+ H+NL+RL G C+ E+LL+Y Y+ N S+ L + + + L+ R +I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
GL YLH H +IIHRD+KA+NILLD+E + + DFG+A++ ++ T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 241 FGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEF 279
G+I PEY+ G S K+DVF +G++LLE+++G++ +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 321 bits (826), Expect = e-110
Identities = 89/231 (38%), Positives = 130/231 (56%), Gaps = 15/231 (6%)
Query: 59 ELPLFSFSSVAAATNNFSD------TNKLGEGGFGPVYKGVLAKGDEIAVKRLS----VR 108
FSF + TNNF + NK+GEGGFG VYKG + +AVK+L+ +
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 109 SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL 168
+ + Q+ E V+AK QH+NLV LLG + D+ L+Y Y+PN SL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 169 LELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228
L R +I +G G+ +LH + IHRD+K++NILLD+ KISDFG+AR +
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEF 279
T+R+ GT Y+ PE + +G + KSD++SFG++LLEI++G +
Sbjct: 187 AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 2e-97
Identities = 90/243 (37%), Positives = 136/243 (55%), Gaps = 19/243 (7%)
Query: 63 FSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALV 122
+ ATNNF +G G FG VYKGVL G ++A+KR + S QG++E + E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 123 IAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL-LELGTRLQIIEGI 181
++ +H +LV L+G C ER+E +LIY+Y+ N +L L+ + + + RL+I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF-KGNESKANTNRVAGT 240
GL YLH + IIHRD+K+ NILLD+ PKI+DFG+++ + +++ +T V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
Query: 241 FGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIK 300
GYI PEY +G + KSDV+SFG++L E+L + Q+ +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-------------VQSLPREMVN 251
Query: 301 LVE 303
L E
Sbjct: 252 LAE 254
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-75
Identities = 56/239 (23%), Positives = 103/239 (43%), Gaps = 22/239 (9%)
Query: 63 FSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALV 122
++ + G FG V+K L + +AVK ++ +Q + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 123 IAKVQHKNLVRLLGCCIERD----EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
+ ++H+N+++ +G + LI + SL FL K ++ I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 179 EGIVEGLLYLHLH-------SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231
E + GL YLH + I HRD+K+ N+LL + I+DFG+A F+ +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 232 ANTNRVAGTFGYIPPEYVYQGI-----CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL 285
+T+ GT Y+ PE + I ++ D+++ G++L E+ S + Y+
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-64
Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 34/246 (13%)
Query: 63 FSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALV 122
+ S + +N +G G +G VYKG L +AVK S +RQ NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 123 --IAKVQHKNLVRLLGCCIE-----RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL 175
+ ++H N+ R + R E LL+ EY PN SL +L T + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 176 QIIEGIVEGLLYLH------LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN- 228
++ + GL YLH H + I HRDL + N+L+ + ISDFG++ GN
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 229 -----ESKANTNRVAGTFGYIPPEYVYQGI-------CSIKSDVFSFGMLLLEILSGKKN 276
E GT Y+ PE + + + D+++ G++ EI +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 277 TEFYHT 282
+
Sbjct: 235 LFPGES 240
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-55
Identities = 60/199 (30%), Positives = 107/199 (53%), Gaps = 8/199 (4%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLG 136
K+G G FG V++ G ++AVK L + + + E E ++ +++H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
+ ++ EYL SL L + R L+ RL + + +G+ YLH + I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPI 160
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG-ICS 255
+HR+LK+ N+L+DK+ K+ DFG++R+ + + AGT ++ PE V + +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPE-VLRDEPSN 217
Query: 256 IKSDVFSFGMLLLEILSGK 274
KSDV+SFG++L E+ + +
Sbjct: 218 EKSDVYSFGVILWELATLQ 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-54
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRL----SVRSRQGLQELKNEALVIAKVQHKNLVRL 134
+G GGFG VY+ GDE+AVK Q ++ ++ EA + A ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
G C++ L+ E+ L+ L + + I G+ YLH + V
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 195 RIIHRDLKASNILLDKEMKP--------KISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
IIHRDLK+SNIL+ ++++ KI+DFG+AR + + AG + ++ P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AGAYAWMAP 183
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSGK 274
E + + S SDV+S+G+LL E+L+G+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-53
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
+G G FG V K + ++A+K++ S + E +++V H N+V+L G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+ + L+ EY SL L A + +G+ YLH +IH
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 199 RDLKASNILLDKEMK-PKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIK 257
RDLK N+LL KI DFG A + + + G+ ++ PE S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 258 SDVFSFGMLLLEILSGKK 275
DVFS+G++L E+++ +K
Sbjct: 184 CDVFSWGIILWEVITRRK 201
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-52
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLG 136
++G G FG VYKG GD +AVK L+V + Q LQ KNE V+ K +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+L ++ ++ SL L E+ + I G+ YLH S
Sbjct: 88 YSTA--PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE---YVYQG 252
IIHRDLK++NI L ++ KI DFG+A +++G+ ++ PE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
S +SDV++FG++L E+++G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 9e-52
Identities = 47/229 (20%), Positives = 95/229 (41%), Gaps = 29/229 (12%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLG 136
KL E G ++KG +G++I VK L VR S + ++ E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 137 CCIERDEKLL--IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
C I ++P SL L + T V+ + ++ + G+ +LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTLEPL 133
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG-- 252
I L + ++++D++M +IS + F+ + ++ PE Q
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPE-ALQKKP 184
Query: 253 --ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKI 299
+D++SF +LL E+++ + + ++ K+
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE---VPFA-------DLSNMEIGMKV 223
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-50
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 79 NKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQG-------LQELKNEALVIAKVQHKN 130
++G+GGFG V+KG L K +A+K L + +G QE + E +++ + H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+V+L G ++ E++P L L D K ++ +L+++ I G+ Y+
Sbjct: 85 IVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ- 139
Query: 191 HSRVRIIHRDLKASNILLDK-----EMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
+ I+HRDL++ NI L + K++DFG+++ + G F ++
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLL----GNFQWMA 194
Query: 246 PEYVYQG---ICSIKSDVFSFGMLLLEILSGKK 275
PE + K+D +SF M+L IL+G+
Sbjct: 195 PE-TIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-49
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 79 NKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
LG+G FG K G+ + +K L + + E V+ ++H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 138 CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRII 197
+ I EY+ +L + R+ + I G+ YLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---II 130
Query: 198 HRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR------------VAGTFGYIP 245
HRDL + N L+ + ++DFG+AR+ +++ R V G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
PE + K DVFSFG++L EI+
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-48
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLG 136
+G+G FG VY G G+ +A++ + + + L+ K E + + +H+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
C+ +I ++L + D +++L++ QI + IV+G+ YLH I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR---VAGTFGYIPPE------ 247
+H+DLK+ N+ D K I+DFG+ I ++ ++ G ++ PE
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 248 ---YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ S SDVF+ G + E+ + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-45
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQG-LQELKNEALVIAKVQHKNLVRLLGC 137
+G+G +G V++G +G+ +AVK S R + +E E ++H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRET--ELYNTVMLRHENILGFIAS 70
Query: 138 CIERDEK----LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH---- 189
+ LI Y SL +L + L+ + L+I+ I GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 190 -LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT--NRVAGTFGYIPP 246
+ I HRDLK+ NIL+ K + I+D G+A + + ++ + N GT Y+ P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 247 E------YVYQGICSIKSDVFSFGMLLLEILSG 273
E V + D+++FG++L E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 80 KLGEGGFGPVYKGVLAKGDEI--AVKRL-SVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
++G G FG V+ G L + D AVK + EA ++ + H N+VRL+G
Sbjct: 121 QIGRGNFGEVFSGRL-RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
C ++ ++ E + FL T+ L + T LQ++ G+ YL
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVYQ 251
IHRDL A N L+ ++ KISDFGM+R A +G +P PE +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-----SGGLRQVPVKWTAPEALNY 289
Query: 252 GICSIKSDVFSFGMLLLEILS-------GKKNTE 278
G S +SDV+SFG+LL E S N +
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-43
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 32/238 (13%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALV--IAKVQHKNLVRLLG 136
++G+G +G V+ G +G+++AVK E + ++H+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98
Query: 137 CCIERDEK----LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH--- 189
I+ LI +Y N SL +L K L+ + L++ V GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 190 --LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN--TNRVAGTFGYIP 245
+ I HRDLK+ NIL+ K I+D G+A F + ++ + N GT Y+P
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 246 PEYVYQGI-------CSIKSDVFSFGMLLLEILSGK---KNTEFYHTGYLSINGYDQT 293
PE V I +D++SFG++L E+ E Y Y + D +
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-43
Identities = 68/241 (28%), Positives = 116/241 (48%), Gaps = 24/241 (9%)
Query: 79 NKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+LG+G FG V G+ +AVK+L + + L++ + E ++ +QH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 134 LLGCCIERDEK--LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
G C + LI EYLP SL +L +R ++ LQ I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 161
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----P 246
R IHRDL NIL++ E + KI DFG+ ++ ++ G P P
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAP 217
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING---YDQTQVASKIKLVE 303
E + + S+ SDV+SFG++L E+ + + ++ ++ + G Q V I+L++
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 304 S 304
+
Sbjct: 278 N 278
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 67/241 (27%), Positives = 115/241 (47%), Gaps = 24/241 (9%)
Query: 79 NKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+LG+G FG V G+ +AVK+L + + L++ + E ++ +QH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 134 LLGCCIERDEK--LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
G C + LI EYLP SL +L + ++ LQ I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----P 246
R IHRDL NIL++ E + KI DFG+ ++ ++ G P P
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAP 186
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING---YDQTQVASKIKLVE 303
E + + S+ SDV+SFG++L E+ + + ++ ++ + G Q V I+L++
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 304 S 304
+
Sbjct: 247 N 247
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-43
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 33/224 (14%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGL---QELKNEALVIAKVQHKNLVRLL 135
++G G FG V+ G D++A+K + R+G ++ EA V+ K+ H LV+L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
G C+E+ L+ E++ + L +L T+R L T L + + EG+ YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 124
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVY 250
+IHRDL A N L+ + K+SDFGM R ++ ++T P PE
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG------TKFPVKWASPEVFS 178
Query: 251 QGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
S KSDV+SFG+L+ E+ S + N+E TG+
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 79 NKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
++LG+G FG V G +AVK+L ++ + E ++ + +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 134 LLGCCIERDEK--LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
G + L+ EYLP+ L FL R L+ L I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----P 246
R +HRDL A NIL++ E KI+DFG+A++ ++ V G P P
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILS 272
E + I S +SDV+SFG++L E+ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 27/222 (12%)
Query: 79 NKLGEGGFGPVYKGVLAKGD-EIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
+KLG G +G VY+GV K +AVK L + + ++E EA V+ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 138 CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRII 197
C +I E++ +L +L + R + L + I + YL + I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 198 HRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVYQG 252
HRDL A N L+ + K++DFG++R+ G+ A+ P PE +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPIKWTAPESLAYN 187
Query: 253 ICSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
SIKSDV++FG+LL EI + G ++ Y Y
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-42
Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 30/237 (12%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQG-LQELKNEALVIAKVQHKNLVRLLGC 137
+G+G FG V++G +G+E+AVK S R + +E E ++H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA--EIYQTVMLRHENILGFIAA 104
Query: 138 CIERDEK----LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH---- 189
+ + L+ +Y + SL +L R + + +++ GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 190 -LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK---ANTNRVAGTFGYIP 245
+ I HRDLK+ NIL+ K I+D G+A A +RV GT Y+
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMA 219
Query: 246 PE------YVYQGICSIKSDVFSFGMLLLEILSGKK---NTEFYHTGYLSINGYDQT 293
PE + ++D+++ G++ EI E Y Y + D +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 32/227 (14%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE-----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLV 132
LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
RLLG C+ LI + +P L ++ + + + L I +G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PE 247
R++HRDL A N+L+ KI+DFG+A++ E + + G +P E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 248 YVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
+ I + +SDV+S+G+ + E+++ G +E G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-42
Identities = 69/241 (28%), Positives = 100/241 (41%), Gaps = 26/241 (10%)
Query: 79 NKLGEGGFGPVYKGVL-----AKGDEIAVKRL-SVRSRQGLQELKNEALVIAKVQHKNLV 132
LGEG FG V G+ +AVK L + Q K E ++ + H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 133 RLLGCCIERDEK--LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ GCC + L+ EY+P SL +L R + L L + I EG+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP----- 245
IHRDL A N+LLD + KI DFG+A+ G P
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYA 205
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSING-YDQTQVASKIKLVE 303
PE + + SDV+SFG+ L E+L+ + I Q V +L+E
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 304 S 304
Sbjct: 266 R 266
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-42
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
+LG G FG V G ++A+K + S E EA V+ + H+ LV+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
++ +I EY+ N L +L R + L++ + + E + YL + +H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVYQGI 253
RDL A N L++ + K+SDFG++R +E ++ P PE +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG------SKFPVRWSPPEVLMYSK 197
Query: 254 CSIKSDVFSFGMLLLEILS 272
S KSD+++FG+L+ EI S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 65/241 (26%), Positives = 107/241 (44%), Gaps = 24/241 (9%)
Query: 79 NKLGEGGFGPVYKGVLA-----KGDEIAVKRL-SVRSRQGLQELKNEALVIAKVQHKNLV 132
LGEG FG V G+++AVK L + +LK E ++ + H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 133 RLLGCCIERDEK--LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ G C E LI E+LP+ SL +L + + L +L+ I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGS 144
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP----- 245
+ +HRDL A N+L++ E + KI DFG+ + + ++ P
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSPVFWYA 197
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSING-YDQTQVASKIKLVE 303
PE + Q I SDV+SFG+ L E+L+ ++ I + Q V + ++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 304 S 304
Sbjct: 258 E 258
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 63/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEI--AVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
+KLG G +G VY+GV K + AVK L + + ++E EA V+ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
C +I E++ +L +L + ++ + L + I + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL---EKKNF 339
Query: 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGY--IPPEYVYQGIC 254
IHR+L A N L+ + K++DFG++R+ G+ T F PE +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKF 396
Query: 255 SIKSDVFSFGMLLLEILS 272
SIKSDV++FG+LL EI +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE------IAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+LGEG FG V+ +AVK L S Q+ + EA ++ +QH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFL------------FDATKRVLLELGTRLQIIEG 180
R G C E L+++EY+ + L+ FL + L LG L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAG 239
+ G++YL + + +HRDL N L+ + + KI DFGM+R I+ + +
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR---- 219
Query: 240 TFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
+P PE + + +SDV+SFG++L EI +
Sbjct: 220 --TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-41
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
+LG G FG V G ++AVK + S E EA + K+ H LV+ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
+ ++ EY+ N L +L + LE L++ + EG+ +L + IHR
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 200 DLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVYQGIC 254
DL A N L+D+++ K+SDFGM R ++ ++ P PE +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG------TKFPVKWSAPEVFHYFKY 182
Query: 255 SIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
S KSDV++FG+L+ E+ S N+E G+
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-41
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 41/235 (17%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE------IAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+LGEG FG V+ +AVK L + ++ + EA ++ +QH+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFL-------------FDATKRVLLELGTRLQIIE 179
+ G C + D ++++EY+ + L+ FL + L L L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 180 GIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVA 238
I G++YL + +HRDL N L+ + KI DFGM+R ++ + + +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH--- 194
Query: 239 GTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+P PE + + +SDV+SFG++L EI + NTE
Sbjct: 195 ---TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 73/221 (33%), Positives = 106/221 (47%), Gaps = 27/221 (12%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
+LG G FG V+ G ++AVK L S EA ++ ++QH+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+ + +I EY+ N SL FL + L + L + I EG+ ++ IH
Sbjct: 78 TQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVYQGI 253
RDL+A+NIL+ + KI+DFG+AR+ + NE A P PE + G
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG------AKFPIKWTAPEAINYGT 186
Query: 254 CSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
+IKSDV+SFG+LL EI++ G N E GY
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-41
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
+G+G FG V G +G+++AVK + + Q EA V+ +++H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 139 IERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRII 197
+E L ++ EY+ SL +L + VL L+ + E + YL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL---EGNNFV 311
Query: 198 HRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGY--IPPEYVYQGICS 255
HRDL A N+L+ ++ K+SDFG+ + +A++ + G PE + + S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 256 IKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
KSDV+SFG+LL EI S + GY
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 403
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-40
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVR 133
+G G G V G L + +A+K L + + ++ +EA ++ + H N++R
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
L G +++ EY+ N SLD FL + + + ++ G+ G+ YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEY 248
+ +HRDL A N+L+D + K+SDFG++R+ + + A T G IP PE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG----GKIPIRWTAPEA 225
Query: 249 VYQGICSIKSDVFSFGMLLLEILS 272
+ S SDV+SFG+++ E+L+
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE-----IAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLV 132
LG G FG VYKG+ E +A+K L + + +E+ +EA V+A V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
RLLG C+ LI + +P L ++ + + + L I +G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PE 247
R++HRDL A N+L+ KI+DFG+A++ E + + G +P E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 248 YVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+ I + +SDV+S+G+ + E+++ G +E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
KLG G FG V+ K ++AVK + S ++ EA V+ +QH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+ + +I E++ SL FL + L + I EG+ ++ + IH
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVYQGI 253
RDL+A+NIL+ + KI+DFG+AR+ + NE A P PE + G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG------AKFPIKWTAPEAINFGS 361
Query: 254 CSIKSDVFSFGMLLLEILS 272
+IKSDV+SFG+LL+EI++
Sbjct: 362 FTIKSDVWSFGILLMEIVT 380
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-40
Identities = 66/236 (27%), Positives = 111/236 (47%), Gaps = 39/236 (16%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE----IAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLV 132
LGEG FG V +G L + D +AVK + + S++ ++E +EA + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 133 RLLGCCIERD-----EKLLIYEYLPNKSLDFFL---FDATKRVLLELGTRLQIIEGIVEG 184
RLLG CIE + ++I ++ L +L T + L T L+ + I G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTFGY 243
+ YL S +HRDL A N +L +M ++DFG+++ I+ G+ +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI------AK 210
Query: 244 IP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
+P E + + + KSDV++FG+ + EI + G +N E Y G+
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-40
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE----IAVKRL-SVRSRQGLQELKNEALVIAKVQHKNLVR 133
+G+G FG VY G + A+K L + Q ++ E L++ + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 134 LLGCCIERDE-KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
L+G + + ++ Y+ + L F+ + + + + G+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYL---A 141
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PE 247
+ +HRDL A N +LD+ K++DFG+AR E + +P E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY---YSVQQHRHARLPVKWTALE 198
Query: 248 YVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
+ + KSDV+SFG+LL E+L+ + H G
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 80 KLGEGGFGPVYKGVLAKGDE-----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVR 133
+G G FG VYKG+L +A+K L + + + EA ++ + H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
L G + ++I EY+ N +LD FL + + + ++ GI G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---AN 165
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEY 248
+ +HRDL A NIL++ + K+SDFG++R+ + + T G IP PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG----GKIPIRWTAPEA 221
Query: 249 VYQGICSIKSDVFSFGMLLLEILS-------GKKNTE 278
+ + SDV+SFG+++ E+++ N E
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-40
Identities = 63/230 (27%), Positives = 92/230 (40%), Gaps = 31/230 (13%)
Query: 80 KLGEGGFGPVYKGVL--AKGDEI--AVKRL---SVRSRQGLQELKNEALVIAKVQHKNLV 132
KLG+G FG V +G G + AVK L + + + + E + + H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
RL G + ++ E P SL L LGT + + EG+ YL
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYL---E 138
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PE 247
R IHRDL A N+LL KI DFG+ R N+ V +P PE
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY----VMQEHRKVPFAWCAPE 194
Query: 248 YVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYHTGYLSINGY 290
+ S SD + FG+ L E+ + G ++ H + G
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--KIDKEGE 242
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-40
Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQG--LQELKNEALVIAKVQHKNLVRLLG 136
+G+G FG V G +G+++AVK + + Q EA V+ +++H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGD-YRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 137 CCIERDEKLLI-YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+E L I EY+ SL +L + R +L L+ + E + YL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNN 137
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVY 250
+HRDL A N+L+ ++ K+SDFG+ + S G +P PE +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT------GKLPVKWTAPEALR 187
Query: 251 QGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
+ S KSDV+SFG+LL EI S + GY
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 231
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-40
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE-----IAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLV 132
LG G FG V+KGV E + +K + +S RQ Q + + L I + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
RLLG C L+ +YLP SL + R L L I +G+ YL
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL---E 132
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PE 247
++HR+L A N+LL + +++DFG+A + ++ + + P E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALE 187
Query: 248 YVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
++ G + +SDV+S+G+ + E+++ G + E G
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-40
Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 37/231 (16%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE----IAVKRL--SVRSRQGLQELKNEALVIAKVQHKNLV 132
LG+G FG V + L + D +AVK L + + ++E EA + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 133 RLLGCCIERDEK------LLIYEYLPNKSLDFFLFD---ATKRVLLELGTRLQIIEGIVE 183
+L+G + K ++I ++ + L FL L L T ++ + I
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTFG 242
G+ YL S IHRDL A N +L ++M ++DFG++R I+ G+ +
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA------S 199
Query: 243 YIP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+P E + + ++ SDV++FG+ + EI++ G +N E Y+
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-40
Identities = 69/239 (28%), Positives = 101/239 (42%), Gaps = 44/239 (18%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE---IAVKRL-SVRSRQGLQELKNEALVIAKV-QHKNLVR 133
+ +GEG FG V K + K A+KR+ S+ ++ E V+ K+ H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFL-------------FDATKRVLLELGTRLQIIEG 180
LLG C R L EY P+ +L FL + L L
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
+ G+ YL S+ + IHRDL A NIL+ + KI+DFG++R T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM----- 200
Query: 241 FGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
G +P E + + + SDV+S+G+LL EI+S G E Y GY
Sbjct: 201 -GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-40
Identities = 70/230 (30%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 79 NKLGEGGFGPVYKGVL--AKGDE----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNL 131
LG G FG VY+G + D +AVK L S Q + EAL+I+K H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFL----FDATKRVLLELGTRLQIIEGIVEGLLY 187
VR +G ++ + ++ E + L FL ++ L + L + I G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 188 LHLHSRVRIIHRDLKASNILLDKE---MKPKISDFGMAR-IFKGNESKANTNRVAGTFGY 243
L IHRD+ A N LL KI DFGMAR I++ + +
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC------AM 206
Query: 244 IP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+P PE +GI + K+D +SFG+LL EI S K N E
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-40
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE----IAVKRL-SVRSRQGLQELKNEALVIAKVQHKNLVR 133
+G G FG VY G L D AVK L + + + E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 134 LLGCCIERDEKLL-IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
LLG C+ + L + Y+ + L F+ + + + + +G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTFGYIP-----P 246
+ +HRDL A N +LD++ K++DFG+AR ++ + T +P
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK----TGAKLPVKWMAL 201
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH---TGY 284
E + + KSDV+SFG+LL E+++ + G
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 53/237 (22%), Positives = 95/237 (40%), Gaps = 48/237 (20%)
Query: 80 KLGEGGFGPVYKGVLAKGD--------EIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
LG+G F ++KGV + E+ +K L R + A +++K+ HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
V G C+ DE +L+ E++ SLD +L + + + +L++ + + + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL--- 129
Query: 192 SRVRIIHRDLKASNILLDKEMKP--------KISDFGMARIFKGNESKANTNRVAGTFGY 243
+IH ++ A NILL +E K+SD G++ +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQ 178
Query: 244 IP-----PE-YVYQGICSIKSDVFSFGMLLLEILS-------GKKNTE---FYHTGY 284
PE ++ +D +SFG L EI S + FY +
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVR 133
+G G FG V G L + +A+K L V + + ++ EA ++ + H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
L G + +++ EY+ N SLD FL + + + ++ GI G+ YL S
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYL---SD 165
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEY 248
+ +HRDL A NIL++ + K+SDFG+ R+ + + A T R G IP PE
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG----GKIPIRWTSPEA 221
Query: 249 VYQGICSIKSDVFSFGMLLLEILS 272
+ + SDV+S+G++L E++S
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 35/220 (15%)
Query: 79 NKLGEGGFGPVYKGVL---AKGDE---IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNL 131
+LGE FG VYKG L A G++ +A+K L + +E ++EA++ A++QH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFL-------------FDATKRVLLELGTRLQII 178
V LLG + +I+ Y + L FL D T + LE + ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRV 237
I G+ YL S ++H+DL N+L+ ++ KISD G+ R ++ + K N
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN-- 189
Query: 238 AGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
+P PE + G SI SD++S+G++L E+ S
Sbjct: 190 ----SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 36/230 (15%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE------IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNL 131
+LG+G FG VY+GV + +A+K ++ S + E NEA V+ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFL-------FDATKRVLLELGTRLQIIEGIVEG 184
VRLLG + L+I E + L +L + L +Q+ I +G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTFGY 243
+ YL + + +HRDL A N ++ ++ KI DFGM R I++ + + G
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK------GL 201
Query: 244 IP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+P PE + G+ + SDV+SFG++L EI + G N +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 70/230 (30%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 79 NKLGEGGFGPVYKGVL--AKGDE----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNL 131
LG G FG VY+G + D +AVK L S Q + EAL+I+K H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFL----FDATKRVLLELGTRLQIIEGIVEGLLY 187
VR +G ++ + ++ E + L FL ++ L + L + I G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 188 LHLHSRVRIIHRDLKASNILLDKE---MKPKISDFGMAR-IFKGNESKANTNRVAGTFGY 243
L IHRD+ A N LL KI DFGMAR I++ +
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC------AM 247
Query: 244 IP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+P PE +GI + K+D +SFG+LL EI S K N E
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-39
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE----IAVKRL-SVRSRQGLQELKNEALVIAKVQHKNLVR 133
+G G FG VY G L D AVK L + + + E +++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 134 LLGCCIERDEKLL-IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
LLG C+ + L + Y+ + L F+ + + + + + +G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PE 247
+ +HRDL A N +LD++ K++DFG+AR E + N+ T +P E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALE 266
Query: 248 YVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH 281
+ + KSDV+SFG+LL E+++ +
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-39
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 80 KLGEGGFGPVYKGVL-AKGDEI--AVKRL--SVRSRQGLQELKNEALVIAKVQHKNLVRL 134
+LG G FG V KG K AVK L EL EA V+ ++ + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+G C E + +L+ E L+ +L + ++ ++++ + G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYV 249
+HRDL A N+LL + KISDFG+++ + +E+ A T G P PE +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPECI 192
Query: 250 YQGICSIKSDVFSFGMLLLEILS-------GKKNTE 278
S KSDV+SFG+L+ E S G K +E
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-39
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 80 KLGEGGFGPVYKGVLAKGDE---IAVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRLL 135
+LG G FG V +GV + +A+K L + +E+ EA ++ ++ + +VRL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
G C + + +L+ E L FL KR + + +++ + G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVY 250
+HRDL A N+LL KISDFG+++ ++S A + G P PE +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECIN 186
Query: 251 QGICSIKSDVFSFGMLLLEILS-------GKKNTE 278
S +SDV+S+G+ + E LS K E
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 80 KLGEGGFGPVYKGVLAKGDE----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRL 134
+GEG FG V++G+ + +A+K S ++ EAL + + H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+G + +I E L FL ++ L+L + + + L YL
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ESK 135
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYV 249
R +HRD+ A N+L+ K+ DFG++R + + + G +P PE +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESI 189
Query: 250 YQGICSIKSDVFSFGMLLLEILS-------GKKNTE 278
+ SDV+ FG+ + EIL G KN +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
KLG+G FG V+ G +A+K L + + EA V+ K++H+ LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
E + ++ EY+ SL FL L L + + I G+ Y+ R+ +H
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVYQGI 253
RDL+A+NIL+ + + K++DFG+AR+ + NE A P PE G
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG------AKFPIKWTAPEAALYGR 440
Query: 254 CSIKSDVFSFGMLLLEILS 272
+IKSDV+SFG+LL E+ +
Sbjct: 441 FTIKSDVWSFGILLTELTT 459
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 72/250 (28%), Positives = 112/250 (44%), Gaps = 53/250 (21%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE------IAVKRL-SVRSRQGLQELKNEALVIAKVQHKNL 131
LGEG FG V K +AVK L S L++L +E V+ +V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFL---------------------FDATKRVLLE 170
++L G C + LLI EY SL FL D L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 171 LGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNE 229
+G + I +G+ YL + ++++HRDL A NIL+ + K KISDFG++R +++ +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 230 SKANTNRVAGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNT 277
+ G IP E ++ I + +SDV+SFG+LL EI++ G
Sbjct: 206 YVKRSQ------GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 278 EFYH---TGY 284
++ TG+
Sbjct: 260 RLFNLLKTGH 269
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 50/244 (20%)
Query: 79 NKLGEGGFGPVYKGV---LAKGDE---IAVKRL-SVRSRQGLQELKNEALVIAKVQHKNL 131
+GEG FG V++ L + +AVK L S + + EA ++A+ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFL---------------------FDATKRVLLE 170
V+LLG C L++EY+ L+ FL + L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 171 LGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNE 229
+L I + G+ YL S + +HRDL N L+ + M KI+DFG++R I+ +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 230 SKANTNRVAGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNT 277
KA+ N IP PE ++ + +SDV+++G++L EI S G +
Sbjct: 230 YKADGN------DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 278 EFYH 281
E +
Sbjct: 284 EVIY 287
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-38
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 80 KLGEGGFGPVYKGVL--AKGDEI--AVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRL 134
LGEG FG VY+GV KG++I AVK + ++ +EA+++ + H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+G E + +I E P L +L L++ T + I + + YL +
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYL---ESI 132
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYV 249
+HRD+ NIL+ K+ DFG++R + + + +P PE +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTRLPIKWMSPESI 186
Query: 250 YQGICSIKSDVFSFGMLLLEILS-------GKKNTE 278
+ SDV+ F + + EILS +N +
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 4e-38
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 80 KLGEGGFGPVYKGVLAKGDE---IAVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRLL 135
+LG G FG V +GV + +A+K L + +E+ EA ++ ++ + +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
G C + + +L+ E L FL KR + + +++ + G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVY 250
+HR+L A N+LL KISDFG+++ ++S A + G P PE +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECIN 512
Query: 251 QGICSIKSDVFSFGMLLLEILS-------GKKNTE 278
S +SDV+S+G+ + E LS K E
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-38
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
LG+G +G VY G L+ IA+K + R + Q L E + ++HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 140 ERDEKLLIY-EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
E + I+ E +P SL L + T + I+EGL YLH + +I+H
Sbjct: 90 ENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 199 RDLKASNILLD-KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI--CS 255
RD+K N+L++ KISDFG ++ G T GT Y+ PE + +G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYG 203
Query: 256 IKSDVFSFGMLLLEILSGK 274
+D++S G ++E+ +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 65/245 (26%), Positives = 106/245 (43%), Gaps = 48/245 (19%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE--------IAVKRL-SVRSRQGLQELKNEALVIAKV-QH 128
LGEG FG V D+ +AVK L + + L +L +E ++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFL-------------FDATKRVLLELGTRL 175
KN++ LLG C + +I EY +L +L + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANT 234
+ G+ YL + + IHRDL A N+L+ + KI+DFG+AR I + K T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 235 NRVAGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH- 281
N G +P PE ++ + + +SDV+SFG+L+ EI + G E +
Sbjct: 218 N------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 282 --TGY 284
G+
Sbjct: 272 LKEGH 276
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-38
Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
KLG+G FG V+ G +A+K L + + EA V+ K++H+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
E + ++ EY+ SL FL L L + + I G+ Y+ R+ +H
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYVYQGI 253
RDL+A+NIL+ + + K++DFG+AR+ + NE A P PE G
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG------AKFPIKWTAPEAALYGR 357
Query: 254 CSIKSDVFSFGMLLLEILS 272
+IKSDV+SFG+LL E+ +
Sbjct: 358 FTIKSDVWSFGILLTELTT 376
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 56/313 (17%)
Query: 14 FYLRRKLKSKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFS---FSSVAA 70
LRR++ E+ + + L LS+ A+ + E ELP F
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPR--- 80
Query: 71 ATNNFSDTNKLGEGGFGPVYKGVLAKGDE--------IAVKRL-SVRSRQGLQELKNEAL 121
+ + LGEG FG V D+ +AVK L + + L +L +E
Sbjct: 81 --DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138
Query: 122 VIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFL-------------FDATKRV 167
++ + +HKN++ LLG C + +I EY +L +L +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 168 LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFK 226
+ + + G+ YL + + IHRDL A N+L+ + KI+DFG+AR I
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 227 GNESKANTNRVAGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GK 274
+ K TN G +P PE ++ + + +SDV+SFG+L+ EI + G
Sbjct: 256 IDYYKKTTN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309
Query: 275 KNTEFYH---TGY 284
E + G+
Sbjct: 310 PVEELFKLLKEGH 322
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 65/223 (29%), Positives = 93/223 (41%), Gaps = 38/223 (17%)
Query: 79 NKLGEGGFGPVYKGV---LAKGDE---IAVKRL-SVRSRQGLQELKNEALVIAKV-QHKN 130
LG G FG V + L K D +AVK L + L +E V++ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFL---------------FDATKRVLLELGTRL 175
+V LLG C L+I EY L FL + L+L L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANT 234
+ +G+ +L + IHRDL A NILL KI DFG+AR I +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 235 NRVAGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
N +P PE ++ + + +SDV+S+G+ L E+ S
Sbjct: 206 N------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 79 NKLGEGGFGPVYKGVLAKGDE------IAVKRL-SVRSRQGLQELKNEALVIAKV-QHKN 130
LG G FG V + D+ +AVK L + + L +E ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 131 LVRLLGCCIERDEKL-LIYEYLPNKSLDFFL-------------FDATKRVLLELGTRLQ 176
+V LLG C + L +I E+ +L +L + + L L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 177 IIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTN 235
+ +G+ +L + + IHRDL A NILL ++ KI DFG+AR I+K + +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 236 RVAGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
+P PE ++ + +I+SDV+SFG+LL EI S
Sbjct: 210 ------ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 79 NKLGEGGFGPVYKGV---LAKGDE---IAVKRL-SVRSRQGLQELKNEALVIAKV-QHKN 130
LG G FG V + L K D +AVK L S + L +E +++ + QH+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFL-----------FDATKRVLLELGTRLQIIE 179
+V LLG C L+I EY L FL A L
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 180 GIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVA 238
+ +G+ +L + IHRD+ A N+LL KI DFG+AR I + N
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN--- 225
Query: 239 GTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
+P PE ++ + +++SDV+S+G+LL EI S
Sbjct: 226 ---ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLG 136
++G G F VYKG+ E+A L R ++ Q K EA ++ +QH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 137 CCI---ERDEKLLIY-EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+ + +++ E + + +L +L + ++++ I++GL +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 193 RVRIIHRDLKASNILLD-KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
IIHRDLK NI + KI D G+A + + + +KA V GT ++ PE +
Sbjct: 150 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEE 204
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
DV++FGM +LE+ + +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 69/245 (28%), Positives = 107/245 (43%), Gaps = 48/245 (19%)
Query: 79 NKLGEGGFGPVYKGVLAKGD--------EIAVKRL-SVRSRQGLQELKNEALVIAKV-QH 128
LGEG FG V D ++AVK L S + + L +L +E ++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFL-------------FDATKRVLLELGTRL 175
KN++ LLG C + +I EY +L +L L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANT 234
+ G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR I + K T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 235 NRVAGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS-------GKKNTEFYH- 281
N G +P PE ++ I + +SDV+SFG+LL EI + G E +
Sbjct: 252 N------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 282 --TGY 284
G+
Sbjct: 306 LKEGH 310
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 80 KLGEGGFGPVYKGVL--AKGDEI--AVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRL 134
+GEG FG V++G+ + + A+K S ++ EAL + + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+G + +I E L FL ++ L+L + + + L YL
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP-----PEYV 249
R +HRD+ A N+L+ K+ DFG++R + + + G +P PE +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESI 564
Query: 250 YQGICSIKSDVFSFGMLLLEILS-------GKKNTE 278
+ SDV+ FG+ + EIL G KN +
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-36
Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 27/215 (12%)
Query: 80 KLGEGGFGPVYKGVLAK----GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLL 135
KLGEGGF V L + G A+KR+ +Q +E + EA + H N++RL+
Sbjct: 36 KLGEGGFSYVD---LVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 136 GCCIERDEK----LLIYEYLPNKSL-DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
C+ L+ + +L + K L L ++ GI GL +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA-------GTFGY 243
HRDLK +NILL E +P + D G + + T Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 244 IPPE----YVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + I ++DV+S G +L ++ G+
Sbjct: 210 RAPELFSVQSHCVI-DERTDVWSLGCVLYAMMFGE 243
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 63/228 (27%), Positives = 95/228 (41%), Gaps = 43/228 (18%)
Query: 79 NKLGEGGFGPVYKGV---LAKGDE---IAVKRL-SVRSRQGLQELKNEALVIAKV-QHKN 130
LG G FG V ++K +AVK L + L +E ++ ++ H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFL--------------------FDATKRVLLE 170
+V LLG C LI+EY L +L + +L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 171 LGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNE 229
L + +G+ +L +HRDL A N+L+ KI DFG+AR I +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 230 SKANTNRVAGTFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS 272
N +P PE +++GI +IKSDV+S+G+LL EI S
Sbjct: 228 YVVRGN------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLL 135
K+G G F VY+ L G +A+K++ + + + E ++ ++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 136 GCCIERDEKLLIY-EYLPNKSLDFFLFDATKR-VLLELGTRLQIIEGIVEGLLYLHLHSR 193
IE + +L I E L + K+ L+ T + + L ++H
Sbjct: 99 ASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-- 155
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
R++HRD+K +N+ + K+ D G+ R F + A++ + GT Y+ PE +++
Sbjct: 156 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENG 212
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
+ KSD++S G LL E+ + +
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQ 233
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVK--RLSVRSRQGLQELKNEALVIAKVQHK 129
+ K+GEG FG G + +K +S S + +E + E V+A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
N+V+ E ++ +Y L + + E L I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-DQILDWFVQICLALKHVH 142
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
+I+HRD+K+ NI L K+ ++ DFG+AR+ A GT Y+ PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPE-- 195
Query: 250 YQGIC-----SIKSDVFSFGMLLLEILSGK 274
IC + KSD+++ G +L E+ + K
Sbjct: 196 ---ICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 29/224 (12%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGD--EIAVKRLSV-RSRQGLQELKNEALVIAKVQHK 129
+F LG GGFG V++ K D A+KR+ + +++ E +AK++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 130 NLVRLLGCCIERDE---------KLLIY---EYLPNKSLDFFLFDATKRVLLELGTRLQI 177
+VR +E++ K+ +Y + ++L ++ E L I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 178 IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV 237
I E + +LH ++HRDLK SNI + K+ DFG+ +E +
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 238 A----------GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEIL 271
GT Y+ PE ++ S K D+FS G++L E+L
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
+F + +G GGFG V+K G +KR+ + ++ + E +AK+ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 132 VRLLGCCIERDEKL----------------LIYEYLPNKSLDFFLFDATKRVLLELGTRL 175
V GC D + E+ +L+ ++ L + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK-VLAL 125
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
++ E I +G+ Y+H ++I+RDLK SNI L + KI DFG+ K N+ K
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRTR- 180
Query: 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
GT Y+ PE + + D+++ G++L E+L
Sbjct: 181 -SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 18/215 (8%)
Query: 66 SSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIA 124
+ + ++G G FG V++ G + AVK++ + E + A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACA 105
Query: 125 KVQHKNLVRLLGCCIERDEKLLIY-EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVE 183
+ +V L G E + I+ E L SL + L E + +E
Sbjct: 106 GLSSPRIVPLYGAVREGP-WVNIFMELLEGGSLGQLI--KQMGCLPEDRALY-YLGQALE 161
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNESKANTNR---VAG 239
GL YLH RI+H D+KA N+LL + + + DFG A + + + + G
Sbjct: 162 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 240 TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
T ++ PE V C K D++S ++L +L+G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 57/240 (23%), Positives = 88/240 (36%), Gaps = 17/240 (7%)
Query: 42 ELSNKANNRRKSTKREVELPLFSFSSVAAAT-NNFSDTNKLGEGGFGPVYKGV-LAKGDE 99
+L + + R ++ P + S + +F ++LG G +G V+K G
Sbjct: 25 QLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL 84
Query: 100 IAVK--RLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIY-EYLPNKS 155
AVK R + E KV QH VRL E L + E S
Sbjct: 85 YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYLQTELC-GPS 142
Query: 156 LDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPK 215
L L + + L +LH ++H D+K +NI L + K
Sbjct: 143 LQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197
Query: 216 ISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
+ DFG+ G G Y+ PE + QG +DVFS G+ +LE+ +
Sbjct: 198 LGDFGLLVEL-GTAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 56/241 (23%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 37 KADDIELSNKANNRRKSTKREVELP--LFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV- 93
+ ++L + + + L K+GEG G V
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLARE 66
Query: 94 LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153
G ++AVK + +R +Q + L NE +++ QH N+V + + +E ++ E+L
Sbjct: 67 KHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126
Query: 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK 213
+L D +V L + E +++ L YLH +IHRD+K+ +ILL + +
Sbjct: 127 GALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGR 179
Query: 214 PKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
K+SDFG + K + + GT ++ PE + + + + + D++S G++++E++ G
Sbjct: 180 VKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
Query: 274 K 274
+
Sbjct: 238 E 238
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN 130
++F + LG+G FG V K A+K++ + + L + +E +++A + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFF---------LFD--ATKRVLLELGTRLQIIE 179
+VR +ER + + KS F L+D ++ + + ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 180 GIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA------- 232
I+E L Y+H IIHRDLK NI +D+ KI DFG+A+ +
Sbjct: 124 QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 233 -----NTNRVAGTFGYIPPEYVYQGICSI--KSDVFSFGMLLLEILSG 273
N GT Y+ E V G K D++S G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-32
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRS-----RQGLQELKNEALVIAKV 126
++F ++LG G G V+K + A K + + Q ++EL+ V+ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 88
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL 186
+V G E + E++ SLD L A + LG + +++GL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLT 145
Query: 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
YL + +I+HRD+K SNIL++ + K+ DFG++ +S AN+ GT Y+ P
Sbjct: 146 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGTRSYMSP 199
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSGK 274
E + S++SD++S G+ L+E+ G+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 58/231 (25%), Positives = 87/231 (37%), Gaps = 27/231 (11%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGC 137
L EGGF VY+ + G E A+KRL + + + E + K+ H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 138 CIERDEK-------LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
E+ L+ L L FL R L T L+I + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA----------GT 240
+ IIHRDLK N+LL + K+ DFG A + + + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 241 FGYIPPE----YVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI 287
Y PE Y I K D+++ G +L + + F L I
Sbjct: 214 PMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQ--HPFEDGAKLRI 261
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 23/242 (9%)
Query: 48 NNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKR--L 105
++ S+ ++ F S++ +S ++G GG V++ + K A+K L
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL 62
Query: 106 SVRSRQGLQELKNEALVIAKVQHKNL--VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDA 163
Q L +NE + K+Q + +RL I ++ E ++D +
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLK 119
Query: 164 TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223
K+ + + + ++E + +H H I+H DLK +N L+ M K+ DFG+A
Sbjct: 120 KKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGM-LKLIDFGIAN 174
Query: 224 IFKGNESKANTNRVAGTFGYIPPE-----------YVYQGICSIKSDVFSFGMLLLEILS 272
+ + + + GT Y+PPE + S KSDV+S G +L +
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 273 GK 274
GK
Sbjct: 235 GK 236
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 61/222 (27%), Positives = 116/222 (52%), Gaps = 10/222 (4%)
Query: 54 TKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG 112
+ E+ L S SV ++ K+G+G G VY + +A G E+A+++++++ +
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 113 LQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELG 172
+ + NE LV+ + ++ N+V L + DE ++ EYL SL D ++ G
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEG 116
Query: 173 TRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232
+ ++ L +LH + ++IHRD+K+ NILL + K++DFG +SK
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
+T + GT ++ PE V + K D++S G++ +E++ G+
Sbjct: 174 ST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLG 136
+G G +G K + G + K L + Q L +E ++ +++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 137 CCIERDEKLL--IYEYLPNKSLDFFLFDATK-RVLLELGTRLQIIEGIVEGLLYLH--LH 191
I+R L + EY L + TK R L+ L+++ + L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
++HRDLK +N+ LD + K+ DFG+ARI + S A T GT Y+ PE + +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNR 190
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
+ KSD++S G LL E+ +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALM 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 81 LGEGGFGPVYKGVLAK-GDEIAVK---RLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+GGF ++ A + A K + + +++ E + + H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
E ++ + ++ E +SL + ++ L E R + IV G YLH +
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN-- 160
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
R+IHRDLK N+ L+++++ KI DFG+A + + + + GT YI PE + +
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
S + DV+S G ++ +L GK
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLV 132
+F + LG G G + + ++AVKR+ + E ++ + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
R +R + + E +L + L L +++ GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATL-QEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSL- 137
Query: 193 RVRIIHRDLKASNILL-----DKEMKPKISDFGMARIFK-GNESKANTNRVAGTFGYIPP 246
I+HRDLK NIL+ ++K ISDFG+ + G S + + V GT G+I P
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 247 EYVYQGIC----SIKSDVFSFGMLLLEILSG 273
E + C + D+FS G + ++S
Sbjct: 196 E-MLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 18/235 (7%)
Query: 45 NKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVK 103
+ + ++ R L S F KLGEG +G VYK + G +A+K
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 104 RLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL-DFFLFD 162
++ V S LQE+ E ++ + ++V+ G + + ++ EY S+ D +
Sbjct: 61 QVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIR 116
Query: 163 ATKRVLLELGTRLQI---IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDF 219
+ L E +I ++ ++GL YLH R IHRD+KA NILL+ E K++DF
Sbjct: 117 LRNKTLTED----EIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADF 169
Query: 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
G+A +K NT V GT ++ PE + + + +D++S G+ +E+ GK
Sbjct: 170 GVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKR--LSVRSRQGLQELKNEALVIAKVQHKNL--VRL 134
++G GG V++ + K A+K L Q L +NE + K+Q + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
I ++ E N L+ +L K+ ++ R + ++E + +H H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE------- 247
I+H DLK +N L+ M K+ DFG+A + + + + G Y+PPE
Sbjct: 175 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 248 ----YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ S KSDV+S G +L + GK
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 81 LGEGGFGPVYKGVLAK-GDEIAVK---RLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+GGF ++ A + A K + + +++ E + + H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
E ++ + ++ E +SL + ++ L E R + IV G YLH +
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN-- 134
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
R+IHRDLK N+ L+++++ KI DFG+A + + + + GT YI PE + +
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
S + DV+S G ++ +L GK
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR--QGLQELKNEALVIAKVQHKNL--VRL 134
++G GG V++ + K A+K +++ Q L +NE + K+Q + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
I ++ E N L+ +L K+ ++ R + ++E + +H H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE------- 247
I+H DLK +N L+ M K+ DFG+A + + + + GT Y+PPE
Sbjct: 128 GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 248 ----YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ S KSDV+S G +L + GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVK---RLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+G F VY+ + G E+A+K + ++ +Q ++NE + +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
E + L+ E N + + E R + I+ G+LYLH H
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH---G 132
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
I+HRDL SN+LL + M KI+DFG+A K K T + GT YI PE +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHG 190
Query: 256 IKSDVFSFGMLLLEILSGK 274
++SDV+S G + +L G+
Sbjct: 191 LESDVWSLGCMFYTLLIGR 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+ +LG+G FG VYK G A K + +S + L++ E ++A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
LLG + ++ E+ P ++D + R L E ++ + ++E L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHSK-- 136
Query: 194 VRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
RIIHRDLKA N+L+ E +++DFG++ K ++ GT ++ PE V
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCET 193
Query: 254 CS-----IKSDVFSFGMLLLEILSGK 274
K+D++S G+ L+E+ +
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG-LQELKNEALVIAKVQHKNLV 132
F+ K+G+G FG V+KG+ +A+K + + + +++++ E V+++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+ G ++ + +I EYL S D + L+ I+ I++GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
+ IHRD+KA+N+LL + + K++DFG+A + K NT GT ++ PE + Q
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
K+D++S G+ +E+ G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLS-VRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
LG+G V++G GD A+K + + + + E V+ K+ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 138 CIERDEKLLIY---EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
E E+ P SL L + + L L ++ +V G+ +L +
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 195 RIIHRDLKASNILL----DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
I+HR++K NI+ D + K++DFG AR + +E + + + GT Y+ P+ +Y
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPD-MY 187
Query: 251 QGICSI---------KSDVFSFGMLLLEILSGK 274
+ D++S G+ +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 53 STKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRS-- 109
S + +L + + D ++G G +G V K V +I AVKR+
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 110 ---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKR 166
+Q L +L +V+ +V+ G + + E + + S D F K
Sbjct: 62 KEQKQLLMDLD---VVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KY 113
Query: 167 VLLELGTRL------QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFG 220
V L + +I V+ L +L ++IIHRD+K SNILLD+ K+ DFG
Sbjct: 114 VYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
Query: 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC----SIKSDVFSFGMLLLEILSGK 274
++ +S A T G Y+ PE + ++SDV+S G+ L E+ +G+
Sbjct: 172 ISGQL--VDSIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-29
Identities = 66/243 (27%), Positives = 111/243 (45%), Gaps = 27/243 (11%)
Query: 42 ELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEI 100
+ R + ++ ++ FSD ++G G FG VY + + +
Sbjct: 25 AMDPMPAGGRAGSLKDPDVA--ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVV 82
Query: 101 AVKRLSVRSRQG---LQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLD 157
A+K++S +Q Q++ E + K++H N ++ GC + L+ EY + D
Sbjct: 83 AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD 142
Query: 158 FFLFDATKRVLLELGTRLQI---IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214
L + K+ L E+ +I G ++GL YLH H +IHRD+KA NILL +
Sbjct: 143 --LLEVHKKPLQEV----EIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV 193
Query: 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEIL 271
K+ DFG A + AN+ GT ++ PE + +G K DV+S G+ +E+
Sbjct: 194 KLGDFGSA----SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
Query: 272 SGK 274
K
Sbjct: 248 ERK 250
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRS-----RQGLQELKNEALVIAKV 126
++ +LG G +G V K +I AVKR+ ++ L +L + + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD---ISMRTV 63
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL------QIIEG 180
V G + + E + + SLD F + +++ G + +I
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVS 117
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
IV+ L +LH S++ +IHRD+K SN+L++ + K+ DFG++ + +K + AG
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGC 172
Query: 241 FGYIPPE----YVYQGICSIKSDVFSFGMLLLEILSGK 274
Y+ PE + Q S+KSD++S G+ ++E+ +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLS-VRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
LG+G V++G GD A+K + + + + E V+ K+ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 138 CIERDEKLLIY---EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
E E+ P SL L + + L L ++ +V G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 195 RIIHRDLKASNILL----DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
I+HR++K NI+ D + K++DFG AR + +E + + + GT Y+ P+ +Y
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPD-MY 187
Query: 251 QGICSI---------KSDVFSFGMLLLEILSGK 274
+ D++S G+ +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 49/229 (21%), Positives = 85/229 (37%), Gaps = 36/229 (15%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKR--LSVRSRQGLQELKNEALVIAKV-Q 127
T F + K+G G FG V+K V G A+KR + Q E A + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 128 HKNLVRLLGCCIERDEKLLIY-EYLPNKSLDFFLFDATKRV-LLELGTRLQIIEGIVEGL 185
H ++VR E D +LI EY SL + + + + + ++ + GL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKP-------------------KISDFGMARIFK 226
Y+H ++H D+K SNI + + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--- 182
Query: 227 GNESKANTNRVAGTFGYIPPEYVYQGI-CSIKSDVFSFGMLLLEILSGK 274
++ G ++ E + + K+D+F+ + ++ +
Sbjct: 183 ---RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 72 TNNFSDT----NKLGEGGFGPVYKGV-LAKGDEIAVKRLS---VRSRQGLQELKNEALVI 123
T FSD LG+G FG V G E AVK +S V+ + + L E ++
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 124 AKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGI 181
++ H N+++L ++ L+ E LFD +++ E+ +II +
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAA-RIIRQV 135
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVA 238
+ G+ Y+H + I+HRDLK N+LL K+ +I DFG++ F+ ++
Sbjct: 136 LSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKI 189
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
GT YI PE V G K DV+S G++L +LSG
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 45 NKANNRRKSTKREVELPLFSFSSVAAATNNFSDT----NKLGEGGFGPVYKGV-LAKGDE 99
+ ++ R++ + +L + + + S+ KLG G +G V E
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 100 IAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLD 157
A+K + S +L E V+ + H N+++L ++ L+ E L
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL- 123
Query: 158 FFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEM 212
FD + E+ II+ ++ G+ YLH H+ I+HRDLK N+LL +K+
Sbjct: 124 ---FDEIIHRMKFNEVDAA-VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA 176
Query: 213 KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272
KI DFG++ +F+ + GT YI PE V + K DV+S G++L +L+
Sbjct: 177 LIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232
Query: 273 GK 274
G
Sbjct: 233 GY 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLL 135
KLG GG VY ++A+K + + L+ + E +++ H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
E D L+ EY+ +L ++ L + T + I++G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
I+HRD+K NIL+D KI DFG+A+ S TN V GT Y PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 256 IKSDVFSFGMLLLEILSGK 274
+D++S G++L E+L G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 25/225 (11%)
Query: 61 PLFSFSSVAAATNNFSDT----NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE 115
+ V ++ D +LG G FG V++ A G+ A K + +
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200
Query: 116 LKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGT-- 173
++ E ++ ++H LV L + +E ++IYE++ LF+ +V E
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFE---KVADEHNKMS 253
Query: 174 ---RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL--DKEMKPKISDFGMARIFKGN 228
++ + + +GL ++H ++ +H DLK NI+ + + K+ DFG+
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310
Query: 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
+ + GT + PE +D++S G+L +LSG
Sbjct: 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 23/242 (9%)
Query: 44 SNKANNRRKSTKREVELPLFSFSSVAAATNNFSD------TNKLGEGGFGPVYKGV-LAK 96
+ F V A + T LG G FG V+K A
Sbjct: 54 VKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT 113
Query: 97 GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156
G ++A K + R + +E+KNE V+ ++ H NL++L +++ +L+ EY+
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE- 172
Query: 157 DFFLFD---ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL-DKEM 212
LFD L EL T ++ I EG+ ++H I+H DLK NIL +++
Sbjct: 173 ---LFDRIIDESYNLTELDTI-LFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDA 225
Query: 213 KP-KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEIL 271
K KI DFG+AR +K E GT ++ PE V S +D++S G++ +L
Sbjct: 226 KQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
Query: 272 SG 273
SG
Sbjct: 283 SG 284
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 37/196 (18%)
Query: 70 AATNNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQG-----------LQELK 117
++++ F KLG G + VYKG+ A+K + + S +G ++ELK
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 118 NEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN---KSLDFFLFDATKRVLLELGTR 174
H+N+VRL ++ L++E++ N K +D T R L +
Sbjct: 62 ----------HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 175 ---LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231
Q+++G L + H + +I+HRDLK N+L++K + K+ DFG+AR F G
Sbjct: 112 YFQWQLLQG----LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVN 163
Query: 232 ANTNRVAGTFGYIPPE 247
++ V T Y P+
Sbjct: 164 TFSSEVV-TLWYRAPD 178
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 45/206 (21%), Positives = 84/206 (40%), Gaps = 30/206 (14%)
Query: 80 KLGEGGFGPVYKGV--LAKGDEIAVKRLSVRSRQGLQE-LKNEALVIAKVQHKNLVRLL- 135
+ GG G +Y + G + +K L Q E +A+V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 136 -GCCIERDEKLLIY---EYLPNKSLDFFLFDATKRVL---LELGTRLQIIEGIVEGLLYL 188
+R + Y EY+ +SL KR L + + + I+ L YL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSL--------KRSKGQKLPVAEAIAYLLEILPALSYL 198
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
H + +++ DLK NI+L +E + K+ D G + + GT G+ PE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPE- 247
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGK 274
+ + ++ +D+++ G L +
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDL 273
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 72 TNNFSDT----NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR--SRQGLQELKNEALVIA 124
F++ LG+G FG V K E AVK ++ + + E ++
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 125 KVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIV 182
K+ H N+++L + ++ E L FD ++ E +II+ +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVF 131
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAG 239
G+ Y+H H I+HRDLK NILL +K+ KI DFG++ F+ N G
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIG 185
Query: 240 TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
T YI PE V +G K DV+S G++L +LSG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 1e-26
Identities = 25/249 (10%), Positives = 63/249 (25%), Gaps = 43/249 (17%)
Query: 61 PLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR---SRQGLQEL 116
S ++ L G V+ + + ++ A+K ++ SR L+ L
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 117 KNEALVIAKVQHKNLVRLLGCC-------IERDEKLLIYEYLPNKSLD------FFLFDA 163
A++ ++ + + L D L A
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 164 TKRVLLELGT----------------RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNIL 207
L L + + ++ L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226
Query: 208 LDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI--KSDVFSFGM 265
+ + + + D + + Y P E++ + + + G+
Sbjct: 227 IMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 266 LLLEILSGK 274
+ +
Sbjct: 282 SIYRVWCLF 290
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 34/190 (17%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRL------------SVRSRQGLQELKNE 119
NF K+GEG +G VYK G+ +A+K++ ++R L+EL
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-- 60
Query: 120 ALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN--KSLDFFLFDATKRVLLELGTRLQI 177
H N+V+LL ++ L++E+L K DA+ + L
Sbjct: 61 --------HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSY 108
Query: 178 IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV 237
+ +++GL + H H R++HRDLK N+L++ E K++DFG+AR F G + T+ V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164
Query: 238 AGTFGYIPPE 247
T Y PE
Sbjct: 165 V-TLWYRAPE 173
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 56/217 (25%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSV-RSRQGLQELKNEALVIAKVQHKN 130
+++ +G G V K +++A+KR+++ + + + EL E +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIE---------GI 181
+V + +DE L+ + L S+ D K ++ + + +++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM-ARIFKGNESKANTNR--VA 238
+EGL YLH + IHRD+KA NILL ++ +I+DFG+ A + G + N R
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 239 GTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGK 274
GT ++ PE + Q K+D++SFG+ +E+ +G
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 40/192 (20%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRL------------SVRSRQGLQELKNEA 120
+ K+GEG +G VYK ++G +A+KR+ ++R L+EL
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--- 77
Query: 121 LVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN--KSLDFFLFDATKRVLLELGTR---L 175
H N+V L+ L++E++ K + D K L + +
Sbjct: 78 -------HPNIVSLIDVIHSERCLTLVFEFMEKDLKKV----LDENKTGLQDSQIKIYLY 126
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
Q++ G + + H H RI+HRDLK N+L++ + K++DFG+AR F G ++ T+
Sbjct: 127 QLLRG----VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTH 178
Query: 236 RVAGTFGYIPPE 247
V T Y P+
Sbjct: 179 EVV-TLWYRAPD 189
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 55/222 (24%), Positives = 81/222 (36%), Gaps = 34/222 (15%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNE-ALVIAKVQHKNLVRLLGC 137
LG G G V +G +AVKR+ E L+ H N++R C
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIRYY-C 76
Query: 138 CIERDEKL-LIYEYLPNKSLDFFL---FDATKRVLLELGTRLQIIEGIVEGLLYLHLHSR 193
D L + E D L + + ++ I G+ +LH
Sbjct: 77 SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-- 134
Query: 194 VRIIHRDLKASNILLDKEMKP-------------KISDFGMARIFKGNES--KANTNRVA 238
+IIHRDLK NIL+ + ISDFG+ + +S + N N +
Sbjct: 135 -KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 239 GTFGYIPPE-------YVYQGICSIKSDVFSFGMLLLEILSG 273
GT G+ PE + + D+FS G + ILS
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 27/247 (10%)
Query: 37 KADDIELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDT----NKLGEGGFGPVYKG 92
K D ++++ K+ V P V + D +LG G FG V++
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQP------VEVKQGSVYDYYDILEELGSGAFGVVHRC 70
Query: 93 V-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151
V A G K ++ +KNE ++ ++ H L+ L ++ E +LI E+L
Sbjct: 71 VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130
Query: 152 PNKSLDFFLFD---ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208
LFD A + E + EGL ++H H I+H D+K NI+
Sbjct: 131 SGGE----LFDRIAAEDYKMSEAEVI-NYMRQACEGLKHMHEH---SIVHLDIKPENIMC 182
Query: 209 -DKEMKP-KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGML 266
K+ KI DFG+A +E T + PE V + +D+++ G+L
Sbjct: 183 ETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
Query: 267 LLEILSG 273
+LSG
Sbjct: 240 GYVLLSG 246
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 44/221 (19%), Positives = 87/221 (39%), Gaps = 16/221 (7%)
Query: 66 SSVAAATNNFSDTNKLGEG--GFGPVYKGV-LAKGDEIAVKRLSV--RSRQGLQELKNEA 120
SS + +G+G V G+ + V+R+++ S + + L+ E
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 121 LVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEG 180
V H N+V I +E ++ ++ S + + EL I++G
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQG 136
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT-----N 235
+++ L Y+H +HR +KAS+IL+ + K +S + +
Sbjct: 137 VLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 236 RVAGTFGYIPPEYVYQGIC--SIKSDVFSFGMLLLEILSGK 274
++ PE + Q + KSD++S G+ E+ +G
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRS-----RQGLQELKNEALVIAKV 126
N+ + ++G G G V+K K + AVK++ ++ L +L +V+
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD---VVLKSH 81
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL-LELGTRLQIIEGIVEGL 185
+V+ G I + + E + + + LG + IV+ L
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK---MTVAIVKAL 137
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
YL + +IHRD+K SNILLD+ + K+ DFG++ + KA G Y+
Sbjct: 138 YYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSA-GCAAYMA 192
Query: 246 PE-----YVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + I++DV+S G+ L+E+ +G+
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 79 NKLGEGGFGPVYKGVLAK----GDEIAVKRLS----VRSRQGLQELKNEALVIAKVQHKN 130
LG+G FG VY LA+ +A+K L ++ Q L+ E + + ++H N
Sbjct: 15 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPN 70
Query: 131 LVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
++RL G ++ LI EY P ++ + + E T I + L Y H
Sbjct: 71 ILRLYGY-FHDATRVYLILEYAPLGTV-YRELQKLSK-FDEQRTA-TYITELANALSYCH 126
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
R+IHRD+K N+LL + KI+DFG + + + + GT Y+PPE +
Sbjct: 127 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTD--LCGTLDYLPPEMI 179
Query: 250 YQGICSIKSDVFSFGMLLLEILSGK 274
+ K D++S G+L E L GK
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 36/190 (18%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQG-----------LQELKNEA 120
+ +KLGEG + VYKG D + A+K + + +G L++LK
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK--- 58
Query: 121 LVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN---KSLDFFLFDATKRVLLELGTRLQI 177
H N+V L L++EYL + LD ++ +
Sbjct: 59 -------HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD------DCGNIINMHNVKLF 105
Query: 178 IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRV 237
+ ++ GL Y H +++HRDLK N+L+++ + K++DFG+AR +K N V
Sbjct: 106 LFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEV 161
Query: 238 AGTFGYIPPE 247
T Y PP+
Sbjct: 162 V-TLWYRPPD 170
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLV 132
F +G G +G VYKG + G A+K + V +E+K E ++ K H+N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 133 RLLGC-----CIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL 186
G D++L L+ E+ S+ + + L E I I+ GL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLS 143
Query: 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
+LH H ++IHRD+K N+LL + + K+ DFG++ + NT GT ++ P
Sbjct: 144 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAP 198
Query: 247 EYVYQGICS-----IKSDVFSFGMLLLEILSGK 274
E + KSD++S G+ +E+ G
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 40/192 (20%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRL------------SVRSRQGLQELKNEA 120
+ K+GEG +G VYK G+ A+K++ ++R L+ELK
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58
Query: 121 LVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN--KSLDFFLFDATKRVLLELGTR---L 175
H N+V+L + +L++E+L K L D + L + + L
Sbjct: 59 -------HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKL----LDVCEGGLESVTAKSFLL 107
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
Q++ G + Y H R++HRDLK N+L+++E + KI+DFG+AR F G + T+
Sbjct: 108 QLLNG----IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTH 159
Query: 236 RVAGTFGYIPPE 247
+ T Y P+
Sbjct: 160 EIV-TLWYRAPD 170
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG--LQELKNEALVIAKVQHKNLVRLLG 136
LG+G FG V K E AVK ++ S + + E ++ K+ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 137 CCIERDEKLLIYEYLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+ ++ E L FD ++ E +II+ + G+ Y+H H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGITYMHKHN-- 141
Query: 195 RIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
I+HRDLK NILL +K+ KI DFG++ F+ N GT YI PE V +
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLR 196
Query: 252 GICSIKSDVFSFGMLLLEILSG 273
G K DV+S G++L +LSG
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 18/200 (9%)
Query: 80 KLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
+G G +G V V A K++ + + K E ++ + H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 139 IERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
+ + L+ E LF+ KRV E +I++ ++ + Y H +
Sbjct: 76 EDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYCHKL---NV 127
Query: 197 IHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
HRDLK N L + K+ DFG+A FK + GT Y+ P+ V +G+
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQ-VLEGL 183
Query: 254 CSIKSDVFSFGMLLLEILSG 273
+ D +S G+++ +L G
Sbjct: 184 YGPECDEWSAGVMMYVLLCG 203
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 33/213 (15%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE-------LKNEALVIAKVQHKNL 131
LG GG V+ L ++AVK L R L + EA A + H +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL----RADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 132 VRLLGCCIERDEKLLIY----EYLPNKSLDFFLFDATKRVLLELG-----TRLQIIEGIV 182
V + + EY+ +L + ++ G +++I
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTL--------RDIVHTEGPMTPKRAIEVIADAC 126
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAGTF 241
+ L + H + IIHRD+K +NI++ K+ DFG+AR I S T V GT
Sbjct: 127 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
Y+ PE +SDV+S G +L E+L+G+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 57/261 (21%), Positives = 105/261 (40%), Gaps = 55/261 (21%)
Query: 44 SNKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAK--GDEIA 101
SN + +++ + N++ L +G F + L + A
Sbjct: 14 SNLIYLNKYVKEKDKYI------------NDYRIIRTLNQGKFNKII---LCEKDNKFYA 58
Query: 102 VKRLS-----------------VRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144
+K+ + + + KNE +I ++++ + G I ++
Sbjct: 59 LKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDE 117
Query: 145 L-LIYEYLPNKSL-----DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+ +IYEY+ N S+ FF+ D + + II+ ++ Y+H + I H
Sbjct: 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICH 175
Query: 199 RDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV-----YQGI 253
RD+K SNIL+DK + K+SDFG + K GT+ ++PPE+ Y G
Sbjct: 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKG--SRGTYEFMPPEFFSNESSYNG- 230
Query: 254 CSIKSDVFSFGMLLLEILSGK 274
K D++S G+ L +
Sbjct: 231 --AKVDIWSLGICLYVMFYNV 249
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 21/208 (10%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE-LKNEALVIAKVQHKNLVRLLGC 137
+LG GGFG V + + G+++A+K+ +E E ++ K+ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-E 79
Query: 138 CIE-------RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ D LL EY L +L L+ G ++ I L YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 191 HSRVRIIHRDLKASNILLDKEMKP---KISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
+ RIIHRDLK NI+L + KI D G A+ GT Y+ PE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQYLAPE 193
Query: 248 YVYQGIC-SIKSDVFSFGMLLLEILSGK 274
+ + ++ D +SFG L E ++G
Sbjct: 194 -LLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 30/233 (12%), Positives = 68/233 (29%), Gaps = 43/233 (18%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQH-------- 128
LG+ + G+ V ++++K E L + ++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 129 --------KNLVRLLGCCIERDEK-----------LLIYEYLPNKSLDFF--LFD-ATKR 166
+LV+ + +Y + + F L ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 167 VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226
L RLQ+ ++ L LH ++H L+ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 227 GNESKANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGK 274
G + + R + + + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 41/193 (21%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRL------------SVRSRQGLQELKNE 119
+ K+GEG +G V+K + EI A+KR+ ++R L+ELK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-- 59
Query: 120 ALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN--KSLDFFLFDATKRVLLELGTR--- 174
HKN+VRL + L++E+ K FD+ L +
Sbjct: 60 --------HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY----FDSCNGDLDPEIVKSFL 107
Query: 175 LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT 234
Q+++G L + H ++HRDLK N+L+++ + K+++FG+AR F G + +
Sbjct: 108 FQLLKG----LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYS 159
Query: 235 NRVAGTFGYIPPE 247
V T Y PP+
Sbjct: 160 AEVV-TLWYRPPD 171
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 38/223 (17%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK--GDEIAVKRL------------SVRSRQGLQELKN 118
+ ++GEG +G V+K K G +A+KR+ ++R L+ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 119 EALVIAKVQHKNLVRLL----GCCIERDEKL-LIYEYLPN--KSLDFFLFDATKRVLLEL 171
+H N+VRL +R+ KL L++E++ + D +
Sbjct: 71 F-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY----LDKVPEPGVPT 119
Query: 172 GTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231
T ++ ++ GL +LH H R++HRDLK NIL+ + K++DFG+ARI+ +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMA 175
Query: 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
T+ V T Y PE + Q + D++S G + E+ K
Sbjct: 176 L-TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 57/252 (22%), Positives = 102/252 (40%), Gaps = 35/252 (13%)
Query: 45 NKANNRRKSTKREVELPLFSFSSVAAATNNFSDT----NKLGEGGFGPVYKGV-LAKGDE 99
+ ++ + + + V ++ KLG G +G V E
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 100 IAVKRLS-------------VRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146
A+K + + +E+ NE ++ + H N+++L ++ L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 147 IYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKAS 204
+ E+ L F+ + E I++ I+ G+ YLH H+ I+HRD+K
Sbjct: 124 VTEFYEGGEL----FEQIINRHKFDECDAA-NIMKQILSGICYLHKHN---IVHRDIKPE 175
Query: 205 NILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVF 261
NILL + + KI DFG++ F + GT YI PE V + + K DV+
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVW 231
Query: 262 SFGMLLLEILSG 273
S G+++ +L G
Sbjct: 232 SCGVIMYILLCG 243
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 49/226 (21%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLSVRSRQG---------------LQEL 116
+ + LGEG F VYK ++I A+K++ + R LQEL
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 117 KNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN--KSLDFFLFDATKRVLLELGTR 174
H N++ LL + L+++++ + + VL +
Sbjct: 70 S----------HPNIIGLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTPSHIK 115
Query: 175 ---LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231
L ++G L YLH H I+HRDLK +N+LLD+ K++DFG+A+ F G+ ++
Sbjct: 116 AYMLMTLQG----LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNR 167
Query: 232 ANTNRVAGTFGYIPPEYVYQGI---CSIKSDVFSFGMLLLEILSGK 274
A T++V T Y PE ++ + D+++ G +L E+L
Sbjct: 168 AYTHQVV-TRWYRAPELLFGARMYGVGV--DMWAVGCILAELLLRV 210
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 30/223 (13%), Positives = 66/223 (29%), Gaps = 24/223 (10%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV------LAKGDEIAVKRLSVRSRQGLQELKNEALVIAK 125
+ + LGEG F VY+ + +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFL---FDATKRVLLELGTRLQIIEGIV 182
++ + ++ +L+ E +L + + ++V+ + + ++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-ML 182
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEMKP-----------KISDFGMARIFKGNESK 231
+ +H IIH D+K N +L + D G + K
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
T G+ E + + + D F + +L G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQH 128
N F LG+GGFG V + ++ A K+L ++ R+G NE ++ KV
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 129 KNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
+ +V L E + L L+ + L F ++ + E E I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
LH RI++RDLK NILLD +ISD G+A ++ GT GY+ PE
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355
Query: 248 YVYQGICSIKSDVFSFGMLLLEILSGK 274
V + D ++ G LL E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLS-VRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
KLG G FG V+ + G E +K ++ RS+ +++++ E V+ + H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 138 CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTR--------LQIIEGIVEGLLYLH 189
+ ++ E L + R++ ++++ ++ L Y H
Sbjct: 89 FEDYHNMYIVMETCEGGEL----LE---RIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 190 LHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
++H+DLK NIL KI DFG+A +FK +E + AGT Y+ P
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAP 195
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSG 273
E V++ + K D++S G+++ +L+G
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
LG G F V+ G A+K + L+NE V+ K++H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
L+ + + LFD + V E +I+ ++ + YLH + I
Sbjct: 76 ESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDAS-LVIQQVLSAVKYLHEN---GI 127
Query: 197 IHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+HRDLK N+L ++ K I+DFG++++ + + GT GY+ PE + Q
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKP 183
Query: 254 CSIKSDVFSFGMLLLEILSG 273
S D +S G++ +L G
Sbjct: 184 YSKAVDCWSIGVITYILLCG 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 36/137 (26%), Positives = 57/137 (41%), Gaps = 13/137 (9%)
Query: 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208
+ ++L ++ E G L I I E + +LH ++HRDLK SNI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFF 197
Query: 209 DKEMKPKISDFGMARIFKGNESKANTNRVA----------GTFGYIPPEYVYQGICSIKS 258
+ K+ DFG+ +E + GT Y+ PE ++ S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 259 DVFSFGMLLLEILSGKK 275
D+FS G++L E+L
Sbjct: 258 DIFSLGLILFELLYSFS 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 20/73 (27%), Positives = 38/73 (52%), Gaps = 4/73 (5%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI--AVKRLSVRSRQG-LQELKNEALVIAKVQHK 129
+F +G GGFG V++ K D+ A+KR+ + +R+ +++ E +AK++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 130 NLVRLLGCCIERD 142
+VR +E
Sbjct: 65 GIVRYFNAWLETP 77
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 72 TNNFSDT----NKLGEGGFGPVYKGVLAK-GDEIAVKRLSVR--SRQGLQELKNEALVIA 124
+ FSD +LG+G F V + V G E A K ++ + S + Q+L+ EA +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 125 KVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIV 182
K+QH N+VRL E L+++ + L F+ + E I+ I+
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQIL 115
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAG 239
E + Y H + I+HR+LK N+LL K K++DFG+A +E+ + AG
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169
Query: 240 TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
T GY+ PE + + S D+++ G++L +L G
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQH 128
+ F D LG GGFG V+ + ++ A K+L+ ++ R+G Q E ++AKV
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 129 KNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKR--VLLELGTRLQIIEGIVEGL 185
+ +V L E L L+ + + + +++ + E + IV GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
+LH II+RDLK N+LLD + +ISD G+A K ++K AGT G++
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMA 357
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + D F+ G+ L E+++ +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 24/203 (11%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
LG G FG V++ V + K + V+ +K E ++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL------QIIEGIVEGLLYLHLHS 192
+E ++I+E++ +F+ + L + + E L +LH H+
Sbjct: 71 ESMEELVMIFEFISGLD----IFER----INTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 193 RVRIIHRDLKASNILL-DKEMKP-KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
I H D++ NI+ + KI +FG AR K + N + Y PE
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176
Query: 251 QGICSIKSDVFSFGMLLLEILSG 273
+ S +D++S G L+ +LSG
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 72 TNNFSDT----NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR--SRQGLQELKNEALVIA 124
F++ +LG+G F V + V + G E A ++ + S + Q+L+ EA +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 125 KVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIV 182
++H N+VRL E LI++ + LF+ + E I+ I+
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADAS-HCIQQIL 120
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAG 239
E +L+ H ++HR+LK N+LL K K++DFG+A +G + AG
Sbjct: 121 EAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175
Query: 240 TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
T GY+ PE + + D+++ G++L +L G
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 31/212 (14%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVK-----RLSVRSRQGLQELKNEALVIAKVQHKNLVR 133
+G+G F V + + G + AVK + + ++LK EA + ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 134 LLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL---------QIIEGIVEG 184
LL +++E++ L +++ + I+E
Sbjct: 91 LLETYSSDGMLYMVFEFMDGAD----LCFE----IVKRADAGFVYSEAVASHYMRQILEA 142
Query: 185 LLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTF 241
L Y H + IIHRD+K +LL + K+ FG+A + A GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
++ PE V + DV+ G++L +LSG
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-24
Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 36/213 (16%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRL------SVRSRQGLQELKNE----ALVIAKVQHK 129
LG+GGFG V+ G L ++A+K + E V A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 130 NLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRL---QIIEGIVEGL 185
++RLL E E L+ E P + D F + K L E +R Q++ I
Sbjct: 99 GVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI---- 152
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
H HSR ++HRD+K NIL+D K+ DFG + GT Y
Sbjct: 153 --QHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT----DFDGTRVYS 205
Query: 245 PPEYV----YQGICSIKSDVFSFGMLLLEILSG 273
PPE++ Y + + V+S G+LL +++ G
Sbjct: 206 PPEWISRHQYHA---LPATVWSLGILLYDMVCG 235
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-24
Identities = 47/207 (22%), Positives = 84/207 (40%), Gaps = 27/207 (13%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRL--------SVRSRQGLQELKNEALVIAKVQHKN 130
+G GG G VY+ + +A+K + R+R ++ EA ++Q +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-----MQREARTAGRLQEPH 95
Query: 131 LVRL--LGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
+V + G E D +L + + L L ++ L + I+ I L
Sbjct: 96 VVPIHDFG---EIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDA 149
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
H HRD+K NIL+ + + DFG+A +E GT Y+ PE
Sbjct: 150 AH---AAGATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPE 205
Query: 248 YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ + ++D+++ +L E L+G
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-24
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG------LQELKNEALVIAKVQHKNLV 132
+LG G F V K + G E A K + R + +E++ E ++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHL 190
L R + +LI E + LFD A K L E I+ I++G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQILDGVNYLHT 133
Query: 191 HSRVRIIHRDLKASNILLDKEMKP----KISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
I H DLK NI+L + P K+ DFG+A + + GT ++ P
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAP 187
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSG 273
E V +++D++S G++ +LSG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-24
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLS----VRSRQGLQELKNEALVIAKVQHKNLV 132
LG+G FG VY LA+ +A+K L + Q L+ E + + ++H N++
Sbjct: 22 LGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNIL 77
Query: 133 RLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
R+ +++ L+ E+ P L + R E + + E + + L Y H
Sbjct: 78 RMYNY-FHDRKRIYLMLEFAPRGEL-YKELQKHGR-FDEQRSATFMEE-LADALHYCHER 133
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
++IHRD+K N+L+ + + KI+DFG + + T + GT Y+PPE +
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRT--MCGTLDYLPPEMIEG 186
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
K D++ G+L E L G
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGM 209
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-24
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 41/216 (18%)
Query: 48 NNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRL- 105
++ S+ ++ F S+ + + +GEG +G V K G +A+K+
Sbjct: 4 HHHHHSSGVDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 106 -----------SVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNK 154
++R + L++L+ H+NLV LL C ++ L++E++ +
Sbjct: 60 ESDDDKMVKKIAMREIKLLKQLR----------HENLVNLLEVCKKKKRWYLVFEFVDHT 109
Query: 155 SLDFFLFDATKRVLLELGTR---LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE 211
LD + L + QII GI + H H IIHRD+K NIL+ +
Sbjct: 110 ILD--DLELFPNGLDYQVVQKYLFQIINGIG----FCHSH---NIIHRDIKPENILVSQS 160
Query: 212 MKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
K+ DFG AR + + VA T Y PE
Sbjct: 161 GVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRAPE 194
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-24
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 33/227 (14%)
Query: 37 KADDIELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDT----NKLGEGGFGPVYKG 92
K +D + N +S E ELP ++ A F + +G G V +
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWA------AAKEFYQKYDPKDVIGRGVSSVVRRC 113
Query: 93 V-LAKGDEIAVKRLSVRSRQGLQE--------LKNEALVIAKV-QHKNLVRLLGCCIERD 142
V A G E AVK + V + + E + E ++ +V H +++ L+
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173
Query: 143 EKLLIYEYLPNKSLDFFLFDA-TKRVLL-ELGTRLQIIEGIVEGLLYLHLHSRVRIIHRD 200
L+++ + L FD T++V L E TR I+ ++E + +LH + I+HRD
Sbjct: 174 FMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMRSLLEAVSFLHAN---NIVHRD 225
Query: 201 LKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
LK NILLD M+ ++SDFG + + E + GT GY+ PE
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPE 269
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG------LQELKNEALVIAKVQHKNLV 132
+LG G F V K + G E A K + R + +E++ E ++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHL 190
L R + +LI E + LFD A K L E I+ I++G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQILDGVNYLHT 133
Query: 191 HSRVRIIHRDLKASNILLDKEMKP----KISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
I H DLK NI+L + P K+ DFG+A + + GT ++ P
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAP 187
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSG 273
E V +++D++S G++ +LSG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 71 ATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRL---------------SVRSRQGLQ 114
AT+ + ++G G +G VYK G +A+K + +VR L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 115 ELKNEALVIAKVQHKNLVRLL----GCCIERDEKL-LIYEYLPN--KSLDFFLFDATKRV 167
L+ +H N+VRL+ +R+ K+ L++E++ ++ D
Sbjct: 67 RLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTY----LDKAPPP 115
Query: 168 LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227
L T ++ + GL +LH + I+HRDLK NIL+ K++DFG+ARI+
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY-- 170
Query: 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
+ A T V T Y PE + Q + D++S G + E+ K
Sbjct: 171 SYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 68 VAAATNNFSDT----NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVR--SRQGLQELKNEA 120
+ A+ FSD +LG+G F V + V G E A K ++ + S + Q+L+ EA
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 121 LVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQII 178
+ K+QH N+VRL E L+++ + L F+ + E I
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCI 134
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTN 235
+ I+E + Y H + I+HR+LK N+LL K K++DFG+A +E+ +
Sbjct: 135 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WH 188
Query: 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
AGT GY+ PE + + S D+++ G++L +L G
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 62/233 (26%), Positives = 92/233 (39%), Gaps = 62/233 (26%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRL------------SVRSRQGLQELKNE 119
+ + KLGEG +G VYK + +E A+KR+ ++R L+EL+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-- 91
Query: 120 ALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN---KSLD---FFLFDATKRVLLELGT 173
H+N++ L LI+EY N K +D K L +L
Sbjct: 92 --------HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL-- 141
Query: 174 RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP-----KISDFGMARIFKGN 228
+ G+ + H R +HRDLK N+LL KI DFG+AR F G
Sbjct: 142 --------INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GI 189
Query: 229 ESKANTNRVAGTFGYIPPE-------YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ T+ + T Y PPE Y S D++S + E+L
Sbjct: 190 PIRQFTHEII-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-23
Identities = 32/239 (13%), Positives = 74/239 (30%), Gaps = 54/239 (22%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQ--------- 127
LG+ + G+ V ++++K E L + ++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 128 ----------------HKNLVRLLGCCIERDEK--LLIYEYLPNKSLDFF--LFD-ATKR 166
K ++R+ + +Y + + F L ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 167 VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226
L RLQ+ ++ L LH + ++H L+ +I+LD+ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 227 GNESKANTNRVAGTFGYIPPEYV-----------YQGICSIKSDVFSFGMLLLEILSGK 274
+ + G+ PPE + + + D ++ G+++ I
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG------LQELKNEALVIAKVQHKNLV 132
+LG G F V K G E A K + R +E++ E ++ +++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHL 190
L + + +LI E + LFD A K L E Q ++ I++G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEAT-QFLKQILDGVHYLHS 126
Query: 191 HSRVRIIHRDLKASNILLDKEMKP----KISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
RI H DLK NI+L + P K+ DFG+A + + GT ++ P
Sbjct: 127 K---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAP 180
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSG 273
E V +++D++S G++ +LSG
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 81 LGEGGFGPVYKGVLAK----GDEIAVKRLS----VRSRQGLQELKNEALVIAKVQHKNLV 132
LGEG F V LA+ E A+K L ++ + + + E V++++ H V
Sbjct: 38 LGEGSFSTVV---LARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPFFV 93
Query: 133 RLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
+L + DEKL Y N L E TR E IV L YLH
Sbjct: 94 KLYFTF-QDDEKLYFGLSYAKNGEL-LKYIRKIGS-FDETCTRFYTAE-IVSALEYLHGK 149
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
IIHRDLK NILL+++M +I+DFG A++ +A N GT Y+ PE + +
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
SD+++ G ++ ++++G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGL 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 34/212 (16%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRL------SVRSRQGLQELKNEALVIAKVQHK--NL 131
LG GGFG VY G+ ++ +A+K + + E +++ KV +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 132 VRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRL---QIIEGIVEGLLY 187
+RLL ER + LI E P D F F + L E R Q++E +
Sbjct: 111 IRLLDW-FERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAV------ 162
Query: 188 LHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
H H+ ++HRD+K NIL+D + K+ DFG + K GT Y PP
Sbjct: 163 RHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPP 217
Query: 247 EYV----YQGICSIKSDVFSFGMLLLEILSGK 274
E++ Y G + V+S G+LL +++ G
Sbjct: 218 EWIRYHRYHG---RSAAVWSLGILLYDMVCGD 246
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-23
Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 57/229 (24%)
Query: 80 KLGEGGFGPVYKGV---LAKGDEIAVKRL--------SVRSRQGLQELKNEALVIAKVQH 128
K+G G +G VYK + A+K++ + R L+ELK H
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK----------H 77
Query: 129 KNLVRLLGCCIER-DEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIV---- 182
N++ L + D K+ L+++Y D + R +Q+ G+V
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 183 ----EGLLYLHLHSRVRIIHRDLKASNILLDKEMKP----KISDFGMARIFKGNESKANT 234
+G+ YLH + ++HRDLK +NIL+ E KI+D G AR+F + K
Sbjct: 135 YQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLA 190
Query: 235 NRVAG--TFGYIPPE-------YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ TF Y PE Y +I D+++ G + E+L+ +
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYT----KAI--DIWAIGCIFAELLTSE 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
+++ +G G FG V++ L + DE+A+K++ R +EL+ ++ V+H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 132 VRLLGCCIERDEKL------LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEG----- 180
V L +K L+ EY+P +++ R Q +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVP-ETV--------YRASRHYAKLKQTMPMLLIKL 145
Query: 181 ----IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP-KISDFGMARIFKGNESKANTN 235
++ L Y+H I HRD+K N+LLD K+ DFG A+I E N +
Sbjct: 146 YMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVS 200
Query: 236 RVAGTFGYIPPEYVYQGI---CSIKSDVFSFGMLLLEILSGK 274
+ + Y PE ++ +I D++S G ++ E++ G+
Sbjct: 201 YIC-SRYYRAPELIFGATNYTTNI--DIWSTGCVMAELMQGQ 239
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-23
Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 31/239 (12%)
Query: 53 STKREVELPLFSFSSVAAATNNFSDT-----NKLGEGGFGPVYKGV-LAKGDEIAVKRLS 106
+ L + + + NF++ +LG G F V + + + G E A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 107 VR--SRQGLQELKNEALVIAKVQH-KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDA 163
R + E+ +E V+ + ++ L E +LI EY + F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS- 118
Query: 164 TKRVLLELGTRL------QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKP 214
L EL + ++I+ I+EG+ YLH + I+H DLK NILL
Sbjct: 119 --LCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173
Query: 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
KI DFGM+R + GT Y+ PE + + +D+++ G++ +L+
Sbjct: 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-22
Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 33/189 (17%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRL------------SVRSRQGLQELKNE 119
+ K+GEG +G V+K +I A+K+ ++R + L++LK
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-- 60
Query: 120 ALVIAKVQHKNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
H NLV LL R +L L++EY + ++ L D +R + E + I
Sbjct: 61 --------HPNLVNLL-EVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVK-SIT 108
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
++ + + H H IHRD+K NIL+ K K+ DFG AR+ S + VA
Sbjct: 109 WQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
Query: 239 GTFGYIPPE 247
T Y PE
Sbjct: 165 -TRWYRSPE 172
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 71 ATNNFSDT----NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGL---------QEL 116
+T+ F + LG G V + + E AVK + V +
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 117 KNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDA--TKRVLLELGT 173
E ++ KV H N+++L L+++ + L FD K L E T
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKET 126
Query: 174 RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233
R +I+ ++E + LH I+HRDLK NILLD +M K++DFG + E
Sbjct: 127 R-KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--- 179
Query: 234 TNRVAGTFGYIPPEYVYQGICSIKS------DVFSFGMLLLEILSG 273
V GT Y+ PE + + D++S G+++ +L+G
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-22
Identities = 54/276 (19%), Positives = 96/276 (34%), Gaps = 54/276 (19%)
Query: 48 NNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVK--- 103
++ S+ RE F S+ + +G+G +G V + A+K
Sbjct: 3 HHHHHSSGRENLY--FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 104 --RLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL---------- 151
++ + + ++ +K E ++ K+ H N+ RL + L+ E
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 152 ---------------------PNKSLDFFLFDATKRVLLELGTRL------QIIEGIVEG 184
+ + + + L I+ I
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 185 LLYLHLHSRVRIIHRDLKASNILL--DKEMKPKISDFGMARIFKGNESKANT--NRVAGT 240
L YLH I HRD+K N L +K + K+ DFG+++ F + AGT
Sbjct: 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 241 FGYIPPEYVYQGICSI--KSDVFSFGMLLLEILSGK 274
++ PE + S K D +S G+LL +L G
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 54/233 (23%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRL------------SVRSRQGLQELKNE 119
+ + K+G+G FG V+K G ++A+K++ ++R + LQ LK
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-- 74
Query: 120 ALVIAKVQHKNLVRLLGCCIERDEKL--------LIYEYLPNKSLDFFLFDATKRVLLEL 171
H+N+V L+ C + L++++ D + V L
Sbjct: 75 --------HENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTL 123
Query: 172 GTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231
++++ ++ GL Y+H + +I+HRD+KA+N+L+ ++ K++DFG+AR F ++
Sbjct: 124 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 232 AN---TNRVAGTFGYIPPE-------YVYQGICSIKSDVFSFGMLLLEILSGK 274
TNRV T Y PPE Y D++ G ++ E+ +
Sbjct: 181 QPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLS--------VRSRQGLQELKNEALVIAKVQHKN 130
LG G G V ++A++ +S R ++ E ++ K+ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEGLLYL 188
++++ + ++ ++ E + L FD + L E +L ++ + YL
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKL-YFYQMLLAVQYL 255
Query: 189 HLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
H + IIHRDLK N+LL +++ KI+DFG ++I G S T + GT Y+
Sbjct: 256 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTYLA 309
Query: 246 PEYVYQGIC---SIKSDVFSFGMLLLEILSG 273
PE + + D +S G++L LSG
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLS----VRSRQGLQELKNEALVIAKVQHKNLVRLL 135
LGEG +G V + + AVK L R G +K E ++ +++HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 136 GCCIERDEKLLIY---EYLPNKSLDFFLFDATKRVLLELGTRL--QIIEGIVEGLLYLHL 190
+ +EK +Y EY + KR + Q+I+G +E +L
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG-LE-----YL 125
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV- 249
HS+ I+H+D+K N+LL KIS G+A + G+ + PPE
Sbjct: 126 HSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 250 ----YQGICSIKSDVFSFGMLLLEILSGK 274
+ G K D++S G+ L I +G
Sbjct: 185 GLDTFSG---FKVDIWSAGVTLYNITTGL 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVR------SRQGLQELKNEALVIAKVQHKNLV 132
+LG G F V K + G + A K + R ++++ E ++ ++QH N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFD--ATKRVLLELGTRLQIIEGIVEGLLYLHL 190
L + + +LI E + LFD A K L E + ++ I+ G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEAT-EFLKQILNGVYYLHS 132
Query: 191 HSRVRIIHRDLKASNILLDKEMKP----KISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
I H DLK NI+L P KI DFG+A + GT ++ P
Sbjct: 133 LQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAP 186
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSG 273
E V +++D++S G++ +LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 24/213 (11%)
Query: 72 TNNFSDT----NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV 126
+ F+D +G G + + + A E AVK + R +E +++
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYG 73
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEG 184
QH N++ L + ++ E + L D ++ E ++ I +
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKT 128
Query: 185 LLYLHLHSRVRIIHRDLKASNILL-DKEMKP---KISDFGMARIFKGNESKANTNRVAGT 240
+ YLH ++HRDLK SNIL D+ P +I DFG A+ + T T
Sbjct: 129 VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
Query: 241 FGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
++ PE + + D++S G+LL +L+G
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLS--------VRSRQGLQELKNEALVIAKVQHKN 130
LG G G V ++A+K +S R ++ E ++ K+ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEGLLYL 188
++++ + ++ ++ E + L FD + L E + ++ + YL
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQMLLAVQYL 130
Query: 189 HLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
H + IIHRDLK N+LL +++ KI+DFG ++I G S T + GT Y+
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTYLA 184
Query: 246 PEYVYQGIC---SIKSDVFSFGMLLLEILSG 273
PE + + D +S G++L LSG
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 25/210 (11%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCC 138
LGEG V + L E AVK + + + E ++ + Q H+N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
E D L++E + S+ +R EL +++ + L +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEAS-VVVQDVASALDFLHNK---GI 132
Query: 197 IHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNR-----VAGTFGYIPPEY 248
HRDLK NIL ++ KI DF + K N + + G+ Y+ PE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 249 VYQGICSIKS-----DVFSFGMLLLEILSG 273
V D++S G++L +LSG
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 49/227 (21%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN 130
+++DT +G G FG VY+ L G+ +A+K++ R +EL+ ++ K+ H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 131 LVRLLGCCIERDEKL------LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEG---- 180
+VRL EK L+ +Y+P +++ RV Q +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETV--------YRVARHYSRAKQTLPVIYVK 159
Query: 181 -----IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP-KISDFGMARIFKGNESKANT 234
+ L Y+H I HRD+K N+LLD + K+ DFG A+ E N
Sbjct: 160 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 214
Query: 235 NRVAGTFGYIPPE-------YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ + + Y PE Y + DV+S G +L E+L G+
Sbjct: 215 SYIC-SRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQH 128
N+FS +G GGFG VY A ++ A+K L ++ +QG NE ++++ V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 129 KN---LVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
+ +V + +KL I + + L + L V E R E I+ G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILG 304
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
L ++H +++RDLK +NILLD+ +ISD G+A F + + GT GY+
Sbjct: 305 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 357
Query: 245 PPEYVYQGICSIKS-DVFSFGMLLLEILSGK 274
PE + +G+ S D FS G +L ++L G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 5e-21
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE-LKNEALVIAKVQHKNLVRLLGCC 138
LGEG +G V V + +AVK + ++ E +K E + + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 139 IERDEKL-LIYEYLPNKSLDFFLFD--ATKRVLLELGTR---LQIIEGIVEGLLYLHLHS 192
L EY L FD + E + Q++ G+V +LH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV------YLHG 123
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV--- 249
I HRD+K N+LLD+ KISDFG+A +F+ N + N++ GT Y+ PE +
Sbjct: 124 I-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 250 -YQGICSIKSDVFSFGMLLLEILSG 273
+ DV+S G++L +L+G
Sbjct: 183 EFHA---EPVDVWSCGIVLTAMLAG 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-21
Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
+LG G VY+ A+K ++ + ++ E V+ ++ H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196
E L+ E + L FD K E ++ I+E + YLH + I
Sbjct: 118 ETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA-DAVKQILEAVAYLHEN---GI 169
Query: 197 IHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI 253
+HRDLK N+L + KI+DFG+++I + V GT GY PE +
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCA 226
Query: 254 CSIKSDVFSFGMLLLEILSG 273
+ D++S G++ +L G
Sbjct: 227 YGPEVDMWSVGIITYILLCG 246
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGC 137
+G+G F V + G E+A+K + + LQ+L E ++ + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 138 CIERDEKL-LIYEYLPNKSLDFFLFD--ATKRVLLELGTR---LQIIEGIVEGLLYLHLH 191
IE ++ L LI EY + FD + E R QI+ + Y H
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCHQK 133
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV-- 249
RI+HRDLKA N+LLD +M KI+DFG + F K + G Y PE
Sbjct: 134 ---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDA--FCGAPPYAAPELFQG 187
Query: 250 --YQGICSIKSDVFSFGMLLLEILSGK 274
Y G + DV+S G++L ++SG
Sbjct: 188 KKYDG---PEVDVWSLGVILYTLVSGS 211
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE-LKNEALVIAKVQHKNLVRLLGCC 138
LGEG +G V V + +AVK + ++ E +K E + + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 139 IERDEKL-LIYEYLPNKSLDFFLFD--ATKRVLLELGTR---LQIIEGIVEGLLYLHLHS 192
L EY L FD + E + Q++ G+V +LH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV------YLHG 123
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV--- 249
I HRD+K N+LLD+ KISDFG+A +F+ N + N++ GT Y+ PE +
Sbjct: 124 I-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 250 -YQGICSIKSDVFSFGMLLLEILSG 273
+ DV+S G++L +L+G
Sbjct: 183 EFHA---EPVDVWSCGIVLTAMLAG 204
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 27/216 (12%)
Query: 72 TNNFSD-------TNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVI 123
+ F LGEG F K V AVK +S ++ + E +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITAL 59
Query: 124 AKVQ-HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDA--TKRVLLELGTRLQIIEG 180
+ H N+V+L ++ L+ E L L F+ K+ E I+
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRK 114
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRV 237
+V + ++H ++HRDLK N+L + ++ KI DFG AR+ + T
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--P 169
Query: 238 AGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
T Y PE + Q D++S G++L +LSG
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 32/210 (15%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVK--------RLSVRSRQGLQELKNEALVIAKVQHKNL 131
LG G FG V+ V K E+ VK L ++ E ++++V+H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 132 VRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRL---QIIEGIVEGLLY 187
+++L E L+ E + LD F F L E Q++ + Y
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----Y 145
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
L L IIHRD+K NI++ ++ K+ DFG A + + T GT Y PE
Sbjct: 146 LRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT--FCGTIEYCAPE 199
Query: 248 YV----YQGICSIKSDVFSFGMLLLEILSG 273
+ Y+G + +++S G+ L ++
Sbjct: 200 VLMGNPYRG---PELEMWSLGVTLYTLVFE 226
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 54/234 (23%), Positives = 103/234 (44%), Gaps = 57/234 (24%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLS--------------------------VRSRQGL 113
+G+G +G V A+K LS ++ R +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 114 QELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY---EYLPNKSLDFFLFD-ATKRVLL 169
+++ E ++ K+ H N+V+L+ ++ + +Y E + + + T + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 170 ELGTRL---QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226
E R +I+G +E YLH +IIHRD+K SN+L+ ++ KI+DFG++ FK
Sbjct: 136 EDQARFYFQDLIKG-IE---YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 227 GNESKANTNRVAGTFGYIPPEYV------YQGICSIKSDVFSFGMLLLEILSGK 274
G+++ + GT ++ PE + + G DV++ G+ L + G+
Sbjct: 189 GSDALLSN--TVGTPAFMAPESLSETRKIFSG---KALDVWAMGVTLYCFVFGQ 237
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 32/208 (15%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVK---RLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG G FG V G G ++AVK R +RS + ++K E + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFD--ATKRVLLELGTRL---QIIEGIVEGLLYLHL 190
I ++ EY+ L FD + E+ R QI+ + Y H
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCHR 129
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV- 249
H ++HRDLK N+LLD M KI+DFG++ + E T G+ Y PE +
Sbjct: 130 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT--SCGSPNYAAPEVIS 183
Query: 250 ---YQGICSIKSDVFSFGMLLLEILSGK 274
Y G + D++S G++L +L G
Sbjct: 184 GRLYAG---PEVDIWSCGVILYALLCGT 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 52/240 (21%), Positives = 94/240 (39%), Gaps = 53/240 (22%)
Query: 64 SFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRL----SVRSRQGLQELKN 118
+ + F G+G FG V G G +A+K++ R+R+ LQ ++
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQ- 71
Query: 119 EALVIAKVQHKNLVRLLGCCIERDEK-------LLIYEYLPNKSLDFFLFDATKRVLLEL 171
+A + H N+V+L E+ ++ EY+P +L R
Sbjct: 72 ---DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTL--------HRCCRNY 119
Query: 172 GTRLQIIEG---------IVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGM 221
R ++ + LHL S + HRD+K N+L+++ K+ DFG
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 222 ARIFKGNESKANTNRVAGTFGYIPPE-------YVYQGICSIKSDVFSFGMLLLEILSGK 274
A+ +E N + + Y PE Y ++ D++S G + E++ G+
Sbjct: 179 AKKLSPSE--PNVAYICSRY-YRAPELIFGNQHYT----TAV--DIWSVGCIFAEMMLGE 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 26/203 (12%), Positives = 61/203 (30%), Gaps = 49/203 (24%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRL---SVRSRQGLQELKNEALVIAKVQHKNLVRLL 135
G ++ + A ++A+ + V LQE + L ++++ + R+L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELG----TRLQIIEGIVEGLLYLHLH 191
R L++ E++ SL + + + ++ ++ + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSL---------QEVADTSPSPVGAIRAMQSLAAAADAAH-- 146
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
R + S + +S G V +P
Sbjct: 147 -RAGVALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA---- 179
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
+ + D+ G L +L +
Sbjct: 180 ---NPQDDIRGIGASLYALLVNR 199
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVK---RLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG G FG V G G ++AVK R +RS + +++ E + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFD--ATKRVLLELGTRL---QIIEGIVEGLLYLHL 190
I + ++ EY+ L FD L E +R QI+ G+ Y H
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCHR 134
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV- 249
H ++HRDLK N+LLD M KI+DFG++ + E T+ G+ Y PE +
Sbjct: 135 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS--CGSPNYAAPEVIS 188
Query: 250 ---YQGICSIKSDVFSFGMLLLEILSGK 274
Y G + D++S G++L +L G
Sbjct: 189 GRLYAG---PEVDIWSSGVILYALLCGT 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+G FG V A+K L + ++ + E V+ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ ++L + EY L F L + +RV E R E IV L +LHS
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALD--YLHSEKN 269
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
+++RDLK N++LDK+ KI+DFG+ + + + T GT Y+ PE +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYG 327
Query: 256 IKSDVFSFGMLLLEILSGK 274
D + G+++ E++ G+
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVK---RLSVRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LGEG FG V ++A+K R ++ ++ E + ++H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFD--ATKRVLLELGTRL---QIIEGIVEGLLYLHL 190
I + ++ EY + LFD K+ + E R QII I Y H
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCHR 126
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV- 249
H +I+HRDLK N+LLD + KI+DFG++ I T+ G+ Y PE +
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS--CGSPNYAAPEVIN 180
Query: 250 ---YQGICSIKSDVFSFGMLLLEILSGK 274
Y G + DV+S G++L +L G+
Sbjct: 181 GKLYAG---PEVDVWSCGIVLYVMLVGR 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
+G G FG V L D++ A+K L+ + R + E V+ K + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ D L L+ +Y L L + L E R + E +V + +H
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQLH--- 195
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
+HRD+K NIL+D +++DFG + + ++ GT YI PE + Q +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPE-ILQAMEG 253
Query: 256 IKS------DVFSFGMLLLEILSGKKNTEFY 280
K D +S G+ + E+L G+ T FY
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGE--TPFY 282
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 47/229 (20%), Positives = 83/229 (36%), Gaps = 53/229 (23%)
Query: 72 TNNFSDT-----NKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAK 125
+D LG G G V + G + A+K L + + E +
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQ 77
Query: 126 VQ-HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFF----------LFDATKRVLLELGTR 174
++V +L +YE + + LF + E G +
Sbjct: 78 ASGGPHIVCILD----------VYENMHHGKRCLLIIMECMEGGELFSR----IQERGDQ 123
Query: 175 L-------QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARI 224
+I+ I + +LH H+ I HRD+K N+L +K+ K++DFG A+
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
N + T Y+ PE + D++S G+++ +L G
Sbjct: 181 TTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 46/210 (21%), Positives = 82/210 (39%), Gaps = 35/210 (16%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLG- 136
LG G G V + ++ A+K L + + E + + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123
Query: 137 ---CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRL-------QIIEGIVEGLL 186
R L++ E L L F + + G + +I++ I E +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSR----IQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 187 YLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGY 243
YLH + I HRD+K N+L K++DFG A+ + S T Y
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYY 229
Query: 244 IPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
+ PE + D++S G+++ +L G
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
+G+G FG V ++ A+K ++ R ++ + E ++ ++H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ +E + ++ + L L + L E +L I E +V L YL R
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICE-LVMALDYLQNQ---R 135
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
IIHRD+K NILLD+ I+DF +A + +AGT Y+ PE +
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGA 192
Query: 256 IKS---DVFSFGMLLLEILSGK 274
S D +S G+ E+L G+
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGR 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
LG+G FG V A+K L + ++ + E+ V+ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ ++L + EY L F L + +RV E R E IV L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
+++RD+K N++LDK+ KI+DFG+ + + + T GT Y+ PE +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYG 183
Query: 256 IKSDVFSFGMLLLEILSGK 274
D + G+++ E++ G+
Sbjct: 184 RAVDWWGLGVVMYEMMCGR 202
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 45/213 (21%), Positives = 83/213 (38%), Gaps = 23/213 (10%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
+G G F V + + ++ A+K ++ + R + + E V+ + + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ + L L+ EY L L + R + E IV + +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDSVHRLG--- 182
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
+HRD+K NILLD+ +++DFG + + + GT Y+ PE + Q +
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPE-ILQAVGG 240
Query: 256 IKSDVF--------SFGMLLLEILSGKKNTEFY 280
+ G+ E+ G+ T FY
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQ--TPFY 271
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 54/246 (21%), Positives = 108/246 (43%), Gaps = 47/246 (19%)
Query: 47 ANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRL 105
N R + E + + + +++ KLG G + V++ + + +++ VK L
Sbjct: 14 VNTHRPREYWDYESHVVEWGN----QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 69
Query: 106 S-VRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK----LLIYEYLPNKSLDFFL 160
V+ ++ +E+K ++ N++ L I +D L++E++ N
Sbjct: 70 KPVKKKKIKREIK---ILENLRGGPNIITLA--DIVKDPVSRTPALVFEHVNNTDF---- 120
Query: 161 FDATKRVLLELGTRLQI---IEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKI 216
K++ L T I + I++ L Y H I+HRD+K N+++D E K ++
Sbjct: 121 ----KQLYQTL-TDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRL 172
Query: 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPE-------YVYQGICSIKSDVFSFGMLLLE 269
D+G+A + + RVA + + PE Y Y S+ D++S G +L
Sbjct: 173 IDWGLAEF--YHPGQEYNVRVA-SRYFKGPELLVDYQMYDY----SL--DMWSLGCMLAS 223
Query: 270 ILSGKK 275
++ K+
Sbjct: 224 MIFRKE 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS----VRSRQGLQELKNEALVIAKVQHKNLVRLL 135
LG G FG V + A+K L V+ +Q ++ NE ++ V LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLVKLE 107
Query: 136 GCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ ++ EY+ + L E R + IV YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS 255
+I+RDLK N+L+D++ +++DFG A K + + T + GT + PE + +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWT--LCGTPEALAPEIILSKGYN 216
Query: 256 IKSDVFSFGMLLLEILSG 273
D ++ G+L+ E+ +G
Sbjct: 217 KAVDWWALGVLIYEMAAG 234
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 58/206 (28%), Positives = 85/206 (41%), Gaps = 32/206 (15%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
+G G FG + +AVK + R + ++ E + ++H N+VR I
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEV-I 85
Query: 140 ERDEKL-LIYEYLPNKSLDFFLFD--ATKRVLLELGTRL---QIIEGIVEGLLYLHLHSR 193
L +I EY L ++ E R Q++ G V Y H
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSG-VS---YCHSM-- 135
Query: 194 VRIIHRDLKASNILLDKEMKP--KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV-- 249
+I HRDLK N LLD P KI DFG ++ + S+ + GT YI PE +
Sbjct: 136 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS--TVGTPAYIAPEVLLR 191
Query: 250 --YQGICSIKSDVFSFGMLLLEILSG 273
Y G +DV+S G+ L +L G
Sbjct: 192 QEYDG---KIADVWSCGVTLYVMLVG 214
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 81 LGEGGFGPVY---KGVLAKGDEI-AVKRLS----VRSRQGLQELKNEALVIAKVQHKNLV 132
LG+GG+G V+ K A +I A+K L VR+ + K E ++ +V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 133 RLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
L+ + KL LI EYL L L + + +E + E I L +LH
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE-ISMALGHLHQK 140
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
II+RDLK NI+L+ + K++DFG+ + + + +T GT Y+ PE + +
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMR 195
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
+ D +S G L+ ++L+G
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGA 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 40/115 (34%), Positives = 61/115 (53%), Gaps = 23/115 (20%)
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR-IFKGNESKANTNRVAG 239
+ +G+ +L + + IHRDL A NILL ++ KI DFG+AR I+K + +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD---- 254
Query: 240 TFGYIP-----PEYVYQGICSIKSDVFSFGMLLLEILS-G-------KKNTEFYH 281
+P PE ++ + +I+SDV+SFG+LL EI S G K + EF
Sbjct: 255 --ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 35/161 (21%), Positives = 55/161 (34%), Gaps = 19/161 (11%)
Query: 79 NKLGEGGFGPVYKGVL------AKGDEIAVKRL-SVRSRQGLQELKNEALVIAKV-QHKN 130
LG G FG V + A +AVK L + + L +E ++ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 131 LVRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
+V LLG C + L +I E+ +L +L R + + +G +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230
V I DLK + S F + E
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 1e-15
Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS----VRSRQGLQELKNEALVIAKVQHKNLVRLL 135
LG G FG V+ A+K L VR +Q ++ +E L+++ V H ++R+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFIIRMW 72
Query: 136 GCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
G + +++ +I +Y+ L F L ++R + E + L YLH
Sbjct: 73 GTF-QDAQQIFMIMDYIEGGEL-FSLLRKSQR-FPNPVAKFYAAE-VCLALEYLHSKD-- 126
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
II+RDLK NILLDK KI+DFG A K T + GT YI PE V
Sbjct: 127 -IIYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYT--LCGTPDYIAPEVVSTKPY 180
Query: 255 SIKSDVFSFGMLLLEILSG 273
+ D +SFG+L+ E+L+G
Sbjct: 181 NKSIDWWSFGILIYEMLAG 199
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKV-QHKNLVRLL 135
+G G + V L K D I A+K + V + + ++ E V + H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 136 GCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
C + + +L + EY+ L F + +R L E R E I L YLH
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG-- 130
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
II+RDLK N+LLD E K++D+GM + +T GT YI PE +
Sbjct: 131 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRGEDY 187
Query: 255 SIKSDVFSFGMLLLEILSGK 274
D ++ G+L+ E+++G+
Sbjct: 188 GFSVDWWALGVLMFEMMAGR 207
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 60/200 (30%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKV-QHKNLVRLL 135
LG+G FG V DE+ AVK L V ++ E V+A + L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 136 GCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
C + ++L + EY+ L + + E E I GL +L
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAE-IAIGLFFLQSKG-- 462
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
II+RDLK N++LD E KI+DFGM + + T GT YI PE +
Sbjct: 463 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQPY 519
Query: 255 SIKSDVFSFGMLLLEILSGK 274
D ++FG+LL E+L+G+
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQ 539
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKV-QHKNLVRLL 135
+G G + V L K D I A++ + V + + ++ E V + H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 136 GCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
C + + +L + EY+ L F + +R L E R E I L YLH
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG-- 173
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
II+RDLK N+LLD E K++D+GM + +T GT YI PE +
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRGEDY 230
Query: 255 SIKSDVFSFGMLLLEILSGK 274
D ++ G+L+ E+++G+
Sbjct: 231 GFSVDWWALGVLMFEMMAGR 250
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 45/250 (18%), Positives = 87/250 (34%), Gaps = 63/250 (25%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN 130
+ +S LG G FG V + + G A+K++ R +EL ++ + H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDHVN 61
Query: 131 LVRLLGC---------------------CIERDEKLLIYEYLPNKSLDFF-------LFD 162
+++L+ + + ++ +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 163 AT-KRVLLELGTRLQIIEG---------IVEGLLYLHLHSRVRIIHRDLKASNILLDKEM 212
T +VL + I + + ++H I HRD+K N+L++ +
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKD 178
Query: 213 -KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE-------YVYQGICSIKSDVFSFG 264
K+ DFG A+ +E + + F Y PE Y + D++S G
Sbjct: 179 NTLKLCDFGSAKKLIPSE--PSVAYICSRF-YRAPELMLGATEY------TPSIDLWSIG 229
Query: 265 MLLLEILSGK 274
+ E++ GK
Sbjct: 230 CVFGELILGK 239
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 3e-15
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 81 LGEGGFGPVY---KGVLAKGDEI-AVKRL---SVRSRQGLQELKNEALVIAKVQHKNLVR 133
LG+G FG V+ K + ++ A+K L +++ R K E ++ +V H +V+
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVK 90
Query: 134 LLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
L + + KL LI ++L L L + + + E + + E + L +LH
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAE-LALALDHLHSLG 146
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
II+RDLK NILLD+E K++DFG+++ +E KA + GT Y+ PE V +
Sbjct: 147 ---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRR 201
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
+ +D +SFG+L+ E+L+G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGT 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 59/209 (28%), Positives = 85/209 (40%), Gaps = 20/209 (9%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQHKNLVRLLG 136
+G G FG V ++ A+K LS + R E ++A +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 137 CCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVR 195
+ D L ++ EY+P L L + E R E +V L +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL-VNLMS--NYDVPEKWARFYTAE-VVLALDAIHSMG--- 188
Query: 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV-YQGIC 254
IHRD+K N+LLDK K++DFG + GT YI PE + QG
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGD 247
Query: 255 SI--KS-DVFSFGMLLLEILSGKKNTEFY 280
+ D +S G+ L E+L G T FY
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGD--TPFY 274
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 8e-15
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 27/232 (11%)
Query: 48 NNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLS 106
N R S + ++++ F + LG+G FG V+ K ++ A+K L
Sbjct: 4 NKERPSLQIKLKIEDFILHKM------------LGKGSFGKVFLAEFKKTNQFFAIKALK 51
Query: 107 ---VRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKL-LIYEYLPNKSLDFFLF 161
V ++ E V++ +H L + C + E L + EYL L + +
Sbjct: 52 KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI- 109
Query: 162 DATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221
+ E I+ GL +LH I++RDLK NILLDK+ KI+DFGM
Sbjct: 110 -QSCHKFDLSRATFYAAE-IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 164
Query: 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG 273
+ ++K NT GT YI PE + + D +SFG+LL E+L G
Sbjct: 165 CKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 48/226 (21%), Positives = 82/226 (36%), Gaps = 38/226 (16%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAK------ 125
+ ++ + G +G V GV ++G +A+KR+ G + K
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 126 -----VQHKNLVRLLGCCIERDEKL-----LIYEYLPN------KSLDFFLFDATKRVLL 169
H N++ L + +E L+ E + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 170 ELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229
I+ GL LH ++HRDL NILL I DF +AR +
Sbjct: 141 -----YHIL----LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 230 SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGK 274
+K T+ V Y PE V Q + D++S G ++ E+ + K
Sbjct: 189 NK--THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 27/239 (11%)
Query: 42 ELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEI- 100
E S + N ++ + + F F V LG+G FG V + + ++
Sbjct: 4 ESSKEGNGIGVNSSNRLGIDNFEFIRV------------LGKGSFGKVMLARVKETGDLY 51
Query: 101 AVKRLS---VRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKL-LIYEYLPNKS 155
AVK L + ++ E +++ H L +L CC + ++L + E++
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGD 110
Query: 156 LDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPK 215
L F + R E R E I+ L++LH II+RDLK N+LLD E K
Sbjct: 111 LMFHIQK--SRRFDEARARFYAAE-IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCK 164
Query: 216 ISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
++DFGM + N T GT YI PE + + + D ++ G+LL E+L G
Sbjct: 165 LADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 65/250 (26%), Positives = 104/250 (41%), Gaps = 27/250 (10%)
Query: 31 DLSMNLKADDIELSNKANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVY 90
MN ++ N S+ + F F V +G+G FG V
Sbjct: 8 PELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKV------------IGKGSFGKVL 55
Query: 91 KGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAK-VQHKNLVRLLGCCIERDEKL 145
+ AVK L + ++ + + +E V+ K V+H LV L + +KL
Sbjct: 56 LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL 114
Query: 146 -LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKAS 204
+ +Y+ L + L +R LE R E I L YLH + I++RDLK
Sbjct: 115 YFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHSLN---IVYRDLKPE 168
Query: 205 NILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFG 264
NILLD + ++DFG+ + + S +T GT Y+ PE +++ D + G
Sbjct: 169 NILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 265 MLLLEILSGK 274
+L E+L G
Sbjct: 227 AVLYEMLYGL 236
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 35/219 (15%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS------VRSRQGLQELKNEALVIA 124
+ + +G G G V A +A+K+LS +++ +EL ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 125 KVQHKNLVRLL------GCCIERDEKLLIYEYLP---NKSLDFFLFDATKRVLLELGTRL 175
V HKN++ LL E + ++ E + + + L LL
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-----Y 134
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
Q++ GI HLHS IIHRDLK SNI++ + KI DFG+AR S T
Sbjct: 135 QMLCGI------KHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 185
Query: 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
V T Y PE + D++S G ++ E++ G
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS------VRSRQGLQELKNEALVIA 124
+ + +G G G V A +A+K+LS +++ +EL ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 125 KVQHKNLVRLL-----GCCIERDEKL-LIYEYLP---NKSLDFFLFDATKRVLLELGTRL 175
V HKN++ LL +E + + L+ E + + + L LL
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL-----Y 171
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
Q++ GI HLHS IIHRDLK SNI++ + KI DFG+AR S T
Sbjct: 172 QMLCGI------KHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 222
Query: 236 RVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
V T Y PE + D++S G ++ E++ K
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 60/200 (30%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 81 LGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKV-QHKNLVRLL 135
LG+G FG V DE+ AVK L V ++ E V+A + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 136 GCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
C + ++L + EY+ L + + E E I GL +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAE-IAIGLFFLQSK--- 140
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
II+RDLK N++LD E KI+DFGM + + T GT YI PE +
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQPY 198
Query: 255 SIKSDVFSFGMLLLEILSGK 274
D ++FG+LL E+L+G+
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQ 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 42/164 (25%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
N F K+G G FG +Y G + +E+A+K +V+++ +L E+ + +Q
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 132 V-RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ + +E D +L+ + L SL+ LF+ R L L T L + + ++ + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRK-LSLKTVLMLADQMINRVEFVHS 121
Query: 191 HSRVRIIHRDLKASNILLDKEMKPK---ISDFGMARIFKGNESK 231
S +HRD+K N L+ + I DFG+A+ ++ +
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 50/233 (21%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRS----RQGLQELKNEALVIAKV 126
+ + D LG GG G V+ V +A+K++ + + L+E+K +I ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRL 65
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLEL-GTRL-QIIEG---- 180
H N+V++ +L + ++ E T L ++E
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIV-------QEYMETDLANVLEQGPLL 118
Query: 181 ----------IVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNE 229
++ GL Y+H ++HRDLK +N+ ++ E + KI DFG+ARI +
Sbjct: 119 EEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 230 SKAN--TNRVAGTFGYIPPEYV-----Y-QGICSIKSDVFSFGMLLLEILSGK 274
S + + T Y P + Y + I D+++ G + E+L+GK
Sbjct: 176 SHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAI-----DMWAAGCIFAEMLTGK 222
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
N + K+G G FG +Y G +A G+E+A+K V+++ +L E+ + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 132 V-RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ + C E D +++ E L SL+ LF+ R L T L + + ++ + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRK-FSLKTVLLLADQMISRIEYIHS 123
Query: 191 HSRVRIIHRDLKASNILLDKEMKPK---ISDFGMARIFKGNESK 231
+ IHRD+K N L+ K I DFG+A+ ++ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 81 LGEGGFGPVY---KGVLAKGDEI-AVKRLS----VRSRQGLQELKNEALVIAKVQHKN-L 131
LG G +G V+ K ++ A+K L V+ + + + E V+ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 132 VRLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
V L + + KL LI +Y+ L L + + E ++ + E IV L +LH
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGE-IVLALEHLHK 177
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
II+RD+K NILLD ++DFG+++ F +E++ GT Y+ P+ +
Sbjct: 178 LG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPD-IV 232
Query: 251 QGICS--IKS-DVFSFGMLLLEILSGK 274
+G S K+ D +S G+L+ E+L+G
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 36/194 (18%), Positives = 88/194 (45%), Gaps = 35/194 (18%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLS------VRSRQGLQELKNEALVIA 124
+ + + +G G +G V + + +A+K++ + ++ L+E+ ++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 125 KVQHKNLVRLLGCCI----ERDEKL-LIYEYLPN------KSLDFFLFDATKRVLLELGT 173
++ H ++V++L I E+ ++L ++ E + ++ +L + + LL
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV-YLTELHIKTLL---- 162
Query: 174 RLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233
++ G+ Y+H I+HRDLK +N L++++ K+ DFG+AR E+ +
Sbjct: 163 -YNLL----VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 234 TNRVAGTFGYIPPE 247
++ +
Sbjct: 215 QLPISPREDDMNLV 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 15/166 (9%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH-KN 130
NF K+G G FG + G L + +A+K ++SR +L E ++
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ ++ ++ E L SL+ LFD R L T L I ++ + Y+H
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTF-SLKTVLMIAIQLISRMEYVHS 123
Query: 191 HSRVRIIHRDLKASNILLDKEMKPK-----ISDFGMARIFKGNESK 231
+ +I+RD+K N L+ + I DF +A+ + E+K
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 34/166 (20%), Positives = 71/166 (42%), Gaps = 15/166 (9%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
++ ++GEG FG +++G L ++A+K RS +L++E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67
Query: 132 V-RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+ + E +L+ + L SL+ L D R + T + ++ + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGRKF-SVKTVAMAAKQMLARVQSIHE 124
Query: 191 HSRVRIIHRDLKASNILLDKEMKPK-----ISDFGMARIFKGNESK 231
S +++RD+K N L+ + + DFGM + ++ +K
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 56/235 (23%), Positives = 105/235 (44%), Gaps = 63/235 (26%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS-----VRSRQGLQELKNEALVIAK 125
+++ + +GEG +G V +A+K++S ++ L+E+K ++ +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 126 VQHKNLVRLLGC----CIERDEKL-LIYEY-------------LPNKSLDFFLFDATKRV 167
+H+N++ + IE+ + + ++ + L N + +FL+
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY------ 135
Query: 168 LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227
QI+ G+ ++HS ++HRDLK SN+LL+ KI DFG+AR+
Sbjct: 136 --------QILRGL------KYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 228 NESKAN--TNRVAGTFGYIPPEYV-----Y-QGICSIKSDVFSFGMLLLEILSGK 274
+ T VA T Y PE + Y + I D++S G +L E+LS +
Sbjct: 181 DHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSI-----DIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 49/220 (22%), Positives = 101/220 (45%), Gaps = 38/220 (17%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS------VRSRQGLQELKNEALVIA 124
+ +G G +G V + + G+++A+K+LS + +++ +EL ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 125 KVQHKNLVRLL-----GCCIERDEKL-LIYEYLP---NKSLDFFLFDATKRVLLELGTRL 175
+QH+N++ LL + L+ ++ K + + + L+
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-----Y 133
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN 235
Q+++G+ ++HS ++HRDLK N+ ++++ + KI DFG+AR T
Sbjct: 134 QMLKGL------KYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHA----DAEMTG 182
Query: 236 RVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGK 274
V T Y PE + + D++S G ++ E+L+GK
Sbjct: 183 YVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 36/165 (21%), Positives = 61/165 (36%), Gaps = 44/165 (26%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGC 137
LG G G V + ++ A+K L + + E + + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVD- 78
Query: 138 CIERDEKLLIYEYLPNKSLDFF----------LFDATKRVLLELGTRL-------QIIEG 180
+YE L LF + + G + +I++
Sbjct: 79 ---------VYENLYAGRKCLLIVMECLDGGELFSR----IQDRGDQAFTEREASEIMKS 125
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMA 222
I E + YLH + I HRD+K N+L K++DFG A
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 7e-12
Identities = 37/207 (17%), Positives = 67/207 (32%), Gaps = 47/207 (22%)
Query: 63 FSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS--------RQGLQ 114
FS T K+GEG FG V++ + A +A+K +++ ++ +
Sbjct: 11 VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 115 ELKNEALV---------IAKVQHKNLVRLLGCCIERDE--KLLIYEYL--------PNKS 155
E+ E ++ + + + L + LL+ + N
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 156 LDFF----------------LFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHR 199
DFF + + L L T I+ + L + +R HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLA--VAEASLRFEHR 186
Query: 200 DLKASNILLDKEMKPKISDFGMARIFK 226
DL N+LL K K+ +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 55/229 (24%), Positives = 104/229 (45%), Gaps = 55/229 (24%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS------VRSRQGLQELKNEALVIA 124
+ D +G G +G V V + G ++A+K+L + +++ +EL+ ++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 125 KVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLL--EL-GTRL-QIIEG 180
++H+N++ LL + P+++LD F L GT L ++++
Sbjct: 80 HMRHENVIGLLDV------------FTPDETLDDF-----TDFYLVMPFMGTDLGKLMKH 122
Query: 181 --------------IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226
+++GL Y+H IIHRDLK N+ ++++ + KI DFG+AR
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA- 178
Query: 227 GNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGK 274
T V T Y PE + + D++S G ++ E+++GK
Sbjct: 179 ---DSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 47/240 (19%), Positives = 95/240 (39%), Gaps = 66/240 (27%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQG-----LQELKNEALVIAK 125
+++F + LGEG +G V G+ +A+K++ + L+E+K ++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 126 VQHKNLVRLLGC----CIERDEKL-LIYEYLP--------NKSLD-----FFLFDATKRV 167
+H+N++ + E ++ +I E + + L +F++
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY------ 119
Query: 168 LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227
Q + + LH +IHRDLK SN+L++ K+ DFG+ARI
Sbjct: 120 --------QTLRAV------KVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 228 NESKANTNRVAGTF--GYI------PPEYVYQGICSIKS-----DVFSFGMLLLEILSGK 274
+ + + + ++ PE + + DV+S G +L E+ +
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 55/229 (24%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS------VRSRQGLQELKNEALVIA 124
+ + + +G G +G V K G +AVK+LS + +++ +EL+ ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 125 KVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLL--EL-GTRL-QIIEG 180
++H+N++ LL + P +SL+ F V L L G L I++
Sbjct: 84 HMKHENVIGLLDV------------FTPARSLEEF-----NDVYLVTHLMGADLNNIVKC 126
Query: 181 --------------IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226
I+ GL Y+H IIHRDLK SN+ ++++ + KI DFG+AR
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 181
Query: 227 GNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGK 274
+ T VA T Y PE + + D++S G ++ E+L+G+
Sbjct: 182 --TADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 46/259 (17%), Positives = 91/259 (35%), Gaps = 72/259 (27%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS------VRSRQGLQELKNEALVIA 124
+N+ + +G G +G VY +A+K+++ + ++ L+E+ ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 125 KVQHKNLVRLLGCCIERDEKL-----LIYEYLP---------NKSLD-----FFLFDATK 165
+++ ++RL I D ++ E L L+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY---- 136
Query: 166 RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225
++ G +H IIHRDLK +N LL+++ K+ DFG+AR
Sbjct: 137 ----------NLLLGE------NFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
Query: 226 KGNESKANTNRVAGTFGYIPP---------EYV----Y--------QGICSIKSDVFSFG 264
+ N + P +V Y Q + D++S G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
Query: 265 MLLLEILSGKKNTEFYHTG 283
+ E+L+ ++ T
Sbjct: 240 CIFAELLNMLQSHINDPTN 258
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 37/175 (21%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 80 KLGEGGFGPVYKGV------LAKGDEIAVKRLSVRSRQGLQELK-----NEALVIAKVQH 128
+G+GGFG +Y + VK + ELK + I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 129 KNLVRLLG----------CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
++ LG + + +I + L +++A + T LQ+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKR-FSRKTVLQLS 158
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI--SDFGMARIFKGNESK 231
I++ L Y+H H +H D+KASN+LL+ + ++ D+G+A +
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 66/245 (26%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLS------VRSRQGLQELKNEALVIA 124
+ KLG+G +G V+K + G+ +AVK++ +++ +E+ ++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 125 KVQHKNLVRLLGCCI-ERDEKL-LIYEYLP--------NKSLD-----FFLFDATKRVLL 169
H+N+V LL + D + L+++Y+ L+ + ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY-------- 116
Query: 170 ELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229
Q+I+ I +LHS ++HRD+K SNILL+ E K++DFG++R F
Sbjct: 117 ------QLIKVI------KYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 230 SKANTNRVAGTFGYIPP--------EYV----YQG---ICSIKS-----DVFSFGMLLLE 269
N ++ +YV Y+ + D++S G +L E
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223
Query: 270 ILSGK 274
IL GK
Sbjct: 224 ILCGK 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 26/170 (15%), Positives = 64/170 (37%), Gaps = 27/170 (15%)
Query: 79 NKLGEGGFGPVYKGV---------LAKGDEIAVK----------RLSVRSRQGLQELKNE 119
+ G +Y+ + + ++K + R N+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 120 ALVIAKVQHKNLVRLLGCCIERDE-KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQII 178
+ + +G + +D+ + L+ L +SL D + + +L + LQ+
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI--SDFGMARIFK 226
+++ L +LH + +H ++ A NI +D E + ++ + +G A +
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 35/174 (20%), Positives = 70/174 (40%), Gaps = 30/174 (17%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV------ 132
K+G GGFG +Y K ++ A + V ++ L +E +V K+ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-LFSELKFYQRVAKKDCIKKWIER 102
Query: 133 ---------RLLGC----CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIE 179
G R + ++ E L L + + T LQ+
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGT--FKKSTVLQLGI 158
Query: 180 GIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI--SDFGMARIFKGNESK 231
+++ L Y+H + +H D+KA+N+LL + ++ +D+G++ + N +
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 34/218 (15%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS-----RQGLQELK-----NEALVIAKVQ- 127
KLG G F V+ + +A+K VR E+K N+A +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKI--VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 128 -HKNLVRLLGCCIERDEKL----LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIV 182
++++LL + +++E L ++L + R + + + QI + ++
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLL 141
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEMKP------KISDFGMARIFKGNESKANTNR 236
GL Y+H R IIH D+K N+L++ P KI+D G A + + + + R
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 237 VAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
Y PE + +D++S L+ E+++G
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 49/221 (22%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS-----RQGLQELKNEALVIAK 125
+ + + +G+G FG V K + + +A+K +++ Q E++ ++
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK--IIKNKKAFLNQAQIEVR----LLEL 106
Query: 126 VQH------KNLVRLLGCCIERDEKLLIYEYL-PNKSLDFFLFD---ATKRVLLELGTRL 175
+ +V L + R+ L++E L N L+D T + L
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN------LYDLLRNTNFRGVSLNLTR 160
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP--KISDFGMARIFKGNESKAN 233
+ + + LL+L + IIH DLK NILL + KI DFG + +
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRI 215
Query: 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
+ F Y PE + + D++S G +L+E+ +G+
Sbjct: 216 YQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 58/222 (26%)
Query: 81 LGEGGFGPVYKGV-LAKGDEIAVKRLSVRS-----RQGLQELKNEALVIAKVQHK----- 129
+G+G FG V K +A+K VR+ RQ +E++ ++ ++ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK--MVRNEKRFHRQAAEEIR----ILEHLRKQDKDNT 158
Query: 130 -NLVRLLGCCIERD------EKLLI--YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEG 180
N++ +L R+ E L + YE + F ++
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK----------FAHS 208
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP--KISDFGMARIFKGNESKANTNRVA 238
I++ L LH + RIIH DLK NILL ++ + K+ DFG + ++
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQR--------- 255
Query: 239 GTFGYI------PPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
+ YI PE + + D++S G +L E+L+G
Sbjct: 256 -VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 30/148 (20%), Positives = 53/148 (35%), Gaps = 56/148 (37%)
Query: 176 QIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL--------------------------- 208
+II+ +++GL YLH ++ RIIH D+K NILL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 209 ----------------------DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPP 246
+++K KI+D G A + ++ T Y
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSL 262
Query: 247 EYVYQGICSIKSDVFSFGMLLLEILSGK 274
E + + +D++S + E+ +G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 2e-05
Identities = 51/341 (14%), Positives = 97/341 (28%), Gaps = 85/341 (24%)
Query: 27 LMLFDLSMNLKADDIELSNKANNRRKSTKREVELPLFSF--SSVAAATNNFSDTNKLGEG 84
L LF L +K + EV + F S + S ++
Sbjct: 65 LRLFWT----------LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE 114
Query: 85 GFGPVYKG--VLAKGDEIAVKRLS--VRSRQGLQELKNEA--------------LVIAKV 126
+Y V AK + V RL ++ RQ L EL+ + +
Sbjct: 115 QRDRLYNDNQVFAKYN---VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 127 QHKNLVRL---------LGCCIERDEKL-----LIYEYLPNKSLDFFLFDATKRVLLELG 172
+ L C + L L+Y+ PN + K + +
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 173 TRLQII---EGIVEGLLYL------------HLHSRVRIIHRDLKASNILLDKEMKPKIS 217
L+ + + LL L +L ++ + R + ++ L
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291
Query: 218 DFGMARIFKGNESKANTNRVAGT-FGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKN 276
D + +E K+ + +P E + + L I++
Sbjct: 292 DH-HSMTLTPDEVKSLLLKYLDCRPQDLPRE-----VLTT-------NPRRLSIIA---- 334
Query: 277 TEFYHTGYLSINGYDQTQVASKIKLVESCLA--RP--FRQY 313
E G + + + ++ES L P +R+
Sbjct: 335 -ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 7e-04
Identities = 48/328 (14%), Positives = 95/328 (28%), Gaps = 91/328 (27%)
Query: 22 SKGENLMLFDLSMNLKADDIELSNKANNRRKSTKREVEL--PLFSFSSVAAATNNFSDT- 78
+ E L ++ + D+ REV P S +A + + T
Sbjct: 299 TPDEVKSLLLKYLDCRPQDL-------------PREVLTTNPR-RLSIIAESIRDGLATW 344
Query: 79 -------------------NKLGEGGFGPVYK--GVLAKGDEIAVKRLSV--------RS 109
N L + ++ V I LS+
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 110 RQGLQELKNEALVIAKVQHKNLVRLLGC----CIERDE-----KLLIYEYLPNKSLDFFL 160
+ +L +L + K ++ + + ++ + + ++ Y K+ D
Sbjct: 405 MVVVNKLHKYSL-VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD--S 461
Query: 161 FDATKRVLLELGTRLQIIEGIVEGLLYLHL--H-SRVRIIHRDLKASNILLDKE-MKPKI 216
D L + Y H+ H + R + LD ++ KI
Sbjct: 462 DDLIPPYL--------------DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI 507
Query: 217 SDFGMARIFKGNESKANTNRVAGTF-GYI---PPEYVYQGICSIKSDVFSFGMLLLEILS 272
A G S NT + + YI P+Y + + +I + E L
Sbjct: 508 RHDSTAWNASG--SILNTLQQLKFYKPYICDNDPKY-ERLVNAILDFLPKIE----ENLI 560
Query: 273 GKKNTEFYHTGYLSING--YDQT--QVA 296
K T+ ++ + +++ QV
Sbjct: 561 CSKYTDLLRIALMAEDEAIFEEAHKQVQ 588
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 50/233 (21%), Positives = 78/233 (33%), Gaps = 56/233 (24%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS-----RQGLQELKN-EALVIAKVQHKNLV 132
K+G+G FG V + AVK VR+ R E + + + + N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK--VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 133 RLLGCCIERD------EKLLI--YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184
+ G + D E L YE + + + F + K I++
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKL----------YCIEILKA 149
Query: 185 LLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA------ 238
L YL ++ + H DLK NILLD K T
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 239 --GTFGYIPPEYVYQGICS---------------IKSDVFSFGMLLLEILSGK 274
TF +Y I + + SD++SFG +L E+ +G
Sbjct: 207 GCATFKS---DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.55 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.64 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.56 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.4 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.34 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.15 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.02 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.84 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.71 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.57 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.56 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.47 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.31 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.9 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.01 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.21 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.18 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.05 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.32 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.64 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-58 Score=399.67 Aligned_cols=241 Identities=25% Similarity=0.356 Sum_probs=207.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|++. +|+.||+|++... .....+.+.+|++++++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999954 6999999999643 3345678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||++||+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999986543 4899999999999999999999998 999999999999999999999999999877654
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i 302 (334)
.........+||+.|+|||++.+..++.++||||+||++|||++|++||...+....- . ..+....+....+++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV 265 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence 4444456678999999999999999999999999999999999999999764322100 0 011122456688999
Q ss_pred cccccCCccchhhhhhh
Q 037681 303 ESCLARPFRQYCCILKV 319 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~ 319 (334)
..||..+|.+|.+..++
T Consensus 266 ~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEM 282 (311)
T ss_dssp HHHSCSSGGGSTTSGGG
T ss_pred HHHccCCHhHCcChHHH
Confidence 99999999999998774
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=401.93 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=209.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+.|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999965 69999999997665555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 999999988542 3899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccccchhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSINGYDQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~i 302 (334)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||....... ..........+..+.+++
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 304 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 304 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 2345789999999999999999999999999999999999999997543210 000011122456688999
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..||..+|.+|+++.++.+..+
T Consensus 305 ~~~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 305 DRLLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGG
T ss_pred HHHcCCChhHCcCHHHHhcCHh
Confidence 9999999999999999888665
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=399.64 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=208.3
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|.+.+.||+|+||+||+|.+. ++..||||+++.......+.|.+|++++++++|||||+++++|.+++..|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888999999999999999853 467899999987777777889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc----------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 147 IYEYLPNKSLDFFLFDAT----------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
|||||++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 2345899999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------ccc
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SIN 288 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~ 288 (334)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||........ ...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 249 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986654433333444579999999999999999999999999999999999 9999987543210 001
Q ss_pred ccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 289 GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 289 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
......+..+.+++..||..+|.+|+++.++..+.
T Consensus 250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L 284 (299)
T 4asz_A 250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 11122456688999999999999999998876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-58 Score=404.06 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=201.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++++.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 6999999999643 34456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
||+||+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 999999999986543 334789999999999999999999998 999999999999999999999999999865322
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccchhcccchhhhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYDQTQVASKIKLV 302 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~i 302 (334)
.......+||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+.......+..+.+++
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 112344679999999999999999999999999999999999999997643321 111111222456688999
Q ss_pred cccccCCccchhhhhhhhhc
Q 037681 303 ESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~ 322 (334)
..||..+|.+|+++.++.+.
T Consensus 258 ~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999988664
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-57 Score=397.07 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=200.6
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|.+.+.||+|+||+||+|.+. ++..||||+++.......+.|.+|+++|++++|||||+++++|.+.+..|+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 57788899999999999999854 477899999987777778889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhccc------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCce
Q 037681 147 IYEYLPNKSLDFFLFDATK------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
|||||++|+|.+++..... ..++++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999865432 245899999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS------- 286 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~------- 286 (334)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||........-
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987654443333445679999999999999999999999999999999999 99999765432100
Q ss_pred ccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 287 INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 287 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
-.......+..+.+++..||..+|.+|+++.++...
T Consensus 278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 001111245568899999999999999999887554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=391.32 Aligned_cols=243 Identities=25% Similarity=0.429 Sum_probs=196.0
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.+++++.+.||+|+||+||+|++. ..||||+++.. .....+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 368888999999999999999865 36999998643 45556789999999999999999999998864 56899999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
||++|+|.+++.... ..+++..+..|+.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999986543 34899999999999999999999998 9999999999999999999999999998765433
Q ss_pred CccccccccccCCccCcccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------ccccccchhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ---GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------LSINGYDQTQ 294 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------~~~~~~~~~~ 294 (334)
........+||+.|||||++.+ +.++.++|||||||++|||+||+.||....... ..+.......
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 3334455789999999999863 468999999999999999999999997654321 1111112223
Q ss_pred ccchhhhccccccCCccchhhhhhhhhc
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+..+.+++..||..+|.+|+++.++.+.
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 5567889999999999999998887543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-56 Score=403.63 Aligned_cols=243 Identities=22% Similarity=0.325 Sum_probs=209.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+.|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999965 69999999998666666677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
+||+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|++||+|||+|..+.....
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 999999988542 3899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~i 302 (334)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||........ .........+..+.+++
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence 23457899999999999999999999999999999999999999975432100 00001112456688999
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..||..+|.+|+++.++.+..+
T Consensus 382 ~~~L~~dP~~R~ta~ell~Hp~ 403 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKHPF 403 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGG
T ss_pred HHHcCCChhHCcCHHHHhcCHH
Confidence 9999999999999999888655
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=392.40 Aligned_cols=248 Identities=26% Similarity=0.376 Sum_probs=205.7
Q ss_pred cCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
+++++.+.||+|+||+||+|.+. +++.||||+++.. .....+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45667889999999999999853 4678999999644 3344578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcc-------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC
Q 037681 146 LIYEYLPNKSLDFFLFDAT-------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM 212 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 212 (334)
+|||||++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999986532 1345899999999999999999999998 99999999999999999
Q ss_pred ceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc------
Q 037681 213 KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL------ 285 (334)
Q Consensus 213 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~------ 285 (334)
++||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |+.||........
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987654443334455679999999999999999999999999999999998 8999986543210
Q ss_pred -cccccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 286 -SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 286 -~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.........+..+.+++..||..+|.+|+++.++.+..
T Consensus 263 ~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 263 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 00111122455688999999999999999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-56 Score=382.09 Aligned_cols=247 Identities=22% Similarity=0.369 Sum_probs=192.5
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|.+ .+|+.||+|++... .......+.+|+.++++++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 46999999998643 2344567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+ +|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 578888875543 4999999999999999999999998 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCcc------cccccchhcccchhhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------SINGYDQTQVASKIKL 301 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 301 (334)
. .....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||........ .-.......+....++
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL 242 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 2 2334689999999999988776 5799999999999999999999975432100 0001112245668899
Q ss_pred ccccccCCccchhhhhhhhhcc---CCcccc
Q 037681 302 VESCLARPFRQYCCILKVRTFG---FNLPNA 329 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~---~~~~~~ 329 (334)
+.+||..+|.+|+++.++.+.. .++|..
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~~~p~~ 273 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKVDLPEY 273 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHTTCCGG
T ss_pred HHHHccCChhHCcCHHHHHcCcccccCCChh
Confidence 9999999999999999988744 345544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=380.42 Aligned_cols=240 Identities=25% Similarity=0.402 Sum_probs=196.6
Q ss_pred CcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe----cCcceEEE
Q 037681 76 SDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE----RDEKLLIY 148 (334)
Q Consensus 76 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 148 (334)
.+.+.||+|+||+||+|.+. ++..||+|++... .....+.+.+|+.++++++|||||+++++|.+ .+..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999965 6889999998643 44456789999999999999999999999876 34579999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 227 (334)
|||++|+|.+++.... .+++..+..++.||+.||+|||+++. +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999996543 48999999999999999999998742 4999999999999974 78999999999975432
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------cccchhcccch
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---------NGYDQTQVASK 298 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---------~~~~~~~~~~~ 298 (334)
. .....+||+.|+|||++.+ .++.++|||||||++|||+||+.||.........+ ..........+
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence 2 2345689999999998864 69999999999999999999999997543321000 01112234567
Q ss_pred hhhccccccCCccchhhhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+++..||..+|.+|+++.++.+.++
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcc
Confidence 88999999999999999999887654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-56 Score=390.99 Aligned_cols=238 Identities=24% Similarity=0.328 Sum_probs=198.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+.|++.+.||+|+||+||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56788889999999999999964 699999999975422 246999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeeccccccccCCCC
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARIFKGNES 230 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 230 (334)
+||+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+| ++||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999996543 4899999999999999999999998 99999999999999887 699999999987654322
Q ss_pred c---cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhcccch
Q 037681 231 K---ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQVASK 298 (334)
Q Consensus 231 ~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~~~~~ 298 (334)
. ......+||+.|||||++.+..++.++|||||||++|||+||++||........ ++.......+..+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 1 123346799999999999999999999999999999999999999976544311 1111222245568
Q ss_pred hhhccccccCCccchhhhhhhhh
Q 037681 299 IKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.+++..||..+|.+|+++.++.+
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHH
Confidence 88999999999999999888754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=388.17 Aligned_cols=244 Identities=25% Similarity=0.287 Sum_probs=195.7
Q ss_pred cCCCcCCccccCCcccEEEEEec----CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++++.||+|+||+||+|+.. +++.||+|+++... ......+.+|+.++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 58999999999999999999852 47889999986432 2233467889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|||||+||+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999986543 4899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchhh
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKIK 300 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~ 300 (334)
.... .....+||+.|+|||++.+..++.++||||+||++|||+||+.||........- -.......+....+
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 255 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 255 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 3222 234568999999999999999999999999999999999999999764332100 00111224567889
Q ss_pred hccccccCCccchhh-----hhhhhhccC
Q 037681 301 LVESCLARPFRQYCC-----ILKVRTFGF 324 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~-----~~~~~~~~~ 324 (334)
++..||..+|.+|++ +.++++..+
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 999999999999987 445655443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=377.07 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=190.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc-------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE------- 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------- 143 (334)
++|++++.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 57999999999999999999964 6899999999744 34445678999999999999999999999976553
Q ss_pred -----ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEee
Q 037681 144 -----KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISD 218 (334)
Q Consensus 144 -----~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 218 (334)
.|+|||||++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999976554444566778899999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCc----------cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-----
Q 037681 219 FGMARIFKGNESK----------ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG----- 283 (334)
Q Consensus 219 fg~~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----- 283 (334)
||+|+........ ......+||+.|+|||++.+..++.++|||||||++|||++ ||......
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9999876543221 11234579999999999999999999999999999999996 66532211
Q ss_pred ---cccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 ---YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 ---~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+............+++..||..+|.+|++..++.+..+
T Consensus 239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 11111111113344567999999999999999999877543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=383.40 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=209.5
Q ss_pred hHHHHhhcCCCcCCccccCCcccEEEEEecC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCC-CCcceEeeE
Q 037681 66 SSVAAATNNFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQH-KNLVRLLGC 137 (334)
Q Consensus 66 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~ 137 (334)
+.+....++|++.+.||+|+||+||+|.+.. ++.||||.+... .....+.+.+|+.++.+++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444556899999999999999999998542 357999998754 34456778999999999965 899999999
Q ss_pred EEec-CcceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 037681 138 CIER-DEKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKA 203 (334)
Q Consensus 138 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp 203 (334)
|.++ +..++|||||++|+|.++++.... ...+++..+..++.||+.||+|||+++ |+||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 9765 568999999999999999975432 235889999999999999999999998 99999999
Q ss_pred CCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccC
Q 037681 204 SNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHT 282 (334)
Q Consensus 204 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~ 282 (334)
+|||+++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655444444556789999999999999999999999999999999998 9999987543
Q ss_pred Cccccc--------ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 283 GYLSIN--------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 283 ~~~~~~--------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
...-.. .........+.+++..||..+|.+|+++.++.+.
T Consensus 294 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 294 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 311100 0111135568899999999999999999988765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=369.15 Aligned_cols=244 Identities=22% Similarity=0.320 Sum_probs=188.3
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC----cceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD----EKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 148 (334)
++|.+.+.||+|+||+||+|++. |+.||||+++..... ......|+..+.+++|||||++++++.+++ ..|+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46788899999999999999874 899999999654322 222345666667889999999999998765 469999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc-----CCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH-----SRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
||+++|+|.+++... .+++..+.+++.|++.||+|||++ ..++|+||||||+|||++.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999653 388999999999999999999987 12349999999999999999999999999998
Q ss_pred cccCCCCc--cccccccccCCccCccccccC------CCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc-----
Q 037681 224 IFKGNESK--ANTNRVAGTFGYIPPEYVYQG------ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY----- 290 (334)
Q Consensus 224 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~----- 290 (334)
........ .......||+.|+|||++.+. .++.++|||||||++|||+||++|+........++...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543321 123345799999999998754 46789999999999999999988775433221111100
Q ss_pred ---------------------chh--cccchhhhccccccCCccchhhhhhhhhc
Q 037681 291 ---------------------DQT--QVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 291 ---------------------~~~--~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
... ....+.+++..||..+|.+|+++.++.+.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000 11246689999999999999999887664
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=371.04 Aligned_cols=245 Identities=19% Similarity=0.256 Sum_probs=198.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec------Cc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER------DE 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 143 (334)
++|++++.||+|+||+||+|.+. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999964 6999999999643 344456788999999999999999999997643 56
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+|||||+ |+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 799999996 5788887543 34999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCC--CccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cc
Q 037681 224 IFKGNE--SKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LS 286 (334)
Q Consensus 224 ~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~ 286 (334)
.+.... ........+||+.|+|||++.+. .++.++||||+||++|||++|++||...+... ..
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 654322 12234457899999999998765 57999999999999999999999997542110 00
Q ss_pred -----------------------ccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 287 -----------------------INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 287 -----------------------~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+............+++.+||..+|.+|.+..++.+..+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 00000112445678999999999999999999887665
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=363.44 Aligned_cols=243 Identities=22% Similarity=0.285 Sum_probs=195.6
Q ss_pred hhcCCCcCCccccCCcccEEEEEec----CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcce
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 145 (334)
..++|++.+.||+|+||+||+|+.+ +++.||+|.+.... ....+.+|+++++.+ +||||+++++++.+.+..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999853 46789999886443 335678999999998 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeecccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARI 224 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~ 224 (334)
+||||+++|+|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999998873 2889999999999999999999999 9999999999999876 7999999999976
Q ss_pred ccCCCCc--------------------------cccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCC
Q 037681 225 FKGNESK--------------------------ANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNT 277 (334)
Q Consensus 225 ~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~ 277 (334)
....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 4332110 112335799999999998775 5899999999999999999999999
Q ss_pred CCccCCcccc----------------------------------c---------------------------ccchhccc
Q 037681 278 EFYHTGYLSI----------------------------------N---------------------------GYDQTQVA 296 (334)
Q Consensus 278 ~~~~~~~~~~----------------------------------~---------------------------~~~~~~~~ 296 (334)
....+....+ . ......+.
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 5432210000 0 00001234
Q ss_pred chhhhccccccCCccchhhhhhhhhccC
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+++.+||..+|.+|.+..+..+.++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 5678999999999999999998877654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=380.01 Aligned_cols=243 Identities=26% Similarity=0.337 Sum_probs=197.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHH---HHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQEL---KNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.... ......+ ..++.+++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999965 69999999996321 1222233 3446677778999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+||||++||+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999986543 4899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-ccc--------ccchhc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-SIN--------GYDQTQ 294 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~--------~~~~~~ 294 (334)
+.... ....+||+.|+|||++.+ ..|+.++|+|||||++|||++|++||........ .+. .+....
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~ 417 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence 54332 344689999999999964 5799999999999999999999999975433211 000 011124
Q ss_pred ccchhhhccccccCCccchhh-----hhhhhhccC
Q 037681 295 VASKIKLVESCLARPFRQYCC-----ILKVRTFGF 324 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~-----~~~~~~~~~ 324 (334)
+....++|..||..+|.+|.+ ..+++...+
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 566889999999999999977 345555443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=379.30 Aligned_cols=244 Identities=19% Similarity=0.286 Sum_probs=209.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
++|++.+.||+|+||.||+|.++ +|+.||+|.+........+.+.+|+.+|+.++||||+++++++.+.+..|+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999964 69999999998776666788899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC--CceEEeeccccccccCCC
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE--MKPKISDFGMARIFKGNE 229 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~ 229 (334)
+||+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999998885432 34899999999999999999999998 9999999999999854 899999999998765432
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccccc-hhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSINGYD-QTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~-~~~~~~~~ 299 (334)
.....+||+.|+|||++.+..++.++||||+||++|||++|++||....... ..+.... ...+....
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 2344689999999999999999999999999999999999999997654321 1111111 12455678
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++..||..+|.+|+++.++.+..+
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCcC
Confidence 8999999999999999999887655
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=331.95 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=207.8
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||+|+||+||+|.+ .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999995 56899999999766555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999988543 3889999999999999999999998 99999999999999999999999999876543332
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhcccchhhh
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQVASKIKL 301 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~ 301 (334)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ............+.++
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 23345799999999999999999999999999999999999999975432110 0001112234557889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+..||..+|.+|+++.++.+..+
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGG
T ss_pred HHHHccCChhHCcCHHHHhhChh
Confidence 99999999999999999887654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=335.07 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=206.2
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999996 57999999998643 4455677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999886543 3899999999999999999999998 999999999999999999999999999765433
Q ss_pred CCccccccccccCCccCccccccCCCC-cchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICS-IKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKL 301 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~ 301 (334)
. .....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||+........ . ............++
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 2 23446799999999999887764 7999999999999999999999765322100 0 00111135667889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+..||..+|.+|+++.++.+.++
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTT
T ss_pred HHHHCCCChhHCcCHHHHhcCHh
Confidence 99999999999999999887655
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=333.71 Aligned_cols=254 Identities=35% Similarity=0.556 Sum_probs=211.6
Q ss_pred HHHHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 67 SVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 67 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++...+++|++.+.||+|+||.||+|.+.+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 33456689999999999999999999988899999999877666667889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhccc-ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATK-RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999998865432 235889999999999999999999998 999999999999999999999999999765
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-ccc----------------
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-SIN---------------- 288 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~---------------- 288 (334)
.............||+.|+|||.+.+..++.++||||||+++|||++|+.||....+... ...
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 433333333445689999999999889999999999999999999999999975433211 000
Q ss_pred ------ccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 289 ------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 289 ------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.........+.+++..|+..+|.+|+++.++....
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00111334567888999999999999998876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=328.87 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=208.9
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|.+.+.||+|+||+||+|.+. ++..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 368999999999999999999964 6899999998777777788899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999986533 34899999999999999999999998 99999999999999999999999999986543322
Q ss_pred cc------------ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc--------
Q 037681 231 KA------------NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY-------- 290 (334)
Q Consensus 231 ~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~-------- 290 (334)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 11 1114579999999999999999999999999999999999999988765442222111
Q ss_pred -chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 291 -DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 291 -~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.......+.+++..|+..+|.+|+++.++..+-.
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1113567888999999999999999988776543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=334.38 Aligned_cols=244 Identities=24% Similarity=0.290 Sum_probs=203.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|... +|+.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 68999999999999999999965 6899999999643 2344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++++||+|||++......
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999998886533 4899999999999999999999998 999999999999999999999999999753322
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~i 302 (334)
. ......+||+.|+|||++.+..++.++|+||||+++|||++|+.||......... -..+.......+.+++
T Consensus 159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 236 (337)
T 1o6l_A 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 1 2234567999999999999999999999999999999999999999754322100 0011122456688999
Q ss_pred cccccCCccchh-----hhhhhhhccC
Q 037681 303 ESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
..||..+|.+|+ +..++.+..+
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 999999999997 6777666544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=333.73 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=204.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 378999999999999999999965 78999999986443 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999998885433 3899999999999999999999998 9999999999999999999999999998654333
Q ss_pred CccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc---------chhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY---------DQTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~ 299 (334)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.........+..+ .......+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 3333445679999999999987765 778999999999999999999997654432211111 112355677
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++..||..+|.+|+++.++....+
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHHHccCChhhCcCHHHHhhChh
Confidence 8999999999999999999887665
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=336.16 Aligned_cols=237 Identities=26% Similarity=0.350 Sum_probs=195.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|++.+.||+|+||+||+|... +|+.||+|++... .......+..|..++..+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 479999999999999999999965 5899999998643 334456778999999988 79999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++....
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999998886543 3899999999999999999999998 9999999999999999999999999997533
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchhh
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKIK 300 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~ 300 (334)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... -..+.........+
T Consensus 176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 253 (353)
T 3txo_A 176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATG 253 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 22 12234568999999999999889999999999999999999999999764332100 00011124556888
Q ss_pred hccccccCCccchhhh
Q 037681 301 LVESCLARPFRQYCCI 316 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~ 316 (334)
++..||..+|.+|.+.
T Consensus 254 li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGS 269 (353)
T ss_dssp HHHHHTCSSGGGSTTS
T ss_pred HHHHHhhhCHHHccCC
Confidence 9999999999999887
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=333.63 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=204.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA--------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
.++|++.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999852 3457999999754 344567789999999999 899999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
+..|+||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999876432 134788999999999999999999998 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS- 286 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~- 286 (334)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986654433333344567889999999999999999999999999999999 99999765332110
Q ss_pred ------ccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 287 ------INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 287 ------~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
...........+.+++..||..+|.+|+++.++...
T Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000111234568889999999999999998887654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=330.48 Aligned_cols=264 Identities=36% Similarity=0.607 Sum_probs=214.7
Q ss_pred CCccChhHHHHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEE
Q 037681 60 LPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCC 138 (334)
Q Consensus 60 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 138 (334)
...++..++....++|++.+.||+|+||.||+|...+|+.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 34577888899999999999999999999999998889999999987543 22234688999999999999999999999
Q ss_pred EecCcceEEEEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 139 IERDEKLLIYEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 139 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
.+.+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||++...+|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999987654 23458999999999999999999999922229999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---cc---------
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---YL--------- 285 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~--------- 285 (334)
|||++........ .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||+..... ..
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999986543322 2233456999999999998889999999999999999999999999622100 00
Q ss_pred ----ccc---------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ----SIN---------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ----~~~---------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+. .........+.+++..|+..+|.+|+++.++.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 000 011113456888999999999999999988776553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=332.19 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=203.4
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcc
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 144 (334)
...++|++.+.||+|+||+||+|.++ +|+.||+|.++... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34579999999999999999999965 58899999996432 33456678899999887 899999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+||||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++++||+|||++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999886543 3899999999999999999999998 99999999999999999999999999975
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------cccccchhcccch
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------SINGYDQTQVASK 298 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~ 298 (334)
..... ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||........ .-..+........
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 245 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 245 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHH
Confidence 43222 223456899999999999999999999999999999999999999975432210 0001111245668
Q ss_pred hhhccccccCCccchhhhh-hhhhccC
Q 037681 299 IKLVESCLARPFRQYCCIL-KVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~-~~~~~~~ 324 (334)
.+++..||..+|.+|++.. +++...+
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 8999999999999999887 6665443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=326.21 Aligned_cols=241 Identities=23% Similarity=0.357 Sum_probs=204.8
Q ss_pred CCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 75 FSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
|+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677789999999999999965 6999999999876666677889999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 127 ~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (321)
T 2c30_A 127 GALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 197 (321)
T ss_dssp CBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence 9999987542 3899999999999999999999998 99999999999999999999999999976543322 2
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhcccchhhhccc
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQVASKIKLVES 304 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~ 304 (334)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +...........+.+++..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence 3345799999999999999999999999999999999999999975432100 0000111234557889999
Q ss_pred cccCCccchhhhhhhhhccC
Q 037681 305 CLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~~~ 324 (334)
||..+|.+|+++.++....+
T Consensus 278 ~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 278 MLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HSCSSTTTSCCHHHHHTSGG
T ss_pred HccCChhhCcCHHHHhcChh
Confidence 99999999999999887665
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=326.76 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=197.8
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||+||+|.. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 47899999999999999999987 4889999998644 34455778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++........+++..++.++.|++.||+|||+++. +|+||||||+||+++.++.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99999999998765544558999999999999999999997742 39999999999999999999999999997543222
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--------ccccchhcccchhhh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--------INGYDQTQVASKIKL 301 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~ 301 (334)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ...........+.++
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 271 (309)
T 3p86_A 194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 1233457899999999999999999999999999999999999999765432110 001112245568899
Q ss_pred ccccccCCccchhhhhhhhhc
Q 037681 302 VESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+..||..+|.+|+++.++.+.
T Consensus 272 i~~~l~~dP~~Rps~~~ll~~ 292 (309)
T 3p86_A 272 IEGCWTNEPWKRPSFATIMDL 292 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999998887653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=331.31 Aligned_cols=246 Identities=24% Similarity=0.309 Sum_probs=206.5
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChh------hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQ------GLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
.++|++.+.||+|+||.||+|... +|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 368999999999999999999965 6899999999754321 346789999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC----ceEEeecc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM----KPKISDFG 220 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg 220 (334)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999998543 34899999999999999999999998 99999999999998776 79999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------cccccc-c
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---------YLSING-Y 290 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---------~~~~~~-~ 290 (334)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...... ...+.. .
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 998754432 233457999999999999889999999999999999999999999754322 011111 1
Q ss_pred chhcccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 291 DQTQVASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 291 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
.......+.+++..||..+|.+|+++.++...++--
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 112455688899999999999999999988876643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=332.99 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=201.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 68999999999999999999955 5889999998643 2334577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999886533 4899999999999999999999998 999999999999999999999999999865433
Q ss_pred CCccccccccccCCccCcccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc---------ccccchhccc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQ---GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---------INGYDQTQVA 296 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---------~~~~~~~~~~ 296 (334)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+......
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 245 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ 245 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence 2 2344679999999999864 45889999999999999999999999754332110 0111122456
Q ss_pred chhhhccccccCCccchhh-hhhhhhcc
Q 037681 297 SKIKLVESCLARPFRQYCC-ILKVRTFG 323 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~-~~~~~~~~ 323 (334)
.+.+++..||..+|.+|++ +.+++...
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp 273 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFP 273 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence 6889999999999999987 66665543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=335.07 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=199.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|++.+.||+|+||+||+|+.. +++.||+|+++.. .....+.+..|..++.++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 478999999999999999999965 5788999998643 233445678899999887 89999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999998886543 3899999999999999999999998 9999999999999999999999999997532
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc---cc------------ccc
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---IN------------GYD 291 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---~~------------~~~ 291 (334)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. .+.
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 282 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence 22 12244568999999999999999999999999999999999999999643221100 00 011
Q ss_pred hhcccchhhhccccccCCccchhhh------hhhhhccC
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCI------LKVRTFGF 324 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~------~~~~~~~~ 324 (334)
........+++..||..+|.+|.+. .+++...+
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 1134567889999999999999763 45555544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=326.67 Aligned_cols=241 Identities=27% Similarity=0.338 Sum_probs=202.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|... +|+.||+|++... .....+.+.+|..+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 68999999999999999999965 6899999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999986543 3889999999999999999999998 999999999999999999999999999864322
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i 302 (334)
....+||+.|+|||++.+..++.++|+||||+++|||++|+.||........ .. ..+.......+.+++
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 2345799999999999999999999999999999999999999975432110 00 001112355688899
Q ss_pred cccccCCccchh-----hhhhhhhccC
Q 037681 303 ESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
..||..+|.+|+ ++.+++...+
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 999999999998 6666666544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=327.79 Aligned_cols=242 Identities=22% Similarity=0.345 Sum_probs=201.8
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|.+.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999996 57899999998643 2223457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+ +|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 678877775443 3899999999999999999999998 999999999999999999999999999765433
Q ss_pred CCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCccc--cc----ccchhcccchhhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--IN----GYDQTQVASKIKL 301 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~----~~~~~~~~~~~~~ 301 (334)
. .....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||+........ .. ......+..+.++
T Consensus 162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL 238 (336)
T ss_dssp B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHH
T ss_pred c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 2 2334579999999999987776 68999999999999999999999765433110 00 0111145668899
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+..||..+|.+|+++.++.+..+
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHH
T ss_pred HHHHcCCChhHCcCHHHHHhChh
Confidence 99999999999999999877654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=340.68 Aligned_cols=251 Identities=20% Similarity=0.229 Sum_probs=202.7
Q ss_pred HHHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 68 VAAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 68 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
.....++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|..++..++||||++++++|.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3345579999999999999999999966 47889999986421 2223347889999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||+++|+|..++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 999999999999999986532 34899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-----------ccc
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-----------LSI 287 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----------~~~ 287 (334)
....... ......+||+.|+|||++. ...++.++|||||||++|||++|++||....... ..+
T Consensus 224 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 224 KLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp ECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 6543322 2233467999999999986 5678999999999999999999999997543221 111
Q ss_pred cccchhcccchhhhccccccCCccc--hhhhhhhhhccC
Q 037681 288 NGYDQTQVASKIKLVESCLARPFRQ--YCCILKVRTFGF 324 (334)
Q Consensus 288 ~~~~~~~~~~~~~~i~~~l~~~~~~--~~~~~~~~~~~~ 324 (334)
............+++..||..++.. |+++.+++...+
T Consensus 303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 1111224556788999999777766 777777776554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=322.91 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=198.5
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||+||+|.+.+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 37899999999999999999998889999999986442 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++ +|..++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9986 6766664432 34889999999999999999999998 9999999999999999999999999998654322
Q ss_pred CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--------------cccc-----
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------------SING----- 289 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------------~~~~----- 289 (334)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ .+..
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 2 2233568999999999876 5689999999999999999999999975433210 0000
Q ss_pred -----------------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 -----------------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 -----------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
........+.+++..||..+|.+|+++.++.+..+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 00012345678999999999999999999887554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.42 Aligned_cols=259 Identities=37% Similarity=0.553 Sum_probs=213.0
Q ss_pred CCccChhHHHHhhcCCCcC------CccccCCcccEEEEEecCCCEEEEEEeccc----ChhhHHHHHHHHHHHHhcCCC
Q 037681 60 LPLFSFSSVAAATNNFSDT------NKLGEGGFGPVYKGVLAKGDEIAVKRLSVR----SRQGLQELKNEALVIAKVQHK 129 (334)
Q Consensus 60 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~ 129 (334)
...+++.++..++++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3456778888888888766 8999999999999987 4889999998642 234467789999999999999
Q ss_pred CcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC
Q 037681 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD 209 (334)
Q Consensus 130 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~ 209 (334)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+++ ++||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999876555556899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc-
Q 037681 210 KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN- 288 (334)
Q Consensus 210 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~- 288 (334)
.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999986554333333344578999999998764 578999999999999999999999986544321100
Q ss_pred ------------c--------cchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 289 ------------G--------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 289 ------------~--------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
. ........+.+++..|+..+|.+|+++.++...-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 0111234577899999999999999998876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=322.21 Aligned_cols=243 Identities=23% Similarity=0.373 Sum_probs=196.9
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 368999999999999999999954 6899999998533 344567789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999986543 4899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----------cc-cccchhccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------SI-NGYDQTQVA 296 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------~~-~~~~~~~~~ 296 (334)
... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .. .........
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 221 223345799999999999999999999999999999999999999976533210 00 011122456
Q ss_pred chhhhccccccCCccchh-hhhhhhh
Q 037681 297 SKIKLVESCLARPFRQYC-CILKVRT 321 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~-~~~~~~~ 321 (334)
.+.+++..|+..+|.+|+ ++.++..
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~ 268 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKD 268 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHH
Confidence 688899999999999997 5555443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=328.59 Aligned_cols=241 Identities=22% Similarity=0.284 Sum_probs=203.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999965 6899999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999886543 3899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~i 302 (334)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+ ..+.......+.+++
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 2345799999999999999999999999999999999999999975432100 00 011122456788999
Q ss_pred cccccCCccchhh-----hhhhhhccC
Q 037681 303 ESCLARPFRQYCC-----ILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~-----~~~~~~~~~ 324 (334)
..||..+|.+|++ +.+++...+
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 9999999999987 666666554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=326.64 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=201.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc------
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE------ 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 143 (334)
.++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 368999999999999999999975 79999999997443 3455778999999999999999999999866542
Q ss_pred ---------------------------------------------------ceEEEEecCCCChhhhhhhcccccccchH
Q 037681 144 ---------------------------------------------------KLLIYEYLPNKSLDFFLFDATKRVLLELG 172 (334)
Q Consensus 144 ---------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 172 (334)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999776655556777
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc----------cccccccccCC
Q 037681 173 TRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK----------ANTNRVAGTFG 242 (334)
Q Consensus 173 ~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~g~~~ 242 (334)
.++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999998 999999999999999999999999999876543211 12233569999
Q ss_pred ccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-----cccccccchhcccchhhhccccccCCccchhhhh
Q 037681 243 YIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG-----YLSINGYDQTQVASKIKLVESCLARPFRQYCCIL 317 (334)
Q Consensus 243 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~ 317 (334)
|+|||.+.+..++.++||||||+++|||++|..|+...... ...+..........+.+++..||..+|.+|+++.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 99999999999999999999999999999998775432110 1111111122345668899999999999999999
Q ss_pred hhhhccC
Q 037681 318 KVRTFGF 324 (334)
Q Consensus 318 ~~~~~~~ 324 (334)
++.+..+
T Consensus 322 ~~l~~~~ 328 (332)
T 3qd2_B 322 DIIENAI 328 (332)
T ss_dssp HHHHSTT
T ss_pred HHhhchh
Confidence 9887654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=324.81 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=204.5
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 368999999999999999999965 58889999987543 3446688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC--CCceEEeeccccccccCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK--EMKPKISDFGMARIFKGN 228 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~ 228 (334)
+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999885432 34899999999999999999999998 999999999999987 789999999999876433
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccccc-hhcccch
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSINGYD-QTQVASK 298 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~-~~~~~~~ 298 (334)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..+.... ...+..+
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 2 2334578999999999998889999999999999999999999997643221 0111101 1235568
Q ss_pred hhhccccccCCccchhhhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+++..||..+|.+|+++.++....+
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChh
Confidence 89999999999999999998877554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=325.89 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=200.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 68999999999999999999965 5889999999643 344566788999999988 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++++||+|||++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999998886543 3899999999999999999999998 99999999999999999999999999975322
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------c--------cccch
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------I--------NGYDQ 292 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~--------~~~~~ 292 (334)
.. ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||......... + .....
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 240 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence 21 2234567999999999999999999999999999999999999999753221100 0 00111
Q ss_pred hcccchhhhccccccCCccchhhh------hhhhhccC
Q 037681 293 TQVASKIKLVESCLARPFRQYCCI------LKVRTFGF 324 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~------~~~~~~~~ 324 (334)
.......+++..||..+|.+|++. .+++...+
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 134567889999999999999874 45555443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=323.26 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=205.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR------QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
++|++.+.||+|+||.||+|... +|+.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 67999999999999999999965 689999999864422 13577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC----ceEEeeccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM----KPKISDFGM 221 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~ 221 (334)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999998543 34899999999999999999999998 99999999999998877 799999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YD 291 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~ 291 (334)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..+.. ..
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 98754322 1234579999999999998999999999999999999999999996543211 00110 01
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
......+.+++..||..+|.+|+++.++....+--
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 12355678899999999999999999998877643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=329.05 Aligned_cols=245 Identities=25% Similarity=0.328 Sum_probs=202.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|++.+.||+|+||+||+|... +++.||+|++... .....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 478999999999999999999965 4788999998643 233456788899999988 79999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++++||+|||++....
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999886543 3899999999999999999999998 9999999999999999999999999997533
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhh
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIK 300 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~ 300 (334)
... ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||......... + ..+.......+.+
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 250 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA 250 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 221 2234567999999999999999999999999999999999999999754322100 0 0011224567889
Q ss_pred hccccccCCccchhh-----hhhhhhccC
Q 037681 301 LVESCLARPFRQYCC-----ILKVRTFGF 324 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~-----~~~~~~~~~ 324 (334)
++..||..+|.+|++ ..+++...+
T Consensus 251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp HHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 999999999999984 455555443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=324.74 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=200.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|++.+.||+|+||.||+|.+. .+..||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 368999999999999999999964 3446999999754 44556788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999985543 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccc
Q 037681 227 GNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVAS 297 (334)
Q Consensus 227 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~ 297 (334)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ...........
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence 43221 12223346778999999998999999999999999999999 99999765332100 00011124556
Q ss_pred hhhhccccccCCccchhhhhhhhhcc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+.+++..|+..+|.+|+++.++...-
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHH
Confidence 88899999999999999988876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=328.35 Aligned_cols=245 Identities=21% Similarity=0.278 Sum_probs=206.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||+|+||.||+|... +|+.+|+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 368999999999999999999965 6889999999766655667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC--CCceEEeeccccccccCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK--EMKPKISDFGMARIFKGN 228 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~ 228 (334)
+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999998885432 34899999999999999999999998 999999999999974 467999999999876433
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cchhcccch
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YDQTQVASK 298 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~~~~~~~~ 298 (334)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.. ........+
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 22 233578999999999999999999999999999999999999997643210 00000 011235568
Q ss_pred hhhccccccCCccchhhhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+++..||..+|.+|+++.++....+
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 89999999999999999999887665
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=335.26 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=204.1
Q ss_pred hhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
..++|++.+.||+|+||.||+|.. .+|+.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 347899999999999999999985 468899999986543 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC---CCCceEEeecccccc
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD---KEMKPKISDFGMARI 224 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~ 224 (334)
|||+++|+|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999988886543 3899999999999999999999998 99999999999998 467899999999976
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------cccccccc-hhc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---------YLSINGYD-QTQ 294 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---------~~~~~~~~-~~~ 294 (334)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|.+||...... ...+.... ...
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 543322 223467999999999999989999999999999999999999999654321 11111111 124
Q ss_pred ccchhhhccccccCCccchhhhhhhhhccC
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+.+++..||..+|.+|+++.++.+..+
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 566889999999999999999999887765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=328.05 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=202.9
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-----RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
.++|++.+.||+|+||+||+|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 368999999999999999999964 68999999986321 123577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc---eEEeeccc
Q 037681 146 LIYEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK---PKISDFGM 221 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~ 221 (334)
+||||+++++|.+.+.... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999987775433 2335889999999999999999999998 999999999999976654 99999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--------cccccccc-h
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------YLSINGYD-Q 292 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------~~~~~~~~-~ 292 (334)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+.... .
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccc
Confidence 987644322 233457999999999999999999999999999999999999999754221 00000000 1
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.....+.+++..||..+|.+|+++.++....
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 2355688899999999999999998877644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=327.37 Aligned_cols=244 Identities=25% Similarity=0.356 Sum_probs=203.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 468999999999999999999965 6899999999643 3445577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC---ceEEeeccccccc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM---KPKISDFGMARIF 225 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~ 225 (334)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||++...
T Consensus 108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999998887543 34899999999999999999999998 99999999999997654 5999999999765
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------cccccccc-hhcc
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---------YLSINGYD-QTQV 295 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---------~~~~~~~~-~~~~ 295 (334)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|++||...... ...+.... ....
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 4322 223457999999999999989999999999999999999999999754321 01111111 1235
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++..||..+|.+|+++.++....+
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 56889999999999999999988776543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=333.29 Aligned_cols=247 Identities=27% Similarity=0.353 Sum_probs=202.5
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
..++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3468899999999999999999975 6899999998744 3334456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 192 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999986533 34889999999999999999999998 999999999999999999999999999764332
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccchhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVASKIK 300 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~ 300 (334)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......... ...........+.+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 346 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 22211222345778999999998899999999999999999998 99999765432100 00011113456788
Q ss_pred hccccccCCccchhhhhhhhhc
Q 037681 301 LVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
++..|+..+|.+|+++.++...
T Consensus 347 li~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 347 LMEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCchhCcCHHHHHHH
Confidence 9999999999999999887654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=335.72 Aligned_cols=250 Identities=21% Similarity=0.262 Sum_probs=202.7
Q ss_pred HHHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 68 VAAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 68 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
.....++|++.+.||+|+||+||+|... +|+.||+|++... .....+.+.+|..++..++||||+++++++.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3344689999999999999999999964 6999999998642 22334557889999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||+++|+|..++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++.
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhe
Confidence 999999999999999986543 24899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccCccccc-------cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-----------c
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVY-------QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-----------L 285 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----------~ 285 (334)
....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||....... .
T Consensus 211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289 (412)
T ss_dssp ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence 6543322 1223467999999999987 3568999999999999999999999997643321 0
Q ss_pred cccccchhcccchhhhccccccCCccch---hhhhhhhhccC
Q 037681 286 SINGYDQTQVASKIKLVESCLARPFRQY---CCILKVRTFGF 324 (334)
Q Consensus 286 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~---~~~~~~~~~~~ 324 (334)
.+.......+....+++.+||. +|.+| +++.+++...+
T Consensus 290 ~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 290 SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 1111112245668889999998 88877 46777776655
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=324.59 Aligned_cols=243 Identities=24% Similarity=0.355 Sum_probs=197.4
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc----ceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE----KLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv 147 (334)
.++|++.+.||+|+||+||+|.+. ++.||+|++..... .......|+.++++++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 378999999999999999999876 78999999965433 33455678899999999999999999988654 5999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc----------CCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH----------SRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
|||+++|+|.+++... .+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999998543 289999999999999999999988 7 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccCcccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-ccccc--
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-----GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-LSING-- 289 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~-- 289 (334)
|||++................||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .++..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987655444333444679999999999876 355678999999999999999999997543321 11100
Q ss_pred --------cc----------------h--hcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 290 --------YD----------------Q--TQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 290 --------~~----------------~--~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.. . .....+.+++..||..+|.+|+++.++....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 313 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00 0 0122378899999999999999998876643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=314.43 Aligned_cols=249 Identities=27% Similarity=0.358 Sum_probs=206.3
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 368999999999999999999988888999999975432 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999986543 24899999999999999999999998 999999999999999999999999999865443221
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccc-------cccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSI-------NGYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~i~ 303 (334)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||+......... ..........+.+++.
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMY 239 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHH
Confidence 2223456778999999998899999999999999999999 999997654321100 0001113556888999
Q ss_pred ccccCCccchhhhhhhhhccCCcc
Q 037681 304 SCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
.|+..+|.+|+++.++.+.-..+.
T Consensus 240 ~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 240 SCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp HTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HHcCCChhhCcCHHHHHHHHHHhh
Confidence 999999999999988776654443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=323.57 Aligned_cols=244 Identities=25% Similarity=0.298 Sum_probs=192.0
Q ss_pred cCCCcCCccccCCcccEEEEEe----cCCCEEEEEEeccc----ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL----AKGDEIAVKRLSVR----SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
++|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 6899999999999999999986 46899999998643 223445678899999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999998886533 3888999999999999999999998 99999999999999999999999999875
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccch
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASK 298 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~ 298 (334)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... + ..........+
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 43221 1233457999999999999999999999999999999999999999754322100 0 00111235668
Q ss_pred hhhccccccCCccchh-----hhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
.+++..||..+|.+|+ ++.++....+
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 8999999999999998 5555555443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=337.63 Aligned_cols=249 Identities=21% Similarity=0.222 Sum_probs=203.1
Q ss_pred HHHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 68 VAAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 68 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
+....++|++.+.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345679999999999999999999965 5889999998642 12233457889999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||+++|+|..++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++.
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999988543 3889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccCccccccCC----CCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--ccc------ccc
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGI----CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SIN------GYD 291 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~------~~~ 291 (334)
....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ .+. .+.
T Consensus 217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p 295 (410)
T 3v8s_A 217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 295 (410)
T ss_dssp ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC
Confidence 6543321 2233567999999999987655 78999999999999999999999975432200 000 001
Q ss_pred --hhcccchhhhccccccCCccc--hhhhhhhhhccC
Q 037681 292 --QTQVASKIKLVESCLARPFRQ--YCCILKVRTFGF 324 (334)
Q Consensus 292 --~~~~~~~~~~i~~~l~~~~~~--~~~~~~~~~~~~ 324 (334)
...+....+++..||..++.. |+++.+++...+
T Consensus 296 ~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 296 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 113556888999999988877 888888887665
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=317.73 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=196.4
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|+||+||+|...+|+.+|+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998889999999986443 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++ +|..++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 7877775432 34889999999999999999999998 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cccc-------
Q 037681 231 KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LSIN------- 288 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~~~------- 288 (334)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..+.
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 1233468999999999875 458999999999999999999999997542210 0000
Q ss_pred --------------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 --------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 --------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.........+.+++..||..+|.+|+++.++.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000112345668999999999999999998877554
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=332.46 Aligned_cols=257 Identities=25% Similarity=0.319 Sum_probs=208.2
Q ss_pred hhHHHHhhcCCCcCCccccCCcccEEEEEe------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEee
Q 037681 65 FSSVAAATNNFSDTNKLGEGGFGPVYKGVL------AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLG 136 (334)
Q Consensus 65 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 136 (334)
........++|++.+.||+|+||.||+|.+ .+++.||+|.+... .....+.+.+|+.++.++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 344555668999999999999999999973 23578999999754 344456789999999999 7999999999
Q ss_pred EEEecCc-ceEEEEecCCCChhhhhhhccc--------------------------------------------------
Q 037681 137 CCIERDE-KLLIYEYLPNKSLDFFLFDATK-------------------------------------------------- 165 (334)
Q Consensus 137 ~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------- 165 (334)
++.+.+. .++||||+++|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9987655 8999999999999999865432
Q ss_pred -------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 166 -------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 166 -------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 122888999999999999999999998 9999999999999999999999999998664443333
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccc--------cccchhcccchhhhcc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSI--------NGYDQTQVASKIKLVE 303 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~i~ 303 (334)
......||+.|+|||++.+..++.++||||||+++|||++ |+.||.......... ..........+.+++.
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 330 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 3445678999999999999999999999999999999998 999997654331100 0111114556889999
Q ss_pred ccccCCccchhhhhhhhhccC
Q 037681 304 SCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.|+..+|.+|+++.++...-.
T Consensus 331 ~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHHHH
Confidence 999999999999988766543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=321.82 Aligned_cols=249 Identities=29% Similarity=0.383 Sum_probs=206.1
Q ss_pred hhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
..++|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3478999999999999999999852 3578999998743 34556788999999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhccc---------------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 037681 144 KLLIYEYLPNKSLDFFLFDATK---------------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLK 202 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk 202 (334)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999876432 234889999999999999999999998 9999999
Q ss_pred CCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCcc
Q 037681 203 ASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYH 281 (334)
Q Consensus 203 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~ 281 (334)
|+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986654433333334567889999999998899999999999999999999 999997654
Q ss_pred CCccc-------ccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 282 TGYLS-------INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 282 ~~~~~-------~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
..... ...........+.+++..|+..+|.+|+++.++...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32110 011112245668899999999999999998887653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=314.92 Aligned_cols=243 Identities=26% Similarity=0.396 Sum_probs=202.6
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 68999999999999999999988889999999974432 33678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ .
T Consensus 89 ~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 999999985533 34889999999999999999999998 99999999999999999999999999976533221 1
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc------cc-ccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS------IN-GYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~------~~-~~~~~~~~~~~~~i~~ 304 (334)
......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||......... .. .........+.+++..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence 2223456788999999998999999999999999999999 99999764332100 00 0011135568889999
Q ss_pred cccCCccchhhhhhhhhc
Q 037681 305 CLARPFRQYCCILKVRTF 322 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~ 322 (334)
|+..+|.+|+++.++.+.
T Consensus 243 ~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCcccCcCHHHHHHH
Confidence 999999999999887654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=319.59 Aligned_cols=246 Identities=23% Similarity=0.283 Sum_probs=201.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC--cceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERD--EKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 147 (334)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 368999999999999999999965 58999999987433 334567789999999999999999999998765 67999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee----CCCCceEEeeccccc
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL----DKEMKPKISDFGMAR 223 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~ 223 (334)
|||+++++|.+++........+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999977655555899999999999999999999998 9999999999999 777889999999998
Q ss_pred cccCCCCccccccccccCCccCccccc--------cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc--------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVY--------QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI-------- 287 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-------- 287 (334)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||..........
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 7644322 23356899999999886 5778999999999999999999999996433211000
Q ss_pred -----------------c----------ccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 288 -----------------N----------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 288 -----------------~----------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
. .........+.+++..||..+|.+|+++.++.+-.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 0 00111334577899999999999999998876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=316.96 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=196.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|+||+||+|.+. +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999965 6899999998643 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|++++.+..+. .. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~-~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD-SC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH-HT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH-hC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875444433 22 234899999999999999999999998 9999999999999999999999999998654322
Q ss_pred CccccccccccCCccCccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------------ccc-----
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGI-CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------------SIN----- 288 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------------~~~----- 288 (334)
. ......||+.|+|||++.+.. ++.++||||||+++|+|++|..|+........ .+.
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 2 233456899999999987765 79999999999999999998888532211100 000
Q ss_pred ----------------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 ----------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ----------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...........+++..||..+|.+|+++.++.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 000112345678999999999999999999887654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=312.70 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=206.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999965 6899999998643 33445778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+.......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999888543 34899999999999999999999998 9999999999999999999999999997654333
Q ss_pred CccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc---------chhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY---------DQTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~ 299 (334)
.........|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.........+..+ .......+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 2223344678999999999987665 778999999999999999999997654432111111 112355678
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++..||..+|.+|+++.++....+
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHHHCCCCchhCCCHHHHhcCcc
Confidence 8999999999999999999887665
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=324.76 Aligned_cols=246 Identities=22% Similarity=0.278 Sum_probs=204.8
Q ss_pred hhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCcceEeeEEEec
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSR--------QGLQELKNEALVIAKVQHKNLVRLLGCCIER 141 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 141 (334)
..++|++.+.||+|+||.||+|.+ .+++.||+|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999995 4688999999864421 1334567899999999999999999999999
Q ss_pred CcceEEEEecCCC-ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecc
Q 037681 142 DEKLLIYEYLPNK-SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFG 220 (334)
Q Consensus 142 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 220 (334)
+..++||||+.+| +|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 8988885543 3899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccchhcccchh
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKI 299 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 299 (334)
++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....................+.
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~ 252 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELM 252 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHH
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHH
Confidence 9986543322 234579999999999988776 889999999999999999999997644321111111122456788
Q ss_pred hhccccccCCccchhhhhhhhhccCC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
+++..||..+|.+|+++.++....+.
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred HHHHHHccCChhhCcCHHHHhcCccc
Confidence 99999999999999999999887763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=325.04 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=206.7
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD 142 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 142 (334)
...++|++.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34579999999999999999999964 3478999999754 3445677899999999999999999999999999
Q ss_pred cceEEEEecCCCChhhhhhhccc---------------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccC
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATK---------------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDL 201 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dl 201 (334)
..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999866421 145889999999999999999999998 999999
Q ss_pred CCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCc
Q 037681 202 KASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFY 280 (334)
Q Consensus 202 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~ 280 (334)
||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999976543322222334567899999999998899999999999999999999 99999764
Q ss_pred cCCcc-------cccccchhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 281 HTGYL-------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 281 ~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
..... ............+.+++..|+..+|.+|+++.++...-..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332 (343)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence 33210 1111112245568889999999999999999887665443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=328.74 Aligned_cols=248 Identities=27% Similarity=0.372 Sum_probs=202.4
Q ss_pred hcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
.++|++.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 368999999999999999999843 3668999998643 444556788999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhccc----ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC---ceEEe
Q 037681 145 LLIYEYLPNKSLDFFLFDATK----RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM---KPKIS 217 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~ 217 (334)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999876432 234888999999999999999999998 99999999999998555 59999
Q ss_pred eccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccc
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------ING 289 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~ 289 (334)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......... ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~ 306 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 306 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999976533322233334567899999999999999999999999999999998 99999765332100 001
Q ss_pred cchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 290 YDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 290 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
........+.+++..||..+|.+|+++.++.+.
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 339 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111234568899999999999999998887654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=321.72 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=186.5
Q ss_pred hcCCCcCCccccCCcccEEEEEecC-CC---EEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc-
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK-GD---EIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK- 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~---~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 144 (334)
.++|++.+.||+|+||.||+|.+.. +. .||+|.+... .....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4789999999999999999999654 32 7999998654 344567889999999999999999999999877655
Q ss_pred -----eEEEEecCCCChhhhhhhccc---ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 145 -----LLIYEYLPNKSLDFFLFDATK---RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 145 -----~lv~e~~~~~~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 999999999999998865432 124889999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------ccc
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SIN 288 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~ 288 (334)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........ ...
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 258 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence 99999986644333333334457889999999999999999999999999999999 9999976543211 001
Q ss_pred ccchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 289 GYDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 289 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.........+.+++..||..+|.+|+++.++..
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111224566889999999999999999665544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=327.52 Aligned_cols=249 Identities=19% Similarity=0.251 Sum_probs=203.8
Q ss_pred hcCCCcCCccccC--CcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEG--GFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|++.+.||+| +||+||+|.+. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3789999999999 99999999965 6999999999644 34456778899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999865432 34899999999999999999999998 9999999999999999999999999886543
Q ss_pred CCCC-----ccccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc----------
Q 037681 227 GNES-----KANTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING---------- 289 (334)
Q Consensus 227 ~~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---------- 289 (334)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 2211 111223468999999999987 57899999999999999999999999764332110000
Q ss_pred ------------------------------------------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 ------------------------------------------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 ------------------------------------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
........+.+++..||..+|.+|+++.++.+..+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 00112445788999999999999999998876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=316.76 Aligned_cols=242 Identities=21% Similarity=0.322 Sum_probs=194.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh--------------------------hhHHHHHHHHHHHH
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR--------------------------QGLQELKNEALVIA 124 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l~ 124 (334)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 378999999999999999999964 688999999864321 12356889999999
Q ss_pred hcCCCCcceEeeEEEe--cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 037681 125 KVQHKNLVRLLGCCIE--RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLK 202 (334)
Q Consensus 125 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk 202 (334)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 5578999999999999876532 34899999999999999999999998 9999999
Q ss_pred CCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCC---CCcchhhHhHHHHHHHHHhCCCCCCC
Q 037681 203 ASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGI---CSIKSDVFSFGMLLLEILSGKKNTEF 279 (334)
Q Consensus 203 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~ 279 (334)
|+||+++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999986543322 223457999999999987655 47889999999999999999999975
Q ss_pred ccCCc---------ccccccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 280 YHTGY---------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 280 ~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
..... ..+. ........+.+++..||..+|.+|+++.++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp SSHHHHHHHHHHCCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred ccHHHHHHHHhcccCCCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 42210 0000 0112345688999999999999999999887654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.05 Aligned_cols=250 Identities=27% Similarity=0.385 Sum_probs=203.7
Q ss_pred hhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecC
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERD 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 142 (334)
..++|++.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3478999999999999999999952 3567999998743 334457789999999999 8999999999999999
Q ss_pred cceEEEEecCCCChhhhhhhcccc--------------------cccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKR--------------------VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLK 202 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk 202 (334)
..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999998654321 23788999999999999999999998 9999999
Q ss_pred CCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCcc
Q 037681 203 ASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYH 281 (334)
Q Consensus 203 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~ 281 (334)
|+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|+|+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986654433333444567889999999999999999999999999999998 999997654
Q ss_pred CCcccc--------cccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 282 TGYLSI--------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 282 ~~~~~~--------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
...... ..........+.+++..||..+|.+|+++.++....
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 321100 001112356788899999999999999988876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=327.82 Aligned_cols=239 Identities=15% Similarity=0.129 Sum_probs=193.3
Q ss_pred HhhcCCCcCCccccCCcccEEEEE------ecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCcceEeeEEEe
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGV------LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ---HKNLVRLLGCCIE 140 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 140 (334)
...++|.+.+.||+|+||+||+|. ..+++.||+|++.... ...+..|+.++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 4468899999987543 346677888888876 9999999999999
Q ss_pred cCcceEEEEecCCCChhhhhhhcc--cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC--------
Q 037681 141 RDEKLLIYEYLPNKSLDFFLFDAT--KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-------- 210 (334)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------- 210 (334)
.+..|+||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999986532 2345899999999999999999999998 999999999999988
Q ss_pred ---CCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc
Q 037681 211 ---EMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI 287 (334)
Q Consensus 211 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 287 (334)
++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||+||+.||..........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 295 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceee
Confidence 89999999999976543333333445679999999999999999999999999999999999999986544432111
Q ss_pred cccch--hcccchhhhccccccCCccchh
Q 037681 288 NGYDQ--TQVASKIKLVESCLARPFRQYC 314 (334)
Q Consensus 288 ~~~~~--~~~~~~~~~i~~~l~~~~~~~~ 314 (334)
..... .......++++.|+..+|..|.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~l~~~p~~r~ 324 (365)
T 3e7e_A 296 EGLFRRLPHLDMWNEFFHVMLNIPDCHHL 324 (365)
T ss_dssp CSCCTTCSSHHHHHHHHHHHHCCCCTTCC
T ss_pred chhccccCcHHHHHHHHHHHcCCCCCCcc
Confidence 11111 1344566788889988887763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=326.41 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=206.2
Q ss_pred hhcCCCcCCccccCCcccEEEEEec--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEe
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA--------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIE 140 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 140 (334)
..++|.+.+.||+|+||.||+|.+. .+..||+|++... .......+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4478999999999999999999852 2357999998754 344567789999999999 89999999999999
Q ss_pred cCcceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCee
Q 037681 141 RDEKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNIL 207 (334)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nil 207 (334)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999876432 234899999999999999999999998 999999999999
Q ss_pred eCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-
Q 037681 208 LDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL- 285 (334)
Q Consensus 208 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~- 285 (334)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986654433333444567889999999999999999999999999999999 9999975432210
Q ss_pred ------cccccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 286 ------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 286 ------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
............+.+++..||..+|.+|+++.++.+..
T Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00001112455688899999999999999988876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=327.08 Aligned_cols=237 Identities=24% Similarity=0.286 Sum_probs=188.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHH-HHhcCCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALV-IAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999965 58899999996432 2334456667766 567899999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999998886543 3888999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhcccchhh
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVASKIK 300 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~ 300 (334)
... ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||........ .+ ..+.........+
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 268 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 268 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHH
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Confidence 222 223456899999999999999999999999999999999999999975432210 00 0011224556888
Q ss_pred hccccccCCccchhhh
Q 037681 301 LVESCLARPFRQYCCI 316 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~ 316 (334)
++..||..+|.+|++.
T Consensus 269 li~~lL~~dp~~R~~~ 284 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGA 284 (373)
T ss_dssp HHHHHTCSSGGGSTTT
T ss_pred HHHHHcccCHHhCCCC
Confidence 9999999999999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=318.41 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=187.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999954 68999999987543 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhccc---ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 150 YLPNKSLDFFLFDATK---RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|++ ++|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 588887754321 234889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cccc---
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LSIN--- 288 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~~~--- 288 (334)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+.
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 3221 2233568999999999876 468999999999999999999999997543210 0000
Q ss_pred ---cc--------------------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 ---GY--------------------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ---~~--------------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+ .......+.+++..||..+|.+|+++.++....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 00 0012345778999999999999999999877654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=334.01 Aligned_cols=243 Identities=25% Similarity=0.381 Sum_probs=204.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|.+.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999965 79999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999988643 34899999999999999999999998 999999999999999999999999999875433
Q ss_pred CCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKL 301 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~ 301 (334)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+........ + ..........+.++
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 246 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL 246 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence 2 2334579999999999987765 68999999999999999999999765432100 0 00111134568889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+..||..+|.+|+++.++....+
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHHcCCCchhCcCHHHHHhCHH
Confidence 99999999999999999887543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.46 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=190.2
Q ss_pred cCCCcCCccccCCcccEEEEEec----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||.||+|.+. ++..||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 68999999999999999999864 4778999998754 444567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999986543 34889999999999999999999998 99999999999999999999999999986643
Q ss_pred CCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-----cccchhcccch
Q 037681 228 NESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-----NGYDQTQVASK 298 (334)
Q Consensus 228 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-----~~~~~~~~~~~ 298 (334)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......... + ..........+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 279 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 3221 11222345778999999999999999999999999999998 99999754332100 0 00011234568
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..|+..+|.+|+++.++...
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHHH
Confidence 899999999999999998876553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=323.46 Aligned_cols=239 Identities=26% Similarity=0.333 Sum_probs=196.0
Q ss_pred CCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 78 TNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999995 46899999999877666678899999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee--CCCCceEEeeccccccccCCCCcccc
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL--DKEMKPKISDFGMARIFKGNESKANT 234 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~ 234 (334)
.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++........ .
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 88875432 34889999999999999999999998 9999999999999 5678999999999987643322 2
Q ss_pred ccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccc-cchhcccchhhhccc
Q 037681 235 NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SING-YDQTQVASKIKLVES 304 (334)
Q Consensus 235 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~-~~~~~~~~~~~~i~~ 304 (334)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.. ........+.+++..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 234699999999999989999999999999999999999999975432210 0000 111245678899999
Q ss_pred cccCCccchhhhhhhhhccC
Q 037681 305 CLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~~~ 324 (334)
||..+|.+|+++.++....+
T Consensus 326 ~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp TSCSSGGGSCCHHHHHHSHH
T ss_pred HcCCChhhCCCHHHHhcCcC
Confidence 99999999999998877544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=325.39 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=195.6
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCC--CCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQH--KNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++.+++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3679999999999999999999888999999998643 34455778999999999976 9999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|| +.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 56789999886543 4889999999999999999999998 99999999999997 57899999999987654
Q ss_pred CCCccccccccccCCccCcccccc-----------CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--------
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQ-----------GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN-------- 288 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-------- 288 (334)
...........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........+.
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 433333345679999999999864 6788999999999999999999999976433211000
Q ss_pred -ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 -GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 -~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.......+.+++..||..+|.+|+++.++....+
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 111113346789999999999999999988876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=337.38 Aligned_cols=245 Identities=24% Similarity=0.279 Sum_probs=193.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999954 6899999998643 334456678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|||+++++|..++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||++....
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999998885543 48999999999999999999998 77 9999999999999999999999999997533
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchhh
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKIK 300 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~ 300 (334)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... -..........+.+
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 378 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 222 2234467999999999999999999999999999999999999999654322100 00111224556889
Q ss_pred hccccccCCccchh-----hhhhhhhccC
Q 037681 301 LVESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 301 ~i~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
++..||..+|.+|+ ++.++....+
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 99999999999998 7877776554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=321.61 Aligned_cols=241 Identities=22% Similarity=0.299 Sum_probs=191.4
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc---
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK--- 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--- 144 (334)
.++|++.+.||+|+||.||+|.+ .+++.||+|++... .......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 37899999999999999999995 56889999999754 334456788999999999999999999998876654
Q ss_pred -eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 145 -LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 145 -~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
|+||||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999986543 4899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCC-ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc----------ccch
Q 037681 224 IFKGNES-KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN----------GYDQ 292 (334)
Q Consensus 224 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----------~~~~ 292 (334)
....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ....
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 6543322 1223345689999999999999999999999999999999999999976533211000 0011
Q ss_pred hcccchhhhccccccCCccchhhhhh
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILK 318 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~ 318 (334)
.....+.+++..||..+|.+|++..+
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 13556888999999999999986554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=324.39 Aligned_cols=243 Identities=22% Similarity=0.258 Sum_probs=192.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||+|+||+||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 368999999999999999999965 68999999986433 2336688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc--eEEeeccccccccCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK--PKISDFGMARIFKGN 228 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~ 228 (334)
+++|+|..++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++......
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999998886543 3899999999999999999999998 999999999999987765 999999998743222
Q ss_pred CCccccccccccCCccCccccccCCCCcc-hhhHhHHHHHHHHHhCCCCCCCccCCccccc----------ccch--hcc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIK-SDVFSFGMLLLEILSGKKNTEFYHTGYLSIN----------GYDQ--TQV 295 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~----------~~~~--~~~ 295 (334)
. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........... .... ...
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 1 2233569999999999988777655 8999999999999999999976443211000 0000 134
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++..||..+|.+|+++.++.+..+
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 56788999999999999999999887654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=321.26 Aligned_cols=245 Identities=21% Similarity=0.277 Sum_probs=190.4
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3478999999999999999999965 58899999987443 33567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEeecccccccc
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKISDFGMARIFK 226 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~ 226 (334)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++....
T Consensus 129 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999998885533 3899999999999999999999998 999999999999975 7899999999997654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc-----------cccchhcc
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI-----------NGYDQTQV 295 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-----------~~~~~~~~ 295 (334)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+ ..+.....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 321 2234578999999999999899999999999999999999999996543321000 01112245
Q ss_pred cchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
..+.+++..||..+|.+|+++.++....+--
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 5688899999999999999999988876643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=319.25 Aligned_cols=244 Identities=24% Similarity=0.362 Sum_probs=197.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCE----EEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDE----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++.+.||+|+||+||+|.+. +++. ||+|.+... .......+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 68999999999999999999954 4443 778877533 2333456778999999999999999999986 567899
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999886542 34889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~~ 298 (334)
............|+..|+|||.+.+..++.++||||||+++|+|++ |+.||......... ...........+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence 5444334445668889999999998999999999999999999999 99999865433110 001111245578
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..|+..+|.+|+++.++...
T Consensus 247 ~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999998886553
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=313.39 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=200.5
Q ss_pred hhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3478999999999999999999988888999999975432 336788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999986533 24899999999999999999999998 99999999999999999999999999976533211
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc------cc-ccchhcccchhhhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS------IN-GYDQTQVASKIKLV 302 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~------~~-~~~~~~~~~~~~~i 302 (334)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......... .. .........+.+++
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 254 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 254 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHH
Confidence 11223446788999999998899999999999999999998 99999765432100 00 01111355688899
Q ss_pred cccccCCccchhhhhhhhhc
Q 037681 303 ESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~ 322 (334)
..|+..+|.+|+++.++...
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 255 YSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999887654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=316.75 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=198.8
Q ss_pred hcCCCcCCccccCCcccEEEEEe-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 144 (334)
.++|++.+.||+|+||+||+|.+ .+++.||+|++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36899999999999999999983 35889999999877777778899999999999999999999998654 458
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999865433 4889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------cc-----------
Q 037681 225 FKGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------LS----------- 286 (334)
Q Consensus 225 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~----------- 286 (334)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433221 12223457778999999999999999999999999999999999886432110 00
Q ss_pred ------ccccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 287 ------INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 287 ------~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
...........+.+++..|+..+|.+|+++.++...-
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 0000111345688899999999999999998876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=336.68 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=205.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999965 6999999998643 223456678999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999998886543 234899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--ccc--------ccchhcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SIN--------GYDQTQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~--------~~~~~~~~~ 297 (334)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+. .+....+..
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 321 2335799999999999998999999999999999999999999976533210 000 111224566
Q ss_pred hhhhccccccCCccchh-----hhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
+.+++..||..+|.+|+ ++.+++...+
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 88899999999999998 6677766544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=320.46 Aligned_cols=243 Identities=25% Similarity=0.392 Sum_probs=192.6
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCE----EEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDE----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++.+.||+|+||+||+|.+. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 68999999999999999999954 4443 588877533 3345678899999999999999999999998754 789
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999886543 34889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~~ 298 (334)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ...........+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 4443333334557889999999999999999999999999999999 99999765432110 001111245568
Q ss_pred hhhccccccCCccchhhhhhhhh
Q 037681 299 IKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.+++..|+..+|.+|+++.++..
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 88999999999999999888654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=334.56 Aligned_cols=240 Identities=25% Similarity=0.383 Sum_probs=200.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||+||+|... +|+.||+|++.... ......+..|+.++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999965 69999999996432 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhccc-ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 148 YEYLPNKSLDFFLFDATK-RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|||+++|+|..++..... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++++||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999988865432 345899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc--------cccchhccc
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI--------NGYDQTQVA 296 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~--------~~~~~~~~~ 296 (334)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+ ..+......
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 3322 23345799999999999999999999999999999999999999976432110 00 011122456
Q ss_pred chhhhccccccCCccchhhh
Q 037681 297 SKIKLVESCLARPFRQYCCI 316 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~ 316 (334)
...+++..||..+|.+|+++
T Consensus 419 ~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCC
T ss_pred HHHHHHHHhccCCHhHCCCC
Confidence 68889999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=320.35 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=206.2
Q ss_pred HHHhhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe
Q 037681 68 VAAATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE 140 (334)
Q Consensus 68 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 140 (334)
.....++|++.+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3345578999999999999999999854 3678999998643 33445678899999999999999999999999
Q ss_pred cCcceEEEEecCCCChhhhhhhcccc-------cccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc
Q 037681 141 RDEKLLIYEYLPNKSLDFFLFDATKR-------VLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK 213 (334)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 213 (334)
.+..++||||+++++|.+++...... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence 99999999999999999998654321 34688999999999999999999998 999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc-------c
Q 037681 214 PKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY-------L 285 (334)
Q Consensus 214 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~-------~ 285 (334)
+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||....... .
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 99999999976543332222333457889999999998999999999999999999999 899987643221 0
Q ss_pred cccccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 286 SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 286 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
............+.+++..|+..+|.+|+++.++...-
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11111122455688899999999999999998876653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=317.42 Aligned_cols=236 Identities=24% Similarity=0.296 Sum_probs=177.5
Q ss_pred CCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEEecCCCC
Q 037681 78 TNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYEYLPNKS 155 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 155 (334)
.+.||+|+||.||+|.+. +++.||+|.+... ....+.+|+.+++.+. ||||+++++++.+.+..|+||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999965 6899999998643 3356778999999997 9999999999999999999999999999
Q ss_pred hhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC---ceEEeeccccccccCCCCcc
Q 037681 156 LDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM---KPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 156 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~ 232 (334)
|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++........
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 999886543 4899999999999999999999998 99999999999997765 899999999976543322
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc----------------ccccccc-hhcc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY----------------LSINGYD-QTQV 295 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----------------~~~~~~~-~~~~ 295 (334)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..+.... ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 2334568999999999999999999999999999999999999997643210 0001001 1135
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++..||..+|.+|+++.++....+
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 66888999999999999999998876654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=314.80 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=197.8
Q ss_pred cCCCcC-CccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDT-NKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~-~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
+.|++. +.||+|+||+||+|.+ .+++.||+|++..........+.+|+.++.++ +||||+++++++.+.+..|+|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 678885 7899999999999995 46899999999766555667889999999985 79999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc---eEEeecccccccc
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK---PKISDFGMARIFK 226 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~ 226 (334)
|+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999886543 3889999999999999999999998 999999999999988776 9999999987653
Q ss_pred CCCC-----ccccccccccCCccCcccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------
Q 037681 227 GNES-----KANTNRVAGTFGYIPPEYVYQ-----GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--------- 287 (334)
Q Consensus 227 ~~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------- 287 (334)
.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........+
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223468999999999865 567889999999999999999999997654321110
Q ss_pred ---------------cccc-hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 ---------------NGYD-QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ---------------~~~~-~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.... ......+.+++..||..+|.+|+++.++.+..+
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 0000 113446788999999999999999999888665
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=324.42 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=190.0
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecC--cce
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSV--RSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERD--EKL 145 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~ 145 (334)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++.. ........+.+|+.++.++. ||||+++++++...+ ..|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 47899999999999999999995 4689999999853 24455677889999999997 999999999998654 679
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999998 5788777542 4888999999999999999999998 999999999999999999999999999765
Q ss_pred cCCC-------------------CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc
Q 037681 226 KGNE-------------------SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL 285 (334)
Q Consensus 226 ~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 285 (334)
.... .........||+.|+|||++.+ ..++.++||||+||++|||++|++||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3211 1112234579999999999876 6789999999999999999999999975432100
Q ss_pred ----------------------------------------cccccch-------------hcccchhhhccccccCCccc
Q 037681 286 ----------------------------------------SINGYDQ-------------TQVASKIKLVESCLARPFRQ 312 (334)
Q Consensus 286 ----------------------------------------~~~~~~~-------------~~~~~~~~~i~~~l~~~~~~ 312 (334)
.+..... .......+++.+||..+|.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 0000000 12446789999999999999
Q ss_pred hhhhhhhhhccC
Q 037681 313 YCCILKVRTFGF 324 (334)
Q Consensus 313 ~~~~~~~~~~~~ 324 (334)
|+++.++.+..+
T Consensus 320 R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 320 RISANDALKHPF 331 (388)
T ss_dssp SCCHHHHTTSTT
T ss_pred CCCHHHHhCCHH
Confidence 999999888766
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=318.15 Aligned_cols=243 Identities=19% Similarity=0.221 Sum_probs=200.1
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36899999999999999999995 5688999999864432 24578999999999 99999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc-----eEEeecccccc
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK-----PKISDFGMARI 224 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~ 224 (334)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 899999886542 34899999999999999999999998 999999999999998887 99999999987
Q ss_pred ccCCCCcc-----ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--ccccc------
Q 037681 225 FKGNESKA-----NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--INGYD------ 291 (334)
Q Consensus 225 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~~~------ 291 (334)
........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... +....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 54332211 123567999999999999999999999999999999999999999875433110 00000
Q ss_pred -----hhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 292 -----QTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 292 -----~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
......+.+++..|+..+|..|+++.++...
T Consensus 240 ~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~ 275 (330)
T 2izr_A 240 PIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKL 275 (330)
T ss_dssp CHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHH
Confidence 0012278889999999999999998876653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=327.58 Aligned_cols=244 Identities=23% Similarity=0.364 Sum_probs=196.0
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcC--CCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQ--HKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 569999999999999999999888999999998643 3455678899999999996 599999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
| +.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++......
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 67889999886543 4788899999999999999999998 99999999999996 578999999999876543
Q ss_pred CCccccccccccCCccCcccccc-----------CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc---------
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQ-----------GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--------- 288 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--------- 288 (334)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 33323345679999999999864 4688999999999999999999999976432210000
Q ss_pred ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.......+.+++..||..+|.+|+++.++....+
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 011112446788999999999999999998876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=320.13 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=201.3
Q ss_pred HHHhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec
Q 037681 68 VAAATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR-----SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER 141 (334)
Q Consensus 68 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 141 (334)
+....++|++.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445568999999999999999999996 46889999998643 334567889999999999999999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhcc-------------------------------------cccccchHHHHHHHHHHHHH
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDAT-------------------------------------KRVLLELGTRLQIIEGIVEG 184 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~~ 184 (334)
+..++||||+++|+|.+++.... ....+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999998884211 12234677888999999999
Q ss_pred HHHhhhcCCCCeEeccCCCCCeeeCCCC--ceEEeeccccccccCCCC--ccccccccccCCccCcccccc--CCCCcch
Q 037681 185 LLYLHLHSRVRIIHRDLKASNILLDKEM--KPKISDFGMARIFKGNES--KANTNRVAGTFGYIPPEYVYQ--GICSIKS 258 (334)
Q Consensus 185 l~~LH~~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~--~~~~~~~ 258 (334)
|+|||+++ |+||||||+||+++.++ .+||+|||++..+..... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999986543221 112334578999999999865 6788999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 259 DVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 259 DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
||||||+++|||++|+.||....... ..+.. ........+.+++..||..+|.+|+++.++.+..+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~ 333 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChh
Confidence 99999999999999999997543321 00000 00113556889999999999999999998877554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=309.49 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=185.5
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36899999999999999999996 468999999986432 22346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|..++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999886532 34899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----cccc--cchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----SING--YDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----~~~~--~~~~~~~~~~~~ 301 (334)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .... ........+.++
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL 242 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHH
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHH
Confidence 221 12235689999999999988899999999999999999999999976433211 0001 111135567889
Q ss_pred ccccccCCccchhhhhhhhhccCC
Q 037681 302 VESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
+..||..+|.+|+++.++....+-
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred HHHHcccCHhhCCCHHHHhcCccc
Confidence 999999999999999998886663
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=316.51 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=205.5
Q ss_pred hcCCCcCCccccCCcccEEEEEe------cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL------AKGDEIAVKRLSVRS-RQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 143 (334)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999984 246789999997543 34457789999999999 99999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhccc---------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 144 KLLIYEYLPNKSLDFFLFDATK---------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999865432 124889999999999999999999998 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccc
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSI 287 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~ 287 (334)
+.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999987654443333344567889999999999999999999999999999999 999997654321100
Q ss_pred c-------c-cchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 288 N-------G-YDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 288 ~-------~-~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
. . ........+.+++..|+..+|.+|+++.++...
T Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 0 0 011245568899999999999999998887654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=315.18 Aligned_cols=244 Identities=24% Similarity=0.315 Sum_probs=205.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChh------hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQ------GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
++|++.+.||+|+||.||+|... +|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 68999999999999999999965 6899999998644221 3577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC----ceEEeeccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM----KPKISDFGM 221 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~ 221 (334)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999986533 4899999999999999999999998 99999999999999887 799999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccc-cc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SING-YD 291 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~-~~ 291 (334)
+........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .+.. ..
T Consensus 166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 986543321 2345689999999999999999999999999999999999999975432200 0000 01
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
......+.+++..||..+|.+|+++.++....+-
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 1235567899999999999999999999887764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=309.04 Aligned_cols=243 Identities=20% Similarity=0.300 Sum_probs=202.9
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||+|+||.||+|.+. ++..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 468999999999999999999965 4778999999766555678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee---CCCCceEEeeccccccccC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 227 (334)
+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||++ +.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999988875543 3899999999999999999999998 9999999999999 7888999999999976543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccc-hhcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYD-QTQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~-~~~~~~ 297 (334)
.. ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........ ...... ......
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred cc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 32 2234568999999998865 489999999999999999999999976433210 011000 123556
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..|+..+|.+|+++.++....+
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 888999999999999999988766443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=316.94 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=203.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA--------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
.++|++.+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999853 4678999998754 344567789999999999 899999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999865432 124788999999999999999999998 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-- 285 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-- 285 (334)
+.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987654433233334457889999999988889999999999999999999 9999976432210
Q ss_pred -----cccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 286 -----SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 286 -----~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
............+.+++..|+..+|.+|+++.++...
T Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0001111235568889999999999999998887654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=317.73 Aligned_cols=258 Identities=25% Similarity=0.331 Sum_probs=208.6
Q ss_pred hHHHHhhcCCCcCCccccCCcccEEEEEe------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeE
Q 037681 66 SSVAAATNNFSDTNKLGEGGFGPVYKGVL------AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGC 137 (334)
Q Consensus 66 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 137 (334)
.......++|++.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.++.++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34444568999999999999999999984 24678999998754 334456788999999999 79999999999
Q ss_pred EEecC-cceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 037681 138 CIERD-EKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKA 203 (334)
Q Consensus 138 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp 203 (334)
+...+ ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 88765 48999999999999999866443 123788999999999999999999998 99999999
Q ss_pred CCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccC
Q 037681 204 SNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHT 282 (334)
Q Consensus 204 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~ 282 (334)
+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999986654433333344567899999999999999999999999999999998 9999976543
Q ss_pred Ccccc--------cccchhcccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 283 GYLSI--------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 283 ~~~~~--------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
..... ..........+.+++..||..+|.+|+++.++......+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 21100 001112455688999999999999999999887654443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=310.25 Aligned_cols=243 Identities=26% Similarity=0.337 Sum_probs=200.2
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 368999999999999999999855 5778999998543 223356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|..++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999998886543 3889999999999999999999988 99999999999999999999999999865332
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~ 301 (334)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... . ..........+.++
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 2 123356899999999999999999999999999999999999999754322100 0 00111134567889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+..||..+|.+|+++.++.+..+
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHH
T ss_pred HHHHhccChhhCCCHHHHhhCcc
Confidence 99999999999999999887665
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=307.53 Aligned_cols=244 Identities=26% Similarity=0.366 Sum_probs=203.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999965 5889999998643 3445577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc---eEEeeccccccc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK---PKISDFGMARIF 225 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~ 225 (334)
||+++++|...+.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999988775543 4899999999999999999999998 999999999999976655 999999999765
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccccc-hhcc
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSINGYD-QTQV 295 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~-~~~~ 295 (334)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... ....
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence 43222 233578999999999999999999999999999999999999996543220 0000000 1235
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++..||..+|.+|+++.++.+..+
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 56889999999999999999998877544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=331.95 Aligned_cols=251 Identities=26% Similarity=0.382 Sum_probs=205.4
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
....++|++.+.||+|+||.||+|.+.++..||||.++... ...+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34557899999999999999999998888899999997543 34678999999999999999999999986 66789999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999986543 224788899999999999999999998 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-----cccchhcccchhh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-----NGYDQTQVASKIK 300 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-----~~~~~~~~~~~~~ 300 (334)
.. .......++..|+|||.+....++.++||||||+++|||++ |+.||......... + ..........+.+
T Consensus 338 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 338 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp HH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred ce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 11222346788999999998999999999999999999999 99999765432100 0 0001113456888
Q ss_pred hccccccCCccchhhhhhhhhccCCc
Q 037681 301 LVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
++..|+..+|.+|+++.++......+
T Consensus 417 li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHHHHHHHH
Confidence 99999999999999998887655544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=320.29 Aligned_cols=251 Identities=25% Similarity=0.254 Sum_probs=203.0
Q ss_pred cChhHHHHhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----CCCcceEee
Q 037681 63 FSFSSVAAATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-----HKNLVRLLG 136 (334)
Q Consensus 63 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~ 136 (334)
+++.......++|++.+.||+|+||+||+|.+ .+++.||+|++.. .......+..|+.+++.+. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34444445568999999999999999999996 4688999999863 3344566788999999986 999999999
Q ss_pred EEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC------
Q 037681 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK------ 210 (334)
Q Consensus 137 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~------ 210 (334)
++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 8899988865432 24889999999999999999999998 999999999999975
Q ss_pred -------------------CCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHH
Q 037681 211 -------------------EMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEIL 271 (334)
Q Consensus 211 -------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell 271 (334)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 788999999999764322 23357899999999999999999999999999999999
Q ss_pred hCCCCCCCccCCcc---------cccc-----------------------c--------------------chhcccchh
Q 037681 272 SGKKNTEFYHTGYL---------SING-----------------------Y--------------------DQTQVASKI 299 (334)
Q Consensus 272 ~g~~p~~~~~~~~~---------~~~~-----------------------~--------------------~~~~~~~~~ 299 (334)
+|+.||........ +... | .......+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 99999965321100 0000 0 000114455
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++..||..+|.+|+++.++.+..+
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHhcCChhhCCCHHHHhcCcc
Confidence 8999999999999999998876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=330.94 Aligned_cols=241 Identities=22% Similarity=0.237 Sum_probs=192.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------ 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 142 (334)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999954 6889999999643 4455677889999999999999999999997654
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
..|+||||++++ +...+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 459999999875 4444421 2788999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------------
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------ 284 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------ 284 (334)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8654321 2344679999999999999999999999999999999999999997543100
Q ss_pred ------------------ccccccchh------------cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 ------------------LSINGYDQT------------QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 ------------------~~~~~~~~~------------~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+...... ......+++.+||..+|.+|+++.++.+..+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 000000000 1345788999999999999999999888765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=313.64 Aligned_cols=243 Identities=21% Similarity=0.198 Sum_probs=192.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||+||+|.+. +|+.||||++... ..........|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368999999999999999999965 6999999988643 233334455566555555 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+ +++|..++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 568887775543 34899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----cc-cccchhcccchhhhc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----SI-NGYDQTQVASKIKLV 302 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----~~-~~~~~~~~~~~~~~i 302 (334)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+........ .. ..+.......+.+++
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVL 285 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHH
Confidence 22 2233568999999998865 789999999999999999999776543221100 00 011122456788999
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..||..+|.+|+++.++....+
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHcCCChhhCcCHHHHHhCcc
Confidence 9999999999999999887654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.74 Aligned_cols=244 Identities=22% Similarity=0.264 Sum_probs=195.6
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|+||+||+|.+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999965 5899999988543 23345677899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|..++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999988775433 3899999999999999999999998 9999999999999999999999999998654322
Q ss_pred CccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------------------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--------------------- 287 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------------------- 287 (334)
. ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 2234568999999999875 678999999999999999999999997543210000
Q ss_pred ----------------cccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 ----------------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ----------------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..........+.+++..||..+|.+|+++.++.+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 0000112344778999999999999999999877654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=307.83 Aligned_cols=241 Identities=29% Similarity=0.436 Sum_probs=191.0
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS----RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|.+. ++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 68999999999999999999975 8899999986432 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC--------CCceEEeecc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK--------EMKPKISDFG 220 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~--------~~~~kl~Dfg 220 (334)
||+++++|.+++.. ..+++..++.++.|++.||.|||+++..+++||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999988843 24899999999999999999999987556889999999999986 6789999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc--------cccch
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--------NGYDQ 292 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------~~~~~ 292 (334)
++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .....
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence 997654322 223468999999999999999999999999999999999999997654321100 01112
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhc
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.....+.+++..|+..+|.+|+++.++.+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 245568899999999999999999887654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=311.03 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=196.0
Q ss_pred hhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC-----hhhHHHHHHHHHHHHhc---CCCCcceEeeEEEec
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS-----RQGLQELKNEALVIAKV---QHKNLVRLLGCCIER 141 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~ 141 (334)
..++|++.+.||+|+||+||+|.+ .+++.||+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999995 568999999986432 12234566777777766 499999999999876
Q ss_pred C-----cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 142 D-----EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 142 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
. ..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 589888865432 33899999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-----------
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------- 285 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------- 285 (334)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999997654322 23446789999999999999999999999999999999999999965432100
Q ss_pred ---ccc-------------------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ---SIN-------------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ---~~~-------------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+. .........+.+++..||..+|.+|+++.++.+..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 000 000113445678999999999999999999887665
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=328.45 Aligned_cols=246 Identities=21% Similarity=0.281 Sum_probs=183.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec-----Cc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-----DE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 143 (334)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999954 6899999998642 444567789999999999999999999998543 46
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||+. ++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 6788777543 34899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCc-------------------------cccccccccCCccCcccc-ccCCCCcchhhHhHHHHHHHHHh-----
Q 037681 224 IFKGNESK-------------------------ANTNRVAGTFGYIPPEYV-YQGICSIKSDVFSFGMLLLEILS----- 272 (334)
Q Consensus 224 ~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~----- 272 (334)
........ ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 65422110 122345789999999976 46679999999999999999999
Q ss_pred ------CCCCCCCccCC---------------------------------------------------------cccccc
Q 037681 273 ------GKKNTEFYHTG---------------------------------------------------------YLSING 289 (334)
Q Consensus 273 ------g~~p~~~~~~~---------------------------------------------------------~~~~~~ 289 (334)
|+++|...... ...+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 55555432210 000000
Q ss_pred cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..........+++.+||..+|.+|+++.++....+
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence 00112456788999999999999999999887665
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=310.08 Aligned_cols=243 Identities=27% Similarity=0.442 Sum_probs=188.9
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||+|.+. ..+|+|.+... .....+.+.+|+.++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 478999999999999999999864 46999998644 445567889999999999999999999965 5567899999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999998885443 34889999999999999999999998 9999999999999999999999999997654333
Q ss_pred CccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------ccccccchhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------LSINGYDQTQ 294 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------~~~~~~~~~~ 294 (334)
.........||+.|+|||.+. +..++.++||||||+++|+|++|+.||....... ..+.......
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 333334467899999999986 5678889999999999999999999997653321 1111112224
Q ss_pred ccchhhhccccccCCccchhhhhhhhhc
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
...+.+++..||..+|.+|+++.++...
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 4568899999999999999999887654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.00 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=203.1
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcce
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 145 (334)
..++|++.+.||+|+||+||+|... +++.||+|++... .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999955 5889999998643 234456778899999987 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999986543 3899999999999999999999998 999999999999999999999999999754
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------cccccchhcccchh
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------SINGYDQTQVASKI 299 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 299 (334)
.... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||........ .-..+.........
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 570 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 570 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHH
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence 3222 224457899999999999999999999999999999999999999976433210 00011122466788
Q ss_pred hhccccccCCccchhhh-----hhhhhcc
Q 037681 300 KLVESCLARPFRQYCCI-----LKVRTFG 323 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~-----~~~~~~~ 323 (334)
+++..||..+|.+|.+. .+++...
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 99999999999999876 5555543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=307.55 Aligned_cols=245 Identities=23% Similarity=0.286 Sum_probs=204.5
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|.+.+.||+|+||.||+|.+. +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 368999999999999999999965 5888999988643 344567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999998875433 4899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------cccccchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------SINGYDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 301 (334)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ............+.++
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 245 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHH
Confidence 222 22335689999999999988899999999999999999999999976432110 0000111234567889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+..|+..+|.+|+++.++....+
T Consensus 246 i~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHcccChhhCcCHHHHhhChh
Confidence 99999999999999999887543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=318.52 Aligned_cols=240 Identities=28% Similarity=0.386 Sum_probs=197.5
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
+.|++.+.||+|+||+||+|.. .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5689999999999999999995 56889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+. |++.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9998 56766664332 34899999999999999999999998 99999999999999999999999999976432
Q ss_pred CCccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------ccc-cchhcccc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------ING-YDQTQVAS 297 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~~-~~~~~~~~ 297 (334)
.....||+.|+|||++. +..++.++||||||+++|||++|+.||......... ... ........
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 281 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 22356899999999884 567899999999999999999999998654321100 000 01113455
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..||..+|.+|+++.++....+
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChh
Confidence 788999999999999999998877654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=325.43 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=194.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec-----Ccc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-----DEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 144 (334)
++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++... +..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 78999999999999999999964 5888999999643 344567889999999999999999999999776 568
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+||||++ ++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 99999987 5888887543 34899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCc--------------------cccccccccCCccCcccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC
Q 037681 225 FKGNESK--------------------ANTNRVAGTFGYIPPEYV-YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG 283 (334)
Q Consensus 225 ~~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 283 (334)
....... .......||+.|+|||++ .+..++.++||||+||++|||++|..||.....+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6433211 123456799999999986 5667999999999999999999866655432111
Q ss_pred -cccccc----------------------------------------------------------------cchhcccch
Q 037681 284 -YLSING----------------------------------------------------------------YDQTQVASK 298 (334)
Q Consensus 284 -~~~~~~----------------------------------------------------------------~~~~~~~~~ 298 (334)
...+.+ .........
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 111100 001135567
Q ss_pred hhhccccccCCccchhhhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+++.+||..+|.+|+++.++.+..+
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPY 364 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChh
Confidence 78999999999999999999887665
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=310.85 Aligned_cols=245 Identities=17% Similarity=0.205 Sum_probs=201.9
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+.... ....+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 36899999999999999999995 568999999886432 234578899999999 79999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc-----eEEeecccccc
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK-----PKISDFGMARI 224 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~ 224 (334)
|+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999986543 24899999999999999999999998 999999999999987766 99999999987
Q ss_pred ccCCCCc-----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--------------
Q 037681 225 FKGNESK-----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------------- 285 (334)
Q Consensus 225 ~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------------- 285 (334)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 123445799999999999999999999999999999999999999987543211
Q ss_pred cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+...........+.+++..|+..+|.+|+++.++...-.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 000011123557889999999999999999888765533
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.24 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=197.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|.+.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 68999999999999999999964 6889999998644 233467889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee---CCCCceEEeecccccccc
Q 037681 151 LPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFK 226 (334)
Q Consensus 151 ~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 226 (334)
+++++|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999988875432 2345899999999999999999999998 9999999999999 456789999999997654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhcccc
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQVAS 297 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~~~~ 297 (334)
... ......||+.|+|||.+. ..++.++||||||+++|+|++|+.||........ .+..........
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence 322 223456899999999875 5688999999999999999999999976432210 011011113556
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..||..+|.+|+++.++....+
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 788999999999999999998876543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=308.34 Aligned_cols=244 Identities=22% Similarity=0.297 Sum_probs=189.4
Q ss_pred hcCCCcCCccccCCcccEEEEEecC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3689999999999999999998643 446999988643 3445677899999999999999999999984 567899
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999986543 34889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~~ 298 (334)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......... ...........+
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 246 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 246 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 33221 1223456788999999998899999999999999999997 99999765432110 001112245568
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..|+..+|.+|+++.++...
T Consensus 247 ~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 247 YSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 899999999999999999887654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=317.12 Aligned_cols=249 Identities=26% Similarity=0.383 Sum_probs=204.7
Q ss_pred hhcCCCcCCccccCCcccEEEEEecC-C-----CEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecC
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLAK-G-----DEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERD 142 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 142 (334)
..++|++.+.||+|+||.||+|.+.. + ..||+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34789999999999999999999542 3 47999998754 344567789999999999 8999999999999999
Q ss_pred cceEEEEecCCCChhhhhhhccc-----------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATK-----------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE 211 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 211 (334)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999865432 234789999999999999999999998 9999999999999999
Q ss_pred CceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccccc--
Q 037681 212 MKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSIN-- 288 (334)
Q Consensus 212 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~-- 288 (334)
+.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999986654433333344567889999999998999999999999999999998 9999976543311000
Q ss_pred ------ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 ------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 ------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.........+.+++..|+..+|..|+++.++...
T Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 0011134567889999999999999999887664
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=325.50 Aligned_cols=239 Identities=27% Similarity=0.387 Sum_probs=198.5
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-cceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-EKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 150 (334)
.++|++.+.||+|+||.||+|.+. |+.||||.++... ..+.+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467889999999999999999876 7899999997543 4578899999999999999999999987765 68999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 99999999997543 234788999999999999999999998 999999999999999999999999999753221
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-----cccchhcccchhhhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-----NGYDQTQVASKIKLV 302 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-----~~~~~~~~~~~~~~i 302 (334)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......... + ..........+.+++
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 419 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 112356889999999999999999999999999999998 99999865433110 0 001111356688899
Q ss_pred cccccCCccchhhhhhhhhc
Q 037681 303 ESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~ 322 (334)
..|+..+|.+|+++.++...
T Consensus 420 ~~cl~~dp~~Rpt~~~l~~~ 439 (450)
T 1k9a_A 420 KNCWHLDAATRPTFLQLREQ 439 (450)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999887654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=327.35 Aligned_cols=242 Identities=15% Similarity=0.156 Sum_probs=190.5
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecc---cChhhHHHHHHHH---HHHHhcCCCCcceEe-------eE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSV---RSRQGLQELKNEA---LVIAKVQHKNLVRLL-------GC 137 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~---~~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~ 137 (334)
.++|++.+.||+|+||+||+|.+ .+|+.||||++.. ......+.+.+|+ ..+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999995 5699999999873 2344567888999 455566899999998 66
Q ss_pred EEecCc-----------------ceEEEEecCCCChhhhhhhccc----ccccchHHHHHHHHHHHHHHHHhhhcCCCCe
Q 037681 138 CIERDE-----------------KLLIYEYLPNKSLDFFLFDATK----RVLLELGTRLQIIEGIVEGLLYLHLHSRVRI 196 (334)
Q Consensus 138 ~~~~~~-----------------~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 196 (334)
+.+.+. .|+||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665542 78999999 5799998865432 122445888899999999999999998 9
Q ss_pred EeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccC-----------CCCcchhhHhHHH
Q 037681 197 IHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG-----------ICSIKSDVFSFGM 265 (334)
Q Consensus 197 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwslG~ 265 (334)
+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999975321 2234567 999999999877 8999999999999
Q ss_pred HHHHHHhCCCCCCCccCCccc--ccccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 266 LLLEILSGKKNTEFYHTGYLS--INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 266 il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
++|||++|+.||......... ...........+.+++..||..+|.+|+++.++.+..
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 361 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred HHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence 999999999999765433111 1111122456788999999999999999998877643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=310.32 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=198.1
Q ss_pred hcCCCcCCccccCCcccEEEEEecC-C-------CEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK-G-------DEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
.++|++.+.||+|+||+||+|.+.. + ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3689999999999999999998543 3 4699999977666677889999999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc--------eE
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK--------PK 215 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~k 215 (334)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999986543 23889999999999999999999998 999999999999988877 99
Q ss_pred EeeccccccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCC-CCCCccCCcc-----ccc
Q 037681 216 ISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKK-NTEFYHTGYL-----SIN 288 (334)
Q Consensus 216 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~-p~~~~~~~~~-----~~~ 288 (334)
|+|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|.. |+........ ...
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC
Confidence 999999864321 223458899999999987 778999999999999999999554 4443222100 000
Q ss_pred ccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 289 GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 289 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.........+.+++..||..+|.+|+++.++...-
T Consensus 236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 11112456788999999999999999988866543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=310.86 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=191.1
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHh--cCCCCcceEeeEEEec----Ccce
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAK--VQHKNLVRLLGCCIER----DEKL 145 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~ 145 (334)
.++|++.+.||+|+||+||+|.+ +++.||+|++.... ...+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 47899999999999999999987 58999999986442 3445566777666 7999999999997653 4578
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhh--------hcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH--------LHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
+||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999998432 3899999999999999999999 777 9999999999999999999999
Q ss_pred eccccccccCCCCc--cccccccccCCccCccccccC------CCCcchhhHhHHHHHHHHHhC----------CCCCCC
Q 037681 218 DFGMARIFKGNESK--ANTNRVAGTFGYIPPEYVYQG------ICSIKSDVFSFGMLLLEILSG----------KKNTEF 279 (334)
Q Consensus 218 Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~p~~~ 279 (334)
|||++......... .......||+.|+|||.+.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999765443221 112334799999999999876 455799999999999999999 778765
Q ss_pred ccCCccccccc------------------chhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 280 YHTGYLSINGY------------------DQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 280 ~~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.......+... .......+.+++..||..+|.+|+++.++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 43322111110 01123457889999999999999999887654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=313.95 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=196.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|+||.||+|.+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 68999999999999999999965 5899999988543 23345667899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|..+..... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999988764333 3899999999999999999999998 9999999999999999999999999997654322
Q ss_pred CccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc----------------------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---------------------- 286 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---------------------- 286 (334)
. ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.........
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 1 22335689999999998765 7899999999999999999999999754321000
Q ss_pred ------c---------cccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 287 ------I---------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 287 ------~---------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+ ..........+.+++..||..+|.+|+++.++.+..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0 0000113456789999999999999999998877544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=310.78 Aligned_cols=240 Identities=25% Similarity=0.355 Sum_probs=192.0
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 68899999999999999999875 788999998643 34577899999999999999999999886 45899999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc-eEEeeccccccccCCCCc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK-PKISDFGMARIFKGNESK 231 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~ 231 (334)
+++|.+++........++...++.++.|++.||.|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999876554445788899999999999999999932223999999999999988876 799999999754322
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------cccchhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---------NGYDQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~i 302 (334)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ..........+.+++
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHH
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHH
Confidence 223468999999999999999999999999999999999999997654321110 011122345678899
Q ss_pred cccccCCccchhhhhhhhhc
Q 037681 303 ESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~ 322 (334)
..|+..+|.+|+++.++...
T Consensus 238 ~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 238 TRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHH
Confidence 99999999999998887653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=332.56 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=204.9
Q ss_pred hhcCCCcCCccccCCcccEEEEEecC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
..++|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678889999999999999999764 8899999987543 345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999986543 234889999999999999999999998 9999999999999999999999999998754332
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--cc-----ccchhcccchhhh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--IN-----GYDQTQVASKIKL 301 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~~-----~~~~~~~~~~~~~ 301 (334)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......... +. .........+.++
T Consensus 373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2 12223446788999999998899999999999999999999 99999765432100 00 0011134567889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+..||..+|.+|+++.++...-.
T Consensus 452 i~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHHHHH
Confidence 99999999999999998766543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=313.63 Aligned_cols=245 Identities=23% Similarity=0.292 Sum_probs=204.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|.+.+.||+|+||.||++.+. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 478999999999999999999965 5788999998643 344567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999998875533 4899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~ 301 (334)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... . ..........+.++
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 271 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 271 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHH
Confidence 222 223456899999999999889999999999999999999999999764321100 0 00111234567889
Q ss_pred ccccccCCccchhhhhhhhhccC
Q 037681 302 VESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+..||..+|.+|+++.++....+
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHccCChhHCcCHHHHhcCcc
Confidence 99999999999999998877543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=320.63 Aligned_cols=241 Identities=22% Similarity=0.242 Sum_probs=189.6
Q ss_pred hcCCCcC-CccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHh-cCCCCcceEeeEEEe----cCcc
Q 037681 72 TNNFSDT-NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAK-VQHKNLVRLLGCCIE----RDEK 144 (334)
Q Consensus 72 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~ 144 (334)
.++|.+. +.||+|+||+||+|.+. +|+.||+|++... ..+.+|+.++.+ .+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 68999999999999965 6889999998632 456778888744 589999999999876 5668
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEeeccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKISDFGM 221 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~ 221 (334)
|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999986543 234899999999999999999999998 999999999999987 78899999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------------cc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------------IN 288 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------------~~ 288 (334)
+....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 98654222 233467899999999999999999999999999999999999999765432110 00
Q ss_pred ccc-hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 GYD-QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ~~~-~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
... ......+.+++..||..+|.+|+++.++....+
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 000 113456888999999999999999998876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=308.52 Aligned_cols=243 Identities=25% Similarity=0.400 Sum_probs=205.0
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+.|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 6799999999999999999985 468999999986443 34567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 102 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999998853 24899999999999999999999998 99999999999999999999999999976543322
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------cccccchhcccchhhhcc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGYDQTQVASKIKLVE 303 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~ 303 (334)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ ............+.+++.
T Consensus 175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence 22345689999999999999999999999999999999999999976433210 000111123456889999
Q ss_pred ccccCCccchhhhhhhhhccC
Q 037681 304 SCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.||..+|.+|+++.++....+
T Consensus 253 ~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 253 ACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HHCCSSGGGSCCHHHHTTCHH
T ss_pred HHcCCChhhCcCHHHHhhChh
Confidence 999999999999998877654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=321.24 Aligned_cols=245 Identities=18% Similarity=0.203 Sum_probs=193.4
Q ss_pred hcCCCcCCccccCCcccEEEEEecC------CCEEEEEEecccChhhH-----------HHHHHHHHHHHhcCCCCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSVRSRQGL-----------QELKNEALVIAKVQHKNLVRL 134 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~ 134 (334)
.++|++.+.||+|+||.||+|.+.. ++.||+|.+........ .....|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998754 46899999865432211 123445667778889999999
Q ss_pred eeEEEec----CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC-
Q 037681 135 LGCCIER----DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD- 209 (334)
Q Consensus 135 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~- 209 (334)
++++... ...|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998875 4479999999 999999986532 34899999999999999999999998 99999999999998
Q ss_pred -CCCceEEeeccccccccCCCCc-----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC
Q 037681 210 -KEMKPKISDFGMARIFKGNESK-----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG 283 (334)
Q Consensus 210 -~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 283 (334)
.++.+||+|||++..+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999765432211 1123345999999999999999999999999999999999999999864332
Q ss_pred cccc-----------cccc------hhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 284 YLSI-----------NGYD------QTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 284 ~~~~-----------~~~~------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.... .... ......+.+++..|+..+|.+|+++.++...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 1100 0000 1125568889999999999999998887654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=306.45 Aligned_cols=243 Identities=26% Similarity=0.382 Sum_probs=201.9
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||.||+|.+.+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 68999999999999999999988888999999975432 33678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp TCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 999999986543 34789999999999999999999998 9999999999999999999999999997653221 11
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc------c-cccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS------I-NGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~------~-~~~~~~~~~~~~~~i~~ 304 (334)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......... . ..........+.+++..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 240 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHH
Confidence 1223456788999999988899999999999999999999 89999764322100 0 00011135568889999
Q ss_pred cccCCccchhhhhhhhhc
Q 037681 305 CLARPFRQYCCILKVRTF 322 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~ 322 (334)
|+..+|.+|+++.++...
T Consensus 241 ~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 241 CWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999887654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=316.49 Aligned_cols=239 Identities=22% Similarity=0.316 Sum_probs=192.6
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------c
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------E 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 143 (334)
++|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 6899999999999999999996 46999999998532 3444567889999999999999999999998764 3
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||+ +++|..++... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 59999999 78998887542 3889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------ 284 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------ 284 (334)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......
T Consensus 177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 64322 233578999999999877 679999999999999999999999997543210
Q ss_pred -------------------ccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 -------------------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 -------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+............+++.+||..+|.+|+++.++....+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 0111111223556788999999999999999998877654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=310.49 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=191.4
Q ss_pred hhcCCCcCCccccCCcccEEEEEec----CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc-
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE- 143 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 143 (334)
..++|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4478999999999999999999854 3457999998644 34456778999999999999999999999987653
Q ss_pred ----ceEEEEecCCCChhhhhhhc---ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 144 ----KLLIYEYLPNKSLDFFLFDA---TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 144 ----~~lv~e~~~~~~L~~~l~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
.++||||+++++|..++... .....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 49999999999999988432 22345899999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------ccc
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SIN 288 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~ 288 (334)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ...
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 99999986544332223334557889999999999999999999999999999999 8999876543210 001
Q ss_pred ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.........+.+++..|+..+|.+|+++.++...
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1112245568899999999999999998887654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=306.05 Aligned_cols=246 Identities=21% Similarity=0.261 Sum_probs=200.5
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||+||+|.+. +++.||+|.+... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 468999999999999999999965 7999999998743 333456778899999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhhccc-ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC---------------
Q 037681 148 YEYLPNKSLDFFLFDATK-RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE--------------- 211 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--------------- 211 (334)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999865432 245899999999999999999999998 9999999999999844
Q ss_pred ----CceEEeeccccccccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCC---
Q 037681 212 ----MKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--- 283 (334)
Q Consensus 212 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~--- 283 (334)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH
Confidence 479999999997654322 23589999999998766 5678999999999999999999876433211
Q ss_pred -cccccccchhcccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 284 -YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 284 -~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
..............+.+++..||..+|.+|+++.++.+..+-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 1111111222456788999999999999999999988776643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=306.52 Aligned_cols=247 Identities=27% Similarity=0.380 Sum_probs=200.6
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
++|.....||+|+||.||+|.+ .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999995 468899999997666666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeeccccccccCCCC
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~ 230 (334)
++++|.+++........+++..+..++.|++.||.|||+++ ++|+||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999876544445778889999999999999999998 999999999999987 88999999999976543221
Q ss_pred ccccccccccCCccCccccccCC--CCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------cccchhcccchh
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGI--CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---------NGYDQTQVASKI 299 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~ 299 (334)
......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.......... ..........+.
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHH
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHH
Confidence 123456899999999987643 7899999999999999999999997543321100 011122455678
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++..||..+|.+|+++.++....+
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHccCChhhCCCHHHHhcChh
Confidence 8999999999999999998876554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=307.76 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=204.8
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
..++|++.+.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 3478999999999999999999965 4888999998744 3345778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999986543 344889999999999999999999998 9999999999999999999999999998654332
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccchhhh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVASKIKL 301 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~ 301 (334)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......... ...........+.++
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 244 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 2 22333457889999999998999999999999999999999 99999765432100 000111234568899
Q ss_pred ccccccCCccchhhhhhhhhc
Q 037681 302 VESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+..|+..+|.+|+++.++...
T Consensus 245 i~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 245 MRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCChhhCcCHHHHHHH
Confidence 999999999999999887654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.44 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=197.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+...... ..+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 468999999999999999999965 6889999999654322 34678888887 79999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC----CceEEeeccccccc
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE----MKPKISDFGMARIF 225 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~ 225 (334)
|+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||++..+ +.+||+|||++...
T Consensus 97 ~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999998886543 4899999999999999999999998 9999999999998443 35999999999865
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------ccccc-cch
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------LSING-YDQ 292 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------~~~~~-~~~ 292 (334)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.. ...
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 43322 2334578999999999988889999999999999999999999997532210 00110 111
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.....+.+++..||..+|.+|++..++....+
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 24566788999999999999999988776544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=323.55 Aligned_cols=245 Identities=21% Similarity=0.266 Sum_probs=191.6
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCcceEeeEEEe
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--------RQGLQELKNEALVIAKVQHKNLVRLLGCCIE 140 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 140 (334)
...++|.+.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34579999999999999999999954 58999999986432 112234789999999999999999999975
Q ss_pred cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC---ceEEe
Q 037681 141 RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM---KPKIS 217 (334)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~ 217 (334)
.+..|+||||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 455799999999999988875433 4899999999999999999999998 99999999999997544 59999
Q ss_pred eccccccccCCCCccccccccccCCccCcccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--------
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ---GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------- 286 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------- 286 (334)
|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~ 361 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence 999998654322 2334679999999999853 67788999999999999999999999764332110
Q ss_pred --c-cccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 287 --I-NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 287 --~-~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+ ..........+.+++..||..+|.+|+++.++.+..+
T Consensus 362 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 0 0011124567889999999999999999998887655
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=317.88 Aligned_cols=245 Identities=25% Similarity=0.307 Sum_probs=198.4
Q ss_pred cCCCcCCccccCCcccEEEEEe----cCCCEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL----AKGDEIAVKRLSVRS----RQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDE 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 143 (334)
++|++.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999996 368999999986432 23345567899999999 69999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999986543 3889999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c--------cccc
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I--------NGYD 291 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~--------~~~~ 291 (334)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... + ..+.
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence 6543222 12334579999999999875 34788999999999999999999999754322110 0 0111
Q ss_pred hhcccchhhhccccccCCccchh-----hhhhhhhccC
Q 037681 292 QTQVASKIKLVESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
......+.+++..||..+|.+|+ ++.++.+..+
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 12345577899999999999998 7777776554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=310.23 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=198.9
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 378999999999999999999965 5889999999776666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|..++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999998876533 23899999999999999999999998 9999999999999999999999999875432111
Q ss_pred ccccccccccCCccCcccc-----ccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhccc
Q 037681 231 KANTNRVAGTFGYIPPEYV-----YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQVA 296 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~~~ 296 (334)
.......||+.|+|||.+ .+..++.++||||||+++|+|++|+.||........ ...........
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 112234689999999988 366788999999999999999999999976543210 00001111345
Q ss_pred chhhhccccccCCccchhhhhhhhhccC
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.+++..|+..+|.+|+++.++....+
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 6788999999999999999999887655
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=306.84 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=202.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 68999999999999999999965 57789999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999998886543 3889999999999999999999998 999999999999999999999999998754322
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i 302 (334)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... . ..........+.+++
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence 123356899999999999999999999999999999999999999754322100 0 001122355678899
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..|+..+|.+|+++.++....+
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHH
T ss_pred HHHhhcCHhhCCCHHHHhhCHH
Confidence 9999999999999998876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.68 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=191.6
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCE----EEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDE----IAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++.+.||+|+||.||+|.+. +++. |++|.+... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 68999999999999999999954 4543 577776533 3445678899999999999999999999998754 789
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999886543 34889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~~ 298 (334)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ...........+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 4433333334457889999999999999999999999999999999 99999765432110 001111245568
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..||..+|.+|+++.++...
T Consensus 249 ~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 889999999999999998886653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=315.22 Aligned_cols=244 Identities=22% Similarity=0.339 Sum_probs=191.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|.+.+.||+|+||+||+|... +++.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999965 6899999998644322 122345799999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++ +|..++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 985 7877775433 34889999999999999999999998 9999999999999999999999999997543222
Q ss_pred ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cccccc-----
Q 037681 231 KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LSINGY----- 290 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~~~~~----- 290 (334)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ..+...
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 12233568999999999876 568999999999999999999999997643210 000000
Q ss_pred -----------------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 291 -----------------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 291 -----------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.......+.+++..||..+|.+|+++.++.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 0012345678999999999999999999887665
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=304.48 Aligned_cols=242 Identities=23% Similarity=0.338 Sum_probs=199.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR------QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
++|++.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 67999999999999999999965 689999999864321 13577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC----ceEEeeccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM----KPKISDFGM 221 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~ 221 (334)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999986533 4899999999999999999999998 99999999999998877 899999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------ccc-ccc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SIN-GYD 291 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~-~~~ 291 (334)
+....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .+. ...
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhc
Confidence 97654322 12335689999999999989999999999999999999999999976432210 000 001
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
......+.+++..|+..+|.+|+++.++....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 12355688899999999999999998877654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=305.35 Aligned_cols=245 Identities=25% Similarity=0.396 Sum_probs=200.6
Q ss_pred cCCCcCC-ccccCCcccEEEEEec---CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTN-KLGEGGFGPVYKGVLA---KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|.+.+ .||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5677766 9999999999999853 5778999999754 445567889999999999999999999999 55678999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 9999999999988543 234899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccch
Q 037681 228 NESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASK 298 (334)
Q Consensus 228 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~ 298 (334)
.... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||........ ............+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHH
Confidence 3221 11223456889999999988889999999999999999998 9999976543210 0011112245678
Q ss_pred hhhccccccCCccchhhhhhhhhcc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+++..|+..+|.+|+++.++....
T Consensus 243 ~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 243 YALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHH
Confidence 8899999999999999998876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=317.30 Aligned_cols=248 Identities=18% Similarity=0.212 Sum_probs=193.9
Q ss_pred cCCCcCCccccCCcccEEEEEec----CCCEEEEEEecccChh-----------hHHHHHHHHHHHHhcCCCCcceEeeE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVRSRQ-----------GLQELKNEALVIAKVQHKNLVRLLGC 137 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~ 137 (334)
++|++.+.||+|+||.||+|.+. ++..+|+|........ ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 68999999999999999999965 5778999988644321 12335678889999999999999999
Q ss_pred EEe----cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-
Q 037681 138 CIE----RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM- 212 (334)
Q Consensus 138 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~- 212 (334)
+.. ....|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 988 67789999999 999999986543 4899999999999999999999998 99999999999998877
Q ss_pred -ceEEeeccccccccCCCC-----ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc
Q 037681 213 -KPKISDFGMARIFKGNES-----KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS 286 (334)
Q Consensus 213 -~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 286 (334)
.+||+|||++..+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999976543221 11123457999999999999999999999999999999999999999653322111
Q ss_pred cccc---------------ch--hcccchhhhccccccCCccchhhhhhhhhccCCcc
Q 037681 287 INGY---------------DQ--TQVASKIKLVESCLARPFRQYCCILKVRTFGFNLP 327 (334)
Q Consensus 287 ~~~~---------------~~--~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 327 (334)
.... .. .....+.+++..|+..+|.+|+++.++........
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1000 00 23346888999999999999999998877655433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=309.63 Aligned_cols=243 Identities=22% Similarity=0.299 Sum_probs=200.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|.+.+.||+|+||.||+|... +|+.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 368999999999999999999965 6899999999765544556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee---CCCCceEEeeccccccccC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 227 (334)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999998885543 3889999999999999999999998 9999999999999 7788999999999875332
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cchhcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YDQTQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~~~~~~~ 297 (334)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..+.. ........
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 1 2233568999999999999999999999999999999999999997543210 00110 11123566
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..||..+|.+|+++.++....+
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 889999999999999999998876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=327.50 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=198.9
Q ss_pred HhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
...++|++.+.||+|+||.||+|.+..+..||||.++... ...+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3457889999999999999999998877889999997543 234678999999999999999999999876 67899999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 259 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999986532 234889999999999999999999998 9999999999999999999999999998654332
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-----cccchhcccchhhh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-----NGYDQTQVASKIKL 301 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-----~~~~~~~~~~~~~~ 301 (334)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......... + ..........+.++
T Consensus 335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2 11223456788999999998999999999999999999999 99999765332100 0 00111234567889
Q ss_pred ccccccCCccchhhhhhhhhccCC
Q 037681 302 VESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
+..|+..+|.+|+++.++......
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~~L~~ 437 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQAFLED 437 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 999999999999999887765443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=316.66 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=191.2
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
...++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44578999999999999999999954 68899999996443 2234567799999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC-----CCCceEEeeccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD-----KEMKPKISDFGM 221 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-----~~~~~kl~Dfg~ 221 (334)
||||+++ +|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 8888875543 3899999999999999999999998 99999999999994 445699999999
Q ss_pred cccccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LS 286 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~ 286 (334)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 986543221 22335689999999998764 58999999999999999999999996543210 00
Q ss_pred c------cccch----------------hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 287 I------NGYDQ----------------TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 287 ~------~~~~~----------------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+ ..|.. .....+.+++..||..+|.+|+++.++.+..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 0 00000 02355678999999999999999999887655
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=304.95 Aligned_cols=241 Identities=24% Similarity=0.441 Sum_probs=195.4
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChh-------hHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQ-------GLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 37899999999999999999996 47899999998643221 1267889999999999999999999986544
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc-----eEEee
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK-----PKISD 218 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~D 218 (334)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ .+++||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999988775433 34899999999999999999999875 23999999999999988776 99999
Q ss_pred ccccccccCCCCccccccccccCCccCccccc--cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--------
Q 037681 219 FGMARIFKGNESKANTNRVAGTFGYIPPEYVY--QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN-------- 288 (334)
Q Consensus 219 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-------- 288 (334)
||++..... ......||+.|+|||.+. ...++.++||||||+++|+|++|+.||.........+.
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 999974332 233457899999999984 45678899999999999999999999986554322111
Q ss_pred --ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 --GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 --~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.........+.+++..||..+|.+|+++.++.+.
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1111245568899999999999999999887654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=307.33 Aligned_cols=244 Identities=17% Similarity=0.199 Sum_probs=191.3
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
..++|++.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999999999999965 6889999998644 23345778899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999886543 4899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccccchhcccc
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSINGYDQTQVAS 297 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~~~~~~~ 297 (334)
.... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .............
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 3221 12234568999999999999999999999999999999999999997643220 0001111224556
Q ss_pred hhhhccccccCCccchh-hhhhhhh
Q 037681 298 KIKLVESCLARPFRQYC-CILKVRT 321 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~-~~~~~~~ 321 (334)
+.+++..||..+|.+|+ ++.++..
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 88899999999999998 6666554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.40 Aligned_cols=247 Identities=21% Similarity=0.347 Sum_probs=202.9
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--------hhhHHHHHHHHHHHHhc-CCCCcceEeeEE
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--------RQGLQELKNEALVIAKV-QHKNLVRLLGCC 138 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 138 (334)
....++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344578999999999999999999975 69999999986443 12245678899999999 799999999999
Q ss_pred EecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEee
Q 037681 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISD 218 (334)
Q Consensus 139 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 218 (334)
...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999886533 4899999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCccccccccccCCccCcccccc------CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------
Q 037681 219 FGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ------GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------- 284 (334)
Q Consensus 219 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------- 284 (334)
||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~ 320 (365)
T 2y7j_A 244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320 (365)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 99998654332 2234679999999998863 357889999999999999999999996542210
Q ss_pred -ccccccc-hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 -LSINGYD-QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 -~~~~~~~-~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+..-. ......+.+++..||..+|.+|+++.++....+
T Consensus 321 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 321 QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 0000000 113445888999999999999999998877554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=304.24 Aligned_cols=245 Identities=29% Similarity=0.420 Sum_probs=201.3
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 47899999999999999999998888899999986443 23567899999999999999999999986 45689999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 9999999986532 224889999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-----cccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-----NGYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-----~~~~~~~~~~~~~~i~ 303 (334)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......... + ..........+.+++.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 244 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHH
Confidence 12223456788999999988889999999999999999999 99999764332100 0 0011123557889999
Q ss_pred ccccCCccchhhhhhhhhcc
Q 037681 304 SCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~~ 323 (334)
.|+..+|.+|+++.++...-
T Consensus 245 ~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 245 LCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp HHTCSSGGGSCCHHHHHHHH
T ss_pred HHhccChhhCCCHHHHHHHH
Confidence 99999999999988876543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.01 Aligned_cols=245 Identities=27% Similarity=0.402 Sum_probs=199.4
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3478999999999999999999965 58999999986543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999988533 234899999999999999999999998 9999999999999999999999999997654332
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhcccchhh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQVASKIK 300 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~ 300 (334)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ ............+.+
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 2 22345689999999999988999999999999999999999999976432110 000011113556889
Q ss_pred hccccccCCccchhhhhhhhhccC
Q 037681 301 LVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
++..||..+|..|+++.++....+
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred HHHHHccCChhhCcCHHHHHhCHH
Confidence 999999999999999998876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=303.61 Aligned_cols=244 Identities=23% Similarity=0.359 Sum_probs=195.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|.+.+.||+|+||.||+|.+. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999965 69999999986432 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999886543 3889999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCcc------cccccchhcccchhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------SINGYDQTQVASKIK 300 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~ 300 (334)
.. ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ ............+.+
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 22 1233568999999999987765 6899999999999999999999975432110 000011113456788
Q ss_pred hccccccCCccchhhhhhhhhccC
Q 037681 301 LVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
++..|+..+|.+|+++.++.+..+
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHccCChhhCCCHHHHHhChh
Confidence 999999999999999999887544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=310.36 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=203.9
Q ss_pred hhHHHHhhcCCCcC-CccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcC-CCCcceEeeEEE
Q 037681 65 FSSVAAATNNFSDT-NKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQ-HKNLVRLLGCCI 139 (334)
Q Consensus 65 ~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 139 (334)
+.......+.|.+. +.||+|+||.||+|... +++.||+|.+... .......+.+|+.++..+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445556788887 89999999999999965 6899999998643 2334577889999999994 699999999999
Q ss_pred ecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEE
Q 037681 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKI 216 (334)
Q Consensus 140 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl 216 (334)
+.+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 9999999999999999998875432 234899999999999999999999998 999999999999987 789999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cc
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SI 287 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~ 287 (334)
+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ..
T Consensus 176 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 252 (327)
T 3lm5_A 176 VDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred eeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc
Confidence 9999998654322 12345789999999999999999999999999999999999999975433210 00
Q ss_pred c-ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 N-GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ~-~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. .........+.+++..||..+|.+|+++.++....+
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 253 SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 0 001123456788999999999999999999887655
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=312.46 Aligned_cols=245 Identities=25% Similarity=0.360 Sum_probs=202.7
Q ss_pred cCCCcCCccccCCcccEEEEEe-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe--cCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE--RDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 145 (334)
++|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999983 3588899999987777777889999999999999999999999874 45688
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999865432 4899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------c---c------
Q 037681 226 KGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------I---N------ 288 (334)
Q Consensus 226 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~---~------ 288 (334)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... . .
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 433221 1223345788899999999889999999999999999999999998644321000 0 0
Q ss_pred ------ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 ------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 ------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.........+.+++..|+..+|.+|+++.++...
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011134568899999999999999999887544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=327.49 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=196.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.++|++.+.||+|+||+||+|... ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 367999999999999999999965 68899999986442 334577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC---CceEEeeccccccc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE---MKPKISDFGMARIF 225 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~ 225 (334)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.. +.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999988775543 3889999999999999999999998 9999999999999764 45999999999876
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------cccccccc-hhcc
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG---------YLSINGYD-QTQV 295 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---------~~~~~~~~-~~~~ 295 (334)
.... ......||+.|+|||++. ..++.++||||+||++|+|++|++||...... ...+.... ...+
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence 5332 233457999999999875 56899999999999999999999999764332 01111111 1245
Q ss_pred cchhhhccccccCCccchhhhhhhhhcc
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
..+.+++..||..+|.+|+++.++.+.+
T Consensus 266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred HHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 5688999999999999999998876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=314.87 Aligned_cols=246 Identities=21% Similarity=0.315 Sum_probs=194.2
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh-----hhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR-----QGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3478999999999999999999964 689999999864322 1234678999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||+++ +|..++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 7777775432 34888999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCC--------------cccccc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------YLSING 289 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------~~~~~~ 289 (334)
...... ......||+.|+|||.+.+. .++.++||||||+++|||++|.+||...... ...+..
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 543222 22345789999999998654 5889999999999999999999998654311 000000
Q ss_pred --------------------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 --------------------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 --------------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
........+.+++..||..+|.+|+++.++....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00112456788999999999999999999887665
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=306.22 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=203.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe--cCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE--RDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 146 (334)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999965 6899999998643 34456778999999999999999999998854 567899
Q ss_pred EEEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcC--CCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 147 IYEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHS--RVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+++|+||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999886543 2344899999999999999999999876 1239999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccchhccc
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYDQTQVA 296 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~ 296 (334)
....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ............
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCH
Confidence 6543221 1223568999999999998899999999999999999999999997653321 011111122456
Q ss_pred chhhhccccccCCccchhhhhhhhhccCCc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
.+.+++..||..+|.+|+++.++....+..
T Consensus 243 ~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 243 ELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 788999999999999999999988766543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=310.84 Aligned_cols=249 Identities=27% Similarity=0.370 Sum_probs=198.3
Q ss_pred hcCCCcCCccccCCcccEEEEEe------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL------AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
.++|++.+.||+|+||.||+|.+ .++..||+|.+... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 37899999999999999999983 24778999998643 344556788999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhccc----ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEe
Q 037681 145 LLIYEYLPNKSLDFFLFDATK----RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKIS 217 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~ 217 (334)
|+||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999876432 134888999999999999999999998 999999999999984 4469999
Q ss_pred eccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccc
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SING 289 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~ 289 (334)
|||++................|++.|+|||.+.+..++.++||||||+++|+|++ |+.||........ ....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 265 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence 9999976543333233334567899999999988999999999999999999998 9999975432210 0001
Q ss_pred cchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 290 YDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 290 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
........+.+++..||..+|.+|+++.++....
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 299 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 1112455688999999999999999998876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=321.47 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=197.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC--cceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERD--EKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 147 (334)
.++|.+.+.||+|+||+||+|.+. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 368999999999999999999965 58999999987432 334567789999999999999999999998765 67999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee----CCCCceEEeeccccc
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL----DKEMKPKISDFGMAR 223 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~ 223 (334)
|||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976655555899999999999999999999998 9999999999999 777889999999998
Q ss_pred cccCCCCccccccccccCCccCcccccc--------CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc-------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQ--------GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN------- 288 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~------- 288 (334)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 654322 2234569999999998864 5678899999999999999999999964332110000
Q ss_pred ----------------------------ccchhcccchhhhccccccCCccchhhhhhh
Q 037681 289 ----------------------------GYDQTQVASKIKLVESCLARPFRQYCCILKV 319 (334)
Q Consensus 289 ----------------------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~ 319 (334)
.........+.+++..||..+|.+|+++.++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~ 300 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHH
Confidence 0001133456789999999999999888765
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=326.74 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=199.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh-------------hhHHHHHHHHHHHHhcCCCCcceEeeE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR-------------QGLQELKNEALVIAKVQHKNLVRLLGC 137 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 137 (334)
.++|.+.+.||+|+||+||+|... +++.+|+|++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 478999999999999999999965 588999999864321 335678899999999999999999999
Q ss_pred EEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC---ce
Q 037681 138 CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM---KP 214 (334)
Q Consensus 138 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~ 214 (334)
+.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999988885543 3899999999999999999999998 99999999999998776 69
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------c
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------L 285 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~ 285 (334)
||+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++|++||....... .
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999998764332 233457999999999876 568999999999999999999999997653321 0
Q ss_pred cccccc-hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 SINGYD-QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ~~~~~~-~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.... ...+..+.+++..||..+|.+|+++.++...++
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 001001 124567889999999999999999998776544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=317.27 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=200.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 68999999999999999999965 6899999998754 344567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH-SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999986543 388999999999999999999985 7 999999999999999999999999998754321
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc----------------------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---------------------- 287 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---------------------- 287 (334)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1233578999999999999999999999999999999999999997533210000
Q ss_pred ---------------------------cccc-hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 ---------------------------NGYD-QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 ---------------------------~~~~-~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.... ......+.+++..||..+|.+|+++.++....+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000 002345778999999999999999988876544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=326.38 Aligned_cols=243 Identities=25% Similarity=0.315 Sum_probs=199.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999965 6899999998633 2334577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC---CCCceEEeeccccccc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD---KEMKPKISDFGMARIF 225 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~ 225 (334)
||+++++|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999988875543 3899999999999999999999998 99999999999995 4567999999999765
Q ss_pred cCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cchhcc
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YDQTQV 295 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~~~~~ 295 (334)
.... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||....... ..+.. .....+
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 4332 2334579999999999865 58999999999999999999999996543210 00110 011235
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++..||..+|.+|+++.++...++
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 56889999999999999999988776543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=328.44 Aligned_cols=243 Identities=24% Similarity=0.322 Sum_probs=202.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 368999999999999999999965 7899999998643 234567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee---CCCCceEEeecccccc
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARI 224 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~ 224 (334)
|||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999988885543 3899999999999999999999998 9999999999999 5678999999999986
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cchhc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YDQTQ 294 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~~~~ 294 (334)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||....... ..+.. .....
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 54332 2334579999999998865 68999999999999999999999997643220 01110 01124
Q ss_pred ccchhhhccccccCCccchhhhhhhhhccC
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+..+.+++..||..+|.+|+++.++....+
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 556889999999999999999988776544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=300.90 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=197.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec----Ccce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER----DEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~ 145 (334)
+.|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.++++++||||+++++++... ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788889999999999999964 5888999988643 445567889999999999999999999998763 4579
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC-CCCceEEeecccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD-KEMKPKISDFGMARI 224 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~ 224 (334)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ .+++|+||||+||+++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999986543 3889999999999999999999874 2399999999999997 788999999999975
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------cccchhcc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---------NGYDQTQV 295 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---------~~~~~~~~ 295 (334)
.... ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||.......... ........
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence 4322 223356899999999876 558999999999999999999999997643321100 11111234
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++..||..+|.+|+++.++....+
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 56889999999999999999998887654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=314.10 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=195.4
Q ss_pred hhHHHHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccC-----------hhhHHHHHHHHHHHHhcCCCCcce
Q 037681 65 FSSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS-----------RQGLQELKNEALVIAKVQHKNLVR 133 (334)
Q Consensus 65 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~ 133 (334)
..++....++|++.+.||+|+||.||+|...+|..||+|++.... ....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456677789999999999999999999998889999999985322 222477899999999999999999
Q ss_pred EeeEEEecC-----cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 134 LLGCCIERD-----EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 134 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
+++++...+ ..|+||||++ |+|..++... ...+++..+..++.||+.||.|||+++ |+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999986533 4699999998 4676666533 334899999999999999999999998 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-- 285 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-- 285 (334)
+.++.+||+|||++....... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999997543222 2234568999999999876 6789999999999999999999999975431100
Q ss_pred ------------------------------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ------------------------------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ------------------------------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+..........+.+++..||..+|.+|+++.++.+..+
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 000001112445788999999999999999998887654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=315.44 Aligned_cols=239 Identities=23% Similarity=0.300 Sum_probs=180.7
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec------Cc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER------DE 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 143 (334)
++|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 7899999999999999999995 46889999998643 344567788999999999999999999998754 55
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+|+|++ +++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 79999998 6788887754 23899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-----------------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------------- 285 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------------- 285 (334)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 64322 233578999999999876 6789999999999999999999999975432100
Q ss_pred --------------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 --------------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 --------------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+............+++.+||..+|.+|+++.++....+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 000000112345788999999999999999998877654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=307.55 Aligned_cols=244 Identities=23% Similarity=0.359 Sum_probs=199.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe----------
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE---------- 140 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------- 140 (334)
.++|++.+.||+|+||.||+|.+. +++.||+|.+.... ..+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 468999999999999999999975 79999999987543 345789999999999999999998864
Q ss_pred ------cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCce
Q 037681 141 ------RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 141 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 345799999999999999986543 235889999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--ccch
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--GYDQ 292 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--~~~~ 292 (334)
||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..|+.........+. ....
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD 238 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCT
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccc
Confidence 9999999986544322 2334689999999999999999999999999999999999998753211100000 0111
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhccCCc
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTFGFNL 326 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 326 (334)
.....+.+++..||..+|.+|+++.++......+
T Consensus 239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2345678899999999999999999887664433
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=302.50 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=196.0
Q ss_pred hcCCCcCCccccCCcccEEEEEecC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|.+.+.||+|+||+||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4789999999999999999998543 235999998754 34456788999999999999999999999864 45789
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999986533 34889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~~ 298 (334)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......... ...........+
T Consensus 165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (281)
T 3cc6_A 165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL 243 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHH
Confidence 3322 11223456889999999988899999999999999999998 99999754332110 000111134568
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..|+..+|.+|+++.++...
T Consensus 244 ~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 244 YTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCchhCcCHHHHHHH
Confidence 899999999999999999887654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.38 Aligned_cols=244 Identities=21% Similarity=0.283 Sum_probs=198.2
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC-----cce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD-----EKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 145 (334)
++|++.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++.... ..|
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 68999999999999999999955 6888999998743 3444577889999999999999999999997653 579
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+++ +|..++... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 107 iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 107 IVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999985 888777542 3899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCc-cccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------------------
Q 037681 226 KGNESK-ANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------------ 285 (334)
Q Consensus 226 ~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------------ 285 (334)
...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 432221 11234579999999998654 4589999999999999999999999975432110
Q ss_pred -------------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 -------------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 -------------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
++..........+.+++..||..+|.+|+++.++....+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000011123456789999999999999999999887665
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=313.02 Aligned_cols=244 Identities=22% Similarity=0.327 Sum_probs=202.8
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhh-----------------HHHHHHHHHHHHhcCCCCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQG-----------------LQELKNEALVIAKVQHKNLVRL 134 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~iv~~ 134 (334)
.++|++.+.||+|+||.||+|.. +|+.||+|.+....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999999 89999999986432211 1788999999999999999999
Q ss_pred eeEEEecCcceEEEEecCCCChhhh------hhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCee
Q 037681 135 LGCCIERDEKLLIYEYLPNKSLDFF------LFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNIL 207 (334)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nil 207 (334)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||.|||+ ++ ++|+||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 4332 13458999999999999999999998 88 999999999999
Q ss_pred eCCCCceEEeeccccccccCCCCccccccccccCCccCccccccC-CCCc-chhhHhHHHHHHHHHhCCCCCCCccCC--
Q 037681 208 LDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG-ICSI-KSDVFSFGMLLLEILSGKKNTEFYHTG-- 283 (334)
Q Consensus 208 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DiwslG~il~ell~g~~p~~~~~~~-- 283 (334)
++.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|+|++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999865433 23345689999999999877 6666 999999999999999999999765441
Q ss_pred --------ccccccc----------------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 --------YLSINGY----------------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 --------~~~~~~~----------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+... .......+.+++..||..+|.+|+++.++....+
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 0011100 0224556789999999999999999999887655
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=309.90 Aligned_cols=245 Identities=24% Similarity=0.388 Sum_probs=193.6
Q ss_pred cCCCcCCccccCCcccEEEEEecC-----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 678888999999999999998543 235999998754 34445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 124 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999986532 34889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccc
Q 037681 227 GNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVAS 297 (334)
Q Consensus 227 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~ 297 (334)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ...........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 278 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHH
Confidence 33221 11222346788999999998999999999999999999999 99999654322100 00011124556
Q ss_pred hhhhccccccCCccchhhhhhhhhc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+.+++..|+..+|.+|+++.++...
T Consensus 279 l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 279 IYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999998876554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=306.85 Aligned_cols=247 Identities=21% Similarity=0.320 Sum_probs=192.1
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 6899999999999999999995 46899999998642 3445677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999886432 2345889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc---------ccccc-hhcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---------INGYD-QTQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---------~~~~~-~~~~~~ 297 (334)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... +.... ......
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 221 123356899999999999999999999999999999999999998654322100 01011 123456
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..|+..+|.+|+++.++.....
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 889999999999999999988765443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=309.77 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=197.2
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIER-------- 141 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------- 141 (334)
++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999996 578999999886432 23345778999999999999999999999874
Q ss_pred CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
+..++||||+++ +|...+.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 457999999986 5655554332 23899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCC--ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------
Q 037681 222 ARIFKGNES--KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------------- 284 (334)
Q Consensus 222 ~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------------- 284 (334)
+........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|++||.......
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 986542221 222334568999999998876 568999999999999999999999997543210
Q ss_pred ccccccch------------------------hcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 285 LSINGYDQ------------------------TQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 285 ~~~~~~~~------------------------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
..+..... .....+.+++..||..+|.+|+++.++.+..+-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 00000000 013447789999999999999999998887664
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=304.14 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=195.0
Q ss_pred cCCCcCCccccCCcccEEEEEecC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEE-ecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCI-ERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~l 146 (334)
.+|++.+.||+|+||+||+|.+.+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 578889999999999999998542 225889988643 4455678899999999999999999999865 4567899
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 105 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999986533 34788999999999999999999998 9999999999999999999999999997654
Q ss_pred CCCC--ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccccc-------ccchhccc
Q 037681 227 GNES--KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSIN-------GYDQTQVA 296 (334)
Q Consensus 227 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~-------~~~~~~~~ 296 (334)
.... ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||........... ........
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence 3221 112233457889999999999999999999999999999999 6666655433211100 00111355
Q ss_pred chhhhccccccCCccchhhhhhhhhcc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
.+.+++..|+..+|.+|+++.++.+.-
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 688899999999999999988876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=307.02 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=197.5
Q ss_pred cCCCcCCccccCCcccEEEEEe-----cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Ccc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEK 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 144 (334)
+.|++.+.||+|+||.||+|.+ .+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999983 35889999998744 334457889999999999999999999999876 568
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999985543 24899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC----------ccccc-----
Q 037681 225 FKGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG----------YLSIN----- 288 (334)
Q Consensus 225 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----------~~~~~----- 288 (334)
....... .......||..|+|||.+.+..++.++||||||+++|+|++|..|+...... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6543321 2233456788899999999999999999999999999999999986432110 00000
Q ss_pred -------ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 -------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 -------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.........+.+++..||..+|.+|+++.++.+.
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 0011134568899999999999999999887654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=301.29 Aligned_cols=240 Identities=20% Similarity=0.302 Sum_probs=197.7
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--CcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|.+. ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 68999999999999999999986 889999998754 344567789999999999999999999999887 6789999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++.... ...+++..++.++.|++.||.|||+++. +++||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 9999999999986543 2358999999999999999999997642 39999999999999999999999999875422
Q ss_pred CCccccccccccCCccCccccccCCCCc---chhhHhHHHHHHHHHhCCCCCCCccCCccc--------ccccchhcccc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSI---KSDVFSFGMLLLEILSGKKNTEFYHTGYLS--------INGYDQTQVAS 297 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DiwslG~il~ell~g~~p~~~~~~~~~~--------~~~~~~~~~~~ 297 (334)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||......... ...........
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 12246899999999998765544 799999999999999999999765332110 00111224566
Q ss_pred hhhhccccccCCccchhhhhhhhhc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+.+++..|+..+|.+|+++.++...
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999998887654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=307.41 Aligned_cols=237 Identities=18% Similarity=0.322 Sum_probs=196.3
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEe--cCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIE--RDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|.+ .+++.||+|.+.... .+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6899999999999999999985 568999999987443 367889999999997 9999999999988 56689999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 227 (334)
||+++++|..++.. +++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||++.....
T Consensus 113 e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999888732 788899999999999999999998 99999999999999776 899999999986543
Q ss_pred CCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc------------------
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN------------------ 288 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~------------------ 288 (334)
... .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........+.
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 322 233568999999999876 6789999999999999999999999954322100000
Q ss_pred ---------------------cc-----chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 ---------------------GY-----DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ---------------------~~-----~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.. .......+.+++..||..+|.+|+++.++.+..+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 00 0003556788999999999999999999887665
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=317.05 Aligned_cols=242 Identities=22% Similarity=0.315 Sum_probs=192.3
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc------ceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE------KLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~l 146 (334)
.+|++.+.||+|+||+||+|.+..+..+|+|++...... ..+|+.+++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 579999999999999999999877777999988543221 2369999999999999999999976543 789
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC-CCCceEEeeccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD-KEMKPKISDFGMARIF 225 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 225 (334)
||||++++.+............+++..+..++.||+.||+|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999988655544433333445899999999999999999999998 99999999999998 7899999999999865
Q ss_pred cCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------------------
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------------- 285 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------------- 285 (334)
..... .....||+.|+|||++.+. .++.++||||+||++|||++|++||........
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 43322 2235689999999998764 589999999999999999999999976432100
Q ss_pred -------ccc--------c-cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 -------SIN--------G-YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 -------~~~--------~-~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+. . +.......+.+++..||..+|.+|++..++....+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 000 0 00113456889999999999999999888776544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=304.57 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=197.2
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCcceEeeEEE--ecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS----RQGLQELKNEALVIAKVQHKNLVRLLGCCI--ERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 144 (334)
.++|.+.+.||+|+||.||+|.+. +++.+|+|.+.... ......+.+|+.++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 378999999999999999999964 68899999986432 234577899999999999999999999984 45578
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||++++ |.+++.... ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 555554432 334889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccCccccccCC--CCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cc----cccchhccc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGI--CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SI----NGYDQTQVA 296 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~----~~~~~~~~~ 296 (334)
..............||+.|+|||++.+.. .+.++||||||+++|+|++|+.||........ .+ .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCH
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCH
Confidence 64333333334456899999999987643 47799999999999999999999975432100 00 001112345
Q ss_pred chhhhccccccCCccchhhhhhhhhccC
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.+++..|+..+|.+|+++.++....+
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 6789999999999999999999876544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=310.07 Aligned_cols=249 Identities=25% Similarity=0.253 Sum_probs=184.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEe--------c
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIE--------R 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--------~ 141 (334)
..+|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 368999999999999999999964 68999999997777777788899999999996 9999999999853 3
Q ss_pred CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
...++||||++ |+|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 34789999996 688888765444556899999999999999999999774 2399999999999999999999999999
Q ss_pred cccccCCCCcc----------ccccccccCCccCcccc---ccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc
Q 037681 222 ARIFKGNESKA----------NTNRVAGTFGYIPPEYV---YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN 288 (334)
Q Consensus 222 ~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 288 (334)
+.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 98654322111 11134589999999998 567789999999999999999999999975433211100
Q ss_pred cc----chhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 GY----DQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 ~~----~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.. .......+.+++..||..+|.+|+++.++...
T Consensus 265 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 265 KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp -CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01 11134567889999999999999998876654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=307.00 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=186.0
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ......+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 47899999999999999999996 468899999986442 222333445555688889999999999999999999999
Q ss_pred EecCCCChhhhhhhc-ccccccchHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 149 EYLPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLHLH-SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 149 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||+++ +|.+++... .....+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99985 776666432 2334589999999999999999999998 8 9999999999999999999999999997654
Q ss_pred CCCCccccccccccCCccCcccc----ccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc---------chh
Q 037681 227 GNESKANTNRVAGTFGYIPPEYV----YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY---------DQT 293 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~---------~~~ 293 (334)
.... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.........+... ...
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 3322 2234689999999996 46678999999999999999999999997643321111110 111
Q ss_pred cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 294 QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
....+.+++..|+..+|.+|+++.++....+
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 3456888999999999999999998876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=310.80 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=197.4
Q ss_pred HHHHhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEe----
Q 037681 67 SVAAATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIE---- 140 (334)
Q Consensus 67 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---- 140 (334)
.+....++|++.+.||+|+||.||+|.+ .+++.||+|.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3344568999999999999999999996 468999999986443 3346788999999999 79999999999987
Q ss_pred --cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEee
Q 037681 141 --RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISD 218 (334)
Q Consensus 141 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 218 (334)
.+..++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 457899999999999999986543 345889999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------
Q 037681 219 FGMARIFKGNESKANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------- 286 (334)
Q Consensus 219 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------- 286 (334)
||++........ ......|++.|+|||++. +..++.++||||||+++|+|++|+.||.........
T Consensus 173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 999876543221 123356899999999986 567889999999999999999999999764322100
Q ss_pred cccc-chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 287 INGY-DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 287 ~~~~-~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.... .......+.+++..||..+|.+|+++.++....+
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 0000 1113456889999999999999999998877543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=307.05 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=198.8
Q ss_pred cCC-CcCCccccCCcccEEEEEec-----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec--Cc
Q 037681 73 NNF-SDTNKLGEGGFGPVYKGVLA-----KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER--DE 143 (334)
Q Consensus 73 ~~y-~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 143 (334)
++| ++++.||+|+||+||++.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 455 89999999999999988642 5788999999754 344567789999999999999999999999884 56
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.++||||+++++|.+++.... +++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 789999999999999985432 889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------------
Q 037681 224 IFKGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--------------- 287 (334)
Q Consensus 224 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------------- 287 (334)
........ .......+|..|+|||.+.+..++.++||||||+++|+|++|+.||.........+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 76543221 12333457888999999998899999999999999999999999986532110000
Q ss_pred -------cccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 288 -------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 288 -------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..........+.+++..||..+|.+|+++.++...-.
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0001113456889999999999999999988776543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=310.18 Aligned_cols=250 Identities=24% Similarity=0.268 Sum_probs=199.7
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe----cCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE----RDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 146 (334)
.++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 47899999999999999999996 5789999999977777777889999999999999999999999873 346789
Q ss_pred EEEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 147 IYEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999998886532 2345899999999999999999999998 999999999999999999999999998754
Q ss_pred cCCCCc-------cccccccccCCccCccccccCC---CCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc------
Q 037681 226 KGNESK-------ANTNRVAGTFGYIPPEYVYQGI---CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING------ 289 (334)
Q Consensus 226 ~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~------ 289 (334)
...... .......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||+........+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 321110 0112245799999999987544 688999999999999999999999653221110000
Q ss_pred ---cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 ---YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 ---~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
........+.+++..||..+|.+|+++.++...-.
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 01123556889999999999999999888766543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=306.95 Aligned_cols=244 Identities=26% Similarity=0.377 Sum_probs=190.0
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhc--CCCCcceEeeEEEec----C
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV--QHKNLVRLLGCCIER----D 142 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~ 142 (334)
....++|++.+.||+|+||.||+|.+. ++.||+|++..... .....|.+++... +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344579999999999999999999876 89999999864332 3344555555554 899999999999887 6
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc--------CCCCeEeccCCCCCeeeCCCCce
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH--------SRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
..++||||+++|+|.+++... .+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 789999999999999998543 389999999999999999999988 6 9999999999999999999
Q ss_pred EEeeccccccccCCCCc--cccccccccCCccCccccccCCCCcc------hhhHhHHHHHHHHHhC----------CCC
Q 037681 215 KISDFGMARIFKGNESK--ANTNRVAGTFGYIPPEYVYQGICSIK------SDVFSFGMLLLEILSG----------KKN 276 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~------~DiwslG~il~ell~g----------~~p 276 (334)
||+|||++......... .......||+.|+|||++.+...+.. +||||||+++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999999765433221 11224579999999999987766554 9999999999999999 566
Q ss_pred CCCccCCcccccccc------------------hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 277 TEFYHTGYLSINGYD------------------QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 277 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
|.............. ......+.+++..||..+|.+|+++.++.+.-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 654332211111000 01233477899999999999999998876643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=300.08 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=202.5
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---------hhhHHHHHHHHHHHHhcC-CCCcceEeeEEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---------RQGLQELKNEALVIAKVQ-HKNLVRLLGCCI 139 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 139 (334)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3479999999999999999999965 68899999986442 223456789999999995 999999999999
Q ss_pred ecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeec
Q 037681 140 ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDF 219 (334)
Q Consensus 140 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 219 (334)
..+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999986543 4899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccCccccc------cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------
Q 037681 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVY------QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------- 284 (334)
Q Consensus 220 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------- 284 (334)
|++....... ......|++.|+|||.+. ...++.++||||||+++|+|++|+.||.......
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 9997654332 223456899999999885 4567889999999999999999999996543210
Q ss_pred ccccc-cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 LSING-YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 ~~~~~-~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.. ........+.+++..||..+|.+|+++.++....+
T Consensus 246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 00000 01123456889999999999999999999887655
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=306.22 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=192.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEE------------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI------------ 139 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------------ 139 (334)
++|.+.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 68999999999999999999966 48899999998777777788999999999999999999999874
Q ss_pred --ecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC-CCCceEE
Q 037681 140 --ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD-KEMKPKI 216 (334)
Q Consensus 140 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl 216 (334)
+.+..++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++ .++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3456799999998 589888743 23889999999999999999999998 99999999999997 5679999
Q ss_pred eeccccccccCCCC-ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------
Q 037681 217 SDFGMARIFKGNES-KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------- 285 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------- 285 (334)
+|||++........ ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999986543211 112233467999999998765 6789999999999999999999999976432100
Q ss_pred ---------------------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ---------------------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ---------------------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
++..........+.+++..||..+|.+|+++.++....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 000001123556888999999999999999998877544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=314.42 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=187.0
Q ss_pred cCCCcCCccccCCcccEEEEEec--CC--CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe-cCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA--KG--DEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE-RDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~--~~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 146 (334)
..|.+.+.||+|+||+||+|.+. ++ ..||+|.+... .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35677889999999999999853 22 35899988643 34556788999999999999999999998754 457899
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999986433 34788899999999999999999998 9999999999999999999999999997654
Q ss_pred CCCCc--cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccc-------cccchhccc
Q 037681 227 GNESK--ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSI-------NGYDQTQVA 296 (334)
Q Consensus 227 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~-------~~~~~~~~~ 296 (334)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.......... .........
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~ 323 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 323 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 32211 11223457789999999999999999999999999999999 777886654321100 000111345
Q ss_pred chhhhccccccCCccchhhhhhhhhc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+.+++..|+..+|.+|+++.++...
T Consensus 324 ~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 324 PLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 68889999999999999998887654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=301.13 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=195.4
Q ss_pred CCCcCCccccCCcccEEEEEec-CCC---EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc-eEE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGD---EIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK-LLI 147 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~---~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv 147 (334)
.|.+.+.||+|+||+||+|.+. +++ .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5666789999999999999853 233 6999998643 445567889999999999999999999999876665 999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+.+++|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999986532 34788999999999999999999998 99999999999999999999999999976543
Q ss_pred CC--CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCC-CCCccCCccc-------ccccchhcccc
Q 037681 228 NE--SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKN-TEFYHTGYLS-------INGYDQTQVAS 297 (334)
Q Consensus 228 ~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p-~~~~~~~~~~-------~~~~~~~~~~~ 297 (334)
.. .........+++.|+|||.+.+..++.++||||||+++|+|++|..| |......... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDS 256 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHH
Confidence 22 11223345678999999999999999999999999999999995555 4433221100 00011113456
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..|+..+|.+|+++.++...-.
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 889999999999999999887665443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=307.05 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=186.0
Q ss_pred HhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
...++|++.+.||+|+||.||+|.+ .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457999999999999999999995 468999999886432 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcc-----cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccc
Q 037681 148 YEYLPNKSLDFFLFDAT-----KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMA 222 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 222 (334)
|||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 99999999999886421 2345889999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCC---ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc----------ccc
Q 037681 223 RIFKGNES---KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------SIN 288 (334)
Q Consensus 223 ~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------~~~ 288 (334)
........ ........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 76543211 111234568999999999875 5689999999999999999999999976433210 000
Q ss_pred c------cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 G------YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ~------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. ........+.+++..|+..+|.+|+++.++.+..+
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 0 00112345778999999999999999999887654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=304.08 Aligned_cols=244 Identities=26% Similarity=0.362 Sum_probs=196.7
Q ss_pred hcCCCcCC-ccccCCcccEEEEEe---cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 72 TNNFSDTN-KLGEGGFGPVYKGVL---AKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 72 ~~~y~~~~-~lg~G~~g~V~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
.++|.+.+ .||+|+||.||+|.+ .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 36788887 999999999999964 246789999987442 33357789999999999999999999999 667789
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999986543 3889999999999999999999998 999999999999999999999999999866
Q ss_pred cCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhccc
Q 037681 226 KGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVA 296 (334)
Q Consensus 226 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~ 296 (334)
...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........ ...........
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 247 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 433221 11222346788999999988889999999999999999999 9999976533210 00111122456
Q ss_pred chhhhccccccCCccchhhhhhhhhc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+.+++..|+..+|.+|+++.++...
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78899999999999999998887654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=302.29 Aligned_cols=244 Identities=22% Similarity=0.320 Sum_probs=194.1
Q ss_pred hhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEE-EecCcceEEE
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC-IERDEKLLIY 148 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 148 (334)
..++|++.+.||+|+||.||+|.+ .+++.||+|.+..... ...+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 347899999999999999999995 5688999998754322 23578899999999988877776665 5666789999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee---CCCCceEEeeccccccc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIF 225 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 225 (334)
||+ +++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 8999998864332 3899999999999999999999998 9999999999999 78899999999999876
Q ss_pred cCCCCc-----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--ccccc-------
Q 037681 226 KGNESK-----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--INGYD------- 291 (334)
Q Consensus 226 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~~~------- 291 (334)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... +....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543221 1223457899999999999999999999999999999999999999865443111 10000
Q ss_pred -----hhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 292 -----QTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 292 -----~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
...+..+.+++..|+..+|.+|+++.++...
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 274 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH
Confidence 1125678899999999999999998887664
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=307.52 Aligned_cols=243 Identities=27% Similarity=0.379 Sum_probs=194.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCE--EEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDE--IAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~--vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||.||+|.+. ++.. +|+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999954 4654 488988643 334456788999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcc-------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCce
Q 037681 148 YEYLPNKSLDFFLFDAT-------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986543 1235899999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--cc----
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--SI---- 287 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--~~---- 287 (334)
||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........ .+
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 99999998743211 11223456889999999988889999999999999999998 9999976533210 00
Q ss_pred -cccchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 288 -NGYDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 288 -~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
..........+.+++..||..+|.+|+++.++..
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 293 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0011124556889999999999999999877654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=300.03 Aligned_cols=244 Identities=22% Similarity=0.308 Sum_probs=197.1
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEE-EecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC-IERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999996 5789999998865432 24688999999999988877666665 55667799999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee---CCCCceEEeecccccccc
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFK 226 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 226 (334)
|+ +++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 899999886433 24899999999999999999999998 9999999999999 478899999999998765
Q ss_pred CCCCc-----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--ccccccc--------
Q 037681 227 GNESK-----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--LSINGYD-------- 291 (334)
Q Consensus 227 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~~~~-------- 291 (334)
..... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 43221 11234579999999999999999999999999999999999999998654321 1111100
Q ss_pred ----hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 292 ----QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 292 ----~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
...+..+.+++..|+..+|.+|+++.++...-
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 11345688999999999999999988776543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=300.61 Aligned_cols=239 Identities=27% Similarity=0.386 Sum_probs=191.5
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec-CcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-DEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~ 150 (334)
.++|++.+.||+|+||.||+|... |+.||+|.+.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 368999999999999999999875 8899999986443 456788999999999999999999997654 478999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999886543 234788999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-----cccchhcccchhhhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-----NGYDQTQVASKIKLV 302 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-----~~~~~~~~~~~~~~i 302 (334)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......... . ..........+.+++
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 122357889999999998999999999999999999998 99999765332100 0 001112355688899
Q ss_pred cccccCCccchhhhhhhhhc
Q 037681 303 ESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~ 322 (334)
..|+..+|.+|+++.++...
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLREQ 267 (278)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCChhhCCCHHHHHHH
Confidence 99999999999998887654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=310.00 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=197.9
Q ss_pred hHHHHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcC--CCCcceEeeEEEec
Q 037681 66 SSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQ--HKNLVRLLGCCIER 141 (334)
Q Consensus 66 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~ 141 (334)
..+....++|++.+.||+|+||.||+|.+.+++.||+|.+... .....+.+.+|+.++.+++ ||||+++++++.+.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3334455789999999999999999999888999999998643 3455678899999999997 59999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
+..++||| +.+++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||++++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999 66789999886543 4889999999999999999999998 999999999999965 7999999999
Q ss_pred cccccCCCCccccccccccCCccCcccccc-----------CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQ-----------GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN-- 288 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-- 288 (334)
+................|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.........+.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 986654333222334568999999999865 4688899999999999999999999976433211000
Q ss_pred -------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 -------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 -------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.........+.+++..||..+|.+|+++.++....+
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 011113456788999999999999999998876554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=306.89 Aligned_cols=243 Identities=21% Similarity=0.272 Sum_probs=194.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS--------RQGLQELKNEALVIAKVQHKNLVRLLGCCIERD 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 142 (334)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 468999999999999999999965 57899999986432 122345789999999999999999999987654
Q ss_pred cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc---eEEeec
Q 037681 143 EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK---PKISDF 219 (334)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Df 219 (334)
.|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999988875433 4899999999999999999999998 999999999999987654 999999
Q ss_pred cccccccCCCCccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--------
Q 037681 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN-------- 288 (334)
Q Consensus 220 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-------- 288 (334)
|++....... ......||+.|+|||++. +..++.++||||||+++|+|++|+.||...........
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 9997654321 123456899999999874 56788999999999999999999999976543211000
Q ss_pred ---ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 ---GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 ---~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.........+.+++..||..+|.+|+++.++....+
T Consensus 239 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277 (322)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence 001123566889999999999999999998877554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=314.80 Aligned_cols=241 Identities=17% Similarity=0.183 Sum_probs=196.3
Q ss_pred cCCCcCCccccCCcccEEEEEecC---------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcce----------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK---------GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR---------- 133 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------- 133 (334)
++|++.+.||+|+||.||+|.+.. ++.||+|.+... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 689999999999999999999653 788999998644 35788999999999999988
Q ss_pred -----EeeEEEe-cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCee
Q 037681 134 -----LLGCCIE-RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNIL 207 (334)
Q Consensus 134 -----~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nil 207 (334)
+++++.. .+..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6677776 66789999999 999999987542 245899999999999999999999998 999999999999
Q ss_pred eCCCC--ceEEeeccccccccCCCCc-----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCc
Q 037681 208 LDKEM--KPKISDFGMARIFKGNESK-----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFY 280 (334)
Q Consensus 208 l~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 280 (334)
++.++ .+||+|||++......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99988 8999999999765432211 1123347999999999999989999999999999999999999999875
Q ss_pred cCCcccccccch-----------------hcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 281 HTGYLSINGYDQ-----------------TQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 281 ~~~~~~~~~~~~-----------------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
......+..... .....+.+++..|+..+|.+|+++.++...-
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 432111111100 1256788999999999999999988876543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.26 Aligned_cols=241 Identities=11% Similarity=0.108 Sum_probs=180.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhc--CCCCcceEe-------eEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKV--QHKNLVRLL-------GCC 138 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~ 138 (334)
..+|.+.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 356999999999999999999965 68899999997643 23455677785544444 699988755 455
Q ss_pred EecC-----------------cceEEEEecCCCChhhhhhhcccccccchHHH------HHHHHHHHHHHHHhhhcCCCC
Q 037681 139 IERD-----------------EKLLIYEYLPNKSLDFFLFDATKRVLLELGTR------LQIIEGIVEGLLYLHLHSRVR 195 (334)
Q Consensus 139 ~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~~~~~ 195 (334)
...+ ..|+||||++ ++|.+++..... .+++..+ ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 4433 3799999999 899999876432 2455556 778899999999999998
Q ss_pred eEeccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhC
Q 037681 196 IIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSG 273 (334)
Q Consensus 196 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g 273 (334)
|+||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999864321 113456799999999987 6799999999999999999999
Q ss_pred CCCCCCccCCccc-ccc----------c----chhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 274 KKNTEFYHTGYLS-ING----------Y----DQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 274 ~~p~~~~~~~~~~-~~~----------~----~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+.||......... +.. . .......+.+++..||..+|.+|+++.++....
T Consensus 290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 9999876432110 000 0 012356788899999999999999998876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.40 Aligned_cols=244 Identities=21% Similarity=0.276 Sum_probs=191.2
Q ss_pred HhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec-------
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIER------- 141 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------- 141 (334)
...++|++.+.||+|+||+||+|.+ .+|+.||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4457999999999999999999995 57899999998644322 24799999999999999999998543
Q ss_pred -------------------------------CcceEEEEecCCCChhhhhhhc-ccccccchHHHHHHHHHHHHHHHHhh
Q 037681 142 -------------------------------DEKLLIYEYLPNKSLDFFLFDA-TKRVLLELGTRLQIIEGIVEGLLYLH 189 (334)
Q Consensus 142 -------------------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH 189 (334)
...++||||+++ +|...+... .....+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 237899999985 776666432 22345899999999999999999999
Q ss_pred hcCCCCeEeccCCCCCeeeC-CCCceEEeeccccccccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHH
Q 037681 190 LHSRVRIIHRDLKASNILLD-KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLL 267 (334)
Q Consensus 190 ~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il 267 (334)
+++ |+||||||+||+++ .++.+||+|||++........ .....||+.|+|||.+.+. .++.++||||+||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 99999999999997 678999999999986543322 2335689999999998765 589999999999999
Q ss_pred HHHHhCCCCCCCccCCcc-----------------------------ccc--ccc----hhcccchhhhccccccCCccc
Q 037681 268 LEILSGKKNTEFYHTGYL-----------------------------SIN--GYD----QTQVASKIKLVESCLARPFRQ 312 (334)
Q Consensus 268 ~ell~g~~p~~~~~~~~~-----------------------------~~~--~~~----~~~~~~~~~~i~~~l~~~~~~ 312 (334)
|||++|+.||........ .+. .|. ......+.+++..||..+|.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999999975432100 000 000 013445789999999999999
Q ss_pred hhhhhhhhhccC
Q 037681 313 YCCILKVRTFGF 324 (334)
Q Consensus 313 ~~~~~~~~~~~~ 324 (334)
|+++.++....+
T Consensus 313 R~t~~e~l~hp~ 324 (383)
T 3eb0_A 313 RINPYEAMAHPF 324 (383)
T ss_dssp SCCHHHHHTSGG
T ss_pred CCCHHHHhcCHH
Confidence 999888776544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=329.40 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=203.0
Q ss_pred HhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
...++|++.+.||+|+||.||+|.+..+..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..|+|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788999999999999999998878889999997543 234678999999999999999999999876 67899999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 342 ~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999986532 234889999999999999999999998 9999999999999999999999999997654221
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-c----ccchhcccchhhh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-N----GYDQTQVASKIKL 301 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-~----~~~~~~~~~~~~~ 301 (334)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......... + . .........+.++
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 11222346788999999998999999999999999999999 99999765332100 0 0 0011234568889
Q ss_pred ccccccCCccchhhhhhhhhccCC
Q 037681 302 VESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
+..||..+|.+|+++.++..+...
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~L~~ 520 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAFLED 520 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHcCCChhHCcCHHHHHHHHHH
Confidence 999999999999999887765443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=310.39 Aligned_cols=240 Identities=22% Similarity=0.265 Sum_probs=188.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------c
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------E 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 143 (334)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 68999999999999999999954 6889999998643 3445567889999999999999999999998665 6
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||+++ +|...+.. .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 105 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7999999986 66666531 2788999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------------------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------- 284 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------- 284 (334)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 653221 2234578999999999999999999999999999999999999997543210
Q ss_pred ------------ccccccc-----------------hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 ------------LSINGYD-----------------QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 ------------~~~~~~~-----------------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.... ......+.+++..||..+|.+|+++.++....+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 0000000 001345788999999999999999999877653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=329.74 Aligned_cols=237 Identities=25% Similarity=0.398 Sum_probs=190.4
Q ss_pred ccccCCcccEEEEEec---CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCCCC
Q 037681 80 KLGEGGFGPVYKGVLA---KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKS 155 (334)
Q Consensus 80 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 155 (334)
.||+|+||.||+|.+. ++..||||+++.. .....+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4567999999754 33456789999999999999999999999976 56899999999999
Q ss_pred hhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc-ccc
Q 037681 156 LDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK-ANT 234 (334)
Q Consensus 156 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 234 (334)
|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ ...
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99988643 334899999999999999999999998 999999999999999999999999999865433221 112
Q ss_pred ccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------ccccchhcccchhhhccccc
Q 037681 235 NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGYDQTQVASKIKLVESCL 306 (334)
Q Consensus 235 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l 306 (334)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||......... ...........+.+++..|+
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 576 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 576 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHc
Confidence 22345689999999998999999999999999999998 99999865443110 00111124567888999999
Q ss_pred cCCccchhhhhhhhhc
Q 037681 307 ARPFRQYCCILKVRTF 322 (334)
Q Consensus 307 ~~~~~~~~~~~~~~~~ 322 (334)
..+|.+|+++.++...
T Consensus 577 ~~dP~~RPs~~~l~~~ 592 (613)
T 2ozo_A 577 IYKWEDRPDFLTVEQR 592 (613)
T ss_dssp CSSTTTSCCHHHHHHH
T ss_pred CCChhHCcCHHHHHHH
Confidence 9999999998887553
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=313.86 Aligned_cols=242 Identities=19% Similarity=0.241 Sum_probs=196.9
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhc------CCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKV------QHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~ 144 (334)
..+|++.+.||+|+||+||+|.+. +++.||+|++... ......+.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 367999999999999999999855 5889999998643 33445677888888877 577999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc--eEEeecccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK--PKISDFGMA 222 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~ 222 (334)
++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 578777765432 33889999999999999999999998 999999999999999887 999999999
Q ss_pred ccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------------cc--
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------------SI-- 287 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------------~~-- 287 (334)
...... .....||+.|+|||++.+..++.++|||||||++|||++|++||........ .+
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 754322 2235789999999999999999999999999999999999999975432100 00
Q ss_pred ----------------------------------------------cccch----hcccchhhhccccccCCccchhhhh
Q 037681 288 ----------------------------------------------NGYDQ----TQVASKIKLVESCLARPFRQYCCIL 317 (334)
Q Consensus 288 ----------------------------------------------~~~~~----~~~~~~~~~i~~~l~~~~~~~~~~~ 317 (334)
..|.. .....+.+++..||..+|.+|+++.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 00000 0134467899999999999999999
Q ss_pred hhhhccC
Q 037681 318 KVRTFGF 324 (334)
Q Consensus 318 ~~~~~~~ 324 (334)
++.+..+
T Consensus 405 e~L~Hpw 411 (429)
T 3kvw_A 405 QALRHPW 411 (429)
T ss_dssp HHHTSTT
T ss_pred HHhCChh
Confidence 9888766
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.68 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=200.2
Q ss_pred cCCCcCCccccCCcccEEEEEe-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC--cce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-----AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD--EKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 145 (334)
++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 6789999999999999999983 358899999998776677788999999999999999999999987654 689
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 121 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999986543 24889999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC--------cc-c-----c---
Q 037681 226 KGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------YL-S-----I--- 287 (334)
Q Consensus 226 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------~~-~-----~--- 287 (334)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|..|+...... .. . +
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 543221 1122345677899999998888999999999999999999999987643110 00 0 0
Q ss_pred ------cccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 288 ------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 288 ------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
..........+.+++..|+..+|.+|+++.++...
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011134568889999999999999999887654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=314.18 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=180.6
Q ss_pred cCCCc-CCccccCCcccEEEEEec---CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe--cCcceE
Q 037681 73 NNFSD-TNKLGEGGFGPVYKGVLA---KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE--RDEKLL 146 (334)
Q Consensus 73 ~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 146 (334)
+.|++ .+.||+|+||+||+|.+. +++.||+|++.... ....+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45665 458999999999999965 57889999986432 23567899999999999999999999965 567899
Q ss_pred EEEecCCCChhhhhhhcc------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee----CCCCceEE
Q 037681 147 IYEYLPNKSLDFFLFDAT------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL----DKEMKPKI 216 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl 216 (334)
||||+++ +|..++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 6666654322 1224889999999999999999999998 9999999999999 67789999
Q ss_pred eeccccccccCCCC-ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc----------
Q 037681 217 SDFGMARIFKGNES-KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------- 284 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------- 284 (334)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|++||.......
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999986543221 122334678999999999887 458999999999999999999999996443210
Q ss_pred -------------ccccccc------------------------------hhcccchhhhccccccCCccchhhhhhhhh
Q 037681 285 -------------LSINGYD------------------------------QTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 285 -------------~~~~~~~------------------------------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
..+.... ......+.+++..||..+|.+|+++.++..
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 001455678999999999999999999888
Q ss_pred ccC
Q 037681 322 FGF 324 (334)
Q Consensus 322 ~~~ 324 (334)
..+
T Consensus 334 hp~ 336 (405)
T 3rgf_A 334 DPY 336 (405)
T ss_dssp SGG
T ss_pred Chh
Confidence 776
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=308.72 Aligned_cols=252 Identities=17% Similarity=0.205 Sum_probs=186.3
Q ss_pred hHHHHhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc-
Q 037681 66 SSVAAATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE- 143 (334)
Q Consensus 66 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 143 (334)
.......++|++.+.||+|+||.||+|.+. +|+.||+|++.... .......+++..+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344556689999999999999999999964 68999999885432 233456678888899999999999999976544
Q ss_pred ------ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhh--hcCCCCeEeccCCCCCeeeCC-CCce
Q 037681 144 ------KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH--LHSRVRIIHRDLKASNILLDK-EMKP 214 (334)
Q Consensus 144 ------~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~dlkp~Nill~~-~~~~ 214 (334)
.++||||++++.+..+.........+++..+..++.|++.||.||| +++ |+||||||+||+++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987543333322233445888999999999999999999 887 999999999999986 8999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------- 286 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------- 286 (334)
||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.........
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999986543322 2335689999999998654 4899999999999999999999999754321000
Q ss_pred ---------------------------ccc----cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 287 ---------------------------ING----YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 287 ---------------------------~~~----~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.. ........+.+++..||..+|.+|+++.++....+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 000 00002346788999999999999999998877655
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=307.25 Aligned_cols=245 Identities=21% Similarity=0.268 Sum_probs=196.2
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec-----Ccc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-----DEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 144 (334)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+... .......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 378999999999999999999965 6889999998643 344456788999999999999999999988764 568
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||++ ++|..++... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 5888877542 3899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCCcc--------ccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-----------
Q 037681 225 FKGNESKA--------NTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY----------- 284 (334)
Q Consensus 225 ~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----------- 284 (334)
........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 54322111 1223468999999998764 778999999999999999999999997543110
Q ss_pred ----c-----------------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 ----L-----------------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 ----~-----------------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. .+..........+.+++..||..+|.+|+++.++.+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 0 000001123455778999999999999999999887554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=301.98 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=191.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec--CCC--EEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA--KGD--EIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 368999999999999999999853 233 6899988643 3345678899999999999999999999998754 8
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 99999999999999886543 34889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--------cccccchhc
Q 037681 225 FKGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL--------SINGYDQTQ 294 (334)
Q Consensus 225 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~--------~~~~~~~~~ 294 (334)
....... .......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||........ .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 6443221 12223457788999999988889999999999999999999 9999976533210 000111224
Q ss_pred ccchhhhccccccCCccchhhhhhhhhccC
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+.+++..|+..+|.+|+++.++...-.
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 566889999999999999999998876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=312.57 Aligned_cols=242 Identities=21% Similarity=0.230 Sum_probs=194.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC--------CCCcceEeeEEE---
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ--------HKNLVRLLGCCI--- 139 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~--- 139 (334)
.++|++.+.||+|+||+||+|.+. +++.||+|++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 378999999999999999999954 5889999998643 444567889999999985 788999999988
Q ss_pred -ecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCCeeeCCCC-----
Q 037681 140 -ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH-SRVRIIHRDLKASNILLDKEM----- 212 (334)
Q Consensus 140 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~----- 212 (334)
+....++||||+.+ ++...+.... ...+++..+..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 45578999999955 5544443322 23489999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------ceEEeeccccccccCCCCccccccccccCCccCccc
Q 037681 213 --------------------------------------------KPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248 (334)
Q Consensus 213 --------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 248 (334)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999865432 233468999999999
Q ss_pred cccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc----------------------------------------
Q 037681 249 VYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN---------------------------------------- 288 (334)
Q Consensus 249 ~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~---------------------------------------- 288 (334)
+.+..++.++|||||||++|||++|+.||...........
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999975432210000
Q ss_pred --------------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 --------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 --------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.......+.+++..||..+|.+|+++.++.+..+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 000112345678999999999999999999887654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=310.11 Aligned_cols=241 Identities=27% Similarity=0.380 Sum_probs=184.0
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHH--HHhcCCCCcceEeeEEEe-----cCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALV--IAKVQHKNLVRLLGCCIE-----RDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~-----~~~~ 144 (334)
.++|++.+.||+|+||.||+|.. +++.||+|++..... ..+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 37899999999999999999976 589999999864432 333444444 455899999999986543 2246
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc---------CCCCeEeccCCCCCeeeCCCCceE
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH---------SRVRIIHRDLKASNILLDKEMKPK 215 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~~~~ivH~dlkp~Nill~~~~~~k 215 (334)
++||||+++|+|.+++.... .++..+..++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 89999999999999985433 57888999999999999999988 7 99999999999999999999
Q ss_pred EeeccccccccCCCC------ccccccccccCCccCcccccc-------CCCCcchhhHhHHHHHHHHHhCCCCCCCccC
Q 037681 216 ISDFGMARIFKGNES------KANTNRVAGTFGYIPPEYVYQ-------GICSIKSDVFSFGMLLLEILSGKKNTEFYHT 282 (334)
Q Consensus 216 l~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 282 (334)
|+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999986543221 112223569999999999876 4566789999999999999999777643222
Q ss_pred Ccccccc--------------------------cchh------cccchhhhccccccCCccchhhhhhhhhcc
Q 037681 283 GYLSING--------------------------YDQT------QVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 283 ~~~~~~~--------------------------~~~~------~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
....... .... ....+.+++..||..+|.+|+++.++.+.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 1000000 0000 112488999999999999999998876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=316.52 Aligned_cols=241 Identities=24% Similarity=0.320 Sum_probs=188.6
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------cce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------EKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~ 145 (334)
.+|++.+.||+|+||.||+|.+. +|+.||||++..... ...+|++++++++||||+++++++...+ ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 47999999999999999999975 589999999864322 2346999999999999999999986432 257
Q ss_pred EEEEecCCCChhhhhhh-cccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-CceEEeeccccc
Q 037681 146 LIYEYLPNKSLDFFLFD-ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMAR 223 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~ 223 (334)
+||||+++ ++...+.. ......+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999987 45444432 223345899999999999999999999998 9999999999999965 568999999998
Q ss_pred cccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-----------------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------------- 285 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------------- 285 (334)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||........
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 6543322 2235689999999998764 789999999999999999999999975431100
Q ss_pred ---------cccc-----c----chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ---------SING-----Y----DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ---------~~~~-----~----~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.. | .........+++.+||..+|.+|+++.++....+
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 0000 0 0112456889999999999999999988776544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=308.16 Aligned_cols=238 Identities=22% Similarity=0.321 Sum_probs=193.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc-----
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK----- 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----- 144 (334)
++|.+.+.||+|+||.||+|.+. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 68999999999999999999954 6889999998643 344467788999999999999999999999877665
Q ss_pred -eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 145 -LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 145 -~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
++||||++ ++|..++.. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 122 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred EEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999998 577666521 2889999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------ 284 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------ 284 (334)
..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 54322 233568999999999877 688999999999999999999999997543110
Q ss_pred -------------------ccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 -------------------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 -------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+..........+.+++..||..+|.+|+++.++....+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 0000011113566889999999999999999999887665
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.86 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=195.9
Q ss_pred HHHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHh--cCCCCcceEeeEEEecC---
Q 037681 68 VAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAK--VQHKNLVRLLGCCIERD--- 142 (334)
Q Consensus 68 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~--- 142 (334)
.....++|++.+.||+|+||.||+|.+. |+.||+|.+.... ...+.+|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 3445579999999999999999999874 8999999986432 3567788888887 78999999999998876
Q ss_pred -cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhh--------hcCCCCeEeccCCCCCeeeCCCCc
Q 037681 143 -EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH--------LHSRVRIIHRDLKASNILLDKEMK 213 (334)
Q Consensus 143 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~dlkp~Nill~~~~~ 213 (334)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 789999999999999998543 3889999999999999999999 677 999999999999999999
Q ss_pred eEEeeccccccccCCCCcc--ccccccccCCccCccccccC------CCCcchhhHhHHHHHHHHHhC----------CC
Q 037681 214 PKISDFGMARIFKGNESKA--NTNRVAGTFGYIPPEYVYQG------ICSIKSDVFSFGMLLLEILSG----------KK 275 (334)
Q Consensus 214 ~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~ 275 (334)
+||+|||++.......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999997665433211 22345789999999998765 234689999999999999999 67
Q ss_pred CCCCccCCccccccc---------c---------hhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 276 NTEFYHTGYLSINGY---------D---------QTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 276 p~~~~~~~~~~~~~~---------~---------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
||............+ . ......+.+++..||..+|.+|+++.++...-
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 776543221111000 0 01223577899999999999999998876643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.08 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=195.4
Q ss_pred hhcCCCcCCccccCCcccEEEEEe--cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCcceEeeEEE----
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVL--AKGDEIAVKRLSVRS--RQGLQELKNEALVIAKV---QHKNLVRLLGCCI---- 139 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~---- 139 (334)
..++|++.+.||+|+||.||+|.+ .+|+.||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347899999999999999999997 357889999886432 22233456777777666 8999999999987
Q ss_pred -ecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEee
Q 037681 140 -ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISD 218 (334)
Q Consensus 140 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 218 (334)
.....++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 589888865432 34889999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------
Q 037681 219 FGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------------- 284 (334)
Q Consensus 219 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------------- 284 (334)
||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99997643221 2334568999999999999999999999999999999999999997543210
Q ss_pred ccc-------------------cccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 LSI-------------------NGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 ~~~-------------------~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+ ..........+.+++..||..+|.+|+++.++....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000 0011113345678999999999999999988876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=328.39 Aligned_cols=237 Identities=26% Similarity=0.366 Sum_probs=190.4
Q ss_pred CccccCCcccEEEEEec---CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLA---KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
+.||+|+||.||+|.+. .+..||||+++.. .....+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999743 4678999999753 3344678999999999999999999999986 4568899999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC-cc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES-KA 232 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 232 (334)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999986433 4899999999999999999999998 99999999999999999999999999987643322 11
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~ 304 (334)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ ............+.+++..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 607 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 607 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 2223456788999999999999999999999999999998 9999976543210 0011112245568899999
Q ss_pred cccCCccchhhhhhhhhc
Q 037681 305 CLARPFRQYCCILKVRTF 322 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~ 322 (334)
|+..+|.+|+++.++...
T Consensus 608 cl~~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 608 CWTYDVENRPGFAAVELR 625 (635)
T ss_dssp HTCSSTTTSCCHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHH
Confidence 999999999999887654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=306.35 Aligned_cols=245 Identities=23% Similarity=0.327 Sum_probs=200.3
Q ss_pred HhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChh------hHHHHHHHHHHHHhcC--CCCcceEeeEEEe
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQ------GLQELKNEALVIAKVQ--HKNLVRLLGCCIE 140 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 140 (334)
...++|++.+.||+|+||.||+|.+ .+++.||+|.+...... ....+.+|+.++++++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999995 46889999998643211 2245667999999996 5999999999999
Q ss_pred cCcceEEEEecCC-CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC-CCCceEEee
Q 037681 141 RDEKLLIYEYLPN-KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD-KEMKPKISD 218 (334)
Q Consensus 141 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~D 218 (334)
.+..++|+|++.+ ++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 89998886533 4889999999999999999999998 99999999999998 778999999
Q ss_pred ccccccccCCCCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccchhcccc
Q 037681 219 FGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVAS 297 (334)
Q Consensus 219 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 297 (334)
||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....................
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 269 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 269 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHH
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHH
Confidence 99998654322 233568999999999877665 6889999999999999999999975432111111112224567
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..||..+|.+|+++.++.+..+
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 889999999999999999999887655
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=303.20 Aligned_cols=238 Identities=22% Similarity=0.319 Sum_probs=193.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE------ 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 143 (334)
++|.+.+.||+|+||.||+|.+. +|+.||+|.+... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 68999999999999999999964 6889999998643 34445678899999999999999999999987654
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||++ ++|..++.. .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 399999998 577766632 2889999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc------------------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------ 284 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------ 284 (334)
..... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 54322 233568999999999876 678999999999999999999999997543110
Q ss_pred -------------------ccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 -------------------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 -------------------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+..........+.+++..||..+|.+|+++.++....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0001111123556789999999999999999999887665
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=313.17 Aligned_cols=243 Identities=21% Similarity=0.325 Sum_probs=196.6
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC-CCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH-KNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+..|+.+++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 37899999999999999999995 56899999987644322 357889999999987 556666666677788899999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee---CCCCceEEeecccccccc
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL---DKEMKPKISDFGMARIFK 226 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 226 (334)
|+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 8999998864332 4899999999999999999999998 9999999999999 578899999999998765
Q ss_pred CCCCc-----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc--cccc----------
Q 037681 227 GNESK-----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--SING---------- 289 (334)
Q Consensus 227 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~---------- 289 (334)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43321 112246799999999999999999999999999999999999999987544210 0000
Q ss_pred --cchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 290 --YDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 290 --~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
........+.+++..|+..+|.+|+++.++...
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~ 272 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRL 272 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 001134568899999999999999988876654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.57 Aligned_cols=242 Identities=21% Similarity=0.280 Sum_probs=197.3
Q ss_pred hcCCCcCCccccCCcccEEEEEe--cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC------CcceEeeEEEecCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL--AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHK------NLVRLLGCCIERDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~ 143 (334)
.++|++.+.||+|+||.||+|.+ .+++.||+|++... ....+.+.+|+.+++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999986 35889999998643 34456788999999998765 49999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-------------
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK------------- 210 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~------------- 210 (334)
.++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 788988886543 234889999999999999999999998 999999999999987
Q ss_pred ------CCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc
Q 037681 211 ------EMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY 284 (334)
Q Consensus 211 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 284 (334)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999764322 233578999999999999999999999999999999999999997543210
Q ss_pred c---------ccc------------------ccc-----------------------hhcccchhhhccccccCCccchh
Q 037681 285 L---------SIN------------------GYD-----------------------QTQVASKIKLVESCLARPFRQYC 314 (334)
Q Consensus 285 ~---------~~~------------------~~~-----------------------~~~~~~~~~~i~~~l~~~~~~~~ 314 (334)
. .+. .|. ......+.+++..||..+|.+|+
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 0 000 000 00124467999999999999999
Q ss_pred hhhhhhhccC
Q 037681 315 CILKVRTFGF 324 (334)
Q Consensus 315 ~~~~~~~~~~ 324 (334)
++.++.+..+
T Consensus 322 t~~ell~hp~ 331 (339)
T 1z57_A 322 TLREALKHPF 331 (339)
T ss_dssp CHHHHTTSGG
T ss_pred CHHHHhcCHH
Confidence 9998877654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=301.68 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=176.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHH-HHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEAL-VIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|+||.||+|... +|+.||+|.+... .......+..|.. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 78999999999999999999964 6889999999754 2333445555665 6777899999999999999999999999
Q ss_pred ecCCCChhhhhhhc--ccccccchHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 150 YLPNKSLDFFLFDA--TKRVLLELGTRLQIIEGIVEGLLYLHLH-SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 150 ~~~~~~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
|+++ +|..++... .....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9986 676665431 1234588999999999999999999998 8 9999999999999999999999999997654
Q ss_pred CCCCccccccccccCCccCcccc----ccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc------------
Q 037681 227 GNESKANTNRVAGTFGYIPPEYV----YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY------------ 290 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~------------ 290 (334)
.... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.........+...
T Consensus 178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3aln_A 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence 3221 2234689999999998 45678999999999999999999999997643221111100
Q ss_pred chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 291 DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 291 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.......+.+++..||..+|.+|+++.++....+
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 0113456888999999999999999998876544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=293.86 Aligned_cols=244 Identities=24% Similarity=0.303 Sum_probs=200.0
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
...++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 33478999999999999999999965 6899999998643 23456788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC---CceEEeeccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE---MKPKISDFGMAR 223 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~ 223 (334)
||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999988875543 3899999999999999999999998 9999999999999754 469999999997
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccc-cchh
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SING-YDQT 293 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~-~~~~ 293 (334)
....... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........ .+.. ....
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTT
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhh
Confidence 6543321 223458999999998865 488999999999999999999999975432100 0000 0012
Q ss_pred cccchhhhccccccCCccchhhhhhhhhcc
Q 037681 294 QVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
....+.+++..|+..+|.+|+++.++....
T Consensus 249 ~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 345688899999999999999998887654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=302.60 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=192.2
Q ss_pred HhhcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChh------hHHHHHHHHHHHHhc----CCCCcceEeeEE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQ------GLQELKNEALVIAKV----QHKNLVRLLGCC 138 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~iv~~~~~~ 138 (334)
...++|++.+.||+|+||.||+|.+ .+++.||+|.+...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999985 46889999998644321 223355789999988 899999999999
Q ss_pred EecCcceEEEEe-cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC-CCCceEE
Q 037681 139 IERDEKLLIYEY-LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD-KEMKPKI 216 (334)
Q Consensus 139 ~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl 216 (334)
.+.+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 78999999886543 3899999999999999999999998 99999999999998 7899999
Q ss_pred eeccccccccCCCCccccccccccCCccCccccccCCCC-cchhhHhHHHHHHHHHhCCCCCCCccCCcccccccchhcc
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICS-IKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQV 295 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 295 (334)
+|||++....... .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||..................
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSC
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCC
Confidence 9999998654322 2345689999999998776654 5899999999999999999999754221111111122245
Q ss_pred cchhhhccccccCCccchhhhhhhhhccC
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..+.+++..|+..+|.+|+++.++....+
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 66888999999999999999999887655
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=293.74 Aligned_cols=245 Identities=23% Similarity=0.380 Sum_probs=191.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe----------
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE---------- 140 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------- 140 (334)
.++|++.+.||+|+||.||+|.+. +++.||+|.+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 468999999999999999999964 689999999864 34455778899999999999999999998865
Q ss_pred ---cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 141 ---RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 141 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 345789999999999999986533 34778899999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCC------------ccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCC-
Q 037681 218 DFGMARIFKGNES------------KANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG- 283 (334)
Q Consensus 218 Dfg~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~- 283 (334)
|||++........ ........||+.|+|||.+.+. .++.++||||||+++|+|++ ||......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 9999976542210 1122345689999999998754 78999999999999999998 44321110
Q ss_pred ---------ccccc-ccchhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 284 ---------YLSIN-GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 284 ---------~~~~~-~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
...+. .+.......+.+++..||..+|.+|+++.++....+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 00011 0111133447889999999999999999999887664
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=310.98 Aligned_cols=246 Identities=24% Similarity=0.289 Sum_probs=185.3
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+.|.+.+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++.++ +||||+++++++.+.+..|+||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4455678899999999987766779999999986432 35678899999886 8999999999999999999999999
Q ss_pred CCCChhhhhhhccccc----ccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC-------------Cce
Q 037681 152 PNKSLDFFLFDATKRV----LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-------------MKP 214 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-------------~~~ 214 (334)
+ |+|.+++....... ..++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 59999886543211 1133456789999999999999998 9999999999999654 489
Q ss_pred EEeeccccccccCCCCc--cccccccccCCccCcccccc-------CCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCc
Q 037681 215 KISDFGMARIFKGNESK--ANTNRVAGTFGYIPPEYVYQ-------GICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGY 284 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~ 284 (334)
||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 12234579999999999865 568899999999999999999 999997543211
Q ss_pred c-------ccccc----chhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 285 L-------SINGY----DQTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 285 ~-------~~~~~----~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
. .+... .......+.+++..||..+|.+|+++.++....+-
T Consensus 248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 0 00000 01123567899999999999999999998876553
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=302.55 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=196.4
Q ss_pred HhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
...++|++.+.||+|+||.||+|.+.. .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345789999999999999999998753 4899988643 233345677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++ ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999986533 34889999999999999999999998 99999999999998 67999999999875432
Q ss_pred CC---CccccccccccCCccCcccccc---------CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------cc
Q 037681 228 NE---SKANTNRVAGTFGYIPPEYVYQ---------GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------IN 288 (334)
Q Consensus 228 ~~---~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~ 288 (334)
.. .........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 11 1122233458999999999864 45788999999999999999999999764332100 00
Q ss_pred cc-chhcccchhhhccccccCCccchhhhhhhhhccCCccc
Q 037681 289 GY-DQTQVASKIKLVESCLARPFRQYCCILKVRTFGFNLPN 328 (334)
Q Consensus 289 ~~-~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~ 328 (334)
.. .......+.+++..|+..+|.+|+++.++...-..+..
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 00 01134578899999999999999999988777665544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=322.82 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=196.9
Q ss_pred HhhcCCCcCCccccCCcccEEEEEecC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
...++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345789999999999999999998642 457999988643 3444577899999999999999999999985 5678
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999986533 34889999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhccc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVA 296 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~ 296 (334)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........ ...........
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 543322 12223456789999999998899999999999999999997 9999976433210 00011122346
Q ss_pred chhhhccccccCCccchhhhhhhhhc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+.+++..|+..+|.+|+++.++...
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 78899999999999999999887654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=299.07 Aligned_cols=241 Identities=20% Similarity=0.224 Sum_probs=172.3
Q ss_pred hcCCCcCC-ccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe----cCcce
Q 037681 72 TNNFSDTN-KLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE----RDEKL 145 (334)
Q Consensus 72 ~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 145 (334)
.++|.+.+ .||+|+||.||+|.+. +|+.||+|++.... . ........++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 37899865 6999999999999965 68999999986431 1 12222334566799999999999876 44579
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEeecccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKISDFGMA 222 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~ 222 (334)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999865432 35899999999999999999999998 999999999999976 455999999999
Q ss_pred ccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-------------ccc
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-------------ING 289 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------------~~~ 289 (334)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... +..
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 7644221 23356899999999998888999999999999999999999999654332110 000
Q ss_pred cc-hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 290 YD-QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 290 ~~-~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.. ......+.+++..||..+|.+|+++.++....+
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00 123556888999999999999999998877554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=317.80 Aligned_cols=244 Identities=26% Similarity=0.345 Sum_probs=195.0
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe------cCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE------RDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 143 (334)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 37899999999999999999996 46899999988643 44556778999999999999999999998765 667
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCc---eEEeecc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMK---PKISDFG 220 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg 220 (334)
.++||||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999977655556899999999999999999999998 999999999999987765 9999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccC------------------
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT------------------ 282 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------------------ 282 (334)
.+........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9986543322 2345789999999999999999999999999999999999999954210
Q ss_pred -----Ccccccc-------cchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 283 -----GYLSING-------YDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 283 -----~~~~~~~-------~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
+...+.. ........+.+++..||..+|.+|++..++..
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 0000000 11113456888999999999999999876543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=306.74 Aligned_cols=243 Identities=22% Similarity=0.297 Sum_probs=185.4
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.+|++.+.||+|+||+|+.....+|+.||||++..... ..+.+|+.+++++ +||||+++++++.+.+..|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 57888999999999997765566799999999864332 2356799999999 7999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-----CCceEEeecccccccc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-----EMKPKISDFGMARIFK 226 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~ 226 (334)
+ |+|.+++..... ......+..++.||+.||.|||+++ |+||||||+||+++. ...+||+|||++....
T Consensus 101 ~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 7 588888865432 2455567789999999999999998 999999999999953 2358899999998664
Q ss_pred CCCC-ccccccccccCCccCccccc---cCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc-------cccc--ch
Q 037681 227 GNES-KANTNRVAGTFGYIPPEYVY---QGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS-------INGY--DQ 292 (334)
Q Consensus 227 ~~~~-~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~-------~~~~--~~ 292 (334)
.... ........||+.|+|||++. ...++.++|||||||++|||++ |..||......... .... ..
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccc
Confidence 3321 12234467999999999987 4567889999999999999999 99998654322110 0000 01
Q ss_pred hcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 293 TQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 293 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.......+++..||..+|.+|+++.++....+
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 12334678999999999999999999887665
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=302.81 Aligned_cols=242 Identities=19% Similarity=0.270 Sum_probs=193.5
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCCcceEeeEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-----------HKNLVRLLGCCI 139 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~ 139 (334)
.++|++.+.||+|+||+||+|.+ .+++.||+|++... ......+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999996 46889999998643 334567788999998886 899999999998
Q ss_pred ecC----cceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCCeeeC-----
Q 037681 140 ERD----EKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH-SRVRIIHRDLKASNILLD----- 209 (334)
Q Consensus 140 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~dlkp~Nill~----- 209 (334)
..+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++ + |+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 678999999 8899888865432 3388999999999999999999998 8 99999999999994
Q ss_pred -CCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--
Q 037681 210 -KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-- 286 (334)
Q Consensus 210 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-- 286 (334)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999765432 22346899999999999999999999999999999999999999754321000
Q ss_pred ----------------------------------------cc------------ccchhcccchhhhccccccCCccchh
Q 037681 287 ----------------------------------------IN------------GYDQTQVASKIKLVESCLARPFRQYC 314 (334)
Q Consensus 287 ----------------------------------------~~------------~~~~~~~~~~~~~i~~~l~~~~~~~~ 314 (334)
.. .........+.+++..||..+|.+|+
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 00 00011234577899999999999999
Q ss_pred hhhhhhhccC
Q 037681 315 CILKVRTFGF 324 (334)
Q Consensus 315 ~~~~~~~~~~ 324 (334)
++.++.+..+
T Consensus 327 t~~ell~hp~ 336 (373)
T 1q8y_A 327 DAGGLVNHPW 336 (373)
T ss_dssp CHHHHHTCGG
T ss_pred CHHHHhhChh
Confidence 9999887655
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.24 Aligned_cols=201 Identities=24% Similarity=0.307 Sum_probs=168.7
Q ss_pred hhcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CC-----CcceEeeEEEecCc
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HK-----NLVRLLGCCIERDE 143 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~ 143 (334)
..++|++.+.||+|+||+||+|.+. +++.||||++... ......+..|+.+++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3579999999999999999999965 5788999998643 344566778888888885 54 49999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC--CCCceEEeeccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD--KEMKPKISDFGM 221 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~ 221 (334)
.++||||+++ +|.+++..... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCCC-CHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999965 88888865432 2388999999999999999999953 12399999999999994 477899999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFY 280 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 280 (334)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9865322 23357899999999999999999999999999999999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.42 Aligned_cols=242 Identities=22% Similarity=0.272 Sum_probs=193.5
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CC-CEEEEEEecccChhhHHHHHHHHHHHHhcCCCC------cceEeeEEEecCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KG-DEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN------LVRLLGCCIERDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~ 143 (334)
.++|++.+.||+|+||+||+|... ++ ..||+|++... ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 378999999999999999999964 34 68999998643 344567788999999997665 9999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee---------------
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL--------------- 208 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill--------------- 208 (334)
.++||||+. +++..++.... ...+++..+..++.||+.||.|||+++ |+||||||+||++
T Consensus 97 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELLG-KNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEeccC-CChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 999999994 55555554432 234889999999999999999999998 9999999999999
Q ss_pred ----CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc
Q 037681 209 ----DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY 284 (334)
Q Consensus 209 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 284 (334)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999764322 233578999999999999999999999999999999999999997543210
Q ss_pred c---------cccc------------------cc-----------------------hhcccchhhhccccccCCccchh
Q 037681 285 L---------SING------------------YD-----------------------QTQVASKIKLVESCLARPFRQYC 314 (334)
Q Consensus 285 ~---------~~~~------------------~~-----------------------~~~~~~~~~~i~~~l~~~~~~~~ 314 (334)
. .... |. ......+.+++..||..+|.+|+
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 0 0000 00 00123566899999999999999
Q ss_pred hhhhhhhccC
Q 037681 315 CILKVRTFGF 324 (334)
Q Consensus 315 ~~~~~~~~~~ 324 (334)
++.++.+..+
T Consensus 327 t~~e~l~hp~ 336 (355)
T 2eu9_A 327 TLAEALLHPF 336 (355)
T ss_dssp CHHHHTTSGG
T ss_pred CHHHHhcChh
Confidence 9999877554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=293.50 Aligned_cols=243 Identities=24% Similarity=0.376 Sum_probs=177.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hh-hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQ-GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++.+.||+|+||.||+|.+. +|+.||+|.+.... .. ..+.+..+..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 68999999999999999999965 68999999986442 22 22334455567888899999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc-CCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH-SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
|+ ++++..+.... ...+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 44555444322 23488999999999999999999985 8 999999999999999999999999999765432
Q ss_pred CCccccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc----------cchh
Q 037681 229 ESKANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING----------YDQT 293 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----------~~~~ 293 (334)
.. .....||+.|+|||.+. +..++.++||||||+++|+|++|+.||.........+.. ....
T Consensus 179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 21 23356899999999984 456888999999999999999999999764322110000 0011
Q ss_pred cccchhhhccccccCCccchhhhhhhhhccC
Q 037681 294 QVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
....+.+++..||..+|.+|+++.++....+
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 3456889999999999999999988776543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.90 Aligned_cols=229 Identities=21% Similarity=0.290 Sum_probs=187.7
Q ss_pred hcCCCcCCccccCCcccEEEEEec--CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc-----
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA--KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE----- 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 143 (334)
.++|++.+.||+|+||.||+|.+. +|+.||||.+... .......+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999965 5889999988643 34455678899999999999999999999988766
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ .+||+|||++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999877633 4899999999999999999999998 9999999999999885 89999999998
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccchhcccchhhhcc
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIKLVE 303 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 303 (334)
..... ....||+.|+|||++.+.. +.++||||||+++|+|++|.+|+.........-..........+.+++.
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 302 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLR 302 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHH
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHh
Confidence 65432 3356999999999987654 8899999999999999999998875433221111111113456788999
Q ss_pred ccccCCccchhhh
Q 037681 304 SCLARPFRQYCCI 316 (334)
Q Consensus 304 ~~l~~~~~~~~~~ 316 (334)
+||..+|.+|++.
T Consensus 303 ~~l~~dP~~R~~~ 315 (681)
T 2pzi_A 303 RAIDPDPRQRFTT 315 (681)
T ss_dssp HHTCSSGGGSCSS
T ss_pred hhccCChhhCCCH
Confidence 9999999999853
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=296.85 Aligned_cols=222 Identities=15% Similarity=0.150 Sum_probs=174.7
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcC---------CCCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS--------RQGLQELKNEALVIAKVQ---------HKNLVRL 134 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~iv~~ 134 (334)
.++|++.+.||+|+||+||+|++ +|+.||+|++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46899999999999999999998 68999999997542 223477889999998886 6666666
Q ss_pred eeEE-----------------Ee-------------cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHH
Q 037681 135 LGCC-----------------IE-------------RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEG 184 (334)
Q Consensus 135 ~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~ 184 (334)
.+++ .+ .+..|+||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 6553 32 6788999999999976555532 237899999999999999
Q ss_pred HHHhh-hcCCCCeEeccCCCCCeeeCCCC--------------------ceEEeeccccccccCCCCccccccccccCCc
Q 037681 185 LLYLH-LHSRVRIIHRDLKASNILLDKEM--------------------KPKISDFGMARIFKGNESKANTNRVAGTFGY 243 (334)
Q Consensus 185 l~~LH-~~~~~~ivH~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y 243 (334)
|+||| +++ |+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 898 99999999999999887 8999999999865432 34799999
Q ss_pred cCccccccCCCCcchhhHhHHHH-HHHHHhCCCCCCCcc--------------CCcccccccchhcccchhhhccccccC
Q 037681 244 IPPEYVYQGICSIKSDVFSFGML-LLEILSGKKNTEFYH--------------TGYLSINGYDQTQVASKIKLVESCLAR 308 (334)
Q Consensus 244 ~aPE~~~~~~~~~~~DiwslG~i-l~ell~g~~p~~~~~--------------~~~~~~~~~~~~~~~~~~~~i~~~l~~ 308 (334)
+|||++.+.. +.++||||+|++ .+++++|..||.... ................+.+++..||..
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 322 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF 322 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence 9999998766 889999998777 788899999985421 000111111122456788999999987
Q ss_pred C
Q 037681 309 P 309 (334)
Q Consensus 309 ~ 309 (334)
+
T Consensus 323 d 323 (336)
T 2vuw_A 323 S 323 (336)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=277.52 Aligned_cols=212 Identities=10% Similarity=0.034 Sum_probs=175.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 68999999999999999999965 48999999997442 344577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++++|.+++... .....+..++.|++.||+|||+++ |+||||||+||+++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999998432 244567889999999999999998 9999999999999999999998443
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------cc-------ccchhcc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------IN-------GYDQTQV 295 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~-------~~~~~~~ 295 (334)
|++ .++.++||||||+++|||++|+.||......... .. .......
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence 233 2678999999999999999999999865442110 00 1111245
Q ss_pred cchhhhccccccCCccchhhhhhhhhc
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
..+.+++.+||..+|..| ++.++...
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 568899999999999999 88776654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=276.88 Aligned_cols=219 Identities=22% Similarity=0.259 Sum_probs=177.0
Q ss_pred cCCCcC-CccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHH-HhcCCCCcceEeeEEEe----cCcce
Q 037681 73 NNFSDT-NKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVI-AKVQHKNLVRLLGCCIE----RDEKL 145 (334)
Q Consensus 73 ~~y~~~-~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~ 145 (334)
++|.+. +.||+|+||.||+|.+ .+++.||+|.+... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 678877 7799999999999996 46899999998632 4567788887 55689999999999987 66789
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEeecccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKISDFGMA 222 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~ 222 (334)
+||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999987643 234899999999999999999999998 999999999999988 788999999998
Q ss_pred ccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--ccc--------cc-
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--ING--------YD- 291 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~--------~~- 291 (334)
.... +..++.++||||||+++|||++|+.||......... ... ..
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 6422 244677899999999999999999999654322100 000 00
Q ss_pred ---hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 292 ---QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 292 ---~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
......+.+++..||..+|.+|+++.++....+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 113556888999999999999999998877544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=291.07 Aligned_cols=239 Identities=17% Similarity=0.173 Sum_probs=178.3
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCC-CCcce--------------
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQH-KNLVR-------------- 133 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~iv~-------------- 133 (334)
.+|...+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+.++..++| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577889999999999999994 469999999987332 2336778999999999977 22111
Q ss_pred -------EeeEEEe-----cCcceEEEEecCCCChhhhhhhc----ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 037681 134 -------LLGCCIE-----RDEKLLIYEYLPNKSLDFFLFDA----TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRII 197 (334)
Q Consensus 134 -------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv 197 (334)
+..++.. ....+++|+++ +++|.+++... .....+++..++.++.|++.||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 12346666654 67888877421 12345788899999999999999999998 99
Q ss_pred eccCCCCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCcccc----------ccCCCCcchhhHhHHHHH
Q 037681 198 HRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV----------YQGICSIKSDVFSFGMLL 267 (334)
Q Consensus 198 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DiwslG~il 267 (334)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999998764322 334567 999999998 555688899999999999
Q ss_pred HHHHhCCCCCCCccCCccc--ccccchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 268 LEILSGKKNTEFYHTGYLS--INGYDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 268 ~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
|||++|+.||......... ........+..+.+++..||..+|.+|+++.++..
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999765433111 11111124567889999999999999999766544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=271.06 Aligned_cols=185 Identities=17% Similarity=0.138 Sum_probs=129.2
Q ss_pred ccccCCcccEEEEE-ecCCCEEEEEEeccc----------ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEE
Q 037681 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVR----------SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 80 ~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 147 (334)
..+.|++|.+..++ .-.|+.+++|.+... .....+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45566666665554 335889999998543 123346789999999999 699999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||++|++|.+++.... +++.. +|+.||+.||+|+|++| ||||||||+|||++.+|++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999996543 35543 58899999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCC
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKN 276 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 276 (334)
... .....+||+.|+|||++.+ .+..++|+||+|++++++.+|..|
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 322 2345689999999998865 456789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=242.32 Aligned_cols=186 Identities=21% Similarity=0.189 Sum_probs=145.5
Q ss_pred CcCCccccCCcccEEEEEecCCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 76 SDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRS--------RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 76 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
...+.||+|+||.||+|.. .+..+++|+..... ....+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 47889998764321 11234578999999999999999666666678888999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998854 4579999999999999998 999999999999998 999999999987643
Q ss_pred CCCcc-----ccccccccCCccCcccccc--CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 037681 228 NESKA-----NTNRVAGTFGYIPPEYVYQ--GICSIKSDVFSFGMLLLEILSGKKNTE 278 (334)
Q Consensus 228 ~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~ 278 (334)
..... ......||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 22111 1235679999999999976 567888999999999999888887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=200.89 Aligned_cols=148 Identities=20% Similarity=0.138 Sum_probs=118.6
Q ss_pred HhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccCh------------------hhHHHHHHHHHHHHhcCCCCc
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR------------------QGLQELKNEALVIAKVQHKNL 131 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i 131 (334)
.....|.+.+.||+|+||.||+|.+.+|+.||+|.++.... .....+.+|+.++++++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 34456667799999999999999997799999999864321 13456889999999999 4
Q ss_pred ceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC
Q 037681 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE 211 (334)
Q Consensus 132 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 211 (334)
+++.+++. .+..|+||||+++++|.+ +.. .....++.|++.||.|||+++ |+||||||+|||++ +
T Consensus 164 ~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 164 LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence 56666543 356799999999999977 311 223469999999999999998 99999999999999 9
Q ss_pred CceEEeeccccccccCCCCccccccccccCCccCccccc
Q 037681 212 MKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250 (334)
Q Consensus 212 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 250 (334)
+.+||+|||++.. +..+.|||.+.
T Consensus 229 ~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999999999853 34578898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=171.93 Aligned_cols=137 Identities=18% Similarity=0.167 Sum_probs=105.9
Q ss_pred CCCcCCccccCCcccEEEEEe-cCCCE--EEEEEecccChh------------------------hHHHHHHHHHHHHhc
Q 037681 74 NFSDTNKLGEGGFGPVYKGVL-AKGDE--IAVKRLSVRSRQ------------------------GLQELKNEALVIAKV 126 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~-~~~~~--vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l 126 (334)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367788999999999999997 67888 999987533111 113578899999999
Q ss_pred CCCCc--ceEeeEEEecCcceEEEEecCC-C----ChhhhhhhcccccccchHHHHHHHHHHHHHHHHhh-hcCCCCeEe
Q 037681 127 QHKNL--VRLLGCCIERDEKLLIYEYLPN-K----SLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH-LHSRVRIIH 198 (334)
Q Consensus 127 ~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH 198 (334)
.|+++ +.+++. +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| +++ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88764 344432 367899999942 4 45443311 235567789999999999999 888 999
Q ss_pred ccCCCCCeeeCCCCceEEeeccccccc
Q 037681 199 RDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 199 ~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.4e-20 Score=163.57 Aligned_cols=138 Identities=14% Similarity=0.175 Sum_probs=99.8
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccCh--------------hhHH--------HHHHHHHHHHhcCCCC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR--------------QGLQ--------ELKNEALVIAKVQHKN 130 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~~ 130 (334)
.-|++.+.||+|++|.||+|...+|+.||||+++.... .... ...+|...|.++.+++
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34999999999999999999988999999998752200 0001 1235666666665444
Q ss_pred cceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC
Q 037681 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK 210 (334)
Q Consensus 131 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 210 (334)
+.-..-+. ....++||||++|++|..+. +......++.|++.+|.+||++| ||||||||.|||+++
T Consensus 175 v~vp~p~~--~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIA--QSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEE--EETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCCeeee--ccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 32111111 12347999999998875443 11233568899999999999998 999999999999987
Q ss_pred CC----------ceEEeecccccc
Q 037681 211 EM----------KPKISDFGMARI 224 (334)
Q Consensus 211 ~~----------~~kl~Dfg~~~~ 224 (334)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=3e-14 Score=121.67 Aligned_cols=146 Identities=15% Similarity=0.088 Sum_probs=113.2
Q ss_pred HHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEE
Q 037681 69 AAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 69 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 147 (334)
.....+|.+...++.|+.+.||++... ++.+++|............+.+|+.+++.+. +..+.++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 334467888888998999999998754 7889999886432223346888999999884 67788999999988899999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS----------------------------------- 192 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------- 192 (334)
|||++|.++..... +......++.+++.++..||+..
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999865421 12233468889999999999810
Q ss_pred ---------------------CCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 193 ---------------------RVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 193 ---------------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999876556799998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=7.3e-13 Score=112.72 Aligned_cols=137 Identities=16% Similarity=0.148 Sum_probs=98.9
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN--LVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~ 150 (334)
.+|.+....+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345543333456669999998767788999987543 2245778999998886444 55688888887888999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS-------------------------------------- 192 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------- 192 (334)
++|.++. ... .+ ...++.+++..+..||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 110 11 1246677777888887643
Q ss_pred -----------------CCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 193 -----------------RVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 193 -----------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-11 Score=108.75 Aligned_cols=142 Identities=13% Similarity=0.239 Sum_probs=104.7
Q ss_pred cCCccccCCcccEEEEEecCCCEEEEEEec--ccC-hhhHHHHHHHHHHHHhcC--CCCcceEeeEEEec---CcceEEE
Q 037681 77 DTNKLGEGGFGPVYKGVLAKGDEIAVKRLS--VRS-RQGLQELKNEALVIAKVQ--HKNLVRLLGCCIER---DEKLLIY 148 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~ 148 (334)
.++.++.|.++.||++... +..+++|+.. ... ......+.+|..+++.+. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999998765 4678888765 221 122356788999999997 45578888888776 4579999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS------------------------------------ 192 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------ 192 (334)
||++|..+.+.. ...++......++.+++.+|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774321 112567777889999999999999731
Q ss_pred -------------------CCCeEeccCCCCCeeeCCCCc--eEEeecccccc
Q 037681 193 -------------------RVRIIHRDLKASNILLDKEMK--PKISDFGMARI 224 (334)
Q Consensus 193 -------------------~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~ 224 (334)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=106.88 Aligned_cols=183 Identities=19% Similarity=0.177 Sum_probs=119.1
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCC--cceEeeEEEecC---cceEEEEec
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKN--LVRLLGCCIERD---EKLLIYEYL 151 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~~ 151 (334)
++.++.|....||++. ..+++|.... ......+.+|..+++.+. +.. +.+++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 5688887542 234567889999998883 333 344554443333 358999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH---------------------------------------- 191 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------------------------------------- 191 (334)
+|.++..... ..++...+..++.+++..+..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988864321 1256666777888888888888851
Q ss_pred ---------------CCCCeEeccCCCCCeeeCC--CCceEEeeccccccccCCCCccccccccccCCc---cCcccccc
Q 037681 192 ---------------SRVRIIHRDLKASNILLDK--EMKPKISDFGMARIFKGNESKANTNRVAGTFGY---IPPEYVYQ 251 (334)
Q Consensus 192 ---------------~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y---~aPE~~~~ 251 (334)
....++|+|++|.||+++. +..+.|+||+.+..-..... ....... ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHH
Confidence 1134899999999999988 45688999998864321100 0001111 12221110
Q ss_pred -----CCC---------CcchhhHhHHHHHHHHHhCCCCC
Q 037681 252 -----GIC---------SIKSDVFSFGMLLLEILSGKKNT 277 (334)
Q Consensus 252 -----~~~---------~~~~DiwslG~il~ell~g~~p~ 277 (334)
+.. ..-.+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001 11268999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=7.2e-08 Score=83.88 Aligned_cols=136 Identities=21% Similarity=0.194 Sum_probs=91.1
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC---CcceEeeEEE-ecCcceEEEEecCC
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHK---NLVRLLGCCI-ERDEKLLIYEYLPN 153 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~ 153 (334)
++.++.|....||.. |..+++|.. ........+..|..+++.+.+. .+.+.+.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 567888874 2334456788999999999652 3566666664 34567899999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH------------------------------------------ 191 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------------------------------------------ 191 (334)
..+...... .++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888652110 023333334444444444444432
Q ss_pred ---------------CCCCeEeccCCCCCeeeCC---CCc-eEEeecccccc
Q 037681 192 ---------------SRVRIIHRDLKASNILLDK---EMK-PKISDFGMARI 224 (334)
Q Consensus 192 ---------------~~~~ivH~dlkp~Nill~~---~~~-~kl~Dfg~~~~ 224 (334)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2334799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.9e-07 Score=78.42 Aligned_cols=134 Identities=16% Similarity=0.158 Sum_probs=94.8
Q ss_pred ccccCCcc-cEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 80 KLGEGGFG-PVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 80 ~lg~G~~g-~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
.+..|..| .||+.... ++..+++|.-... ....+.+|...|+.+. +--+.+++.++.+.+..|+|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44455554 58987754 4567888876432 3456788999998884 33367888899999999999999999887
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcC--------------------------------------------
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS-------------------------------------------- 192 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------------- 192 (334)
...... .......+..+++..|.-||...
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654321 11223346666777777777421
Q ss_pred -----------CCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 193 -----------RVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 193 -----------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
...++|+|+.+.||++++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1128999999999999987777799998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=1.3e-07 Score=84.13 Aligned_cols=80 Identities=9% Similarity=-0.007 Sum_probs=54.6
Q ss_pred CCcc-ccCCcccEEEEEec-------CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcC-C--CCcceEeeEEEec--
Q 037681 78 TNKL-GEGGFGPVYKGVLA-------KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQ-H--KNLVRLLGCCIER-- 141 (334)
Q Consensus 78 ~~~l-g~G~~g~V~~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~-- 141 (334)
.+.| +.|....+|+.... ++..+++|...... ......+..|..+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999988754 25678888764322 101245678888888874 2 3567788877655
Q ss_pred -CcceEEEEecCCCChh
Q 037681 142 -DEKLLIYEYLPNKSLD 157 (334)
Q Consensus 142 -~~~~lv~e~~~~~~L~ 157 (334)
+..|+||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.40 E-value=1.9e-06 Score=75.80 Aligned_cols=141 Identities=13% Similarity=0.136 Sum_probs=77.8
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC--CCcceEee------EEEecCcceEEEEe
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH--KNLVRLLG------CCIERDEKLLIYEY 150 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~------~~~~~~~~~lv~e~ 150 (334)
+.|+.|..+.||++...+| .+++|..... . ..+..|..++..+.. -.+.+++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999876544 5888988642 2 233445555554421 12333332 12345677899999
Q ss_pred cCCCChhh--------------hhhhccccc--c---------cchHH-------------------------------H
Q 037681 151 LPNKSLDF--------------FLFDATKRV--L---------LELGT-------------------------------R 174 (334)
Q Consensus 151 ~~~~~L~~--------------~l~~~~~~~--~---------l~~~~-------------------------------~ 174 (334)
++|..+.. .++...... + ..+.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99865420 011110000 0 01110 0
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 175 LQIIEGIVEGLLYLHL----------HSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 175 ~~i~~qi~~~l~~LH~----------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
..+..++..++.+|+. .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223445666653 1234599999999999998788899999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2e-06 Score=77.57 Aligned_cols=75 Identities=11% Similarity=0.217 Sum_probs=49.9
Q ss_pred CCccccCCcccEEEEEec-CCCEEEEEEecccCh-------hhHHHHHHHHHHHHhcCC--CC-cceEeeEEEecCcceE
Q 037681 78 TNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR-------QGLQELKNEALVIAKVQH--KN-LVRLLGCCIERDEKLL 146 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~l 146 (334)
.+.+|.|..+.||++... ++..+++|....... .....+..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 468899997653211 123456778888887742 33 4455543 4556789
Q ss_pred EEEecCCC
Q 037681 147 IYEYLPNK 154 (334)
Q Consensus 147 v~e~~~~~ 154 (334)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.21 E-value=9e-06 Score=69.84 Aligned_cols=79 Identities=19% Similarity=0.232 Sum_probs=57.9
Q ss_pred CCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC---CcceEeeEEEecCcceEEEEe
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHK---NLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~lv~e~ 150 (334)
...-++.+|.|..+.||+....+|+.+++|+...........+..|...|+.+... -+.+++.+ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 34456789999999999999999999999987544444445678899999888422 24445543 245899999
Q ss_pred cCCCCh
Q 037681 151 LPNKSL 156 (334)
Q Consensus 151 ~~~~~L 156 (334)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.8e-05 Score=67.45 Aligned_cols=75 Identities=17% Similarity=0.099 Sum_probs=59.6
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCcceEeeEEEecCcceEEEEecCCC
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ---HKNLVRLLGCCIERDEKLLIYEYLPNK 154 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~ 154 (334)
.+.|+.|....+|+... ++..+++|..... ....+..|...|+.+. ...+++++.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999875 4678888876532 3466788988888874 356888888888888899999999998
Q ss_pred Ch
Q 037681 155 SL 156 (334)
Q Consensus 155 ~L 156 (334)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.3e-05 Score=70.08 Aligned_cols=73 Identities=15% Similarity=0.211 Sum_probs=45.2
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEeccc----Chh-----hHHHHHHHHHHHH-hcCCCCcceEeeEEEecCcceEE
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR----SRQ-----GLQELKNEALVIA-KVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~----~~~-----~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
.+.||.|..+.||++.. ++..+++|..... ... ....+..|+..+. ......+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999864 4678999953221 010 1223333433322 22334566677665 5678999
Q ss_pred EEec-CC
Q 037681 148 YEYL-PN 153 (334)
Q Consensus 148 ~e~~-~~ 153 (334)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.84 E-value=6.4e-05 Score=65.46 Aligned_cols=143 Identities=16% Similarity=0.077 Sum_probs=76.5
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cceEeeE------EEecCcceEEEEe
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN--LVRLLGC------CIERDEKLLIYEY 150 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e~ 150 (334)
+.|+.|....+|+....+| .+++|..... .....+..|..++..+...+ +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4566788889999876655 6788887642 11234556777776663212 2333321 1234567899999
Q ss_pred cCCCChhhh--------------hhhcccc--cc-------cchHHHHH------------HHHHHHHHHHHhhhc----
Q 037681 151 LPNKSLDFF--------------LFDATKR--VL-------LELGTRLQ------------IIEGIVEGLLYLHLH---- 191 (334)
Q Consensus 151 ~~~~~L~~~--------------l~~~~~~--~~-------l~~~~~~~------------i~~qi~~~l~~LH~~---- 191 (334)
++|..+... ++..... .+ ..+..... +...+...++.+...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 998654210 1110000 00 01111000 001133444555432
Q ss_pred CCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 192 ~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
....++|+|+.+.||++++++.+.++||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 133599999999999998876568999987753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=9.5e-05 Score=65.87 Aligned_cols=142 Identities=21% Similarity=0.248 Sum_probs=81.1
Q ss_pred CCccccCCcccEEEEEec--------CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcceEEE
Q 037681 78 TNKLGEGGFGPVYKGVLA--------KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++.+..|-...+|++... ++..+++|+.... ......+.+|..+++.+. +.-..++++.+.+ -+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888889998864 2468888875322 223456678999988874 3223566666543 2899
Q ss_pred EecCCCChhhh-h----------------hhcc---ccccc-chHHHHHHHHHHHH-------------------HHHH-
Q 037681 149 EYLPNKSLDFF-L----------------FDAT---KRVLL-ELGTRLQIIEGIVE-------------------GLLY- 187 (334)
Q Consensus 149 e~~~~~~L~~~-l----------------~~~~---~~~~l-~~~~~~~i~~qi~~-------------------~l~~- 187 (334)
||++|.++..- + +... .+.+. -+.++.++..++.. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998766321 0 0000 00011 12344444443321 1222
Q ss_pred ---hhhc-CCCCeEeccCCCCCeeeCCC----CceEEeecccccc
Q 037681 188 ---LHLH-SRVRIIHRDLKASNILLDKE----MKPKISDFGMARI 224 (334)
Q Consensus 188 ---LH~~-~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~ 224 (334)
|... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2221 22348999999999999876 6899999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00028 Score=61.68 Aligned_cols=32 Identities=31% Similarity=0.510 Sum_probs=27.2
Q ss_pred CCCeEeccCCCCCeeeCCC----CceEEeecccccc
Q 037681 193 RVRIIHRDLKASNILLDKE----MKPKISDFGMARI 224 (334)
Q Consensus 193 ~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~ 224 (334)
...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3459999999999999874 6799999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.78 E-value=5.5e-05 Score=65.30 Aligned_cols=71 Identities=10% Similarity=0.181 Sum_probs=44.1
Q ss_pred CCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-ceEeeEEEecCcceEEEEec-CCCC
Q 037681 78 TNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL-VRLLGCCIERDEKLLIYEYL-PNKS 155 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~~ 155 (334)
++.|+.|....+|++ ..+++|......... .....|..+++.+...++ .+++.. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678888999999998 457888765432211 123457777776643233 455544 344567899999 6655
Q ss_pred h
Q 037681 156 L 156 (334)
Q Consensus 156 L 156 (334)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.77 E-value=5.4e-05 Score=68.81 Aligned_cols=73 Identities=15% Similarity=0.267 Sum_probs=48.8
Q ss_pred CCccccCCcccEEEEEecC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-ceEeeEEEecCcceEEE
Q 037681 78 TNKLGEGGFGPVYKGVLAK--------GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL-VRLLGCCIERDEKLLIY 148 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 148 (334)
++.|+.|....+|++...+ +..+++|+..... ....+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567788889999998653 4788888774311 11445578888888753333 566665532 3899
Q ss_pred EecCCCCh
Q 037681 149 EYLPNKSL 156 (334)
Q Consensus 149 e~~~~~~L 156 (334)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00014 Score=66.47 Aligned_cols=74 Identities=11% Similarity=0.078 Sum_probs=47.0
Q ss_pred CCccccCCcccEEEEEecC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-ceEeeEEEecCcceEEEEecCCCC
Q 037681 78 TNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL-VRLLGCCIERDEKLLIYEYLPNKS 155 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~ 155 (334)
++.|+.|-...+|++...+ +..+++|+......... .-..|..++..+...++ .++++.+. + .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3567778888999988764 46788887643222111 12578888888865555 56776662 2 35999999865
Q ss_pred h
Q 037681 156 L 156 (334)
Q Consensus 156 L 156 (334)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00057 Score=59.53 Aligned_cols=76 Identities=8% Similarity=0.037 Sum_probs=48.6
Q ss_pred CccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cceEeeE-----EEecCcceEEEEec
Q 037681 79 NKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN--LVRLLGC-----CIERDEKLLIYEYL 151 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~lv~e~~ 151 (334)
..++ |....||++...+|+.+++|...... .....+..|..++..+...+ +++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 77889998876667789999886321 12345667887777774222 3444432 12245567899999
Q ss_pred CCCCh
Q 037681 152 PNKSL 156 (334)
Q Consensus 152 ~~~~L 156 (334)
+|..+
T Consensus 110 ~G~~~ 114 (328)
T 1zyl_A 110 GGRQF 114 (328)
T ss_dssp CCEEC
T ss_pred CCCCC
Confidence 88654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00034 Score=61.45 Aligned_cols=31 Identities=26% Similarity=0.387 Sum_probs=27.2
Q ss_pred CCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 194 VRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 194 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999878899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00017 Score=64.04 Aligned_cols=74 Identities=15% Similarity=0.114 Sum_probs=44.0
Q ss_pred CCccccCCcccEEEEEecC---------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-cceEeeEEEecCcceEE
Q 037681 78 TNKLGEGGFGPVYKGVLAK---------GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN-LVRLLGCCIERDEKLLI 147 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 147 (334)
.+.++.|....+|++...+ +..+++|........ ......|..+++.+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3567778888999987543 267888876433221 112357788887775333 44666543 2 3789
Q ss_pred EEecCCCCh
Q 037681 148 YEYLPNKSL 156 (334)
Q Consensus 148 ~e~~~~~~L 156 (334)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.013 Score=52.87 Aligned_cols=74 Identities=12% Similarity=0.107 Sum_probs=47.3
Q ss_pred CCccccCCcccEEEEEecC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-cceEeeEEEecCcceEEE
Q 037681 78 TNKLGEGGFGPVYKGVLAK--------GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN-LVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 148 (334)
++.+..|-...+|+....+ +..+++++....... .-...+|..+++.+...+ ..++++.+ . -+.|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3567667778899988653 578888876433222 122357888887774322 45555533 2 37899
Q ss_pred EecCCCCh
Q 037681 149 EYLPNKSL 156 (334)
Q Consensus 149 e~~~~~~L 156 (334)
||++|..+
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.31 E-value=0.013 Score=47.29 Aligned_cols=99 Identities=15% Similarity=0.095 Sum_probs=63.4
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCccc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKAN 233 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 233 (334)
-+|.+.|.... .+++++++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|+|...+ +.+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 36788886543 469999999999999999877621110 11334457899999999887764 1110
Q ss_pred cccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh
Q 037681 234 TNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS 272 (334)
Q Consensus 234 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 272 (334)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123467888653 445678899999999999885
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.90 E-value=0.029 Score=50.20 Aligned_cols=29 Identities=31% Similarity=0.465 Sum_probs=24.7
Q ss_pred eEeccCCCCCeee------CCCCceEEeecccccc
Q 037681 196 IIHRDLKASNILL------DKEMKPKISDFGMARI 224 (334)
Q Consensus 196 ivH~dlkp~Nill------~~~~~~kl~Dfg~~~~ 224 (334)
++|+|+.+.||++ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4456799999998754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.01 E-value=0.15 Score=41.06 Aligned_cols=126 Identities=13% Similarity=0.095 Sum_probs=83.2
Q ss_pred cCCCCcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCC
Q 037681 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASN 205 (334)
Q Consensus 126 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N 205 (334)
..||++++. .+-.+.+...+.++ ...+...+-. -..++...+++++.+|+....+++. -+|--++|+|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~--~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYD--INDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEEC--CCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred ccCCcccce-EEEEcccEEEEEEE--cCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 368888876 45455554444444 3333333321 1126788889999999988766653 3688899999
Q ss_pred eeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc
Q 037681 206 ILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL 285 (334)
Q Consensus 206 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 285 (334)
++++.++.+++.-.|+... ++|. ..+...=.-.+=+++..+++++..|+.+-.+..
T Consensus 110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~l 165 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNL 165 (215)
T ss_dssp EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCG
T ss_pred EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChH
Confidence 9999999999987776432 1222 111122244677889999999999998877765
Q ss_pred cc
Q 037681 286 SI 287 (334)
Q Consensus 286 ~~ 287 (334)
.+
T Consensus 166 el 167 (215)
T 4ann_A 166 EL 167 (215)
T ss_dssp GG
T ss_pred hh
Confidence 55
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.21 E-value=0.059 Score=31.08 Aligned_cols=8 Identities=63% Similarity=0.941 Sum_probs=3.3
Q ss_pred HHHHHhhh
Q 037681 13 AFYLRRKL 20 (334)
Q Consensus 13 ~~~~~~k~ 20 (334)
++|+||++
T Consensus 31 ~~~~RRRr 38 (44)
T 2l2t_A 31 AVYVRRKS 38 (44)
T ss_dssp HHHHHTTC
T ss_pred HHHhhhhh
Confidence 34444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.18 E-value=0.07 Score=30.70 Aligned_cols=18 Identities=17% Similarity=0.279 Sum_probs=8.1
Q ss_pred HHHHHHHHHHHHhhhhcc
Q 037681 6 FVNLVIVAFYLRRKLKSK 23 (334)
Q Consensus 6 ~~~~~~~~~~~~~k~~~~ 23 (334)
+++++++.+|+||++.++
T Consensus 25 vi~~l~~~~~~RRR~~~~ 42 (44)
T 2jwa_A 25 VVLGVVFGILIKRRQQKI 42 (44)
T ss_dssp HHHHHHHHHHHHHHCSCC
T ss_pred HHHHHHHHhheehhhhhc
Confidence 333344445555554443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.05 E-value=0.068 Score=30.90 Aligned_cols=8 Identities=25% Similarity=0.858 Sum_probs=3.3
Q ss_pred HHHHHhhh
Q 037681 13 AFYLRRKL 20 (334)
Q Consensus 13 ~~~~~~k~ 20 (334)
++|+||++
T Consensus 32 ~~~~RRr~ 39 (44)
T 2ks1_B 32 GLFMRRRH 39 (44)
T ss_dssp HHHHHTTT
T ss_pred HHHhhhhH
Confidence 34444433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.32 E-value=1.1 Score=36.19 Aligned_cols=119 Identities=11% Similarity=0.091 Sum_probs=76.4
Q ss_pred CCCCcceEeeEEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHH-HhhhcCCCCeEeccCCCCC
Q 037681 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL-YLHLHSRVRIIHRDLKASN 205 (334)
Q Consensus 127 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH~dlkp~N 205 (334)
.||++ -..+-.+.+...+.++--+++.-...+ . .++...+++++.+|+.... +++. -+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~---~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---R---KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---H---TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---H---hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 68888 333335555555555543332111122 1 2678888999999988777 5542 4688899999
Q ss_pred eeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccC
Q 037681 206 ILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT 282 (334)
Q Consensus 206 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 282 (334)
++++.++.+++.-.|+-.. ++|.-+ +..-=.-.+=+++..++.++..|+.+-.
T Consensus 115 L~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe~l~~ 167 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFDEYLK 167 (219)
T ss_dssp EEECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHHHHHH
T ss_pred EEEeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHHHHHh
Confidence 9999999999987776432 233211 1111234677888889999998877655
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.64 E-value=0.18 Score=45.94 Aligned_cols=60 Identities=12% Similarity=0.079 Sum_probs=17.0
Q ss_pred cCCccccCCcccEEEEEecC-CCEEEE------EEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEE
Q 037681 77 DTNKLGEGGFGPVYKGVLAK-GDEIAV------KRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~~~-~~~vai------K~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 139 (334)
+.+.|| ||.||+|.+.. ..+||+ |..... ..+....+.+|..++..++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345665 99999999653 357888 655422 2333456778888899999999999888754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 334 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-61
Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+ ++G G FG VYKG + + ++ + Q LQ KNE V+ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+G + ++ ++ SL L + E+ + I +G+ YLH S
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY-- 250
IIHRDLK++NI L +++ KI DFG+A + +++G+ ++ PE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 251 -QGICSIKSDVFSFGMLLLEILSGKK 275
+ S +SDV++FG++L E+++G+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-57
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 71 ATNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGL-QELKNEALVIAKVQH 128
++F ++LG G G V+K G +A K + + + + ++ E V+ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
+V G E + E++ SLD L K + ++ +++GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
+ +I+HRD+K SNIL++ + K+ DFG++ + N GT Y+ PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGK 274
+ S++SD++S G+ L+E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 8e-57
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+LG G FG V+ G ++AVK L + EA ++ ++QH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
RL + + +I EY+ N SL FL + L + L + I EG+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
IHRDL+A+NIL+ + KI+DFG+AR+ + NE A + PE + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 253 ICSIKSDVFSFGMLLLEILSGKK 275
+IKSDV+SFG+LL EI++ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-54
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 7/203 (3%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+ + ++G G FG V+ G D++A+K + ++ EA V+ K+ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+L G C+E+ L++E++ + L +L E T L + + EG+ YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEA- 120
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
+IHRDL A N L+ + K+SDFGM R ++ ++ + PE
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 253 ICSIKSDVFSFGMLLLEILSGKK 275
S KSDV+SFG+L+ E+ S K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-53
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 7/203 (3%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+ KLG+G FG V+ G +A+K L + EA V+ K++H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+L + ++ EY+ SL FL T + L + + I G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERM- 132
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
+HRDL+A+NIL+ + + K++DFG+AR+ + NE A + PE G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 253 ICSIKSDVFSFGMLLLEILSGKK 275
+IKSDV+SFG+LL E+ + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR 212
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-52
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 7/203 (3%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+ + +LG G FG V G ++A+K + E EA V+ + H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
+L G C ++ +I EY+ N L +L + R + L++ + + E + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
+ +HRDL A N L++ + K+SDFG++R +E ++ + PPE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMYS 176
Query: 253 ICSIKSDVFSFGMLLLEILSGKK 275
S KSD+++FG+L+ EI S K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (438), Expect = 2e-52
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 22/230 (9%)
Query: 63 FSFSSVAAATNNFSDT---------NKLGEGGFGPVYKGVLAKGDE----IAVKRL-SVR 108
F+F A F+ +G G FG V G L + +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 109 SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL 168
+ + ++ +EA ++ + H N++ L G + ++I E++ N SLD FL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 169 LELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228
+ + ++ GI G+ YL +HRDL A NIL++ + K+SDFG++R + +
Sbjct: 127 VI--QLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 229 ESKANTNRVAG---TFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
S G + PE + + SDV+S+G+++ E++S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-52
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 79 NKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGC 137
+LG+G FG VYK + A K + +S + L++ E ++A H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 138 CIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRII 197
+ ++ E+ ++D + + + L + + ++ L YLH + +II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 198 HRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY-----QG 252
HRDLKA NIL + K++DFG++ + ++ GT ++ PE V
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 190
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
K+DV+S G+ L+E+ +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE 212
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 9e-52
Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 20/235 (8%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKN 130
++ +G G +G K + G + K L S Q L +E ++ +++H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 131 LVRLLGCCIERDEKLL--IYEYLPNKSLDFFLFDATK-RVLLELGTRLQIIEGIVEGLLY 187
+VR I+R L + EY L + TK R L+ L+++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 188 LHLHSRV--RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
H S ++HRDLK +N+ LD + K+ DFG+ARI + S A GT Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIK 300
PE + + + KSD++S G LL E+ + Q ++A KI+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYEL----------CALMPPFTAFSQKELAGKIR 227
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-51
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+G+G FG V G +G+++AVK + ++ Q EA V+ +++H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 133 RLLGCCIERDEKL-LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
+LLG +E L ++ EY+ SL +L R +L L+ + E + YL +
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
+HRDL A N+L+ ++ K+SDFG+ + E+ + + + PE + +
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 252 GICSIKSDVFSFGMLLLEILSGKK 275
S KSDV+SFG+LL EI S +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 3e-51
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 75 FSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG---LQELKNEALVIAKVQHKN 130
FSD ++G G FG VY + + +A+K++S +Q Q++ E + K++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
++ GC + L+ EY + D + L+ + G ++GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV- 249
H +IHRD+KA NILL + K+ DFG A I N GT ++ PE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVIL 184
Query: 250 --YQGICSIKSDVFSFGMLLLEILSGK 274
+G K DV+S G+ +E+ K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-51
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSV-RSRQGLQELKNEALVIAKVQHKN 130
++ LGEG +G V V + +AVK + + R+ + +K E + + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+V+ G E + + L EY L + + + + ++ G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
I HRD+K N+LLD+ KISDFG+A +F+ N + N++ GT Y+ PE +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 251 -QGICSIKSDVFSFGMLLLEILSGK 274
+ + DV+S G++L +L+G+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 2e-50
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 7/204 (3%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
+ + +KLG G +G VY+GV K +AVK L ++E EA V+ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
V+LLG C +I E++ +L +L + R + L + I + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
IHRDL A N L+ + K++DFG++R+ G+ A+ + PE +
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 252 GICSIKSDVFSFGMLLLEILSGKK 275
SIKSDV++FG+LL EI +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-50
Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 21/236 (8%)
Query: 71 ATNNFS-DTNKLGEGGFGPVYKGVLA---KGDEIAVKRLSVRSRQG-LQELKNEALVIAK 125
+N +LG G FG V +GV K ++A+K L + + +E+ EA ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185
+ + +VRL+G C + + +L+ E L FL KR + + +++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES-KANTNRVAGTFGYI 244
YL + +HRDL A N+LL KISDFG+++ ++S + +
Sbjct: 123 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIK 300
PE + S +SDV+S+G+ + E LS G +V + I+
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALS---------YGQKPYKKMKGPEVMAFIE 226
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-50
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 79 NKLGEGGFGPVYKGVLAK-GDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLL 135
++G G F VYKG+ + E+A L R ++ Q K EA ++ +QH N+VR
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 136 GCCIE----RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
+ +L+ E + + +L +L + ++++ I++GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 192 SRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
+ IIHRDLK NI + KI D G+A + + + V GT ++ PE +Y
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE-MY 185
Query: 251 QGICSIKSDVFSFGMLLLEILSGKK 275
+ DV++FGM +LE+ + +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-50
Identities = 58/212 (27%), Positives = 112/212 (52%), Gaps = 10/212 (4%)
Query: 64 SFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALV 122
S SV ++ K+G+G G VY + +A G E+A+++++++ + + + NE LV
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 123 IAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIV 182
+ + ++ N+V L + DE ++ EYL SL + + + G + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFG 242
+ L +LH + ++IHRD+K+ NILL + K++DFG +SK +T + GT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 181
Query: 243 YIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
++ PE V + K D++S G++ +E++ G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 7e-50
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 31/231 (13%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSVRSRQGLQ-ELKNEALVIAK 125
NN +GEG FG V++ +AVK L + +Q + + EA ++A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL----------------- 168
+ N+V+LLG C L++EY+ L+ FL + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 169 ----LELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224
L +L I + G+ YL + +HRDL N L+ + M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
+ A ++PPE ++ + +SDV+++G++L EI S
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-49
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAKGD----EIAVKRLSVRSRQG-LQELKNEALVIAKVQH 128
+F+ +G G FG VY G L D AVK L+ + G + + E +++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 129 KNLVRLLGCCIERDEK-LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
N++ LLG C+ + L++ Y+ + L F+ + + + + + +G+ +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKF 145
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR--VAGTFGYIP 245
L + +HRDL A N +LD++ K++DFG+AR E + N+ ++
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
E + + KSDV+SFG+LL E+++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-49
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 22/230 (9%)
Query: 77 DTNKLGEGGFGPVYKGVLAK---GDEIAVKRLSVRSRQG--LQELKNEALVIAKVQHKNL 131
+ +LG G FG V KG +AVK L + EL EA V+ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
VR++G C E + +L+ E L+ +L + ++ ++++ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 192 SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTN-RVAGTFGYIPPEYVY 250
+HRDL A N+LL + KISDFG+++ + +E+ + PE +
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 251 QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIK 300
S KSDV+SFG+L+ E S G G ++V + ++
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS---------YGQKPYRGMKGSEVTAMLE 224
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEI-AVKRLS---VRSRQGLQELKNEALVIAKVQH 128
+F LG+G FG VY + I A+K L + +L+ E + + ++H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
N++RL G + LI EY P ++ L +K + I + L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
H R+IHRD+K N+LL + KI+DFG + + + GT Y+PPE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGK 274
+ + K D++S G+L E L GK
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-48
Identities = 62/233 (26%), Positives = 93/233 (39%), Gaps = 26/233 (11%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSVRSRQG-LQELKNEALVIAK 125
N S LG G FG V + +AVK L + + L +E V++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 126 V-QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFD---------------ATKRVLL 169
+ H N+V LLG C L+I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 170 ELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229
+L L + +G+ +L IHRDL A NILL KI DFG+AR K +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHT 282
+ ++ PE ++ + + +SDV+S+G+ L E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-48
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 31/231 (13%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDE------IAVKRLSVRSRQG-LQELKNEALVIAK 125
N LG G FG V + +AVK L ++ + L +E ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 126 V-QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRV----------------- 167
+ H+N+V LLG C LI+EY L +L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 168 ---LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224
+L L + +G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
+ + ++ PE +++GI +IKSDV+S+G+LL EI S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 1e-47
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDE-----IAVKRLSVRSRQG-LQELKNEALVIAKV 126
+ + +G G FG VYKG+L +A+K L + + EA ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 127 QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL 186
H N++RL G + ++I EY+ N +LD FL + K + + ++ GI G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 187 YLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT-NRVAGTFGYIP 245
YL + +HRDL A NIL++ + K+SDFG++R+ + + T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
PE + + SDV+SFG+++ E+++ +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE 211
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-47
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 23/221 (10%)
Query: 80 KLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCI 139
+G+G FG V++G +G+E+AVK S R + + E ++H+N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 67
Query: 140 ERDEKL----LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH---- 191
+ + L+ +Y + SL +L R + + +++ GL +LH+
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 192 -SRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES--KANTNRVAGTFGYIPPEY 248
+ I HRDLK+ NIL+ K I+D G+A N GT Y+ PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 249 VYQGI------CSIKSDVFSFGMLLLEILSGKKNTEFYHTG 283
+ I ++D+++ G++ EI +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-47
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 75 FSDTNKLGEGGFGPVYKGVLAKGDE-----IAVKRLS-VRSRQGLQELKNEALVIAKVQH 128
F LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
++ RLLG C+ LI + +P L ++ + + + L I +G+ YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
R++HRDL A N+L+ KI+DFG+A++ E + + ++ E
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGKK 275
+ I + +SDV+S+G+ + E+++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-46
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGD---EIAVKRLS-VRSRQGLQELKNEALVIAKV-Q 127
N+ + +GEG FG V K + K + A+KR+ S+ ++ E V+ K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFL-------------FDATKRVLLELGTR 174
H N++ LLG C R L EY P+ +L FL + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 175 LQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT 234
L + G+ YL + IHRDL A NIL+ + KI+DFG++R +
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 235 NRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
++ E + + + SDV+S+G+LL EI+S
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-46
Identities = 68/245 (27%), Positives = 98/245 (40%), Gaps = 23/245 (9%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVL----AKGDEIAVKRLS---VRSRQGLQELKNEALVIAK 125
+ KLG+G FG V +G K +AVK L + + + + E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185
+ H+NL+RL G + K+ + E P SL L LGT + + EG+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 124
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK-ANTNRVAGTFGYI 244
YL R IHRDL A N+LL KI DFG+ R N+ F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIKLVES 304
PE + S SD + FG+ L E+ + G G + +Q+ KI
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTY---------GQEPWIGLNGSQILHKIDKEGE 232
Query: 305 CLARP 309
L RP
Sbjct: 233 RLPRP 237
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-46
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQHK 129
+F LGEG F V LA E A+K L + + + E V++++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
V+L + ++ Y N L ++ + IV L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
IIHRDLK NILL+++M +I+DFG A++ +A N GT Y+ PE +
Sbjct: 126 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 250 YQGICSIKSDVFSFGMLLLEILSGK 274
+ SD+++ G ++ ++++G
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (396), Expect = 1e-45
Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
+++ +LG G FG V++ A G+ A K + + ++ E ++ ++H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
V L + +E ++IYE++ L + D + + ++ + + +GL ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 143
Query: 192 SRVRIIHRDLKASNILL--DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
+H DLK NI+ + + K+ DFG+ +S GT + PE
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197
Query: 250 YQGICSIKSDVFSFGMLLLEILSGK 274
+D++S G+L +LSG
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-44
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 17/217 (7%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVL------AKGDEIAVKRLSVR-SRQGLQELKNEALVIAK 125
+ + +LG+G FG VY+GV +A+K ++ S + E NEA V+ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 126 VQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLF-------DATKRVLLELGTRLQII 178
++VRLLG + L+I E + L +L + L +Q+
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 179 EGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVA 238
I +G+ YL+ + + +HRDL A N ++ ++ KI DFGM R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 239 GTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
++ PE + G+ + SDV+SFG++L EI + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-43
Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 21/226 (9%)
Query: 80 KLGEGGFGPVYKGVLAKGDE----IAVKRLSVRSRQGLQE-LKNEALVIAKVQHKNLVRL 134
+GEG FG V++G+ + +A+K + ++E EAL + + H ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 135 LGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
+G E + +I E L FL L+L + + + L YL
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESK--- 127
Query: 195 RIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC 254
R +HRD+ A N+L+ K+ DFG++R + + ++ ++ PE +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRF 186
Query: 255 SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKIK 300
+ SDV+ FG+ + EIL G G V +I+
Sbjct: 187 TSASDVWMFGVCMWEILM---------HGVKPFQGVKNNDVIGRIE 223
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (379), Expect = 4e-43
Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 11/198 (5%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
+LG G FG V++ V A G K ++ +KNE ++ ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
++ E +LI E+L L + A + + + + EGL ++H H I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 199 RDLKASNILLD--KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI 256
D+K NI+ + K KI DFG+A +E T + PE V +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGF 207
Query: 257 KSDVFSFGMLLLEILSGK 274
+D+++ G+L +LSG
Sbjct: 208 YTDMWAIGVLGYVLLSGL 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (369), Expect = 5e-42
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 15/207 (7%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQH 128
+F LG G FG V+ G A+K L V + ++ +E L+++ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
++R+ G + + +I +Y+ L L + + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
II+RDLK NILLDK KI+DFG A+ + GT YI PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGKK 275
V + D +SFG+L+ E+L+G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (372), Expect = 5e-42
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS---VRSRQGLQELKNEALVIAKVQ- 127
N+FS +G GGFG VY A G A+K L ++ +QG NE ++++ V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 128 --HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGL 185
+V + D+ I + + L + L + + I+ GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
++H +++RDLK +NILLD+ +ISD G+A F SK + GT GY+
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMA 173
Query: 246 PEYVYQGI-CSIKSDVFSFGMLLLEILSGK 274
PE + +G+ +D FS G +L ++L G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-42
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 7/207 (3%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG-LQELKNEALVIAKVQHK 129
+++ + +GEG +G V +A+K++S Q Q E ++ + +H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
N++ + + + YL + L+ K L + I+ GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANT-NRVAGTFGYIPPEY 248
++HRDLK SN+LL+ KI DFG+AR+ + T Y PE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 249 VYQGICSIKS-DVFSFGMLLLEILSGK 274
+ KS D++S G +L E+LS +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-41
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 26/226 (11%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVL--------AKGDEIAVKRLSVR-SRQGLQELKNEALVI 123
+ LGEG FG V + ++AVK L + + L +L +E ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 124 AKV-QHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVL-------------L 169
+ +HKN++ LLG C + +I EY +L +L L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 170 ELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229
+ + G+ YL + IHRDL A N+L+ ++ KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
T ++ PE ++ I + +SDV+SFG+LL EI +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 5e-41
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 25/225 (11%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK------GDEIAVKRLSVRSRQGLQE--LKNEALVIA 124
+ LG G FG V + +AVK L + + ++I
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 125 KVQHKNLVRLLGCCIERDEKLLI-YEYLPNKSLDFFLF-------------DATKRVLLE 170
H N+V LLG C + L++ E+ +L +L + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 171 LGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230
L + + +G+ +L + IHRDL A NILL ++ KI DFG+AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKK 275
++ PE ++ + +I+SDV+SFG+LL EI S
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 12/198 (6%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
LG G FG V++ V + K + V+ +K E ++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 139 IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIH 198
+E ++I+E++ + + T L + + + E L +LH H I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 199 RDLKASNILLD--KEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSI 256
D++ NI+ + KI +FG AR K + N + Y PE + S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182
Query: 257 KSDVFSFGMLLLEILSGK 274
+D++S G L+ +LSG
Sbjct: 183 ATDMWSLGTLVYVLLSGI 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (352), Expect = 5e-40
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 15/212 (7%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQ 127
++ + LG GG V+ L ++AVK L R + EA A +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 128 HKNLVRLLGCCIERDEKL----LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVE 183
H +V + ++ EY+ +L + + +++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK-GNESKANTNRVAGTFG 242
L + H + IIHRD+K +NI++ K+ DFG+AR S T V GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 243 YIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
Y+ PE +SDV+S G +L E+L+G+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-40
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS---VRSRQGLQELKNEALVIAKV-Q 127
+F LG+G FG V+ K A+K L V ++ E V++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 128 HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
H L + ++ + EYL L + + K +L I+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
LH I++RDLK NILLDK+ KI+DFGM + ++K NT GT YI PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 248 YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ + D +SFG+LL E+L G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-39
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVK--RLSVRSRQGLQELKNEALVIAKVQHKN 130
NF K+GEG +G VYK G+ +A+K RL + E ++ ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+V+LL ++ L++E+L F DA+ + L + +++GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
H R++HRDLK N+L++ E K++DFG+AR F G + T+ V + P +
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 251 QGICSIKSDVFSFGMLLLEILSGK 274
S D++S G + E+++ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 6e-39
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 74 NFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLV 132
+++DT +G G FG VY+ L G+ +A+K++ R +EL+ ++ K+ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIV 76
Query: 133 RLLGCCIERDEK------LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLL 186
RL EK L+ +Y+P + + L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 187 YLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNESKANTNRVAGTFGYIP 245
Y+H I HRD+K N+LLD + K+ DFG A+ E N + + + P
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAP 191
Query: 246 PEYVYQGICSIKSDVFSFGMLLLEILSGK 274
+ DV+S G +L E+L G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (342), Expect = 3e-38
Identities = 45/205 (21%), Positives = 87/205 (42%), Gaps = 8/205 (3%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQE-LKNEALVIAKVQHK 129
+ + + LG G F V +A+K ++ ++ +G + ++NE V+ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
N+V L LI + + L + ++ ++I +++ + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
V + LD++ K ISDFG++++ + GT GY+ PE +
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVL 181
Query: 250 YQGICSIKSDVFSFGMLLLEILSGK 274
Q S D +S G++ +L G
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-38
Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 79 NKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQE-----LKNEALVIAKVQHKNLV 132
+ LGEG F VYK +A+K++ + R ++ E ++ ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
LL + L+++++ ++L + ++GL YLH H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 193 RVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQG 252
I+HRDLK +N+LLD+ K++DFG+A+ F G+ ++A T++V + P
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 253 ICSIKSDVFSFGMLLLEILSGK 274
+ + D+++ G +L E+L
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV 198
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 134 bits (338), Expect = 7e-38
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 74 NFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRS---------RQGLQELKNEALVI 123
N+ LG G V + + E AVK + V ++ + E ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 124 AKVQ-HKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIV 182
KV H N+++L L+++ + L +L T++V L +I+ ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 183 EGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFG 242
E + LH I+HRDLK NILLD +M K++DFG + E V GT
Sbjct: 121 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174
Query: 243 YIPPEYVYQGIC------SIKSDVFSFGMLLLEILSGK 274
Y+ PE + + + D++S G+++ +L+G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (338), Expect = 7e-38
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 9/204 (4%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVK--RLSVRSRQGLQELKNEALVIAKVQHKN 130
+ K+GEG +G VYK G+ A+K RL E ++ +++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
+V+L + +L++E+L LE T + ++ G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 191 HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVY 250
R++HRDLK N+L+++E + KI+DFG+AR F G + T+ + + P +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 251 QGICSIKSDVFSFGMLLLEILSGK 274
S D++S G + E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 2e-37
Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 16/218 (7%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
N + K+G G FG +Y G +A G+E+A+K V+++ +L E+ + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
+ + C + ++ L SL+ +++ L T L + + ++ + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 192 SRVRIIHRDLKASNIL---LDKEMKPKISDFGMARIFKGNESKAN-----TNRVAGTFGY 243
IHRD+K N L K I DFG+A+ ++ + + + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 244 IPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYH 281
S + D+ S G +L+ G +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (333), Expect = 5e-37
Identities = 37/220 (16%), Positives = 86/220 (39%), Gaps = 18/220 (8%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL 131
++ ++GEG FG +++G L ++A+K RS +L++E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 132 VRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH 191
+ + + ++ L SL+ L ++ + T + ++ + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEK 120
Query: 192 SRVRIIHRDLKASNILLDKEMKP-----KISDFGMARIFKGNESKAN-----TNRVAGTF 241
+++RD+K N L+ + + DFGM + ++ +K + ++GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 242 GYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYH 281
Y+ S + D+ + G + + L G +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-37
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 16/214 (7%)
Query: 71 ATNNFSDTNKLGEGGFGPVYKGVLAK--GDEIAVKRLSVRSRQGLQELK-----NEALVI 123
A + ++GEG +G V+K K G +A+KR+ V++ + L +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 124 AKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLD---FFLFDATKRVLLELGTRLQIIEG 180
+H N+VRL C L + +D D + T ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 181 IVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGT 240
++ GL +LH H R++HRDLK NIL+ + K++DFG+ARI+ + V T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 241 FGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
Y PE + Q + D++S G + E+ K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-36
Identities = 64/242 (26%), Positives = 99/242 (40%), Gaps = 24/242 (9%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKN------EALVIAKVQ--HKN 130
LG GGFG VY G+ ++ +A+K + EL N E +++ KV
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 131 LVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL 190
++RLL D +LI E F T+R L+ ++E + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 191 HSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
++HRD+K NIL+D + K+ DFG + K GT Y PPE++
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181
Query: 250 -YQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASK--IKLVESCL 306
Y + V+S G+LL +++ G F H + Q S L+ CL
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 239
Query: 307 AR 308
A
Sbjct: 240 AL 241
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-35
Identities = 48/216 (22%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQG--LQELKNEALVIAKVQHK 129
+ + K+G+G FG V+K K G ++A+K++ + + + E ++ ++H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 130 NLVRLLGCCIERDEK--------LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGI 181
N+V L+ C + L++++ + K L E+ +Q++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 182 VEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR--VAG 239
L L+ R +I+HRD+KA+N+L+ ++ K++DFG+AR F ++
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 240 TFGYIPPEYVYQGI-CSIKSDVFSFGMLLLEILSGK 274
T Y PPE + D++ G ++ E+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-35
Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 12/206 (5%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLS---VRSRQGLQELKNEALVIAKVQH 128
N+F LG+G FG V A G A+K L + ++ + E+ V+ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
L L D + EY L F L ++ + IV L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
H +++RD+K N++LDK+ KI+DFG+ + + + GT Y+ PE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEV 176
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGK 274
+ D + G+++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 9e-35
Identities = 45/206 (21%), Positives = 90/206 (43%), Gaps = 10/206 (4%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVK--RLSVRSRQGLQELKNEALVIAKVQHK 129
+ K+GEG +G V+K + + +A+K RL E ++ +++HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 130 NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLH 189
N+VRL + L++E+ +F + +++GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI---VKSFLFQLLKGLGFCH 118
Query: 190 LHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYV 249
++HRDLK N+L+++ + K+++FG+AR F G + + V + P
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 250 YQGICSIKSDVFSFGMLLLEILSGKK 275
+ S D++S G + E+ + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-34
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQG------LQELKNEALVIAKVQHKNLV 132
+LG G F V K + G + A K + R + ++++ E ++ ++QH N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 133 RLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS 192
L + + +LI E + L FL ++ L + ++ I+ G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL- 132
Query: 193 RVRIIHRDLKASNILLDKEMKP----KISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
+I H DLK NI+L P KI DFG+A + GT ++ PE
Sbjct: 133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 187
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGK 274
V +++D++S G++ +LSG
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (302), Expect = 4e-32
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 15/227 (6%)
Query: 52 KSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS---V 107
K + + S A + F LG G FG V + G+ A+K L V
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 108 RSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRV 167
+ ++ NE ++ V LV+L + ++ EY+ + L +
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIG 136
Query: 168 LLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227
IV YLH +I+RDLK N+L+D++ +++DFG A+ KG
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
T + GT + PE + + D ++ G+L+ E+ +G
Sbjct: 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-31
Identities = 48/203 (23%), Positives = 85/203 (41%), Gaps = 21/203 (10%)
Query: 81 LGEGGFGPVYKGVLAK-GDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCC 138
LG G G V + + ++ A+K L Q + + E + + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 139 ----IERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRV 194
R L++ E L L + D + E +I++ I E + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SI 130
Query: 195 RIIHRDLKASNILLDKEMKP---KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQ 251
I HRD+K N+L + K++DFG A+ + S T Y+ PE +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 252 GICSIKSDVFSFGMLLLEILSGK 274
D++S G+++ +L G
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-31
Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 11/206 (5%)
Query: 73 NNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRL--SVRSRQGLQELKNEALVIAKVQHK 129
+ D +G G +G V V G ++A+K+L +S + E ++ ++H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 130 NLVRLLGCCIERDEKLLIYE-YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
N++ LL + + YL + L K L ++ +++GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEY 248
H IIHRDLK N+ ++++ + KI DFG+AR T V + P
Sbjct: 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVI 190
Query: 249 VYQGICSIKSDVFSFGMLLLEILSGK 274
+ + D++S G ++ E+++GK
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (288), Expect = 3e-30
Identities = 46/233 (19%), Positives = 100/233 (42%), Gaps = 23/233 (9%)
Query: 47 ANNRRKSTKREVELPLFSFSSVAAATNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRL 105
N R + E + + + +++ KLG G + V++ + + +++ VK L
Sbjct: 13 VNTHRPREYWDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 68
Query: 106 SVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEKL--LIYEYLPNKSLDFFLFD 162
+ +++K E ++ ++ N++ L + + L++E++ N
Sbjct: 69 KPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-- 123
Query: 163 ATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGM 221
+ L + R + I++ L Y H I+HRD+K N+++D E K ++ D+G+
Sbjct: 124 ---QTLTDYDIR-FYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176
Query: 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
A + + RVA + P V + D++S G +L ++ K
Sbjct: 177 AEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 6e-29
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLS----VRSRQGLQELKNEALVIA 124
NF LG G +G V+ G A+K L V+ + + + E V+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 125 KVQHK-NLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVE 183
++ LV L + LI +Y+ L L + T ++ + E
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF------TEHEVQIYVGE 137
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGY 243
+L L ++ II+RD+K NILLD ++DFG+++ F +E++ GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 244 IPPEYVYQGICSI--KSDVFSFGMLLLEILSGK 274
+ P+ V G D +S G+L+ E+L+G
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-27
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 72 TNNFSDTNKLGEGGFGPVYKGV-LAKGDEIAVKRLS--VRSRQGLQELKNEALVIAKVQH 128
+ + + +G G +G V G +AVK+LS +S + E ++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 129 KNLVRLLGCCIERDE-KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLY 187
+N++ LL + YL + L + K L +I I+ GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 188 LHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPE 247
+H IIHRDLK SN+ ++++ + KI DFG+AR T VA + P
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 189
Query: 248 YVYQGICSIKSDVFSFGMLLLEILSGK 274
+ + D++S G ++ E+L+G+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 4e-27
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 21/211 (9%)
Query: 73 NNFSDTNKLGEGGFGPVYKGVLAK-GDEIAVKRLS--VRSRQGLQELKNEALVIAKVQHK 129
+ + +G G G V A +A+K+LS +++ + E +++ V HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 130 NLVRLLGCCI------ERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVE 183
N++ LL E + L+ E + + ++ ++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------RMSYLLYQMLC 130
Query: 184 GLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGY 243
G+ +LH IIHRDLK SNI++ + KI DFG+AR + T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 244 IPPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + D++S G ++ E++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 6e-26
Identities = 38/210 (18%), Positives = 76/210 (36%), Gaps = 18/210 (8%)
Query: 80 KLGEGGFGPVYKGV-LAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCC 138
KLG G F V+ + +A+K + + + ++E ++ +V + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 139 IERDEKLLIYEYLPNKSLDFF-------------LFDATKRVLLELGTRLQIIEGIVEGL 185
KLL + + L + + L QI + ++ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 186 LYLHLHSRVRIIHRDLKASNILLDKE-MKPKISDFGMARIFKGNESKANTNRVAGTFGYI 244
Y+H IIH D+K N+L++ + +A + + T Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 245 PPEYVYQGICSIKSDVFSFGMLLLEILSGK 274
PE + +D++S L+ E+++G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.5 bits (221), Expect = 7e-22
Identities = 33/168 (19%), Positives = 62/168 (36%), Gaps = 20/168 (11%)
Query: 79 NKLGEGGFGPVYKGVLAKGDEIAVK--RLSVRS--------RQGLQELKNEALVIAKVQH 128
+GEG V+ K E VK ++ S G A+ A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 129 KNLVRLLGCCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYL 188
+ L +L G + + Y + N ++ L DA + + + ++++ I+E +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 189 HLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKANTNR 236
+ I+H DL N+L+ E I DF + + R
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILER 163
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.56 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.5 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.1 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-57 Score=386.27 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=206.0
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 368999999999999999999964 68999999986543 3344678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999885433 4899999999999999999999998 9999999999999999999999999998765444
Q ss_pred CccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCccccccc---------chhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGY---------DQTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~ 299 (334)
........+||+.|+|||++.+..+ +.++||||+||++|||+||++||.........+... ....+....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence 4344455789999999999988775 678999999999999999999997654432111111 111355677
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++.+||..+|.+|+++.++.+.++
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHh
Confidence 8999999999999999999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=381.64 Aligned_cols=243 Identities=23% Similarity=0.388 Sum_probs=208.0
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
++|++.+.||+|+||+||+|.+ .+|+.||+|++........+.+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999995 469999999997665556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++|+|..++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++..+.....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999999876442 3899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc---------ccccchhcccchhhhc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS---------INGYDQTQVASKIKLV 302 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~i 302 (334)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||......... -.......+..+.+++
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 250 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence 234467999999999999999999999999999999999999999754332100 0011122356688999
Q ss_pred cccccCCccchhhhhhhhhccC
Q 037681 303 ESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..||..+|.+|+++.++.+..+
T Consensus 251 ~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTTCGG
T ss_pred HHHccCChhHCcCHHHHhcCHh
Confidence 9999999999999999887654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=375.22 Aligned_cols=241 Identities=26% Similarity=0.337 Sum_probs=205.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|+++ +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999965 6889999998632 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999886543 3899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i 302 (334)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........- . .......+..+.+++
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 235 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 235 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 233467999999999999999999999999999999999999999764322100 0 001112456688899
Q ss_pred cccccCCccchhhhhhhhhcc
Q 037681 303 ESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~~ 323 (334)
..||..+|.+|+++.++.+.+
T Consensus 236 ~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTCH
T ss_pred HHHccCCHhHCcCHHHHHcCc
Confidence 999999999999999987754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=376.95 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=196.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe--cCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE--RDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 147 (334)
++|++.+.||+|+||+||+|++. +|+.||+|.+... .....+.+.+|+.++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 68999999999999999999964 6899999998644 34456778999999999999999999999865 4567999
Q ss_pred EEecCCCChhhhhhhcc-cccccchHHHHHHHHHHHHHHHHhhhcCC--CCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 148 YEYLPNKSLDFFLFDAT-KRVLLELGTRLQIIEGIVEGLLYLHLHSR--VRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+++. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999886533 34469999999999999999999998642 2499999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------ccccccchhcccc
Q 037681 225 FKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-------LSINGYDQTQVAS 297 (334)
Q Consensus 225 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~ 297 (334)
...... ......||+.|+|||++.+..++.++|||||||++|||+||++||....... ..+.......+..
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 241 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 643322 2334679999999999999999999999999999999999999997654321 1111122224567
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..||..+|.+|+++.++.+.++
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 889999999999999999999877654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=379.13 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=207.1
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
+.|++.+.||+|+||+||+|.+. +|..||+|++........+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57899999999999999999964 68899999998776677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++|+|..++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||++.......
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 9999998875433 34899999999999999999999998 9999999999999999999999999997543221
Q ss_pred cccccccccCCccCccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cccccchhcccc
Q 037681 232 ANTNRVAGTFGYIPPEYVY-----QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SINGYDQTQVAS 297 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~~~~~~~~~~~ 297 (334)
.......||+.|+|||++. +..++.++|||||||++|||+||+.||........ +........+..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 1233467999999999984 45688999999999999999999999976543211 011111224567
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..||..+|.+|+++.++.+.++
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 889999999999999999999887654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=378.40 Aligned_cols=242 Identities=24% Similarity=0.340 Sum_probs=201.4
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999964 6899999998643 2344577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999998875543 4899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i 302 (334)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ..+....+....+++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 4433444567999999999999999999999999999999999999999764322100 0 011122456788899
Q ss_pred cccccCCccchhhhhhhh
Q 037681 303 ESCLARPFRQYCCILKVR 320 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~ 320 (334)
..||..+|.+|+++.++.
T Consensus 242 ~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HTTSCSSGGGSTTSGGGT
T ss_pred HHHccCCHhHCcCHHHHc
Confidence 999999999999988753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=370.37 Aligned_cols=243 Identities=27% Similarity=0.444 Sum_probs=195.6
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++.+.||+|+||+||+|++. ..||||+++.. .....+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 378999999999999999999864 46999998643 4556678999999999999999999999875 456899999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999886543 34899999999999999999999998 9999999999999999999999999998765443
Q ss_pred CccccccccccCCccCcccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc------------cccccchhc
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQ---GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------SINGYDQTQ 294 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------~~~~~~~~~ 294 (334)
.........||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ .+.......
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 3334455689999999999864 3578999999999999999999999986543211 111111223
Q ss_pred ccchhhhccccccCCccchhhhhhhhhc
Q 037681 295 VASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 295 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
+..+.+++..||..+|.+|+++.++...
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4568899999999999999999887654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=380.57 Aligned_cols=243 Identities=24% Similarity=0.334 Sum_probs=202.4
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
.++|++++.||+|+||+||+|.+. +|+.||+|+++.. .......+.+|+.++++++||||++++++|.+++..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999999999964 6889999998754 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
|+++|+|.+++.... .+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++++||+|||+|......
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999986543 38999999999999999999997 47 999999999999999999999999999865422
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--------------------
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN-------------------- 288 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-------------------- 288 (334)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...........
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 22346899999999999999999999999999999999999999965332100000
Q ss_pred -----------------------------cc-chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 -----------------------------GY-DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 -----------------------------~~-~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.. ....+....+++..||..+|.+|+++.++.+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 00 0002345778999999999999999998877543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=361.61 Aligned_cols=240 Identities=25% Similarity=0.401 Sum_probs=196.0
Q ss_pred CcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe----cCcceEEE
Q 037681 76 SDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE----RDEKLLIY 148 (334)
Q Consensus 76 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 148 (334)
+..+.||+|+||+||+|.+. ++..||+|.+... .....+.+.+|++++++++||||+++++++.+ ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999965 6889999998643 44556778999999999999999999999875 34579999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC-CCCceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD-KEMKPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 227 (334)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999986543 4899999999999999999999874 3499999999999996 578999999999976432
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc---------cccchhcccch
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI---------NGYDQTQVASK 298 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---------~~~~~~~~~~~ 298 (334)
. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.......... ..........+
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence 2 2334679999999998865 69999999999999999999999997543321100 11112245568
Q ss_pred hhhccccccCCccchhhhhhhhhccC
Q 037681 299 IKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+++..||..+|++|+++.++.+.++
T Consensus 243 ~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 243 KEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 89999999999999999999877543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-53 Score=371.42 Aligned_cols=243 Identities=21% Similarity=0.279 Sum_probs=189.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS-RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
+.|++.+.||+|+||+||+|.+. +|+.||+|++.... ......+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 67999999999999999999965 68999999986443 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC---CCCceEEeeccccccccC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD---KEMKPKISDFGMARIFKG 227 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~ 227 (334)
++||+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||++. +++.+||+|||++.....
T Consensus 89 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999986533 4899999999999999999999998 99999999999994 578999999999986543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cchhcccc
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YDQTQVAS 297 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~~~~~~~ 297 (334)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|++||....... ..+.. .....+..
T Consensus 163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 239 (307)
T d1a06a_ 163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence 32 2334679999999999999999999999999999999999999997643221 11111 11123556
Q ss_pred hhhhccccccCCccchhhhhhhhhccC
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+.+++..||..+|.+|+++.++...++
T Consensus 240 ~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 240 AKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 789999999999999999999988654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.9e-53 Score=375.21 Aligned_cols=244 Identities=19% Similarity=0.279 Sum_probs=207.8
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 68999999999999999999964 68999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC--CCceEEeeccccccccCCC
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK--EMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~ 229 (334)
++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.......
T Consensus 106 ~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999998885432 34899999999999999999999998 999999999999954 5789999999998764332
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cchhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YDQTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~~~~~~~~~ 299 (334)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.. .....+..+.
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 2334679999999999999999999999999999999999999997543321 00111 1111355678
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++.+||..+|.+|+++.++.+..+
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCcc
Confidence 8999999999999999999888654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=365.05 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=192.8
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||+||+|.+.+++.||||+++... ...+.+.+|+.++++++||||++++++|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 6889999999999999999999888899999997543 334678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 999999876543 34889999999999999999999998 999999999999999999999999999866443222
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCccCCcc--cc----c-ccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG-KKNTEFYHTGYL--SI----N-GYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~--~~----~-~~~~~~~~~~~~~i~~ 304 (334)
......||+.|+|||++.+..++.++|||||||++|||+|| ++|+........ .. . .........+.+++..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 22335689999999999999999999999999999999995 555554322100 00 0 0011135568899999
Q ss_pred cccCCccchhhhhhhhhc
Q 037681 305 CLARPFRQYCCILKVRTF 322 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~ 322 (334)
||..+|.+|+++.++.+.
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999887654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.7e-53 Score=374.00 Aligned_cols=244 Identities=22% Similarity=0.288 Sum_probs=207.6
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
++|++.+.||+|+||+||+|.+ .+|+.||+|++..........+.+|+.++++++||||+++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 6899999999999999999996 469999999998766666678889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeC--CCCceEEeeccccccccCCC
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLD--KEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~ 229 (334)
++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 109 ~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999998776443 234899999999999999999999998 99999999999997 56899999999998765432
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cchhcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YDQTQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~~~~~~~~~ 299 (334)
......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+.. .....+..+.
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 2334678999999999999999999999999999999999999997643321 11111 1112455688
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++..||..+|.+|+++.++....+
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCHh
Confidence 9999999999999999999877543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=372.38 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=203.9
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++++.||+|+||+||+|++ .+|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6899999999999999999996 47999999999643 2345677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999998886543 3899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~i 302 (334)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|++||........- -..+....+....+++
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 22 234568999999999999999999999999999999999999999765432100 0011122456688999
Q ss_pred cccccCCccchhh-----hhhhhhc
Q 037681 303 ESCLARPFRQYCC-----ILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~-----~~~~~~~ 322 (334)
..||..+|.+|.+ +.++++.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhhccCCchhhcccccccHHHHHcC
Confidence 9999999999974 4555553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-53 Score=370.81 Aligned_cols=239 Identities=27% Similarity=0.395 Sum_probs=199.7
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
+.|+.++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999954 68889999986442 344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
|||++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999997666433 34899999999999999999999998 99999999999999999999999999976432
Q ss_pred CCccccccccccCCccCcccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------ccccc-chhcccc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQ---GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------SINGY-DQTQVAS 297 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~-~~~~~~~ 297 (334)
.....||+.|+|||++.+ +.++.++|||||||++|||++|+.||........ ..... ....+..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 242 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHH
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHH
Confidence 233579999999999864 4688999999999999999999999975432210 00000 1113556
Q ss_pred hhhhccccccCCccchhhhhhhhhcc
Q 037681 298 KIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+.+++..||..+|.+|+++.++.+..
T Consensus 243 ~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 243 FRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 88999999999999999999987643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=357.29 Aligned_cols=243 Identities=26% Similarity=0.380 Sum_probs=205.6
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||+||+|++++++.||||+++.... ..+.+.+|+.++++++||||++++++|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999998888999999875433 34679999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+|+|..++..... .+++..+++++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999888755433 4788999999999999999999998 999999999999999999999999999865443322
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCccc--c-----cccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLS--I-----NGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~--~-----~~~~~~~~~~~~~~i~~ 304 (334)
......||+.|+|||.+.+..++.++||||||+++|||+| |+.||+........ + ..........+.+++..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 2333568999999999999999999999999999999998 89999876543111 0 00011134568899999
Q ss_pred cccCCccchhhhhhhhhc
Q 037681 305 CLARPFRQYCCILKVRTF 322 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~~ 322 (334)
||..+|.+|+++.++.+.
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999887664
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-53 Score=366.42 Aligned_cols=245 Identities=26% Similarity=0.362 Sum_probs=203.3
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++|++.+.||+|+||+||+|.+. +|+.||||+++... ...+.+.+|+.++++++||||++++++|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 468999999999999999999965 58899999986443 3457799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999886543 345899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc--------cccchhcccchhhhc
Q 037681 231 KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--------NGYDQTQVASKIKLV 302 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~i 302 (334)
.......|++.|+|||++.++.++.++|||||||++|||++|..|+....+....+ .......+..+.+++
T Consensus 171 -~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 249 (287)
T d1opja_ 171 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249 (287)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred -eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence 22333568899999999999999999999999999999999766654332211000 011112456688999
Q ss_pred cccccCCccchhhhhhhhhc
Q 037681 303 ESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 303 ~~~l~~~~~~~~~~~~~~~~ 322 (334)
..||..+|.+|+++.++...
T Consensus 250 ~~cl~~dP~~Rps~~ei~~~ 269 (287)
T d1opja_ 250 RACWQWNPSDRPSFAEIHQA 269 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=363.52 Aligned_cols=244 Identities=29% Similarity=0.416 Sum_probs=199.6
Q ss_pred hcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
.++|++.+.||+|+||+||+|.++++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence 36889999999999999999999888899999997443 34467999999999999999999999875 45679999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence 9999988775433 334899999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--------ccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--------GYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~i~ 303 (334)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+.........+. .........+.+++.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence 223345689999999999989999999999999999999996555433222100000 001124556889999
Q ss_pred ccccCCccchhhhhhhhhc
Q 037681 304 SCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~ 322 (334)
.||..+|.+|+++.++.+.
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~ 263 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSV 263 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999887653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=370.08 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=203.0
Q ss_pred hcCCCcCCccccCCcccEEEEEecC-C-----CEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK-G-----DEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 143 (334)
.++|++.+.||+|+||+||+|++.. + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3689999999999999999998643 2 26899988643 344456788999999998 89999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhccc--------------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCC
Q 037681 144 KLLIYEYLPNKSLDFFLFDATK--------------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKA 203 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp 203 (334)
.|+||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999865432 235889999999999999999999998 99999999
Q ss_pred CCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccC
Q 037681 204 SNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHT 282 (334)
Q Consensus 204 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~ 282 (334)
+||+++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |++||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655444333445678999999999999999999999999999999998 8999986544
Q ss_pred Cccccc--------ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 283 GYLSIN--------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 283 ~~~~~~--------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
...-.. ......+..+.+++..||..+|.+|+++.++.+.
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 311000 0111235568899999999999999999988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=362.03 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=205.5
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS------RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
++|++.+.||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 6799999999999999999996 468999999986331 223578899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC----ceEEeeccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM----KPKISDFGM 221 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~ 221 (334)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999986543 4899999999999999999999998 99999999999998776 599999999
Q ss_pred cccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccc-cc
Q 037681 222 ARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSING-YD 291 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~-~~ 291 (334)
+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+.. ..
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 98764332 2334578999999999999999999999999999999999999997643321 01110 11
Q ss_pred hhcccchhhhccccccCCccchhhhhhhhhccCC
Q 037681 292 QTQVASKIKLVESCLARPFRQYCCILKVRTFGFN 325 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~ 325 (334)
...+..+.+++.+||..+|.+|+++.++.+..+-
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1234567889999999999999999999876653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-53 Score=365.96 Aligned_cols=245 Identities=23% Similarity=0.351 Sum_probs=190.8
Q ss_pred cCCCcCCccccCCcccEEEEEecC-CC---EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAK-GD---EIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~-~~---~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||+||+|.++. ++ .||||.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 578888999999999999999653 32 5889988643 455567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++|+|..++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999876533 34899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcc---ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhccc
Q 037681 228 NESKA---NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVA 296 (334)
Q Consensus 228 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~ 296 (334)
..... ......||+.|+|||.+.++.++.++|||||||++|||+| |++||........ .-.........
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence 33221 1222457899999999999999999999999999999998 8999976543210 00001112455
Q ss_pred chhhhccccccCCccchhhhhhhhhc
Q 037681 297 SKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 297 ~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+.+++..||..+|.+|+++.++.+.
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 68899999999999999998886543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-52 Score=366.17 Aligned_cols=241 Identities=27% Similarity=0.342 Sum_probs=202.4
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++.+.||+|+||+||+|++ .+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 6899999999999999999996 46999999998633 2344677899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||++||+|..++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999888755443 788888999999999999999998 999999999999999999999999999875432
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~i 302 (334)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ..........+.+++
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 232 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 23467999999999999999999999999999999999999999765332100 0 011122456688899
Q ss_pred cccccCCccchh-----hhhhhhhccC
Q 037681 303 ESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
..||..+|.+|. ++.++++.++
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHhhhCHHhccccchhhHHHHHcCcc
Confidence 999999999885 6666665443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=360.55 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=198.8
Q ss_pred cCCCcCC-ccccCCcccEEEEEec---CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTN-KLGEGGFGPVYKGVLA---KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|.+.+ .||+|+||+||+|.++ ++..||||+++.. .....+.+.+|++++++++||||+++++++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999854 3457999998644 44556789999999999999999999999864 568999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999875433 34899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCC-ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccch
Q 037681 228 NES-KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASK 298 (334)
Q Consensus 228 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~ 298 (334)
... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||........ .-.......+..+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 241 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 241 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 332 222334568999999999999999999999999999999998 9999986543210 0001112245568
Q ss_pred hhhccccccCCccchhhhhhhhh
Q 037681 299 IKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.+++..||..+|.+|+++.++.+
T Consensus 242 ~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 242 YALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH
Confidence 89999999999999999887754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=357.26 Aligned_cols=236 Identities=26% Similarity=0.373 Sum_probs=191.7
Q ss_pred CccccCCcccEEEEEecC---CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecCC
Q 037681 79 NKLGEGGFGPVYKGVLAK---GDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLPN 153 (334)
Q Consensus 79 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 153 (334)
++||+|+||+||+|.+.. ++.||||+++.. +....+.+.+|+.++++++||||++++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998543 467999998643 33445679999999999999999999999864 567899999999
Q ss_pred CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC-cc
Q 037681 154 KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES-KA 232 (334)
Q Consensus 154 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 232 (334)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999886543 3899999999999999999999998 99999999999999999999999999987644332 22
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~ 304 (334)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||........ .-.......+..+.+++..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~ 245 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 245 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 2334568999999999999999999999999999999998 8999986543210 0001111235668899999
Q ss_pred cccCCccchhhhhhhhh
Q 037681 305 CLARPFRQYCCILKVRT 321 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~ 321 (334)
||..+|.+|+++.++..
T Consensus 246 cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 246 CWTYDVENRPGFAAVEL 262 (277)
T ss_dssp HTCSSTTTSCCHHHHHH
T ss_pred HcCCCHhHCcCHHHHHH
Confidence 99999999999988754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-51 Score=366.37 Aligned_cols=241 Identities=21% Similarity=0.273 Sum_probs=203.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 148 (334)
++|++++.||+|+||+||+|+++ +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999964 6999999998633 2344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGN 228 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 228 (334)
||+.+|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999998886543 3899999999999999999999998 999999999999999999999999999875432
Q ss_pred CCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc------ccccchhcccchhhhc
Q 037681 229 ESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS------INGYDQTQVASKIKLV 302 (334)
Q Consensus 229 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~i 302 (334)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......... ...........+.+++
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 23467999999999999999999999999999999999999999754322100 0011112456788999
Q ss_pred cccccCCccchh-----hhhhhhhccC
Q 037681 303 ESCLARPFRQYC-----CILKVRTFGF 324 (334)
Q Consensus 303 ~~~l~~~~~~~~-----~~~~~~~~~~ 324 (334)
..||..+|.+|. ++.++++.++
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHhhhCHHhccccccccHHHHHcCcc
Confidence 999999998884 6777766443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=360.84 Aligned_cols=242 Identities=26% Similarity=0.361 Sum_probs=200.6
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc---ChhhHHHHHHHHHHHH-hcCCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR---SRQGLQELKNEALVIA-KVQHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||+||+|++. +|+.||||+++.. .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999965 6899999999643 2334456667777665 68999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccC
Q 037681 148 YEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKG 227 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 227 (334)
|||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999986544 3889999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--c----cccchhcccchhhh
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--I----NGYDQTQVASKIKL 301 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~----~~~~~~~~~~~~~~ 301 (334)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........- . .......+..+.++
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl 233 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 322 234467999999999999999999999999999999999999999764332100 0 01111245678899
Q ss_pred ccccccCCccchhhhh-hhhhc
Q 037681 302 VESCLARPFRQYCCIL-KVRTF 322 (334)
Q Consensus 302 i~~~l~~~~~~~~~~~-~~~~~ 322 (334)
+.+||..+|.+|+++. +++..
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHhcccCCCCCcCHHHHHHhC
Confidence 9999999999999875 56553
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=355.84 Aligned_cols=244 Identities=24% Similarity=0.393 Sum_probs=191.6
Q ss_pred cCCCcCCccccCCcccEEEEEecCC-----CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKG-----DEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++.+.||+|+||.||+|.++.+ ..||||++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5788899999999999999996542 36999998643 34445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+.++++.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999988775443 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCC-ccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--------ccchhcccc
Q 037681 227 GNES-KANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--------GYDQTQVAS 297 (334)
Q Consensus 227 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--------~~~~~~~~~ 297 (334)
.... ........||+.|+|||++.++.++.++|||||||++|||++|..|+.........+. .........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence 4322 1223335689999999999999999999999999999999996665543222110000 011124456
Q ss_pred hhhhccccccCCccchhhhhhhhh
Q 037681 298 KIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 298 ~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
+.+++..||..+|.+|+++.++..
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHH
Confidence 889999999999999999888755
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-51 Score=363.10 Aligned_cols=241 Identities=25% Similarity=0.324 Sum_probs=196.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccC---hhhHHHHH---HHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRS---RQGLQELK---NEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+. .++.+++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999965 69999999985321 12222333 4467777888999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+++|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999986543 3789999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc-cc--------ccchhcc
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS-IN--------GYDQTQV 295 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~--------~~~~~~~ 295 (334)
.... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......... +. ......+
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSC
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Confidence 4332 334579999999999874 56899999999999999999999999765432110 00 0111245
Q ss_pred cchhhhccccccCCccchhhh-----hhhhhcc
Q 037681 296 ASKIKLVESCLARPFRQYCCI-----LKVRTFG 323 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~-----~~~~~~~ 323 (334)
..+.+++..||..+|.+|++. .++++..
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp 266 (364)
T d1omwa3 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence 668899999999999999983 5555543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.5e-51 Score=349.51 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=203.6
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC---------hhhHHHHHHHHHHHHhcC-CCCcceEeeEEEe
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS---------RQGLQELKNEALVIAKVQ-HKNLVRLLGCCIE 140 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 140 (334)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 37899999999999999999996 468899999986432 122346789999999997 9999999999999
Q ss_pred cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecc
Q 037681 141 RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFG 220 (334)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 220 (334)
++..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999996543 4899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccCcccccc------CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQ------GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------- 285 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------- 285 (334)
+++....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 9987654322 234679999999999853 3468899999999999999999999986543210
Q ss_pred cccc-cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 SING-YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ~~~~-~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+.. .....++.+.+++..||..+|.+|+++.++.+.++
T Consensus 233 ~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 233 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 0111 01124556889999999999999999999877554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-51 Score=352.06 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=192.7
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc----c
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE----K 144 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~ 144 (334)
++|++.+.||+|+||+||+|.+ .+|+.||||+++.. +......+.+|+.++++++||||+++++++...+. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6899999999999999999996 46899999999643 34455678999999999999999999999987553 7
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
|+||||++|++|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++++|||.+..
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999998875543 4899999999999999999999998 99999999999999999999999999875
Q ss_pred ccCCC-CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------cc-cccchh
Q 037681 225 FKGNE-SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL---------SI-NGYDQT 293 (334)
Q Consensus 225 ~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---------~~-~~~~~~ 293 (334)
..... .........||+.|+|||++.+..++.++|||||||++|||+||++||........ .. ......
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 43322 22233456799999999999999999999999999999999999999976433211 00 011112
Q ss_pred cccchhhhccccccCCccchh-hhhhhh
Q 037681 294 QVASKIKLVESCLARPFRQYC-CILKVR 320 (334)
Q Consensus 294 ~~~~~~~~i~~~l~~~~~~~~-~~~~~~ 320 (334)
.+..+.+++.+||..+|.+|+ ++.+++
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 456688999999999999997 566554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-51 Score=358.19 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=204.9
Q ss_pred hhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCc
Q 037681 71 ATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDE 143 (334)
Q Consensus 71 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 143 (334)
+.++|++.+.||+|+||+||+|+.. ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999864 3568999998754 33445679999999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhccc---------------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCC
Q 037681 144 KLLIYEYLPNKSLDFFLFDATK---------------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLK 202 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk 202 (334)
.+++|||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ ++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 9999999999999998864321 224788899999999999999999998 9999999
Q ss_pred CCCeeeCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCC-CCCCCcc
Q 037681 203 ASNILLDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK-KNTEFYH 281 (334)
Q Consensus 203 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~p~~~~~ 281 (334)
|+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998665444434444567899999999999999999999999999999999985 5676554
Q ss_pred CCc-------ccccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 282 TGY-------LSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 282 ~~~-------~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
... ..........+..+.+++..||..+|.+|+++.++.++
T Consensus 248 ~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~ 295 (301)
T d1lufa_ 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295 (301)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 321 11111222245568899999999999999999988664
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=357.35 Aligned_cols=242 Identities=20% Similarity=0.286 Sum_probs=203.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 151 (334)
++|++.+.||+|+||+||+|.+. +|+.||+|.++..... ...+.+|+.+|++++||||+++++++.+++..|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 68999999999999999999965 6889999999755433 356789999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCC--CceEEeeccccccccCCC
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKE--MKPKISDFGMARIFKGNE 229 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~ 229 (334)
+||+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||++.......
T Consensus 84 ~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999885432 34899999999999999999999998 9999999999999754 589999999998654332
Q ss_pred CccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc---------ccccccch-hcccchh
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY---------LSINGYDQ-TQVASKI 299 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~~-~~~~~~~ 299 (334)
......||+.|+|||...+..++.++||||+||++|+|++|+.||....... ..+..... ..+..+.
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 2334578999999999999999999999999999999999999997654321 11111111 1345678
Q ss_pred hhccccccCCccchhhhhhhhhcc
Q 037681 300 KLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
+++..||..+|.+|+++.++.+.+
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHccCChhHCcCHHHHhcCH
Confidence 999999999999999999887643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=354.08 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=194.3
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEecC
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEYLP 152 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 152 (334)
++|++.+.||+|+||+||+|.+++++.||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 6899999999999999999998888889999996443 33477999999999999999999999985 456899999999
Q ss_pred CCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCcc
Q 037681 153 NKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESKA 232 (334)
Q Consensus 153 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 232 (334)
+|+|..++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....... .
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 999988876543 234899999999999999999999998 99999999999999999999999999986543322 2
Q ss_pred ccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccc--------cccchhcccchhhhccc
Q 037681 233 NTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSI--------NGYDQTQVASKIKLVES 304 (334)
Q Consensus 233 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~i~~ 304 (334)
......||+.|+|||.+.++.++.++||||||+++|||++|..|+.........+ .......+..+.+++..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 249 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHH
Confidence 2333568999999999999999999999999999999999666554332211000 01112245668899999
Q ss_pred cccCCccchhhhhhhhh
Q 037681 305 CLARPFRQYCCILKVRT 321 (334)
Q Consensus 305 ~l~~~~~~~~~~~~~~~ 321 (334)
||..+|++|+++.++..
T Consensus 250 cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 250 CWRKEPEERPTFEYLQA 266 (285)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcccCHhHCcCHHHHHH
Confidence 99999999999998765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=356.76 Aligned_cols=243 Identities=25% Similarity=0.387 Sum_probs=194.3
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGD----EIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
++|++++.||+|+||+||+|.+. +|+ +||+|+++.. .....+.+.+|+.++++++||||++++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 57999999999999999999864 444 5888988643 344567899999999999999999999999864 5678
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
++||+.+++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++++||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 899999999988775543 34899999999999999999999998 9999999999999999999999999998766
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~ 298 (334)
............||+.|+|||.+.++.++.++|||||||++|||+| |++||+....... .-..........+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 5444444445578999999999999999999999999999999998 8899876543311 0001111245568
Q ss_pred hhhccccccCCccchhhhhhhhh
Q 037681 299 IKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.+++..|+..+|.+|+++.++..
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~ 265 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELII 265 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHH
Confidence 88999999999999999988654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=348.94 Aligned_cols=244 Identities=22% Similarity=0.300 Sum_probs=190.7
Q ss_pred hcCCCcCCccccCCcccEEEEEecC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceE
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK----GDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLL 146 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 146 (334)
.++|++.+.||+|+||+||+|++.. +..||||.++.. .....+.+.+|+.++++++||||+++++++. .+..|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3689999999999999999998643 346889988643 4445677899999999999999999999985 567899
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
||||+++|++..++.... ..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999988875433 34899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccch
Q 037681 227 GNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASK 298 (334)
Q Consensus 227 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~ 298 (334)
.... .......||+.|+|||.+.+..++.++|||||||++|||+| |.+||........ .........+..+
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 3322 22334568999999999999999999999999999999998 8999986544311 0011112245678
Q ss_pred hhhccccccCCccchhhhhhhhhc
Q 037681 299 IKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 299 ~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.+++..||..+|.+|+++.++...
T Consensus 239 ~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 899999999999999999887654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=356.41 Aligned_cols=239 Identities=22% Similarity=0.237 Sum_probs=196.2
Q ss_pred cCCCcCC-ccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEe----cCcce
Q 037681 73 NNFSDTN-KLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKV-QHKNLVRLLGCCIE----RDEKL 145 (334)
Q Consensus 73 ~~y~~~~-~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~ 145 (334)
++|.+.. .||+|+||+||+|.+ .+++.||||+++.. ..+.+|+.++.++ +||||++++++|.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 6898875 599999999999996 56899999998632 4567899887655 89999999999876 35689
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEeecccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKISDFGMA 222 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~ 222 (334)
+|||||+||+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 9999999999999986543 235899999999999999999999998 999999999999975 467999999999
Q ss_pred ccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------------cccc
Q 037681 223 RIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL-------------SING 289 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------------~~~~ 289 (334)
+....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||........ .+..
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 87654322 3346799999999999999999999999999999999999999975432210 1111
Q ss_pred cch-hcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 290 YDQ-TQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 290 ~~~-~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
... ..+..+.+++..||..+|.+|+++.++....
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 111 1355688899999999999999999987643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=350.04 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=197.1
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRS--RQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++++.||+|+||+||+|.+ .+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 569999999996432 3346788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
|+.++.+...... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9987655443322 2334899999999999999999999998 9999999999999999999999999998654332
Q ss_pred CccccccccccCCccCccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCCccCC--------------ccccc------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGI-CSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------YLSIN------ 288 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------~~~~~------ 288 (334)
. ......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+.. ...+.
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 2 233457999999999877654 578999999999999999999999643210 00000
Q ss_pred -------cc--------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 -------GY--------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 -------~~--------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+ ....+..+.+++..||..+|.+|+++.++.+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence 00 0012345678999999999999999999887654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=346.71 Aligned_cols=244 Identities=26% Similarity=0.363 Sum_probs=191.1
Q ss_pred cCCCcCCccccCCcccEEEEEec--CCC--EEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcce
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA--KGD--EIAVKRLSVR---SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKL 145 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 145 (334)
++|++.+.||+|+||.||+|++. +++ .||||++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 67999999999999999999853 233 6899988643 34456789999999999999999999999965 5678
Q ss_pred EEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccc
Q 037681 146 LIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIF 225 (334)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 225 (334)
+||||+++|++.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999988775543 34899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCc-cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cc-cccchhcc
Q 037681 226 KGNESK-ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SI-NGYDQTQV 295 (334)
Q Consensus 226 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~-~~~~~~~~ 295 (334)
...... .......|+..|+|||.+.+..++.++||||||+++|||+| |+.||........ .. .......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 544332 22334567889999999999999999999999999999998 8999976533210 00 01111245
Q ss_pred cchhhhccccccCCccchhhhhhhhhc
Q 037681 296 ASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 296 ~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
..+.+++..||..+|++|+++.++.++
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~~ 268 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRDF 268 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 678899999999999999999988654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=349.69 Aligned_cols=240 Identities=21% Similarity=0.279 Sum_probs=192.4
Q ss_pred cCCccccCCcccEEEEEe-cCCCEEEEEEecccChh-----hHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 77 DTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQ-----GLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 77 ~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
.++.||+|+||+||+|.+ .+|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999995 46999999998643221 234688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+.++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 999877666532 334889999999999999999999998 99999999999999999999999999976544322
Q ss_pred ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------cccc-------
Q 037681 231 KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------LSIN------- 288 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~~~~------- 288 (334)
......||+.|+|||++.+ ..++.++||||+||++|||++|++||....... ..+.
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 2234579999999998865 467999999999999999999999996432110 0000
Q ss_pred -------------ccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 289 -------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 289 -------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.........+.+++.+||..+|.+|+++.++.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 000113456788999999999999999999887554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=350.62 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=197.6
Q ss_pred hcCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccCh------hhHHHHHHHHHHHHhcC--CCCcceEeeEEEecC
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSR------QGLQELKNEALVIAKVQ--HKNLVRLLGCCIERD 142 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 142 (334)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999964 689999999864311 12234678999999997 899999999999999
Q ss_pred cceEEEEecCC-CChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-CCceEEeecc
Q 037681 143 EKLLIYEYLPN-KSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-EMKPKISDFG 220 (334)
Q Consensus 143 ~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg 220 (334)
..|+||||+.+ +++..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 56666664433 4899999999999999999999998 999999999999985 4799999999
Q ss_pred ccccccCCCCccccccccccCCccCccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCccCCcccccccchhcccchh
Q 037681 221 MARIFKGNESKANTNRVAGTFGYIPPEYVYQGIC-SIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSINGYDQTQVASKI 299 (334)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 299 (334)
++...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....-...-..+....+..+.
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHH
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHH
Confidence 99764332 2334679999999999987665 677999999999999999999997643210011112223566788
Q ss_pred hhccccccCCccchhhhhhhhhccC
Q 037681 300 KLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 300 ~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
+++..||..+|.+|+++.++.+..+
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHh
Confidence 9999999999999999999988654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=348.25 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=194.7
Q ss_pred HhhcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 70 AATNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 70 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
...++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.+..|...+.++ +|+||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34478999999999999999999853 2457999998643 344456677888888777 689999999998765
Q ss_pred C-cceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCee
Q 037681 142 D-EKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNIL 207 (334)
Q Consensus 142 ~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nil 207 (334)
+ ..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 4 57999999999999999865432 234889999999999999999999998 999999999999
Q ss_pred eCCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCccCCccc
Q 037681 208 LDKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSG-KKNTEFYHTGYLS 286 (334)
Q Consensus 208 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~ 286 (334)
++.++++||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|| .+||........-
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999876554444445556899999999999999999999999999999999986 5577654332110
Q ss_pred --------ccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 287 --------INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 287 --------~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
...........+.+++..||..+|.+|+++.++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 001111245568899999999999999999987654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=342.02 Aligned_cols=238 Identities=27% Similarity=0.382 Sum_probs=191.3
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe-cCcceEEEEec
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIE-RDEKLLIYEYL 151 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 151 (334)
++|++.+.||+|+||.||+|.++ |..||||+++.. ...+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 67888999999999999999985 789999999643 344778999999999999999999999865 45689999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999986543 234899999999999999999999998 999999999999999999999999999764322
Q ss_pred cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc-------cccccchhcccchhhhcc
Q 037681 232 ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-------SINGYDQTQVASKIKLVE 303 (334)
Q Consensus 232 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~i~ 303 (334)
.....+|..|+|||.+.++.++.++||||||+++|||+| |++||........ .-..........+.+++.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 223467899999999999999999999999999999998 7888776533210 000111224567889999
Q ss_pred ccccCCccchhhhhhhhhc
Q 037681 304 SCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 304 ~~l~~~~~~~~~~~~~~~~ 322 (334)
.|+..+|.+|+++.++.+.
T Consensus 235 ~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHH
Confidence 9999999999999887654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=345.47 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=201.6
Q ss_pred hcCCCcCCccccCCcccEEEEEecC--------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEec
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLAK--------GDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIER 141 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 141 (334)
.++|++.+.||+|+||.||+|+... +..||||+++.. .......+.+|...+.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3789999999999999999998532 236999998654 334557788899999888 799999999999999
Q ss_pred CcceEEEEecCCCChhhhhhhccc-------------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATK-------------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999865431 234899999999999999999999998 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcc--
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYL-- 285 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~-- 285 (334)
+.++.+||+|||++................||+.|+|||.+.++.++.++||||||+++|||++ |++||........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999987765554444555678999999999999999999999999999999998 7888876543210
Q ss_pred -----cccccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 286 -----SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 286 -----~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.-.......+..+.+++..|+..+|..|+++.++...
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 290 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0001111245668999999999999999999988764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-49 Score=343.30 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=197.1
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++++.||+|+||+||+|++++|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999989999999999654 233467889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNES 230 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 230 (334)
+.++++..+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9888776665433 34999999999999999999999998 99999999999999999999999999986543322
Q ss_pred ccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------c------ccc-
Q 037681 231 KANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------L------SIN- 288 (334)
Q Consensus 231 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~------~~~- 288 (334)
......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||....... . ...
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2333468999999999875 457899999999999999999999996432110 0 000
Q ss_pred --------------ccchhcccchhhhccccccCCccchhhhhhhhhcc
Q 037681 289 --------------GYDQTQVASKIKLVESCLARPFRQYCCILKVRTFG 323 (334)
Q Consensus 289 --------------~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~ 323 (334)
...........+++..||..+|++|+++.++.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp 282 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 00011234567899999999999999999887654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=346.12 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=205.1
Q ss_pred hcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 143 (334)
.++|++.+.||+|+||.||+|++. ++..||||+++.. .......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 378999999999999999999852 3568999999754 344556788999999999 69999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcc---------------cccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeee
Q 037681 144 KLLIYEYLPNKSLDFFLFDAT---------------KRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILL 208 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill 208 (334)
.++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986543 2235889999999999999999999998 9999999999999
Q ss_pred CCCCceEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCccCCcccc
Q 037681 209 DKEMKPKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILS-GKKNTEFYHTGYLSI 287 (334)
Q Consensus 209 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~ 287 (334)
+.++.+|++|||.++...............||+.|+|||.+.++.++.++||||||+++|||+| |++|+....... .+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 9999999999999987765544444555789999999999999999999999999999999999 566665543321 11
Q ss_pred ccc---------chhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 288 NGY---------DQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 288 ~~~---------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
... .......+.+++..||..+|++|+++.++...
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111 11145678899999999999999999987653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=342.55 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=204.8
Q ss_pred hcCCCcCCccccCCcccEEEEEec------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA------KGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEK 144 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 144 (334)
.++|++.+.||+|+||+||+|.+. ++..||||+++.. .......+.+|+.++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 378999999999999999999853 2578999999643 444456789999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhccc-------ccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEe
Q 037681 145 LLIYEYLPNKSLDFFLFDATK-------RVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKIS 217 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 217 (334)
++||||+++|+|..++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 999999999999998864321 123688899999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCC-CCCCCccCCcc-------cccc
Q 037681 218 DFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK-KNTEFYHTGYL-------SING 289 (334)
Q Consensus 218 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~p~~~~~~~~~-------~~~~ 289 (334)
|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||. +||........ ....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 999998765444444445567899999999999999999999999999999999984 67765433210 0011
Q ss_pred cchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 290 YDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 290 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
........+.+++..|+..+|.+|+++.++...
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111234578999999999999999999887654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=342.21 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=193.5
Q ss_pred hcCCCcCCccccCCcccEEEEEec-C-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhc---CCCCcceEeeEEEe----
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVLA-K-GDEIAVKRLSVR--SRQGLQELKNEALVIAKV---QHKNLVRLLGCCIE---- 140 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---- 140 (334)
.++|++++.||+|+||+||+|.+. + ++.||||+++.. .......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 479999999999999999999963 4 567999998643 222234456777777665 79999999999864
Q ss_pred -cCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeec
Q 037681 141 -RDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDF 219 (334)
Q Consensus 141 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 219 (334)
....+++|||++++++...... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2457899999998877654432 2334889999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc--------------c
Q 037681 220 GMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY--------------L 285 (334)
Q Consensus 220 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------------~ 285 (334)
|++...... .......||+.|+|||++.+..++.++||||+||++|||++|++||....... .
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 998754322 23345679999999999999999999999999999999999999997542110 0
Q ss_pred c-------------------ccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 S-------------------INGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ~-------------------~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
. .............+++.+||..+|.+|+++.++...++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 0 00011112345678999999999999999999887654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=338.09 Aligned_cols=239 Identities=23% Similarity=0.353 Sum_probs=193.4
Q ss_pred CCccccCCcccEEEEEecCC----CEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec-CcceEEEEec
Q 037681 78 TNKLGEGGFGPVYKGVLAKG----DEIAVKRLSV-RSRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-DEKLLIYEYL 151 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~~----~~vaiK~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~ 151 (334)
.+.||+|+||+||+|.+..+ ..||||+++. ......+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999996432 2589999863 4566678899999999999999999999998764 5789999999
Q ss_pred CCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCCCc
Q 037681 152 PNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNESK 231 (334)
Q Consensus 152 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 231 (334)
++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998765433 3678889999999999999999998 999999999999999999999999999876443222
Q ss_pred --cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc---------cchhcccchhh
Q 037681 232 --ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING---------YDQTQVASKIK 300 (334)
Q Consensus 232 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~ 300 (334)
.......||+.|+|||.+.+..++.++||||||+++|||+||..||........ +.. ........+.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-HHHHHHcCCCCCCcccCcHHHHH
Confidence 222335689999999999999999999999999999999998887754332211 111 01113456889
Q ss_pred hccccccCCccchhhhhhhhhc
Q 037681 301 LVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 301 ~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
++..||..+|.+|+++.++.+.
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999887765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=342.79 Aligned_cols=244 Identities=26% Similarity=0.364 Sum_probs=195.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCC--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCcceEeeEEEecCcceEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGD--EIAVKRLSVR-SRQGLQELKNEALVIAKV-QHKNLVRLLGCCIERDEKLLI 147 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 147 (334)
++|++.+.||+|+||+||+|.++ +|. .||||++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 68899999999999999999965 344 4778887533 344556789999999998 799999999999999999999
Q ss_pred EEecCCCChhhhhhhc-------------ccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCce
Q 037681 148 YEYLPNKSLDFFLFDA-------------TKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKP 214 (334)
Q Consensus 148 ~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 214 (334)
|||+++|+|.++++.. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998654 22345899999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCC-CCCCCccCCcc--ccc---
Q 037681 215 KISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGK-KNTEFYHTGYL--SIN--- 288 (334)
Q Consensus 215 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~p~~~~~~~~~--~~~--- 288 (334)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|. +||........ .+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 999999997543221 223456899999999999999999999999999999999975 56765432211 000
Q ss_pred --ccchhcccchhhhccccccCCccchhhhhhhhhc
Q 037681 289 --GYDQTQVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 289 --~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.........+.+++..||..+|++|+++.++.+.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0111245678899999999999999999887643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=336.35 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=186.6
Q ss_pred cCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC----cceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD----EKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 148 (334)
++|.+.+.||+|+||.||+|++ +|+.||||+++..... ......|+..+.+++||||+++++++.+.+ ..|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4677788999999999999986 4889999998644322 122334555556789999999999998765 468999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc-----CCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH-----SRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
||+++|+|.++++.. .+++..++.++.|++.||+|||+. ...+|+||||||+|||++.++.+||+|||++.
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999653 388999999999999999999974 12349999999999999999999999999998
Q ss_pred cccCCCCc--cccccccccCCccCccccccCC------CCcchhhHhHHHHHHHHHhCCCCCCCccCCcccccc------
Q 037681 224 IFKGNESK--ANTNRVAGTFGYIPPEYVYQGI------CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSING------ 289 (334)
Q Consensus 224 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~------ 289 (334)
........ .......||+.|+|||++.+.. ++.++|||||||++|||+||..|+............
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76543322 2234567999999999987543 567899999999999999999887532221111000
Q ss_pred --------------------cchh--cccchhhhccccccCCccchhhhhhhhhc
Q 037681 290 --------------------YDQT--QVASKIKLVESCLARPFRQYCCILKVRTF 322 (334)
Q Consensus 290 --------------------~~~~--~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 322 (334)
.... ....+.+++..||..+|.+|+++.++.+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0000 11237789999999999999999887654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=338.29 Aligned_cols=245 Identities=21% Similarity=0.278 Sum_probs=194.2
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC----cceE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR-SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD----EKLL 146 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~l 146 (334)
++|++++.||+|+||+||+|.+ .+|+.||||++... .....+.+.+|+.+|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 5799999999999999999995 57999999999643 3445667889999999999999999999987654 2355
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeecccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFK 226 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 226 (334)
+++++.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 88 l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 66677899999988543 3899999999999999999999998 9999999999999999999999999997654
Q ss_pred CCCC-ccccccccccCCccCccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCccCC---------------------
Q 037681 227 GNES-KANTNRVAGTFGYIPPEYVY-QGICSIKSDVFSFGMLLLEILSGKKNTEFYHTG--------------------- 283 (334)
Q Consensus 227 ~~~~-~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------------- 283 (334)
.... ........||+.|+|||++. +..++.++||||+||++|+|++|+.||......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3322 22234467999999999985 456789999999999999999999999653210
Q ss_pred ----------------cccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 ----------------YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 ----------------~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..++.......+..+.+++..||..+|..|+++.++....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 00000001112345778999999999999999999887543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=337.46 Aligned_cols=239 Identities=22% Similarity=0.316 Sum_probs=189.9
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------c
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------E 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 143 (334)
++|++++.||+|+||+||+|.+. +|+.||||+++.. .....+.+.+|+.+|++++||||++++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 68999999999999999999964 6999999999643 4445677899999999999999999999998765 4
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||+ +.+|..+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 98 ~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 69999999 5566665532 23899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------------------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTG------------------- 283 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------------------- 283 (334)
..... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|++||......
T Consensus 170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 65432 234578999999999876 45789999999999999999999999754211
Q ss_pred ------------------cccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 ------------------YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 ------------------~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+............+++..||..+|.+|+++.++.+.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 00001111112445678999999999999999999887554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=337.41 Aligned_cols=241 Identities=24% Similarity=0.321 Sum_probs=190.9
Q ss_pred CCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecC------cceE
Q 037681 74 NFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVRLLGCCIERD------EKLL 146 (334)
Q Consensus 74 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~l 146 (334)
+|+.++.||+|+||+||+|++. +|+.||||++...... ..+|+.++++++||||++++++|.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999965 6999999999654322 247999999999999999999986432 3689
Q ss_pred EEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeeccccccc
Q 037681 147 IYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARIF 225 (334)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~ 225 (334)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765554433344456899999999999999999999998 99999999999999775 8999999999876
Q ss_pred cCCCCccccccccccCCccCcccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------------------
Q 037681 226 KGNESKANTNRVAGTFGYIPPEYVYQ-GICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------------- 285 (334)
Q Consensus 226 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------------- 285 (334)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|++||........
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 43322 233578999999998765 5789999999999999999999999965431100
Q ss_pred -------ccc--------c-cchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 -------SIN--------G-YDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 -------~~~--------~-~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+. . ..........+++..||..+|.+|+++.++....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 000 0 00112445778999999999999999999876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=331.95 Aligned_cols=246 Identities=21% Similarity=0.361 Sum_probs=194.2
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEe--------c
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIE--------R 141 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~ 141 (334)
++|++++.||+|+||+||+|++ .+|+.||||++... .......+.+|+.++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 7999999999999999999996 47999999998533 33455778899999999999999999999865 3
Q ss_pred CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccc
Q 037681 142 DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGM 221 (334)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 221 (334)
+..|+||||+.++++...... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 457899999998877655433 234888999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCC--ccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-------------
Q 037681 222 ARIFKGNES--KANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL------------- 285 (334)
Q Consensus 222 ~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------------- 285 (334)
+........ ........||+.|+|||++.+. .++.++||||+||++|||++|+.||........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 976553322 1222335699999999998755 689999999999999999999999974321100
Q ss_pred ----ccccc------c---------------hhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ----SINGY------D---------------QTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ----~~~~~------~---------------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..... . ........+++..||..+|++|+++.++...++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 00000 0 001334567899999999999999999988876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=323.86 Aligned_cols=244 Identities=21% Similarity=0.291 Sum_probs=199.2
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEecCcceEEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIERDEKLLIYE 149 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 149 (334)
++|++++.||+|+||+||+|++ .+|+.||||+++.. .......+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999996 46889999998643 33456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccccccCCC
Q 037681 150 YLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMARIFKGNE 229 (334)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 229 (334)
++.++++..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998887765433 3789999999999999999999998 9999999999999999999999999998764332
Q ss_pred CccccccccccCCccCccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCCccCCcc-----------------------
Q 037681 230 SKANTNRVAGTFGYIPPEYVYQGI-CSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL----------------------- 285 (334)
Q Consensus 230 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------------------- 285 (334)
. ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||........
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2 222345788899999887654 68999999999999999999999743221100
Q ss_pred -------------cccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 -------------SINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 -------------~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
..............+++..||..+|.+|+++.++.+.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 000000112345678999999999999999999887653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=332.45 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=198.1
Q ss_pred cCCCcCCccccCCcccEEEEEec----CCCEEEEEEeccc----ChhhHHHHHHHHHHHHhcCC-CCcceEeeEEEecCc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA----KGDEIAVKRLSVR----SRQGLQELKNEALVIAKVQH-KNLVRLLGCCIERDE 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 143 (334)
++|++++.||+|+||+||+|... +|+.||||.++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 68999999999999999999842 4789999998632 22345667899999999976 899999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.+++|||+.+|+|..++..... +++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999998865443 678889999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccCccccccC--CCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--c--------cc
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQG--ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--G--------YD 291 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--~--------~~ 291 (334)
.+..... .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||........... . ..
T Consensus 178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256 (322)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence 6543322 223346799999999998754 468899999999999999999999976543311100 0 11
Q ss_pred hhcccchhhhccccccCCccchhh-----hhhhhhccC
Q 037681 292 QTQVASKIKLVESCLARPFRQYCC-----ILKVRTFGF 324 (334)
Q Consensus 292 ~~~~~~~~~~i~~~l~~~~~~~~~-----~~~~~~~~~ 324 (334)
...+..+.+++..||..+|.+|.+ +.++.+.++
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 124556889999999999999985 456655433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-45 Score=325.67 Aligned_cols=237 Identities=19% Similarity=0.320 Sum_probs=192.8
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEec--CcceEEE
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIER--DEKLLIY 148 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~ 148 (334)
++|++++.||+|+||+||+|++ .+|+.||||+++... .+.+.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999996 468999999986543 357889999999995 99999999999854 4589999
Q ss_pred EecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCC-ceEEeeccccccccC
Q 037681 149 EYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEM-KPKISDFGMARIFKG 227 (334)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 227 (334)
||+++++|..+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999976541 3889999999999999999999999 99999999999998655 699999999986543
Q ss_pred CCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCCcc---------------------
Q 037681 228 NESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYL--------------------- 285 (334)
Q Consensus 228 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------------------- 285 (334)
... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||........
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 322 3345789999999998765 579999999999999999999999865432100
Q ss_pred ------ccc------------cc-----chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 286 ------SIN------------GY-----DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 286 ------~~~------------~~-----~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
.+. .. ....+....+++.+||..+|.+|+++.++.+..+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000 00 0012344678999999999999999999887554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.6e-46 Score=321.87 Aligned_cols=241 Identities=17% Similarity=0.212 Sum_probs=193.5
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCC-CCcceEeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH-KNLVRLLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.+.| +|++.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 68999999999999999999965 688999998854322 2456788999999975 8999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC-----CCceEEeeccccccc
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK-----EMKPKISDFGMARIF 225 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~ 225 (334)
+ +++|..++.... ..++...+..++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+++..
T Consensus 83 ~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 8 678888775433 24889999999999999999999998 999999999999964 578999999999876
Q ss_pred cCCCCc-----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccc--ccc---------
Q 037681 226 KGNESK-----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLS--ING--------- 289 (334)
Q Consensus 226 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~--------- 289 (334)
...... .......||+.|+|||++.+..++.++||||||+++|||+||+.||......... +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 533221 1233467999999999999999999999999999999999999999765443111 000
Q ss_pred ---cchhcccchhhhccccccCCccchhhhhhhhh
Q 037681 290 ---YDQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 290 ---~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
.....+..+.+++..|+..+|.+|++...+..
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00112345788889999999999986555433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-46 Score=324.41 Aligned_cols=241 Identities=22% Similarity=0.292 Sum_probs=187.1
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcce-EeeEEEecCcceEEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNLVR-LLGCCIERDEKLLIYEY 150 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~ 150 (334)
++|++.+.||+|+||+||+|.+ .+|+.||||.+..... ...+..|+++++.++|++++. +.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999996 4688999998865432 245788999999998776554 55556777788999999
Q ss_pred cCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCC---CCceEEeeccccccccC
Q 037681 151 LPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDK---EMKPKISDFGMARIFKG 227 (334)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~ 227 (334)
+++ ++...+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+++.+..
T Consensus 85 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 955 5555443322 34899999999999999999999998 999999999999853 45799999999987654
Q ss_pred CCCc-----cccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCccccc--cc----------
Q 037681 228 NESK-----ANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGYLSIN--GY---------- 290 (334)
Q Consensus 228 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--~~---------- 290 (334)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3221 223446799999999999999999999999999999999999999976544321111 00
Q ss_pred --chhcccchhhhccccccCCccchhhhhhhhh
Q 037681 291 --DQTQVASKIKLVESCLARPFRQYCCILKVRT 321 (334)
Q Consensus 291 --~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~ 321 (334)
....+..+.+++..|+..+|.+|+++.++.+
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~ 271 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 0112355788999999999999988766543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=327.34 Aligned_cols=241 Identities=22% Similarity=0.290 Sum_probs=192.6
Q ss_pred hcCCCcCCccccCCcccEEEEEe-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec-----Cc
Q 037681 72 TNNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER-----DE 143 (334)
Q Consensus 72 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 143 (334)
.++|++++.||+|+||+||+|++ .+|+.||||++... +....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 36899999999999999999995 46999999999643 344556788999999999999999999998643 34
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.+++++|+.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||.+.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 46778888999999988542 3899999999999999999999998 9999999999999999999999999986
Q ss_pred cccCCCCccccccccccCCccCccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCccCC-------------------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQG-ICSIKSDVFSFGMLLLEILSGKKNTEFYHTG------------------- 283 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~------------------- 283 (334)
.... ......|++.|+|||...+. .++.++||||+||++|+|++|++||......
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 5322 23345789999999987665 5688999999999999999999999643211
Q ss_pred ------------------cccccccchhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 284 ------------------YLSINGYDQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 284 ------------------~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...+............+++.+||..+|.+|+++.++.+..+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 00000001113455778999999999999999999887554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=326.31 Aligned_cols=240 Identities=21% Similarity=0.252 Sum_probs=187.0
Q ss_pred cCCCcCCccccCCcccEEEEEec-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCcceEeeEEEec------Cc
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVLA-KGDEIAVKRLSVR--SRQGLQELKNEALVIAKVQHKNLVRLLGCCIER------DE 143 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 143 (334)
++|++++.||+|+||+||+|.+. +|+.||||++... +......+.+|+.++++++||||++++++|... +.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999965 6999999999643 345566789999999999999999999999643 56
Q ss_pred ceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 144 KLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
.|+||||+.++++..+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 79999999877665432 13789999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-------------------
Q 037681 224 IFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY------------------- 284 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------------------- 284 (334)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+...
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 644322 2334578999999999999999999999999999999999999996432100
Q ss_pred ------------cccccc-----------------chhcccchhhhccccccCCccchhhhhhhhhccC
Q 037681 285 ------------LSINGY-----------------DQTQVASKIKLVESCLARPFRQYCCILKVRTFGF 324 (334)
Q Consensus 285 ------------~~~~~~-----------------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~~ 324 (334)
...... ....+....+++..||..+|.+|+++.++.+.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 000000 0002345678999999999999999999987765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.1e-40 Score=292.27 Aligned_cols=243 Identities=19% Similarity=0.217 Sum_probs=187.2
Q ss_pred cCCCcCCccccCCcccEEEEEe-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCCcceEeeEEEe
Q 037681 73 NNFSDTNKLGEGGFGPVYKGVL-AKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-----------HKNLVRLLGCCIE 140 (334)
Q Consensus 73 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~ 140 (334)
++|++++.||+|+||+||+|++ .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999996 469999999997442 33466788998888875 5789999998865
Q ss_pred c--CcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCc----
Q 037681 141 R--DEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMK---- 213 (334)
Q Consensus 141 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~---- 213 (334)
. ...+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 4566777777666554444344444568889999999999999999997 76 999999999999976653
Q ss_pred --eEEeeccccccccCCCCccccccccccCCccCccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCccCCc-c-----
Q 037681 214 --PKISDFGMARIFKGNESKANTNRVAGTFGYIPPEYVYQGICSIKSDVFSFGMLLLEILSGKKNTEFYHTGY-L----- 285 (334)
Q Consensus 214 --~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~----- 285 (334)
++++|||.+...... .....||+.|+|||++.+..++.++|+||+||++++|++|+.||....... .
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 999999998754322 234579999999999999999999999999999999999999986432110 0
Q ss_pred ---------------------------------cccc---------------cchhcccchhhhccccccCCccchhhhh
Q 037681 286 ---------------------------------SING---------------YDQTQVASKIKLVESCLARPFRQYCCIL 317 (334)
Q Consensus 286 ---------------------------------~~~~---------------~~~~~~~~~~~~i~~~l~~~~~~~~~~~ 317 (334)
.... ..........+++.+||..+|.+|+++.
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0000 0011234578899999999999999999
Q ss_pred hhhhccC
Q 037681 318 KVRTFGF 324 (334)
Q Consensus 318 ~~~~~~~ 324 (334)
++....+
T Consensus 324 e~L~Hp~ 330 (362)
T d1q8ya_ 324 GLVNHPW 330 (362)
T ss_dssp HHHTCGG
T ss_pred HHhcCcc
Confidence 9887654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5.9e-27 Score=189.34 Aligned_cols=165 Identities=18% Similarity=0.178 Sum_probs=121.1
Q ss_pred CCcCCccccCCcccEEEEEecCCCEEEEEEecccCh------------------hhHHHHHHHHHHHHhcCCCCcceEee
Q 037681 75 FSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSR------------------QGLQELKNEALVIAKVQHKNLVRLLG 136 (334)
Q Consensus 75 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 136 (334)
+.+.+.||+|+||+||+|.+.+|+.||||+++.... ........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999988899999998753210 11233456888999999999998876
Q ss_pred EEEecCcceEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcCCCCeEeccCCCCCeeeCCCCceEE
Q 037681 137 CCIERDEKLLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHSRVRIIHRDLKASNILLDKEMKPKI 216 (334)
Q Consensus 137 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 216 (334)
+. ..+++|||+++..+.. ++......++.|++.++.|||+++ |+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 53 3479999998865432 344556689999999999999998 9999999999999865 5999
Q ss_pred eeccccccccCCCCccccccccccCCccCcc-----ccccCCCCcchhhHhHHHHH
Q 037681 217 SDFGMARIFKGNESKANTNRVAGTFGYIPPE-----YVYQGICSIKSDVFSFGMLL 267 (334)
Q Consensus 217 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~~DiwslG~il 267 (334)
+|||.|......... .|.... .+..+.++.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999998754322110 111110 01246678889999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.94 E-value=3.5e-09 Score=87.91 Aligned_cols=149 Identities=15% Similarity=0.094 Sum_probs=101.7
Q ss_pred hHHHHhhcCCCcCCccccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCcceEeeEEEecCcc
Q 037681 66 SSVAAATNNFSDTNKLGEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQ-HKNLVRLLGCCIERDEK 144 (334)
Q Consensus 66 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 144 (334)
+++......|+.++..+.++.+.||+... +++.+++|............+.+|...+..+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 44555556777666655455578998753 46778888876554444556778888887774 33367788888888889
Q ss_pred eEEEEecCCCChhhhhhhcccccccchHHHHHHHHHHHHHHHHhhhcC--------------------------------
Q 037681 145 LLIYEYLPNKSLDFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLHS-------------------------------- 192 (334)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------------- 192 (334)
++||++++|.++..... +......++.+++..+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999988754331 11122234555666666666321
Q ss_pred ------------------------CCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 193 ------------------------RVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 193 ------------------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127999999999999987666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.49 E-value=3.7e-07 Score=74.93 Aligned_cols=130 Identities=17% Similarity=0.148 Sum_probs=84.5
Q ss_pred ccccCCc-ccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC--CCcceEeeEEEecCcceEEEEecCCCCh
Q 037681 80 KLGEGGF-GPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQH--KNLVRLLGCCIERDEKLLIYEYLPNKSL 156 (334)
Q Consensus 80 ~lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L 156 (334)
.+..|.. +.||+....++..+++|....... ..+..|...++.+.. --+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 678998877787888887654432 346677777777643 3356778888888889999999998766
Q ss_pred hhhhhhcccccccchHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 037681 157 DFFLFDATKRVLLELGTRLQIIEGIVEGLLYLHLH--------------------------------------------- 191 (334)
Q Consensus 157 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------------------------------------------- 191 (334)
.... ... ...+.++...+.-||+.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4311 010 11122333333333321
Q ss_pred ----------CCCCeEeccCCCCCeeeCCCCceEEeeccccc
Q 037681 192 ----------SRVRIIHRDLKASNILLDKEMKPKISDFGMAR 223 (334)
Q Consensus 192 ----------~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 223 (334)
....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11238999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.16 E-value=9.1e-06 Score=70.92 Aligned_cols=77 Identities=12% Similarity=0.198 Sum_probs=49.7
Q ss_pred CCccccCCcccEEEEEecC-CCEEEEEEeccc-------ChhhHHHHHHHHHHHHhcC-C-C-CcceEeeEEEecCcceE
Q 037681 78 TNKLGEGGFGPVYKGVLAK-GDEIAVKRLSVR-------SRQGLQELKNEALVIAKVQ-H-K-NLVRLLGCCIERDEKLL 146 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~-------~~~~~~~~~~e~~~l~~l~-h-~-~iv~~~~~~~~~~~~~l 146 (334)
.+.||.|....||++...+ ++.+++|.-... -.....+...|.+.|+.+. + | .+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998654 678999975421 1112345567888887663 2 3 35555543 5567789
Q ss_pred EEEecCCCCh
Q 037681 147 IYEYLPNKSL 156 (334)
Q Consensus 147 v~e~~~~~~L 156 (334)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.56 E-value=0.00019 Score=60.63 Aligned_cols=136 Identities=15% Similarity=0.130 Sum_probs=77.5
Q ss_pred cccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc--ceEe-----eEEEecCcceEEEEecCCCChhh
Q 037681 86 FGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL--VRLL-----GCCIERDEKLLIYEYLPNKSLDF 158 (334)
Q Consensus 86 ~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~~L~~ 158 (334)
--.||++...+|+.+++|+.+.. ....+.+..|...+..|...++ +..+ ..+...+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 36899999888999999987643 2334667788888877742222 1111 12344566788999998755421
Q ss_pred h----h----------hh----c--ccccc-------------------cchHHHHHHHHHHHHHHHHhh----hcCCCC
Q 037681 159 F----L----------FD----A--TKRVL-------------------LELGTRLQIIEGIVEGLLYLH----LHSRVR 195 (334)
Q Consensus 159 ~----l----------~~----~--~~~~~-------------------l~~~~~~~i~~qi~~~l~~LH----~~~~~~ 195 (334)
. . +. . ..... ++......+...+...++.+. +..+.+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 0 00 0 00001 111111112222222233332 222445
Q ss_pred eEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 196 IIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 196 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
++|+|+.|.|||++++ ..++||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.50 E-value=0.00017 Score=62.68 Aligned_cols=73 Identities=14% Similarity=0.246 Sum_probs=48.7
Q ss_pred CCccccCCcccEEEEEecC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-cceEeeEEEecCcceEEE
Q 037681 78 TNKLGEGGFGPVYKGVLAK--------GDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKN-LVRLLGCCIERDEKLLIY 148 (334)
Q Consensus 78 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 148 (334)
++.|+.|-.-.+|++...+ .+.|++++.. ... ......+|..+++.+.-.+ ..++++++. -.+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence 3578878888999988643 3456666654 222 2344567888888885334 456777764 26899
Q ss_pred EecCCCCh
Q 037681 149 EYLPNKSL 156 (334)
Q Consensus 149 e~~~~~~L 156 (334)
||++|..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.10 E-value=0.0023 Score=53.31 Aligned_cols=158 Identities=14% Similarity=-0.001 Sum_probs=79.1
Q ss_pred ChhHHHHhhcCCCcCCcc-----ccCCcccEEEEEecCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc--ceEee
Q 037681 64 SFSSVAAATNNFSDTNKL-----GEGGFGPVYKGVLAKGDEIAVKRLSVRSRQGLQELKNEALVIAKVQHKNL--VRLLG 136 (334)
Q Consensus 64 ~~~~~~~~~~~y~~~~~l-----g~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~ 136 (334)
+..++.....+|.+.+.. ..|---+.|+....+|+ +++|+..... ..+.+..|.+++..|...++ ...+-
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 345555556677765433 34555778998866554 8888875331 22445566667766643221 11111
Q ss_pred ------EEEecCcceEEEEecCCCChhhhh--------------hhc----c--------------------cccccchH
Q 037681 137 ------CCIERDEKLLIYEYLPNKSLDFFL--------------FDA----T--------------------KRVLLELG 172 (334)
Q Consensus 137 ------~~~~~~~~~lv~e~~~~~~L~~~l--------------~~~----~--------------------~~~~l~~~ 172 (334)
+....+....++.+..+....... +.. . ........
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 112234455666666654432100 000 0 00000011
Q ss_pred HHHHHHHHHHHHHHHhhh-cCCCCeEeccCCCCCeeeCCCCceEEeecccccc
Q 037681 173 TRLQIIEGIVEGLLYLHL-HSRVRIIHRDLKASNILLDKEMKPKISDFGMARI 224 (334)
Q Consensus 173 ~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 224 (334)
.....+..+...+.-.+. .-+.+++|+|+.++||+++.+...-++||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111222222222222221 1133599999999999999887778999998753
|